29356888;Adult;Aged;Aged, 80 and over;Complementary Therapies/statistics & numerical data*;Female;Germany/epidemiology;Herb-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/epidemiology*;Neoplasms/therapy*;Physician-Patient Relations;Prevalence;Primary Health Care/statistics & numerical data*;Risk Assessment;Surveys and Questionnaires;Young Adult
29329092;Animals;Aspirin/pharmacokinetics*;Aspirin/pharmacology;Cell Membrane/drug effects;Dogs;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions;Limit of Detection;Linear Models;Madin Darby Canine Kidney Cells;Panax notoginseng/chemistry*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Saponins/blood*;Saponins/chemistry;Saponins/pharmacokinetics*;Saponins/pharmacology
29268027;Animals;Biological Availability;Herb-Drug Interactions*;Humans;Medicine, African Traditional/methods;Pharmaceutical Preparations/metabolism;Plant Preparations/administration & dosage*;Plant Preparations/pharmacology;Plants, Medicinal/chemistry*
29258478;Adolescent;Adult;Cross-Sectional Studies;Female;Herb-Drug Interactions*;Humans;Nonprescription Drugs*/adverse effects;Nonprescription Drugs*/therapeutic use;Phytotherapy/statistics & numerical data;Plant Extracts*/adverse effects;Plant Extracts*/therapeutic use;Pregnancy;Prescription Drugs*/adverse effects;Prescription Drugs*/therapeutic use;Surveys and Questionnaires;Young Adult
29237435;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use*;Female;Herb-Drug Interactions/immunology;Humans;Kaplan-Meier Estimate;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/epidemiology;Pilot Projects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Programmed Cell Death 1 Receptor/antagonists & inhibitors*;Programmed Cell Death 1 Receptor/immunology;Viscum album*
29196903;Age Factors;Aged;Aged, 80 and over;Female;Herb-Drug Interactions;Humans;Male;Phytotherapy;Plant Preparations/administration & dosage*;Prescription Drugs/administration & dosage*
29174652;Anti-Bacterial Agents/pharmacology*;Antioxidants/pharmacology;Antioxidants/therapeutic use;Biological Products/therapeutic use;Drug Therapy, Combination/methods*;Herb-Drug Interactions;Humans;Phenols/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology;Plants, Medicinal/chemistry*;Terpenes/pharmacology*
29154055;Age Factors;Aged;Aged, 80 and over;Chronic Disease/therapy*;Complementary Therapies/statistics & numerical data;Complementary Therapies/utilization*;Cross-Sectional Studies;Ethiopia;Female;Herb-Drug Interactions;Hospitals, Teaching;Humans;Male;Motivation;Patient Acceptance of Health Care*;Patient Satisfaction;Phytotherapy;Socioeconomic Factors;Spiritual Therapies
29145840;Animals;Dopamine/metabolism;Glycyrrhiza*;Herb-Drug Interactions;Locomotion/drug effects;Male;Methanol;Nicotine/pharmacology*;Nucleus Accumbens/chemistry;Nucleus Accumbens/drug effects*;Nucleus Accumbens/metabolism;Oxidative Stress/drug effects*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley
29073478;Animals;Chromatography, High Pressure Liquid/methods*;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics;Flavonoids/blood*;Flavonoids/chemistry;Flavonoids/pharmacokinetics;Ginsenosides/blood*;Ginsenosides/chemistry;Ginsenosides/pharmacokinetics;Herb-Drug Interactions;Injections, Intravenous;Linear Models;Rats;Reproducibility of Results;Sensitivity and Specificity;Spectrometry, Mass, Electrospray Ionization/methods;Tandem Mass Spectrometry/methods*
29027684;Chromatography, Liquid/methods*;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/metabolism;Herb-Drug Interactions;Liliaceae/chemistry*;Limit of Detection;Linear Models;Reproducibility of Results;Tandem Mass Spectrometry/methods*
28905437;Adult;Asian Continental Ancestry Group*;Diabetes Mellitus/drug therapy;Female;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Herbal Medicine*;Humans;Male;Medicine, Ayurvedic*;Middle Aged;Phytotherapy*;Plants, Medicinal;Skin Diseases/drug therapy;Surveys and Questionnaires;United Kingdom;Young Adult
28885074;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme System/drug effects;Depression/drug therapy;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Pharmacokinetics;Phloroglucinol/analogs & derivatives;Phloroglucinol/isolation & purification;Phloroglucinol/pharmacology;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/pharmacology;Terpenes/isolation & purification;Terpenes/pharmacology
28846866;Animals;Behavior, Animal/drug effects;Benzofurans/blood*;Benzofurans/chemistry;Benzofurans/pharmacokinetics*;Choline/chemistry;Choline/pharmacokinetics;Choline/toxicity;Chromatography, High Pressure Liquid/methods;Female;Glycerol/chemistry;Glycerol/pharmacokinetics;Glycerol/toxicity;Herb-Drug Interactions*;Limit of Detection;Linear Models;Male;Mass Spectrometry/methods;Mice;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Solvents/chemistry;Solvents/pharmacokinetics*;Solvents/toxicity;Water
28833680;11-beta-Hydroxysteroid Dehydrogenases/metabolism;Animals;Cell Line, Tumor;Enzyme Inhibitors;Glycyrrhiza/toxicity*;Glycyrrhizic Acid/toxicity*;Herb-Drug Interactions;Humans;Hypertension;Mutagenicity Tests;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/toxicity;Plants, Medicinal/toxicity*;Toxicity Tests
28807159;Animals;Databases, Bibliographic/statistics & numerical data;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional*
28797065;Anticoagulants/pharmacokinetics*;Anticoagulants/therapeutic use;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Randomized Controlled Trials as Topic;Thromboembolism/prevention & control;Treatment Outcome;Warfarin/pharmacokinetics*;Warfarin/therapeutic use
28784133;Animals;Antipsychotic Agents/pharmacology;Antipsychotic Agents/therapeutic use*;Apomorphine;Asteraceae*;Behavior, Animal/drug effects;Catalepsy;Chlorpromazine/pharmacology;Chlorpromazine/therapeutic use;Disease Models, Animal;Haloperidol/pharmacology;Haloperidol/therapeutic use;Herb-Drug Interactions;Hypnotics and Sedatives/pharmacology;Hypnotics and Sedatives/therapeutic use;Mice, Inbred BALB C;Mice, Inbred ICR;Motor Activity/drug effects*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Psychotic Disorders/drug therapy*
28762712;Dietary Supplements/adverse effects;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Risk Factors
28755953;Dietary Supplements/standards;Dietary Supplements/toxicity*;Herb-Drug Interactions;Humans;Kidney/drug effects;Kidney Diseases/epidemiology;Kidney Diseases/etiology*;Plant Extracts/analysis;Plant Extracts/toxicity*;United States/epidemiology
28698304;Cells, Cultured;Hepatocytes/cytology;Hepatocytes/metabolism*;Herb-Drug Interactions*;Humans;Lignans/pharmacokinetics;Lignans/pharmacology;Midazolam/pharmacokinetics*;Midazolam/pharmacology;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Schisandra/chemistry*
28640225;Animals;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Liver/drug effects*;Liver/pathology;Male;Medicine, Chinese Traditional/methods*;Niacinamide/analogs & derivatives*;Niacinamide/blood;Niacinamide/pharmacokinetics;Niacinamide/pharmacology;Niacinamide/toxicity;Phenylurea Compounds/blood;Phenylurea Compounds/pharmacokinetics;Phenylurea Compounds/pharmacology*;Phenylurea Compounds/toxicity;Rats;Rats, Sprague-Dawley
28621744;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions;Isoenzymes/antagonists & inhibitors;Isoenzymes/metabolism*;Xanthenes/chemistry;Xanthones/chemistry*
28603119;Administration, Oral;Animals;Area Under Curve;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacokinetics*;Half-Life;Herb-Drug Interactions*;Indans/administration & dosage;Indans/blood;Indans/pharmacokinetics*;Male;Medicine, Korean Traditional*;Metabolic Clearance Rate;Phytotherapy;Piperidines/administration & dosage;Piperidines/blood;Piperidines/pharmacokinetics*;Plant Extracts/administration & dosage*;Plants, Medicinal;Rats, Sprague-Dawley
28585285;Anti-Infective Agents;Antineoplastic Agents, Phytogenic;Antioxidants/analysis;Beverages;Biflavonoids/analysis;Camellia sinensis/chemistry;Catechin/analysis;Drug Synergism;Flavonoids/analysis;Flavonols/analysis;Glutamates/analysis;Health Promotion*;Herb-Drug Interactions;Humans;Hypoglycemic Agents;Phytochemicals/analysis;Plant Extracts/chemistry;Plants, Medicinal*/adverse effects;Plants, Medicinal*/chemistry;Polyphenols/analysis;Proanthocyanidins/analysis;Sensation;Tea*/chemistry;gamma-Aminobutyric Acid/analysis
28573249;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Female;Garlic;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/surgery;Nurses;Physicians;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts*/adverse effects;Plant Extracts*/therapeutic use;Plants, Medicinal;Professional-Patient Relations;Urtica dioica;Young Adult
28570472;Anticoagulants/adverse effects;Anticoagulants/therapeutic use;Cosmetic Techniques/adverse effects;Cosmetic Techniques/nursing;Herb-Drug Interactions*;Herbal Medicine/trends*;Humans;Nursing Assessment/methods*;Nursing Assessment/standards;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use
28533679;Adult;Area Under Curve;Catechin/analogs & derivatives*;Catechin/isolation & purification;Catechin/pharmacology;Female;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Rosuvastatin Calcium/administration & dosage;Rosuvastatin Calcium/pharmacokinetics*;Tea/chemistry*;Young Adult
28526079;Adult;Aged;Aged, 80 and over;Communication;Complementary Therapies/psychology;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Patients/psychology*;Physicians/psychology;Surveys and Questionnaires;Young Adult
28473993;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Carboxylesterase/genetics;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/pathology;Catechol O-Methyltransferase/genetics;Cytochrome P-450 Enzyme System/genetics;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/therapeutic use*;Gene Expression Regulation/drug effects;Herb-Drug Interactions*;Humans;Organic Anion Transport Protein 1/genetics;Organic Anion Transporters, Sodium-Independent/genetics;Salvia miltiorrhiza/chemistry*
28466663;Animals;Area Under Curve;Chromatography, High Pressure Liquid;Diterpenes, Abietane/administration & dosage;Diterpenes, Abietane/pharmacokinetics;Diterpenes, Abietane/pharmacology*;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Inhibitory Concentration 50;Isoenzymes;Phenanthrenes/administration & dosage;Phenanthrenes/pharmacokinetics;Phenanthrenes/pharmacology*;Rats;Salvia miltiorrhiza/chemistry*
28419964;Animals;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Carbamazepine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P450 Family 2/metabolism*;Drugs, Chinese Herbal/pharmacology*;Half-Life;Herb-Drug Interactions/physiology;Liver/metabolism*;Male;Paeonia/chemistry*;Rats;Rats, Wistar;Steroid 16-alpha-Hydroxylase/metabolism*
28344076;Cyclooctanes/pharmacology*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dioxoles/pharmacology*;Herb-Drug Interactions;Humans;Hydroxylation;Lignans/pharmacology*;Midazolam/pharmacology;Molecular Structure;Nifedipine/pharmacology;Oxidation-Reduction;Schisandra/chemistry*;Testosterone/pharmacology
28342858;Animals;Artocarpus/chemistry*;Cardiotonic Agents/administration & dosage;Cardiotonic Agents/isolation & purification;Cardiotonic Agents/pharmacology*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Isoproterenol/toxicity;Male;Myocardial Contraction/drug effects;Myocardial Infarction/prevention & control*;Myocardium/pathology;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Leaves;Rats;Rats, Sprague-Dawley
28299812;Animals;Chromatography, Liquid;Glucosides/chemistry;Glucosides/pharmacokinetics*;Herb-Drug Interactions*;Losartan/blood;Losartan/chemistry;Losartan/pharmacokinetics*;Male;Mass Spectrometry;Microsomes, Liver/metabolism;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tablets;Tripterygium/chemistry*
28288489;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism*;Flavonoids/pharmacology*;Herb-Drug Interactions/physiology;Liver/metabolism;Plants, Medicinal;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Simvastatin/pharmacokinetics
28282295;Acute Disease;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Chronic Pain/drug therapy*;Disease Models, Animal;Drug Therapy, Combination;Formaldehyde;Herb-Drug Interactions;Hot Temperature;Luteolin/pharmacology;Luteolin/therapeutic use*;Mice;Morphine/pharmacology;Morphine/therapeutic use*;Nociceptive Pain/drug therapy*;Pain/drug therapy;Pain Management;Peripheral Nerve Injuries/complications;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Sciatic Nerve;Sciatic Neuropathy/drug therapy*;Sciatica/drug therapy
28260629;Administration, Oral;Animals;Biological Availability;Chromatography, High Pressure Liquid/methods*;Erlotinib Hydrochloride/blood;Erlotinib Hydrochloride/pharmacokinetics*;Herb-Drug Interactions*;Limit of Detection;Linear Models;Plant Extracts/blood;Plant Extracts/pharmacokinetics*;Quinazolines/blood;Quinazolines/pharmacokinetics*;Rats;Reproducibility of Results;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry/methods;Tea*
28257666;Administration, Oral;Animals;Aspirin/adverse effects*;Blood Volume/drug effects*;Drugs, Chinese Herbal/pharmacokinetics*;Ginsenosides/pharmacokinetics*;Herb-Drug Interactions;Homeostasis/drug effects*;Male;Rats;Rats, Sprague-Dawley;Saponins/adverse effects*;Saponins/pharmacokinetics*
28252553;Adult;Aged;Antineoplastic Agents/therapeutic use*;Complementary Therapies*;Drugs, Chinese Herbal/administration & dosage*;Female;Follow-Up Studies;Herb-Drug Interactions*;Humans;Male;Melanoma/drug therapy*;Melanoma/pathology;Middle Aged;Prognosis;Surveys and Questionnaires
28250272;Binding Sites*;Herb-Drug Interactions;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Protein Binding;Seeds;Serum Albumin/chemistry*;Silymarin/chemistry*;Silymarin/pharmacokinetics;Static Electricity;Thermodynamics
28238155;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Antineoplastic Combined Chemotherapy Protocols/pharmacology;Carboplatin/administration & dosage;Carboplatin/pharmacology;Cell Line, Tumor;Drug Screening Assays, Antitumor;Endometrial Neoplasms/drug therapy;Female;HEK293 Cells;Herb-Drug Interactions;Humans;Middle Aged;Ovarian Neoplasms/drug therapy*;Paclitaxel/administration & dosage;Paclitaxel/pharmacology;Phytotherapy/adverse effects;Phytotherapy/statistics & numerical data;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Uterine Cervical Neoplasms/drug therapy
28219593;Adult;Areca/adverse effects*;Case-Control Studies;Female;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Liver Transplantation*;Male;Mastication;Middle Aged;Retrospective Studies;Tacrolimus/pharmacokinetics*;Taiwan;Transplant Recipients;Young Adult
28176623;Administration, Oral;Animals;Area Under Curve;Biological Availability;Biomarkers/blood;Blood Glucose/drug effects*;Blood Glucose/metabolism;Cinnamomum/chemistry;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/administration & dosage;Cytochrome P-450 CYP3A Inhibitors/isolation & purification;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Cytochrome P-450 CYP3A Inhibitors/toxicity;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Herb-Drug Interactions*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Male;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Extracts/toxicity;Rabbits;Rats, Sprague-Dawley;Thiazolidinediones/administration & dosage;Thiazolidinediones/pharmacokinetics*;Weight Loss/drug effects
28152355;Adult;Australia;Awareness;Child, Preschool;Dietary Supplements/adverse effects*;Dietary Supplements/toxicity;Female;Garcinia cambogia/adverse effects;Garcinia cambogia/toxicity;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Herbal Medicine/methods*;Humans;Male;Massive Hepatic Necrosis/chemically induced;Massive Hepatic Necrosis/surgery;Metals, Heavy/toxicity;Middle Aged;Plant Preparations/therapeutic use;Plant Preparations/toxicity;Plants, Toxic/adverse effects*;Plants, Toxic/toxicity;Risk;Social Control, Formal
28144968;Acute Kidney Injury/chemically induced*;Cytochrome P-450 CYP2C9/physiology;Cytochrome P-450 CYP3A/physiology;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/adverse effects*;Protein Binding;Saponins/adverse effects*;Triterpenes/adverse effects*
28058783;Animals;Female;Herb-Drug Interactions;Humans;Larrea/chemistry*;Lignans/chemistry*;Lignans/pharmacology;Liver/metabolism*;Microsomes, Liver/drug effects*;Rats
28039696;Animals;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/isolation & purification;Antineoplastic Agents, Phytogenic/therapeutic use*;Cachexia/drug therapy*;Cachexia/etiology;Ginger/chemistry*;Herb-Drug Interactions;Humans;Neoplasms/complications;Neoplasms/drug therapy*;Neoplasms/mortality;Neoplasms/pathology;Phytotherapy;Plant Extracts/adverse effects;Plant Extracts/isolation & purification;Plant Extracts/therapeutic use*;Plants, Medicinal;Risk Factors;Treatment Outcome
27996361;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/chemistry*;Amino Acid Sequence;Animals;Binding Sites;Computational Biology/methods*;Flavonoids/chemistry;Flavonoids/toxicity*;Herb-Drug Interactions;Humans;Ligands;Mice;Molecular Docking Simulation;Molecular Dynamics Simulation;Protein Binding;Protein Interaction Domains and Motifs;Sequence Alignment;Structural Homology, Protein
27925507;Anemia/blood;Anemia/chemically induced;Anemia/drug therapy*;Angelica sinensis/chemistry*;Animals;Biomarkers/blood;Disease Models, Animal;Erythrocyte Indices;Erythrocytes/drug effects*;Erythrocytes/metabolism;Erythropoietin/pharmacology;Hematinics/isolation & purification;Hematinics/pharmacology*;Hematinics/toxicity;Hematocrit;Hematopoiesis/drug effects*;Hemoglobins/metabolism;Herb-Drug Interactions;Lisinopril*;Male;Phytotherapy;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Extracts/toxicity;Plant Root Cap/chemistry*;Plants, Medicinal;Polysaccharides/isolation & purification;Polysaccharides/pharmacology*;Polysaccharides/toxicity;Rats, Wistar;Time Factors
27925249;Administration, Oral;Biological Availability;Biotransformation;Buprenorphine/administration & dosage;Buprenorphine/blood;Buprenorphine/metabolism*;Buprenorphine/pharmacokinetics;Caco-2 Cells;Dietary Supplements*/adverse effects;Glucuronides/metabolism*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Intestines/drug effects*;Intestines/metabolism;Liver/drug effects*;Liver/metabolism;Models, Biological;Oxidation-Reduction;Phytochemicals/toxicity*;Protein Binding
27923318;Animals;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Complementary Therapies/trends;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/trends;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry
27919190;Animals;Area Under Curve;Caco-2 Cells;Chromatography, Liquid;Glycyrrhizic Acid/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Mass Spectrometry;Metabolic Clearance Rate;Microsomes, Liver;Random Allocation;Rats;Rats, Sprague-Dawley;Triterpenes/pharmacokinetics*
27916843;Drugs, Chinese Herbal;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Protein Isoforms/antagonists & inhibitors;Sapogenins/pharmacokinetics*;Sapogenins/pharmacology*;Saponins/pharmacokinetics*;Saponins/pharmacology*;Triterpenes/pharmacokinetics*;Triterpenes/pharmacology*
27904048;Animals;Cell Line;Citrus*;Flavanones/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Hesperidin/pharmacology*;Humans;Hymecromone/pharmacology;Insecta;Recombinant Proteins/metabolism;Trifluoperazine/pharmacology
27903949;Aged;Anti-Retroviral Agents/pharmacology;Anti-Retroviral Agents/therapeutic use*;Equisetum/chemistry*;Female;HIV Infections/drug therapy*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
27902536;Herb-Drug Interactions/physiology*;Humans;Mental Disorders/drug therapy*;Mental Disorders/metabolism;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/metabolism;Monoamine Oxidase Inhibitors/therapeutic use;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Plant Preparations/therapeutic use*;Psychotropic Drugs/adverse effects;Psychotropic Drugs/metabolism;Psychotropic Drugs/therapeutic use*
27890005;Animals;Chemical and Drug Induced Liver Injury/etiology*;Enzyme Inhibitors/adverse effects*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Phytochemicals/adverse effects*;Phytochemicals/pharmacology;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Risk
27878352;Anesthetics/adverse effects;Anticoagulants/adverse effects*;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Fibrinolytic Agents/adverse effects;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Hypnotics and Sedatives/adverse effects;Intraoperative Complications/chemically induced*;Male;Middle Aged;Phytotherapy/adverse effects;Platelet Aggregation Inhibitors/adverse effects;Prospective Studies
27847337;Administration, Oral;Andrographis/chemistry*;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Arthritis, Experimental/blood;Arthritis, Experimental/chemically induced;Arthritis, Experimental/drug therapy*;Arthritis, Experimental/physiopathology;Chromatography, High Pressure Liquid;Diterpenes/administration & dosage*;Diterpenes/isolation & purification;Edema/chemically induced;Edema/prevention & control;Female;Freund's Adjuvant;Half-Life;Herb-Drug Interactions*;Hyperalgesia/chemically induced;Hyperalgesia/physiopathology;Hyperalgesia/prevention & control;Metabolic Clearance Rate;Naproxen/administration & dosage;Naproxen/blood;Naproxen/pharmacokinetics*;Nociception/drug effects;Nociceptive Pain/chemically induced;Nociceptive Pain/physiopathology;Nociceptive Pain/prevention & control;Pain Threshold/drug effects;Phytotherapy;Plant Extracts/administration & dosage*;Plant Extracts/isolation & purification;Plants, Medicinal;Rats, Wistar
27847211;Anesthetics/metabolism*;Animals;Herb-Drug Interactions/physiology*;Herbal Medicine/methods;Humans;Phytotherapy*/methods;Plants, Medicinal/metabolism*
27845750;Aspalathus/chemistry*;Chalcones/pharmacology;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Hypoglycemic Agents/pharmacology;Hypolipidemic Agents/pharmacology*;Phenylpropionates/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*
27789327;Animals;Blood Glucose/drug effects*;Diabetes Mellitus, Experimental/drug therapy*;Diabetes Mellitus, Experimental/metabolism;Diabetic Retinopathy/drug therapy*;Diabetic Retinopathy/metabolism;Ethanol/chemistry;Female;Herb-Drug Interactions;Hyperglycemia/drug therapy;Hyperglycemia/metabolism;Hypoglycemic Agents/pharmacology;Insulin/metabolism;Male;Moringa oleifera/chemistry*;Plant Extracts/administration & dosage*;Plant Extracts/chemistry;Plant Leaves/chemistry*;Rats;Rats, Wistar;Retina/drug effects;Retina/metabolism;Sitagliptin Phosphate/pharmacology*
27487816;Animals;Ginkgo biloba/chemistry*;Herb-Drug Interactions/immunology*;Male;Plant Extracts/chemistry*;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/metabolism;Ticlopidine/pharmacokinetics
27804869;Animals;Anxiety/drug therapy*;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Plants, Medicinal*
27766890;Animals;Apigenin/pharmacokinetics*;Biological Availability;Drug Interactions*;Herb-Drug Interactions;Humans;Plant Extracts/pharmacokinetics*
27470545;Anticoagulants/therapeutic use;Herb-Drug Interactions*;Humans;Plants, Medicinal/chemistry*;Treatment Outcome;Warfarin/chemistry;Warfarin/therapeutic use*
27765363;Alkaloids;Animals;Antimetabolites, Antineoplastic/pharmacology;Antimetabolites, Antineoplastic/therapeutic use;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use;Colchicine/analogs & derivatives*;Colchicine/pharmacology;Colchicine/therapeutic use;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacology;Deoxycytidine/therapeutic use;Disease Models, Animal;Female;Glycosides;Herb-Drug Interactions;Humans;Liliaceae/chemistry*;Mice, Inbred C57BL;Pancreas/drug effects*;Pancreatic Neoplasms/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Seeds
27759172;Academic Medical Centers;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Hospitalization/statistics & numerical data*;Humans;Inpatients*;Israel;Male;Middle Aged;Prospective Studies
27751754;Acquired Immunodeficiency Syndrome/diagnosis;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/virology;Anti-Retroviral Agents/adverse effects*;Antiretroviral Therapy, Highly Active/adverse effects;Decision Support Techniques*;Drug Interactions*;Food-Drug Interactions;HIV Infections/diagnosis;HIV Infections/drug therapy*;HIV Infections/virology;Herb-Drug Interactions;Humans;Risk Assessment;Risk Factors;Software Design*;User-Computer Interface
27748172;Aspalathus/adverse effects;Cardiovascular Diseases/therapy*;Drug-Related Side Effects and Adverse Reactions*;Garcinia mangostana/adverse effects;Herb-Drug Interactions*;Humans;Lycium/adverse effects;Plants, Medicinal/adverse effects*;Portugal;Tea/adverse effects
27721546;Animals;Carbon Monoxide/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Humans;Microsomes, Liver/metabolism*;Plant Extracts/pharmacology*;Rats;Tinospora*
27714886;Andrographis/chemistry*;Animals;Butanones/chemistry*;Butanones/pharmacology;Diterpenes/chemistry*;Diterpenes/pharmacokinetics*;Female;Herb-Drug Interactions;Plant Extracts/chemistry*;Plant Extracts/pharmacology;Rats;Rats, Wistar
27709322;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Hospitalization/trends;Humans;Israel;Logistic Models;Male;Middle Aged;Plant Preparations/adverse effects*;Prospective Studies;Surveys and Questionnaires
27693910;Citrus paradisi*;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Dietary Supplements;Food-Drug Interactions*;Fruit and Vegetable Juices*;Herb-Drug Interactions*;Humans;Hypericum*;Micronutrients/administration & dosage;Pharmacovigilance;Solute Carrier Organic Anion Transporter Family Member 1b1/antagonists & inhibitors;Warfarin/pharmacology
27671273;Clinical Competence*;Communication;Community Pharmacy Services*;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Dietary Supplements*/adverse effects;Drug-Related Side Effects and Adverse Reactions/etiology;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Medicine, Traditional/adverse effects;Medicine, Traditional/methods*;Patient Education as Topic;Pharmacists*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Professional Role*;Professional-Patient Relations;Risk Factors
27631192;Antineoplastic Agents/pharmacology*;Apoptosis/drug effects;Cell Cycle/drug effects;Cell Line, Tumor;Cell Proliferation/drug effects;Cytochrome P-450 CYP1A2/drug effects*;Cytochrome P-450 CYP2C19/drug effects*;Cytochrome P-450 CYP2C9/drug effects*;Herb-Drug Interactions*;Humans;Isoenzymes;Lettuce/chemistry*;Pharmacogenomic Testing;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plants, Medicinal;Recombinant Proteins
27558587;Animals;Bicuculline/pharmacology;Conditioning (Psychology)/drug effects*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Fear/drug effects*;Female;Flumazenil/pharmacology;Herb-Drug Interactions;Immobility Response, Tonic/drug effects*;Ovariectomy*;Rats;Social Isolation*
27544221;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Hospitalization/trends*;Humans;Inpatients/statistics & numerical data*;Phytotherapy/utilization*;Prospective Studies
27516439;Adult;Aged;Communication*;Complementary Therapies/utilization*;Cross-Sectional Studies;Dietary Supplements*;Evidence-Based Medicine;Family Practice;Female;Herb-Drug Interactions;Hospitalization;Hospitals;Humans;Inpatients/psychology*;Inpatients/statistics & numerical data;Israel;Male;Middle Aged;Patient-Centered Care;Physician-Patient Relations*;Physicians, Primary Care*;Prospective Studies;Truth Disclosure*
27507204;Animals;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Glucuronosyltransferase/chemistry*;Glucuronosyltransferase/metabolism;Glycyrrhizic Acid/chemistry;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions*;Intestines/chemistry;Intestines/drug effects;Intestines/enzymology*;Kinetics;Liver/chemistry;Liver/drug effects;Liver/enzymology*;Male;Rats;Rats, Sprague-Dawley
27485257;Animals;Biological Transport;Cytochrome P-450 CYP1A2/metabolism*;Dogs;Herb-Drug Interactions*;Herbal Medicine;Humans;Madin Darby Canine Kidney Cells;Models, Biological*;Organic Anion Transport Protein 1/metabolism*;Transfection
27468556;Animals;Drugs, Chinese Herbal/chemistry*;Enzymes/chemistry*;Enzymes/metabolism;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations/chemistry*
27467225;Antidepressive Agents, Second-Generation/administration & dosage;Apium graveolens/adverse effects*;Bipolar Disorder*/chemically induced;Bipolar Disorder*/diagnosis;Bipolar Disorder*/therapy;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Female;Herb-Drug Interactions;Humans;Hypericum*;Menopause/drug effects;Middle Aged;Phytotherapy*/adverse effects;Phytotherapy*/methods;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Roots/adverse effects;Psychiatric Status Rating Scales;Treatment Outcome;Venlafaxine Hydrochloride/administration & dosage*;Withholding Treatment
27459888;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Activation, Metabolic;Administration, Oral;Animals;Area Under Curve;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/toxicity;Chromatography, Liquid;Cytochrome P-450 Enzyme System/metabolism;Dogs;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/toxicity;Herb-Drug Interactions*;Madin Darby Canine Kidney Cells;Male;Metabolic Clearance Rate;Microsomes, Liver/metabolism;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Platelet Aggregation Inhibitors/toxicity;Rats, Sprague-Dawley;Risk Assessment;Tandem Mass Spectrometry;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/blood;Ticlopidine/pharmacokinetics;Ticlopidine/toxicity;Transfection
27457692;Alkaloids/pharmacology;Benzodioxoles/pharmacology;Berberine/pharmacology;Chemistry, Pharmaceutical/methods;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions/physiology*;Humans;Medicine, Ayurvedic;Microsomes, Liver/metabolism*;Pharmaceutical Preparations/metabolism*;Piperidines/pharmacology;Plant Extracts/metabolism*;Plant Extracts/pharmacology*;Polyunsaturated Alkamides/pharmacology;Saponins/pharmacology;Stilbenes/pharmacology;Triterpenes/pharmacology;Withanolides/pharmacology
27444983;Contraceptives, Oral, Combined/adverse effects*;Contraceptives, Oral, Hormonal/adverse effects*;Depression/drug therapy;Female;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Hypericum/chemistry*;Metrorrhagia/chemically induced;Ovulation/drug effects;Plant Extracts/adverse effects*;Randomized Controlled Trials as Topic;Risk Assessment
27427263;Aged;Aged, 80 and over;Dietary Supplements*/adverse effects;Evidence-Based Medicine;Female;Herb-Drug Interactions;Humans;Male;Plants, Medicinal*/adverse effects;Polypharmacy;Practice Guidelines as Topic/standards*
27416488;Administration, Oral;Animals;Biological Availability;Chemistry, Pharmaceutical/methods;Cohort Studies;Dose-Response Relationship, Drug;Female;Herb-Drug Interactions;Hibiscus/chemistry*;Humans;Hydroxocobalamin/pharmacokinetics*;Hydroxocobalamin/therapeutic use*;Intestines/metabolism;Male;Mice;Mice, Inbred C57BL;Middle Aged;Nervous System Diseases/drug therapy;Nervous System Diseases/metabolism;Teas, Herbal;Vitamin B 12 Deficiency/drug therapy*;Vitamin B 12 Deficiency/metabolism;Vitamin B Complex/pharmacokinetics*;Vitamin B Complex/therapeutic use*
27401301;Animals;Anti-HIV Agents/pharmacology*;Anti-HIV Agents/therapeutic use;Antiretroviral Therapy, Highly Active*;Ascorbic Acid/pharmacology;Chemotherapy, Adjuvant/methods;HIV Infections/drug therapy*;Herb-Drug Interactions*;Hypoxis/chemistry*;Lamivudine/pharmacology;Lamivudine/therapeutic use;Male;Nevirapine/pharmacology;Nevirapine/therapeutic use;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Seminiferous Tubules/drug effects;Seminiferous Tubules/pathology;Sperm Count;Sperm Motility/drug effects;Spermatozoa/drug effects*;Stavudine/pharmacology;Stavudine/therapeutic use
27399660;Biological Availability;Cassia/chemistry*;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors/chemistry*;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Enzyme Activation/drug effects;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Kinetics;Lamiales/chemistry*;Mass Spectrometry;Molecular Structure;Plant Extracts/chemistry*;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Tissue Distribution
27357588;Aconitum/chemistry*;Alkaloids/pharmacokinetics*;Animals;Anthraquinones/pharmacology;Area Under Curve;Chromatography, High Pressure Liquid/methods;Diterpenes/pharmacokinetics*;Drugs, Chinese Herbal/pharmacokinetics*;Female;Half-Life;Herb-Drug Interactions/physiology;Male;Plant Extracts/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Rheum/adverse effects*;Tandem Mass Spectrometry/methods
27352447;Cytochrome P-450 Enzyme System/metabolism*;Fruit*;Herb-Drug Interactions*;Humans;Lycium*;Metabolic Detoxication, Phase I*;Oxygenases/metabolism*;Plant Extracts/pharmacology*;Plant Preparations
27288758;Administration, Intravenous;Administration, Oral;Alkaloids/pharmacokinetics*;Animals;Area Under Curve;Benzodioxoles/pharmacokinetics*;Chromatography, High Pressure Liquid;Drug Stability;Herb-Drug Interactions;Male;Piper;Piperidines/pharmacokinetics*;Plant Preparations/pharmacokinetics*;Polyunsaturated Alkamides/pharmacokinetics*;Quality Control;Rats;Rats, Sprague-Dawley;Reference Standards;Reproducibility of Results;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Taxoids/pharmacokinetics*
27240333;Animals;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/pharmacokinetics*;Drug Interactions;Drug Therapy, Combination;Drugs, Chinese Herbal/administration & dosage*;Herb-Drug Interactions;Kidney Function Tests;Liver Function Tests;Male;Rats;Schizophrenia/drug therapy;Tissue Distribution
27223851;Drugs, Chinese Herbal;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Magnoliopsida/chemistry*;Molecular Structure;Oleanolic Acid/analogs & derivatives*;Oleanolic Acid/chemistry;Saponins/chemistry*
27208893;Computer Simulation;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Glucuronides/metabolism;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Inactivation, Metabolic;Kinetics;Models, Molecular;Molecular Structure;Phytosterols/chemistry;Phytosterols/pharmacology*;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Quantitative Structure-Activity Relationship;Saponins/chemistry;Saponins/pharmacology;Static Electricity;Tamoxifen/metabolism;Trifluoperazine/metabolism
27171366;Animals;Dietary Supplements/adverse effects;Dietary Supplements/standards;European Union;Herb-Drug Interactions;Humans;Legislation, Drug;Medicine, Traditional/methods;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/standards;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry*;Russia
27164071;Antipsychotic Agents/pharmacology*;Chromatography, High Pressure Liquid;Clozapine/analogs & derivatives;Clozapine/analysis;Clozapine/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Humans;In Vitro Techniques;Microsomes, Liver/chemistry;Plant Preparations/adverse effects*;Plant Preparations/pharmacology
27157958;Aged;Aged, 80 and over;Cross-Sectional Studies;Drug-Related Side Effects and Adverse Reactions/epidemiology;Female;Herb-Drug Interactions*;Humans;Male;Phytotherapy/statistics & numerical data*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use*;Turkey/epidemiology
27145339;Furans/pharmacology*;Glucosides/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Kinetics;Lignans/pharmacology*
27142346;Animals;Cell Proliferation/drug effects*;Cognition/drug effects*;Cognition Disorders/chemically induced;Cognition Disorders/pathology;Cognition Disorders/prevention & control*;Herb-Drug Interactions;Hippocampus/drug effects;Hippocampus/pathology;Male;Neuroprotective Agents/administration & dosage;Plant Extracts/administration & dosage;Plant Preparations/administration & dosage*;Rats;Rats, Sprague-Dawley;Treatment Outcome;Valproic Acid*;Zingiberaceae/chemistry*
27125594;Aged;Complementary Therapies/adverse effects*;Female;Herb-Drug Interactions;Humans;Male;Middle East;Neoplasms/drug therapy*;Surveys and Questionnaires
27105957;Benzyl Compounds/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Phytolaccaceae/chemistry*;Plant Extracts/pharmacology*;Sulfides/pharmacology*
27090799;Adult;Aged;Aged, 80 and over;Comorbidity;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Drugs, Chinese Herbal/therapeutic use;Female;Formularies, Homeopathic;Germany/epidemiology;Herb-Drug Interactions;Humans;Male;Melanoma/epidemiology*;Melanoma/therapy*;Middle Aged;Surveys and Questionnaires;Vitamins/therapeutic use
27071286;Animals;Anticholesteremic Agents/pharmacology;Antioxidants/pharmacology;Atorvastatin Calcium/pharmacology*;Cynara scolymus*;Disease Models, Animal;Drug Monitoring;Drug Synergism;Herb-Drug Interactions;Hypercholesterolemia/drug therapy*;Hypercholesterolemia/metabolism;Oxidative Stress/drug effects*;Phytotherapy/methods;Plant Extracts/pharmacology*;Plant Leaves;Rats;Treatment Outcome
27061296;Albuterol/pharmacology*;Animals;Bronchodilator Agents/pharmacology*;Dose-Response Relationship, Drug;Drug Synergism;Flavonoids/pharmacology*;Guinea Pigs;Herb-Drug Interactions*;In Vitro Techniques;Ipratropium/pharmacology*;Male;Muscle Relaxation/drug effects*;Muscle, Smooth/drug effects*;Trachea/drug effects*
27057621;Amodiaquine/pharmacology*;Animals;Antimalarials/pharmacology*;Chloroquine/pharmacology;Disease Models, Animal;Drug Resistance;Drug Therapy, Combination;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Malaria/drug therapy*;Malaria/parasitology;Mice;Parasitic Sensitivity Tests;Plant Extracts/pharmacology*;Plasmodium berghei/drug effects*;Time Factors
27054913;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Alkaloids/pharmacology*;Animals;Benzophenanthridines/pharmacology;Berberine Alkaloids/pharmacology;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Dioxoles/pharmacology;Dogs;Eschscholzia/chemistry*;Hep G2 Cells/drug effects;Herb-Drug Interactions;Humans;Madin Darby Canine Kidney Cells/drug effects;Plant Extracts/pharmacology;Receptors, Steroid/genetics;Receptors, Steroid/metabolism*
27023460;Adult;Antitussive Agents/blood;Antitussive Agents/pharmacokinetics*;Antitussive Agents/urine;Asian Continental Ancestry Group/genetics;Cytochrome P-450 CYP2D6/genetics*;Dextromethorphan/blood;Dextromethorphan/pharmacokinetics*;Dextromethorphan/urine;Drugs, Chinese Herbal/pharmacology*;Female;Genotype;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Young Adult
27003511;Animals;Biomedical Research;Clinical Studies as Topic;Herb-Drug Interactions*;Humans;Mice;Plant Preparations*;Rats
27000164;Administration, Oral;Antineoplastic Agents*/administration & dosage;Antineoplastic Agents*/adverse effects;Clinical Competence*;Community Pharmacy Services;Cross-Sectional Studies;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Pharmacists/psychology*
26990021;Animals;Berberine Alkaloids/pharmacokinetics*;Berberine Alkaloids/therapeutic use;Chromatography, High Pressure Liquid/methods*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme System/metabolism*;Dogs;Herb-Drug Interactions;Humans;Isoenzymes/chemistry*;Male
26959552;Animals;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Enzyme Induction/drug effects*;Herb-Drug Interactions;Male;Microsomes, Liver/enzymology*;Pentacyclic Triterpenes/pharmacology*;Rats;Triterpenes/pharmacology*
26954426;Adult;Child, Preschool;Female;Herb-Drug Interactions*;Humans;Male;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Pregnancy
26953389;Adolescent;Adult;Age Factors;Aged;Alcoholism/complications;Child;Child, Preschool;Dose-Response Relationship, Drug;Ethanol/administration & dosage;Ethanol/adverse effects*;Herb-Drug Interactions*;Humans;Infant;Phytotherapy/adverse effects*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Preservatives, Pharmaceutical/administration & dosage;Preservatives, Pharmaceutical/adverse effects*;Risk Factors
26941093;Adult;Aged;Anticoagulants/therapeutic use*;Brazil/epidemiology;Female;Follow-Up Studies;Heart Diseases/drug therapy*;Heart Diseases/epidemiology;Herb-Drug Interactions*;Humans;International Normalized Ratio/methods;Male;Middle Aged;Outpatient Clinics, Hospital*;Pharmacists*;Plants, Medicinal*;Professional Role
26931616;Ampicillin/pharmacology*;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects*;Caffeic Acids/pharmacology;Drug Synergism;Escherichia coli/drug effects;Flavones/pharmacology;Glucosides/pharmacology;Herb-Drug Interactions*;Iridoids/pharmacology;Medicine, Traditional;Olea/chemistry*;Phenols/pharmacology*;Phenylethyl Alcohol/analogs & derivatives;Phenylethyl Alcohol/pharmacology;Plant Extracts/metabolism;Plant Extracts/pharmacology*;Plant Leaves/chemistry;Staphylococcus aureus/drug effects
26926393;Anticoagulants/metabolism;Anticoagulants/pharmacology;Binding Sites;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/metabolism*;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions*;Humans;Molecular Docking Simulation;Protein Binding;Salvia miltiorrhiza/chemistry;Salvia miltiorrhiza/metabolism*;Serum Albumin/metabolism*;Warfarin/metabolism;Warfarin/pharmacology
26915920;Animals;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional/adverse effects;Medicine, Chinese Traditional/methods
26908268;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Caco-2 Cells;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/administration & dosage;Cytochrome P-450 CYP3A Inhibitors/isolation & purification;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Indinavir/pharmacokinetics;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Ritonavir/pharmacology;Sophora/chemistry*;Up-Regulation
26891872;Administration, Oral;Adrenergic beta-1 Receptor Antagonists/pharmacokinetics;Adrenergic beta-1 Receptor Antagonists/pharmacology;Animals;Area Under Curve;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Herb-Drug Interactions;In Vitro Techniques;Inhibitory Concentration 50;Male;Metoprolol/pharmacokinetics*;Metoprolol/pharmacology;Microsomes, Liver/metabolism;Plant Bark;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Terminalia/chemistry*
26891286;Antiretroviral Therapy, Highly Active;Benzoxazines/pharmacology;Cytochrome P-450 CYP2B6/genetics;Cytochrome P-450 CYP2B6/metabolism;Cytochrome P-450 CYP2B6 Inhibitors/chemistry;Cytochrome P-450 CYP2B6 Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Magnoliopsida/chemistry;Nevirapine/pharmacology;Plant Extracts/chemistry*;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*
26887532;Female;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods*;Plant Extracts/adverse effects*
26874879;Animals;Benzylamines/administration & dosage;Benzylamines/blood*;Biological Availability;Chromatography, High Pressure Liquid/methods;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/pharmacology*;Epimedium/chemistry*;Herb-Drug Interactions*;Limit of Detection;Male;Naphthalenes/administration & dosage;Naphthalenes/blood*;Rats;Rats, Sprague-Dawley;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/blood*;Tandem Mass Spectrometry/methods
26872133;Administration, Oral;Animals;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Liver/drug effects;Liver/metabolism;Male;Metoprolol/blood;Metoprolol/pharmacokinetics;Midazolam/blood;Midazolam/pharmacokinetics;Omeprazole/blood;Omeprazole/pharmacokinetics;Phenacetin/blood;Phenacetin/pharmacokinetics;Quinazolines/pharmacology*;Rats, Sprague-Dawley;Tolbutamide/blood;Tolbutamide/pharmacokinetics
26837208;Adult;Aged;Aged, 80 and over;Cohort Studies;Cross-Sectional Studies;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Hospitalization/trends;Humans;Inpatients*;Male;Middle Aged;Prospective Studies;Surveys and Questionnaires
26800424;Alkaloids/administration & dosage;Alkaloids/pharmacology*;Animals;Area Under Curve;Drug Interactions;Glycyrrhizic Acid/administration & dosage;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions;Male;Quinolizines/administration & dosage;Quinolizines/pharmacology*;Rats;Rats, Sprague-Dawley;Ribavirin/administration & dosage;Ribavirin/pharmacokinetics*;Silymarin/administration & dosage;Silymarin/pharmacology*
26776959;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control*;Dietary Supplements*;Functional Food;Gastrointestinal Microbiome/drug effects;Herb-Drug Interactions;Humans;Inflammation/drug therapy;Polyphenols/administration & dosage;Polyphenols/pharmacology*;Randomized Controlled Trials as Topic
26776752;Animals;Biological Assay;Biotransformation;Dietary Supplements/adverse effects*;Dietary Supplements/standards;Dose-Response Relationship, Drug;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions*;Humans;Pharmacovigilance;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics;Plant Preparations/standards;Polypharmacy;Quality Control;Risk Assessment;Toxicity Tests/methods*;Toxicity Tests/standards
26771134;Animals;Chromatography, High Pressure Liquid/methods;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions*;Male;Medicine, Chinese Traditional;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry/methods*
26762235;Animals;Area Under Curve;Biological Availability;Cytochrome P-450 CYP3A/metabolism;Diabetes Mellitus, Experimental*/drug therapy;Diterpenes/pharmacology*;Glyburide*/pharmacokinetics;Glyburide*/pharmacology;Herb-Drug Interactions*;Hypoglycemic Agents*/pharmacokinetics;Hypoglycemic Agents*/pharmacology;Liver/drug effects;Liver/metabolism;Male;Phytotherapy;Plant Extracts/pharmacology*;Rats, Wistar;Reference Values;Triterpenes/pharmacology*
26760391;Dietary Supplements/adverse effects*;Emergency Service, Hospital;Herb-Drug Interactions*;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy*;Plant Preparations/adverse effects*;Serotonin Uptake Inhibitors/therapeutic use
26743226;Animals;Benzamides/pharmacology;Carbachol/pharmacology;Cats;Cells, Cultured;Domperidone/pharmacology;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Esophageal Sphincter, Lower/drug effects;Gastric Emptying/drug effects;Gastrointestinal Motility/drug effects*;Gastrointestinal Transit/drug effects;Herb-Drug Interactions;Indoles/pharmacology;Lonicera*;Male;Morpholines/pharmacology;Muscle Contraction/drug effects;Muscle, Smooth/drug effects;Ondansetron/pharmacology;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Rats;Sulfonamides/pharmacology
26721197;Alkaloids/blood*;Alkaloids/pharmacology;Animals;Chromatography, High Pressure Liquid;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Gymnema sylvestre/chemistry*;Herb-Drug Interactions*;Hypoglycemic Agents/blood*;Hypoglycemic Agents/pharmacology;Male;Plant Extracts/blood*;Plant Extracts/pharmacology;Rats, Wistar;Streptozocin;Sulfonylurea Compounds/blood*;Sulfonylurea Compounds/pharmacology;Tandem Mass Spectrometry
26712778;Animals;Cells, Cultured/drug effects*;Cytochrome P-450 CYP3A/drug effects*;Enzyme Inhibitors/metabolism*;Glycyrrhetinic Acid/metabolism*;Glycyrrhetinic Acid/therapeutic use;Hepatitis, Chronic/drug therapy*;Herb-Drug Interactions;Humans;Male;Mice;Mice, Inbred C57BL;Microsomes, Liver/metabolism*;Plant Extracts/metabolism*;Plant Extracts/therapeutic use;Tandem Mass Spectrometry
26692465;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use*;Apoptosis/drug effects;Doxorubicin/pharmacology;Doxorubicin/therapeutic use*;Drug Synergism;Herb-Drug Interactions*;Humans;K562 Cells;Leukemia/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Viscum album*
26690396;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Anti-HIV Agents/pharmacology*;Biological Transport;Caco-2 Cells;Cell Line, Tumor;Crotalid Venoms/pharmacology*;Cytochrome P-450 CYP3A/metabolism;Herb-Drug Interactions*;Humans;Indinavir/pharmacology*;Ketoconazole/pharmacology;Plant Extracts/pharmacology*;Verapamil/pharmacology
26680654;Adult;Area Under Curve;Chlorzoxazone/pharmacokinetics*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2E1/metabolism*;Enzyme Inhibitors/pharmacology*;Fasting;Half-Life;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Stilbenes/pharmacology*;Young Adult
26670091;Animals;Antineoplastic Agents/therapeutic use*;Female;Herb-Drug Interactions*;Humans;Male;Medical Oncology*;Neoplasms/drug therapy*;Phytotherapy/utilization*;Plant Preparations/adverse effects*
26657265;Animals;Chromatography, High Pressure Liquid/methods;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme Inhibitors/chemistry;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions/physiology;India;Inhibitory Concentration 50;Ketoconazole/metabolism;Ketoconazole/pharmacology;Male;Medicine, Traditional/methods;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Plant Extracts/chemistry*;Plant Extracts/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Swertia/chemistry*;Triterpenes/chemistry;Triterpenes/metabolism;Triterpenes/pharmacology
26656228;Cardiovascular Diseases/drug therapy*;Commiphora;Crataegus;Garlic;Herb-Drug Interactions;Humans;Medicine, Traditional/methods;Phytotherapy/methods*;Plant Extracts/pharmacology*;Plant Gums/pharmacology;Plants, Medicinal*;Terminalia
26634927;Animals;Anticonvulsants/chemistry;Anticonvulsants/pharmacology*;Anticonvulsants/therapeutic use;Benzodiazepines;Citrullus colocynthis/chemistry*;Flavonoids;Flumazenil;Fruit/chemistry;Herb-Drug Interactions;Male;Medicine, Arabic;Mice;Naloxone;Pentylenetetrazole;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Receptors, Opioid/metabolism*;Seizures/chemically induced;Seizures/drug therapy*
26633237;Administration, Oral;Adult;Area Under Curve;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9;Diclofenac/pharmacokinetics*;Half-Life;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Stilbenes/pharmacology*;Young Adult
26630907;Animals;Biomarkers/metabolism;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacokinetics;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional/adverse effects;Medicine, Chinese Traditional/methods*;Time Factors
26619825;Acetaminophen/pharmacokinetics*;Animals;Anisoles/pharmacokinetics;Caffeine/pharmacokinetics*;Fruit/chemistry;Gas Chromatography-Mass Spectrometry;Herb-Drug Interactions*;Male;Mice;Oils, Volatile/pharmacokinetics*;Parasympatholytics;Pimpinella/chemistry;Plant Oils/pharmacokinetics
26599199;Adult;Allied Health Personnel;Animals;Antineoplastic Agents/therapeutic use*;Arum;Camelus;Curcuma;Daucus carota;Female;Garlic;Herb-Drug Interactions*;Herbal Medicine/statistics & numerical data;Honey;Humans;Male;Medical Oncology*;Middle Aged;Middle East;Milk;Neoplasms/drug therapy*;Nigella sativa;Physicians;Phytotherapy/utilization*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Research Personnel;Surveys and Questionnaires;Urtica dioica
26593212;Administration, Oral;Andrographis/chemistry*;Animals;Anti-Inflammatory Agents/pharmacokinetics;Anti-Inflammatory Agents/pharmacology;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Arthritis/drug therapy;Arthritis/metabolism;Chromatography, High Pressure Liquid;Diterpenes/pharmacokinetics*;Diterpenes/pharmacology;Female;Herb-Drug Interactions*;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Plants, Medicinal/chemistry;Pyridines/pharmacokinetics*;Pyridines/pharmacology;Rats;Rats, Wistar;Sulfones/pharmacokinetics*;Sulfones/pharmacology
26577109;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/economics;Acquired Immunodeficiency Syndrome/immunology*;Anti-Retroviral Agents/therapeutic use;Drugs, Chinese Herbal/therapeutic use;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional*/economics;Pilot Projects
26561312;Animals;Cytochrome P-450 Enzyme System/metabolism;Disease Models, Animal;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Isoflavones/pharmacology*;Phytoestrogens/pharmacology;Phytotherapy*;Plants, Medicinal/chemistry;Prescription Drugs/pharmacology*
26526838;Animals;Anti-Retroviral Agents/chemistry;Anti-Retroviral Agents/pharmacokinetics*;Citrus paradisi/metabolism;Garlic/metabolism;Ginkgo biloba/metabolism;Herb-Drug Interactions/physiology*;Humans;Hypericum/metabolism;Panax/metabolism;Plants, Medicinal/chemistry;Plants, Medicinal/metabolism*
26498206;Animals;Cantharidin/pharmacology*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9 Inducers;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inducers/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/drug effects*;Herb-Drug Interactions;Male;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
26482404;Adverse Drug Reaction Reporting Systems/legislation & jurisprudence;Biotransformation;Consumer Product Safety/legislation & jurisprudence*;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Health Policy/legislation & jurisprudence*;Herb-Drug Interactions*;Humans;Pharmacovigilance;Plant Preparations/adverse effects*;Policy Making;Risk Assessment;Risk Factors
26474329;Activation, Metabolic;Animals;Carcinogenesis*;Carcinogens/history;Carcinogens/metabolism;Cytochrome P-450 Enzyme System/history;Cytochrome P-450 Enzyme System/metabolism;Diet*;Drug Interactions;Exercise;Herb-Drug Interactions;History, 20th Century;History, 21st Century;Humans;Lipectomy;Microsomes, Liver/enzymology;Neoplasms/chemically induced;Neoplasms/prevention & control;Xenobiotics/metabolism*
26470816;Adult;Aged;Aged, 80 and over;Databases, Factual*;Drug-Related Side Effects and Adverse Reactions*;Female;Herb-Drug Interactions*;Humans;Male;Medicine, Chinese Traditional*;Middle Aged;Research;Taiwan;Young Adult
26444365;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/metabolism*;Animals;Antineoplastic Agents/pharmacology;Cells, Cultured;Diketopiperazines/pharmacology;Drug Resistance, Multiple;Drug Resistance, Neoplasm;Herb-Drug Interactions/physiology*;Heterocyclic Compounds, 4 or More Rings/pharmacology;Humans;Hydrocharitaceae*;Lethal Dose 50;Mice;Mitoxantrone/pharmacology;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism*;Plant Extracts/metabolism*;Plant Extracts/pharmacology;Plant Leaves
26441065;Animals;Consumer Product Safety;Echinacea*/adverse effects;Female;Herb-Drug Interactions*;Humans;Phytotherapy;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Pregnancy
26438626;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Drug Evaluation, Preclinical/methods;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Milk Thistle/adverse effects;Pharmaceutical Preparations/metabolism*;Plant Extracts/pharmacokinetics*
26400418;ATP-Binding Cassette Transporters/metabolism*;Biological Transport/drug effects;Enterocytes/drug effects*;Enterocytes/metabolism;Flavonoids/pharmacology*;Glucuronides/pharmacology;Hepatocytes/drug effects*;Hepatocytes/metabolism;Herb-Drug Interactions*;Humans
26366963;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/pharmacokinetics;Antiparkinson Agents/pharmacology;Benserazide/administration & dosage;Benserazide/pharmacokinetics;Benserazide/pharmacology*;Biological Availability;Capsules;Carbidopa/administration & dosage;Carbidopa/pharmacokinetics;Carbidopa/pharmacology*;Drug Therapy, Combination;Female;Herb-Drug Interactions;Humans;Levodopa/pharmacokinetics*;Levodopa/pharmacology;Male;Middle Aged;Motor Skills/drug effects;Mucuna/chemistry*;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Phytotherapy/methods*;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Seeds/chemistry
26339628;Computer Simulation;Databases, Factual;Gene Expression;Herb-Drug Interactions/genetics*;Humans;Inactivation, Metabolic/genetics;Models, Molecular;Molecular Docking Simulation*;Plants, Medicinal/chemistry*;Receptors, Steroid/agonists;Receptors, Steroid/chemistry*;Receptors, Steroid/genetics
26318744;Animals;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Isoenzymes/drug effects;Isoenzymes/metabolism;Limit of Detection;Male;Medicine, Chinese Traditional;Pharmaceutical Preparations/metabolism;Pharmacokinetics;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Tandem Mass Spectrometry
26311243;Animals;Herb-Drug Interactions*;Herbal Medicine;Humans;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Plants, Medicinal/adverse effects*
26285764;Binding Sites/physiology;Chromatography, High Pressure Liquid/methods;Cytochrome P-450 Enzyme Inhibitors/analysis*;Cytochrome P-450 Enzyme Inhibitors/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology;Cytochrome P-450 Enzyme System/analysis;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions/physiology*;Glycyrrhiza/chemistry;Glycyrrhiza/metabolism*;Herb-Drug Interactions/physiology*;High-Throughput Screening Assays/methods*;Humans;Isoenzymes/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Tandem Mass Spectrometry/methods
26264198;Animals;Dietary Supplements;Drug Interactions;Herb-Drug Interactions*;Humans;Liver Diseases/prevention & control;Membrane Transport Proteins/metabolism*;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/pharmacology;Plants, Medicinal/chemistry
26253491;Acetaminophen/metabolism;Animals;Area Under Curve;Cytochrome P-450 CYP1A2;Cytochromes/metabolism*;Fruit;Herb-Drug Interactions*;Liver/drug effects;Male;Microsomes, Liver;Phenacetin/metabolism;Phenacetin/pharmacokinetics*;Plant Extracts/pharmacology*;Rats, Sprague-Dawley;Ziziphus*
26223121;Biological Products;Biological Transport;Cytochrome P-450 Enzyme System/physiology*;Drugs, Chinese Herbal;Ginkgo biloba;Glucuronosyltransferase/physiology*;Herb-Drug Interactions*;Humans;Membrane Transport Proteins/physiology*;Oxidation-Reduction;Panax;Plants, Medicinal;Pueraria
26186450;Administration, Oral;Adult;Antitubercular Agents/therapeutic use;CD4 Lymphocyte Count;Drug Administration Schedule;Fabaceae/chemistry*;Female;HIV Infections/blood;HIV Infections/diet therapy;HIV Infections/immunology;HIV Infections/virology*;HIV-1/immunology;Herb-Drug Interactions;Humans;Isoniazid/adverse effects*;Male;Opportunistic Infections/immunology;Opportunistic Infections/prevention & control*;Patient Safety;Plant Leaves/chemistry*;T-Lymphocytes/immunology;T-Lymphocytes/virology;Tuberculosis, Pulmonary/immunology;Tuberculosis, Pulmonary/prevention & control*;Viral Load/immunology
26179835;Cytochrome P-450 CYP1A2 Inducers/administration & dosage;Cytochrome P-450 CYP1A2 Inducers/pharmacology*;Cytochrome P-450 CYP2C9 Inducers/adverse effects*;Epilepsy/chemically induced;Epilepsy/drug therapy*;Fruit and Vegetable Juices/adverse effects*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Morinda/adverse effects*;Phenytoin/administration & dosage;Phenytoin/pharmacology*
26162600;Chronic Disease/drug therapy*;Chronic Disease/epidemiology*;Cross-Sectional Studies;Female;Herb-Drug Interactions*;Humans;Male;Middle East/epidemiology;Phytotherapy/statistics & numerical data*;Plants, Medicinal
26159784;Adolescent;Adult;Adverse Drug Reaction Reporting Systems*;Aged;Anaphylaxis/chemically induced;Anti-Bacterial Agents/adverse effects;Child;Child, Preschool;China;Databases, Factual*;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/adverse effects*;Female;Herb-Drug Interactions*;Humans;Infant;Injections;Male;Middle Aged;Penicillin G/administration & dosage*;Penicillin G/adverse effects*;Young Adult
26108148;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood*;Anti-Bacterial Agents/urine*;Area Under Curve;Cephalosporins/administration & dosage;Cephalosporins/adverse effects;Cephalosporins/blood*;Cephalosporins/urine*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Kidney/drug effects*;Kidney Function Tests;Limit of Detection;Rats, Sprague-Dawley
26102010;Animals;Curcumin/analogs & derivatives*;Curcumin/pharmacology;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1B1/genetics;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;Diet, High-Fat/adverse effects*;Fructose/adverse effects;Gene Expression Regulation, Enzymologic/drug effects;Herb-Drug Interactions;Inactivation, Metabolic;Liver/drug effects*;Liver/enzymology;Liver/pathology;Male;Membrane Proteins/genetics;Membrane Proteins/metabolism;Mice, Inbred ICR
26100226;Chalcones/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism;Glycyrrhiza*;Herb-Drug Interactions;Humans;Microsomes, Liver/metabolism
26084208;Animals;Cyclooctanes;Dioxoles;Drugs, Chinese Herbal/pharmacology;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Lignans;Plant Extracts/pharmacology*;Polycyclic Compounds;Rats;Schisandra*/chemistry;Structure-Activity Relationship
26052873;Aged;Aged, 80 and over;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Cross-Sectional Studies;Diabetes Mellitus, Type 2/epidemiology;Diabetes Mellitus, Type 2/therapy*;Female;Herb-Drug Interactions;Humans;Hypoglycemic Agents/therapeutic use;Israel/epidemiology;Male;Middle Aged;Surveys and Questionnaires
26036354;Absorption, Physiological;Animals;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/pharmacokinetics;Biotransformation;Comorbidity;Complementary Therapies/adverse effects*;HIV Infections/diagnosis;HIV Infections/drug therapy*;HIV Infections/epidemiology;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics;Polypharmacy;Risk Assessment;Risk Factors;Treatment Outcome
26006029;Animals;Asparagus Plant*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Gymnema sylvestre*;Herb-Drug Interactions;Isoenzymes/antagonists & inhibitors;Plant Extracts/pharmacology*;Rats;Rats, Wistar
25980420;Animals;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/toxicity;Area Under Curve;Cell Line;Chromatography, Liquid;Gastric Mucosa/drug effects;Gastric Mucosa/pathology;Herb-Drug Interactions*;Inflammation/drug therapy;Inflammation/pathology;Macrophages/drug effects;Macrophages/metabolism;Male;Mefenamic Acid/pharmacokinetics;Mefenamic Acid/pharmacology*;Mefenamic Acid/toxicity;Mice;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
25943187;Diabetes Mellitus, Type 2/drug therapy;Diabetes Mellitus, Type 2/metabolism;Drug Interactions;Herb-Drug Interactions;Humans;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology*;Metformin/pharmacokinetics*;Metformin/pharmacology*
25938343;Azabicyclo Compounds/adverse effects;Female;Herb-Drug Interactions;Humans;Hypnotics and Sedatives/adverse effects;Methemoglobin/analysis*;Middle Aged;Oximetry/methods*;Piperazines/adverse effects;Plant Preparations/adverse effects;Spectrophotometry;Sulfhemoglobin/analysis*;Sulfhemoglobinemia/diagnosis*;Wine/adverse effects
25938222;Centella*;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions/physiology;Humans;In Vitro Techniques;Microsomes, Liver/enzymology*;Plant Extracts/pharmacology;Plants, Medicinal;Withania*
25936586;Aryl Hydrocarbon Hydroxylases/metabolism;Chromatography, Liquid;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C8/metabolism;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Hydroxylation;Inhibitory Concentration 50;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Moraceae/chemistry;Plant Roots/chemistry;Tandem Mass Spectrometry;Xanthones/pharmacology*
25920220;Averrhoa/chemistry*;Cytochrome P-450 CYP2D6 Inhibitors/isolation & purification*;Cytochrome P-450 CYP3A Inhibitors/isolation & purification*;Herb-Drug Interactions;Plants, Medicinal/chemistry
25908622;Animals;Anticoagulants/pharmacokinetics*;Chromatography, Liquid;Drug Administration Schedule;Herb-Drug Interactions;Injections, Intraperitoneal;Isoflavones/administration & dosage;Isoflavones/pharmacology*;Male;Platelet Aggregation Inhibitors/pharmacokinetics*;Rats;Rats, Wistar;Tandem Mass Spectrometry;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics;Vasodilator Agents/administration & dosage;Vasodilator Agents/pharmacology*;Warfarin/pharmacokinetics*
25891082;Administration, Oral;Animals;Biotransformation;Caffeic Acids/administration & dosage;Caffeic Acids/isolation & purification;Caffeic Acids/pharmacokinetics*;Caffeic Acids/toxicity;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/isolation & purification;Cardiovascular Agents/pharmacokinetics*;Cardiovascular Agents/toxicity;Catechol O-Methyltransferase/metabolism;Chromatography, Liquid;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/toxicity;Herb-Drug Interactions;Humans;Injections, Intravenous;Kidney Tubules/metabolism;Liver/enzymology*;Male;Mass Spectrometry;Membrane Transport Proteins/metabolism;Methylation;Microsomes, Liver/enzymology;Organic Anion Transport Protein 1/metabolism;Phytotherapy;Plant Roots;Plants, Medicinal;Rats, Sprague-Dawley;Renal Elimination;Salvia miltiorrhiza/chemistry*;Sulfates/metabolism
25872596;Adolescent;Adult;Alcohol Drinking/epidemiology*;Alcoholic Intoxication/epidemiology;Driving Under the Influence/statistics & numerical data;Female;Herb-Drug Interactions*;Humans;Male;Marijuana Abuse/epidemiology*;Middle Aged;Prevalence;Self-Injurious Behavior/epidemiology;Surveys and Questionnaires*;United States/epidemiology;Young Adult
25858254;Biological Products/pharmacology*;Blotting, Western;Chromatography, Liquid;Drugs, Chinese Herbal/pharmacology*;Estrone/analogs & derivatives*;Estrone/metabolism;Fluorescent Antibody Technique;HEK293 Cells;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Substrate Specificity;Tandem Mass Spectrometry;Transfection
25834921;Alcohol Oxidoreductases/antagonists & inhibitors*;Animals;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P450 Family 2;Cytochromes/antagonists & inhibitors*;Ginsenosides/administration & dosage;Ginsenosides/isolation & purification;Ginsenosides/pharmacology*;Herb-Drug Interactions*;Male;Panax notoginseng/chemistry;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/blood*;Rats, Wistar;Steroid 16-alpha-Hydroxylase/antagonists & inhibitors*;Substrate Specificity
25756365;Adult;Anticonvulsants/adverse effects*;Anticonvulsants/blood;Dose-Response Relationship, Drug;Drug Hypersensitivity Syndrome/blood;Drug Hypersensitivity Syndrome/diagnosis;Eosinophilia/blood;Eosinophilia/chemically induced*;Eosinophilia/diagnosis;Herb-Drug Interactions*;Humans;Male;Panax/adverse effects*;Panax/metabolism;Triazines/adverse effects*;Triazines/blood
25753317;Animals;Chromatography, High Pressure Liquid/methods*;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/pharmacokinetics;Flavonoids/blood*;Flavonoids/pharmacokinetics;Herb-Drug Interactions;Male;Metoprolol/analogs & derivatives;Metoprolol/blood*;Metoprolol/pharmacokinetics;Rats;Rats, Wistar;Tandem Mass Spectrometry/methods*
25729835;Adult;Anti-HIV Agents/adverse effects*;Benzoxazines/pharmacokinetics;Benzoxazines/therapeutic use*;Biotransformation;Ginkgo biloba*;HIV Infections/diagnosis;HIV Infections/drug therapy*;Herb-Drug Interactions*;Humans;Middle Aged;Patient Safety;Plant Extracts/adverse effects*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*;Risk Assessment;Risk Factors;Viral Load
25710938;Animals;Biological Transport/drug effects;Biological Transport/physiology;Caffeic Acids/metabolism*;Cell Line;Food;HEK293 Cells;Herb-Drug Interactions/physiology*;Humans;Kidney Tubules/drug effects;Kidney Tubules/metabolism*;Male;Membrane Transport Proteins/metabolism;Organic Anion Transport Protein 1/metabolism;Probenecid/pharmacology;Rats;Rats, Sprague-Dawley
25705905;Animals;Area Under Curve;Biological Transport/drug effects;Enzymes/metabolism;Half-Life;Herb-Drug Interactions*;Humans;Membrane Transport Proteins/metabolism;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Plants, Medicinal/chemistry;Prescription Drugs/pharmacokinetics*
25686904;Catalytic Domain;Computer Simulation;Cytochrome P-450 CYP2C19/chemistry;Cytochrome P-450 CYP2C19/metabolism*;Cytochrome P-450 CYP2C19 Inhibitors/chemistry;Cytochrome P-450 CYP2C19 Inhibitors/metabolism;Cytochrome P-450 CYP2C19 Inhibitors/pharmacology*;Diterpenes, Abietane/pharmacology*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology;Ethanol;Herb-Drug Interactions;Humans;Hydroxylation;Kinetics;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Molecular Docking Simulation;Phenanthrenes/chemistry;Phenanthrenes/metabolism;Phenanthrenes/pharmacology;Salvia miltiorrhiza/chemistry*
25684704;Centella/chemistry;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Kaempferols/pharmacology;Microsomes, Liver/drug effects*;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry;Quercetin/pharmacology;Triterpenes/pharmacology*;Withania/chemistry
25658125;Animals;Drug Discovery;Herb-Drug Interactions*;Humans;Medicine, Traditional*;Phytotherapy;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plants, Medicinal;Risk Assessment
25653502;Animals;Biological Transport;Dose-Response Relationship, Drug;Glucosides/metabolism*;Glucosides/pharmacology;HEK293 Cells;Herb-Drug Interactions;Humans;Kinetics;LLC-PK1 Cells;Models, Biological;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors;Organic Anion Transporters, Sodium-Independent/genetics;Organic Anion Transporters, Sodium-Independent/metabolism*;Plant Extracts/metabolism*;Plant Extracts/pharmacology;Swine
25647717;China;Consumer Product Safety*/legislation & jurisprudence;Dose-Response Relationship, Drug;Drug Contamination;Drug-Related Side Effects and Adverse Reactions/etiology*;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/standards*;Government Regulation;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional*/standards;Medicine, Chinese Traditional*/trends;Taiwan;United States
25640094;Animals;Carthamus tinctorius/chemistry;Clinical Trials as Topic;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Ginger/chemistry;Ginkgo biloba/chemistry;Glycyrrhiza/chemistry;Herb-Drug Interactions*;Humans;Lycium/chemistry;Medicine, Chinese Traditional/methods*;Panax/chemistry;Prunus persica/chemistry;Salvia miltiorrhiza/chemistry;Singapore;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use*
25623616;Adult;Benzylisoquinolines/blood;Berberine/blood;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP3A/metabolism;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Male;Microsomes, Liver/metabolism;Midazolam/pharmacology*;Milk Thistle*;Plant Extracts/pharmacology*;Silymarin/blood;Tolbutamide/pharmacology*;Young Adult
25618121;Adult;Aged;Aged, 80 and over;Diabetes Mellitus, Type 2/drug therapy*;Diet;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Health Care Surveys;Herb-Drug Interactions;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Nutrition Assessment;Nutritional Status;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Assessment;Risk Factors;Surveys and Questionnaires
25614104;Animals;Anti-HIV Agents/pharmacokinetics*;Atazanavir Sulfate/administration & dosage;Atazanavir Sulfate/pharmacokinetics*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Drug Combinations;Drugs, Chinese Herbal/pharmacokinetics*;Gene Expression Regulation, Enzymologic/drug effects;HIV Infections/drug therapy*;HIV Protease;Herb-Drug Interactions*;Humans;Male;Rats;Rats, Sprague-Dawley;Thailand
25600201;Cytochrome P-450 CYP2C19/metabolism*;Cytochrome P-450 CYP2C19 Inhibitors/isolation & purification;Cytochrome P-450 CYP2C19 Inhibitors/pharmacology*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/isolation & purification;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Hepatocytes/drug effects;Hepatocytes/enzymology;Herb-Drug Interactions;Humans;Kalanchoe*/chemistry;Kinetics;Liver/drug effects*;Liver/enzymology;Methanol/chemistry;Microsomes, Liver/enzymology;Models, Biological;NADP/metabolism;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Recombinant Proteins/metabolism;Risk Assessment;Solvents/chemistry;Testosterone/metabolism
25567192;Animals;Area Under Curve;Chromatography, High Pressure Liquid;Flavones/pharmacology*;Flavonoids/pharmacology;Herb-Drug Interactions*;Male;Piperazines/blood;Piperazines/pharmacokinetics*;Plant Extracts/pharmacology*;Purines/blood;Purines/pharmacokinetics;Rats, Wistar;Sildenafil Citrate;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Zingiberaceae/chemistry*
26958257;Anticoagulants/pharmacology*;Ginkgo biloba/chemistry*;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Statistics as Topic;United States;United States Department of Veterans Affairs;Warfarin/pharmacology*
25533650;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Integrative Medicine*;Medicine, Chinese Traditional*;Membrane Transport Proteins/metabolism
25485843;Adult;Aged;Antineoplastic Agents, Hormonal*/adverse effects;Breast Neoplasms/drug therapy;Drugs, Chinese Herbal*/adverse effects;Endometrial Neoplasms/epidemiology*;Endometrial Neoplasms/etiology*;Female;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional;Middle Aged;Neoplasms, Second Primary*;Odds Ratio;Population Surveillance;Practice Patterns, Physicians'*;Risk;Risk Factors;Taiwan;Tamoxifen*/adverse effects;Young Adult
25475096;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology*
25472767;Animals;Coix*;Cytochrome P-450 Enzyme Inducers/isolation & purification;Cytochrome P-450 Enzyme Inducers/metabolism;Cytochrome P-450 Enzyme Inducers/pharmacology*;Cytochrome P-450 Enzyme Inhibitors/isolation & purification;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions/physiology;Male;Rats;Rats, Sprague-Dawley
25451570;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Inhibitors/chemistry;Herb-Drug Interactions;Humans;Kinetics
25447838;Animals;Apigenin/pharmacology*;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/metabolism*;Cytochrome P450 Family 2;Cytochromes/metabolism;Herb-Drug Interactions;Liver/drug effects;Liver/enzymology;Male;Midazolam/pharmacokinetics*;Phenacetin/pharmacokinetics*;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Steroid 16-alpha-Hydroxylase/metabolism;Tolbutamide/pharmacokinetics*
25428336;Biomedical Research/legislation & jurisprudence*;Clinical Trials as Topic;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence*;Humans;Plants, Medicinal/adverse effects;United States
25413939;Aged;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Female;Herb-Drug Interactions;Humans;Paroxetine/adverse effects*;Paroxetine/therapeutic use*;Phytotherapy*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use*;Rhodiola*;Self Medication;Serotonin Syndrome/chemically induced*;Serotonin Syndrome/diagnosis*;Serotonin Syndrome/psychology;Somatoform Disorders/diagnosis;Somatoform Disorders/drug therapy*;Somatoform Disorders/psychology
25408261;Adolescent;Adult;Asian Continental Ancestry Group*;Biological Availability;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Fruit;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Young Adult
25392581;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2C19/metabolism;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Diclofenac/metabolism;Euphorbiaceae;Herb-Drug Interactions*;Humans;Hydroxylation;Liliaceae;Magnoliopsida;Mephenytoin/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Pharmaceutical Preparations/metabolism*;Phenacetin/metabolism;Plant Extracts/pharmacology*;Plants, Medicinal*;South Africa;Testosterone/metabolism
25377539;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biocatalysis/drug effects;Cell Death/drug effects;Cell Survival/drug effects;Cytochrome P-450 CYP1A2/genetics*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A/metabolism;Echinacea/chemistry*;Genes, Reporter;Hep G2 Cells;Herb-Drug Interactions;Humans;Luciferases/metabolism;Plant Extracts/pharmacology*;RNA, Messenger/genetics;RNA, Messenger/metabolism;Receptors, Steroid/metabolism*;Time Factors;Transcriptional Activation/drug effects;Transcriptional Activation/genetics;Up-Regulation/drug effects*
25343287;Administration, Oral;Amlodipine/administration & dosage;Amlodipine/pharmacokinetics*;Animals;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Half-Life;Herb-Drug Interactions*;Hypertension/drug therapy;Male;Panax/chemistry*;Rats;Rats, Sprague-Dawley;Republic of Korea;Tandem Mass Spectrometry
25339463;Administration, Oral;Animals;Cisplatin/administration & dosage;Cisplatin/blood;Cisplatin/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions*;Injections, Intraperitoneal;Male;Mass Spectrometry;Medicine, Chinese Traditional*;Rats, Sprague-Dawley;Spectrophotometry, Atomic;Ultrafiltration
25336552;Adrenergic alpha-2 Receptor Antagonists/pharmacology*;Antihypertensive Agents/therapeutic use*;Blood Pressure/drug effects;Clonidine/therapeutic use;Emergencies*;Herb-Drug Interactions*;Humans;Hypertension/drug therapy*;Labetalol/therapeutic use;Male;Middle Aged;Yohimbine/pharmacology*
25319228;Adult;Anti-Anxiety Agents/adverse effects;Anti-Anxiety Agents/pharmacology*;Contraceptives, Oral, Combined/adverse effects;Contraceptives, Oral, Combined/pharmacokinetics;Contraceptives, Oral, Combined/pharmacology;Cross-Over Studies;Double-Blind Method;Drug Therapy, Combination;Endometrium/drug effects;Estradiol/blood;Ethinyl Estradiol/adverse effects;Ethinyl Estradiol/pharmacokinetics*;Ethinyl Estradiol/pharmacology*;Female;Herb-Drug Interactions;Humans;Levonorgestrel/adverse effects;Levonorgestrel/pharmacokinetics*;Levonorgestrel/pharmacology*;Oils, Volatile/adverse effects;Oils, Volatile/pharmacology*;Ovarian Follicle/drug effects;Patient Compliance;Plant Oils/adverse effects;Plant Oils/pharmacology*;Progesterone/blood;Sex Hormone-Binding Globulin/drug effects;Young Adult
25312732;Cardiovascular Agents/adverse effects*;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology*;Cardiovascular Agents/therapeutic use;Herb-Drug Interactions*;Humans;Nadolol/pharmacokinetics;Simvastatin/pharmacokinetics;Tea/adverse effects*;Warfarin/pharmacology
25307559;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Humans;Risk Assessment
25297453;ATP Binding Cassette Subfamily B Member 11;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/metabolism;Animals;Blood Proteins/metabolism;Female;Ginsenosides/pharmacokinetics*;HEK293 Cells;Herb-Drug Interactions*;Humans;Kidney/metabolism;Liver/metabolism;Male;Multidrug Resistance-Associated Proteins/metabolism;Neoplasm Proteins/metabolism;Organic Anion Transporters/genetics;Organic Anion Transporters, Sodium-Independent/genetics;Rats, Sprague-Dawley;Solute Carrier Organic Anion Transporter Family Member 1B3;Solute Carrier Organic Anion Transporter Family Member 1b1
25286744;Administration, Oral;Adult;Cross-Over Studies;Cytochrome P-450 CYP2C19/genetics*;Cytochrome P-450 CYP2C19/metabolism;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A Inducers/administration & dosage*;Drug Administration Schedule;Enzyme Induction;Female;Genotype;Germany;Healthy Volunteers;Herb-Drug Interactions*;Humans;Hypericum*;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Pharmacogenetics;Phenotype;Phenylpropionates/administration & dosage;Phenylpropionates/blood;Phenylpropionates/pharmacokinetics*;Plant Extracts/administration & dosage*;Pyridazines/administration & dosage;Pyridazines/blood;Pyridazines/pharmacokinetics*
25256597;Animals;Apigenin/administration & dosage;Apigenin/isolation & purification;Apigenin/pharmacology*;Area Under Curve;Erigeron/chemistry;Glucuronates/administration & dosage;Glucuronates/isolation & purification;Glucuronates/pharmacology*;Herb-Drug Interactions*;Inhibitory Concentration 50;Male;Microsomes, Liver/metabolism;Platelet Aggregation Inhibitors/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics
25243874;Administration, Oral;Animals;Area Under Curve;Dogs;Herb-Drug Interactions*;Lepidium sativum/chemistry*;Male;Nigella sativa/chemistry*;Plant Preparations/pharmacology*;Seeds/chemistry;Theophylline/blood;Theophylline/pharmacokinetics*;Trigonella/chemistry*
25233607;Animals;Herb-Drug Interactions*;Humans;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Plants, Medicinal/chemistry*;Warfarin/adverse effects*;Warfarin/pharmacology
25230280;4-Hydroxycoumarins/administration & dosage;4-Hydroxycoumarins/adverse effects*;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Curcuma/adverse effects*;Female;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Indenes/administration & dosage;Indenes/adverse effects*;International Normalized Ratio;Middle Aged;Mitral Valve Insufficiency/drug therapy*;Phenindione/administration & dosage;Phenindione/adverse effects;Phenindione/analogs & derivatives*;Vitamin K/administration & dosage;Vitamin K/adverse effects;Vitamin K/antagonists & inhibitors*
25224345;Administration, Oral;Amiodarone/administration & dosage;Amiodarone/blood;Amiodarone/metabolism;Amiodarone/pharmacokinetics*;Animals;Biological Availability;Carica/chemistry*;Fruit/chemistry;Herb-Drug Interactions*;Injections, Intravenous;Male;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Wistar
25218322;Animals;Benzofurans/chemistry;Cerebrospinal Fluid/metabolism;Diterpenes, Abietane/chemistry;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics*;Ear, Inner;Ginsenosides/chemistry;Guinea Pigs;Herb-Drug Interactions/physiology;Medicine, Chinese Traditional/methods;Panax notoginseng/chemistry;Salvia miltiorrhiza/chemistry
25216634;Animals;Benzofurans/metabolism*;Benzofurans/pharmacology;Camptothecin/analogs & derivatives*;Camptothecin/metabolism;Camptothecin/pharmacology;Colon/drug effects;Colon/metabolism*;Coumarins/metabolism*;Coumarins/pharmacology;Dose-Response Relationship, Drug;Herb-Drug Interactions/physiology*;Humans;Male;Mice;Mice, 129 Strain
25212027;Alkaloids/pharmacology;Coumarins/pharmacology;Flavonoids/pharmacology;Fruit/chemistry;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional;Morus/chemistry*;Plant Extracts/pharmacology*;Plant Leaves/chemistry;Plant Roots/chemistry;Steroids/pharmacology
25197954;Cell Line, Tumor;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 CYP2C9 Inhibitors/chemistry;Cytochrome P-450 CYP2C9 Inhibitors/isolation & purification;Cytochrome P-450 CYP2C9 Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Isothiocyanates/chemistry;Isothiocyanates/isolation & purification;Isothiocyanates/pharmacology*;RNA, Messenger/metabolism;Receptors, Cytoplasmic and Nuclear/genetics;Receptors, Cytoplasmic and Nuclear/metabolism;Receptors, Steroid/genetics;Receptors, Steroid/metabolism
25196644;Caffeic Acids/pharmacology*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C19/metabolism;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Microsomes, Liver/drug effects*;Oxidation-Reduction;Quercetin/pharmacology*
25166453;Dietary Supplements/adverse effects*;Drug Interactions;Estrogen Replacement Therapy/adverse effects;Estrogens/blood;Estrogens/therapeutic use*;Female;Herb-Drug Interactions*;Humans;Melatonin/administration & dosage;Melatonin/blood;Minerals/administration & dosage;Minerals/metabolism;Vitamins/administration & dosage
25158128;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Plants, Medicinal/adverse effects*
25156015;Andrographis/adverse effects*;Andrographis/chemistry;Animals;Cytochrome P-450 Enzyme Inducers/adverse effects*;Cytochrome P-450 Enzyme Inducers/isolation & purification;Cytochrome P-450 Enzyme Inhibitors/adverse effects*;Cytochrome P-450 Enzyme Inhibitors/isolation & purification;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Diterpenes/adverse effects*;Diterpenes/isolation & purification;Enzyme Induction;Herb-Drug Interactions*;Humans;Isoenzymes;Liver/drug effects*;Liver/enzymology;Phytotherapy;Plant Extracts/adverse effects*;Plant Extracts/isolation & purification;Plants, Medicinal;Risk Assessment
25153228;Camptothecin/analogs & derivatives*;Camptothecin/metabolism;Camptothecin/pharmacology;Dose-Response Relationship, Drug;Herb-Drug Interactions/physiology*;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism*;Plant Preparations/metabolism*;Plant Preparations/pharmacology;Tamoxifen/metabolism*;Tamoxifen/pharmacology
25141924;Animals;Breast Neoplasms/drug therapy*;Breast Neoplasms/genetics;Breast Neoplasms/pathology*;Cell Transformation, Neoplastic/drug effects*;Cyclin-Dependent Kinase Inhibitor p27/metabolism;Disease Models, Animal;Drug Therapy, Combination;Female;Herb-Drug Interactions;Humans;Luciferases/metabolism;MCF-7 Cells;Mice, Inbred BALB C;Mice, Nude;Microtubule-Associated Proteins/metabolism;Neoplasm Transplantation;Phenols/administration & dosage*;Phenols/adverse effects*;Phenols/pharmacology;Tamoxifen/administration & dosage*;Tamoxifen/adverse effects*;Tamoxifen/pharmacology
25138353;Anti-Retroviral Agents;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/biosynthesis*;Enzyme Induction/drug effects;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Papua New Guinea;Plant Extracts/pharmacology*;Plants, Medicinal*;Receptors, Aryl Hydrocarbon/metabolism;Receptors, Steroid/metabolism
25137576;Alnus/chemistry*;Antineoplastic Agents/pharmacology*;Antineoplastic Agents, Phytogenic/chemistry;Antineoplastic Agents, Phytogenic/pharmacology;Antioxidants/chemistry;Antioxidants/pharmacology*;Cell Death/drug effects;Cell Line;Cell Line, Tumor;Cell Proliferation/drug effects;Diarylheptanoids/chemistry;Diarylheptanoids/isolation & purification;Diarylheptanoids/pharmacology*;Doxorubicin/analysis;Doxorubicin/metabolism;Herb-Drug Interactions*;Humans;Mitochondria/drug effects;Mitochondria/ultrastructure;Neoplasms/drug therapy;Neoplasms/metabolism;Plant Bark/chemistry;Reactive Oxygen Species/metabolism;Superoxide Dismutase/genetics;Superoxide Dismutase/metabolism
25099385;Animals;Aryl Hydrocarbon Hydroxylases/analysis;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P450 Family 2;Dose-Response Relationship, Drug;Ferula/adverse effects*;Gene Expression/drug effects*;Herb-Drug Interactions*;Liver/metabolism*;Male;Microsomes, Liver/metabolism;Nigella sativa/adverse effects*;Rats;Steroid 16-alpha-Hydroxylase/analysis;Steroid 16-alpha-Hydroxylase/biosynthesis*;Steroid 16-alpha-Hydroxylase/genetics;Tolbutamide/metabolism;Trigonella/adverse effects*
25091987;Apoptosis/drug effects;Cell Proliferation/drug effects;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/pathology;Dose-Response Relationship, Drug;Fluorouracil/administration & dosage*;HCT116 Cells;HT29 Cells;Herb-Drug Interactions*;Humans;Malaysia;Phytotherapy*;Piper betle*;Plant Extracts/administration & dosage;Plant Leaves
25091466;Animals;Antidepressive Agents/blood;Antidepressive Agents/pharmacokinetics;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics;Isoenzymes/genetics;Isoenzymes/metabolism;Lignans/blood;Lignans/pharmacokinetics;Lignans/pharmacology;Male;Medicine, Chinese Traditional;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Rats, Sprague-Dawley;Schisandra*;Sertraline/blood;Sertraline/pharmacokinetics;Tacrolimus/blood;Tacrolimus/pharmacokinetics
25063588;Aged;Aged, 80 and over;Dietary Supplements*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plants, Medicinal
25052959;Chromatography, Liquid;Cytochrome P-450 Enzyme System/metabolism*;Glucuronosyltransferase/metabolism;Hepatocytes/drug effects;Hepatocytes/enzymology*;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Lonicera/chemistry;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Sepsis/drug therapy*;Tandem Mass Spectrometry
25048609;Adult;Aged;Antineoplastic Agents, Hormonal/adverse effects*;Breast Neoplasms/diagnosis;Breast Neoplasms/drug therapy*;Breast Neoplasms/epidemiology;Databases, Factual;Drugs, Chinese Herbal/adverse effects*;Endometrial Neoplasms/chemically induced*;Endometrial Neoplasms/diagnosis;Endometrial Neoplasms/epidemiology;Endometrial Neoplasms/prevention & control;Female;Herb-Drug Interactions*;Humans;Logistic Models;Medicine, Chinese Traditional*;Middle Aged;Odds Ratio;Phytotherapy;Plants, Medicinal;Proportional Hazards Models;Protective Factors;Risk Assessment;Risk Factors;Taiwan/epidemiology;Tamoxifen/adverse effects*;Young Adult
25044854;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors*;ATP-Binding Cassette Transporters/genetics;Antineoplastic Agents/chemistry;Biological Availability;Breast Neoplasms/metabolism;Drug Resistance, Neoplasm;Female;Flavanones/chemistry;Flavonoids/chemistry*;Gene Expression Regulation, Neoplastic*;HEK293 Cells;Herb-Drug Interactions;Humans;Humulus/chemistry*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Mitoxantrone/chemistry;Neoplasm Proteins/antagonists & inhibitors*;Neoplasm Proteins/genetics;Phytoestrogens/chemistry;Propiophenones/chemistry;Xanthones/chemistry;Xenobiotics/chemistry
25042570;Administration, Oral;Animals;Area Under Curve;Bridged-Ring Compounds/blood;Bridged-Ring Compounds/pharmacokinetics*;Chromatography, High Pressure Liquid/methods*;Drug Stability;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/chemistry;Female;Glucosides/blood;Glucosides/pharmacokinetics*;Half-Life;Herb-Drug Interactions;Isomerism;Limit of Detection;Male;Monoterpenes/blood;Monoterpenes/pharmacokinetics*;Paeonia/chemistry;Rats, Sprague-Dawley;Reproducibility of Results;Tandem Mass Spectrometry/methods*
25039536;Aged, 80 and over;China/epidemiology;Chronic Disease/drug therapy*;Chronic Disease/epidemiology;Cognition Disorders/drug therapy;Cross-Sectional Studies;Drugs, Chinese Herbal/therapeutic use;Educational Status;Female;Herb-Drug Interactions;Humans;Hypertension/drug therapy;Male;Medicine, Chinese Traditional;Neoplasms/drug therapy;Odds Ratio;Osteoarthritis/drug therapy;Polypharmacy*;Prevalence;Respiratory Insufficiency/drug therapy;Rural Population/statistics & numerical data*;Surveys and Questionnaires
25039191;Achyranthes/chemistry*;Animals;Chalcone/administration & dosage;Chalcone/analogs & derivatives*;Chalcone/blood;Chalcone/pharmacokinetics;Chlorogenic Acid/administration & dosage;Chlorogenic Acid/blood;Chlorogenic Acid/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Glucosides/administration & dosage;Glucosides/blood;Glucosides/pharmacokinetics*;Glycosides/administration & dosage;Glycosides/blood;Glycosides/pharmacokinetics*;Glycyrrhizic Acid/administration & dosage;Glycyrrhizic Acid/pharmacokinetics*;Herb-Drug Interactions;Male;Pyrans/administration & dosage;Pyrans/blood;Pyrans/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
25034211;Animals;Cimetidine/pharmacokinetics*;Furosemide/blood;Furosemide/pharmacokinetics*;HEK293 Cells;Herb-Drug Interactions*;Humans;Male;Organic Cation Transport Proteins/antagonists & inhibitors*;Organic Cation Transport Proteins/metabolism;Plant Preparations/pharmacology*;Rats;Rats, Sprague-Dawley
25029715;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use*;Contraindications;Diet*;Drug-Related Side Effects and Adverse Reactions/prevention & control*;Herb-Drug Interactions;Humans;Vegetables/adverse effects*;Warfarin/adverse effects*;Warfarin/therapeutic use*
25028567;Caffeine/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/pharmacokinetics;Dietary Supplements/analysis;Female;Herb-Drug Interactions;Humans;Male;Midazolam/pharmacokinetics;Milk Thistle/chemistry*;Plant Extracts/pharmacology*;Silymarin/analogs & derivatives;Silymarin/blood;Tolbutamide/pharmacokinetics;Young Adult
25026340;Dose-Response Relationship, Drug;Gallic Acid/administration & dosage;Gallic Acid/isolation & purification;Gallic Acid/pharmacology*;HEK293 Cells;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Oleanolic Acid/administration & dosage;Oleanolic Acid/isolation & purification;Oleanolic Acid/pharmacology*;Organic Anion Transporters/antagonists & inhibitors;Organic Cation Transport Proteins/antagonists & inhibitors;Punicaceae/chemistry*;Triterpenes/administration & dosage;Triterpenes/isolation & purification;Triterpenes/pharmacology*
25001901;8-Bromo Cyclic Adenosine Monophosphate/analogs & derivatives;8-Bromo Cyclic Adenosine Monophosphate/pharmacology;Adenosine Diphosphate/pharmacology*;Adenosine Triphosphate/metabolism;Blood Platelets/drug effects;Blood Platelets/metabolism;Calcium/metabolism;Calcium Signaling/drug effects*;Cell Adhesion Molecules/metabolism*;Cordyceps/chemistry;Cyclic AMP/metabolism;Cyclooxygenase 1/metabolism;Deoxyadenosines/pharmacology*;Dose-Response Relationship, Drug;Fibrinogen/metabolism*;Herb-Drug Interactions;Humans;Inositol 1,4,5-Trisphosphate Receptors/metabolism*;Microfilament Proteins/metabolism*;Phosphoproteins/metabolism*;Phosphorylation/drug effects;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/pharmacology;Thionucleotides/pharmacology;Thromboxane A2/metabolism;Thromboxane-A Synthase/metabolism
24997313;Animals;Blueberry Plants/chemistry;Butanones/pharmacology;Camptothecin/administration & dosage;Camptothecin/analogs & derivatives;Camptothecin/pharmacokinetics;Chromatography, Liquid;Fruit/chemistry*;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/genetics*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Ketones/pharmacology*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Rubus/chemistry;Sambucus/chemistry;Tandem Mass Spectrometry;Vaccinium macrocarpon/chemistry;Vaccinium myrtillus/chemistry
24992495;Animals;Area Under Curve;Commiphora/chemistry*;Herb-Drug Interactions/physiology;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry*;Rabbits;Theophylline/pharmacokinetics*;Theophylline/pharmacology
24990552;Animals;Coleus*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Hypoglycemic Agents/pharmacology*;Liver/enzymology*;Male;Mumps Vaccine;Plant Extracts/adverse effects*;Plant Extracts/pharmacology*;Rats, Wistar;Tolbutamide/pharmacology*
24981811;Aged;Creatinine/blood;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Male;Peumus*;Phytotherapy;Tacrolimus/pharmacokinetics*;Transplant Recipients;Transplantation, Homologous
24969526;Animals;Antioxidants/metabolism;Antioxidants/pharmacology*;Catalase/metabolism*;Cytochrome P-450 CYP2E1/metabolism*;Cytosol;Drugs, Chinese Herbal/pharmacology*;Glutathione/metabolism*;Glutathione Transferase/metabolism*;Herb-Drug Interactions;Inactivation, Metabolic/drug effects;Liver/drug effects*;Liver/enzymology;Male;Microsomes;Rats, Sprague-Dawley
24969391;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Probiotics/adverse effects*;Probiotics/therapeutic use;Renal Insufficiency, Chronic/drug therapy*;Treatment Outcome
24961584;Animals;Area Under Curve;Biological Availability;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Liver/drug effects;Liver/metabolism;Male;Nifedipine/administration & dosage;Nifedipine/metabolism;Nifedipine/pharmacokinetics*;Rats, Wistar
24956073;Antidepressive Agents/therapeutic use;Herb-Drug Interactions*;Humans;Hypericum*;Phytotherapy/adverse effects*;Phytotherapy/methods*;Plant Extracts/administration & dosage*;Plant Extracts/adverse effects*;Prescriptions;Retrospective Studies;United States
24933226;Administration, Oral;Animals;Cytochrome P-450 Enzyme Inducers/administration & dosage;Cytochrome P-450 Enzyme Inducers/pharmacology;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics*;Diterpenes, Kaurane/administration & dosage;Diterpenes, Kaurane/pharmacology*;Dose-Response Relationship, Drug;Gene Expression Regulation, Enzymologic/drug effects*;Herb-Drug Interactions;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred C57BL;RNA, Messenger/metabolism
24929108;Animals;Diabetes Mellitus/drug therapy*;Ethnopharmacology;Herb-Drug Interactions;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacology;Hypoglycemic Agents/therapeutic use;Medicine, African Traditional;Nigeria;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Preparations/adverse effects;Plant Preparations/pharmacology;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry*
24922060;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Caco-2 Cells;Cardiotonic Agents/blood*;Digoxin/blood;Drugs, Chinese Herbal/pharmacology*;Ginsenosides/blood*;Herb-Drug Interactions*;Humans;Rats
24892506;Attitude of Health Personnel*;Complementary Therapies/adverse effects;Complementary Therapies/standards*;England;Evidence-Based Practice/standards*;General Practitioners/psychology*;General Practitioners/standards;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Interviews as Topic;Patient Harm/prevention & control*;Qualitative Research;Referral and Consultation/standards;Social Class
24872678;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Bile/metabolism;Biological Transport;Dogs;Drug Interactions;Herb-Drug Interactions*;Humans;Intestinal Absorption;Madin Darby Canine Kidney Cells;Male;Organic Anion Transporters/physiology*;Rats;Rats, Sprague-Dawley;Saponins/pharmacokinetics*
24851484;Anticholesteremic Agents/adverse effects*;Anticholesteremic Agents/therapeutic use;Atorvastatin Calcium;Back Pain/chemically induced;Back Pain/etiology*;Beverages/adverse effects*;Fruit*;Heptanoic Acids/adverse effects*;Heptanoic Acids/therapeutic use;Herb-Drug Interactions;Humans;Hyperlipidemias/drug therapy;Male;Middle Aged;Pyrroles/adverse effects*;Pyrroles/therapeutic use;Vaccinium macrocarpon*
24850941;Aromatherapy*/adverse effects;Curriculum;Education, Pharmacy/methods*;Educational Measurement;Herb-Drug Interactions;Humans;Medication Errors/prevention & control;Oils, Volatile/adverse effects;Oils, Volatile/therapeutic use*;Problem-Based Learning;Program Evaluation;Surveys and Questionnaires;Teaching/methods*
24831257;Animals;Biological Transport/drug effects;HIV Infections/drug therapy;Herb-Drug Interactions*;Humans;Medicine, African Traditional*;Pharmaceutical Preparations/metabolism;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Plants, Medicinal/chemistry
24824478;Beverages;Chrysanthemum;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/pharmacology*;Glycyrrhiza;Herb-Drug Interactions*;Houttuynia;Humans;Magnoliopsida*;Sirolimus/pharmacokinetics*;Taraxacum
24811814;Animals;Diabetes Mellitus, Type 2/drug therapy;Herb-Drug Interactions*;Hypoglycemic Agents/pharmacokinetics*;Male;Medicine, Chinese Traditional*;Rats;Rats, Wistar;Rehmannia*;Thiazolidinediones/pharmacokinetics*
24797776;Dietary Supplements*;Drug Interactions*;Herb-Drug Interactions*;Humans;Internet;Phytotherapy*
24780924;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology;Gene Expression Regulation/drug effects;Herb-Drug Interactions*;Lamivudine/administration & dosage;Lamivudine/pharmacokinetics*;Liver/metabolism;Male;Microdialysis/methods*;Rats;Rats, Sprague-Dawley;Tissue Distribution
24779639;Acetic Acid/chemistry;Animals;Bupleurum/chemistry;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions*;Isoenzymes/metabolism;Male;Mice;Microsomes, Liver;Oleanolic Acid/analogs & derivatives*;Oleanolic Acid/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Saponins/pharmacology*;Time Factors
24769006;Benzofurans/pharmacology*;Cytochrome P-450 CYP2C9/metabolism;Cytochrome P-450 CYP2C9 Inhibitors/pharmacology;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Tandem Mass Spectrometry
24761606;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biological Transport/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal*/isolation & purification;Drugs, Chinese Herbal*/pharmacokinetics;Drugs, Chinese Herbal*/pharmacology;Evidence-Based Medicine/methods;Gastrointestinal Tract/drug effects;Herb-Drug Interactions*;Humans;Kidney/drug effects;Medicine, Chinese Traditional;Pharmacokinetics*;Phytotherapy;Plants, Medicinal/chemistry*
24747521;Animals;Chromatography, Liquid/methods*;Digoxin/blood*;Digoxin/pharmacokinetics;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/pharmacokinetics;Ginkgo biloba/chemistry*;Herb-Drug Interactions;Male;Plant Leaves/chemistry;Rats;Rats, Wistar;Spectrometry, Mass, Electrospray Ionization/methods*
24741187;Animals;Anti-Bacterial Agents/pharmacology;Anti-Bacterial Agents/toxicity*;Free Radicals/metabolism;Gentamicins/pharmacology;Gentamicins/toxicity*;Herb-Drug Interactions;Kidney/drug effects*;Kidney/metabolism;Kidney/pathology;Kidney Diseases/blood;Kidney Diseases/chemically induced;Kidney Diseases/prevention & control*;Kidney Diseases/urine;Kidney Function Tests;Male;Mentha piperita/chemistry*;Microbial Sensitivity Tests;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification;Plant Extracts/therapeutic use*;Rabbits
24736980;Animals;Biological Transport;Drugs, Chinese Herbal/pharmacology*;Genotype;HEK293 Cells;Hepatocytes/drug effects*;Hepatocytes/metabolism*;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Kinetics;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Phenotype;Polymorphism, Genetic;Rats;Rosuvastatin Calcium/metabolism*;Triterpenes/pharmacology*
24735758;Biological Availability;Caco-2 Cells/drug effects*;Cell Survival;Drug Evaluation, Preclinical/methods;Herb-Drug Interactions*;Humans;Intestinal Absorption
24730468;Aryl Hydrocarbon Hydroxylases/metabolism*;Camellia sinensis*;Complementary Therapies;Coumarins/metabolism*;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Milk Thistle/chemistry*;Plant Extracts/pharmacology*;Silymarin/pharmacology;Tolbutamide/metabolism*
24719213;Animals;Area Under Curve;Dogs;Herb-Drug Interactions*;Lepidium sativum*;Male;Nigella sativa*;Piperazines/pharmacokinetics*;Purines/pharmacokinetics;Sildenafil Citrate;Sulfonamides/pharmacokinetics*;Trigonella*
24710903;Animals;Anti-Inflammatory Agents/pharmacology;Anti-Inflammatory Agents/therapeutic use;Cell Survival/drug effects;Citrus/chemistry*;Flavanones/pharmacology*;Flavanones/therapeutic use;Fruit/chemistry*;Herb-Drug Interactions;Lycopersicon esculentum/chemistry*;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
24710899;Administration, Intravenous;Administration, Oral;Animals;Area Under Curve;Biological Availability;Buspirone/pharmacokinetics*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Isoflavones/chemistry;Isoflavones/isolation & purification;Isoflavones/pharmacology*;Liver/drug effects;Liver/enzymology;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Plant Roots/chemistry;Pueraria/chemistry*;Rats;Rats, Sprague-Dawley
24704041;Animals;Biomarkers/urine;Creatinine/urine;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Glycyrrhiza/chemistry*;Herb-Drug Interactions*;Kidney/drug effects;Kidney Diseases/chemically induced;Kidney Diseases/urine;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Rhizome/chemistry*;Strychnine/adverse effects;Strychnine/analogs & derivatives*;Strychnos/adverse effects;Toxicokinetics;Uric Acid/urine
24690772;Alkenes/pharmacology*;Animals;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Microsomes, Liver/metabolism;Piperidines/pharmacology*;Rats
24686576;Acetaminophen/blood;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Analgesics, Non-Narcotic/pharmacology;Animals;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacology;Capsules;Diazepam/blood;Diazepam/pharmacokinetics;Diazepam/pharmacology*;Female;Herb-Drug Interactions*;Hypericum/chemistry*;Male;Mice;Motor Activity/drug effects;Pentobarbital/blood;Pentobarbital/pharmacokinetics;Pentobarbital/pharmacology*;Perylene/analogs & derivatives;Perylene/analysis;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Plants, Medicinal;Serbia;Solvents;Tablets
24679099;Angiogenesis Inhibitors/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Antineoplastic Agents, Alkylating/therapeutic use;Bevacizumab;Brain Neoplasms/drug therapy*;Camptothecin/analogs & derivatives;Camptothecin/therapeutic use;Chemical and Drug Induced Liver Injury*/etiology;Combined Modality Therapy;Dacarbazine/analogs & derivatives*;Dacarbazine/therapeutic use;Disease Progression;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Female;Glioblastoma/drug therapy*;Herb-Drug Interactions*;Humans;Liver/pathology*;Middle Aged;Phytotherapy/adverse effects
24657955;Dose-Response Relationship, Drug;Drug-Related Side Effects and Adverse Reactions;Female;Herb-Drug Interactions*;Humans;Inpatients/statistics & numerical data*;Italy;Male;Nonprescription Drugs/adverse effects;Pharmacovigilance*;Phytotherapy/adverse effects*;Phytotherapy/statistics & numerical data;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects;Preoperative Period*;Risk Factors
24646483;Animals;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology*;Complementary Therapies/adverse effects;Complementary Therapies/methods;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Neoplasms/pathology;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Preparations/adverse effects;Plant Preparations/pharmacology*
24642020;Administration, Oral;Animals;Anthraquinones/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage*;Hemostasis/drug effects;Hemostasis/physiology*;Herb-Drug Interactions/physiology*;Rabbits;Random Allocation;Time Factors
24631340;Andrographis*;Diterpenes/chemistry;Diterpenes/metabolism*;Enzyme Repression/drug effects;Glucuronosyltransferase/drug effects;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology
24612940;Adult;Arylamine N-Acetyltransferase/metabolism;Asian Continental Ancestry Group;Caffeine/administration & dosage;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Dextromethorphan/administration & dosage;Furocoumarins/pharmacology*;Healthy Volunteers;Herb-Drug Interactions;Herbal Medicine*;Humans;Hydrocortisone/analogs & derivatives;Hydrocortisone/urine;Male;Medicine, Traditional*;Phytotherapy*;Plants, Medicinal/chemistry;Xanthine Oxidase/metabolism;Young Adult
24583869;Antimetabolites, Antineoplastic/adverse effects*;Antioxidants/pharmacology*;Caco-2 Cells;Catechin/analogs & derivatives*;Catechin/pharmacology;Herb-Drug Interactions;Humans;Hydrogen Peroxide/metabolism;Intestinal Mucosa/drug effects*;Intestinal Mucosa/immunology;Neoplasms/drug therapy;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Reactive Oxygen Species/metabolism;Tegafur/adverse effects*;alpha-Defensins/genetics;alpha-Defensins/metabolism*
24575655;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects*;Contraindications;Cytochrome P-450 Enzyme System/drug effects;Drug Monitoring;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Liver/metabolism;Phytotherapy*;Plant Extracts*/administration & dosage
26060475;Anti-HIV Agents/metabolism*;Area Under Curve;Dose-Response Relationship, Drug;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Flavanones/pharmacokinetics*;Flavanones/pharmacology;Herb-Drug Interactions*;Humans;In Vitro Techniques;Microsomes, Liver/metabolism*;Predictive Value of Tests;Reverse Transcriptase Inhibitors;Zidovudine/metabolism*;Zidovudine/pharmacology
24566323;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Bacopa/chemistry;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions;Humans;Inactivation, Metabolic;Microsomes, Liver/metabolism;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Saponins/administration & dosage;Triterpenes/administration & dosage
24558885;Animals;Cordyceps/chemistry*;Diabetic Nephropathies/drug therapy*;Diabetic Nephropathies/metabolism;Diabetic Nephropathies/physiopathology;Drugs, Chinese Herbal/administration & dosage*;Herb-Drug Interactions;Humans;Hyperglycemia/drug therapy*;Hyperglycemia/metabolism;Hyperglycemia/physiopathology;Kidney/drug effects*;Kidney/injuries;Kidney/physiopathology;Male;Metabolic Syndrome/drug therapy*;Metabolic Syndrome/metabolism;Metabolic Syndrome/physiopathology;Rats;Rats, Sprague-Dawley;Rhodiola/chemistry*;Rhus/chemistry*
24533823;Animals;Antibiotics, Antineoplastic/pharmacology;Antibiotics, Antineoplastic/therapeutic use;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use;Breast Neoplasms/drug therapy*;Doxorubicin/pharmacology;Doxorubicin/therapeutic use*;Drug Resistance, Multiple/drug effects;Drug Resistance, Neoplasm/drug effects*;Female;Herb-Drug Interactions*;Humans;Ligusticum/chemistry*;MCF-7 Cells;Mice;Mice, Inbred BALB C;Mice, Nude;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Pyrazines/pharmacology;Pyrazines/therapeutic use*
24533750;Adult;Attitude to Health*;Data Collection;Denmark;Female;Follow-Up Studies;Health Personnel;Herb-Drug Interactions*;Herbal Medicine;Humans;Interviews as Topic;Multiple Sclerosis*/drug therapy;Patient Satisfaction;Phytotherapy;Plant Extracts*/therapeutic use;Risk Assessment;Safety;Sensation*;Societies, Medical
24528618;Acupuncture Therapy;Animals;Arrhythmias, Cardiac/drug therapy;Arrhythmias, Cardiac/physiopathology;Arrhythmias, Cardiac/therapy*;Berberis;Cinchona;Complementary Therapies*;Crataegus;Drugs, Chinese Herbal/therapeutic use;Fatty Acids, Omega-3/therapeutic use;Herb-Drug Interactions;Humans;Leonurus;Phytotherapy;Treatment Outcome;Yoga
24525674;Animals;Antineoplastic Agents, Hormonal/administration & dosage;Antineoplastic Agents, Hormonal/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/pathology;Cell Cycle/drug effects;Cell Proliferation/drug effects;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;Humans;MCF-7 Cells;Mice;Mice, Inbred BALB C;Mice, Nude;Signal Transduction/drug effects;Tamoxifen/administration & dosage;Tamoxifen/pharmacology*;Tumor Burden/drug effects;Xenograft Model Antitumor Assays
24525006;Health Personnel;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*
24515579;Autopsy;Cause of Death;DNA, Plant/genetics*;Forensic Toxicology/methods*;Genetic Markers;Herb-Drug Interactions*;Humans;Metabolomics*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/analysis*;Plants, Medicinal*/adverse effects;Plants, Medicinal*/genetics;Plants, Medicinal*/metabolism;Sequence Analysis, DNA*
24510399;Adolescent;Adult;Biotransformation;Curcuma*/chemistry;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP2D6 Inhibitors/chemistry;Cytochrome P-450 CYP2D6 Inhibitors/isolation & purification;Cytochrome P-450 CYP2D6 Inhibitors/pharmacology*;Cytochrome P-450 CYP3A/metabolism*;Dealkylation;Dextromethorphan/analogs & derivatives;Dextromethorphan/pharmacokinetics*;Dextrorphan/pharmacokinetics;Dose-Response Relationship, Drug;Ethanol/chemistry;Healthy Volunteers;Herb-Drug Interactions*;Humans;Linear Models;Liver/drug effects*;Liver/enzymology;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Phytotherapy;Plant Extracts/chemistry;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plants, Medicinal;Powders;Rhizome;Saudi Arabia;Solvents/chemistry;Substrate Specificity;Young Adult
24498827;Animals;Dietary Supplements/adverse effects;Drug Interactions*;Food-Drug Interactions;Herb-Drug Interactions;Holistic Health*;Humans;Pharmacokinetics*;Polypharmacy
24493631;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Caco-2 Cells;Digoxin/metabolism*;Ginsenosides/pharmacology*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Intestines/microbiology;Male;Panax/chemistry*;Rats;Rats, Sprague-Dawley;Rhodamine 123/metabolism*
24492725;Biological Transport;Biological Transport, Active;Cations/metabolism;Cell Line;Diet;Food-Drug Interactions*;Furocoumarins/pharmacology;Ginkgo biloba/chemistry;HEK293 Cells;Herb-Drug Interactions*;Humans;Kidney/metabolism*;Liver/metabolism*;Organic Cation Transport Proteins/antagonists & inhibitors*;Plant Extracts/pharmacology*;Protons;Quercetin/analogs & derivatives;Quercetin/pharmacology;Tetraethylammonium/metabolism*;Xenobiotics/metabolism
24475926;Africa;Anti-HIV Agents/adverse effects*;Cytochrome P-450 Enzyme Inhibitors/adverse effects*;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;HIV Infections/diagnosis;HIV Infections/drug therapy*;Herb-Drug Interactions*;High-Throughput Screening Assays;Humans;Isoenzymes;Phytotherapy;Plant Preparations/adverse effects*;Plants, Medicinal;Recombinant Proteins/metabolism;Risk Assessment;Risk Factors;Substrate Specificity
24472406;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/physiology;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A/physiology;Herb-Drug Interactions*;Humans;Hypericum*;Male;Middle Aged;Sulfonamides/pharmacokinetics*
24464299;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Plant Extracts/pharmacology*;Risk Assessment;Substrate Specificity
24452064;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Plants, Medicinal/adverse effects*
24427969;Chemical and Drug Induced Liver Injury;Dietary Supplements*/adverse effects;Food Safety*;Ginkgo biloba/adverse effects;Hawaii;Herb-Drug Interactions;Humans;Kava/adverse effects;United States
24420925;Animals;Cyclophosphamide/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Diterpenes/pharmacology*;Epoxy Compounds/pharmacology;Herb-Drug Interactions*;Hydroxytestosterones/metabolism;Immunosuppressive Agents/pharmacokinetics*;Injections, Intravenous;Ketoconazole/pharmacology;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Phenanthrenes/pharmacology*;Rats, Sprague-Dawley
24399745;Clinical Trials as Topic;Dietary Supplements*/adverse effects;Female;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Preparations*/adverse effects;Plant Preparations*/therapeutic use;Plants, Medicinal/adverse effects;Pregnancy/drug effects*
24397864;Apoptosis/drug effects;Cell Line, Tumor;Cell Proliferation/drug effects;Cisplatin/pharmacology;Cytostatic Agents/pharmacology;Deoxycytidine/analogs & derivatives;Deoxycytidine/pharmacology;Doxorubicin/pharmacology;Herb-Drug Interactions*;Humans;Male;Mitoxantrone/pharmacology;Neoplasms/drug therapy*;Neoplasms/pathology*;Plant Extracts/pharmacology*;Plant Extracts/standards*;Plants, Medicinal/chemistry;Taxoids/pharmacology;Viscum album/chemistry*
24387348;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antineoplastic Agents/pharmacokinetics*;Clinical Trials as Topic;Complementary Therapies/methods;Cytochrome P-450 Enzyme System/metabolism;Echinacea/chemistry;Garlic/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions*;Humans;Hypericum/chemistry;Neoplasms/drug therapy*;Panax/chemistry;Phytotherapy/methods*;Plant Preparations/pharmacokinetics*
24380838;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/metabolism*;Animals;Area Under Curve;Caco-2 Cells;Cell Line, Tumor;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Digoxin/administration & dosage;Diterpenes/adverse effects*;Emodin/adverse effects*;Ginsenosides/adverse effects*;Glycyrrhetinic Acid/adverse effects;Glycyrrhetinic Acid/analogs & derivatives*;Herb-Drug Interactions*;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/pathology;Protein Conformation;Rats;Verapamil/administration & dosage
24373810;Animals;Chalcone/analogs & derivatives*;Chalcone/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics*;Dextromethorphan/blood;Dextromethorphan/pharmacokinetics;Herb-Drug Interactions;Isoenzymes/antagonists & inhibitors;Isoenzymes/genetics;Liver/drug effects;Liver/enzymology;Male;Midazolam/blood;Midazolam/pharmacokinetics;Phenacetin/blood;Phenacetin/pharmacokinetics;Quinones/pharmacology*;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Tolbutamide/blood;Tolbutamide/pharmacokinetics
25954326;Dietary Supplements;Electronic Health Records*;Herb-Drug Interactions*;Humans;Knowledge Bases*;Medical Order Entry Systems*;Medication Errors/prevention & control;Risk Factors
24365638;Angelica sinensis/chemistry*;Animals;Asian Continental Ancestry Group;Clinical Trials as Topic/methods;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Europe;European Continental Ancestry Group;Female;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional/methods*;Plant Roots
24365615;Beverages/adverse effects*;Chemistry, Clinical/standards*;Digoxin/analysis;Digoxin/blood*;Drug Monitoring/standards;False Positive Reactions;Female;Flavonoids/adverse effects*;Heart Failure/blood;Heart Failure/drug therapy*;Herb-Drug Interactions*;Hibiscus/chemistry;Humans;Rosa/chemistry
24344037;Adult;Aged;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Chi-Square Distribution;Female;Health Behavior*;Health Care Surveys;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/therapy*;Patient Education as Topic;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Factors;Surveys and Questionnaires;Turkey;Young Adult
24335390;Animals;Computer Simulation;Drug Design;Drug Evaluation, Preclinical/methods;Drug Evaluation, Preclinical/trends;Government Regulation;Herb-Drug Interactions*;Humans;Legislation, Drug;Milk Thistle/chemistry;Models, Biological;Pharmaceutical Preparations/chemistry*;Pharmaceutical Preparations/metabolism;Pharmaceutical Preparations/standards;Pharmacokinetics*;Plant Preparations/chemistry*;Plant Preparations/pharmacokinetics;Plant Preparations/standards;Silymarin/pharmacokinetics;Silymarin/pharmacology;Stilbenes/pharmacokinetics;Stilbenes/pharmacology
24325069;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/pharmacology*;Evaluation Studies as Topic;Herb-Drug Interactions*;Integrative Medicine*
24319132;Complementary Therapies/education*;Credentialing;Curriculum*;Education, Dental*;Faculty;Herb-Drug Interactions;Humans;Phytotherapy;Problem-Based Learning;Schools, Dental*;Teaching/methods;Time Factors;United States
24298594;Anticoagulants/adverse effects*;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Lycium*;Vitamin K/antagonists & inhibitors*
24291054;Aged;Aspirin/pharmacology;Aspirin/therapeutic use*;Cross-Over Studies;Diabetes Mellitus, Type 2/complications;Diabetic Angiopathies/prevention & control*;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Phyllanthus emblica*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Platelet Aggregation Inhibitors/pharmacology;Platelet Aggregation Inhibitors/therapeutic use*;Prospective Studies;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacology;Ticlopidine/therapeutic use
24252494;Animals;Area Under Curve;Chlorzoxazone/pharmacokinetics;Chlorzoxazone/pharmacology;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Escin/pharmacokinetics;Escin/pharmacology*;Gene Expression Regulation, Enzymologic/drug effects*;Half-Life;Herb-Drug Interactions;Hypnotics and Sedatives/pharmacokinetics;Hypnotics and Sedatives/pharmacology;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Liver/drug effects;Liver/enzymology;Male;Midazolam/pharmacokinetics;Midazolam/pharmacology;Muscle Relaxants, Central/pharmacokinetics;Muscle Relaxants, Central/pharmacology;RNA, Messenger/genetics;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Tolbutamide/pharmacokinetics;Tolbutamide/pharmacology
24214834;Apiaceae/chemistry*;Coumarins/isolation & purification;Coumarins/pharmacology*;Drugs, Chinese Herbal/pharmacology*;Hep G2 Cells;Herb-Drug Interactions*;Humans;Multidrug Resistance-Associated Proteins/genetics;Multidrug Resistance-Associated Proteins/metabolism*;RNA, Messenger/metabolism;Real-Time Polymerase Chain Reaction;Receptors, Cytoplasmic and Nuclear/metabolism*;Transfection;Up-Regulation
24201019;Animals;Cytochrome P-450 Enzyme System/metabolism;Glycyrrhiza*/adverse effects;Glycyrrhiza*/toxicity;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional*;Membrane Transport Proteins/metabolism
24185586;Adult;Busulfan/pharmacokinetics*;Hematopoietic Stem Cell Transplantation/methods*;Herb-Drug Interactions*;Humans;Male;Transplantation Conditioning/methods*
24171723;Adult;Aged;Aged, 80 and over;Communication;Cross-Sectional Studies;Drug Therapy, Combination*/psychology;Female;Herb-Drug Interactions;Herbal Medicine;Humans;Male;Middle Aged;Norway;Patients/psychology*;Phytotherapy*/psychology;Plant Extracts/therapeutic use;Surveys and Questionnaires;Young Adult
24168107;Administration, Oral;Adult;Agaricales*/chemistry;Amines/administration & dosage;Amines/pharmacokinetics*;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics;Asian Continental Ancestry Group/genetics;China;Cyclohexanecarboxylic Acids/administration & dosage;Cyclohexanecarboxylic Acids/pharmacokinetics*;Diet*;Ergothioneine/blood*;Genotype;Healthy Volunteers*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Organic Cation Transport Proteins/genetics;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/pharmacokinetics*
24163821;Developing Countries;Herb-Drug Interactions*;Herbal Medicine*;Humans;Pharmacy Administration*/legislation & jurisprudence;Pharmacy Administration*/methods;Pharmacy Administration*/standards;Pharmacy Administration*/trends;Phytotherapy/adverse effects*;Plant Preparations*/adverse effects;Plant Preparations*/therapeutic use;Plants, Medicinal/adverse effects*
24157377;Antineoplastic Agents/metabolism;Antineoplastic Agents/pharmacokinetics;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Gene Expression Regulation, Enzymologic;Hep G2 Cells;Herb-Drug Interactions;Humans;Marsdenia/chemistry*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Recombinant Proteins/genetics;Recombinant Proteins/metabolism
24155255;Absorption;Animals;Caco-2 Cells;Chromatography, High Pressure Liquid/methods;Computer Simulation;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/metabolism*;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Humans;Intestine, Small/metabolism;Male;Rats;Rats, Sprague-Dawley
24146513;Animals;Cinnamates/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Hypnotics and Sedatives/pharmacology;Liver/drug effects*;Liver/enzymology;Male;Medicine, Traditional;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Pentobarbital/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Sleep/drug effects*;Thailand;Zingiberaceae/chemistry
24146485;Cytochrome P-450 Enzyme System/metabolism*;Female;Herb-Drug Interactions*;Hibiscus*;Humans;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Plant Extracts/pharmacology*;Protein Isoforms/metabolism
24144799;Animals;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Liver/drug effects*;Liver/metabolism;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Pharmaceutical Preparations/metabolism*;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tripterygium/chemistry*;Triterpenes/pharmacology*
24142885;Adolescent;Adult;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Female;Healthy Volunteers;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Prothrombin Time;Warfarin/blood;Warfarin/pharmacokinetics*;Young Adult
24125938;Adult;Fatal Outcome;Herb-Drug Interactions;Humans;India;Male;Medicine, Traditional/adverse effects*;Phytotherapy/adverse effects*;Phytotherapy/methods;Pulmonary Embolism/chemically induced*;Self Care
24123182;Animals;Bornanes/administration & dosage;Bornanes/pharmacology*;Chromatography, Liquid;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/chemistry;Ginsenosides/blood*;Ginsenosides/chemistry;Ginsenosides/pharmacokinetics*;Herb-Drug Interactions*;Linear Models;Male;Mass Spectrometry;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Sensitivity and Specificity
24118332;Antineoplastic Agents/therapeutic use*;Beverages/utilization;Communication;Complementary Therapies/adverse effects;Complementary Therapies/utilization*;Diet;Dietary Supplements/utilization;Drug Interactions;Drugs, Chinese Herbal/therapeutic use;Female;Health Services Needs and Demand*;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/therapy*;Patient Education as Topic*;Physician-Patient Relations;Radiotherapy*;Vitamins/therapeutic use
24114899;Animals;Blood Glucose/metabolism;Body Weight/physiology;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy;Drug Synergism;Garlic/chemistry*;Glucose Tolerance Test;Glyburide/pharmacology*;Herb-Drug Interactions;Hypoglycemic Agents/pharmacology*;Plant Extracts/pharmacology*;Rats;Rats, Wistar
24074610;Diabetes Complications/drug therapy;Diabetes Mellitus/drug therapy*;Drug Synergism;Drug Therapy, Combination;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/therapeutic use*;Phytochemicals/therapeutic use*;Plant Extracts/therapeutic use*
24068654;Adult;Aged;Antidepressive Agents/pharmacology*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Female;Herb-Drug Interactions*;Humans;Hypericum*;Male;Middle Aged;Plant Extracts/pharmacology*;Taxoids/adverse effects;Taxoids/blood;Taxoids/pharmacokinetics*
24022709;Animals;Carbamazepine/pharmacokinetics*;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism*;Female;Herb-Drug Interactions*;Male;Rabbits;Substrate Specificity;Trigonella*
24005963;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Biphenyl Compounds/pharmacology*;Bupropion/metabolism;Drugs, Chinese Herbal/pharmacology;Enzyme Inhibitors/pharmacology*;Ethanolamines/metabolism;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions;Humans;Hydroxylation;Inactivation, Metabolic;Inhibitory Concentration 50;Lignans/pharmacology*;Liver/enzymology;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Phenacetin/metabolism
24001154;Adult;Area Under Curve;Cross-Over Studies;Double-Blind Method;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Tetrazoles/adverse effects;Tetrazoles/metabolism;Tetrazoles/pharmacokinetics*;Tetrazoles/pharmacology
24000431;Dietary Supplements/adverse effects*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*
24000430;Dietary Supplements/adverse effects*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Risk Factors
23958198;Animals;Beverages*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Fruit;Herb-Drug Interactions*;Humans;Vaccinium macrocarpon*
23957086;Attitude of Health Personnel;Herb-Drug Interactions;Herbal Medicine*/legislation & jurisprudence;Herbal Medicine*/methods;Humans;Phytotherapy/standards*;Plant Preparations/therapeutic use*;Prescriptions/standards
23920676;Consumer Health Information/classification*;Consumer Health Information/statistics & numerical data;Data Mining/methods;Drug-Related Side Effects and Adverse Reactions/classification*;Herb-Drug Interactions*;Humans;Internet/statistics & numerical data*;Meaningful Use/statistics & numerical data*;Phytotherapy/classification*;Prescription Drugs/classification*;Truth Disclosure
23920278;Animals;Area Under Curve;Camellia sinensis/chemistry*;Catechin/analogs & derivatives*;Catechin/pharmacology;Herb-Drug Interactions*;Intestinal Absorption;Male;Nadolol/blood;Nadolol/pharmacokinetics*;Nadolol/urine;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley
23920226;Acylation;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects*;Caprylates/chemistry;Caprylates/pharmacology;Cinnamates/chemistry;Cinnamates/pharmacology;Cross Infection/microbiology;Escherichia coli/drug effects;Esterification;Flowers;Glycosides/chemistry;Glycosides/pharmacology;Herb-Drug Interactions;Ipomoea/chemistry*;Lactones/chemistry;Lactones/pharmacology*;Methicillin-Resistant Staphylococcus aureus/drug effects;Molecular Structure;Oligosaccharides/chemistry;Oligosaccharides/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Salmonella enterica/drug effects;Shigella flexneri/drug effects
23899130;Dioxoles/administration & dosage*;Herb-Drug Interactions*;Humans;Liposarcoma/drug therapy*;Male;Middle Aged;Photinia/chemistry;Plant Extracts/administration & dosage*;Rhabdomyolysis/etiology*;Tetrahydroisoquinolines/administration & dosage*
23897801;Antidepressive Agents/pharmacology;Antiviral Agents/pharmacology;Depression/drug therapy;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Perylene/analogs & derivatives;Perylene/pharmacokinetics;Phloroglucinol/analogs & derivatives;Phloroglucinol/pharmacokinetics;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plants, Medicinal/chemistry*;Terpenes/pharmacokinetics
23886819;Administration, Oral;Amiodarone/pharmacokinetics*;Animals;Area Under Curve;Body Weight;Citrus/chemistry*;Dose-Response Relationship, Drug;Fruit/chemistry*;Half-Life;Herb-Drug Interactions*;Male;Plant Extracts/pharmacology*;Rats;Rats, Wistar
23885542;Attitude to Health;Central Nervous System Agents/administration & dosage*;Central Nervous System Diseases/drug therapy*;Dietary Supplements/adverse effects*;Health Knowledge, Attitudes, Practice;Health Promotion/organization & administration;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Risk Factors
23867078;Analgesics/chemistry;Analgesics/pharmacokinetics;Animals;Biological Availability;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics*;Flavanones/analysis;Flavanones/pharmacokinetics*;Glucosides/analysis;Glucosides/pharmacokinetics*;Herb-Drug Interactions;Male;Parasympatholytics/chemistry;Parasympatholytics/pharmacokinetics;Pentacyclic Triterpenes/analysis;Pentacyclic Triterpenes/pharmacokinetics*;Rats;Rats, Wistar
23866810;Animals;Anti-Bacterial Agents/pharmacology*;Drug Synergism;Fruit;Garcinia mangostana/chemistry*;Herb-Drug Interactions;Humans;Leptospira/drug effects*;Leptospirosis/microbiology*;Microbial Sensitivity Tests;Penicillin G/pharmacology*;Plant Extracts/pharmacology*;Xanthones/pharmacology*
23865865;Animals;Dietary Supplements;Ginkgo biloba/chemistry*;Herb-Drug Interactions*;Humans;Phytotherapy/methods;Plant Extracts/pharmacokinetics*
23850985;Animals;Cell Line, Tumor;Cell Survival/drug effects;Cells, Cultured;Curcuma;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions;Humans;Mice;Microsomes, Liver/metabolism;RNA, Messenger/metabolism;Receptors, Aryl Hydrocarbon/metabolism;Receptors, Cytoplasmic and Nuclear/metabolism;Receptors, Steroid/metabolism;Recombinant Proteins/genetics;Recombinant Proteins/metabolism;Sesquiterpenes/pharmacology*;Sesquiterpenes, Germacrane/pharmacology*
23844611;ATP-Binding Cassette Transporters/antagonists & inhibitors;Animals;Cytochrome P-450 Enzyme Inhibitors;Dogs;HEK293 Cells;Herb-Drug Interactions*;Humans;Hypoxis/chemistry*;In Vitro Techniques;LLC-PK1 Cells;Madin Darby Canine Kidney Cells;Medicine, African Traditional;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Pharmaceutical Preparations*;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Substrate Specificity;Swine
23843424;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Equisetum/chemistry;Female;Foeniculum/chemistry;Ginger/chemistry;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Plant Extracts/pharmacology*;Pregnancy;Rosaceae/chemistry;Sambucus/chemistry;Tandem Mass Spectrometry;Vaccinium/chemistry
23835282;Binding, Competitive;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Dextromethorphan/metabolism;Drug Discovery;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacology*;Galactosides/metabolism;Galactosides/pharmacology;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Isoenzymes/genetics;Isoenzymes/metabolism;Kinetics;Methylation/drug effects;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Oenanthe/chemistry;Quercetin/analogs & derivatives*;Quercetin/metabolism;Quercetin/pharmacology;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism
23831483;Anti-Bacterial Agents/pharmacology;Anti-Bacterial Agents/therapeutic use;Biofilms/drug effects*;Cell Movement/drug effects;Ciprofloxacin/pharmacology*;Drug Resistance, Multiple/drug effects;Ginger/chemistry*;Guaiacol/analogs & derivatives*;Guaiacol/pharmacology;Guaiacol/therapeutic use;Herb-Drug Interactions;Phytotherapy;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Pseudomonas Infections/drug therapy;Pseudomonas Infections/microbiology*;Pseudomonas aeruginosa/drug effects*;Pseudomonas aeruginosa/pathogenicity;Pseudomonas aeruginosa/physiology
23828331;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Beta vulgaris*;Breast Neoplasms/drug therapy*;Cell Line, Tumor;Cell Survival/drug effects;Doxorubicin/pharmacology;Doxorubicin/therapeutic use*;Drug Combinations;Drug Synergism;Female;Herb-Drug Interactions;Humans;MCF-7 Cells;Male;Pancreatic Neoplasms/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Prostatic Neoplasms/drug therapy*
23820895;Adolescent;Adult;Age Factors;Attitude to Health*;Community Pharmacy Services;Consumer Product Safety*;Dietary Supplements/adverse effects*;Educational Status;Female;Food-Drug Interactions;Herb-Drug Interactions;Humans;Male;Middle Aged;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Self Care/adverse effects*;Serbia;Surveys and Questionnaires;Young Adult
23813259;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations, Dental/adverse effects*;Phytotherapy/adverse effects;Risk Assessment
23807811;Administration, Oral;Animals;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Blood Coagulation/drug effects;Chromatography, Liquid;Curcuma/chemistry*;Curcumin/pharmacology*;Herb-Drug Interactions;Male;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Random Allocation;Rats;Rats, Wistar;Tandem Mass Spectrometry;Ticlopidine/analogs & derivatives*;Ticlopidine/blood;Ticlopidine/pharmacokinetics;Warfarin/blood;Warfarin/pharmacokinetics*
23801821;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism*;Milk Thistle/chemistry*;Plant Extracts/pharmacology*
23792897;Administration, Oral;Animals;Drugs, Chinese Herbal/administration & dosage*;Epimedium/chemistry*;Herb-Drug Interactions*;Male;Phosphodiesterase 5 Inhibitors/administration & dosage;Phosphodiesterase 5 Inhibitors/chemistry;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Piperazines/administration & dosage;Piperazines/chemistry;Piperazines/pharmacokinetics*;Plant Extracts/administration & dosage*;Plant Extracts/chemistry*;Purines/administration & dosage;Purines/chemistry;Purines/pharmacokinetics;Rats;Sildenafil Citrate;Sulfones/administration & dosage;Sulfones/chemistry;Sulfones/pharmacokinetics*
23794063;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/agonists;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Capsaicin/administration & dosage;Capsaicin/adverse effects;Capsaicin/analogs & derivatives*;Capsaicin/therapeutic use;Capsicum/chemistry;Carrageenan;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/agonists;Diclofenac/therapeutic use*;Disease Models, Animal*;Dose-Response Relationship, Drug;Edema/immunology;Edema/prevention & control*;Female;Fruit/chemistry;Herb-Drug Interactions;Injections, Intramuscular;Injections, Subcutaneous;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Extracts/therapeutic use*;Random Allocation;Rats;Rats, Wistar;Sensory System Agents/administration & dosage;Sensory System Agents/adverse effects;Sensory System Agents/chemistry;Sensory System Agents/therapeutic use*;Transdermal Patch/adverse effects
23791808;Administration, Oral;Animals;China;Chromatography, High Pressure Liquid;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacokinetics*;Ethnopharmacology*;Herb-Drug Interactions;Iridoid Glucosides/administration & dosage;Iridoid Glucosides/blood;Iridoid Glucosides/isolation & purification;Iridoid Glucosides/pharmacokinetics*;Molecular Structure;Oleanolic Acid/administration & dosage;Oleanolic Acid/pharmacology*;Pyrones/administration & dosage;Pyrones/blood;Pyrones/isolation & purification;Pyrones/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Solid Phase Extraction;Spectrometry, Mass, Electrospray Ionization;Swertia/chemistry;Tablets
23774247;Animals;Drug Stability;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Isoflavones/administration & dosage;Isoflavones/blood;Isoflavones/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Saponins/administration & dosage;Saponins/blood;Saponins/pharmacokinetics*;Spectrometry, Mass, Electrospray Ionization/methods;Tandem Mass Spectrometry/methods
23770559;Aged, 80 and over;Anticoagulants/adverse effects*;Artemisia absinthium*;Atrial Fibrillation/drug therapy;Female;Gastrointestinal Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Plant Preparations/adverse effects*;Warfarin/adverse effects*
23769935;Animals;Antineoplastic Agents, Phytogenic/chemistry;Antineoplastic Agents, Phytogenic/isolation & purification;Antineoplastic Agents, Phytogenic/pharmacology;Antineoplastic Agents, Phytogenic/therapeutic use;Antioxidants/chemistry;Antioxidants/isolation & purification;Antioxidants/pharmacology;Antioxidants/therapeutic use*;Biological Products/chemistry;Biological Products/pharmacology;Biological Products/therapeutic use*;Cisplatin/pharmacology;Cisplatin/therapeutic use;Fruiting Bodies, Fungal/chemistry;Ganoderma/chemistry*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Keratinocytes/drug effects*;Keratinocytes/radiation effects;Lanosterol/analogs & derivatives*;Lanosterol/chemistry;Lanosterol/isolation & purification;Lanosterol/pharmacology;Lanosterol/therapeutic use;Male;Molecular Structure;Phytotherapy;Prostatic Neoplasms/drug therapy*;Radiation Injuries, Experimental/drug therapy;Skin Diseases/prevention & control;Xanthine Oxidase/antagonists & inhibitors*
23765408;Adolescent;Antidiarrheals/administration & dosage;Antidiarrheals/blood;Antidiarrheals/pharmacokinetics*;Antidiarrheals/therapeutic use;Berberine/administration & dosage;Berberine/blood;Berberine/pharmacokinetics*;Berberine/therapeutic use;Creatinine/blood;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Nephrotic Syndrome/blood;Nephrotic Syndrome/drug therapy*;Nephrotic Syndrome/immunology;Tacrolimus/administration & dosage;Tacrolimus/blood;Tacrolimus/pharmacokinetics*;Tacrolimus/therapeutic use
23757385;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/metabolism*;Drug Interactions/physiology*;Everolimus;Food-Drug Interactions/physiology*;Herb-Drug Interactions/physiology*;Humans;Pharmacists*/standards;Sirolimus/administration & dosage;Sirolimus/analogs & derivatives*;Sirolimus/metabolism
23742857;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Acanthaceae/chemistry*;Antibodies/metabolism;Caco-2 Cells;Fluorescein;Fluoresceins/metabolism;Herb-Drug Interactions*;Humans;Multidrug Resistance-Associated Proteins/metabolism*;Naphthoquinones/pharmacology*;Plant Extracts/pharmacology*
23738734;Animals;Area Under Curve;Chlorpheniramine/pharmacokinetics*;Chromatography, High Pressure Liquid/methods;Diclofenac/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Limit of Detection;Male;Rats;Rats, Wistar;Tandem Mass Spectrometry/methods;Tissue Distribution
23731657;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Area Under Curve;Biological Transport/drug effects;Brain/drug effects*;Brain/metabolism;Caco-2 Cells;Digoxin/metabolism;Herb-Drug Interactions*;Humans;Intestines/drug effects*;Intestines/metabolism;Lignans/pharmacology*;Plant Extracts/pharmacology*;Rats;Schisandra/chemistry*;Verapamil/pharmacology;Vincristine/metabolism
23725528;Analgesics/adverse effects;Analgesics/chemistry;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Antitussive Agents/adverse effects;Antitussive Agents/chemistry;Antitussive Agents/pharmacology;Antitussive Agents/therapeutic use;Dietary Supplements*/adverse effects;Ethnopharmacology;Evidence-Based Medicine*;Herb-Drug Interactions;Humans;Mitragyna/adverse effects;Mitragyna/chemistry*;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Plant Leaves/adverse effects;Plant Leaves/chemistry*;Psychotropic Drugs/adverse effects;Psychotropic Drugs/chemistry;Psychotropic Drugs/pharmacology;Psychotropic Drugs/therapeutic use;Secologanin Tryptamine Alkaloids/analysis
23722570;Animals;China;Drugs, Chinese Herbal/classification*;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/toxicity*;Herb-Drug Interactions;Humans;Materia Medica/classification*;Materia Medica/pharmacology;Materia Medica/toxicity*;Medicine, Chinese Traditional
23722257;Animals;Chromatography, Liquid/methods*;Drug Stability;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Imidazoles/blood;Imidazoles/pharmacokinetics*;Losartan/administration & dosage;Losartan/blood;Losartan/pharmacokinetics*;Male;Mass Spectrometry/methods*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Salvia miltiorrhiza;Sensitivity and Specificity;Tetrazoles/blood;Tetrazoles/pharmacokinetics*
23702042;Animals;Apiaceae/chemistry*;Cell Line;Coumarins/chemistry;Coumarins/pharmacology*;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A/metabolism;Gene Expression/drug effects;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions;Humans;Male;Medicine, Chinese Traditional/methods;Membrane Proteins/genetics*;Membrane Proteins/metabolism;Mice;Mice, Inbred BALB C;Plant Extracts/chemistry;Plant Extracts/pharmacology*;RNA, Messenger/genetics;Receptors, Steroid/genetics;Receptors, Steroid/metabolism*;Transcriptional Activation;Up-Regulation/drug effects
23695160;Antineoplastic Agents/adverse effects;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Antioxidants/pharmacology;Drug Interactions;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/utilization;Plants, Medicinal*/adverse effects;Risk Assessment
23677886;Animals;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/pharmacokinetics;Herb-Drug Interactions;Humans;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics;Plant Roots*/chemistry;Pueraria*
23671711;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Risk Assessment;Risk Factors
23628674;Animals;Capsules;Cytochrome P-450 CYP3A Inhibitors;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Immunosuppressive Agents/pharmacokinetics*;Male;Medicine, Chinese Traditional*;Rats;Rats, Sprague-Dawley;Tacrolimus/pharmacokinetics*
23594788;Animals;Biomarkers/metabolism;Cell Line;Cyclosporine/adverse effects*;Herb-Drug Interactions;Humans;Immunosuppressive Agents/adverse effects*;Kidney Diseases/chemically induced;Kidney Diseases/drug therapy*;Kidney Diseases/pathology;Male;Mice;Oxidative Stress/drug effects*;Panax*;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Random Allocation
23590720;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Animals;Area Under Curve;Biological Availability;Cell Line, Tumor;Cell Survival/drug effects;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Dose-Response Relationship, Drug;Fruit/chemistry;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics;Male;Morus/chemistry*;Polyphenols/administration & dosage;Polyphenols/pharmacology*;Rats;Rats, Sprague-Dawley
23583485;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2B6;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C8;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Gynostemma;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Inhibitory Concentration 50;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Extracts/pharmacology
23582408;Administration, Oral;Animals;Berberine/adverse effects;Berberine/pharmacokinetics;Berberine/therapeutic use*;Cinnamomum aromaticum/chemistry;Diabetes Mellitus, Experimental/drug therapy*;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Hypoglycemic Agents/chemistry;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/therapeutic use*;Male;Mice;Phytotherapy;Random Allocation
23249852;Animals;Antiviral Agents/metabolism*;Antiviral Agents/pharmacokinetics;Antiviral Agents/therapeutic use;Carboxylesterase/metabolism;Cell Death/drug effects;Cells, Cultured;Drugs, Chinese Herbal/pharmacology*;Drugs, Chinese Herbal/therapeutic use;Enzyme Activation/drug effects;Glutathione/metabolism;Herb-Drug Interactions*;Humans;Influenza A Virus, H5N1 Subtype*;Influenza, Human/drug therapy*;Lonicera;Oseltamivir/metabolism*;Oseltamivir/pharmacokinetics;Oseltamivir/therapeutic use;Perilla frutescens;Phytotherapy*;Rats
23538078;Cerebrovascular Disorders/drug therapy*;Dementia/drug therapy*;Herb-Drug Interactions;Humans;Intermittent Claudication/drug therapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
23538077;Clinical Trials as Topic;Herb-Drug Interactions;Humans;Hypericum*;Mental Disorders/drug therapy*;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
23538075;Clinical Trials as Topic;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Mental Disorders/prevention & control*;Phytotherapy*
23535538;Animals;Body Weight;Coleus*;Cytochrome P-450 Enzyme System/metabolism*;Diet*;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Dietary Sucrose/pharmacology;Dietary Supplements;Glutathione Transferase/metabolism*;Herb-Drug Interactions*;Liver/drug effects*;Liver/metabolism;Male;Mice;Mice, Inbred ICR;Organ Size;Plant Extracts/pharmacology*;Starch/pharmacology
23510861;Administration, Oral;Animals;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Enzyme Induction;Glucuronosyltransferase/biosynthesis;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Indole Alkaloids/administration & dosage;Indole Alkaloids/pharmacology*;Liver/drug effects*;Liver/enzymology;Male;Membrane Transport Proteins/drug effects*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Metabolic Detoxication, Phase I;Metabolic Detoxication, Phase II;Mice;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Quinazolines/administration & dosage;Quinazolines/pharmacology*;Real-Time Polymerase Chain Reaction;Reverse Transcriptase Polymerase Chain Reaction;Substrate Specificity;Sulfotransferases/genetics;Sulfotransferases/metabolism*;Up-Regulation
23458730;Animals;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors*;Dextromethorphan/metabolism*;Dextromethorphan/pharmacokinetics;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology*;Flavonoids/pharmacology*;Herb-Drug Interactions*;Male;Microsomes, Liver/enzymology;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis/chemistry
23451885;Adult;Anticholesteremic Agents/pharmacokinetics;Healthy Volunteers;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacokinetics*;Simvastatin/analogs & derivatives;Simvastatin/blood;Simvastatin/pharmacokinetics*;Young Adult
23422332;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Astragalus Plant;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Male;Polymorphism, Single Nucleotide;Substrate Specificity;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics;Therapeutic Equivalency
23409697;Cause of Death;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
23401262;Administration, Oral;Animals;Dogs;Half-Life;Herb-Drug Interactions*;Lepidium sativum/chemistry*;Male;Nigella sativa/chemistry*;Phenytoin/pharmacokinetics*;Seeds/chemistry;Trigonella/chemistry*
23394826;Cytochrome P-450 CYP3A/metabolism*;Enzyme Activation/drug effects;Garlic/chemistry;Herb-Drug Interactions*;Humans;Hypericum/chemistry;Milk Thistle/chemistry;Neoplasms/drug therapy*;Neoplasms/enzymology*;Panax/chemistry;Phytotherapy*;Plant Preparations/pharmacology;Plant Preparations/therapeutic use*
23376044;Acetic Acid/chemistry*;Animals;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2E1*/biosynthesis;Cytochrome P-450 CYP2E1*/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System*/biosynthesis;Cytochrome P-450 Enzyme System*/metabolism;Cytochromes*/biosynthesis;Cytochromes*/metabolism;Dapsone/blood;Dapsone/pharmacokinetics;Dose-Response Relationship, Drug;Drug Compounding;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/pharmacokinetics*;Enzyme Induction;Herb-Drug Interactions;Male;RNA, Messenger/biosynthesis;Rats;Rats, Sprague-Dawley;Real-Time Polymerase Chain Reaction;Schisandra/chemistry*;Substrate Specificity;Theophylline/blood;Theophylline/pharmacokinetics
23371804;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Diabetic Neuropathies/drug therapy*;Drug Evaluation, Preclinical;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;In Vitro Techniques;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Plant Preparations/therapeutic use
23356591;Advertising as Topic/methods*;Aged;Consumer Health Information/methods*;Dietary Supplements/adverse effects*;Female;Focus Groups;Herb-Drug Interactions*;Humans;Male;Middle Aged;Pilot Projects;Safety*;Surveys and Questionnaires;United States
23344089;Administration, Oral;Animals;Anti-Infective Agents/pharmacokinetics*;Area Under Curve;Ciprofloxacin/pharmacokinetics*;Female;Ginger*;Half-Life;Herb-Drug Interactions*;Isoniazid/pharmacokinetics*;Lung/metabolism;Male;Metabolic Clearance Rate;Plant Extracts/pharmacology*;Rats
23340957;Animals;Cytochrome P-450 CYP3A/metabolism*;Drug Combinations;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/chemistry*;Enediynes/analysis;Enediynes/pharmacology*;Fatty Alcohols/analysis;Fatty Alcohols/pharmacology*;Herb-Drug Interactions*;Humans;Hydroxylation/drug effects;In Vitro Techniques;Injections;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Midazolam/chemistry;Midazolam/metabolism;Midazolam/pharmacokinetics*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats
23339253;Cyclooctanes/chemistry;Cyclooctanes/pharmacology*;Dioxoles/chemistry;Dioxoles/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Lignans/chemistry;Lignans/pharmacology*;Molecular Structure;Polycyclic Compounds/chemistry;Polycyclic Compounds/pharmacology*;Protein Isoforms
23333907;Anesthetics, Intravenous/metabolism*;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Microsomes, Liver;Phenanthrenes/pharmacology*;Plants, Medicinal/chemistry;Propofol/metabolism*;Salvia miltiorrhiza/chemistry
23330543;Drug Interactions;Herb-Drug Interactions*;Humans;Plant Preparations/pharmacokinetics;Plant Preparations/pharmacology*;Receptors, Cytoplasmic and Nuclear/genetics;Receptors, Cytoplasmic and Nuclear/metabolism*
23327826;Administration, Oral;Angiotensin II Type 1 Receptor Blockers/administration & dosage;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Animals;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Female;Herb-Drug Interactions;Imidazoles/metabolism;Losartan/administration & dosage;Losartan/blood;Losartan/pharmacokinetics*;Plant Extracts/administration & dosage*;Rabbits;Rhodiola*;Tetrazoles/metabolism
23306165;Ginsenosides/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions*;Humans;Hymecromone/analogs & derivatives;Hymecromone/metabolism;Isoenzymes/antagonists & inhibitors;Panax;Structure-Activity Relationship
23297551;Acquired Immunodeficiency Syndrome/drug therapy*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans
23291634;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Carica/chemistry;Digoxin/metabolism*;Digoxin/pharmacokinetics;Herb-Drug Interactions*;Intestinal Absorption/drug effects;Loranthaceae/chemistry;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Vernonia/chemistry
23286284;Algorithms;Camptothecin/analogs & derivatives*;Camptothecin/chemistry;Camptothecin/pharmacology;Carboxylesterase/antagonists & inhibitors*;Clinical Trials, Phase I as Topic;Diterpenes, Abietane/chemistry;Diterpenes, Abietane/isolation & purification*;Diterpenes, Abietane/pharmacokinetics;Diterpenes, Abietane/pharmacology*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional;Molecular Structure;Phenanthrolines/pharmacology*;Plant Roots/chemistry;Salvia miltiorrhiza/chemistry*
23285916;Adolescent;Adult;Aged;Aged, 80 and over;Drug Combinations;Drug Therapy;Drugs, Chinese Herbal/administration & dosage*;Female;Herb-Drug Interactions;Hospital Information Systems*;Humans;Male;Middle Aged;Outcome Assessment (Health Care)*;Young Adult
23277336;Anticoagulants/pharmacology*;Contraindications;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Panax/adverse effects*;Phytotherapy/adverse effects*;Randomized Controlled Trials as Topic;Stroke/drug therapy*;Warfarin/pharmacology*
23249200;Anti-HIV Agents/pharmacokinetics;Anticoagulants/pharmacokinetics;Antidepressive Agents/pharmacokinetics;Antineoplastic Agents/pharmacokinetics;Diagnostic Techniques and Procedures*;Drugs, Chinese Herbal/pharmacokinetics;Epigenomics;Genomics;Herb-Drug Interactions/genetics*;Humans;Immunosuppressive Agents/pharmacokinetics;Medicine, Chinese Traditional/methods*;Pharmacogenetics;Platelet Aggregation Inhibitors/pharmacokinetics;Polymorphism, Genetic;Proteomics;Randomized Controlled Trials as Topic;Risk Factors;Therapeutics/methods*
23229784;Animals;Benzofurans/pharmacology;CHO Cells;Caffeic Acids/pharmacology;Cinnamates/pharmacology;Cricetulus;Depsides/pharmacology;Drugs, Chinese Herbal/pharmacology*;HEK293 Cells;Herb-Drug Interactions*;Humans;Lactates/pharmacology;Organic Anion Transport Protein 1/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Phenanthrolines/pharmacology*;Salvia miltiorrhiza/chemistry*
23224634;Animals;Anticarcinogenic Agents/adverse effects;Anticarcinogenic Agents/therapeutic use*;Brassica;Case-Control Studies;DNA Damage/drug effects;Feeding Behavior;Glucosinolates/adverse effects;Glucosinolates/therapeutic use;Herb-Drug Interactions;Humans;Isothiocyanates;Mice;Neoplasms/drug therapy*;Neoplasms/prevention & control*;Neoplasms, Experimental/drug therapy;Neoplastic Stem Cells/drug effects;Phytotherapy/methods*;Plant Extracts/therapeutic use*;Thiocyanates/adverse effects;Thiocyanates/therapeutic use*;Transplantation, Heterologous
23209194;ATP Binding Cassette Transporter, Sub-Family B;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Transport;Biotransformation;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dogs;Dose-Response Relationship, Drug;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Fabaceae/chemistry*;Female;HEK293 Cells;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Hydroxylation;Isoenzymes;Kinetics;LLC-PK1 Cells;Madin Darby Canine Kidney Cells;Male;Membrane Transport Modulators/isolation & purification;Membrane Transport Modulators/pharmacology*;Membrane Transport Proteins/drug effects*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Midazolam/metabolism;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors;Organic Anion Transporters, Sodium-Independent/metabolism;Plant Leaves;Plant Preparations/isolation & purification;Plant Preparations/pharmacology*;Plants, Medicinal;Solute Carrier Organic Anion Transporter Family Member 1B3;Solute Carrier Organic Anion Transporter Family Member 1b1;Substrate Specificity;Swine;Testosterone/metabolism;Transfection
23207062;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Animals;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme System/metabolism*;Dapsone/pharmacokinetics;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Enzyme Activators/pharmacology;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Isoenzymes/metabolism;Male;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Rheum*;Theophylline/pharmacokinetics;Tolbutamide/pharmacokinetics;Wine
23195128;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Antioxidants/pharmacology;Disease Models, Animal;Fabaceae/chemistry*;Flavonoids/analysis;Fruit/chemistry*;Herb-Drug Interactions*;Male;Naloxone/pharmacology*;Narcotic Antagonists;Pain/chemically induced;Pain/drug therapy*;Pain Measurement/methods;Pharmaceutical Solutions/administration & dosage;Pharmaceutical Solutions/pharmacology;Pharmaceutical Solutions/therapeutic use;Phenols/analysis;Phytotherapy/methods*;Plant Extracts/administration & dosage;Plant Extracts/antagonists & inhibitors;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use*;Rats;Rats, Wistar
23189719;Aconitum/chemistry*;Animals;Chromatography, High Pressure Liquid/methods;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/administration & dosage*;Gene Expression/drug effects*;Glycyrrhiza/chemistry*;Herb-Drug Interactions*;Male;Rats;Rats, Sprague-Dawley
23188923;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Plant Preparations/adverse effects;Plant Preparations/pharmacology
23178632;Amiodarone/administration & dosage;Amiodarone/pharmacokinetics*;Amiodarone/pharmacology;Animals;Area Under Curve;Body Weight/drug effects;Drug Administration Schedule;Fucus*;Herb-Drug Interactions*;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Seaweed
23162896;Antineoplastic Agents, Phytogenic/pharmacology;Camptothecin/analogs & derivatives*;Camptothecin/pharmacology;Cell Proliferation/drug effects*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Dose-Response Relationship, Drug;Hep G2 Cells;Herb-Drug Interactions*;Humans;Quercetin/administration & dosage;Quercetin/analogs & derivatives*;Quercetin/pharmacology;RNA, Messenger/metabolism;Receptors, Steroid/metabolism;Transcriptional Activation/drug effects;Up-Regulation
23159385;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/antagonists & inhibitors;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology;Adrenergic Agonists/pharmacology;Animals;Aorta, Thoracic/drug effects;Aorta, Thoracic/physiology;Aspidosperma/chemistry;Blood Pressure/drug effects;Blood Pressure/physiology;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology*;Ethanol/chemistry;Heart Rate/drug effects;Heart Rate/physiology;Herb-Drug Interactions/physiology*;In Vitro Techniques;Male;Phenylephrine/antagonists & inhibitors;Phenylephrine/pharmacology;Plant Extracts/antagonists & inhibitors;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Potassium Channel Blockers/pharmacology*;Rats;Rats, Wistar;Vasodilation/drug effects*;Vasodilation/physiology;Vasodilator Agents/antagonists & inhibitors;Vasodilator Agents/chemistry;Vasodilator Agents/pharmacology*
23157874;Adult;Age Distribution;Chronic Disease/drug therapy*;Complementary Therapies/adverse effects;Complementary Therapies/economics;Complementary Therapies/utilization*;Cost Savings/methods;Cross-Sectional Studies;Educational Status;Female;Health Surveys;Herb-Drug Interactions*;Humans;Male;Middle Aged;Polypharmacy;Prescription Drugs/adverse effects;Prescription Drugs/economics;Prescription Drugs/therapeutic use*;Risk Factors;Self Report;Sex Distribution;Socioeconomic Factors;South Australia
23148031;Glucuronosyltransferase/antagonists & inhibitors*;Glycyrrhetinic Acid/pharmacology*;Glycyrrhiza/chemistry;Glycyrrhizic Acid/pharmacology;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Kinetics;Liver/enzymology
23147465;Animals;Cuscuta/chemistry*;Cyclic GMP/physiology;Enzyme Inhibitors/pharmacology;Erectile Dysfunction/drug therapy*;Herb-Drug Interactions;Male;Muscle Relaxation/drug effects*;Muscle, Smooth/drug effects;NG-Nitroarginine Methyl Ester/pharmacology;Penile Erection/drug effects*;Penis/drug effects*;Penis/physiology*;Phytotherapy*;Piperazines/pharmacology;Plant Extracts/pharmacology*;Purines/pharmacology;Rabbits;Sildenafil Citrate;Sulfones/pharmacology
23146043;Animals;Anticoagulants/metabolism;Anticoagulants/pharmacology;Caseins/administration & dosage;Coleus/chemistry*;Colforsin/pharmacology*;Cytochrome P-450 Enzyme System/metabolism*;Diet;Dietary Proteins/administration & dosage;Dose-Response Relationship, Drug;Herb-Drug Interactions*;Liver/drug effects*;Liver/enzymology;Liver/metabolism;Male;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Plant Extracts/pharmacology*;Warfarin/metabolism*;Warfarin/pharmacology
23122083;Animals;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/chemistry;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/metabolism;Fermentation;Herb-Drug Interactions*;Humans;Kinetics;Lactobacillus/metabolism;Male;Microsomes, Liver/chemistry;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley
23121117;Chemical and Drug Induced Liver Injury/etiology*;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Liver/drug effects*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plants, Medicinal/adverse effects*
23117091;Analgesics/antagonists & inhibitors;Analgesics/pharmacology;Analgesics/therapeutic use*;Animals;Anti-Inflammatory Agents/pharmacology;Anti-Inflammatory Agents/therapeutic use*;Antipyretics/pharmacology;Antipyretics/therapeutic use*;Artemisia/chemistry*;Caffeine/pharmacology;Carrageenan;Edema/chemically induced;Edema/drug therapy;Female;Fever/drug therapy*;Herb-Drug Interactions*;Male;Methanol/chemistry;Mice;Mice, Inbred BALB C;Naloxone/pharmacology;Pain/chemically induced;Pain/drug therapy;Phytotherapy/methods*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Rats;Rats, Sprague-Dawley;Sodium Glutamate/pharmacology
23104244;Animals;Aryl Hydrocarbon Hydroxylases;Biotransformation;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP1B1;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology*;Fermentation;Herb-Drug Interactions*;Liver/drug effects;Liver/enzymology;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley;Tandem Mass Spectrometry
23102508;Cytochrome P-450 Enzyme Inhibitors*;Dextromethorphan;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Kinetics;Microsomes, Liver;Molecular Docking Simulation;Phenacetin;Phenanthrenes/pharmacology*;Salvia miltiorrhiza/chemistry*;Testosterone;Tolbutamide
23092794;Chemical and Drug Induced Liver Injury/enzymology;Chemical and Drug Induced Liver Injury/etiology*;Complementary Therapies/adverse effects;Complementary Therapies/methods;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;HIV Infections/drug therapy;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/pharmacokinetics;HIV Integrase Inhibitors/therapeutic use;Herb-Drug Interactions*;Humans;Liver/drug effects;Liver/enzymology;Liver/pathology;Male;Middle Aged;Panax/adverse effects*;Pyrrolidinones/adverse effects*;Pyrrolidinones/pharmacokinetics;Pyrrolidinones/therapeutic use;Raltegravir Potassium
23067030;Animals;Clinical Trials as Topic;Contraindications;Dietary Supplements/adverse effects*;Disease Models, Animal;Herb-Drug Interactions*;Humans;Plant Preparations*;Rats;Research Design
23067026;Animals;Contraindications;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Plant Preparations*
23064285;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Anti-Arrhythmia Agents/metabolism*;Biological Transport;Caco-2 Cells;Cell Survival/drug effects;Digoxin/metabolism*;Herb-Drug Interactions*;Humans;Magnoliopsida;Medicine, African Traditional*;Plant Bark;Plant Extracts/pharmacology*;Plant Leaves
23058057;Animals;Area Under Curve;Bornanes/administration & dosage;Bornanes/pharmacology*;Brain/metabolism;Chromatography, High Pressure Liquid;Corpus Striatum/metabolism;Drug Combinations;Drug Delivery Systems;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Emulsions;Half-Life;Herb-Drug Interactions;Male;Microdialysis;Pyrazines/administration & dosage;Pyrazines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tissue Distribution;Vasodilator Agents/administration & dosage;Vasodilator Agents/pharmacokinetics
23028841;Adult;Adverse Drug Reaction Reporting Systems/statistics & numerical data*;Aged;Biological Products/adverse effects*;Canada;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Pharmacies;Pharmacists*;Prescription Drugs/adverse effects*;Public Health Surveillance;Surveys and Questionnaires
23028251;Alkaloids/administration & dosage;Alkaloids/pharmacology*;Animals;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/pharmacology*;Benzodioxoles/administration & dosage;Benzodioxoles/pharmacology*;Biological Availability;Curcumin/administration & dosage;Curcumin/pharmacokinetics;Databases, Factual;Dietary Supplements;Drug Compounding/methods;Drug Therapy, Combination/methods;Drug-Related Side Effects and Adverse Reactions/prevention & control;Herb-Drug Interactions;Humans;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics;Piperidines/administration & dosage;Piperidines/pharmacology*;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Plants, Medicinal/chemistry*;Polyunsaturated Alkamides/administration & dosage;Polyunsaturated Alkamides/pharmacology*
23026308;Animals;Astragalus Plant;Diabetes Mellitus, Experimental/metabolism;Diabetes Mellitus, Type 2/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Hypoglycemic Agents/pharmacokinetics*;Male;Rats;Rats, Wistar;Thiazolidinediones/pharmacokinetics*
23000442;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Drugs, Chinese Herbal/pharmacology;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology*;Pyrans/pharmacology*;Recombinant Proteins/genetics;Recombinant Proteins/metabolism
22998215;Administration, Oral;Alkaloids/administration & dosage;Alkaloids/adverse effects*;Alkaloids/pharmacokinetics;Animals;Heart Diseases/chemically induced;Heart Diseases/metabolism;Herb-Drug Interactions/physiology*;Humans;Membrane Transport Proteins/metabolism;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Ranunculaceae*;Rhizome*
22996305;Administration, Oral;Animals;Area Under Curve;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Schisandra/chemistry;Tablets
22993742;Adult;Attitude of Health Personnel*;Clinical Competence*;Cross-Sectional Studies;Female;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Herbal Medicine*;Humans;Internal Medicine/methods;Male;Middle Aged;Needs Assessment;Physicians/statistics & numerical data*;Surveys and Questionnaires;United Kingdom
22981724;Angelica;Animals;Benzopyrans/pharmacology*;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Butyrates/pharmacology*;Herb-Drug Interactions;Male;Rats;Rats, Sprague-Dawley;Theophylline/blood;Theophylline/pharmacokinetics*
22980806;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Availability;Cell Line, Tumor;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Glycyrrhiza/chemistry*;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions;Humans;Male;Plant Extracts/pharmacology*;Plant Roots/chemistry;Rats;Rats, Sprague-Dawley
22975634;Administration, Oral;Animals;Area Under Curve;Brassica/metabolism*;Caffeine/pharmacokinetics;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP2E1/genetics;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Cytochromes/antagonists & inhibitors;Cytochromes/genetics;Cytochromes/metabolism;Dextromethorphan/pharmacokinetics;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Liver/enzymology;Metabolic Clearance Rate;Midazolam/pharmacokinetics*;Omeprazole/pharmacokinetics;RNA, Messenger/genetics;RNA, Messenger/metabolism;Rats;Tolbutamide/pharmacokinetics
22951920;Aged;Drug Labeling/legislation & jurisprudence*;Herb-Drug Interactions*;Humans;Pharmacokinetics;Plant Preparations/pharmacology;Polypharmacy;United States
22947027;Animals;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects*;Antiparasitic Agents/therapeutic use;Central Nervous System Diseases/chemically induced;Central Nervous System Diseases/pathology;Central Nervous System Diseases/veterinary*;Food Contamination;Herb-Drug Interactions*;Horse Diseases/chemically induced*;Horse Diseases/pathology;Horses;Ivermectin/administration & dosage;Ivermectin/adverse effects*;Ivermectin/therapeutic use;Plants, Toxic;Solanum/classification;Solanum/toxicity*
22943125;Animals;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional/methods*;Medicine, East Asian Traditional/methods*;Pharmaceutical Services/organization & administration;Pharmacists/organization & administration;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/standards;Quality Assurance, Health Care;Vietnam
22935233;Drug Interactions;Herb-Drug Interactions;Herbal Medicine/classification;Herbal Medicine/methods;Humans;Medicine, Ayurvedic*;Neoplasms/classification;Neoplasms/therapy;Phytotherapy/methods
22928833;Antiviral Agents/pharmacology;Antiviral Agents/therapeutic use*;Benzofurans/pharmacology;Benzofurans/therapeutic use*;Cell Line;Chromones/pharmacology;Chromones/therapeutic use*;Cimicifuga/chemistry*;Cytokines/metabolism;Dose-Response Relationship, Drug;Drug Synergism;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Fibrinolytic Agents/pharmacology;Heparin/pharmacology;Herb-Drug Interactions;Humans;Interferon-beta/metabolism;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Respiratory Syncytial Virus Infections/drug therapy*;Respiratory Syncytial Virus Infections/metabolism;Respiratory Syncytial Virus Infections/virology;Respiratory Syncytial Virus, Human/drug effects*;Respiratory Syncytial Virus, Human/pathogenicity
22926042;Animals;Central Nervous System Agents/chemistry;Central Nervous System Agents/pharmacokinetics*;Herb-Drug Interactions*;Male;Mice;Oils, Volatile/chemistry*;Oils, Volatile/pharmacokinetics*;Pimpinella/chemistry*;Plant Oils/chemistry;Plant Oils/pharmacokinetics*;Seeds/chemistry
22906201;Adolescent;Adult;Age Factors;Aged;Ambulatory Surgical Procedures*;Anesthesia*/classification;Anesthesiology;Chi-Square Distribution;Cough/drug therapy;Cross-Sectional Studies;Data Collection;Female;Health Care Surveys;Herb-Drug Interactions;Herbal Medicine;Humans;Malaria/drug therapy;Male;Marital Status;Middle Aged;Nigeria;Patient Satisfaction;Physician-Patient Relations;Phytotherapy/utilization*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal;Sex Factors;Surveys and Questionnaires;Urban Population;Young Adult
22889991;Area Under Curve;Beverages;Celiprolol/blood*;Celiprolol/chemistry;Celiprolol/pharmacokinetics;Chromatography, High Pressure Liquid/methods*;Drug Stability;Fruit;Herb-Drug Interactions;Humans;Linear Models;Malus;Reproducibility of Results;Sensitivity and Specificity;Solid Phase Extraction/methods;Spectrometry, Fluorescence/methods*
22876741;Adverse Drug Reaction Reporting Systems/standards*;Adverse Drug Reaction Reporting Systems/statistics & numerical data;Drug-Related Side Effects and Adverse Reactions*/chemically induced;Herb-Drug Interactions*;Humans;Pharmacovigilance*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects;Risk
22875751;Consumer Product Safety;Dietary Supplements*/adverse effects;Food-Drug Interactions*;Health Promotion*;Herb-Drug Interactions*;Humans;Patient Education as Topic;Professional-Patient Relations;Quality of Health Care;United States
22875040;Adult;Aged;Aged, 80 and over;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Cardiotonic Agents/adverse effects;Cardiotonic Agents/therapeutic use*;Chi-Square Distribution;Comorbidity;Digoxin/adverse effects;Digoxin/therapeutic use*;Drug Utilization;Drug Utilization Review;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Female;Health Services/utilization;Herb-Drug Interactions;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Retrospective Studies;Risk Assessment;Risk Factors;Taiwan;Time Factors
22870815;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/pharmacology*;Furocoumarins/pharmacology*;Herb-Drug Interactions*;Intestinal Absorption/drug effects*;Intestines/drug effects*;Intestines/enzymology;Male;Medicine, Kampo;Metabolic Clearance Rate;Midazolam/blood;Midazolam/pharmacokinetics*;Propanolamines/blood;Propanolamines/pharmacokinetics*;Rats;Rats, Wistar
22869560;Adult;Anti-HIV Agents/therapeutic use;Echinacea/chemistry*;Female;HIV Infections/drug therapy*;Herb-Drug Interactions;Humans;Male;Middle Aged;Plant Extracts/therapeutic use*;Pyridazines/therapeutic use*
22867637;Animals;Anticoagulants/administration & dosage*;Anticoagulants/blood;Anticoagulants/pharmacokinetics;Area Under Curve;Aspirin/administration & dosage*;Aspirin/blood;Aspirin/pharmacokinetics;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics;Herb-Drug Interactions*;Lactates/blood;Male;Prothrombin Time;Rats;Rats, Sprague-Dawley;Salicylic Acid/blood;Warfarin/administration & dosage*;Warfarin/blood;Warfarin/pharmacokinetics
22864989;Drug Labeling/legislation & jurisprudence;Drug Synergism;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Organic Anion Transporters/drug effects*;Pharmacokinetics*;Plant Preparations/pharmacology*;United States;United States Food and Drug Administration/legislation & jurisprudence
22864323;Aged;Anticoagulants/therapeutic use*;Aortic Valve;Atrial Fibrillation/drug therapy;Avena/adverse effects*;Avena/chemistry;Heart Valve Prosthesis;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Panax/adverse effects*;Panax/chemistry;Tribulus/adverse effects*;Tribulus/chemistry;Warfarin/therapeutic use*
22863918;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Antineoplastic Combined Chemotherapy Protocols;Cell Communication/drug effects*;Cell Communication/physiology;Cisplatin/pharmacology;Cisplatin/therapeutic use*;Connexins/metabolism;Dose-Response Relationship, Drug;Drug Synergism;Female;Gap Junctions/drug effects*;Gap Junctions/physiology;HeLa Cells;Herb-Drug Interactions;Humans;Panax notoginseng/chemistry*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Saponins/pharmacology;Saponins/therapeutic use*;Transfection;Uterine Cervical Neoplasms/drug therapy;Uterine Cervical Neoplasms/physiopathology*
22863650;Acupuncture Therapy;Attitude of Health Personnel*;Communication;Complementary Therapies/methods*;Consensus;Cooperative Behavior;Delphi Technique;Exercise;Herb-Drug Interactions;Humans;Internet;Neoplasms/therapy*;Phytotherapy;Quality of Life;Research*
22855269;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Echinacea;Garlic;Ginkgo biloba;Herb-Drug Interactions*;Humans;Hydrastis;Milk Thistle;Panax;Pharmacokinetics*;Plant Preparations/pharmacology*
22854226;Academic Medical Centers;Adult;Aged;Aged, 80 and over;Communication*;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Hospitalization;Humans;Inpatients/psychology*;Inpatients/statistics & numerical data;Internal Medicine;Interviews as Topic;Israel;Male;Middle Aged;Physician-Patient Relations*;Phytotherapy/statistics & numerical data;Phytotherapy/utilization*;Prevalence;Quality of Life;Self Concept;Socioeconomic Factors;Surveys and Questionnaires;Truth Disclosure
22850760;Adult;Asian Continental Ancestry Group/genetics;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Haplotypes;Herb-Drug Interactions/genetics*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Organic Anion Transporters/genetics*;Polymorphism, Single Nucleotide/genetics;Quinolines/pharmacokinetics*;Solute Carrier Organic Anion Transporter Family Member 1b1
22819301;Cytochrome P-450 Enzyme System/metabolism*;Gentianaceae/chemistry*;Herb-Drug Interactions*;Humans;Phenacetin/metabolism;Plant Extracts/pharmacology*;Testosterone/metabolism;Tolbutamide/metabolism;Xanthones/pharmacology*
22814819;Cell Culture Techniques/methods*;Cell Line;Chemistry, Pharmaceutical/standards*;Dietary Supplements/toxicity*;Drug Evaluation, Preclinical/methods*;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions*;Humans;Liver/metabolism;Pharmacokinetics;Plant Preparations/chemistry*;Plant Preparations/standards;Plant Preparations/toxicity*;Reagent Kits, Diagnostic
22813711;Administration, Oral;Animals;Anticonvulsants/pharmacokinetics;Area Under Curve;Brain/metabolism;Carbamazepine/analogs & derivatives;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid/methods;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Fallopia japonica/chemistry*;Herb-Drug Interactions*;Kidney/metabolism;Liver/metabolism;Male;Multidrug Resistance-Associated Proteins/antagonists & inhibitors;Multidrug Resistance-Associated Proteins/metabolism;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Stilbenes/isolation & purification;Tissue Distribution
22796279;Animals;Bromocriptine/pharmacology;Cell Line;Disease Models, Animal;Dopamine/biosynthesis;Dopamine D2 Receptor Antagonists;Dopamine Plasma Membrane Transport Proteins/metabolism;Dose-Response Relationship, Drug;Estradiol/metabolism;Female;Glycyrrhiza/chemistry*;Haloperidol/pharmacology;Herb-Drug Interactions;Hyperprolactinemia/blood;Hyperprolactinemia/chemically induced;Hyperprolactinemia/drug therapy*;Metoclopramide/adverse effects;PC12 Cells;Paeonia/chemistry*;Phytotherapy/methods*;Plant Extracts/antagonists & inhibitors;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use*;Progesterone/metabolism;Prolactin/biosynthesis;Prolactin/secretion;Rabbits;Rats, Sprague-Dawley;Receptors, Dopamine D2/agonists;Receptors, Dopamine D2/metabolism*
22747079;Complementary Therapies/adverse effects*;Curcuma/chemistry;Drugs, Chinese Herbal/adverse effects*;Garlic/chemistry;Ginger/chemistry;Glycyrrhiza/chemistry;Herb-Drug Interactions;Herbal Medicine*;Phytotherapy/adverse effects*;Tea/chemistry
22741403;Aristolochia/adverse effects;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional/adverse effects*;Phytotherapy/adverse effects
22736593;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions*;Humans;Panax/chemistry;Sapogenins/pharmacology*
22735598;Alpinia/chemistry*;Anti-Bacterial Agents/pharmacology*;Bacterial Proteins/antagonists & inhibitors;Benzyl Alcohols/isolation & purification;Benzyl Alcohols/pharmacology;Coumarins/isolation & purification;Coumarins/pharmacology;Drug Resistance/drug effects*;Ethidium/pharmacology*;Eugenol/analogs & derivatives;Eugenol/isolation & purification;Eugenol/pharmacology;Herb-Drug Interactions;Microbial Sensitivity Tests;Mycobacterium smegmatis/drug effects*;Phenols/isolation & purification;Phenols/pharmacology*;Phytotherapy;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rhizome;Tuberculosis/drug therapy;Tuberculosis/microbiology
22718621;Animals;Chemistry, Pharmaceutical;Cytochrome P-450 Enzyme System/physiology*;Herb-Drug Interactions*;Humans;Salvia miltiorrhiza*/chemistry
22703874;Adipose Tissue/drug effects*;Adipose Tissue/metabolism;Anthocyanins/pharmacology;Anthocyanins/therapeutic use*;Anti-Inflammatory Agents/pharmacology;Anti-Inflammatory Agents/therapeutic use;Atorvastatin Calcium;Cells, Cultured;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Fruit;Glucosides/pharmacology;Glucosides/therapeutic use*;Heptanoic Acids/pharmacology;Heptanoic Acids/therapeutic use*;Herb-Drug Interactions;Humans;Inflammation/chemically induced;Inflammation/metabolism;Inflammation/prevention & control*;Interleukin-6/metabolism*;Lipopolysaccharides;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Prunus/chemistry*;Pyrroles/pharmacology;Pyrroles/therapeutic use*;Stem Cells/drug effects
22700632;Adult;Adverse Drug Reaction Reporting Systems*;Aged;Aged, 80 and over;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Comorbidity;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Safety;Pelargonium*;Pharmacovigilance*;Plant Extracts/adverse effects*;Plant Roots;Respiratory System Agents/adverse effects*;Risk Assessment;Risk Factors
22686837;Administration, Oral;Adult;Area Under Curve;Biological Availability;Drug Therapy, Combination/methods;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Schisandra/chemistry*;Sirolimus/blood;Sirolimus/pharmacokinetics;Sirolimus/pharmacology*
22675703;Beverages;Brazil;Caffeine/adverse effects;Caffeine/analysis;Caffeine/therapeutic use*;Fruit/adverse effects;Herb-Drug Interactions;Humans;Paullinia*/adverse effects;Paullinia*/chemistry;Phytotherapy*/adverse effects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use
22673828;Drug Labeling/legislation & jurisprudence*;Drug and Narcotic Control/legislation & jurisprudence*;Europe;Guidelines as Topic;Herb-Drug Interactions*;Humans;Pharmacokinetics*;Plant Preparations/pharmacology*;Plant Preparations/standards
22670731;Herb-Drug Interactions*;Herbal Medicine/methods;Humans;Plant Preparations*;Plants, Medicinal*
22669039;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions*;Humans;Hymecromone/analogs & derivatives;Hymecromone/metabolism;Kinetics;Tripterygium/chemistry*;Triterpenes/chemistry;Triterpenes/pharmacology*
22648787;Animals;Blood Pressure/drug effects;Chromatography, High Pressure Liquid;Computer Simulation*;Cytochrome P-450 CYP2D6/metabolism*;Flavonoids/chemistry;Flavonoids/pharmacology*;Heart Rate/drug effects;Herb-Drug Interactions*;Isoflavones/chemistry;Isoflavones/pharmacology;Male;Metoprolol/blood;Metoprolol/pharmacology*;Models, Molecular;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Reference Standards;Systole/drug effects
22643032;Absorption;Animals;Herb-Drug Interactions;Humans;Plant Preparations/pharmacokinetics*;Plants, Medicinal/metabolism*
22642738;Adjuvants, Immunologic/administration & dosage;Adjuvants, Immunologic/adverse effects;Adjuvants, Immunologic/therapeutic use;Alanine Transaminase/metabolism;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury/etiology*;Chemical and Drug Induced Liver Injury/physiopathology;Coumarins/administration & dosage;Coumarins/adverse effects*;Drug Combinations;Female;Herb-Drug Interactions;Humans;Injections, Intramuscular;Injections, Subcutaneous;Interferon beta-1b;Interferon-beta/administration & dosage;Interferon-beta/adverse effects*;Interferon-beta/therapeutic use;Multiple Sclerosis/drug therapy;Resins, Plant/administration & dosage;Resins, Plant/adverse effects*;Rutin/administration & dosage;Rutin/adverse effects*;Severity of Illness Index;Young Adult
22612723;Anthelmintics/pharmacokinetics;Anthelmintics/pharmacology;Anti-Retroviral Agents/pharmacokinetics;Anti-Retroviral Agents/pharmacology;Antifungal Agents/pharmacokinetics;Antifungal Agents/pharmacology;Antimalarials/pharmacokinetics;Antimalarials/pharmacology;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology;Biological Transport/drug effects;Biological Transport/physiology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology;Central Nervous System/drug effects;Herb-Drug Interactions*;Hormones/pharmacokinetics;Hormones/pharmacology;Humans;Immunologic Factors/pharmacokinetics;Immunologic Factors/pharmacology;Plants, Medicinal/chemistry*
22610955;Data Mining/methods*;Drug Combinations;Drug Prescriptions/classification*;Drug Therapy, Combination/methods;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/classification*;Herb-Drug Interactions/physiology;Humans;Medicine, Chinese Traditional/methods*;Respiratory Tract Diseases/drug therapy*;Respiratory Tract Diseases/epidemiology;Review Literature as Topic
22608805;Animals;Chromatography, Liquid/methods*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Flavonoids/blood;Flavonoids/chemistry;Flavonoids/pharmacokinetics;Glucosides/blood;Glucosides/chemistry;Glucosides/pharmacokinetics;Herb-Drug Interactions*;Levofloxacin*;Male;Mass Spectrometry/methods*;Ofloxacin/pharmacology*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Rutin/blood;Rutin/chemistry;Rutin/pharmacokinetics
22607644;Antineoplastic Agents, Phytogenic/pharmacokinetics;Blood Platelets/metabolism;Carcinoma, Non-Small-Cell Lung/drug therapy*;Carcinoma, Non-Small-Cell Lung/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Dietary Supplements/adverse effects;Echinacea*;Etoposide/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Phytotherapy/adverse effects;Plant Extracts/pharmacology*;Platelet Count;Thrombocytopenia/blood;Thrombocytopenia/etiology*
22606944;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Animals;Aryl Hydrocarbon Hydroxylases/biosynthesis;Biotransformation/drug effects;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A/biosynthesis;Enzyme Induction;Herb-Drug Interactions*;Humans;Hypericum*;Pharmacokinetics;Plant Preparations/pharmacology*;Plants, Medicinal;Up-Regulation
22588833;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements;Herb-Drug Interactions*;Humans;Magnoliopsida*;Phenotype;Phytotherapy/methods*;Plant Extracts/pharmacology*;Substrate Specificity
22578672;Acute Kidney Injury/chemically induced*;Age Factors;Complementary Therapies/adverse effects*;Drug Contamination;Herb-Drug Interactions;Humans;Kidney Failure, Chronic/chemically induced*;Medicine, Traditional/adverse effects*;Plant Preparations/adverse effects*;Renal Insufficiency, Chronic/chemically induced*;Sex Factors
22568242;Animals;Coumaric Acids/blood;Coumaric Acids/metabolism*;Coumaric Acids/urine;Drugs, Chinese Herbal/metabolism*;Gallic Acid/blood;Gallic Acid/metabolism*;Gallic Acid/urine;Herb-Drug Interactions*;Male;Metabolome;Rats;Rats, Sprague-Dawley;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
22565299;Adenosine Triphosphate/metabolism;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements;Herb-Drug Interactions*;Humans;Magnoliopsida*;Membrane Transport Proteins/metabolism;Pharmacokinetics*;Plant Preparations/pharmacology*;Transferases/metabolism
22562327;Cognition Disorders/drug therapy;Dementia/drug therapy;Evidence-Based Medicine;Ginkgo biloba*/adverse effects;Herb-Drug Interactions*;Humans;Intermittent Claudication/drug therapy;Macular Degeneration/drug therapy;Phytotherapy/adverse effects;Plant Preparations*/adverse effects;Plant Preparations*/therapeutic use;Stroke/drug therapy;Tinnitus/drug therapy;Treatment Outcome
22549240;Animals;Blood Pressure/drug effects*;Cyclooxygenase 2 Inhibitors/adverse effects;Cyclooxygenase 2 Inhibitors/pharmacokinetics*;Cyclooxygenase 2 Inhibitors/pharmacology;Herb-Drug Interactions*;Hypericum*;Male;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Pyridines/pharmacology;Rats;Rats, Wistar;Sulfones/adverse effects;Sulfones/pharmacokinetics*;Sulfones/pharmacology
22546220;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Antineoplastic Combined Chemotherapy Protocols/pharmacology;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Apoptosis/drug effects;Cell Line, Tumor;Cell Proliferation/drug effects;Colorectal Neoplasms/drug therapy*;Colorectal Neoplasms/genetics;Colorectal Neoplasms/metabolism;Drug Synergism;Herb-Drug Interactions*;Humans;Inhibitor of Apoptosis Proteins/genetics;Inhibitor of Apoptosis Proteins/metabolism;Inhibitory Concentration 50;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;RNA, Messenger/metabolism;Stomach Neoplasms/drug therapy*;Stomach Neoplasms/genetics;Stomach Neoplasms/metabolism;Taxoids/administration & dosage;Taxoids/pharmacology;Taxoids/therapeutic use*;Tubulin/genetics;Tubulin/metabolism;Xanthones/administration & dosage;Xanthones/pharmacology;Xanthones/therapeutic use*;tau Proteins/genetics;tau Proteins/metabolism
22541637;Amino Acids/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Dextromethorphan/metabolism;Dextrorphan/metabolism;Diterpenes, Abietane/chemistry;Diterpenes, Abietane/pharmacology*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Kinetics;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Phenanthrolines/chemistry;Phenanthrolines/pharmacology*;Protein Binding;Quinidine/chemistry;Quinidine/pharmacology;Salvia miltiorrhiza/chemistry*
22536985;Acinetobacter/drug effects*;Acinetobacter/growth & development;Acinetobacter Infections/drug therapy;Acinetobacter Infections/microbiology*;Alkaloids/analysis;Alkaloids/pharmacology;Anti-Bacterial Agents/pharmacology*;Anti-Bacterial Agents/therapeutic use;Drug Resistance/drug effects*;Drug Synergism;Herb-Drug Interactions;Holarrhena/chemistry*;Humans;Magnoliopsida/chemistry;Medicine, East Asian Traditional;Novobiocin/pharmacology*;Novobiocin/therapeutic use;Phytotherapy;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plants, Medicinal/chemistry;Tannins/analysis;Tannins/pharmacology;Thailand;Triterpenes/analysis;Triterpenes/pharmacology
22533708;Anti-Bacterial Agents/pharmacology;Ciprofloxacin/pharmacology;Drug Resistance, Bacterial;Escherichia coli/drug effects*;Escherichia coli/enzymology;Escherichia coli/genetics;Herb-Drug Interactions*;Kanamycin/pharmacology;Microbial Sensitivity Tests;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*;Polyphenols/chemistry;Polyphenols/pharmacology*;Quercetin/chemistry;Quercetin/pharmacology;beta-Galactosidase/metabolism
22532034;Animals;Antineoplastic Agents/pharmacology;Boronic Acids/pharmacology;Bortezomib;DNA Damage/drug effects;Herb-Drug Interactions;Humans;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Lung Neoplasms/prevention & control;Maximum Tolerated Dose;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Pyrazines/pharmacology;Tea*
22528756;Drug Design;Drug Discovery*/trends;Drug Synergism;Herb-Drug Interactions;Humans;Molecular Targeted Therapy*/trends;Plants, Medicinal
22509899;Absorption;Animals;Biological Availability;Biotransformation/drug effects;Enzymes/metabolism;Herb-Drug Interactions;Humans;Membrane Transport Modulators/isolation & purification;Membrane Transport Modulators/pharmacology*;Membrane Transport Proteins/drug effects;Membrane Transport Proteins/metabolism;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Leaves;Plants, Medicinal;Polyphenols/isolation & purification;Polyphenols/pharmacology*;Tea*/chemistry
22477279;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Dietary Supplements/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*
22475333;Animals;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacology*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional
22475332;Animals;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Humans;Plants, Medicinal/metabolism*
22471362;Acetyltransferases/metabolism;Adult;Caffeine/metabolism*;Caffeine/urine;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Dextromethorphan/metabolism*;Dextromethorphan/urine;Drugs, Chinese Herbal/pharmacology*;Drugs, Chinese Herbal/therapeutic use;Estrogens/metabolism;Female;Herb-Drug Interactions*;Humans;Hydrocortisone/metabolism*;Hydrocortisone/urine;Menopause;Phenotype;Phytotherapy/adverse effects;Reference Values;Xanthine Oxidase/metabolism;Young Adult
22465502;Acridines/pharmacology*;Acridones;Alkaloids/pharmacology*;Cytochrome P-450 CYP2D6 Inhibitors*;Dextromethorphan/metabolism*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Indonesia;Liver/drug effects*;Liver/enzymology;Methylation;Microsomes/drug effects;NADP/metabolism;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry;Rutaceae/chemistry*
22465277;Animals;Area Under Curve;Aspirin/analysis*;Aspirin/blood;Aspirin/pharmacokinetics;Bleeding Time;Brain Chemistry;Drug Stability;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Male;Microdialysis/methods*;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Salicylic Acid/analysis*;Salicylic Acid/blood;Salicylic Acid/pharmacokinetics
22459282;Anti-Bacterial Agents/pharmacology*;Benzoxepins/adverse effects;Benzoxepins/pharmacology*;Cell Membrane/drug effects;Depsides/adverse effects;Depsides/pharmacology*;Drug Synergism;Drug Therapy, Combination;Fluoresceins/metabolism;Herb-Drug Interactions;Leukocytes, Mononuclear/drug effects;Lichens/chemistry*;Methicillin-Resistant Staphylococcus aureus/drug effects*;Permeability
22392461;Aged;Beverages*/adverse effects;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/metabolism*;Female;Herb-Drug Interactions/physiology*;Humans;International Normalized Ratio/methods;Lycium*;Warfarin/adverse effects;Warfarin/blood*
22381135;Administration, Oral;Adult;Atorvastatin Calcium;Cholesterol/blood;Ginkgo biloba/chemistry*;Heptanoic Acids/administration & dosage;Heptanoic Acids/blood*;Heptanoic Acids/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Pyrroles/administration & dosage;Pyrroles/blood*;Pyrroles/pharmacokinetics*;Treatment Outcome
22375948;Animals;Drug Combinations;Drug Interactions;Herb-Drug Interactions;Humans;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology
22359586;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Administration, Oral;Animals;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/physiology*;Herb-Drug Interactions*;Herbal Medicine/methods;Indinavir/administration & dosage;Indinavir/blood;Indinavir/pharmacokinetics*;Plant Preparations/blood;Plant Preparations/pharmacokinetics*;RNA, Messenger/analysis;Rats;Sophora*
22339466;Animals;Biological Availability;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Liver/metabolism;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics*;Phyllanthus*;Plant Preparations/administration & dosage*;Plant Preparations/pharmacology;Rats;Rats, Sprague-Dawley
22329195;Anticarcinogenic Agents/adverse effects;Anticarcinogenic Agents/therapeutic use;Camellia sinensis*;Catechin/adverse effects;Catechin/analogs & derivatives;Catechin/therapeutic use;Herb-Drug Interactions*;Neoplasms/drug therapy*;Neoplasms/prevention & control;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Plant Leaves
22322396;Adenosine Triphosphate/metabolism;Animals;Chemistry, Pharmaceutical;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements;Drug Contamination;Drug Synergism;Herb-Drug Interactions*;Humans;Membrane Transport Proteins/metabolism;Pharmacogenetics;Pharmacokinetics*;Plant Extracts/pharmacology;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Transferases/metabolism
22320169;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adrenal Cortex Hormones/therapeutic use;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use*;Antineoplastic Combined Chemotherapy Protocols;Cell Phone*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Databases, Factual*;Hemorrhage;Herb-Drug Interactions*;Humans;Hypertension;Hypoglycemia;Internet*;Liver/drug effects;Neoplasms/drug therapy;Phytotherapy*;Plant Preparations/therapeutic use*;Serotonin Syndrome;Software
22315916;Adverse Drug Reaction Reporting Systems;Dietary Supplements*;Drug Interactions*;Evidence-Based Medicine;Herb-Drug Interactions;Humans;United States
22313151;Animals;Biotransformation;Chemistry, Pharmaceutical;Dietary Supplements*/adverse effects;Drug Stability;Drug-Related Side Effects and Adverse Reactions;Evidence-Based Medicine;Garlic*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Phytotherapy*/adverse effects;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plants, Medicinal;Risk Assessment;Risk Factors;Solubility
22309869;Adult;Aged;Attitude of Health Personnel*;California;Clinical Competence;Communication;Dental Hygienists/education*;Dietary Supplements*;Education, Continuing;Educational Status;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy*;Professional Practice;Professional-Patient Relations;Self Concept;Surveys and Questionnaires;Young Adult
22300597;Anticoagulants/adverse effects*;Dietary Supplements/adverse effects*;Hemorrhage/epidemiology;Hemorrhage/etiology*;Herb-Drug Interactions*;Homeostasis/drug effects*;Homeostasis/physiology;Humans;Platelet Aggregation Inhibitors/adverse effects
22298448;Animals;Astragalus Plant;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/pharmacology*;Fabaceae;Herb-Drug Interactions*;Humans;Magnolia;Magnoliopsida*;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Paeonia;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis
22292789;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism;Plant Preparations/pharmacokinetics*;Plants, Medicinal/metabolism*
22292646;Animals;Benzoates/pharmacology*;Blood Platelets/drug effects;Bone Marrow Cells/drug effects*;Bone Marrow Cells/radiation effects*;Bridged-Ring Compounds/pharmacology*;Chemotherapy, Adjuvant/methods;Cyclophosphamide/pharmacology;Cyclophosphamide/toxicity;Cytarabine/pharmacology;Cytarabine/toxicity;Drug Synergism;Drugs, Chinese Herbal/pharmacology;Female;Glucosides/pharmacology*;Hemoglobins/drug effects;Herb-Drug Interactions;Leukocytes/radiation effects;Male;Mice;Mice, Inbred BALB C;Monoterpenes;Paeonia/chemistry*;Plant Extracts/pharmacology;Plant Roots/chemistry;Rabbits;X-Rays
22283868;Acute Kidney Injury/chemically induced*;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Aristolochia/chemistry*;Cyclophosphamide/administration & dosage;Doxorubicin/administration & dosage;Fatal Outcome;Herb-Drug Interactions;Humans;Lymphoma, Large B-Cell, Diffuse/drug therapy*;Male;Medicine, Traditional/adverse effects*;Middle Aged;Plant Extracts/adverse effects*;Prednisone/administration & dosage;Self Administration;Vincristine/administration & dosage
22275232;Animals;Area Under Curve;Biological Transport;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Half-Life;Herb-Drug Interactions;Intestine, Small/drug effects;Intestine, Small/metabolism*;Male;Molecular Structure;Nitrendipine/blood;Nitrendipine/pharmacokinetics*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Punicaceae/metabolism*;Rats;Rats, Wistar
22257149;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Herb-Drug Interactions*;Humans
22236736;Age Factors;Continental Population Groups;Genotype;Herb-Drug Interactions/physiology*;Humans;Patient Education as Topic;Pharmaceutical Preparations*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics;Plant Preparations/pharmacology*;Sex Factors
22208477;Adult;Aryl Hydrocarbon Hydroxylases/blood*;Aryl Hydrocarbon Hydroxylases/genetics;China;Cross-Over Studies;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2D6/blood*;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP3A/blood*;Cytochrome P-450 CYP3A/genetics;Dextromethorphan/administration & dosage;Dextromethorphan/pharmacokinetics;Drugs, Chinese Herbal/administration & dosage*;Genotype;Herb-Drug Interactions*;Humans;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Omeprazole/administration & dosage;Omeprazole/pharmacokinetics;Placebos
23983383;Acquired Immunodeficiency Syndrome/drug therapy*;Adult;Age Factors;Anti-HIV Agents/therapeutic use*;Cross-Sectional Studies;Female;HIV*;Herb-Drug Interactions;Humans;Male;Medicine, African Traditional/utilization*;Multivariate Analysis;Patient Acceptance of Health Care*;Phytotherapy/utilization*;Rural Population;Sex Factors;Socioeconomic Factors;South Africa;Surveys and Questionnaires;Urban Population
22189672;Adult;Biotransformation/drug effects;Caffeine/blood;Caffeine/pharmacokinetics;Cross-Over Studies;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements*/adverse effects;Dose-Response Relationship, Drug;Drug Combinations;Enzyme Induction/drug effects;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Female;Ginkgolides/blood;Headache/chemically induced;Herb-Drug Interactions*;Humans;Male;Phenotype;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Young Adult
22181338;Adolescent;Adult;Aged;Double-Blind Method;Female;Ginkgo biloba*;Herb-Drug Interactions;Humans;Iodine Radioisotopes/adverse effects*;Iodine Radioisotopes/therapeutic use;Lymphocytes/cytology;Lymphocytes/drug effects;Male;Micronuclei, Chromosome-Defective/chemically induced;Middle Aged;Mutagens/analysis;Plant Extracts/therapeutic use*;Radiation Injuries/prevention & control*;Radiopharmaceuticals/adverse effects*;Radiopharmaceuticals/therapeutic use;Thyroid Function Tests;Thyroid Neoplasms/drug therapy*
22164401;Aged;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Factors/therapeutic use;Emergency Service, Hospital*;Evidence-Based Medicine;Female;Hematoma, Subdural/diagnosis;Hematoma, Subdural/diagnostic imaging;Hematoma, Subdural/etiology;Hematoma, Subdural/therapy*;Hemorrhage/diagnosis;Hemorrhage/diagnostic imaging;Hemorrhage/etiology;Hemorrhage/therapy*;Herb-Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Physical Examination;Plasma;Retroperitoneal Space;Tomography, X-Ray Computed;Warfarin/adverse effects;Warfarin/pharmacology;Warfarin/therapeutic use*
22157964;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Antioxidants/pharmacology;Chronic Disease;Clinical Trials as Topic;Contraindications;Curcumin/pharmacology*;Curcumin/therapeutic use;Herb-Drug Interactions;Humans;Inflammation/complications;Inflammation/drug therapy*;Inflammation/metabolism;Medicine, Ayurvedic;Neoplasms/etiology;Neoplasms/metabolism;Neoplasms/prevention & control*;Plants, Medicinal
22157509;Animals;Anti-Anxiety Agents/pharmacology;Anti-Anxiety Agents/therapeutic use*;Anxiety/drug therapy*;Behavior, Animal/drug effects;Benzodiazepines/metabolism;Binding Sites;Flavanones/pharmacology;Flavanones/therapeutic use*;Herb-Drug Interactions;Male;Maze Learning/drug effects;Mentha/chemistry*;Motor Activity/drug effects*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Prospective Studies;Random Allocation;Rats;Rats, Sprague-Dawley;Receptors, GABA-A/metabolism;gamma-Aminobutyric Acid/metabolism
22157508;Affect;Clinical Competence;Cognition;Cognition Disorders/drug therapy*;Herb-Drug Interactions;Herbal Medicine*;Humans;Mood Disorders/drug therapy*;Nursing;Phytotherapy*;Plant Extracts/therapeutic use*
22139695;Administration, Oral;Allyl Compounds/administration & dosage;Allyl Compounds/adverse effects;Allyl Compounds/pharmacology*;Animals;Dietary Supplements/adverse effects;Dietary Supplements/analysis;Dipyridamole/administration & dosage;Dipyridamole/adverse effects;Dipyridamole/blood;Dipyridamole/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Interactions;Garlic/chemistry;Half-Life;Herb-Drug Interactions;Ileum/drug effects;Ileum/metabolism;In Vitro Techniques;Injections, Intravenous;Intestinal Absorption/drug effects;Jejunum/drug effects;Jejunum/metabolism;Male;Metabolic Clearance Rate/drug effects;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Platelet Aggregation Inhibitors/pharmacology*;Rats;Rats, Sprague-Dawley;Solubility;Sulfides/administration & dosage;Sulfides/adverse effects;Sulfides/pharmacology*
22139686;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport/drug effects;Drug Interactions*;Food-Drug Interactions;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Humans;Intestines/drug effects*;Intestines/metabolism;Kidney/drug effects*;Kidney/metabolism;Liver/drug effects*;Liver/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacology
22139685;Animals;Biological Transport/drug effects;Biotransformation/drug effects;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Gene Expression Regulation/drug effects;Herb-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestines/drug effects*;Intestines/enzymology*;Intestines/metabolism;Liver/drug effects*;Liver/enzymology*;Liver/metabolism;Pharmacokinetics*;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology
22139684;Animals;Biological Availability;Biological Transport/drug effects;Biotransformation/drug effects;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Drug Evaluation, Preclinical/methods;Enzyme Induction/drug effects;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism;Liver/drug effects;Liver/enzymology;Liver/metabolism;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology;Recombinant Proteins/antagonists & inhibitors;Recombinant Proteins/metabolism
22139678;Animals;Biotransformation;Drug Discovery/economics;Drug Evaluation, Preclinical/economics;Drug Industry/economics;Drug Industry/methods*;Drug Interactions;Drugs, Investigational/adverse effects;Drugs, Investigational/economics;Drugs, Investigational/pharmacokinetics*;Herb-Drug Interactions;Humans
22136282;Animals;Anticoagulants/therapeutic use;Blood Coagulation/drug effects*;Coagulants/therapeutic use;Evidence-Based Medicine;Fibrinolytic Agents/therapeutic use;Hemorrhage/chemically induced;Herb-Drug Interactions;Humans;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal;Platelet Aggregation Inhibitors/therapeutic use;Risk Assessment;Risk Factors
22132388;Administration, Oral;Administration, Topical;Aloe*/adverse effects;Aloe*/chemistry;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/administration & dosage*;Plant Extracts/adverse effects;Skin Diseases/drug therapy*
22113252;Adult;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics;Antipsychotic Agents/therapeutic use*;Clozapine/blood;Clozapine/pharmacokinetics;Clozapine/therapeutic use*;Drug Resistance;Female;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Plant Preparations/adverse effects*;Schizophrenia, Disorganized/drug therapy*;Schizophrenia, Disorganized/physiopathology;Severity of Illness Index;Treatment Outcome
22108633;Dietary Supplements*/adverse effects;European Union;Food Contamination;Herb-Drug Interactions;Humans;Legislation, Food;Phytotherapy/adverse effects;Plant Preparations/adverse effects*;Plants, Edible*/adverse effects
22106566;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
22101086;Alkaloids/isolation & purification;Alkaloids/pharmacology*;Animals;Annona*/chemistry;Antidepressive Agents/pharmacology*;Behavior, Animal/drug effects;Brain/drug effects;Brain/metabolism;Clomipramine/pharmacology;Dopamine/metabolism;Fluoxetine/pharmacology;Herb-Drug Interactions;Homovanillic Acid/metabolism;Hydroxyindoleacetic Acid/metabolism;Imipramine/pharmacology;Male;Medicine, Traditional;Mexico;Mice;Plant Components, Aerial/chemistry;Plant Extracts/analysis;Plant Extracts/pharmacology*;Serotonin/metabolism;Swimming
22098637;Animals;Anti-Bacterial Agents/pharmacokinetics*;Ceftriaxone/pharmacokinetics*;Drug Interactions;Female;Goats;Herb-Drug Interactions*;Milk/metabolism;Phytotherapy
22097347;Adult;Anticoagulants/pharmacology*;Double-Blind Method;Female;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Plant Extracts/pharmacology*;Warfarin/blood;Warfarin/pharmacology*;Young Adult
22091645;Administration, Oral;Animals;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Dogs/blood*;Herb-Drug Interactions*;Hypericum*;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male
22089445;Anti-Retroviral Agents/pharmacokinetics;Anti-Retroviral Agents/pharmacology;Anti-Retroviral Agents/therapeutic use*;Biological Availability;Communicable Diseases;Diet;Food-Drug Interactions*;HIV Infections/complications;HIV Infections/drug therapy*;HIV Infections/metabolism;Health Resources;Herb-Drug Interactions*;Humans;Metabolic Diseases/complications;Micronutrients/pharmacology*;Nutritional Status*;Phytotherapy;Plant Preparations/pharmacology*;Poverty
22083560;Animals;Apiaceae/metabolism;Chromatography, High Pressure Liquid/methods*;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/metabolism;Furocoumarins/analysis;Furocoumarins/metabolism*;Herb-Drug Interactions*;Inhibitory Concentration 50;Liver/drug effects;Liver/metabolism;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Molecular Structure;Nifedipine/chemistry;Nifedipine/pharmacology;Oxidation-Reduction/drug effects;Rats;Rats, Wistar;Time Factors
22079696;Animals;Area Under Curve;Caffeine/blood;Caffeine/pharmacokinetics;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacology*;Enzyme Inhibitors/pharmacology*;Erigeron*;Herb-Drug Interactions*;Metoprolol/blood;Metoprolol/pharmacokinetics;Midazolam/blood;Midazolam/pharmacokinetics;Rats;Rats, Sprague-Dawley;Tolbutamide/blood;Tolbutamide/pharmacokinetics
22078631;Adult;Androstenes/administration & dosage;Androstenes/adverse effects;Antioxidants/therapeutic use*;Catechin/analysis;Catechin/therapeutic use;Contraceptives, Oral, Combined/administration & dosage;Contraceptives, Oral, Combined/adverse effects*;Dietary Supplements*/analysis;Double-Blind Method;Estrogens/administration & dosage;Estrogens/adverse effects*;Ethinyl Estradiol/administration & dosage;Ethinyl Estradiol/adverse effects;Female;Herb-Drug Interactions*;Humans;Lipid Peroxidation/drug effects;Menstruation/blood;Menstruation/drug effects;Menstruation/metabolism;Oxidative Stress/drug effects*;Reactive Oxygen Species/antagonists & inhibitors*;Reactive Oxygen Species/blood;Tea/chemistry
22076909;Administration, Oral;Analgesics/pharmacology;Animals;Codeine/pharmacology;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Emulsions/chemistry;Gas Chromatography-Mass Spectrometry;Herb-Drug Interactions*;Male;Mentha piperita/chemistry*;Mice;Midazolam/adverse effects;Oils, Volatile/administration & dosage;Oils, Volatile/pharmacology*;Pentobarbital/pharmacology;Plant Leaves/chemistry;Plant Oils/administration & dosage;Plant Oils/pharmacology*;Sleep/drug effects;Time Factors
22066443;Administration, Oral;Animals;Gas Chromatography-Mass Spectrometry;Herb-Drug Interactions*;Houttuynia/chemistry*;Injections, Intravenous;Ketones/administration & dosage;Ketones/pharmacokinetics*;Oils, Volatile/administration & dosage;Oils, Volatile/pharmacokinetics*;Plants, Medicinal/chemistry*;Rats
22056022;Animals;Biomarkers/metabolism;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology;Enzyme Activation;Enzyme Inhibitors/pharmacology*;Ethanol/chemistry;Herb-Drug Interactions;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Phenacetin/pharmacology;Phenanthrolines/chemistry;Phenanthrolines/pharmacology;Plant Roots/chemistry;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry*;Testosterone/pharmacology;Water/chemistry
22039823;Animals;Biological Transport/genetics*;Enzymes/genetics*;Enzymes/metabolism;Genetic Variation;Herb-Drug Interactions/genetics*;Herbal Medicine/methods;Humans;Inactivation, Metabolic/genetics*
22039821;Catalytic Domain;Cytochrome P-450 CYP2D6/chemistry;Cytochrome P-450 CYP2D6/genetics*;Cytochrome P-450 CYP2D6/metabolism*;Drug Evaluation, Preclinical/methods*;Herb-Drug Interactions;Herbal Medicine/methods;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Medicine, Chinese Traditional/methods;Molecular Docking Simulation/methods*;Mutation;Protein Binding;Quantitative Structure-Activity Relationship;Substrate Specificity
22024968;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme System/metabolism;HIV Infections/drug therapy;HIV Infections/metabolism*;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Herb-Drug Interactions*;Humans;Medicine, African Traditional*;Plants, Medicinal;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/therapeutic use
22023882;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Angelica*;Animals;Coumarins/pharmacology*;Drugs, Chinese Herbal/pharmacology*;Female;Flavonoids/blood;Flavonoids/metabolism;Flavonoids/pharmacokinetics*;Herb-Drug Interactions;In Vitro Techniques;Intestinal Absorption/drug effects;Intestines/metabolism;Male;Oils, Volatile/pharmacology*;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis*
22010398;Ginkgo biloba*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
21988365;Ajmaline/adverse effects;Anti-Arrhythmia Agents/adverse effects;Antihypertensive Agents/adverse effects*;Bradycardia/chemically induced*;Dietary Supplements/adverse effects;Drug Contamination;Female;Herb-Drug Interactions*;Humans;Hypertension/drug therapy;Hypotension/chemically induced*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Preparations/adverse effects;Reserpine/adverse effects
21969115;Anti-Infective Agents/isolation & purification;Anti-Infective Agents/pharmacology*;Antitubercular Agents/isolation & purification;Antitubercular Agents/pharmacology;Drug Synergism;Escherichia coli/drug effects*;Furans/isolation & purification;Furans/pharmacology*;Herb-Drug Interactions;Lythraceae/chemistry*;Mycobacterium tuberculosis/drug effects*;Nalidixic Acid/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Tetralones/chemistry;Tetralones/isolation & purification;Tetralones/pharmacology*
21963808;Andrographis*;Animals;Binding Sites;Cells, Cultured;Cytochrome P-450 CYP1A1/biosynthesis*;Cytochrome P-450 CYP1A1/genetics;Diterpenes/chemistry;Diterpenes/metabolism*;Enzyme Induction/drug effects;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions;Ligands;Male;Mice;Mice, Inbred C57BL;Models, Molecular;Molecular Conformation;RNA, Messenger/biosynthesis;Receptors, Aryl Hydrocarbon/chemistry;Receptors, Aryl Hydrocarbon/metabolism*;beta-Naphthoflavone/pharmacology
21959528;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Inactivation, Metabolic*;Nonprescription Drugs;Phytotherapy*;Plants, Medicinal/metabolism*;Prescription Drugs
21946639;Adult;Anticoagulants/adverse effects;Community Pharmacy Services*;Consumer Advocacy*;Consumer Product Safety;Food, Organic*;Health Education*;Herb-Drug Interactions;Humans;Male;New Zealand;Self Medication*;Warfarin/adverse effects
21943317;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adolescent;Adult;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Double-Blind Method;Genistein/pharmacology*;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Male;Metabolic Clearance Rate;Midazolam/pharmacokinetics*;Propanolamines/pharmacokinetics*;Protein Kinase Inhibitors/pharmacology*
21939995;Adult;Antirheumatic Agents;Complementary Therapies/adverse effects;Complementary Therapies/utilization;Cross-Sectional Studies;Disclosure;Female;HIV Infections/drug therapy*;Health Care Surveys;Herb-Drug Interactions;Humans;Logistic Models;Male;Middle Aged;Physician-Patient Relations;Phytotherapy/adverse effects;Phytotherapy/utilization*;Socioeconomic Factors;Surveys and Questionnaires
21928376;Animals;Anti-Anxiety Agents/administration & dosage;Anti-Anxiety Agents/chemistry;Anti-Anxiety Agents/pharmacology;Anti-Inflammatory Agents/administration & dosage;Anti-Inflammatory Agents/chemistry;Anti-Inflammatory Agents/pharmacology;Cat's Claw/chemistry*;Diazepam/administration & dosage;Diazepam/chemistry;Diazepam/pharmacology*;Drug Combinations;Drug Interactions;Eucalyptus/chemistry*;Exploratory Behavior/drug effects;Female;Herb-Drug Interactions*;Male;Mice;Motor Activity/drug effects;Muscle Relaxation;Plant Bark/chemistry;Plant Leaves/chemistry;Plant Preparations/administration & dosage;Plant Preparations/chemistry;Plant Preparations/pharmacology
21925256;Administration, Oral;Caco-2 Cells;Calcitriol/pharmacology;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Diterpenes/administration & dosage;Diterpenes/pharmacology*;Dose-Response Relationship, Drug;Down-Regulation;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Gene Expression Regulation, Enzymologic/drug effects;Herb-Drug Interactions;Humans;Hydroxylation;Intestines/drug effects*;Intestines/enzymology;Medicine, Chinese Traditional;Nifedipine/metabolism;Oxidation-Reduction;Plants, Medicinal;RNA, Messenger/metabolism;Testosterone/metabolism;Time Factors
21920422;Administration, Oral;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacology;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacology;Berberine/administration & dosage;Berberine/adverse effects;Berberine/pharmacology*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Dose-Response Relationship, Drug;Gene Expression/drug effects*;Herb-Drug Interactions;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacology;Liver/drug effects*;Male;Mice;Mice, Inbred C57BL;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*;RNA, Messenger/metabolism
21919844;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Animals;Cytochrome P-450 Enzyme System/metabolism;Garlic/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions*;Humans;Panax/chemistry;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Plant Preparations/chemistry;Plant Preparations/metabolism*;Plant Preparations/pharmacokinetics
21910346;Adenocarcinoma/pathology;Cell Differentiation/drug effects*;Cell Line, Tumor;Cell Proliferation/drug effects*;Endometrial Neoplasms/pathology;Female;Fluorouracil/pharmacology*;Herb-Drug Interactions;Humans;Plant Extracts/pharmacology*;Rosa/chemistry
21907570;Animals;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacology;Colorectal Neoplasms/drug therapy;Drugs, Chinese Herbal/administration & dosage*;Herb-Drug Interactions*;Hyperalgesia/chemically induced;Hyperalgesia/drug therapy;Hyperalgesia/prevention & control;Male;Medicine, Kampo;Mice;Mice, Inbred BALB C;Organoplatinum Compounds/adverse effects*;Organoplatinum Compounds/pharmacology;Pain/chemically induced;Pain/drug therapy;Pain/prevention & control;Peripheral Nervous System Diseases/chemically induced*;Peripheral Nervous System Diseases/drug therapy;Peripheral Nervous System Diseases/prevention & control*;Rats;Rats, Sprague-Dawley;Tumor Cells, Cultured
21906668;Acetaminophen/pharmacology;Administration, Oral;Alkaloids/pharmacology;Animals;Benzodioxoles/pharmacology;Biotransformation;Caco-2 Cells;Catechin/pharmacology;Chromatography, Liquid;Curcumin/administration & dosage;Curcumin/pharmacology*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Flavanones/administration & dosage;Flavanones/blood;Flavanones/pharmacokinetics*;Glucuronides/metabolism;Herb-Drug Interactions*;Humans;Intestinal Absorption*/drug effects;Jejunum/drug effects*;Jejunum/metabolism;Male;Medicine, Chinese Traditional;Perfusion;Piperidines/pharmacology;Plant Roots;Plants, Medicinal;Polyunsaturated Alkamides/pharmacology;Rats;Rats, Sprague-Dawley;Scutellaria baicalensis*/chemistry;Sulfates/metabolism;Tandem Mass Spectrometry
21901498;Animals;Biological Availability;Drug Administration Schedule;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Edetic Acid/pharmacology;Herb-Drug Interactions*;Male;Medicine, Kampo;Rats;Rats, Wistar;Tetracycline/pharmacokinetics;Tetracycline/pharmacology*
21892916;Drug Contamination;Drugs, Chinese Herbal/toxicity*;Herb-Drug Interactions;Herbal Medicine;Medicine, Chinese Traditional/adverse effects*;Phytotherapy/adverse effects;Plants, Medicinal/toxicity*
21879526;Anthropology;Chemical and Drug Induced Liver Injury;Ethnopharmacology;Hawaii;Herb-Drug Interactions;Herbal Medicine/standards;Humans;Kava/adverse effects*;Medicine, Traditional*;Phytotherapy/adverse effects*;Risk Assessment
21878380;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/blood;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/pharmacology*;Chromatography, High Pressure Liquid;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Linear Models;Male;Prothrombin Time;Rats;Rats, Wistar;Warfarin/administration & dosage;Warfarin/blood;Warfarin/pharmacokinetics*
21867654;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Legislation, Drug;Liver Failure, Acute/chemically induced;Liver Failure, Acute/diagnosis;Plant Extracts/adverse effects;Plant Preparations/adverse effects*;Risk Factors
21838705;Animals;Antiviral Agents/pharmacokinetics;Biological Transport;Caco-2 Cells;Cardiovascular Agents/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Darunavir;Garlic/chemistry*;Hep G2 Cells;Hepatocytes/drug effects;Hepatocytes/metabolism;Herb-Drug Interactions*;Humans;Intestine, Small/drug effects;Intestine, Small/metabolism;Male;Membrane Transport Proteins/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Reproducibility of Results;Sulfonamides/pharmacokinetics
21827497;Animals;Body Weight/drug effects*;Caseins/administration & dosage;Diet, Protein-Restricted*;Dietary Proteins/administration & dosage;Ginkgo biloba*;Herb-Drug Interactions*;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology*;Liver/drug effects;Male;Organ Size/drug effects;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Serum Albumin/metabolism;Tolbutamide/blood;Tolbutamide/pharmacokinetics;Tolbutamide/pharmacology*
21827215;Carbamates/blood;Carbamates/pharmacokinetics*;Carbamates/pharmacology;Cross-Over Studies;Cytochrome P-450 Enzyme System/metabolism;Depression/drug therapy*;Genotype;Herb-Drug Interactions/genetics*;Humans;Hypericum*;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Organic Anion Transporters/genetics;Phytotherapy;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/pharmacology;Placebos;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Receptors, Steroid/agonists*;Receptors, Steroid/genetics;Receptors, Steroid/metabolism;Solute Carrier Organic Anion Transporter Family Member 1b1;Young Adult
21823195;Acute Coronary Syndrome/complications;Acute Coronary Syndrome/drug therapy;Acute Coronary Syndrome/epidemiology*;Aged;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aspirin/therapeutic use;Cardiovascular Diseases/complications;Cardiovascular Diseases/drug therapy;Cardiovascular Diseases/epidemiology;Cohort Studies;Cytochrome P-450 CYP2C19;Databases, Factual;Drug Interactions;Esomeprazole;Female;Herb-Drug Interactions;Hospitalization;Humans;Male;Middle Aged;Omeprazole/adverse effects;Omeprazole/therapeutic use;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Proton Pump Inhibitors/adverse effects*;Proton Pump Inhibitors/therapeutic use;Recurrence;Retrospective Studies;Ticlopidine/adverse effects;Ticlopidine/analogs & derivatives;Ticlopidine/therapeutic use;Treatment Outcome
21804969;Animals;Carcinogens;Dietary Supplements/adverse effects*;Europe;Food Contamination/legislation & jurisprudence;Food Contamination/prevention & control;Food Safety*;Herb-Drug Interactions;Humans;Legislation, Food;Mutagens;Plant Preparations/adverse effects*;Plants, Edible/adverse effects*;Risk Assessment
21804213;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Apiaceae/chemistry;Biological Transport/drug effects;Blood-Brain Barrier/cytology;Blood-Brain Barrier/drug effects*;Blood-Brain Barrier/metabolism;Caco-2 Cells;Cattle;Citrus paradisi/chemistry;Coumarins/pharmacokinetics;Coumarins/pharmacology*;Endothelial Cells/drug effects;Endothelial Cells/metabolism;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology*;Fluoresceins/metabolism;Furans/pharmacokinetics;Furans/pharmacology*;Furocoumarins/pharmacokinetics;Furocoumarins/pharmacology*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Male;Medicine, Kampo;Permeability;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Rutaceae/chemistry;Verapamil/metabolism
21802929;Animals;Anticoagulants/adverse effects*;Blood Coagulation/drug effects;Coagulants/pharmacology;Cyclopentanes/administration & dosage;Cyclopentanes/pharmacology*;Cytochrome P-450 Enzyme System/chemistry*;Cytochrome P-450 Enzyme System/drug effects;Enzyme Induction;Furans/administration & dosage;Furans/pharmacology*;Ginkgo biloba/chemistry*;Ginkgolides/administration & dosage;Ginkgolides/pharmacology*;Herb-Drug Interactions;Lactones/administration & dosage;Lactones/pharmacology;Liver/chemistry;Liver/drug effects;Male;Mice;Mice, Inbred ICR;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Warfarin/administration & dosage;Warfarin/adverse effects*
21802919;Aged;Alanine Transaminase/metabolism;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury/diagnosis*;Chemical and Drug Induced Liver Injury/enzymology*;Chemical and Drug Induced Liver Injury/epidemiology;Drug-Related Side Effects and Adverse Reactions;Female;Herb-Drug Interactions*;Hospitalization;Humans;Liver/drug effects*;Liver/enzymology;Male;Middle Aged;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Pilot Projects;Plants, Medicinal/adverse effects;Plants, Medicinal/metabolism*;Prevalence;Republic of Korea/epidemiology;Retrospective Studies
21796700;Animals;Antineoplastic Agents, Phytogenic/pharmacokinetics*;China;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Male;Paclitaxel/pharmacokinetics*;Phytotherapy;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Schisandra/chemistry*
21756221;Absorption;Africa;Beverages;Genetic Variation;Herb-Drug Interactions*;Humans;Phytotherapy*;Tissue Distribution
21749828;Animals;Bufanolides/pharmacology*;Cattle;Chromatography, High Pressure Liquid;Herb-Drug Interactions*;Humans;Serum Albumin;Serum Albumin, Bovine;Verapamil/pharmacology*
21749392;Animals;Cattle;Cell Survival;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Drug-Related Side Effects and Adverse Reactions;Glycosides/pharmacology;Harpagophytum/chemistry*;Herb-Drug Interactions*;Iridoid Glycosides;Luminescent Measurements;Phytotherapy;Plant Preparations/pharmacology*;Plants, Medicinal/chemistry*;Pyrans/pharmacology;Receptors, Steroid/metabolism;Retinoid X Receptors/metabolism
21742280;Adult;Birth Weight/drug effects;Cesarean Section;Female;Health Care Surveys;Herb-Drug Interactions*;Humans;Iron, Dietary/therapeutic use*;Norway;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Plants, Medicinal*;Polypharmacy;Pregnancy;Pregnancy Complications/drug therapy*;Pregnancy Outcome*;Surveys and Questionnaires
21742023;Action Potentials;Animals;Anti-Anxiety Agents/pharmacology*;CA1 Region, Hippocampal/cytology;CA1 Region, Hippocampal/drug effects*;CA1 Region, Hippocampal/metabolism;Dose-Response Relationship, Drug;Herb-Drug Interactions*;Male;Neurons/drug effects*;Neurons/metabolism;Plant Preparations/pharmacology*;Rats;Rats, Sprague-Dawley;Receptor, Serotonin, 5-HT1A/drug effects;Receptor, Serotonin, 5-HT1A/metabolism;Receptor, Serotonin, 5-HT2A/drug effects;Receptor, Serotonin, 5-HT2A/metabolism;Serotonin Agents/pharmacology*;Triterpenes/pharmacology*
21729114;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Inhibitory Concentration 50;Isoenzymes;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Republic of Korea
21717139;Animals;Drugs, Chinese Herbal/pharmacology*;Fluorobenzenes/pharmacokinetics*;Herb-Drug Interactions*;Lactates/pharmacology*;Male;Pyrimidines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Rosuvastatin Calcium;Solute Carrier Organic Anion Transporter Family Member 1b1/physiology;Sulfonamides/pharmacokinetics*;Triterpenes/pharmacology*
21715270;Aegle/chemistry*;Amides/isolation & purification;Amides/pharmacology*;Animals;Calcium/metabolism;Cell Culture Techniques;Cell Line, Tumor;Dinitrophenols/antagonists & inhibitors;Dinitrophenols/pharmacology;Herb-Drug Interactions*;Histamine Release/drug effects*;Ionomycin/antagonists & inhibitors;Ionomycin/pharmacology;Male;Mast Cells/drug effects*;Mast Cells/metabolism;Rats;Rats, Wistar;Serum Albumin, Bovine/antagonists & inhibitors;Serum Albumin, Bovine/pharmacology;Tetradecanoylphorbol Acetate/antagonists & inhibitors;Tetradecanoylphorbol Acetate/pharmacology;Thapsigargin/antagonists & inhibitors;Thapsigargin/pharmacology;p-Methoxy-N-methylphenethylamine/antagonists & inhibitors;p-Methoxy-N-methylphenethylamine/pharmacology
21704146;Administration, Oral;Animals;Biological Availability;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/blood;Cardiovascular Agents/pharmacokinetics*;Carthamus tinctorius;Coumaric Acids/administration & dosage;Coumaric Acids/blood;Coumaric Acids/pharmacokinetics*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions*;Intestinal Absorption/drug effects;Male;Platelet Aggregation Inhibitors/administration & dosage*;Rats;Rats, Sprague-Dawley;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*
21696342;Animals;Body Temperature/drug effects*;Brain/drug effects;Cannabinoids/adverse effects;Cannabis/adverse effects*;Cognition/drug effects*;Conditioning (Psychology)/drug effects*;Herb-Drug Interactions*;Humans;N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage;N-Methyl-3,4-methylenedioxyamphetamine/adverse effects*;Synaptic Transmission/drug effects*
21692140;Canada;Drug Contamination/statistics & numerical data;Drug Industry;Health Communication/methods*;Herb-Drug Interactions;Humans;Information Dissemination/methods;Plant Preparations/adverse effects*;Plant Preparations/metabolism;Plant Preparations/poisoning;Risk Assessment;Risk Management/methods*
21686183;Computational Biology;Crystallography, X-Ray;Cytochrome P-450 CYP1A2/chemistry*;Cytochrome P-450 CYP1A2 Inhibitors/chemistry*;Drug Discovery;Herb-Drug Interactions*;Molecular Conformation;Substrate Specificity
21671861;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Antineoplastic Agents, Phytogenic/pharmacology;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy;Plants, Medicinal/chemistry*
21667558;Anxiety Disorders/drug therapy*;Depressive Disorder/drug therapy*;Drug Therapy, Combination;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/therapeutic use*;Somatoform Disorders/drug therapy*
21658754;Aged;Aged, 80 and over;Dietary Supplements/adverse effects*;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*;Emergency Nursing/methods*;Female;Geriatric Nursing/methods*;Herb-Drug Interactions;Herbal Medicine;Humans;Male;Nonprescription Drugs/adverse effects*;Pharmaceutical Preparations/administration & dosage;Plants, Medicinal/adverse effects*
21657088;Animals;Biomarkers, Pharmacological;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Humans
21649517;Adolescent;Adult;Age Factors;Aged;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Drug Prescriptions/statistics & numerical data*;Drug Therapy, Combination/adverse effects;Drug Therapy, Combination/trends;Ginkgo biloba*;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;Insurance, Health;Middle Aged;Odds Ratio;Phytotherapy/adverse effects*;Plant Extracts;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Retrospective Studies;Risk;Sex Factors;Taiwan;Young Adult
21646440;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors;Drug Monitoring;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Female;Half-Life;Herb-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male;Metabolic Clearance Rate/drug effects;Midazolam/blood;Midazolam/pharmacokinetics*;Panax/chemistry*;Plant Roots/chemistry;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics;Young Adult
21645607;Adolescent;Adult;Age Factors;Aged;Awareness;Communication;Cultural Characteristics;Drug-Related Side Effects and Adverse Reactions;Educational Status;Employment;Female;Health Behavior*/ethnology;Health Care Surveys;Health Knowledge, Attitudes, Practice*/ethnology;Herb-Drug Interactions;Humans;Jamaica;Male;Medicine, Traditional/utilization*;Middle Aged;Pharmaceutical Preparations*;Physician-Patient Relations;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Plants, Medicinal;Religion and Medicine;Self Medication;Surveys and Questionnaires;Young Adult
21641521;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use;Commerce/standards*;Consumer Health Information/standards*;Contraindications;Cross-Sectional Studies;Depressive Disorder/therapy;Herb-Drug Interactions*;Humans;Hypericum*;Internet/standards*;Phytotherapy*;Plant Extracts/adverse effects*
21632963;Glucuronides/metabolism*;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Plant Extracts/pharmacology*;Trifluoperazine/metabolism*
21619523;Animals;Biological Transport/drug effects;Biotransformation/drug effects;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Intestine, Small/drug effects;Intestine, Small/enzymology;Intestine, Small/metabolism;Liver/drug effects;Liver/enzymology;Liver/metabolism;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plant Preparations/pharmacokinetics*;Plants, Medicinal/chemistry;Species Specificity;Translational Medical Research*/trends
21619521;Animals;Biological Availability;Biotransformation;Gene Knockout Techniques;Herb-Drug Interactions*;Humans;Metabolomics/methods;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology
21619520;Animals;Biotransformation;Carcinogens/pharmacokinetics;Carcinogens/toxicity*;Chemical and Drug Induced Liver Injury/metabolism*;Herb-Drug Interactions;Humans;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry*;Pyrrolizidine Alkaloids/pharmacokinetics*;Pyrrolizidine Alkaloids/toxicity*
21619519;Animals;Biological Availability;Biotransformation;Ginsenosides/adverse effects;Ginsenosides/analysis;Ginsenosides/pharmacokinetics;Ginsenosides/therapeutic use;Herb-Drug Interactions*;Humans;Panax/chemistry*;Phytotherapy;Plant Preparations/adverse effects;Plant Preparations/chemistry;Plant Preparations/pharmacokinetics*;Plant Preparations/therapeutic use;Plant Roots/chemistry*;Saponins/adverse effects;Saponins/analysis;Saponins/pharmacokinetics;Saponins/therapeutic use
21619518;Animals;Biological Transport/drug effects;Biotransformation/drug effects;Drug Interactions;Herb-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestine, Small/drug effects;Intestine, Small/enzymology;Intestine, Small/metabolism;Liver/drug effects;Liver/enzymology;Liver/metabolism;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Plant Preparations/pharmacology;Plants, Medicinal/chemistry*;Tissue Distribution/drug effects
21614461;Adult;Analysis of Variance;Cross-Over Studies;Fluorides, Topical/adverse effects;Herb-Drug Interactions;Humans;Mouthwashes/adverse effects*;Oils, Volatile/adverse effects*;Phenols/adverse effects*;Plant Oils/adverse effects;Reproducibility of Results;Single-Blind Method;Tea/adverse effects;Tin Fluorides/adverse effects*;Tongue/drug effects*;Tooth Discoloration/chemically induced*
21609190;Animals;Herb-Drug Interactions*;Herbal Medicine*;Humans;Inactivation, Metabolic*;Plant Preparations/pharmacokinetics*;Plants, Medicinal/chemistry*;Plants, Medicinal/toxicity
21567510;Animals;Area Under Curve;Benzofurans/blood;Benzofurans/metabolism;Benzofurans/pharmacokinetics*;Bile/metabolism*;Biological Transport/drug effects;Chromatography, High Pressure Liquid;Chromatography, Liquid;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Male;Mass Spectrometry;Organic Anion Transporters/antagonists & inhibitors*;Plant Extracts/blood;Plant Extracts/metabolism;Plant Extracts/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Rifampin/pharmacology*;Salvia miltiorrhiza/chemistry*
21558883;Aged;Aged, 80 and over;Atrial Fibrillation/blood*;Atrial Fibrillation/drug therapy*;Cohort Studies;Follow-Up Studies;Herb-Drug Interactions*/physiology;Humans;International Normalized Ratio/methods;Male;Middle Aged;Plant Preparations/blood;Plant Preparations/therapeutic use*;Surveys and Questionnaires;Time Factors;Warfarin/blood;Warfarin/therapeutic use*
21556089;Adolescent;Adult;Child;Depression/drug therapy*;Herb-Drug Interactions;Humans;Hypericum*;Phytotherapy*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Factors;Treatment Outcome
21545833;Administration, Oral;Animals;Cell Line, Tumor;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Evaluation, Preclinical;Fabaceae*;Formazans;Herb-Drug Interactions*;Humans;Male;Nevirapine/administration & dosage;Nevirapine/metabolism;Nevirapine/pharmacokinetics*;Nevirapine/pharmacology;Plant Extracts/administration & dosage;Plant Extracts/metabolism;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/metabolism;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/pharmacology;Tetrazolium Salts;Time Factors
21544887;Glucuronosyltransferase/antagonists & inhibitors*;Herb-Drug Interactions;Humans;Hymecromone/analogs & derivatives*;Hymecromone/metabolism;Isoenzymes;Kinetics;Monoterpenes/pharmacology*;Plant Extracts/pharmacology*;Recombinant Proteins
21542296;Angelica/chemistry*;Animals;Drug Synergism;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Duodenum/metabolism;Flavonoids/isolation & purification;Flavonoids/pharmacokinetics*;Herb-Drug Interactions;Intestinal Absorption/drug effects*;Intestines/metabolism;Male;Perfusion;Permeability;Plants, Medicinal/chemistry;Portal Vein/metabolism;Rats;Rats, Sprague-Dawley;Scutellaria/chemistry*;Verapamil/pharmacology
21538851;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Animals;Cytochrome P-450 Enzyme Inhibitors;Dietary Supplements/adverse effects*;Dietary Supplements/analysis;Glucuronosyltransferase/metabolism;Hepatic Insufficiency/chemically induced;Herb-Drug Interactions;Humans;Kinetics;Phytotherapy/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/chemistry;Plant Extracts/metabolism;Plant Extracts/pharmacology;Tea/chemistry*
21538623;Cell Line;Cytochrome P-450 Enzyme System/metabolism*;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Liver/cytology;Liver/drug effects*;Liver/enzymology;Plant Extracts/pharmacology*;Plant Lectins/pharmacology*;Species Specificity;Viscum/chemistry*;Viscum/classification
21527329;Absorption/drug effects;Animals;Area Under Curve;Capsules;Drugs, Chinese Herbal/pharmacology*;Glyburide/blood;Glyburide/pharmacokinetics*;Herb-Drug Interactions*;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Male;Malvaceae*;Rats;Rats, Sprague-Dawley
21524698;4-Butyrolactone/analogs & derivatives;4-Butyrolactone/pharmacology;Berberine/pharmacology;Cyclooctanes/pharmacology;Cytochrome P-450 CYP3A/metabolism*;Dioxoles/pharmacology;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Genes, Reporter;Hep G2 Cells;Herb-Drug Interactions*;Humans;Lignans/pharmacology;Magnoliopsida/chemistry*;Medicine, Chinese Traditional;Plants, Medicinal/chemistry;Receptors, Steroid/metabolism*;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction/drug effects;Stilbenes/pharmacology
21508758;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Herb-Drug Interactions;Humans;Legislation, Food;Physician-Patient Relations;Plant Preparations/adverse effects;United States
21495267;Animals;Anti-Infective Agents/pharmacokinetics*;Antimalarials/pharmacology;Herb-Drug Interactions*;Male;Metronidazole/pharmacokinetics*;Plant Extracts/pharmacology*;Rats;Rats, Wistar
21480802;Animals;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Disease Models, Animal;Female;Herb-Drug Interactions*;Hibiscus/chemistry*;Humans;Hydrochlorothiazide/adverse effects;Hydrochlorothiazide/pharmacokinetics*;Hypertension/drug therapy*;Hypertension/physiopathology;Male;Mice;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics*;Rabbits;Rats;Urination/drug effects
21480130;Aged, 80 and over;Anticoagulants/adverse effects*;Drug Interactions;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Male;Plant Preparations/adverse effects*;Warfarin/adverse effects*
21462089;ATP-Binding Cassette Transporters/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adenosine Triphosphatases/metabolism*;Analysis of Variance;Antineoplastic Agents/pharmacology*;Cell Line, Tumor;Cell Survival/drug effects;Colchicine/pharmacology;Daunorubicin/pharmacology;Drug Resistance, Neoplasm;Flavonoids/pharmacology*;Herb-Drug Interactions*;Humans;Verapamil/pharmacology;Vinblastine/pharmacology
21456393;Anti-Inflammatory Agents/therapeutic use;Antineoplastic Agents/therapeutic use*;Bromelains/therapeutic use*;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy
21441484;Animals;Anti-HIV Agents*;Antiretroviral Therapy, Highly Active;Clinical Trials as Topic;Drugs, Chinese Herbal*;Enzyme Inhibitors;HIV-1/enzymology;Herb-Drug Interactions;Humans;Research*
21436933;Counseling/methods*;Counseling/standards;Dietary Supplements*/adverse effects;Health Surveys/methods;Health Surveys/standards;Herb-Drug Interactions;Humans;Patient Education as Topic/methods*;Patient Education as Topic/standards;Pharmacists*/standards;Pilot Projects;Plant Preparations*/adverse effects;Reproducibility of Results
21425377;Alkaloids/pharmacology*;Coptis/chemistry*;Cytochrome P-450 Enzyme System/drug effects*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Isoenzymes/drug effects;Microsomes, Liver/drug effects*;Rhizome/chemistry
21421030;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics;Cyclosporine/pharmacology;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Infusions, Intravenous;Male;Platelet Aggregation Inhibitors/pharmacokinetics;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry;Taxoids/administration & dosage;Taxoids/pharmacokinetics*;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics
21417789;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions/physiology*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology;Intestines/metabolism;Pharmaceutical Preparations/metabolism;Plant Preparations/adverse effects*;Plant Preparations/metabolism*
21397894;Ampicillin/pharmacology;Anti-Bacterial Agents/pharmacology*;Bacteria, Aerobic/drug effects*;Bacteria, Anaerobic/drug effects;Clove Oil/pharmacology*;Colony Count, Microbial;Dental Caries/microbiology;Drug Synergism;Eugenol/pharmacology;Gentamicins/pharmacology;Herb-Drug Interactions;Microbial Sensitivity Tests;Mouth/microbiology*;Periodontitis/microbiology;Sesquiterpenes/pharmacology
21385154;Biological Products/adverse effects;Biological Products/chemistry;Biological Products/metabolism*;Biological Products/pharmacokinetics*;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Herb-Drug Interactions;Humans;Tissue Distribution
21368384;Europe;Herb-Drug Interactions;Humans;Kidney Diseases/drug therapy*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Serenoa/chemistry;Urinary Tract Infections/drug therapy
21359185;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/therapeutic use*;Combined Modality Therapy/adverse effects;Cross-Sectional Studies;Drugs, Chinese Herbal/therapeutic use*;Epidemiologic Studies;Female;Herb-Drug Interactions/physiology*;Humans;Male;Medicine, Chinese Traditional/adverse effects;Medicine, Chinese Traditional/utilization*;Retrospective Studies;Schizophrenia/drug therapy*;Schizophrenia/epidemiology*;Surveys and Questionnaires;Young Adult
21351298;Animals;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A/metabolism*;Enzyme Inhibitors/pharmacology*;Glycyrrhiza/chemistry*;Glycyrrhizic Acid/pharmacology*;Herb-Drug Interactions*;Inhibitory Concentration 50;Ketoconazole/pharmacology;Male;Plant Extracts/pharmacology*;Quinidine/pharmacology;Rats, Wistar;Rhizome
21331509;Animals;Biological Availability;Catechin/analogs & derivatives*;Catechin/blood;Catechin/metabolism;Chemical Precipitation;Herb-Drug Interactions*;Humans;Indoles/blood;Indoles/metabolism*;Indoles/pharmacokinetics*;Magnetic Resonance Spectroscopy;Male;Mass Spectrometry;Mice;Mice, Inbred C57BL;Plant Extracts/metabolism;Pyrroles/blood;Pyrroles/metabolism*;Pyrroles/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Tea/chemistry
21309292;Anesthesia;Animals;Cyclooxygenase 2/drug effects;Cyclooxygenase Inhibitors/pharmacology;Dietary Supplements/adverse effects;Dietary Supplements/utilization;Drug Evaluation, Preclinical;Drug Therapy, Combination;Ellagic Acid/adverse effects;Ellagic Acid/pharmacology*;Flow Cytometry*/methods;Hemorrhage/chemically induced;Herb-Drug Interactions/physiology;Ketorolac/pharmacology;Male;P-Selectin*/analysis;P-Selectin*/drug effects;Phytotherapy/adverse effects;Phytotherapy/utilization;Platelet Activation/drug effects*;Rats;Rats, Sprague-Dawley;Thiazines/pharmacology;Thiazoles/pharmacology
21296832;Anticoagulants/chemistry;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Chromatography, Thin Layer;Coumarins/analysis;Hemolysis/drug effects*;Herb-Drug Interactions;Humans;Medicine, African Traditional;Partial Thromboplastin Time;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plants, Medicinal/chemistry*;Plants, Medicinal/classification;Prothrombin Time;Salicylates/analysis;South Africa;Species Specificity
21296265;Adolescent;Adult;Disclosure/statistics & numerical data*;Drug Prescriptions/statistics & numerical data*;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Phytotherapy/utilization*;Plants, Medicinal;Prescription Drugs;Self Medication/psychology*;Self Medication/statistics & numerical data*;Self Report;Students/psychology*;Students/statistics & numerical data*;Young Adult
21295405;Animals;Cognition Disorders/etiology*;Disease Models, Animal;Excitatory Amino Acid Antagonists/pharmacology;Excitatory Postsynaptic Potentials/drug effects;Exploratory Behavior/physiology;Fluoroacetates/pharmacology;Glycine/metabolism*;Glycine/pharmacology;Herb-Drug Interactions;Hippocampus/metabolism*;Hippocampus/pathology;Hyperalgesia/drug therapy;Hyperalgesia/etiology;In Vitro Techniques;Male;Membrane Potentials/drug effects;Mice;Mice, Inbred Strains;Motor Activity/drug effects;N-Methylaspartate/pharmacology;Neurons/drug effects;Neurons/physiology;Pain Measurement;Pain Threshold/physiology;Patch-Clamp Techniques;Recognition (Psychology);Sarcosine/analogs & derivatives;Sarcosine/therapeutic use;Sciatic Neuropathy/complications*;Sciatic Neuropathy/drug therapy;Sciatic Neuropathy/pathology*
21294484;Herb-Drug Interactions;Humans;Lycium*;Neoplasms/drug therapy*;Phytotherapy*
21287929;Evidence-Based Practice;Garlic/adverse effects;Ginkgo biloba/adverse effects;Glycyrrhiza/adverse effects;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Medication Reconciliation;NADPH-Ferrihemoprotein Reductase/drug effects;NADPH-Ferrihemoprotein Reductase/metabolism;Nursing Assessment;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects*;United Kingdom
21287651;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport/drug effects;Daunorubicin/pharmacokinetics;Dictamnus/chemistry;Digoxin/antagonists & inhibitors;Digoxin/pharmacokinetics;Genes, MDR/drug effects;Genetic Variation;Herb-Drug Interactions*;Humans;LLC-PK1 Cells;Oocytes/drug effects;Oocytes/metabolism;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Poria/chemistry;Rhus/chemistry;Swine;Xenopus laevis
21281847;Adolescent;Child;Dietary Supplements;Docosahexaenoic Acids/adverse effects;Docosahexaenoic Acids/pharmacology;Eicosapentaenoic Acid/adverse effects;Eicosapentaenoic Acid/pharmacology;Herb-Drug Interactions;Herbal Medicine*;Humans;Hypericum/adverse effects;Kava/adverse effects;Melatonin/adverse effects;Melatonin/pharmacology;Mental Disorders/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Valerian/adverse effects
21220081;Chronic Disease;Complementary Therapies*/adverse effects;Complementary Therapies*/psychology;Complementary Therapies*/trends;Complementary Therapies*/utilization;Culture;Global Health;Herb-Drug Interactions;Humans;Life Style;Pain/etiology;Patient Participation*;Physician-Patient Relations*;Rheumatic Diseases/therapy*;Treatment Outcome
21218728;Adult;Attitude of Health Personnel*;Clinical Competence;Cross-Sectional Studies;Female;Health Knowledge, Attitudes, Practice*;Health Services Needs and Demand;Herb-Drug Interactions;Herbal Medicine*/education;Herbal Medicine*/methods;Herbal Medicine*/statistics & numerical data;Humans;Male;Medicine, Arabic;Motivation;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Pharmacies*/organization & administration;Pharmacists/organization & administration;Pharmacists/psychology*;Safety;Saudi Arabia;Surveys and Questionnaires;Urban Health/statistics & numerical data
21213356;Biotransformation;Cimicifuga/adverse effects;Cimicifuga/chemistry;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Fluorescent Dyes/metabolism;Herb-Drug Interactions;Humans;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Viburnum/adverse effects;Viburnum/chemistry;Vitex/chemistry
22754069;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Counseling*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Patient Education as Topic/methods*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Plant Preparations/pharmacology*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Plants, Medicinal/metabolism
21191769;Administration, Oral;Animals;Area Under Curve;Bile/drug effects;Bile/metabolism;Coloring Agents/metabolism*;Coloring Agents/pharmacokinetics;Cyclosporine/metabolism;Cyclosporine/pharmacokinetics;Drug Interactions;Herb-Drug Interactions*;Infusions, Intravenous;Male;Multidrug Resistance-Associated Proteins/metabolism;Phenolsulfonphthalein/metabolism*;Phenolsulfonphthalein/pharmacokinetics;Plant Extracts/metabolism*;Plant Extracts/pharmacokinetics;Plant Extracts/therapeutic use*;Rats;Rats, Sprague-Dawley
21184395;Cytochrome P-450 CYP3A/drug effects;Echinacea/toxicity;Enzyme Induction;Ginkgo biloba/toxicity;Herb-Drug Interactions*;Humans;Hypericum/toxicity;Panax/toxicity;Phytotherapy/adverse effects*;Plant Extracts/toxicity;Plant Preparations/toxicity*;Valerian/toxicity
21178302;Cytochrome P-450 CYP1A1/drug effects*;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP1A2/drug effects*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Enzyme Induction/drug effects*;Ginsenosides*/chemistry;Ginsenosides*/metabolism;Ginsenosides*/pharmacology;Glycosylation;Hep G2 Cells;Herb-Drug Interactions;Humans;Panax/metabolism;Plant Extracts/pharmacology;Structure-Activity Relationship
21178301;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP3A*/metabolism;Cytochrome P-450 CYP3A Inhibitors;Dose-Response Relationship, Drug;Herb-Drug Interactions/physiology*;Humans;Inhibitory Concentration 50;Ketoconazole/pharmacology;Lignans/pharmacology;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology*;Phyllanthus/metabolism;Plant Extracts/chemistry;Plant Extracts/pharmacology*
21170698;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Biological Availability;Clinical Trials as Topic;Cytochrome P-450 CYP2C9;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Herb-Drug Interactions/physiology*;Humans;Hypericum;Losartan/adverse effects;Losartan/pharmacokinetics;Losartan/therapeutic use;Milk Thistle;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics*;Plant Extracts/therapeutic use
21144332;Antineoplastic Agents/therapeutic use;Herb-Drug Interactions;Humans;Neoplasms/drug therapy*;Phytotherapy*;Portugal;Risk Factors
21140309;Aged;Aged, 80 and over;Alzheimer Disease/drug therapy*;Attitude of Health Personnel*;Cross-Sectional Studies;Dementia/drug therapy*;Drug Utilization/statistics & numerical data;Herb-Drug Interactions;Humans;Nonprescription Drugs/adverse effects;Nonprescription Drugs/therapeutic use*;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Surveys and Questionnaires;Treatment Outcome;United Kingdom;Vitamins/adverse effects;Vitamins/therapeutic use*
21139236;Animals;Anti-Infective Agents/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System;Furans/isolation & purification;Herb-Drug Interactions*;Humans;Insecta/cytology;Insecta/drug effects;Microsomes/drug effects;Microsomes/metabolism;Myristica fragrans/chemistry*;Phenols/isolation & purification;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Seeds;Spices*;Sulfaphenazole/pharmacology
21134460;Animals;Herb-Drug Interactions*;Humans;Pharmacokinetics*;Plant Preparations/pharmacology*
21132655;Aristolochic Acids/adverse effects;Herb-Drug Interactions;Humans;Kidney Diseases/chemically induced*;Phytotherapy/adverse effects*
21110181;Atrial Fibrillation/physiopathology;Atrial Fibrillation/therapy;Complementary Therapies/methods*;Evidence-Based Medicine/methods*;Heart Rate/physiology;Herb-Drug Interactions;Humans;Integrative Medicine/methods*;Internet;Medicine, Chinese Traditional/methods*;Surveys and Questionnaires*;Treatment Outcome
21093571;Andrographis*/adverse effects;Andrographis*/chemistry;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Centella*/adverse effects;Centella*/chemistry;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacology*;Ethnopharmacology;Flavonoids/adverse effects;Flavonoids/pharmacology;Herb-Drug Interactions;Humans;In Vitro Techniques;Kinetics;Orthosiphon*/adverse effects;Orthosiphon*/chemistry;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry;Recombinant Proteins/antagonists & inhibitors;Triterpenes/adverse effects;Triterpenes/chemistry;Triterpenes/pharmacology
21084768;Aldehyde Oxidase/antagonists & inhibitors*;Animals;Beverages/adverse effects*;Catechin/analogs & derivatives;Catechin/pharmacology;Cytosol/enzymology;Herb-Drug Interactions;Humans;Liver/drug effects;Male;Niacinamide/analogs & derivatives*;Niacinamide/metabolism;Rats;Tea/chemistry*;Xanthine Oxidase/antagonists & inhibitors
21074339;Consumer Health Information*;Drug Monitoring;Female;Herb-Drug Interactions;Humans;Phytoestrogens/adverse effects*;Phytoestrogens/therapeutic use;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Receptors, Estrogen/drug effects
21067427;Administration, Oral;Animals;Biological Transport;Drug-Related Side Effects and Adverse Reactions;Enzyme Induction/drug effects;Enzyme Inhibitors/adverse effects;Gastrointestinal Motility;Herb-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects;Plant Preparations/pharmacology*
21062640;Acorus/chemistry*;Animals;Anisoles/pharmacology*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Inhibitory Concentration 50;Plant Extracts/pharmacology*;Rats;Rhizome
21062330;Acute Disease;Adult;Aged;Aged, 80 and over;Anti-Infective Agents/therapeutic use;Ascorbic Acid/adverse effects;Ascorbic Acid/pharmacology;Ascorbic Acid/therapeutic use;Ciprofloxacin/therapeutic use;Disease Progression;Double-Blind Method;Drug Synergism;Echinacea*;Female;Herb-Drug Interactions;Humans;Immunity, Innate/drug effects*;Male;Micronutrients/adverse effects;Micronutrients/pharmacology;Micronutrients/therapeutic use*;Middle Aged;Phytotherapy;Placebos;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Pulmonary Disease, Chronic Obstructive/drug therapy*;Pulmonary Disease, Chronic Obstructive/physiopathology;Respiratory Tract Infections/drug therapy;Respiratory Tract Infections/physiopathology;Selenium/adverse effects;Selenium/pharmacology;Selenium/therapeutic use;Treatment Outcome;Vitamins/adverse effects;Vitamins/pharmacology;Vitamins/therapeutic use*;Zinc/adverse effects;Zinc/pharmacology;Zinc/therapeutic use
21054461;Adult;Aphrodisiacs/pharmacology*;Area Under Curve;Biological Availability;Cross-Over Studies;Eurycoma*;Half-Life;Herb-Drug Interactions*;Humans;Male;Phytotherapy;Plant Extracts/pharmacology*;Plant Roots/chemistry;Propranolol/blood;Propranolol/pharmacokinetics*;Propranolol/pharmacology;Quassins/pharmacology*;Sexual Dysfunction, Physiological/drug therapy;Single-Blind Method;Water;Young Adult
21053788;Complementary Therapies/adverse effects;Depression, Postpartum/drug therapy*;Female;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Lactation/drug effects*;Medicine, Ayurvedic;Medicine, Chinese Traditional;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Pregnancy*;Safety*
21053786;Breast Feeding;Depressive Disorder/drug therapy*;Depressive Disorder, Major/drug therapy;Female;Herb-Drug Interactions;Humans;Hypericum*/adverse effects;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Pregnancy
21053623;Acupuncture Points*;Drug Incompatibility;Drug Therapy*;Drugs, Chinese Herbal/analysis*;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions*;Humans;Seasons*
21049395;Animals;Dietary Supplements*;Glucuronosyltransferase/metabolism*;Herb-Drug Interactions*;Humans;Inactivation, Metabolic*;Phytotherapy*;Plant Extracts/pharmacology*;Plants, Medicinal*;United States
21036573;Alpinia/chemistry*;Anti-Bacterial Agents/isolation & purification;Anti-Bacterial Agents/pharmacology*;Ceftazidime/pharmacology*;Drug Synergism;Flavanones/isolation & purification;Flavanones/pharmacology;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Herb-Drug Interactions;Kaempferols/isolation & purification;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quercetin/isolation & purification;Quercetin/pharmacology;Rhizome;Staphylococcus aureus/drug effects*;Staphylococcus aureus/enzymology;Staphylococcus aureus/ultrastructure;beta-Lactam Resistance/drug effects*;beta-Lactamase Inhibitors
21035317;Cell Culture Techniques;Drug Synergism;Herb-Drug Interactions;Inhibitory Concentration 50;Nitroimidazoles/pharmacology*;Plant Leaves;Sesquiterpenes/pharmacology*;Trypanocidal Agents/pharmacology*;Trypanosoma cruzi/drug effects*;Trypanosoma cruzi/growth & development
20979526;Drug-Related Side Effects and Adverse Reactions;Female;Herb-Drug Interactions;Humans;Middle Aged;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Thrombocytopenia/etiology*
20970932;Aged;Aging/physiology;Consumer Health Information;Herb-Drug Interactions;Humans;Nonprescription Drugs/adverse effects;Nonprescription Drugs/therapeutic use;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*
20966981;Anticoagulants/adverse effects;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects;Postoperative Hemorrhage/etiology;Risk Factors
20939821;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/pharmacokinetics;Administration, Oral;Biological Availability;Glucuronidase/metabolism;Herb-Drug Interactions;Humans;Oxidation-Reduction;Phytotherapy*;Plant Preparations/chemistry;Plant Preparations/metabolism*;Plant Preparations/pharmacokinetics*;Plant Preparations/toxicity
20930420;Animals;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Enzyme Induction;Herb-Drug Interactions;Male;Microsomes, Liver/enzymology*;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley;Sophora/chemistry;Theophylline/metabolism*;Theophylline/pharmacokinetics
20883765;Animals;Antioxidants/pharmacology*;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Fruit;Herb-Drug Interactions*;Male;Medicine, Ayurvedic;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Phytotherapy*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Wistar
20851588;Alkaloids/isolation & purification;Alkaloids/pharmacology*;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions*;Humans;Isoquinolines/isolation & purification;Isoquinolines/pharmacology*;Papaveraceae/chemistry*;Plant Extracts/chemistry;Plant Extracts/pharmacology*
20845605;Adult;Attention/drug effects;Citalopram/adverse effects*;Female;Herb-Drug Interactions*;Humans;Phytotherapy*;Rhodiola/adverse effects*;Serotonin Uptake Inhibitors/adverse effects*
20837659;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Animals;Caco-2 Cells;Digoxin/pharmacokinetics;Etoposide/pharmacokinetics;Ginsenosides/pharmacology*;Herb-Drug Interactions*;Humans;Ileum/metabolism;Male;Rats;Rats, Sprague-Dawley;Rhodamine 123/pharmacokinetics;Terfenadine/analogs & derivatives;Terfenadine/pharmacokinetics;Verapamil/pharmacology
20833993;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Capsaicin/pharmacology;Capsaicin/therapeutic use;Carcinoma, Hepatocellular/drug therapy*;Catechin/analogs & derivatives;Catechin/pharmacology;Catechin/therapeutic use;Cell Line, Tumor;Cells, Cultured;Curcumin/pharmacology;Curcumin/therapeutic use;Drug Synergism;Hep G2 Cells;Herb-Drug Interactions*;Humans;Liver Neoplasms/drug therapy*;Lovastatin/pharmacology;Lovastatin/therapeutic use*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
20832765;Antineoplastic Agents/therapeutic use*;Drugs, Chinese Herbal/therapeutic use*;Evidence-Based Medicine/methods;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*
20828605;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Cell Survival/drug effects;Cells, Cultured;Cytochrome P-450 CYP2C8;Cytochrome P-450 CYP2C9;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Enzyme Induction/drug effects;Enzyme Inhibitors/toxicity;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Kinetics;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Milk Thistle/chemistry*;Plant Extracts/chemistry;Plant Extracts/toxicity*;Seeds/chemistry*;Silymarin/chemistry;Silymarin/toxicity*
20813291;Dietary Supplements;Herb-Drug Interactions*;Humans;Plants, Medicinal*;Review Literature as Topic
20813290;Herb-Drug Interactions*;Humans;Plants, Medicinal/metabolism*
20813289;Herb-Drug Interactions*;Humans;Physician-Patient Relations*;Phytotherapy/adverse effects*;Plant Preparations/pharmacology*
20736322;Alkaloids/pharmacology;Cell Line;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/genetics;Drugs, Chinese Herbal/pharmacology*;Enzyme Induction/drug effects;Herb-Drug Interactions;Humans;Quinolizines/pharmacology;Receptors, Steroid/metabolism*;Sophora*
20735354;Animals;Drug Interactions;Drug Synergism;Herb-Drug Interactions;Humans;Oils, Volatile/chemistry;Oils, Volatile/pharmacology;Oils, Volatile/therapeutic use;Phytotherapy*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use*;Plant Preparations/chemistry;Plant Preparations/pharmacology;Plant Preparations/therapeutic use;Plants/chemistry*
20701553;Animals;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/pharmacology;Biological Transport;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Hypericum/chemistry;Neoplasms/drug therapy*;Plant Extracts/pharmacology
20694770;China;Drugs, Chinese Herbal/pharmacology;Evidence-Based Medicine;Herb-Drug Interactions*;Humans;Integrative Medicine*
20690308;Ginkgo biloba*;Herb-Drug Interactions;Humans;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*
20679979;Administration, Oral;Aloe*/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Dietary Supplements/standards;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Osteoarthritis*/complications;Osteoarthritis*/drug therapy;Pain*/etiology;Pain*/prevention & control;Phytotherapy/adverse effects;Phytotherapy/methods*;Research Design;Safety
20653549;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use*;Combined Modality Therapy;Complementary Therapies*;Herb-Drug Interactions*;Humans;Medicine, Chinese Traditional;Neoplasms/therapy*;Patents as Topic*;Plants, Medicinal
20653355;Adult;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/metabolism;Drug Combinations;Echinacea*;Enzyme Induction/drug effects;Enzyme Induction/physiology;Female;Herb-Drug Interactions*/physiology;Humans;Lopinavir;Male;Middle Aged;Plant Extracts/administration & dosage;Pyrimidinones/administration & dosage*;Ritonavir/administration & dosage*;Young Adult
20651752;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Male;Materia Medica/adverse effects;Medical History Taking/standards*;Middle Aged;Nonprescription Drugs/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plants, Medicinal/adverse effects;Postoperative Hemorrhage/chemically induced*;Postoperative Hemorrhage/etiology;Tooth Extraction/adverse effects*
20642555;Adult;Antidepressive Agents, Second-Generation/administration & dosage;Antidepressive Agents, Second-Generation/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Bupropion/administration & dosage;Bupropion/analogs & derivatives*;Bupropion/pharmacokinetics*;Cross-Over Studies;Cytochrome P-450 CYP2B6;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Suspensions;Young Adult
20642450;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Animals;Aryl Hydrocarbon Hydroxylases/biosynthesis;Beverages*;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Enzyme Induction;Glycyrrhiza*;Herb-Drug Interactions*;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Roots;Rabbits;Verapamil/administration & dosage;Verapamil/blood;Verapamil/pharmacokinetics*
20641061;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Berberine Alkaloids/metabolism;Berberine Alkaloids/pharmacology*;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions*;Humans;Microsomes, Liver/drug effects;Time Factors
20638257;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2E1 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Diterpenes, Abietane;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Liver/metabolism*;Microsomes, Liver/metabolism;Phenanthrenes/pharmacology*;Protein Isoforms;Salvia miltiorrhiza/chemistry*
20637580;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Half-Life;Herb-Drug Interactions*;Hypnotics and Sedatives/pharmacokinetics;Hypnotics and Sedatives/pharmacology*;Liver/metabolism;Male;Metabolic Clearance Rate/drug effects;Midazolam/pharmacokinetics;Midazolam/pharmacology*;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza*;Sleep/drug effects*
20637575;Analgesics/pharmacology;Analgesics/therapeutic use;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Carrageenan;Drug Synergism;Edema/drug therapy;Edema/etiology;Herb-Drug Interactions;Inflammation/drug therapy*;Male;Monoterpenes/pharmacology;Monoterpenes/therapeutic use*;Naproxen/adverse effects;Naproxen/pharmacology;Naproxen/therapeutic use*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Rats;Rats, Wistar;Stomach Diseases/etiology;Stomach Diseases/pathology;Stomach Diseases/prevention & control*
20636879;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Animals;Antioxidants/pharmacology;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Biological Availability;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Flavonoids/pharmacology*;Herb-Drug Interactions*;Imidazoles/metabolism*;Losartan/metabolism;Losartan/pharmacokinetics*;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tetrazoles/metabolism*
20633025;Cardiovascular Agents/adverse effects;Cardiovascular Agents/therapeutic use*;Communication;Dietary Supplements*/adverse effects;Drug Contamination;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Physician-Patient Relations;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Risk Assessment;Risk Factors;Treatment Outcome
20617421;Animals;Biological Products/chemistry*;Blood Coagulation/drug effects*;Blood Platelets/cytology*;Blood Platelets/drug effects*;Fibrinolytic Agents/chemistry*;Fibrinolytic Agents/pharmacology*;Herb-Drug Interactions;Humans
20615178;Adverse Drug Reaction Reporting Systems;Argentina;Contraindications;Health Knowledge, Attitudes, Practice*;Health Surveys;Herb-Drug Interactions;Humans;Patient Education as Topic;Phytotherapy*/adverse effects;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Plants, Medicinal/adverse effects*;Self Medication/statistics & numerical data*
20610890;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Transport;Darunavir;Duodenum;Garlic*;HIV Protease Inhibitors/pharmacokinetics*;Hep G2 Cells;Herb-Drug Interactions;Humans;Liver/cytology;Liver/drug effects;Male;Membrane Transport Proteins/metabolism*;Multidrug Resistance-Associated Proteins/metabolism;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Ritonavir/pharmacology;Saquinavir/pharmacokinetics*;Sulfonamides/pharmacokinetics*
20609070;Animals;Aporphines/pharmacology*;Area Under Curve;Cytochrome P-450 CYP1A2 Inhibitors*;Half-Life;Herb-Drug Interactions*;Humans;Inactivation, Metabolic;Inhibitory Concentration 50;Male;Nelumbo/chemistry*;Phenacetin/pharmacokinetics*;Plant Leaves;Rats;Rats, Wistar
20609069;Animals;Biological Transport, Active;Caco-2 Cells;Cell Membrane Permeability/drug effects*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;Intestinal Absorption;Intestinal Mucosa/drug effects*;Intestinal Mucosa/metabolism;Jejunum/drug effects*;Jejunum/metabolism;Male;Mannitol/metabolism;Medicine, Chinese Traditional*;Rats;Rats, Sprague-Dawley;Time Factors;Tolbutamide/pharmacokinetics*
20604832;Animals;Area Under Curve;Berberine/pharmacology*;Biological Availability;Cytochrome P-450 CYP3A/metabolism*;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Inactivation, Metabolic;Intestines/metabolism;Liver/metabolism;Magnoliopsida*;Male;Microsomes/metabolism;Rats;Rats, Sprague-Dawley;Verapamil/analogs & derivatives*;Verapamil/blood;Verapamil/metabolism;Verapamil/pharmacokinetics*
20600750;Alanine Transaminase/blood;Animals;Area Under Curve;Aspartate Aminotransferases/blood;Biomarkers/blood;Carbon Tetrachloride;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/prevention & control*;Cytochrome P-450 CYP3A/metabolism*;Dioxoles/pharmacology;Dioxoles/therapeutic use*;Disease Models, Animal;Down-Regulation;Female;Fruit;Herb-Drug Interactions;Lignans/pharmacokinetics*;Lignans/pharmacology;Lignans/therapeutic use;Male;Phytotherapy;Plant Extracts/blood;Plant Extracts/pharmacokinetics*;Plant Extracts/therapeutic use;Protective Agents/pharmacokinetics*;Protective Agents/pharmacology;Protective Agents/therapeutic use;Rats;Rats, Sprague-Dawley;Reference Values;Schisandra/chemistry*
20592321;Adult;Animals;Child;Cholesterol, LDL/blood;Cholesterol, LDL/drug effects;Clinical Trials as Topic;Diabetes Mellitus, Type 2/complications;Dose-Response Relationship, Drug;Dyslipidemias/drug therapy*;Dyslipidemias/physiopathology;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hypolipidemic Agents/administration & dosage;Hypolipidemic Agents/adverse effects;Hypolipidemic Agents/therapeutic use*;Phytosterols/administration & dosage;Phytosterols/adverse effects;Phytosterols/therapeutic use*
20568597;Curcuma*;Herb-Drug Interactions;Humans;Neoplasms/drug therapy;Phytotherapy*
20567279;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Dietary Supplements/adverse effects;Herb-Drug Interactions*;Humans;International Normalized Ratio;Plant Preparations/adverse effects*;Warfarin/adverse effects*;Warfarin/metabolism
20528250;Clinical Trials as Topic;Hematologic Neoplasms/drug therapy*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/chemistry*;Safety;Treatment Outcome
20524938;Alkaloids/isolation & purification;Alkaloids/pharmacokinetics;Alkaloids/pharmacology*;Animals;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Biocatalysis;Blotting, Western;Cell Culture Techniques;Cell Line;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2B1/genetics;Cytochrome P-450 CYP2B1/metabolism*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Liver/drug effects*;Liver/enzymology;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Molecular Structure;Pharmaceutical Preparations/metabolism;Plasmids;Quinolizines/isolation & purification;Quinolizines/pharmacokinetics;Quinolizines/pharmacology*;Rats;Rats, Sprague-Dawley;Real-Time Polymerase Chain Reaction;Sophora/chemistry;Steroid Hydroxylases/genetics;Steroid Hydroxylases/metabolism*;Tandem Mass Spectrometry;Transfection
20523105;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Administration, Oral;Animals;Antineoplastic Agents, Phytogenic/administration & dosage*;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Herb-Drug Interactions*;Injections, Intravenous;Male;Metabolic Clearance Rate/drug effects;Paclitaxel/administration & dosage*;Paclitaxel/blood;Paclitaxel/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Silymarin/pharmacology*
20521597;Adult;Biological Availability;Curcuma/adverse effects*;Curcuma/metabolism;Cytochrome P-450 CYP3A/metabolism;Herb-Drug Interactions;Humans;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/metabolism;Immunosuppressive Agents/pharmacokinetics;Kidney Transplantation;Male;Tacrolimus/adverse effects*;Tacrolimus/metabolism;Tacrolimus/pharmacokinetics
20516361;Blood Glucose/drug effects;Diabetes Mellitus, Type 2/drug therapy;Glipizide/adverse effects;Glipizide/therapeutic use;Herb-Drug Interactions;Humans;Hypoglycemia/chemically induced*;Hypoglycemic Agents/adverse effects*;Hypoglycemic Agents/therapeutic use;Male;Metformin/adverse effects;Metformin/therapeutic use;Mexican Americans;Middle Aged;Opuntia/chemistry;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use
20509982;Appetite/drug effects;Dietary Supplements;Drug Monitoring;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nutritional Status
20509107;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Cell Line;Curcuma/chemistry*;Curcumin/analogs & derivatives;Curcumin/pharmacology*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Herb-Drug Interactions*;Humans;Intestines/cytology;Intestines/drug effects*;Intestines/metabolism;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction
20502012;Aged;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Atrial Fibrillation/complications*;Atrial Fibrillation/epidemiology;Drug Interactions;Female;Food;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Patient Compliance*;Patient Education as Topic*;Quality of Life;Risk Factors;Stroke/epidemiology;Stroke/prevention & control;Surveys and Questionnaires;Thromboembolism/epidemiology;Thromboembolism/prevention & control*;Warfarin/administration & dosage*;Warfarin/adverse effects
20484172;Adolescent;Adult;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/metabolism;Asian Continental Ancestry Group*;Caffeine/pharmacokinetics;Cross-Over Studies;Curcumin/chemistry;Curcumin/pharmacokinetics*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Cytochrome P-450 CYP2A6;Down-Regulation/drug effects;Flavonoids/chemistry;Flavonoids/pharmacokinetics*;Herb-Drug Interactions/physiology;Humans;Male;Phenols/chemistry;Phenols/pharmacokinetics*;Plant Extracts/pharmacokinetics;Polyphenols;Up-Regulation/drug effects;Young Adult
20474062;Aged;Dementia/drug therapy*;England;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Vitamins/therapeutic use*
20457244;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Centella*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Dealkylation;Dextromethorphan/metabolism;Dose-Response Relationship, Drug;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Humans;Hydroxylation;Kinetics;Methylation;Pentacyclic Triterpenes/isolation & purification;Pentacyclic Triterpenes/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Recombinant Proteins/metabolism;Substrate Specificity;Testosterone/metabolism;Tolbutamide/metabolism;Triterpenes/isolation & purification;Triterpenes/pharmacology
20456830;Antiviral Agents/metabolism*;Biological Products/pharmacology;Chromatography, High Pressure Liquid/methods;Female;Fluorometry;Herb-Drug Interactions*;Humans;Male;Medicine, Chinese Traditional;Microsomes, Liver/metabolism*;Oseltamivir/analogs & derivatives*;Oseltamivir/metabolism;Plant Extracts/pharmacology;Prodrugs;Spectrometry, Mass, Electrospray Ionization/methods
20451336;Animals;Consumer Product Safety;Female;Government Regulation*;Herb-Drug Interactions;Humans;Internationality;Legislation, Drug;Menopause*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use
20446359;Dietary Supplements/adverse effects*;Drug Interactions;Herb-Drug Interactions*;Humans;Nonprescription Drugs/adverse effects*;Prescription Drugs/adverse effects*;Risk Assessment;Self Medication/adverse effects*;Vitamins/adverse effects
20438302;Adolescent;Adrenal Cortex Hormones/adverse effects;Adrenal Cortex Hormones/therapeutic use*;Adult;Aged;Aged, 80 and over;Databases, Factual;Female;Glycyrrhiza*;Herb-Drug Interactions*;Humans;International Classification of Diseases;Male;Medicine, Chinese Traditional*;Middle Aged;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Prescriptions;Taiwan;Young Adult
20423241;Choice Behavior;Clinical Trials as Topic;Female;Herb-Drug Interactions;Humans;Legislation, Drug;Menopause*;Phytoestrogens/therapeutic use;Phytotherapy*
20412155;Drug Contamination;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/poisoning;Forensic Toxicology;Herb-Drug Interactions;Humans;Legislation, Drug;Metals, Heavy/analysis;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Plants, Medicinal/poisoning;Plants, Toxic/toxicity
20406629;Animals;Aorta/drug effects;Atropine Derivatives/pharmacology;Benzene Derivatives/antagonists & inhibitors;Benzene Derivatives/pharmacology*;Bradycardia/chemically induced*;Capsaicin/analogs & derivatives;Capsaicin/pharmacology;Cryptocarya*;Dose-Response Relationship, Drug;Herb-Drug Interactions;Hypotension/chemically induced*;In Vitro Techniques;Male;Oils, Volatile/isolation & purification;Oils, Volatile/pharmacology*;Ondansetron/pharmacology;Phenylephrine/antagonists & inhibitors;Phenylephrine/pharmacology;Rats;Rats, Wistar;Reflex/drug effects*;Vagus Nerve/drug effects*;Vagus Nerve/surgery;Vasoconstriction/drug effects
20399862;Animals;Herb-Drug Interactions*;Herbal Medicine;Humans;Pharmacokinetics*;Plant Preparations/pharmacology*
20388141;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Herb-Drug Interactions;Herbal Medicine/standards;Humans;United States;United States Food and Drug Administration/standards
20379805;Disclosure;Drug Contamination;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/chemistry;Forensic Toxicology*;Herb-Drug Interactions;Humans;Medical Records;Phytotherapy/adverse effects*
20363701;Adrenergic beta-Agonists/pharmacology;Albuterol/pharmacology;Animals;Atropine/pharmacology;Costus*;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Drug Synergism;Female;Herb-Drug Interactions;In Vitro Techniques;Medicine, African Traditional*;Muscarinic Antagonists/pharmacology;Oxytocics/pharmacology*;Oxytocin/antagonists & inhibitors;Oxytocin/pharmacology;Plant Extracts/antagonists & inhibitors;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Leaves/chemistry*;Rats;Rats, Wistar;Uterine Contraction/drug effects;Uterus/drug effects*
20359286;Animals;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions;Ginkgo biloba/adverse effects;Ginkgo biloba/metabolism*;Herb-Drug Interactions/physiology*;Humans;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Risk Factors
23043208;Cardiovascular Agents/administration & dosage*;Cardiovascular Diseases/drug therapy*;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Medical History Taking/methods;Phytotherapy/adverse effects*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects*;United States
20347238;Actaea;Animals;Breast Neoplasms/complications*;Breast Neoplasms/drug therapy;Cimicifuga;Diet;Female;Herb-Drug Interactions;Hot Flashes/complications;Hot Flashes/drug therapy*;Humans;Phytoestrogens/adverse effects;Phytoestrogens/therapeutic use*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Soybeans
20345351;Animals;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use*;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use;Enzymes/metabolism;Gene Expression Regulation, Neoplastic/drug effects;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Neoplasms/enzymology;Neoplasms/genetics;Neoplasms/metabolism
20332334;Adult;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Benzamides;Chemical and Drug Induced Liver Injury/diagnosis;Chemical and Drug Induced Liver Injury/etiology*;Cytochrome P-450 CYP3A/metabolism;Dietary Supplements/adverse effects;Herb-Drug Interactions*;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Liver Function Tests;Male;Panax/adverse effects*;Panax/metabolism;Piperazines/administration & dosage;Piperazines/adverse effects*;Piperazines/pharmacokinetics;Piperazines/therapeutic use;Pyrimidines/administration & dosage;Pyrimidines/adverse effects*;Pyrimidines/pharmacokinetics;Pyrimidines/therapeutic use
20214258;Adult;Age Factors;Aged;Aged, 80 and over;Ambulatory Care Facilities;Antihypertensive Agents/therapeutic use;Female;Herb-Drug Interactions;Humans;Hypertension/drug therapy*;Male;Middle Aged;Nigeria/epidemiology;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Surveys and Questionnaires;Young Adult
20206795;Adult;Asian Continental Ancestry Group;Bleeding Time;Blood Platelets/drug effects*;Chromatography, High Pressure Liquid;Cross-Over Studies;Ginkgo biloba*;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Republic of Korea;Ticlopidine/administration & dosage;Ticlopidine/blood;Ticlopidine/pharmacokinetics*;Young Adult
20197523;Cardiovascular Diseases/drug therapy*;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects;Plant Preparations/administration & dosage
20197017;Adolescent;Adult;Area Under Curve;Child;Dose-Response Relationship, Drug;Female;Herb-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics*;Liver Function Tests;Liver Transplantation;Male;Middle Aged;Plant Extracts/pharmacology*;Schisandra/chemistry*;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*;Young Adult
20186406;Asian Continental Ancestry Group;Diazepam/pharmacokinetics*;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Hydrocortisone/analogs & derivatives;Hydrocortisone/urine;Male;Plant Extracts/adverse effects*;Quercetin/blood;Young Adult
20178874;Adolescent;Adult;Aged;Child;Child, Preschool;Drug Utilization;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Infant;Infant, Newborn;Jamaica;Male;Middle Aged;Pharmacies;Phytotherapy/utilization*;Plants, Medicinal*;Polypharmacy;Prescription Drugs*/therapeutic use;Prevalence;Self Medication/methods;Self Medication/utilization*;Young Adult
20152556;Cardiovascular Agents/therapeutic use*;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/etiology;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects*;Treatment Outcome
20147772;Commerce;Cyclosporine/adverse effects;Data Collection;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Hypericum/chemistry*;Patient Education as Topic/standards;Pharmacists/standards*;Phytotherapy/adverse effects
20129259;Aged;Attitude of Health Personnel;Biological Products/administration & dosage*;Communication;Cross-Sectional Studies;Dietary Supplements;Female;Health Status;Herb-Drug Interactions;Humans;Male;Minerals/administration & dosage;Ontario;Telephone*;Vitamins/administration & dosage
20112816;Administration, Oral;Animals;Cardiovascular Agents/administration & dosage;Cardiovascular Agents/pharmacology*;Catalase/metabolism;Creatine Kinase, MB Form/metabolism;Disease Models, Animal;Dose-Response Relationship, Drug;Female;Garlic*/chemistry;Heart Diseases/chemically induced;Heart Diseases/enzymology;Heart Diseases/pathology;Heart Diseases/prevention & control*;Herb-Drug Interactions*;Hydrochlorothiazide/administration & dosage;Hydrochlorothiazide/pharmacology*;Isoproterenol;L-Lactate Dehydrogenase/metabolism;Myocardial Reperfusion Injury/enzymology;Myocardial Reperfusion Injury/pathology;Myocardial Reperfusion Injury/prevention & control*;Myocardium/enzymology;Myocardium/pathology*;Oxidative Stress/drug effects;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification;Plant Extracts/pharmacology*;Plant Roots;Rats;Rats, Wistar;Superoxide Dismutase/metabolism
20106684;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics;Area Under Curve;Female;Herb-Drug Interactions*;Humans;Hypericum*;Male;Oxycodone/administration & dosage;Oxycodone/pharmacokinetics*;Pain Threshold/drug effects;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics*
20096675;Andrographis/chemistry*;Animals;Area Under Curve;Cytochrome P-450 CYP1A2/metabolism;Diterpenes/pharmacology*;Half-Life;Herb-Drug Interactions*;Male;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Theophylline/blood*;Theophylline/pharmacokinetics
20089387;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Cyclooctanes/isolation & purification;Cyclooctanes/pharmacology*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Dioxoles/isolation & purification;Dioxoles/pharmacology*;Drug Resistance, Multiple;Fruit;Glutathione/metabolism*;Hep G2 Cells;Herb-Drug Interactions;Humans;Inhibitory Concentration 50;Lignans/isolation & purification;Lignans/pharmacology*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Schisandra/chemistry*
20077138;Anti-Inflammatory Agents/adverse effects;Biological Products/adverse effects*;Canada;Child;Databases, Factual/statistics & numerical data*;Dexamethasone/adverse effects;Herb-Drug Interactions*;Hospitals, Pediatric;Humans;Pilot Projects
20055162;Animals;Biological Availability;Bornanes/pharmacokinetics*;Herb-Drug Interactions;Intestinal Absorption/drug effects*;Male;Pyrazines/pharmacokinetics*;Rats;Rats, Sprague-Dawley
20047146;Animals;Chemistry, Pharmaceutical;Databases, Factual/statistics & numerical data;Drug Interactions;Drug and Narcotic Control;Herb-Drug Interactions/physiology*;History, 20th Century;History, 21st Century;History, Ancient;Humans;Medicine, Chinese Traditional/history;Medicine, Chinese Traditional/methods*;Medicine, Chinese Traditional/utilization*;Phytotherapy/history;Phytotherapy/methods;Structure-Activity Relationship;Western World*
20040699;Aged;Anticoagulants/pharmacokinetics*;Grifola*;Herb-Drug Interactions*;Humans;International Normalized Ratio*;Male;Warfarin/pharmacokinetics*
20028328;Animals;Cardiovascular Diseases/prevention & control*;Dietary Fiber;Dietary Supplements*;Fatty Acids/pharmacology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Salvia*/chemistry;Seeds/chemistry;alpha-Linolenic Acid/pharmacology
20021292;Clinical Trials as Topic/methods;Cytochrome P-450 Enzyme System/drug effects*;Evidence-Based Medicine;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*
20008216;Adult;Animals;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Arsenicals/therapeutic use;Child;Clinical Trials as Topic;Dietary Supplements*;Digestive System Neoplasms/drug therapy;Drug Screening Assays, Antitumor;Drug Synergism;Drugs, Chinese Herbal/therapeutic use;Ganoderma/chemistry;Hematologic Neoplasms/diet therapy;Hematologic Neoplasms/drug therapy*;Herb-Drug Interactions;Humans;Immunologic Factors/pharmacokinetics;Immunologic Factors/therapeutic use*;Mice;Oxides/therapeutic use;Phytotherapy;Plant Preparations/pharmacokinetics;Plant Preparations/pharmacology;Plant Preparations/therapeutic use;Polyporus;Thalidomide/therapeutic use;beta-Glucans/isolation & purification;beta-Glucans/therapeutic use
19994614;Anesthesiology*;General Surgery*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions*;Humans;Phytotherapy*;Risk Factors
19968403;Chemistry, Pharmaceutical;Drug Compounding;Drugs, Chinese Herbal/history;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;History, 15th Century;History, 21st Century;History, Ancient;History, Medieval;Humans;Medicine, Chinese Traditional/history;Medicine, Chinese Traditional/methods*;Mental Disorders/drug therapy*;Phytotherapy
19952421;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Adenosine Triphosphatases/antagonists & inhibitors*;Adenosine Triphosphate/metabolism;Calcium Channel Blockers/pharmacology;Cell Membrane/drug effects;Glycyrrhiza;Herb-Drug Interactions*;Herbal Medicine;Humans;Hydrolysis;Medicine, Kampo*;Phosphates;Phytotherapy;Plant Extracts/pharmacology*;Plant Roots;Verapamil/pharmacology
19943335;Chemical and Drug Induced Liver Injury/etiology*;Ethanol/adverse effects*;Ethanol/metabolism;Herb-Drug Interactions;Humans;Kava/adverse effects*;Kava/chemistry;Kava/metabolism
19940848;Dietary Supplements*/adverse effects;Dietary Supplements*/standards;Ephedra/adverse effects;Food Industry/legislation & jurisprudence*;Government Regulation;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Legislation, Food/trends*;Pharmacology, Clinical/methods*;United States
19934593;Animals;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Curcumin/pharmacology*;Female;Half-Life;Herb-Drug Interactions*;Male;Norfloxacin/blood;Norfloxacin/pharmacokinetics*;Rabbits
19934397;Anticoagulants/chemistry;Anticoagulants/metabolism*;Aryl Hydrocarbon Hydroxylases/metabolism*;Cytochrome P-450 CYP2C9;Herb-Drug Interactions;Humans;Hydroxylation;In Vitro Techniques;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Milk Thistle/chemistry*;Recombinant Proteins/metabolism;Silymarin/analogs & derivatives*;Silymarin/chemistry;Silymarin/pharmacology;Stereoisomerism;Warfarin/chemistry;Warfarin/metabolism*
19919513;Adult;Antioxidants/chemistry*;Antioxidants/pharmacology*;Comet Assay;DNA Damage/drug effects*;Dioscorea;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;Humans;Hydrogen Peroxide/toxicity;Hydroxybenzoates/analysis;Lymphocytes/drug effects;Male;Middle Aged;Oxidative Stress/drug effects;Paeonia;Rhizome
19913311;Cross-Over Studies;Double-Blind Method;Female;Heart Valve Prosthesis;Heart Valve Prosthesis Implantation*;Herb-Drug Interactions/physiology*;Humans;International Normalized Ratio;Male;Middle Aged;Panax/metabolism*;Plant Extracts/blood*;Plant Extracts/therapeutic use;Prospective Studies;Warfarin/blood*;Warfarin/therapeutic use
19893786;Directories as Topic;Herb-Drug Interactions*;Information Storage and Retrieval*;Internet*;Physicians, Family
19889883;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology;Flavonoids/pharmacology*;Ginkgo biloba/chemistry*;Glucuronides/analysis;Glucuronosyltransferase/antagonists & inhibitors*;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Hydrolysis;Immunosuppressive Agents/metabolism*;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism;Kaempferols/pharmacology;Kinetics;Liver/drug effects;Liver/enzymology;Liver/metabolism;Microsomes/drug effects;Microsomes/enzymology;Microsomes/metabolism;Mycophenolic Acid/analogs & derivatives;Mycophenolic Acid/analysis;Mycophenolic Acid/metabolism*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quercetin/pharmacology
19883532;Anti-Anxiety Agents/pharmacology;Anti-Anxiety Agents/therapeutic use*;Anxiety/drug therapy*;Herb-Drug Interactions;Humans;Kava*;Muscle, Skeletal/drug effects;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*
19879740;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Caco-2 Cells;Cell Line;Curcuma/chemistry*;Curcumin/analogs & derivatives;Curcumin/pharmacology*;Daunorubicin/pharmacokinetics;Dose-Response Relationship, Drug;Drug Resistance;Fluoresceins/pharmacokinetics;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacology*;Rhodamines/pharmacokinetics;Swine
19844860;Antioxidants/pharmacology;Antioxidants/therapeutic use*;Fruit;Herb-Drug Interactions;Humans;Lycium/adverse effects;Lycium/chemistry*;Medicine, Chinese Traditional*;Molecular Structure;Phytotherapy*;Plant Bark;Plant Preparations/chemistry;Plant Preparations/pharmacology;Plant Preparations/therapeutic use*;Plant Roots;Proteoglycans/pharmacology;Proteoglycans/therapeutic use
19830688;Animals;Captopril/pharmacology*;Cardiotonic Agents/pharmacology;Female;Garlic/metabolism*;Herb-Drug Interactions*;Isoproterenol;Myocardial Infarction/drug therapy*;Myocardial Infarction/pathology;Myocardium/pathology;Plant Extracts/pharmacology*;Rats;Rats, Wistar
19825176;Adult;Age Factors;Aged;Complementary Therapies/utilization*;Female;Herb-Drug Interactions*;Humans;Kansas;Male;Medical Records;Middle Aged;Phytotherapy/utilization*;Plant Preparations/administration & dosage*;Preoperative Care*;Retrospective Studies;Self Disclosure;Thoracic Surgical Procedures
19824416;Adult;Anesthesia, General/methods*;Anesthetics, General/administration & dosage;Anesthetics, General/adverse effects*;Catha/chemistry*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects*;Central Nervous System Stimulants/isolation & purification;Contraindications;Female;Hemodynamics/drug effects;Herb-Drug Interactions*;Humans;Ketamine/administration & dosage;Ketamine/adverse effects;Male;Surgical Procedures, Operative/methods;Time Factors
19823793;Age Factors;Aged;Aged, 80 and over;Cytochrome P-450 Enzyme System/physiology;Diagnosis, Differential;Drug Interactions/physiology*;Drug Therapy, Combination/adverse effects*;Drug Tolerance/physiology;Drug-Related Side Effects and Adverse Reactions/diagnosis;Drug-Related Side Effects and Adverse Reactions/etiology*;Drug-Related Side Effects and Adverse Reactions/physiopathology;Food-Drug Interactions;Geriatrics*;Herb-Drug Interactions;Humans;Isoenzymes/physiology;Metabolic Clearance Rate/physiology;Pharmacokinetics*;Polypharmacy*
19815591;Animals;Clinical Trials as Topic;Complementary Therapies/adverse effects;Herb-Drug Interactions/physiology*;Herbal Medicine*;Humans
19806896;Animals;Cyclosporine/pharmacology*;Ginkgolides/pharmacokinetics*;Herb-Drug Interactions*;Lactones/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Tissue Distribution
19798943;Alcohols/chemistry;Chemistry, Pharmaceutical;Drugs, Chinese Herbal/chemistry*;Evodia/chemistry*;Herb-Drug Interactions*;Spectroscopy, Fourier Transform Infrared;Water/chemistry
19790032;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Baculoviridae;Caco-2 Cells;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;DNA, Complementary;Digoxin/metabolism;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Ketoconazole/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rhodiola/chemistry*;Structure-Activity Relationship;Testosterone/metabolism;Verapamil/pharmacology
19790031;Alkynes;Amides/analysis*;Amides/pharmacology;Commerce;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Echinacea/chemistry*;Fatty Acids, Unsaturated/analysis;Fatty Acids, Unsaturated/pharmacology*;Herb-Drug Interactions*;Metabolome*;Metabolomics/methods*;Plant Extracts/chemistry*;Plant Extracts/pharmacology
19785729;Anti-Bacterial Agents/pharmacology*;Antifungal Agents/pharmacology*;Bacteria/drug effects*;Candida albicans/drug effects*;Drug Synergism;Drug Therapy, Combination;Herb-Drug Interactions*;Herbal Medicine;Medicine, Traditional;Microbial Sensitivity Tests;Ocimum*;Phytotherapy;Plant Extracts/pharmacology*;Plant Leaves
19782820;Animals;Cardiovascular System/drug effects;Clinical Competence;Endocrine System/drug effects;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Herbal Medicine*;Humans;Kidney/drug effects;Liver/drug effects;Lung/drug effects;Maternal-Fetal Exchange;Nervous System/drug effects;Plant Extracts/adverse effects*;Plant Extracts/standards;Plant Extracts/toxicity;Pregnancy
19774504;Animals;Area Under Curve;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Diclofenac/pharmacokinetics;Drug Combinations;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Inactivation, Metabolic*;Inhibitory Concentration 50;Injections;Liver/drug effects*;Liver/metabolism;Male;Midazolam/pharmacokinetics;Ophiopogon*;Panax*;Plant Roots;Rats;Rats, Sprague-Dawley;Theophylline/pharmacokinetics
19771928;Aged;Aged, 80 and over;Confidence Intervals;Dietary Supplements/utilization;Epidemiologic Studies;Female;Health Behavior;Health Care Surveys;Herb-Drug Interactions*;Humans;Male;Middle Aged;Multivariate Analysis;Nonprescription Drugs/therapeutic use*;North Carolina/epidemiology;Phytotherapy/utilization*;Plants, Medicinal;Residence Characteristics*;Rural Health;Rural Population/statistics & numerical data*;Self Medication/statistics & numerical data*
19771443;Adolescent;Adult;Child;Complementary Therapies/adverse effects;Complementary Therapies/utilization*;Female;Herb-Drug Interactions;Hospitals, Teaching;Humans;Male;Middle Aged;Otorhinolaryngologic Diseases/therapy*;Phytotherapy/adverse effects;Risk Factors;Specialties, Surgical*;Surveys and Questionnaires;United Kingdom;Utilization Review/statistics & numerical data;Young Adult
19765569;Animals;Antidepressive Agents, Second-Generation/blood;Antidepressive Agents, Second-Generation/pharmacokinetics*;Antioxidants/pharmacology*;Bile/metabolism;Herb-Drug Interactions;Male;Rats;Rats, Sprague-Dawley;Silymarin/pharmacology*;Trazodone/blood;Trazodone/pharmacokinetics*
19760801;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plants, Medicinal/adverse effects;Risk Factors
19756775;Alopecia/etiology;Alopecia/prevention & control;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/classification;Combined Modality Therapy;Complementary Therapies*;Data Display;Databases, Factual*;Fatigue Syndrome, Chronic/etiology;Fatigue Syndrome, Chronic/prevention & control;Herb-Drug Interactions*;Humans;Immune System Diseases/etiology;Immune System Diseases/prevention & control;Inflammation/etiology;Inflammation/prevention & control;Internet;Medicine, Chinese Traditional/methods;Nausea/etiology;Nausea/prevention & control;Neoplasms/complications;Neoplasms/therapy*;Pain/etiology;Pain/prevention & control;Palliative Care;Plants, Medicinal/classification;Social Support;User-Computer Interface
19741040;Administration, Oral;Animals;Area Under Curve;Biotransformation;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drug Administration Schedule;Enzyme Induction;Enzyme Inhibitors/administration & dosage*;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacokinetics;Half-Life;Herb-Drug Interactions*;Hydroxylation;Injections, Intravenous;Intestines/drug effects*;Intestines/enzymology;Lignans/administration & dosage*;Lignans/isolation & purification;Lignans/pharmacokinetics;Liver/drug effects*;Liver/enzymology;Male;Metabolic Clearance Rate;Microsomes/drug effects;Microsomes/enzymology;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Rats;Rats, Sprague-Dawley;Schisandra*/chemistry
19719333;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions/physiology*;Humans
19694739;Administration, Oral;Adult;Antidepressive Agents/pharmacokinetics*;Bupropion/analogs & derivatives*;Bupropion/pharmacokinetics;Chromatography, High Pressure Liquid;Epidemiologic Methods;Ginkgo biloba/metabolism*;Herb-Drug Interactions/physiology;Humans;Male;Plant Extracts/pharmacokinetics*;Young Adult
19685624;Alcohol Deterrents/adverse effects*;Alcohol Deterrents/metabolism;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Hypericum/metabolism;Risk Factors;Taurine/adverse effects;Taurine/analogs & derivatives*;Taurine/metabolism
19685568;Anticholesteremic Agents/therapeutic use;Antihypertensive Agents/therapeutic use;Dietary Supplements/adverse effects*;Drug Interactions;Heart Diseases/drug therapy*;Herb-Drug Interactions;Humans;Polypharmacy
19679455;Animals;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Cells, Cultured;Cytochrome P450 Family 2;Dose-Response Relationship, Drug;Hepatocytes/metabolism;Herb-Drug Interactions*;Hydroxylation/drug effects;Inactivation, Metabolic;Male;Metabolic Clearance Rate;Microsomes, Liver/metabolism;Mixed Function Oxygenases/antagonists & inhibitors;Models, Animal;Phenanthrenes/pharmacology*;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry*;Steroid 16-alpha-Hydroxylase/metabolism*;Tolbutamide/metabolism;Tolbutamide/pharmacokinetics*
19657198;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Depressive Disorder/drug therapy*;Depressive Disorder, Major/drug therapy*;Herb-Drug Interactions;Humans;Hypericum*;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Randomized Controlled Trials as Topic;Risk Factors;Somatoform Disorders/drug therapy
19639535;Apocynaceae/chemistry*;Blood Proteins/metabolism;Caco-2 Cells;Cytochrome P-450 CYP3A Inhibitors*;Gastric Juice/metabolism;Herb-Drug Interactions;Humans;Intestinal Absorption;Intestines/metabolism;Liver/metabolism;Microsomes/metabolism;Molecular Structure;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Pregnanediol/analogs & derivatives*;Pregnanediol/chemistry;Pregnanediol/pharmacokinetics;Pregnanediol/pharmacology
19610041;Antineoplastic Agents, Phytogenic/pharmacology*;Cell Survival;DNA Fragmentation;Dose-Response Relationship, Drug;Doxorubicin/pharmacology*;Herb-Drug Interactions*;Humans;Jurkat Cells;Mistletoe/chemistry*;Plant Extracts/pharmacology*
19610027;Angiotensin II Type 1 Receptor Blockers/pharmacology*;Bupleurum/chemistry*;Cells, Cultured;Chemokines/metabolism*;Cytokines/metabolism*;Enzyme-Linked Immunosorbent Assay;Herb-Drug Interactions;Humans;Mesangial Cells/drug effects*;Mesangial Cells/metabolism;Plant Extracts/pharmacology*
19602433;Antifungal Agents/toxicity;Antineoplastic Agents, Phytogenic/toxicity*;Cell Line, Tumor;Computational Biology;Computer Simulation;Cytotoxins/toxicity*;Drug Screening Assays, Antitumor/methods*;Female;Herb-Drug Interactions;Humans;Iran;Plant Extracts/toxicity*;Toxicity Tests
19577456;Animals;Cytochrome P-450 Enzyme System/metabolism*;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Hydroxylation/drug effects;Inactivation, Metabolic;Male;Microsomes, Liver/metabolism;Phenanthrenes/pharmacology*;Rats;Rats, Sprague-Dawley;Salvia miltiorrhiza/chemistry*;Warfarin/metabolism;Warfarin/pharmacokinetics*
19577448;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Blotting, Western;Cell Line;Dose-Response Relationship, Drug;Glycosides/pharmacology*;Harpagophytum/chemistry*;Herb-Drug Interactions*;Humans;Kidney/drug effects;Phytotherapy;Plant Extracts/pharmacology*;Pyrans/pharmacology*;Up-Regulation
19565315;Anesthetics/adverse effects*;Data Collection;Echinacea/adverse effects;Female;Fertilization in Vitro*;Garlic/adverse effects;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Herbal Medicine/statistics & numerical data*;Humans;Infertility, Female*;Ireland;Panax/adverse effects;Plant Extracts/adverse effects;Reproductive Health Services*;Safety;Surveys and Questionnaires
19559714;Animals;Area Under Curve;Cytochrome P-450 CYP3A/metabolism;Dose-Response Relationship, Drug;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Herb-Drug Interactions*;Hypericum/chemistry*;Indinavir/blood;Indinavir/pharmacokinetics*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Plant Extracts/adverse effects*;Plant Extracts/isolation & purification;Rats;Rats, Wistar;Time Factors
19552494;Aged;Dietary Supplements/adverse effects*;Drug Interactions;Female;Herb-Drug Interactions;Humans;Male;Mexico;Middle Aged;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects*;Phytotherapy/adverse effects*;Polypharmacy*;Prevalence;Risk Factors;Sex Factors;Surveys and Questionnaires;Texas
19551373;Adult;Conscious Sedation/methods*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Herb-Drug Interactions/physiology*;Humans;Hypnotics and Sedatives/adverse effects*;Hypnotics and Sedatives/pharmacology;Male;Middle Aged;Oxazepam/adverse effects*;Oxazepam/pharmacology;Pupil/drug effects;Time Factors;Wakefulness/drug effects*
19545213;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Diet*;Food-Drug Interactions/physiology*;Gene Expression Regulation/physiology*;Herb-Drug Interactions/physiology;Humans
19544697;Dietary Supplements/adverse effects;Herb-Drug Interactions;Humans;Ilex paraguariensis/adverse effects*;Neoplasms/chemically induced*;Plant Leaves/adverse effects;Risk
19533580;Aldehyde Dehydrogenase/metabolism*;Aldehyde Dehydrogenase, Mitochondrial;Animals;Antioxidants/isolation & purification;Antioxidants/pharmacology*;Aorta;Cyclic GMP/metabolism;Drug Tolerance*;Endothelial Cells/drug effects*;Herb-Drug Interactions;Humans;Male;Mitochondrial Proteins/metabolism*;Nitroglycerin/therapeutic use*;Plant Extracts/chemistry;Plant Extracts/pharmacology;Rats;Rats, Sprague-Dawley;Reactive Oxygen Species/metabolism;Swertia/chemistry*;Umbilical Veins;Vasodilator Agents;Xanthenes/isolation & purification;Xanthenes/pharmacology*
19480106;Anesthesia, Dental/adverse effects*;Anesthesia, Dental/methods;Anesthetics, Intravenous/adverse effects*;Anesthetics, Intravenous/pharmacokinetics;Binding, Competitive;Biological Availability;Conscious Sedation/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacokinetics;GABA Modulators/adverse effects*;GABA Modulators/pharmacokinetics;Herb-Drug Interactions/physiology*;Humans;Liver/enzymology;Midazolam/adverse effects*;Midazolam/pharmacokinetics;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics
19476742;Animals;Drug Hypersensitivity/etiology;Gastrointestinal Tract/drug effects;Herb-Drug Interactions;Humans;Kidney/drug effects;Neoplasms/drug therapy;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*
19476734;Animals;Garcinia mangostana*/chemistry;Herb-Drug Interactions;Humans;Neoplasms/therapy*;Phytotherapy*;Plant Extracts*/pharmacology;Plant Extracts*/therapeutic use;Xanthones/adverse effects;Xanthones/pharmacology
19476272;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Breast Neoplasms/drug therapy*;Cimicifuga*;Complementary Therapies*;Female;Herb-Drug Interactions;Humans;Nonprescription Drugs/adverse effects;Nonprescription Drugs/therapeutic use*;Risk Assessment
19475525;Animals;Antineoplastic Agents/adverse effects;Beverages/adverse effects;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Neoplasms/drug therapy;Self Medication/adverse effects;Vitamins/administration & dosage;Vitamins/adverse effects
19459713;Anti-Obesity Agents/adverse effects*;Drug Contamination;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*
19455923;Complementary Therapies;Dental Care*;Garlic/adverse effects;Ginger/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;North America;Panax/adverse effects;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*;Risk Factors;Safety
19451609;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antimutagenic Agents/pharmacology;Antimutagenic Agents/therapeutic use;Antioxidants/pharmacology;Antioxidants/therapeutic use;Antiviral Agents/pharmacology;Antiviral Agents/therapeutic use;Cat's Claw/chemistry*;Herb-Drug Interactions;Humans;Phytotherapy;Plant Extracts*/pharmacology;Plant Extracts*/therapeutic use;Plants, Medicinal
19445319;Antimutagenic Agents/chemistry;Antimutagenic Agents/pharmacokinetics;Antimutagenic Agents/pharmacology;Antioxidants/chemistry;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Aspalathus/chemistry;Beverages*;Biological Availability;Cyclopia Plant/chemistry;Diet*;Herb-Drug Interactions;Phenols/chemistry;Phenols/pharmacokinetics*;Phenols/pharmacology;South Africa
19441067;Adult;Drug Synergism;Herb-Drug Interactions*;Humans;Lorazepam/adverse effects*;Lorazepam/therapeutic use;Male;Passiflora/chemistry*;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects;Self Medication;Valerian/chemistry*
19441062;Animals;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacology*;Glutathione Transferase/metabolism;Herb-Drug Interactions*;Kidney/enzymology;Liver/enzymology;Lung/enzymology;Male;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Seeds/chemistry;Urticaceae/chemistry*
19425276;Antineoplastic Agents, Phytogenic/adverse effects*;Antineoplastic Agents, Phytogenic/therapeutic use;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Phytotherapy*
19422358;Adult;Angelica/chemistry*;Aryl Hydrocarbon Hydroxylases/metabolism*;Caffeine/pharmacology;Chlorzoxazone/pharmacology;Chromatography, High Pressure Liquid;Chromatography, Liquid;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP2E1/metabolism;Dextromethorphan/pharmacology;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Losartan/pharmacology;Male;Midazolam/pharmacology;Omeprazole/pharmacology;Phytotherapy*;Republic of Korea;Scutellaria baicalensis/chemistry*;Tandem Mass Spectrometry;Young Adult
19401473;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adrenergic beta-Antagonists/pharmacokinetics;Adult;Asian Continental Ancestry Group;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/adverse effects*;Ginkgo biloba/adverse effects*;Herb-Drug Interactions;Humans;Male;Propanolamines/pharmacokinetics*;Time Factors
19390395;Aged;Depression/drug therapy;Fatigue/drug therapy;Herb-Drug Interactions*;Humans;Male;Nurse Practitioners/organization & administration*;Nursing Assessment;Obesity/drug therapy;Patient Education as Topic/methods*;Phytotherapy/adverse effects*;Phytotherapy/nursing;Primary Health Care/methods*;Safety;Sleep Initiation and Maintenance Disorders/drug therapy;United States;United States Food and Drug Administration
19387280;Analgesics, Opioid/pharmacology*;Anesthetics/pharmacology;Animals;Dietary Supplements/adverse effects;Dietary Supplements/utilization;Disease Models, Animal;Drug Evaluation, Preclinical;Herb-Drug Interactions;Kava/adverse effects*;Male;Morphine/pharmacology*;Nurse Anesthetists;Pain/prevention & control*;Phytotherapy/adverse effects*;Phytotherapy/methods;Phytotherapy/utilization;Prospective Studies;Random Allocation;Rats;Rats, Sprague-Dawley;Receptors, Opioid, mu*/agonists;Receptors, Opioid, mu*/antagonists & inhibitors;Receptors, Opioid, mu*/drug effects;Risk Factors;Single-Blind Method;Time Factors
19381859;Adolescent;Adult;Artemisia/adverse effects*;Child;Child, Preschool;Drug Combinations;Exanthema/chemically induced;Exanthema/epidemiology;Female;Gardenia/adverse effects*;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/epidemiology;Herb-Drug Interactions;Humans;Infant;Infant, Newborn;Injections;Lonicera/adverse effects*;Male;Phytotherapy/adverse effects;Phytotherapy/methods;Plant Extracts/administration & dosage;Plant Extracts/adverse effects*;Prospective Studies;Risk Factors;Young Adult
19371848;Arnica/adverse effects;Arnica/metabolism;Bromelains/adverse effects;Bromelains/metabolism;Dietary Supplements/adverse effects*;Drug Interactions;Echinacea/adverse effects;Echinacea/metabolism;Ephedra/adverse effects;Ephedra/metabolism;Ginkgo biloba/adverse effects;Ginkgo biloba/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Perioperative Care*;Plant Preparations/adverse effects*;Plant Preparations/metabolism;Quality Control;Reconstructive Surgical Procedures*;Surgery, Plastic;Valerian/adverse effects;Valerian/metabolism
19371257;Aryl Hydrocarbon Hydroxylases/metabolism*;Cells, Cultured;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2E1/metabolism*;Dietary Supplements;Dose-Response Relationship, Drug;Hepatocytes/drug effects;Hepatocytes/enzymology;Herb-Drug Interactions;Humans;Male;Plant Extracts/pharmacology*
19364195;Female;Fibrocystic Breast Disease/drug therapy*;Fruit/chemistry*;Herb-Drug Interactions;Humans;Menstruation Disturbances/drug therapy*;Pain/drug therapy*;Phytotherapy*;Premenstrual Syndrome/drug therapy;Vitex/adverse effects;Vitex/chemistry*
19364194;Herb-Drug Interactions;Olea/chemistry*;Phytotherapy*;Plant Extracts/pharmacology;Plant Extracts/therapeutic use*;Plant Leaves/chemistry*
19353999;Camellia sinensis;Cimicifuga;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Dietary Supplements;Herb-Drug Interactions;Humans;Microsomes, Liver/metabolism;Panax;Phytotherapy*;Plant Extracts/pharmacology*;Quinine/metabolism;Reproducibility of Results;Vitis
19326360;Adult;Drug Therapy, Combination;Female;Herb-Drug Interactions;Humans;Maternal Behavior;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*;Pregnancy;Pregnancy Trimesters;Prescription Drugs/adverse effects;Prevalence;Prognosis;Quebec/epidemiology;Registries/statistics & numerical data;Surveys and Questionnaires;Women's Health
19323340;Anticoagulants/adverse effects;Dental Care*;Dietary Supplements*/adverse effects;Ephedra/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Nonprescription Drugs;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plants, Medicinal/adverse effects;Platelet Aggregation Inhibitors/adverse effects
19292027;Clinical Laboratory Techniques*;Dietary Supplements/adverse effects*;Drug Contamination;Herb-Drug Interactions*;Humans;Medicine, Traditional*;Plant Preparations/adverse effects*;Plant Preparations/metabolism
19292026;Animals;Female;Herb-Drug Interactions*;Herbal Medicine*;Humans;Maternal Exposure/adverse effects;Medicine, Traditional*;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics;Plant Extracts/toxicity*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry
19255814;Adult;Aged;Aged, 80 and over;Analgesics/therapeutic use;Anticoagulants/therapeutic use;Antihypertensive Agents/therapeutic use;Attitude of Health Personnel;Complementary Therapies*;Cross-Sectional Studies;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Male;Middle Aged;Ontario;Osteoarthritis/drug therapy*;Patient Education as Topic;Physician-Patient Relations;Plant Preparations/therapeutic use*;Platelet Aggregation Inhibitors/therapeutic use;Risk Assessment;Self Medication*;Surveys and Questionnaires;Truth Disclosure
20690490;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Depression/drug therapy*;Herb-Drug Interactions;Humans;Hypericum*
19247403;Aesculus*;Chronic Disease;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Seeds;Treatment Outcome;Venous Insufficiency/drug therapy*
19245357;Aged;Aged, 80 and over;Aging*/drug effects;Aging*/physiology;Aging*/psychology;Anesthesia/methods;Cardiovascular System/physiopathology;Cognition;Comorbidity;Drug Interactions;Female;General Surgery/methods;Herb-Drug Interactions;Humans;Kidney/physiology;Liver/physiology;Postoperative Complications/prevention & control;Prescription Drugs/adverse effects;Prescription Drugs/pharmacokinetics;Prescription Drugs/therapeutic use*;Surgical Procedures, Operative*;Women's Health
19234997;Aged;Aged, 80 and over;Consumer Product Safety*;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Female;Health Behavior;Herb-Drug Interactions;Humans;Idaho;Male;Middle Aged;Nonprescription Drugs/administration & dosage*;Nonprescription Drugs/adverse effects;Patient Satisfaction;Pilot Projects;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Surveys and Questionnaires
19219097;Adult;Child;Contraindications;Female;Herb-Drug Interactions;Humans;Lactation;Male;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Pregnancy;Recurrence;Urinary Tract Infections/drug therapy*;Vaccinium macrocarpon*/adverse effects
19207805;Adolescent;Adult;Aged;Chi-Square Distribution;Cross-Sectional Studies;Female;Health Care Surveys;Herb-Drug Interactions;Humans;Kidney Failure, Chronic/ethnology*;Kidney Failure, Chronic/therapy;Male;Middle Aged;Nursing Methodology Research;Patient Acceptance of Health Care/ethnology*;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Phytotherapy/methods;Phytotherapy/psychology*;Phytotherapy/statistics & numerical data;Renal Dialysis/nursing;Renal Dialysis/psychology*;Self Disclosure;Socioeconomic Factors;Surveys and Questionnaires;Turkey
19203654;Biological Products/adverse effects*;Biological Products/therapeutic use;Complementary Therapies/adverse effects*;Complementary Therapies/ethics;Complementary Therapies/legislation & jurisprudence;Health Personnel/ethics;Health Services Needs and Demand/ethics*;Health Services Needs and Demand/legislation & jurisprudence;Herb-Drug Interactions;Humans;Hypersensitivity/immunology;Hypersensitivity/therapy*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use;Plants, Medicinal;Treatment Outcome
19200702;Analgesics/therapeutic use*;Animals;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Asteraceae*;Diclofenac/therapeutic use*;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Herb-Drug Interactions*;Hot Temperature;Hyperalgesia/drug therapy*;Male;Mice;Mice, Inbred BALB C;Phytotherapy;Plant Extracts/therapeutic use*;Plant Roots
19199376;Animals;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/therapeutic use;Dietary Supplements/adverse effects;Drug Interactions;Herb-Drug Interactions;Humans;Internet;Neoplasms/drug therapy*;Nonprescription Drugs/adverse effects*;Nonprescription Drugs/therapeutic use;Vitamins/adverse effects;Vitamins/therapeutic use
19186210;1-Methyl-3-isobutylxanthine/pharmacology;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology;Animals;Aorta/drug effects;Calcium/pharmacology;Drug Synergism;Herb-Drug Interactions*;Ligusticum*;Male;Nitric Oxide Donors/pharmacology;Nitroprusside/pharmacology*;Phenylephrine/pharmacology;Phthalic Anhydrides/pharmacology*;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Vasoconstrictor Agents/pharmacology;Vasodilator Agents/pharmacology*
19185075;Fluorobenzenes/pharmacokinetics;Fluorobenzenes/therapeutic use*;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hypericum/adverse effects*;Male;Middle Aged;Plant Preparations/adverse effects*;Plant Preparations/pharmacology;Pyrimidines/pharmacokinetics;Pyrimidines/therapeutic use*;Rosuvastatin Calcium;Sulfonamides/pharmacokinetics;Sulfonamides/therapeutic use*
19181175;Adult;Communication*;Complementary Therapies/nursing;Complementary Therapies/psychology*;District of Columbia;HIV Infections/psychology*;HIV Infections/therapy;Herb-Drug Interactions;Holistic Health;Humans;Integrative Medicine;Male;Medical History Taking;Nurse Practitioners/organization & administration;Nurse Practitioners/psychology;Nurse-Patient Relations*;Nursing Assessment;Nursing Methodology Research;Patient Acceptance of Health Care/psychology*;Patient Acceptance of Health Care/statistics & numerical data;Practice Guidelines as Topic;Primary Health Care;Safety
19181163;Drug Prescriptions/nursing*;Evidence-Based Practice;Herb-Drug Interactions*;Humans;Medical History Taking;Nurse Practitioners/organization & administration*;Nursing Assessment;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Patient Selection;Phytotherapy/adverse effects*;Phytotherapy/nursing;Phytotherapy/psychology;Safety;United States
19174505;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adult;Aged;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Cross-Sectional Studies;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Data Collection;Databases, Factual;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Phytotherapy/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/chemistry;Plant Extracts/therapeutic use
19173278;Animals;Cytochrome P-450 Enzyme System/drug effects;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacokinetics*;Glycyrrhiza uralensis/chemistry*;Herb-Drug Interactions*;Lidocaine/blood;Lidocaine/pharmacokinetics*;Lidocaine/urine;Male;Medicine, Chinese Traditional;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Rats;Rats, Sprague-Dawley
19170364;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Dental Care for Chronically Ill*;Drug Administration Schedule;Drug Interactions;Evidence-Based Dentistry*;Hemorrhage/prevention & control;Heparin, Low-Molecular-Weight/administration & dosage;Heparin, Low-Molecular-Weight/therapeutic use;Herb-Drug Interactions;Humans;International Normalized Ratio;Interprofessional Relations;Prothrombin Time;Referral and Consultation;Risk Assessment;Safety;Thromboembolism/prevention & control;Warfarin/pharmacology;Warfarin/therapeutic use*
19158465;Alanine Transaminase/blood;Chemical and Drug Induced Liver Injury/diagnosis*;Complementary Therapies;Guidelines as Topic;Herb-Drug Interactions;Humans;Risk Factors;Severity of Illness Index
19133584;Anti-Inflammatory Agents/therapeutic use;Anticonvulsants/antagonists & inhibitors;Anticonvulsants/therapeutic use;Beverages*/adverse effects;Herb-Drug Interactions*;Humans;Plant Preparations*/adverse effects;Prednisolone/therapeutic use;Tabebuia*/adverse effects
19125771;Adult;Aged;Asia, Southeastern;Blood Glucose/analysis;China;Cognition Disorders/chemically induced*;Drugs, Chinese Herbal;Glyburide/poisoning*;Herb-Drug Interactions*;Humans;Hypoglycemia/chemically induced*;Hypoglycemic Agents/poisoning*;Male;Middle Aged;Retrospective Studies
19122289;Analysis of Variance;Arylsulfotransferase;Herb-Drug Interactions*;Humans;Inhibitory Concentration 50;Plant Extracts/pharmacology*;Recombinant Proteins/pharmacology;Sulfotransferases/drug effects*
22435411;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism*;Antineoplastic Agents, Phytogenic/therapeutic use;Cognition Disorders/etiology;Dose-Response Relationship, Drug;Ginkgo biloba/adverse effects*;Hepatocytes/drug effects*;Hepatocytes/metabolism;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Paclitaxel/adverse effects;Paclitaxel/metabolism*;Paclitaxel/therapeutic use;Plant Preparations/adverse effects*
22435350;Adrenergic alpha-2 Receptor Agonists/pharmacology;Adrenergic alpha-2 Receptor Agonists/therapeutic use;Analgesia*;Analgesics/pharmacology*;Analgesics/therapeutic use;Analysis of Variance;Animals;Berberine Alkaloids/pharmacology*;Berberine Alkaloids/therapeutic use;Corydalis/chemistry*;Dexmedetomidine/pharmacology*;Herb-Drug Interactions*;Hot Temperature;Hypnotics and Sedatives/pharmacology;Male;Pain/drug therapy;Pain Threshold/drug effects;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Rats;Rats, Sprague-Dawley;Receptors, Adrenergic, alpha-2/metabolism*;Yohimbine/pharmacology
20408499;Cuba;Cytochrome P-450 Enzyme System/physiology;Female;Herb-Drug Interactions*/genetics;Humans;Legislation, Drug;Male;Pharmacogenetics;Phytotherapy/adverse effects*
19075623;Cooperative Behavior;Herb-Drug Interactions*;Humans
19075622;Communication;Herb-Drug Interactions*;Humans;Risk Assessment;Risk Management*;Risk Reduction Behavior
19075621;Complementary Therapies*;Herb-Drug Interactions*;Humans;Knowledge
19075620;Animals;Arsenicals/administration & dosage;Benzamides;Drug Discovery;Drug Synergism;Gene Expression Profiling*;Herb-Drug Interactions*;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism;Leukemia, Promyelocytic, Acute/drug therapy*;Leukemia, Promyelocytic, Acute/metabolism;Oxides/administration & dosage;Piperazines/administration & dosage;Proteome*;Pyrimidines/administration & dosage;Tretinoin/administration & dosage
19075619;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Animals;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology;Cytochrome P-450 CYP3A/physiology;Enzyme Induction;Herb-Drug Interactions*;Humans;Hypericum*;Perylene/analogs & derivatives;Perylene/pharmacokinetics;Perylene/pharmacology;Photochemotherapy
19075618;Animals;Antineoplastic Agents, Phytogenic/pharmacokinetics;Biological Transport;Blood-Brain Barrier*/drug effects;Blood-Brain Barrier*/physiology;Digoxin/pharmacokinetics;Flavonoids/pharmacokinetics;Herb-Drug Interactions*;Humans;Perylene/analogs & derivatives;Perylene/pharmacology
19075615;Herb-Drug Interactions*;Humans
19067984;Cardiovascular Agents/adverse effects*;Crataegus/adverse effects;Ginkgo biloba/adverse effects;Heart/drug effects*;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Nurse's Role;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/methods;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Ubiquinone/adverse effects;Ubiquinone/analogs & derivatives;Ubiquinone/therapeutic use;Vitamins/adverse effects;Vitamins/therapeutic use
19066872;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/drug effects*;Bupropion/analogs & derivatives*;Bupropion/blood;Bupropion/metabolism*;Bupropion/pharmacokinetics;Cytochrome P-450 CYP2B6;Dopamine Uptake Inhibitors/metabolism;Enzyme Induction/drug effects;Flavonoids/chemistry;Flavonoids/pharmacology*;Glucuronidase/antagonists & inhibitors;Haplotypes;Herb-Drug Interactions;Humans;Hydroxylation/drug effects;Male;Oxidoreductases, N-Demethylating/biosynthesis*;Oxidoreductases, N-Demethylating/drug effects*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Polymorphism, Single Nucleotide;Time Factors
19058404;Herb-Drug Interactions/physiology*;Humans
19053860;Animals;Calcium/metabolism*;Calcium Channel Blockers/pharmacology;Cardiotonic Agents/pharmacology;Crataegus*;Heart Failure/drug therapy;Herb-Drug Interactions;Hypertension/drug therapy;Male;Myocytes, Cardiac/drug effects*;Myocytes, Cardiac/metabolism;Nifedipine/pharmacology;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plant Structures;Rats;Rats, Sprague-Dawley;Sodium-Potassium-Exchanging ATPase/metabolism
19015839;Administration, Oral;Adult;Area Under Curve;Contraceptives, Oral, Combined/administration & dosage;Contraceptives, Oral, Combined/metabolism;Contraceptives, Oral, Combined/pharmacokinetics*;Desogestrel/administration & dosage;Desogestrel/metabolism;Desogestrel/pharmacokinetics*;Ethinyl Estradiol/administration & dosage;Ethinyl Estradiol/metabolism;Ethinyl Estradiol/pharmacokinetics*;Female;Herb-Drug Interactions;Humans;Hypericum;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics*;Tablets
19008635;Animals;Aryl Hydrocarbon Hydroxylases/metabolism;Drug Therapy, Combination*;Drugs, Chinese Herbal/administration & dosage*;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions/physiology*;Humans
18950251;Animals;Harpagophytum/chemistry*;Herb-Drug Interactions;Low Back Pain/drug therapy*;Osteoarthritis/drug therapy*;Phytotherapy/adverse effects;Phytotherapy/methods*;Rheumatic Diseases/drug therapy*
18947363;Binding Sites;Coumarins/metabolism;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Echinacea/chemistry*;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Inhibitory Concentration 50;Ketoconazole/administration & dosage;Ketoconazole/pharmacology*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology;Quinolines/metabolism;Testosterone/metabolism
18928143;Adolescent;Adult;Child;Child, Preschool;Cross-Sectional Studies;Female;Health Behavior*;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Male;Middle Aged;Nigeria/epidemiology;Phytotherapy/psychology;Phytotherapy/utilization*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Professional-Patient Relations;Self Care/methods;Self Medication/psychology;Self Medication/statistics & numerical data*;Surveys and Questionnaires
18928136;Adult;Aged;Female;Health Behavior*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Mexico/epidemiology;Middle Aged;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Plants, Medicinal*;Prevalence;Surveys and Questionnaires;United States/epidemiology;Urban Population/statistics & numerical data
18927522;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages/adverse effects;Citrus paradisi;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Enzyme Inhibitors/adverse effects;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Muscular Diseases/chemically induced*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism;Simvastatin/adverse effects*;Simvastatin/metabolism;Solute Carrier Organic Anion Transporter Family Member 1b1;Tea
18844284;Animals;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Herb-Drug Interactions*;Male;Plant Extracts/pharmacokinetics*;Plant Extracts/pharmacology;Plants, Medicinal;Rats;Rats, Wistar;Rhodiola/chemistry*;Theophylline/blood;Theophylline/pharmacokinetics*;Theophylline/pharmacology;Warfarin/blood;Warfarin/pharmacokinetics*;Warfarin/pharmacology
18844254;Asteraceae/chemistry;Cytochrome P-450 Enzyme Inhibitors*;Female;Flavonoids/pharmacology;Herb-Drug Interactions;Humans;Hydrocharitaceae/chemistry;Male;Mangifera/chemistry;Medicine, Traditional;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Phenols/pharmacology;Phytotherapy;Plant Extracts/pharmacology*;Plants, Medicinal/metabolism;Polyphenols;Polyunsaturated Alkamides/pharmacology
18811084;Anesthesia, Dental*;Conscious Sedation*;Herb-Drug Interactions;Homeopathy*;Humans;Materia Medica;Medical History Taking;Phytotherapy
18776969;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring;Drug Resistance*/genetics;Food-Drug Interactions;Herb-Drug Interactions;Humans;International Normalized Ratio;Mixed Function Oxygenases/genetics;Mixed Function Oxygenases/metabolism;Polymorphism, Genetic;Vitamin K Epoxide Reductases;Warfarin/administration & dosage*;Warfarin/pharmacokinetics
18765169;Adjuvants, Immunologic/adverse effects;Adjuvants, Immunologic/therapeutic use*;Animals;Cell Proliferation/drug effects;Chemotherapy, Adjuvant*/adverse effects;Herb-Drug Interactions;Injections, Intraperitoneal;Leukopenia/chemically induced;Leukopenia/drug therapy;Leukopenia/immunology;Lymphoma/drug therapy*;Lymphoma/immunology;Lymphoma/pathology;Medicine, Ayurvedic;Mice;Mice, Inbred BALB C;Neoplasm Transplantation;Phagocytosis/drug effects;Phagocytosis/immunology;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Th1 Cells/metabolism;Th1 Cells/pathology
18762932;Administration, Oral;Adult;Bridged Bicyclo Compounds/administration & dosage;Bridged Bicyclo Compounds/analysis;Bridged Bicyclo Compounds/pharmacology;Cross-Over Studies;Cytochrome P-450 CYP3A/biosynthesis*;Enzyme Induction;Herb-Drug Interactions;Humans;Hypericum*;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Phloroglucinol/administration & dosage;Phloroglucinol/analogs & derivatives*;Phloroglucinol/analysis;Phloroglucinol/pharmacology;Plant Preparations/administration & dosage;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Powders;Substrate Specificity;Terpenes/administration & dosage;Terpenes/analysis;Terpenes/pharmacology*;Young Adult
18756649;Anxiety Disorders/drug therapy*;Herb-Drug Interactions;Humans;Kava/adverse effects*;Liver/drug effects*;Phytotherapy*;Plant Extracts/adverse effects*
18712519;Atazanavir Sulfate;Cat's Claw*/adverse effects;Female;HIV Protease Inhibitors*/administration & dosage;HIV Protease Inhibitors*/blood;HIV Protease Inhibitors*/pharmacokinetics;HIV Protease Inhibitors*/therapeutic use;Herb-Drug Interactions*;Humans;Metabolic Clearance Rate;Middle Aged;Oligopeptides/administration & dosage;Oligopeptides/blood;Oligopeptides/pharmacokinetics;Oligopeptides/therapeutic use;Plant Preparations*/administration & dosage;Plant Preparations*/adverse effects;Pyridines/administration & dosage;Pyridines/blood;Pyridines/pharmacokinetics;Pyridines/therapeutic use;Ritonavir/administration & dosage;Ritonavir/blood;Ritonavir/pharmacokinetics;Ritonavir/therapeutic use;Saquinavir/administration & dosage;Saquinavir/blood;Saquinavir/pharmacokinetics;Saquinavir/therapeutic use
18711168;Anticholesteremic Agents/adverse effects*;Anticholesteremic Agents/pharmacokinetics;Herb-Drug Interactions;Humans;Male;Middle Aged;Muscle, Skeletal/drug effects*;Pain/chemically induced;Simvastatin/adverse effects*;Simvastatin/pharmacokinetics;Tea*
18698390;Attitude of Health Personnel*;Dietary Supplements*/adverse effects;Drug Interactions;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Legislation, Drug;Patient Education as Topic;Pharmacists*;Plant Preparations*/adverse effects;Professional-Patient Relations;Program Development;Surveys and Questionnaires*
18688789;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biological Availability;Biological Transport, Active/drug effects*;Caco-2 Cells;Digoxin/pharmacokinetics*;Echinacea/chemistry*;Ethanol/pharmacology;Herb-Drug Interactions;Humans;Plant Extracts/pharmacology*;Verapamil/pharmacology
18673195;Drug Design*;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions*;Hypericum/adverse effects*;Hypericum/chemistry;Molecular Structure;Pharmaceutical Preparations/chemistry;Plant Preparations/adverse effects*;Plant Preparations/isolation & purification
18670318;Adenocarcinoma/diagnostic imaging;Adenocarcinoma/drug therapy;Adenocarcinoma/secondary;Adult;Female;Herb-Drug Interactions*;Herbal Medicine*;Humans;Lung Neoplasms/diagnostic imaging;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Plants, Medicinal/adverse effects*;Protein Kinase Inhibitors/therapeutic use*;Quinazolines/therapeutic use*;Receptor, Epidermal Growth Factor/antagonists & inhibitors;Tomography, X-Ray Computed;Treatment Outcome
18657993;Animals;Binding, Competitive/drug effects;Diterpenes, Abietane;Drugs, Chinese Herbal/pharmacology;Herb-Drug Interactions;Humans;Male;Phenanthrenes/pharmacology*;Protein Binding/drug effects;Rats;Rats, Sprague-Dawley;Serum Albumin/metabolism*;Spectrometry, Mass, Electrospray Ionization/methods*;Warfarin/administration & dosage;Warfarin/metabolism*;Warfarin/pharmacokinetics
18638690;Antioxidants/adverse effects;Antioxidants/therapeutic use;Cachexia/therapy;Complementary Therapies*;Dietary Supplements*/adverse effects;Dietary Supplements*/utilization;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/therapy;Herb-Drug Interactions;Hot Flashes/therapy;Humans;Lymphedema/therapy;Neoplasms/diet therapy;Neoplasms/drug therapy;Neoplasms/prevention & control;Neoplasms/radiotherapy;Neoplasms/therapy*;Peripheral Nervous System Diseases/chemically induced;Peripheral Nervous System Diseases/therapy;Phytotherapy;Plant Preparations/adverse effects;Plant Preparations/therapeutic use;Radiation Injuries/therapy;Radiotherapy/adverse effects;Randomized Controlled Trials as Topic/statistics & numerical data;Risk;Stomatitis/therapy
18637192;Consumer Product Safety/standards;Dietary Supplements/standards*;Herb-Drug Interactions*;Humans;Hypericum*;Plant Extracts*;Product Labeling/methods*;Product Labeling/standards*;United States;United States Food and Drug Administration
18634396;Administration, Oral;Anticoagulants/administration & dosage*;Cytochrome P-450 Enzyme System/genetics;Drug Interactions;Drug Resistance/genetics;Food-Drug Interactions*;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Polymorphism, Genetic;Thromboembolism/prevention & control;Warfarin/pharmacology
18624348;Dietary Supplements*;Echinacea;Food, Organic/adverse effects*;Food, Organic/toxicity;Ginkgo biloba;Herb-Drug Interactions;Humans;Research Design*
18623630;Antihypertensive Agents/antagonists & inhibitors*;Benzimidazoles/antagonists & inhibitors*;Blood Pressure/drug effects;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Rhodiola*;Tetrazoles/antagonists & inhibitors*
18619012;Anticoagulants/adverse effects*;Beverages;Herb-Drug Interactions;Humans;International Normalized Ratio;Tea/adverse effects*;Tea/chemistry;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
18618481;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Echinacea/adverse effects*;Herb-Drug Interactions*;Humans;Plants, Medicinal/adverse effects
18618477;Acquired Immunodeficiency Syndrome/drug therapy;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Ethnic Groups/genetics;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Pharmacogenetics/methods*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Polymorphism, Genetic
18584812;Andrographis;Astragalus Plant;Cytochrome P-450 Enzyme System/drug effects*;Echinacea;Eleutherococcus;Herb-Drug Interactions*;Humans;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Respiratory Tract Infections/drug therapy*
18582555;Animals;Central Nervous System Depressants/administration & dosage;Central Nervous System Depressants/pharmacology*;Dose-Response Relationship, Drug;Drug Synergism;Exploratory Behavior/drug effects;Fruit;Herb-Drug Interactions*;Injections, Intraperitoneal;Male;Medicine, Traditional;Mexico;Mice;Mice, Inbred ICR;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Solvents/chemistry;Theaceae/chemistry*
18570167;Adverse Drug Reaction Reporting Systems/statistics & numerical data*;Dietary Supplements/adverse effects*;Dietary Supplements/poisoning;Herb-Drug Interactions;Humans;Poison Control Centers/statistics & numerical data*;Poisoning/epidemiology;Population Surveillance;Prospective Studies;San Francisco/epidemiology;Time Factors
18538093;Antihypertensive Agents/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/therapeutic use;Kidney Diseases*/blood;Kidney Diseases*/metabolism;Plant Preparations/adverse effects
18525278;Diarrhea/chemically induced*;Drug-Related Side Effects and Adverse Reactions*;HIV Infections/drug therapy*;HIV Protease Inhibitors/adverse effects*;HIV-1*;Herb-Drug Interactions*;Humans;Lopinavir;Male;Middle Aged;Pyrimidinones/adverse effects*
18516070;Adolescent;Adult;Anticoagulants/pharmacokinetics;Anticoagulants/pharmacology*;Aryl Hydrocarbon Hydroxylases/genetics;Cross-Over Studies;Cytochrome P-450 CYP2C9;Drug Monitoring;Garlic/chemistry*;Genotype;Herb-Drug Interactions;Humans;International Normalized Ratio;Male;Mixed Function Oxygenases/genetics;Platelet Aggregation/drug effects;Protein Binding/drug effects;Stereoisomerism;Time Factors;Vaccinium macrocarpon/chemistry*;Vitamin K Epoxide Reductases;Warfarin/pharmacokinetics;Warfarin/pharmacology*
18515463;Commiphora/chemistry*;Depressive Disorder/drug therapy;Female;Herb-Drug Interactions*;Humans;Middle Aged;Phytotherapy;Plant Extracts/adverse effects;Recurrence;Serotonin Uptake Inhibitors/pharmacokinetics*;Serotonin Uptake Inhibitors/therapeutic use;Sertraline/pharmacokinetics*;Sertraline/therapeutic use;Terminalia/chemistry*
18479173;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Transport;Clinical Trials as Topic;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism;Drug Evaluation, Preclinical;Enzyme Induction;Herb-Drug Interactions*;Humans;Models, Animal;Models, Biological;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
18433343;Beverages;Clinical Trials as Topic;Cytochrome P-450 Enzyme Inhibitors;Fruit/chemistry*;Herb-Drug Interactions;Humans;Membrane Transport Proteins/physiology;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Plant Extracts/pharmacology*
18429542;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Kava/adverse effects;Nurse's Role*;Patient Education as Topic/organization & administration*;Phytotherapy*/adverse effects;Phytotherapy*/nursing;Plant Extracts/adverse effects
18420532;Administration, Oral;Adult;Area Under Curve;Cytochrome P-450 CYP3A/drug effects*;Cytochrome P-450 CYP3A/metabolism;Female;Forecasting/methods;Ginkgo biloba/chemistry;Herb-Drug Interactions*;Humans;Linear Models;Longitudinal Studies;Male;Midazolam/pharmacokinetics*;Middle Aged;Plant Extracts/pharmacology*;Time Factors
18406030;Adult;Antiretroviral Therapy, Highly Active/adverse effects*;Communication;Cross-Sectional Studies;Educational Status;Female;HIV Infections/drug therapy*;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Logistic Models;Male;Medicine, African Traditional*;Middle Aged;Physician-Patient Relations*;Phytotherapy/adverse effects*;Uganda
18385029;Dental Care*;Dietary Supplements*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Plants, Medicinal/adverse effects;Safety;United States
18379627;Adenosine Triphosphate/metabolism;Animals;Brain/drug effects*;Brain/enzymology;Caffeine/pharmacology;Central Nervous System Stimulants/pharmacology*;Enzyme Inhibitors/pharmacology*;Ethanol/pharmacology*;Herb-Drug Interactions*;Hydrolysis;Kinetics;Malvaceae*;Nuts;Ouabain/pharmacology;Phosphates/metabolism;Plant Preparations/pharmacology*;Rats;Rats, Wistar;Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors*;Sodium-Potassium-Exchanging ATPase/metabolism
18379623;Alanine Transaminase/metabolism;Animals;Aspartate Aminotransferases/metabolism;Biotransformation;Caffeine/metabolism;Caffeine/toxicity*;Central Nervous System Stimulants/metabolism;Central Nervous System Stimulants/toxicity*;Cocos*;Enzyme Induction;Herb-Drug Interactions*;Liver/drug effects*;Liver/enzymology;Microsomes, Liver/enzymology;Nuts;Plant Preparations/pharmacology*;RNA/metabolism;Rats;Rats, Wistar
18379622;Animals;Brain/drug effects*;Brain/metabolism;Caffeine/pharmacology;Central Nervous System Stimulants/pharmacology*;DNA/metabolism;Down-Regulation;Ethanol/pharmacology*;Herb-Drug Interactions*;Malvaceae*;Nerve Tissue Proteins/genetics;Nerve Tissue Proteins/metabolism*;Neurons/drug effects*;Neurons/metabolism;Nuts;Plant Preparations/pharmacology*;RNA Splicing/drug effects;RNA, Messenger/metabolism;Rats;Rats, Wistar;Transcription, Genetic/drug effects
18367983;Digoxin/blood*;Drug Contamination;Drug Monitoring*;Herb-Drug Interactions*;Humans;Hypericum*;Immunoassay;Phytotherapy;Plant Extracts/adverse effects;Plant Extracts/analysis;Plant Preparations/adverse effects*;Plant Preparations/analysis
18363644;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Beverages/adverse effects;Citrus paradisi*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Induction;Evidence-Based Medicine;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum*;Immunosuppressive Agents/adverse effects*;Kidney Transplantation*;Liver/drug effects*;Liver/enzymology;Plant Preparations/adverse effects;Receptors, Steroid/drug effects;Receptors, Steroid/metabolism;Risk Assessment;Up-Regulation
18356703;Adolescent;Child;Complementary Therapies*/adverse effects;Dietary Supplements/adverse effects;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Phytotherapy*/adverse effects;Psychotropic Drugs/adverse effects;Psychotropic Drugs/therapeutic use*;Treatment Outcome
18346508;Adolescent;Biological Products/therapeutic use*;Canada;Child;Child, Preschool;Drug Interactions*;Drug Therapy/utilization;Drug Therapy, Combination;Drug-Related Side Effects and Adverse Reactions;Female;Health Care Surveys;Herb-Drug Interactions*;Humans;Infant;Male;Pharmaceutical Preparations*;Phytotherapy*/utilization;Vitamins/therapeutic use
18338604;Animals;Cardiotonic Agents/isolation & purification;Cardiotonic Agents/pharmacology*;Cell Line, Tumor;Cell Proliferation/drug effects;Cell Survival/drug effects;Cells, Cultured;Creatine Kinase/blood;Creatine Kinase, MB Form/blood;Doxorubicin/adverse effects*;Doxorubicin/pharmacology;Ginsenosides/isolation & purification;Ginsenosides/pharmacology*;Herb-Drug Interactions;Humans;Lactate Dehydrogenases/blood;Male;Mice;Mice, Inbred ICR;Myocytes, Cardiac/cytology;Myocytes, Cardiac/drug effects*;Panax notoginseng*/chemistry;Plants, Medicinal/chemistry;Random Allocation;Rats
18338596;Amygdalin/chemistry*;Amygdalin/isolation & purification;Calcium Sulfate/chemistry*;Drug Combinations;Drugs, Chinese Herbal/chemistry*;Drugs, Chinese Herbal/isolation & purification;Ephedra sinica/chemistry*;Ephedrine/analysis*;Glycyrrhiza uralensis/chemistry;Herb-Drug Interactions;Materia Medica/chemistry;Plants, Medicinal/chemistry;Prunus/chemistry
18332740;Aged;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Community Health Nursing/organization & administration*;Comorbidity;Gallstones/complications*;Herb-Drug Interactions;Histamine H1 Antagonists/adverse effects;Home Care Services/organization & administration*;Humans;Kidney Failure, Chronic/complications*;Male;Nonprescription Drugs/adverse effects;Nurse's Role;Nursing Assessment/organization & administration*;Patient Education as Topic;Prednisone/adverse effects;Spider Bites/complications;Spider Bites/drug therapy*;Spider Bites/nursing
18332358;Adult;Aged;Dietary Supplements/statistics & numerical data*;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy/statistics & numerical data*;Pilot Projects;Plant Extracts/therapeutic use*;Professional-Patient Relations;Self Medication/statistics & numerical data;United States/epidemiology;Urban Population/statistics & numerical data*
18332357;Adult;Aged;Dietary Supplements/statistics & numerical data*;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Patient Education as Topic;Phytotherapy/statistics & numerical data*;Pilot Projects;Plant Extracts/therapeutic use*;Professional-Patient Relations;Self Medication/statistics & numerical data;Surveys and Questionnaires;United States/epidemiology;Urban Population/statistics & numerical data*
18332082;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Bornanes/pharmacology*;China;Cytochrome P-450 CYP2B6;Herb-Drug Interactions*;Humans;Korea;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Mixed Function Oxygenases/metabolism;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Phytotherapy;Plant Preparations/pharmacology*;Stroke/drug therapy;Stroke/prevention & control;Suspensions
18331656;Adult;Antineoplastic Agents/administration & dosage;Attitude to Health;Complementary Therapies/utilization*;Female;Head and Neck Neoplasms/drug therapy;Head and Neck Neoplasms/epidemiology;Head and Neck Neoplasms/therapy*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Patient Acceptance of Health Care/statistics & numerical data;Phytotherapy/statistics & numerical data*;Plant Preparations*/administration & dosage;Scotland/epidemiology;Surveys and Questionnaires;Young Adult
18331390;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Caco-2 Cells;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Digoxin/metabolism;Herb-Drug Interactions;Humans;Ketoconazole/pharmacology;Plant Extracts/pharmacology;Plant Preparations/pharmacology*;Testosterone/metabolism;Verapamil/pharmacology
18324706;Drug Interactions;Drug Therapy*;Herb-Drug Interactions*;Humans;Pharmaceutical Preparations*;Phytotherapy*/adverse effects;Reproducibility of Results
18310985;Aspirin/adverse effects*;Diffusion Magnetic Resonance Imaging;Female;Fibrinolytic Agents/adverse effects*;Herb-Drug Interactions*;Humans;Intracranial Hemorrhages/chemically induced*;Intracranial Hemorrhages/diagnostic imaging;Ischemic Attack, Transient/prevention & control;Middle Aged;Plant Extracts/adverse effects;Platelet Aggregation Inhibitors/adverse effects*;Self Medication/adverse effects*;Stroke/complications;Subtilisins/adverse effects*;Thrombosis/prevention & control;Tomography, X-Ray Computed
18310083;Amino Acid Sequence;DNA, Complementary/genetics;Flavonoids/chemistry*;Flavonoids/metabolism*;Gene Expression Regulation, Plant;Glycosyltransferases/genetics;Glycosyltransferases/metabolism*;Herb-Drug Interactions/genetics;Molecular Sequence Data;Phylogeny;Plant Proteins/genetics;Plant Proteins/metabolism*;Plasmids;Seeds/enzymology*;Soybeans/enzymology*;Substrate Specificity
18296885;Administration, Oral;Animals;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Ginger;Goats/metabolism*;Herb-Drug Interactions;Pefloxacin/administration & dosage*;Pefloxacin/blood;Pefloxacin/pharmacokinetics*;Phytotherapy/veterinary*;Piper;Piper nigrum;Plant Extracts/pharmacology*
18286859;Drug Contamination/statistics & numerical data;Drug Information Services;Drug and Narcotic Control;Evidence-Based Medicine;Health Knowledge, Attitudes, Practice;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Internet;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods;Phytotherapy/psychology;Phytotherapy/utilization*;Psoriasis/prevention & control*;Psoriasis/psychology;Safety;Self Medication/methods;Self Medication/psychology;Self Medication/statistics & numerical data*;Treatment Outcome;United States;United States Food and Drug Administration
18272627;Acetaminophen/adverse effects;Analgesics, Non-Narcotic/adverse effects;Antioxidants/adverse effects;Antioxidants/therapeutic use*;Chemical and Drug Induced Liver Injury*/etiology*;Hemochromatosis/therapy*;Herb-Drug Interactions*;Humans;Milk Thistle/adverse effects*;Phytotherapy/adverse effects*;Protective Agents/adverse effects;Protective Agents/therapeutic use*;Silymarin/adverse effects;Silymarin/therapeutic use*
18272626;Acetaminophen/adverse effects;Acetaminophen/metabolism;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/metabolism;Aspartame/adverse effects;Aspartame/metabolism;Hemochromatosis/chemically induced*;Hemochromatosis/diagnosis;Herb-Drug Interactions*;Humans;Liver Function Tests*;Milk Thistle/adverse effects*;Milk Thistle/metabolism;Sweetening Agents/adverse effects;Sweetening Agents/metabolism
18269091;Animals;Anti-Bacterial Agents/therapeutic use;Anti-Inflammatory Agents/therapeutic use;Gastrointestinal Agents/therapeutic use;Ginger*/adverse effects;Heart Diseases/prevention & control;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects
18261389;Algorithms;Drug Interactions*;Herb-Drug Interactions*;Humans;Phytotherapy*;Probability;Risk Factors
18260050;Animals;Antibiotics, Antineoplastic/adverse effects;Cardiomyopathies/chemically induced;Cardiomyopathies/drug therapy*;Cardiomyopathies/pathology;Cardiotonic Agents/analysis*;Cell Line, Tumor;Doxorubicin/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Humans;Male;Mice;Mice, Inbred ICR;Myocardium/pathology;Panax notoginseng/chemistry*;Phytotherapy*;Random Allocation;Rhizome/chemistry;Saponins/therapeutic use*
18251040;Adult;Alkaloids/adverse effects*;Anesthesia/methods;Anesthesia Recovery Period*;Anesthesia, Spinal;Catha/adverse effects*;Central Nervous System Stimulants/adverse effects;Disorders of Excessive Somnolence/chemically induced*;Dose-Response Relationship, Drug;Electrocardiography;Female;Herb-Drug Interactions*;Humans;Male;Monitoring, Physiologic/methods;Plant Leaves/adverse effects*;Recovery of Function/drug effects;Smoking
18236826;Anti-Retroviral Agents/pharmacology;Anticoagulants/pharmacology;Cardiovascular Agents/pharmacology;Chronic Disease;Dietary Supplements*;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacology;Phytotherapy*;Risk Factors
18223469;Animals;Bufanolides/blood*;Cross Reactions;Digoxin/blood*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/analysis*;False Negative Reactions;False Positive Reactions;Fluorescence Polarization;Herb-Drug Interactions;Humans;Immunoassay;Mice;Sensitivity and Specificity
18214851;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Clinical Trials as Topic;Ginkgo biloba/adverse effects*;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacology*;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Reproducibility of Results
18214850;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Clarithromycin/pharmacology*;Dietary Supplements;Digoxin/blood*;Digoxin/pharmacokinetics;Echinacea/metabolism*;Flavonoids/pharmacology;Ginkgo biloba;Herb-Drug Interactions*;Hypericum/metabolism*;Rifampin/pharmacology*
18214849;Cimicifuga/metabolism;Cytochrome P-450 CYP2D6/metabolism*;Dietary Supplements;Echinacea/metabolism;Herb-Drug Interactions*;Humans;Hydrastis/adverse effects*;Hydrastis/metabolism;Hypericum/metabolism;Kava/metabolism;Milk Thistle/metabolism;Phytotherapy*;Plant Extracts/pharmacology*
18204476;Adult;Alleles;Area Under Curve;Aryl Hydrocarbon Hydroxylases/genetics*;Blood Glucose/drug effects;Cross-Over Studies;Cytochrome P-450 CYP2C9;Female;Genotype;Gliclazide/pharmacokinetics*;Gliclazide/pharmacology;Half-Life;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Insulin/blood;Male;Plant Extracts/pharmacology*;Polymerase Chain Reaction;Restriction Mapping
18204358;Anxiety/drug therapy;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Herb-Drug Interactions*;Humans;Phytotherapy;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/therapeutic use;Sleep Initiation and Maintenance Disorders/drug therapy
18204104;Animals;Evidence-Based Medicine;Female;Fetus/drug effects;Herb-Drug Interactions;Humans;Lactation*;Panax*/chemistry;Plant Extracts/adverse effects*;Plant Extracts/chemistry;Plant Extracts/toxicity;Pregnancy;Rhizome;Risk Assessment
18204103;Animals;Evidence-Based Medicine;Female;Fruit;Herb-Drug Interactions;Humans;Lactation*;Plant Preparations/adverse effects*;Plant Preparations/chemistry;Plant Preparations/toxicity;Pregnancy;Pregnancy Complications, Infectious/drug therapy*;Risk Assessment;Urinary Tract Infections/drug therapy*;Vaccinium macrocarpon*/chemistry
18204102;Abortion, Spontaneous/prevention & control;Animals;Evidence-Based Medicine;Female;Fruit;Herb-Drug Interactions;Humans;Lactation/drug effects*;Menstruation/drug effects;Menstruation-Inducing Agents/adverse effects*;Menstruation-Inducing Agents/chemistry;Menstruation-Inducing Agents/toxicity;Oxytocics/adverse effects*;Oxytocics/chemistry;Oxytocics/toxicity;Phytoestrogens/adverse effects*;Phytoestrogens/chemistry;Phytoestrogens/toxicity;Plant Preparations/adverse effects*;Plant Preparations/chemistry;Plant Preparations/toxicity;Pregnancy;Receptors, Estrogen/drug effects;Receptors, Progesterone/drug effects;Risk Assessment;Uterine Contraction/drug effects;Vitex*/chemistry
18204101;Animals;Caulophyllum*/chemistry;Evidence-Based Medicine;Female;Fetus/drug effects*;Herb-Drug Interactions;Humans;Lactation*;Midwifery;Oxytocics/adverse effects*;Oxytocics/chemistry;Oxytocics/toxicity;Plant Preparations/adverse effects*;Plant Preparations/chemistry;Plant Preparations/toxicity;Pregnancy;Rhizome;Risk Assessment;United States;Uterine Contraction/drug effects*
18184982;Attitude of Health Personnel*;Canada;Clinical Competence*;Data Collection;Female;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;Internship and Residency*;Male;Medical History Taking;Phytotherapy/adverse effects;Phytotherapy/utilization*;Pilot Projects;Plant Preparations/therapeutic use*;Program Evaluation;Students, Medical*;Surveys and Questionnaires
18179003;Adjuvants, Anesthesia/pharmacology;Anesthesia, General;Anesthetics, Inhalation/pharmacology*;Animals;Herb-Drug Interactions*;Isoflurane/pharmacology*;Male;Midazolam/pharmacology;Nurse Anesthetists;Plant Preparations/pharmacology*;Rats;Rats, Sprague-Dawley;Time Factors;Valerian*
22436099;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Curcuma/chemistry*;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Nifedipine/blood;Nifedipine/pharmacokinetics*;Phytotherapy;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Reference Values;Young Adult
18090773;Adult;Aged;Aged, 80 and over;Aspirin/pharmacology;Blood Coagulation/drug effects*;Blood Coagulation Tests;Blood Platelets/drug effects*;Female;Garlic/adverse effects;Ginkgo biloba/adverse effects;Hemorrhagic Disorders/chemically induced;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Male;Middle Aged;Panax/adverse effects;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plant Preparations/adverse effects;Plant Preparations/pharmacology*;Platelet Function Tests;Postoperative Hemorrhage/chemically induced;Serenoa/adverse effects;Single-Blind Method
18081572;Adult;Aged;Alcohol Drinking*;Australia;Complementary Therapies*;Drug Prescriptions*;Drug-Related Side Effects and Adverse Reactions*;Ethanol/pharmacology*;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Nonprescription Drugs*;Pharmaceutical Preparations;Risk Assessment
18077884;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;United States;United States Food and Drug Administration
20014671;Alcoholic Beverages/adverse effects;Calcium, Dietary/adverse effects;Citrus paradisi/adverse effects;Dietary Fiber/adverse effects;Dietary Proteins/adverse effects;Drug Prescriptions/nursing;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Nurse Practitioners/organization & administration*;Patient Education as Topic/organization & administration;Safety Management;Vitamin K/adverse effects
18045358;Administration, Topical;Complementary Therapies;Cosmetics/pharmacology*;Dermatologic Agents/administration & dosage;Esthetics;Female;Herb-Drug Interactions;Humans;Male;Patient Satisfaction;Phytotherapy/methods*;Plant Extracts/administration & dosage*;Skin Aging/drug effects*;Skin Aging/physiology;Skin Care/methods;Treatment Outcome
18043467;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*
17992210;Dietary Supplements/adverse effects;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions;Humans;Polypharmacy
17978084;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/economics;Acquired Immunodeficiency Syndrome/virology;Adolescent;Adult;Antiretroviral Therapy, Highly Active/methods*;Cross-Sectional Studies;Herb-Drug Interactions*;Humans;Medicine, African Traditional*;Middle Aged;Phytotherapy/methods*;Uganda
17971406;Community Pharmacy Services*;Herb-Drug Interactions*;Humans;Pharmacists*;Plant Preparations/adverse effects
17969314;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans
17968815;Administration, Oral;Adult;Area Under Curve;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Half-Life;Herb-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage*;Nifedipine/blood;Nifedipine/pharmacokinetics*;Silymarin/pharmacology*;Time Factors
17961271;Dietary Supplements/standards*;Drug Interactions;Drug Labeling*;European Union;Herb-Drug Interactions;Humans;Legislation, Drug*;Nutrition Policy*;Quality Control
17941846;ATP Binding Cassette Transporter, Sub-Family B/drug effects;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Anticonvulsants/metabolism;Anticonvulsants/pharmacokinetics*;Anticonvulsants/therapeutic use;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Epilepsy/drug therapy*;Epilepsy/metabolism;Herb-Drug Interactions;Humans;Neurotoxins/adverse effects;Neurotoxins/metabolism;Phytotherapy/methods*;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics*;Plant Preparations/therapeutic use;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry;Plants, Medicinal/metabolism;Seizures/chemically induced*;Seizures/metabolism
17934030;Acetaminophen/administration & dosage*;Administration, Oral;Aged;Drug Therapy, Combination;Female;Ferritins/blood;Hemochromatosis/blood;Hemochromatosis/chemically induced*;Hemochromatosis/diagnosis;Hemochromatosis/therapy;Herb-Drug Interactions;Humans;Milk Thistle/adverse effects*;Phlebotomy;Phytotherapy/adverse effects*;Treatment Outcome
17925494;Adult;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements;Drug Administration Schedule;Glucocorticoids/blood;Glucocorticoids/pharmacokinetics*;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Male;Plant Preparations/pharmacology*;Plants, Medicinal;Prednisolone/blood;Prednisolone/pharmacokinetics*;Prednisone/blood;Prednisone/metabolism;Prednisone/pharmacokinetics*
17908423;Anticoagulants/adverse effects*;Dental Care for Chronically Ill*;Garlic/adverse effects;Ginger/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Panax/adverse effects;Plant Preparations/adverse effects*;Platelet Aggregation Inhibitors/adverse effects*;Postoperative Hemorrhage/chemically induced*;Postoperative Hemorrhage/prevention & control;Substance Withdrawal Syndrome*
17906915;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects;Registries
17900071;Aged/psychology*;Aged/statistics & numerical data;Anthropology, Cultural;Communication;Emigration and Immigration;Ethnopharmacology*/methods;Health Knowledge, Attitudes, Practice;Health Services Accessibility;Herb-Drug Interactions;Humans;Nurse's Role;Nurse-Patient Relations;Nursing Methodology Research;Patient Acceptance of Health Care/ethnology*;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods;Phytotherapy/psychology*;Polypharmacy;Qualitative Research;Russia/ethnology;Self Medication/adverse effects;Self Medication/methods;Self Medication/psychology*;Surveys and Questionnaires;Washington
17900036;Antineoplastic Agents/toxicity;Antioxidants/therapeutic use*;Chemotherapy, Adjuvant/adverse effects;Combined Modality Therapy;Dietary Supplements*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/radiotherapy;Radiation-Protective Agents/therapeutic use*;Radiotherapy/adverse effects;Radiotherapy, Adjuvant/adverse effects;Vitamins/therapeutic use*
17883958;2-Pyridinylmethylsulfinylbenzimidazoles/blood;Adult;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/metabolism;Anti-Ulcer Agents/pharmacokinetics;Area Under Curve;Artemisia/chemistry;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Drug Combinations;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacology*;Genotype;Herb-Drug Interactions;Humans;Hydroxylation/drug effects;Male;Omeprazole/analogs & derivatives;Omeprazole/blood;Omeprazole/metabolism;Omeprazole/pharmacokinetics*;Plants, Medicinal/chemistry;Safrole/analogs & derivatives;Safrole/metabolism
17877962;Animals;Antineoplastic Agents/metabolism;Antineoplastic Agents/therapeutic use;Breast Neoplasms/drug therapy;Breast Neoplasms/psychology;Breast Neoplasms/therapy*;Complementary Therapies*/adverse effects;Complementary Therapies*/statistics & numerical data;Complementary Therapies*/utilization;Denmark;Female;Herb-Drug Interactions;Humans;Quality of Life;Risk Factors;Treatment Outcome
17876860;Adrenergic beta-Agonists/metabolism*;Arylsulfotransferase/drug effects*;Arylsulfotransferase/metabolism;Beverages*;Biflavonoids/pharmacology;Biological Availability;Catechin/analogs & derivatives;Catechin/pharmacology;Citrus paradisi/chemistry;Citrus sinensis/chemistry;Flavanones/pharmacology;Flavones/pharmacology;Herb-Drug Interactions;Humans;In Vitro Techniques;Phenols/pharmacology;Polyphenols;Quercetin/pharmacology;Sulfotransferases/drug effects*;Sulfotransferases/metabolism;Tea/chemistry
17846096;Dietary Supplements/adverse effects*;Dietary Supplements/utilization;Herb-Drug Interactions;Humans;Palliative Care/methods*;Phytotherapy*;Terminally Ill/psychology
17785609;Aged;Complementary Therapies/adverse effects*;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions*;Female;Hemorrhage/chemically induced;Hemorrhage/epidemiology;Herb-Drug Interactions*/physiology;Humans;Male;Medicare/trends*;Pharmaceutical Preparations/metabolism;Phytotherapy/adverse effects;Plant Extracts/adverse effects;Plant Extracts/metabolism;Plant Preparations/adverse effects;Plant Preparations/metabolism;Retrospective Studies;Risk Factors;Washington
17766652;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Drug Interactions*;Herb-Drug Interactions*;Humans
17761132;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/therapeutic use*;Antioxidants/adverse effects;Antioxidants/therapeutic use*;Clinical Trials as Topic*;Complementary Therapies*;Dietary Supplements*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/diet therapy;Neoplasms/drug therapy*;Plants, Medicinal/adverse effects*
17761130;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Dietary Supplements*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/diet therapy;Neoplasms/drug therapy*;Prevalence;Risk Factors
17723921;Chemical and Drug Induced Liver Injury*;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*
17723077;Acetaminophen/adverse effects;Adult;Age Factors;Aged;Aged, 80 and over;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Canada;Coenzymes/adverse effects;Complementary Therapies/adverse effects*;Diarrhea/complications;Dietary Supplements/adverse effects;Drug Interactions;Ethanol/adverse effects;Female;Ginger/adverse effects;Hemorrhage/chemically induced*;Herb-Drug Interactions*;Humans;International Normalized Ratio;Longitudinal Studies;Male;Middle Aged;Phytotherapy/adverse effects;Plants, Medicinal/adverse effects;Prospective Studies;Risk Factors;Ubiquinone/adverse effects;Ubiquinone/analogs & derivatives;Vitamins/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
17706549;Animals;Drug Design*;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions*;Humans;Models, Biological;Pharmaceutical Preparations/chemistry;Plant Preparations/adverse effects;Plant Preparations/chemistry;Technology, Pharmaceutical/methods*;Technology, Pharmaceutical/trends
17704986;Drug Approval*;Drug Industry*/standards;Germany;Herb-Drug Interactions*;Humans;Phytotherapy*;Plant Extracts/pharmacology*
17701167;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Aged;Atorvastatin Calcium;Cholesterol/blood;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis;Enzyme Induction;Female;Heptanoic Acids/pharmacokinetics;Heptanoic Acids/therapeutic use*;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hypercholesterolemia/blood;Hypercholesterolemia/drug therapy*;Hypericum*;Intestines/drug effects*;Intestines/enzymology;Intestines/metabolism;Liver/drug effects*;Liver/enzymology;Male;Middle Aged;Plant Preparations/pharmacology*;Pyrroles/pharmacokinetics;Pyrroles/therapeutic use*;Time Factors;Treatment Outcome;Triglycerides/blood;Up-Regulation
17684737;Area Under Curve;Drug Interactions*;Herb-Drug Interactions;Humans;Models, Biological;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Pharmacology*;Risk Assessment;Therapeutic Equivalency
17681658;Administration, Oral;Animals;Area Under Curve;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Ginkgo biloba*;Herb-Drug Interactions;Injections, Intravenous;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
17666620;Anticoagulants/therapeutic use;Female;Gynecologic Surgical Procedures/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use;Herb-Drug Interactions;Humans;Intermittent Pneumatic Compression Devices;Postoperative Complications/prevention & control*;Pulmonary Embolism/prevention & control*;Stockings, Compression;Venous Thrombosis/prevention & control*
17640426;Anticoagulants/adverse effects*;Blood Coagulation Disorders/chemically induced*;Dietary Supplements/adverse effects*;Female;Herb-Drug Interactions*;Humans;Intraoperative Complications/chemically induced*;Male;Otorhinolaryngologic Surgical Procedures*;Patient Education as Topic/methods;Risk Factors
17633503;Echinacea;Ginkgo biloba;Herb-Drug Interactions;Herbal Medicine/education;Herbal Medicine/methods*;Humans;Nonprescription Drugs/therapeutic use;Nurse's Role;Nursing Assessment;Panax;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/nursing*;Safety Management;Self Medication
17616997;Acecainide/pharmacokinetics;Animals;Biological Availability;Female;Herb-Drug Interactions*;Hypericum*;Mice;Perylene/analogs & derivatives;Perylene/pharmacology;Procainamide/pharmacokinetics*
17611934;Cytochrome P-450 Enzyme System/metabolism*;Ginkgo biloba;Herb-Drug Interactions;Humans;Hydrastis;In Vitro Techniques;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Milk Thistle;Panax;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plant Leaves;Plant Roots;Plants, Medicinal*;Rhizome;Seeds;Vitis
17594986;Adult;Biological Transport;Breath Tests;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology*;Erythromycin;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Plant Extracts/pharmacology
17591018;Animals;Chemical and Drug Induced Liver Injury;Complementary Therapies*/adverse effects;Complementary Therapies*/classification;Complementary Therapies*/economics;Costs and Cost Analysis;Drug Evaluation, Preclinical;Global Health;Health Surveys;Hepatitis B, Chronic/therapy*;Hepatitis C, Chronic/therapy*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/economics;Plant Preparations/adverse effects
17581220;Adult;Aged;Blotting, Western;Cells, Cultured;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Dose-Response Relationship, Drug;Drugs, Chinese Herbal/pharmacology*;Enzyme Induction/drug effects;Female;Ginkgolides/pharmacology*;Hepatocytes/drug effects*;Hepatocytes/enzymology;Herb-Drug Interactions;Humans;Hydroxylation;Lactones/pharmacology*;Male;Middle Aged;Phenobarbital/pharmacology;Quercetin/pharmacology;Rifampin/pharmacology;Testosterone/metabolism
17578882;Adult;Biological Products/adverse effects*;Biological Products/metabolism;Community Pharmacy Services*/standards;Female;Herb-Drug Interactions*/physiology;Humans;Male;Middle Aged;Pharmacists*/standards
17575287;Animals;Endometriosis/drug therapy*;Female;Herb-Drug Interactions;Humans;Mice;Phytotherapy*;Plant Preparations/therapeutic use*;Plants, Medicinal/chemistry*
17545337;Asthma/drug therapy;Breast Feeding;Child;Clinical Trials as Topic;Female;Herb-Drug Interactions;Humans;Migraine Disorders/prevention & control;Petasites*;Phytotherapy*;Plant Extracts/therapeutic use*;Pregnancy;Rhinitis, Allergic, Seasonal/drug therapy
17538868;Administration, Oral;Echinacea*;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/blood;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics*;Polyunsaturated Alkamides/administration & dosage;Polyunsaturated Alkamides/blood;Polyunsaturated Alkamides/chemistry;Polyunsaturated Alkamides/pharmacokinetics;Receptors, Cannabinoid/metabolism
17511128;Adult;Aged;Anesthetics/adverse effects;Female;Herb-Drug Interactions*;Humans;Internet;Male;Marketing;Middle Aged;Pharmaceutical Preparations, Dental/adverse effects*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*;Surveys and Questionnaires
17495878;Adult;Clarithromycin/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements*;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology*;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Kava*;Male;Midazolam/pharmacokinetics*;Models, Biological;Phenotype;Plant Preparations/pharmacology*;Rifampin/pharmacology;Risk Assessment;Substrate Specificity
17480135;Aging;Alzheimer Disease/drug therapy*;Antioxidants/therapeutic use;Biomedical Research/organization & administration;Cognition Disorders/drug therapy;Herb-Drug Interactions;Humans;Phytotherapy/methods*;Plant Extracts/therapeutic use;Plants, Medicinal*
17477088;Acenocoumarol/administration & dosage*;Acenocoumarol/adverse effects;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Chronic Disease;Drug Administration Schedule;Drug Interactions;Educational Measurement;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;International Normalized Ratio;Patient Education as Topic/statistics & numerical data*;Poland;Self Care/psychology;Self Care/statistics & numerical data;Surveys and Questionnaires;Venous Thrombosis/drug therapy*
17464162;Cimicifuga/chemistry*;Female;Herb-Drug Interactions;Humans;Menopause*;Middle Aged;Phytotherapy*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Receptors, Estrogen/drug effects*
17425631;Attitude of Health Personnel;Dietary Supplements/utilization*;Empirical Research;Female;Herb-Drug Interactions;Humans;Inpatients/psychology*;Internal Medicine;Israel;Male;Middle Aged;Phytotherapy/utilization*
17405678;Antineoplastic Agents/toxicity;Antioxidants/therapeutic use*;Chemotherapy, Adjuvant/adverse effects;Combined Modality Therapy;Dietary Supplements*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/radiotherapy;Radiation-Protective Agents/therapeutic use*;Radiotherapy/adverse effects;Radiotherapy, Adjuvant/adverse effects;Randomized Controlled Trials as Topic;Survival Analysis;Vitamins/therapeutic use*
17405676;Adult;Aged;Aged, 80 and over;Female;Herb-Drug Interactions*;Humans;Materia Medica/adverse effects*;Middle Aged;Narration;Nonprescription Drugs/adverse effects*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plants, Medicinal/adverse effects*;Surveys and Questionnaires;United States
17400821;Chamomile*;Colic/prevention & control*;Conjunctivitis/chemically induced;Cyclosporine/pharmacology;Dermatitis/prevention & control*;Dermatitis, Contact/etiology;Diarrhea/prevention & control*;Dyspepsia/prevention & control*;Female;Flowers;Herb-Drug Interactions;Humans;Infant;Lactation;Morning Sickness/drug therapy;Phytotherapy*/adverse effects;Plant Extracts/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/therapeutic use*;Pregnancy;Warfarin/pharmacology
17363091;Angioplasty, Balloon, Coronary;Animals;Cardiovascular Diseases/drug therapy*;Diabetes Complications/prevention & control;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Hyperlipidemias/drug therapy;Kidney Diseases/prevention & control;Myocardial Reperfusion Injury/prevention & control;Panax;Peripheral Vascular Diseases/drug therapy;Salvia miltiorrhiza*
17353348;Allyl Compounds/pharmacology*;Animals;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P-450 CYP2B1/genetics;Cytochrome P-450 CYP2B6;Cytochrome P450 Family 2;Disulfides/pharmacology;Female;Herb-Drug Interactions;Humans;Liver/drug effects*;Liver/metabolism;Male;Mice;Mice, Inbred C57BL;Mice, Transgenic;NAD(P)H Dehydrogenase (Quinone)/genetics;NADPH Dehydrogenase/genetics;NF-E2-Related Factor 2/deficiency;NF-E2-Related Factor 2/genetics*;Oxidoreductases, N-Demethylating/genetics;RNA, Messenger/metabolism;Rats;Rats, Wistar;Receptors, Cytoplasmic and Nuclear/deficiency;Receptors, Cytoplasmic and Nuclear/genetics*;Steroid Hydroxylases/genetics;Sulfides/pharmacology*;Transcription Factors/deficiency;Transcription Factors/genetics*
17340748;Alopecia/chemically induced;Antineoplastic Agents/adverse effects*;Appetite/drug effects;Brain/drug effects;Complementary Therapies*/adverse effects;Depression/prevention & control;Diarrhea/chemically induced;Diarrhea/prevention & control;Exercise;Fatigue/chemically induced;Fatigue/prevention & control;Herb-Drug Interactions;Humans;Middle Aged;Nausea/chemically induced;Nausea/prevention & control;Oral Ulcer/chemically induced;Oral Ulcer/prevention & control;Vomiting/chemically induced;Vomiting/prevention & control
17312476;Dietary Supplements*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Preparations*/adverse effects;Postoperative Complications/chemically induced*;Surgery, Plastic*;Vitamins*/adverse effects
17299847;Dementia/prevention & control*;Ginkgo biloba*/adverse effects;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects;Phytotherapy/methods*
17297618;Adult;Arylamine N-Acetyltransferase/drug effects;Arylamine N-Acetyltransferase/metabolism*;Caffeine/pharmacology;Central Nervous System Stimulants/pharmacology;Cytochrome P-450 CYP2D6/drug effects*;Cytochrome P-450 CYP2D6/genetics;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions*;Humans;Male;Xanthine Oxidase/drug effects;Xanthine Oxidase/metabolism*
17290064;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/therapeutic use*;Attitude to Health*;Chicago;Clinical Trials, Phase I as Topic/methods*;Complementary Therapies*;Decision Making*;Dietary Supplements;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/psychology;Neoplasms/therapy;Patient Participation;Patients/psychology*;Plant Preparations/therapeutic use;Prognosis;Quality of Life;Surveys and Questionnaires;Treatment Outcome;Vitamins/therapeutic use
17284505;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Chromatography, High Pressure Liquid;Drug Administration Schedule;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Ibuprofen/administration & dosage;Ibuprofen/blood;Ibuprofen/pharmacokinetics*;Male;Plant Preparations/administration & dosage;Plant Preparations/isolation & purification;Plant Preparations/pharmacology*
17270371;Caco-2 Cells;Calcitriol/pharmacology*;Cell Survival/drug effects;Curcuma*/chemistry;Curcumin/analysis;Curcumin/pharmacology*;Curcumin/toxicity;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Dose-Response Relationship, Drug;Enzyme Induction/drug effects;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology*;Enzyme Inhibitors/toxicity;Herb-Drug Interactions*;Humans;Hydroxylation;Inhibitory Concentration 50;Intestinal Mucosa/drug effects*;Intestinal Mucosa/enzymology;Intestinal Mucosa/pathology;Ketoconazole/pharmacology;Nifedipine/metabolism;Oxidation-Reduction;Plant Extracts/chemistry;Plant Extracts/pharmacology;RNA, Messenger/metabolism;Rhizome;Rifampin/pharmacology;Testosterone/metabolism
17267149;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Antineoplastic Agents, Phytogenic/administration & dosage*;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Genistein/administration & dosage;Genistein/metabolism;Genistein/pharmacology*;Herb-Drug Interactions*;Injections, Intravenous;Male;Metabolic Clearance Rate/drug effects;Nonprescription Drugs*;Paclitaxel/administration & dosage*;Paclitaxel/blood;Paclitaxel/pharmacokinetics*;Phytoestrogens/administration & dosage;Phytoestrogens/metabolism;Phytoestrogens/pharmacology*;Rats;Rats, Sprague-Dawley
17266896;Adverse Drug Reaction Reporting Systems;Drug Information Services*;Drug Interactions*;Drug Labeling*;European Union;Herb-Drug Interactions*;Humans;Hypericum/metabolism;Plants, Medicinal/metabolism;Spain
17243855;Aged;Analgesics, Opioid/therapeutic use;Dizziness/etiology;Herb-Drug Interactions*;Humans;Hypotension, Orthostatic/etiology;Male;Methadone/therapeutic use;Osteoarthritis/drug therapy;Pain/drug therapy;Plants, Medicinal/adverse effects*;Polypharmacy
17243519;Adolescent;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Female;Health Care Surveys;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Herbal Medicine*;Humans;Malaysia;Male;Middle Aged;Patient Acceptance of Health Care/ethnology;Patient Acceptance of Health Care/statistics & numerical data*;Pharmaceutical Preparations;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Plants, Medicinal*;Surveys and Questionnaires
17240097;Asparagus Plant/growth & development*;Conservation of Natural Resources;Herb-Drug Interactions;Humans;Medicine, Ayurvedic*;Phytotherapy/methods*;Plants, Medicinal;Systems Biology
17225526;Adenosine Triphosphate/pharmacology*;Animals;Ephedrine/pharmacology*;Female;Herb-Drug Interactions;Male;Nasal Mucosa/drug effects*;Rats;Rats, Sprague-Dawley
17169523;Adrenergic beta-Antagonists;Adult;Age Factors;Aged;Anesthetics/pharmacology;Angiotensin II Type 1 Receptor Blockers;Angiotensin-Converting Enzyme Inhibitors;Drug Utilization/statistics & numerical data*;Echinacea;Ephedra;Female;France;Ginkgo biloba;Health Surveys;Herb-Drug Interactions;Humans;Hypericum;Male;Medical History Taking*;Middle Aged;Panax;Phytotherapy/utilization*;Plant Preparations/pharmacology;Platelet Aggregation Inhibitors;Preoperative Care*;Prospective Studies;Sex Factors;Valerian
17168768;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biotransformation;Cytochrome P-450 Enzyme System/metabolism;Drug Design*;Drug Evaluation, Preclinical;Drug Monitoring;Drug-Related Side Effects and Adverse Reactions/prevention & control*;Herb-Drug Interactions*;Humans;Models, Biological;Pharmaceutical Preparations/metabolism*;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*
17156416;Adult;Aged;Cross-Sectional Studies;England;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Herbal Medicine*;Humans;Middle Aged;Narration;Nonprescription Drugs/therapeutic use*;Physician-Patient Relations*;Sampling Studies;Surveys and Questionnaires;Tea;Women's Health*
17125440;Adult;Age Factors;Clinical Trials as Topic/statistics & numerical data*;Complementary Therapies/utilization*;Confounding Factors (Epidemiology);Drug Interactions*;Female;Herb-Drug Interactions;Humans;Male;Minerals/administration & dosage;Plant Preparations/administration & dosage;Prospective Studies;Research Subjects*;Sex Factors;Vitamins/administration & dosage
17116126;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors
17096679;Adult;Aged;Female;Herb-Drug Interactions*;Hospitalization*;Humans;Male;Phytotherapy/adverse effects*
17094523;Anesthetics*/adverse effects;Government Regulation;Herb-Drug Interactions*;Humans;Patient Education as Topic;Phytotherapy*/adverse effects
17093003;Complementary Therapies;Cytochrome P-450 Enzyme Inhibitors*;Dietary Supplements*;Herb-Drug Interactions*
17085776;Animals;Female;Ginkgo biloba*;Herb-Drug Interactions;Humans;Lactation*;Lethal Dose 50;Plant Leaves;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Plant Preparations*/toxicity;Platelet Aggregation Inhibitors*/adverse effects;Platelet Aggregation Inhibitors*/chemistry;Platelet Aggregation Inhibitors*/pharmacology;Platelet Aggregation Inhibitors*/therapeutic use;Platelet Aggregation Inhibitors*/toxicity;Postpartum Hemorrhage/chemically induced;Pregnancy*;Risk Assessment;Seeds
17085775;Animals;Female;Herb-Drug Interactions;Humans;Hypericum*/adverse effects;Lactation*;Photosensitivity Disorders/chemically induced;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Pregnancy*;Risk Assessment
17085774;Administration, Oral;Animals;Echinacea*/adverse effects;Female;Herb-Drug Interactions;Humans;Lactation*;Lethal Dose 50;Plant Leaves;Plant Preparations*/administration & dosage;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Plant Preparations*/toxicity;Plant Roots;Plant Stems;Pregnancy*;Risk Assessment
17085773;Cimicifuga*;Female;Herb-Drug Interactions;Humans;Lactation*;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Pregnancy*;Receptors, Estrogen/drug effects;Rhizome;Risk Assessment;Uterine Contraction/drug effects;Uterus/drug effects*
17084954;Animals;Antioxidants/administration & dosage;Antioxidants/pharmacology*;Antioxidants/therapeutic use;Beverages*;Carbon Tetrachloride;Chemical and Drug Induced Liver Injury/etiology;Chemical and Drug Induced Liver Injury/prevention & control;Cytochrome P-450 CYP2E1/metabolism;Female;Herb-Drug Interactions;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred BALB C;Phytotherapy*;Salvia officinalis*
17079360;Adult;Cardiotonic Agents/pharmacokinetics*;Clarithromycin/pharmacology;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Digoxin/pharmacokinetics*;Drug Interactions;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Kava*;Male;Rifampin/pharmacology
17077621;Adjuvants, Pharmaceutic;Aluminum;Animals;Biological Availability;Drugs, Chinese Herbal/chemistry;Drugs, Chinese Herbal/pharmacology*;Gastrointestinal Agents/chemistry;Gastrointestinal Agents/pharmacology*;Herb-Drug Interactions*;Levodopa/pharmacokinetics*;Magnesium;Male;Medicine, Kampo;Nonprescription Drugs;Rats;Rats, Wistar
17050802;Adult;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Ginger;Ginkgo biloba;Health;Herb-Drug Interactions/physiology*;Herbal Medicine*;Humans;Hypericum;Male;Models, Biological*;Panax;Plant Extracts/pharmacology;Warfarin/pharmacokinetics*;Warfarin/pharmacology*
17049775;Animals;Carbon Tetrachloride/toxicity*;Carbon Tetrachloride Poisoning/prevention & control;Dose-Response Relationship, Drug;Enzymes/drug effects;Enzymes/metabolism;Female;Gallic Acid/pharmacology*;Glutathione/metabolism;Glycogen/metabolism;Herb-Drug Interactions;Kidney/drug effects;Kidney/metabolism;Kidney/pathology;Lipid Peroxidation/drug effects;Liver/drug effects;Liver/metabolism;Liver/pathology;Medicine, Ayurvedic;Plant Extracts/pharmacology*;Protective Agents/chemistry;Protective Agents/pharmacology*;Proteins/drug effects;Proteins/metabolism;Rats;Rats, Sprague-Dawley;Silymarin/pharmacology;Terminalia/chemistry*
17038845;Dietary Supplements/adverse effects*;Drug Monitoring;Gastroenterology;Guidelines as Topic;Herb-Drug Interactions;Humans;Medical History Taking/methods*;Nonprescription Drugs/adverse effects*;Nurse's Role;Nursing Assessment/methods*;Nutrition Policy;Patient Education as Topic;Phytotherapy/adverse effects*;Phytotherapy/nursing;Self Medication/adverse effects;Self Medication/nursing
17036225;Child;Complementary Therapies*;Dietary Supplements;Herb-Drug Interactions;Humans;Mind-Body Therapies;Neoplasms/therapy*;Phytotherapy
17030295;Adult;Antiretroviral Therapy, Highly Active/utilization*;British Columbia/epidemiology;Cohort Studies;Complementary Therapies/utilization*;Cross-Sectional Studies;Female;HIV Infections/drug therapy;HIV Infections/epidemiology;HIV Infections/therapy*;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Patient Education as Topic/organization & administration;Socioeconomic Factors;Surveys and Questionnaires
17030294;Adult;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Cross-Sectional Studies;Female;Garlic/adverse effects;Ginkgo biloba/adverse effects;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Malaysia;Male;Middle Aged;Panax/adverse effects;Phytotherapy/adverse effects*;Plants, Medicinal/adverse effects;Platelet Aggregation Inhibitors/administration & dosage*;Surveys and Questionnaires
17023070;Anticoagulants/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Warfarin/adverse effects*
17015952;Animals;Beverages;Citrus paradisi*;Cytochrome P-450 CYP3A Inhibitors;Herb-Drug Interactions*;Male;Medicine, Kampo*;Nifedipine/pharmacokinetics*;Rats;Schisandra*
17010103;Adult;Aged;Clinical Trials as Topic;Cytochrome P-450 CYP3A/metabolism*;Female;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Male;Middle Aged;Plant Extracts/metabolism*;Plant Extracts/pharmacology*;Prospective Studies
17010102;Cross-Over Studies;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/pharmacology*;Platelet Function Tests/methods*;Tetrazoles/pharmacology*;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacology
17001360;Herb-Drug Interactions*;Humans
16988208;Administration, Oral;Adult;Area Under Curve;Benzazepines/administration & dosage;Benzazepines/blood;Benzazepines/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis;Electrocardiography;Female;Gastrointestinal Tract/metabolism;Half-Life;Headache/chemically induced;Heart Rate/drug effects;Herb-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives;Hydrocortisone/urine;Hypericum/chemistry*;Male;Metabolic Clearance Rate;Perylene/analogs & derivatives;Perylene/metabolism;Plant Preparations/administration & dosage;Plant Preparations/blood;Plant Preparations/pharmacokinetics*;Tablets
16983620;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Anti-Retroviral Agents/pharmacokinetics*;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Glucuronosyltransferase/metabolism;Herb-Drug Interactions*;Humans;Plant Extracts/pharmacokinetics;Plants, Medicinal*
16979090;Aged;Alkaloids;Cholinesterase Inhibitors/adverse effects;Dementia/therapy;Evidence-Based Medicine;Galantamine/adverse effects;Geriatric Assessment/methods*;Geriatrics/education;Geriatrics/methods;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Medical History Taking/methods*;Neuroprotective Agents/adverse effects;Nootropic Agents/adverse effects;Phytotherapy/adverse effects*;Phytotherapy/utilization;Sesquiterpenes/adverse effects
16935738;Androgen Antagonists/adverse effects;Dietary Supplements/adverse effects*;Dietary Supplements/utilization;Echinacea/adverse effects;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Isoflavones/adverse effects;Medical History Taking;Nurse's Role;Nursing Assessment;Panax/adverse effects;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic/organization & administration*;Perioperative Care/nursing*;Perioperative Care/psychology;Phytotherapy/adverse effects*;Phytotherapy/nursing*;Phytotherapy/psychology;Phytotherapy/utilization;Plant Extracts/adverse effects;Postanesthesia Nursing/organization & administration;Risk Factors;Soybean Oil/adverse effects;United States
16926962;Aged;Aged, 80 and over;Drug Interactions*;Female;Health Care Surveys;Herb-Drug Interactions;Humans;Male;Nova Scotia;Osteoarthritis/drug therapy*;Primary Health Care/statistics & numerical data;Risk Assessment;Self Care
16918318;Animals;Anticarcinogenic Agents/pharmacology*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Food-Drug Interactions;Gene Expression Regulation, Enzymologic;Glucuronosyltransferase/metabolism;Glutathione Transferase/metabolism;Herb-Drug Interactions*;Humans;Neoplasms/prevention & control;Pharmaceutical Preparations/metabolism*;Plant Preparations/pharmacology*
16907661;Evidence-Based Medicine*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*;Plant Preparations/pharmacology
16905502;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16905501;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16903853;Action Potentials/drug effects;Action Potentials/physiology;Animals;Antidepressive Agents/pharmacology*;Cell Culture Techniques/methods;Cells, Cultured;Cerebral Cortex/cytology;Cerebral Cortex/drug effects*;Cerebral Cortex/physiology;Drug Evaluation, Preclinical/instrumentation;Drug Evaluation, Preclinical/methods;Herb-Drug Interactions/physiology;Hypericum/chemistry;Mice;Microarray Analysis/instrumentation*;Microarray Analysis/methods;Microelectrodes/standards;Nerve Net/cytology;Nerve Net/drug effects*;Nerve Net/physiology;Neural Inhibition/drug effects;Neural Inhibition/physiology;Neurons/drug effects*;Neurons/physiology;Passiflora/chemistry;Plant Extracts/pharmacology*;Receptors, GABA/drug effects;Receptors, GABA/metabolism;Receptors, Serotonin/drug effects;Receptors, Serotonin/metabolism;Serotonin/metabolism;Synaptic Transmission/drug effects;Synaptic Transmission/physiology;Valerian/chemistry;gamma-Aminobutyric Acid/metabolism
16880233;Drug Prescriptions*;Herb-Drug Interactions*;Humans;Medical Oncology*;Neoplasms/therapy*;Plants, Medicinal/adverse effects*
16880232;Complementary Therapies/utilization*;Decision Making;Health Planning Guidelines;Herb-Drug Interactions;Humans;Neoplasms/therapy*
16877262;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Anti-Retroviral Agents/administration & dosage;Anti-Retroviral Agents/metabolism*;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Plant Extracts/adverse effects;Plant Extracts/metabolism*;Plants, Medicinal/chemistry*
16858951;Animals;Anticonvulsants/administration & dosage*;Centella*;Disease Models, Animal;Drug Therapy, Combination;Herb-Drug Interactions*;Male;Mice;Mice, Inbred ICR;Phytotherapy*;Plant Extracts/administration & dosage;Seizures/drug therapy*
16845946;Cytochrome P-450 Enzyme System/drug effects;Herb-Drug Interactions*;Humans;Plant Preparations/pharmacokinetics*;Plant Preparations/therapeutic use*
16835538;Attitude to Health;Dissent and Disputes;Evidence-Based Medicine;Female;Health Knowledge, Attitudes, Practice;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Medical History Taking;Menopause*/physiology;Menopause*/psychology;Nurse's Role;Nursing Assessment;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/nursing;Phytotherapy*/psychology;Plants, Medicinal;Risk Factors;Self Medication
16808005;Amides/administration & dosage;Amides/pharmacology;Amides/therapeutic use;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP2D6 Inhibitors;Dose-Response Relationship, Drug;Fruit;Herb-Drug Interactions;Humans;Microsomes, Liver/drug effects*;Microsomes, Liver/metabolism;Phytotherapy*;Piper nigrum*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
16796701;Adolescent;Adult;Aged;Child;Child, Preschool;Drug Prescriptions/statistics & numerical data;Family Practice/statistics & numerical data*;Female;Herb-Drug Interactions;Herbal Medicine/statistics & numerical data*;Homeopathy/statistics & numerical data*;Humans;Infant;Infant, Newborn;Male;Middle Aged;Plant Preparations/therapeutic use;Practice Patterns, Physicians'/statistics & numerical data*;Scotland
16791400;Angiotensin-Converting Enzyme Inhibitors/adverse effects*;Cathartics/adverse effects;Constipation/chemically induced;Drugs, Chinese Herbal/adverse effects*;Enalapril/adverse effects*;Glycyrrhizic Acid/adverse effects*;Herb-Drug Interactions*;Humans;Hyperaldosteronism/chemically induced*;Hypertension/drug therapy;Male;Potassium/blood;Rhinitis, Allergic, Perennial/drug therapy
16783181;Algorithms;Attitude of Health Personnel*;Audiovisual Aids;Clinical Competence;Decision Trees;Education, Nursing, Continuing/organization & administration*;Focus Groups;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions;Humans;Needs Assessment/organization & administration*;Nursing Assessment;Nursing Education Research;Nursing Methodology Research;Nursing Staff, Hospital*/education;Nursing Staff, Hospital*/psychology;Patient Education as Topic/organization & administration*;Patient Satisfaction;Perioperative Nursing/education;Phytotherapy/adverse effects*;Phytotherapy/nursing;Practice Guidelines as Topic;Preoperative Care;Risk Factors;Surveys and Questionnaires;Total Quality Management/organization & administration
16762125;Aged;Antihypertensive Agents/therapeutic use*;Crataegus*;Diabetes Mellitus, Type 2/complications;Diabetes Mellitus, Type 2/drug therapy*;Double-Blind Method;Female;Herb-Drug Interactions*;Humans;Hypertension/drug therapy*;Hypertension/etiology;Hypoglycemic Agents/therapeutic use;Male;Middle Aged;Phytotherapy/methods*;Treatment Outcome
16758063;Adolescent;Adult;Aged;Aged, 80 and over;Anesthesia*;Female;Herb-Drug Interactions*;Humans;Intraoperative Complications;Male;Middle Aged;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Preoperative Care*;Surveys and Questionnaires
16755466;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/pharmacology*;Cell Line, Tumor;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/genetics;Herb-Drug Interactions;Humans;Hypericum*;Intestine, Small/drug effects;Intestine, Small/enzymology;Liver/drug effects;Liver/enzymology;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;RNA, Messenger/analysis;Reverse Transcriptase Polymerase Chain Reaction
16750959;Adult;Antidepressive Agents, Second-Generation/administration & dosage*;Ataxia/chemically induced;Confusion/chemically induced;Drug Synergism;Fever/chemically induced;Headache/chemically induced;Herb-Drug Interactions*;Hospitalization;Humans;Kava/adverse effects*;Male;Medical History Taking;Paroxetine/administration & dosage*;Plant Extracts/adverse effects;Self Medication/adverse effects*;Sleep Stages/drug effects*;Valerian/adverse effects*
16722828;Adaptation, Physiological;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Humans;Hypericum*;Plant Preparations/metabolism*
16722827;Cyclosporine/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Heart Transplantation;Herb-Drug Interactions;Humans;Hypericum*;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation;Liver Transplantation;Male;Middle Aged;Models, Chemical;Retrospective Studies
16718375;Aldehyde Reductase/metabolism;Animals;Antioxidants/metabolism;Diabetes Mellitus, Experimental;Female;Glucose/metabolism;Glucosephosphate Dehydrogenase/metabolism;Glutathione Peroxidase/metabolism;Glutathione Reductase/metabolism;Herb-Drug Interactions*;Hexokinase/metabolism;Insulin/metabolism;L-Iditol 2-Dehydrogenase/metabolism;Lens, Crystalline/cytology;Lens, Crystalline/drug effects*;Lens, Crystalline/ultrastructure;Lipid Peroxidation;Plant Extracts/pharmacology;Rats;Rats, Wistar;Retina/drug effects*;Retina/ultrastructure;Sorbitol/metabolism;Time Factors;Trigonella/metabolism*;Vanadates/pharmacology*
16699292;Administration, Oral;Animals;Antitubercular Agents/blood;Antitubercular Agents/pharmacokinetics*;Garlic/chemistry*;Herb-Drug Interactions*;Isoniazid/blood;Isoniazid/pharmacokinetics*;Plant Extracts/pharmacology;Rabbits;Rifampin/blood;Rifampin/pharmacokinetics*
16678003;Aged;Critical Care*;Cytochrome P-450 Enzyme System*/classification;Cytochrome P-450 Enzyme System*/drug effects;Cytochrome P-450 Enzyme System*/physiology;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions;Herb-Drug Interactions;Humans;Isoenzymes*/drug effects;Isoenzymes*/metabolism;Isoenzymes*/physiology;Pharmaceutical Preparations*/classification;Pharmaceutical Preparations*/metabolism
16636327;Aged;Anticoagulants/adverse effects*;Beverages;Female;Herb-Drug Interactions*;Humans;Matricaria/adverse effects*;Ointments;Warfarin/adverse effects*
16610971;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Blood Coagulation/drug effects;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacology*
16594744;Clinical Laboratory Techniques;Herb-Drug Interactions*;Humans;Pathology, Clinical/methods*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/classification
16568876;Aged;Aged, 80 and over;Australia;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Drug Interactions;Female;Herb-Drug Interactions;Humans;Logistic Models;Male;Minerals/pharmacology;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Extracts/pharmacology;Vitamins/pharmacology
16557604;Antineoplastic Agents, Phytogenic/therapeutic use;Camellia sinensis;Curcumin/therapeutic use;Drug Synergism*;Genistein/therapeutic use;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Plant Extracts/therapeutic use*;Quercetin/therapeutic use;Signal Transduction
16553520;Aged, 80 and over;Anticoagulants/adverse effects*;Fatty Acids/adverse effects*;Hematuria/chemically induced*;Herb-Drug Interactions*;Humans;Insect Hormones/adverse effects*;Male;Warfarin/adverse effects*
16549570;Adult;Aged;Attitude to Health*;Complementary Therapies/adverse effects;Complementary Therapies/psychology*;Complementary Therapies/utilization;Cross-Sectional Studies;Drug Interactions;Drug Therapy/psychology*;Drug-Related Side Effects and Adverse Reactions;Emergency Service, Hospital;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Victoria
16541172;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Communication;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Female;Food, Organic/adverse effects;Food, Organic/utilization*;Food-Drug Interactions;Herb-Drug Interactions;Humans;Male;Middle Aged;Neoplasms/diet therapy;Neoplasms/drug therapy;Neoplasms/therapy*;Norway;Patient Education as Topic;Physician-Patient Relations;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plants, Medicinal*/adverse effects;Surveys and Questionnaires
16538934;Chondroitin Sulfates/adverse effects;Chondroitin Sulfates/therapeutic use;Dietary Supplements*/adverse effects;Dietary Supplements*/utilization;Drug Information Services;Echinacea/adverse effects;Fish Oils/adverse effects;Fish Oils/therapeutic use;Garlic/adverse effects;Ginkgo biloba/adverse effects;Glucosamine/adverse effects;Glucosamine/therapeutic use;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kidney Failure, Chronic/complications;Kidney Failure, Chronic/prevention & control*;Kidney Failure, Chronic/psychology;Panax/adverse effects;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Selection;Phytotherapy/adverse effects*;Phytotherapy/methods*;Phytotherapy/psychology;Severity of Illness Index
16538644;Antidepressive Agents, Tricyclic/blood;Artifacts;Drug Monitoring/standards*;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Immunoassay;Phytotherapy
16532344;Antineoplastic Combined Chemotherapy Protocols/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Areca/adverse effects*;Breast Neoplasms/drug therapy*;Chemotherapy, Adjuvant/adverse effects;Cyclophosphamide/administration & dosage;Cyclophosphamide/adverse effects;Doxorubicin/administration & dosage;Doxorubicin/adverse effects;Female;Fluorouracil/administration & dosage;Fluorouracil/adverse effects;Herb-Drug Interactions*;Humans;Mastication;Methotrexate/administration & dosage;Methotrexate/adverse effects;Middle Aged;Mucositis/chemically induced*;Mucositis/pathology;Taxoids/administration & dosage;Taxoids/adverse effects
16482732;Ambulatory Care/organization & administration*;Communication;Complementary Therapies/organization & administration*;Credentialing/organization & administration;Evidence-Based Medicine;Health Services Needs and Demand;Herb-Drug Interactions;Humans;Internet;Medical History Taking;Medical Oncology/organization & administration*;Neoplasms/psychology;Neoplasms/therapy;Nurse Clinicians/organization & administration*;Nurse Clinicians/psychology;Nurse's Role;Nurse-Patient Relations;Nursing Assessment;Oncology Nursing/organization & administration*;Patient Acceptance of Health Care;Patient Care Planning/organization & administration*;Patient Care Team/organization & administration;Patient Education as Topic/organization & administration;Practice Guidelines as Topic;Referral and Consultation/organization & administration;Safety Management/organization & administration
16477470;Bridged Bicyclo Compounds/administration & dosage;Bridged Bicyclo Compounds/chemistry;Bridged Bicyclo Compounds/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Herb-Drug Interactions*;Humans;Hypericum/chemistry*;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism;Phloroglucinol/administration & dosage;Phloroglucinol/analogs & derivatives*;Phloroglucinol/chemistry;Phloroglucinol/metabolism;Plants, Medicinal/chemistry;Terpenes/administration & dosage*;Terpenes/chemistry;Terpenes/metabolism
16470916;Animals;Area Under Curve;Calcium Channel Blockers/pharmacokinetics*;Herb-Drug Interactions*;In Vitro Techniques;Kaempferols/pharmacology*;Male;Nifedipine/pharmacokinetics*;Rats;Rats, Sprague-Dawley
16470912;Animals;Anticarcinogenic Agents/pharmacology;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions;Gene Expression Regulation, Enzymologic;Herb-Drug Interactions*;Humans;Plant Preparations/pharmacology*
16459039;Biomedical Research/organization & administration*;Ethnopharmacology/organization & administration*;Herb-Drug Interactions;Humans;Medical History Taking;Physician's Role*
16451764;Adolescent;Adult;Demography;Dentistry*;Disclosure;Female;Health Behavior*;Herb-Drug Interactions;Humans;Internal-External Control;Logistic Models;Male;Middle Aged;Multivariate Analysis;Phytotherapy/psychology*;Plant Preparations/therapeutic use*;Self Medication;Sex Factors;Surveys and Questionnaires
16428919;Adult;Aryl Hydrocarbon Hydroxylases/metabolism*;Cytochrome P-450 CYP2C9;Diclofenac/pharmacokinetics*;Drug Synergism;Female;Ginkgo biloba*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Plant Extracts/pharmacokinetics;Tolbutamide/pharmacokinetics*
16428030;Antidepressive Agents/adverse effects;Antidepressive Agents/chemical synthesis;Antidepressive Agents/therapeutic use;Depression/drug therapy*;Dermatitis, Phototoxic/etiology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Risk Assessment
16428028;Alcohol Dehydrogenase/antagonists & inhibitors*;Alcohol Dehydrogenase/drug effects;Alcohol Dehydrogenase/metabolism*;Alcohol Drinking;Chemical and Drug Induced Liver Injury/etiology;Herb-Drug Interactions;Kava/chemistry*;Lactones/pharmacology*;Plant Extracts/pharmacology;Pyrans/pharmacology;Pyrazoles/pharmacology;Pyrones/pharmacology;Spectrophotometry/methods
16419414;Anticonvulsants/adverse effects*;Aryl Hydrocarbon Hydroxylases/biosynthesis;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C9;Enzyme Induction/drug effects;Fatal Outcome;Ginkgo biloba/adverse effects*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Mixed Function Oxygenases/biosynthesis;Phenytoin/adverse effects*;Seizures/etiology*;Valproic Acid/adverse effects*
16414224;Cytochrome P-450 CYP2D6 Inhibitors*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/pharmacology*;Herb-Drug Interactions;Indonesia;NADP/metabolism;Plant Extracts/pharmacology*;Plants, Medicinal*
16396061;Adult;Drug Interactions;Female;HIV Infections/drug therapy*;HIV Infections/ethnology*;Herb-Drug Interactions;Herbal Medicine*;Hispanic Americans/psychology*;Humans;Interviews as Topic;Male;Phytotherapy/utilization*;Prospective Studies;Surveys and Questionnaires;Texas
16370951;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/therapeutic use;Complementary Therapies;Drug Approval;Herb-Drug Interactions*;Humans;Public Health;United States;United States Food and Drug Administration
16370950;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/therapeutic use;Communication;Data Collection;Decision Making;Herb-Drug Interactions*;Humans;Nonprescription Drugs;Physician-Patient Relations;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Quality Control;Reproducibility of Results
16341856;Adult;Area Under Curve;Bridged Bicyclo Compounds/administration & dosage;Bridged Bicyclo Compounds/pharmacology;Cytochrome P-450 CYP3A/biosynthesis*;Herb-Drug Interactions*;Humans;Hypericum*;Male;Midazolam/pharmacokinetics*;Phloroglucinol/administration & dosage;Phloroglucinol/analogs & derivatives*;Phloroglucinol/pharmacology;Plant Extracts/pharmacology;Tablets;Terpenes/administration & dosage;Terpenes/pharmacology*
16337563;Clinical Trials as Topic/standards;Drug Information Services;Drug Labeling/standards;Evidence-Based Medicine;Herb-Drug Interactions;Humans;Internet;Pain/diagnosis;Pain/drug therapy*;Pain Measurement;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Phytotherapy/adverse effects*;Phytotherapy/economics;Phytotherapy/standards*;Research Design/standards;Safety;Treatment Outcome
16329453;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents, Hormonal/administration & dosage*;Antineoplastic Agents, Hormonal/adverse effects;Aromatase Inhibitors/administration & dosage;Breast Neoplasms/drug therapy*;Contraceptives, Oral, Hormonal/administration & dosage*;Contraceptives, Oral, Hormonal/adverse effects;Female;Herb-Drug Interactions*;Hormone Replacement Therapy*/adverse effects;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors;Surveys and Questionnaires;Tamoxifen/administration & dosage
16329452;Attitude to Health;Documentation;Drug Utilization;Drug and Narcotic Control;Herb-Drug Interactions*;Humans;Informed Consent;Medical Records;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors;Surveys and Questionnaires
16329448;Antineoplastic Agents/administration & dosage*;Breast Neoplasms/drug therapy*;Female;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Risk Factors
16328317;Drug Utilization;Female;Herb-Drug Interactions*;Hospitalization/statistics & numerical data;Humans;Phytotherapy/adverse effects*;Product Surveillance, Postmarketing
16317661;Anti-Obesity Agents/adverse effects;Aristolochic Acids/adverse effects*;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Nephritis/chemically induced*
16294617;Dietary Supplements/adverse effects*;Drug Monitoring/methods;Drug Monitoring/nursing;Herb-Drug Interactions;Humans;Kidney/drug effects*;Kidney Diseases*/chemically induced;Kidney Diseases*/prevention & control;Medical History Taking;Nurse's Role;Nursing Assessment;Patient Education as Topic;Phytotherapy/adverse effects*;Phytotherapy/methods;Phytotherapy/nursing;Risk Factors;United States;United States Food and Drug Administration
16291709;Angina Pectoris/drug therapy;Animals;Benzofurans/pharmacokinetics;Benzofurans/pharmacology;Diterpenes, Abietane;Drugs, Chinese Herbal*/adverse effects;Drugs, Chinese Herbal*/chemistry;Drugs, Chinese Herbal*/pharmacology;Drugs, Chinese Herbal*/therapeutic use;Fibrinolytic Agents*/adverse effects;Fibrinolytic Agents*/chemistry;Fibrinolytic Agents*/pharmacology;Fibrinolytic Agents*/therapeutic use;Herb-Drug Interactions;Humans;Hyperlipidemias/drug therapy;Lactates/pharmacokinetics;Lactates/pharmacology;Phenanthrenes/pharmacokinetics;Phenanthrenes/pharmacology;Phenanthrolines*/adverse effects;Phenanthrolines*/chemistry;Phenanthrolines*/pharmacology;Phenanthrolines*/therapeutic use;Plant Extracts;Randomized Controlled Trials as Topic;Salvia miltiorrhiza;Stroke/drug therapy
16287339;Androgen Antagonists/therapeutic use*;Complementary Therapies;Drug Prescriptions*;Herb-Drug Interactions*;Humans;Male;Plant Extracts/therapeutic use*;Prostatic Hyperplasia/drug therapy*;Serenoa
16263432;Child;Consumer Product Safety*;Drug Contamination;Female;Government Regulation;Herb-Drug Interactions;Herbal Medicine*/legislation & jurisprudence;Herbal Medicine*/standards;Humans;Hypersensitivity;Internationality;Medicine, Traditional;Phytotherapy/adverse effects*;Plant Extracts*/administration & dosage;Plant Extracts*/adverse effects;Plant Extracts*/pharmacology;Plants, Medicinal*;Pregnancy
16260410;Adult;Biomedical Research;Child;Dose-Response Relationship, Drug;Echinacea*;Evidence-Based Medicine*;Female;Herb-Drug Interactions;History, 19th Century;Humans;Leukopenia/drug therapy;Male;Phytotherapy/history;Phytotherapy/standards*;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Plant Extracts/standards;Plants, Medicinal*;Pregnancy;Radiation Injuries/drug therapy;Randomized Controlled Trials as Topic;Research Design;Respiratory Tract Infections/prevention & control;Safety
16255656;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/therapeutic use;Arthritis/drug therapy;Herb-Drug Interactions*;Humans;Plant Extracts/adverse effects;Plant Extracts/therapeutic use
16227061;Ephedra/chemistry;Ephedra/toxicity*;Herb-Drug Interactions;Humans;Hypericum/chemistry;Hypericum/toxicity*;Phytotherapy*
16221754;Administration, Oral;Adult;Area Under Curve;Cimicifuga*;Clarithromycin/administration & dosage;Clarithromycin/pharmacokinetics;Dietary Supplements;Digoxin/antagonists & inhibitors;Digoxin/blood;Digoxin/pharmacokinetics*;Drug Administration Schedule;Female;Genes, MDR/genetics;Half-Life;Haplotypes/genetics;Herb-Drug Interactions;Humans;Male;Milk Thistle*;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Rifampin/administration & dosage;Rifampin/pharmacokinetics;Rifampin/urine
16209856;Antiviral Agents/therapeutic use;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Complementary Therapies/standards*;Europe;Herb-Drug Interactions;Herpes Genitalis/drug therapy*;Humans;Plants, Medicinal;United States
16209114;Complementary Therapies/adverse effects;Complementary Therapies/methods*;Herb-Drug Interactions;Humans;Neoplasms/therapy*
16181542;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biotransformation/physiology*;Cytochrome P-450 CYP3A/physiology*;Drug Interactions/physiology;Drugs, Chinese Herbal/metabolism*;Herb-Drug Interactions/physiology*;Humans;Intestines/metabolism*;Receptors, Cytoplasmic and Nuclear/metabolism
16175124;Clinical Trials as Topic*;Garlic;Ginkgo biloba;Herb-Drug Interactions*;Hypericum;Panax;Phytotherapy*
16168817;Anticoagulants/therapeutic use*;Ginsenosides/adverse effects;Hemorrhage/chemically induced;Herb-Drug Interactions*;Herbal Medicine*;Humans;Panax*/adverse effects;Phytotherapy*/adverse effects;Plant Preparations/adverse effects;Warfarin/therapeutic use*
16168502;Animals;Cardiotonic Agents/therapeutic use*;Digoxin/therapeutic use*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/metabolism*
16162912;Antirheumatic Agents/adverse effects*;Arthritis/therapy;Evidence-Based Medicine;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*
16158798;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Binding, Competitive;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Flavonoids/pharmacokinetics;Food-Drug Interactions*;Furocoumarins/pharmacokinetics;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypnotics and Sedatives/metabolism;Liver/metabolism;Oxidation-Reduction
16156004;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/psychology;Anti-HIV Agents/therapeutic use*;Evidence-Based Medicine;HIV Infections/drug therapy*;HIV Infections/psychology;Herb-Drug Interactions;Herbal Medicine;Humans;Phytotherapy*;Plants, Medicinal*;Quality of Life;Randomized Controlled Trials as Topic;Treatment Outcome
16153141;Aged;Anxiety/drug therapy;Ethanol/adverse effects;Herb-Drug Interactions*;Humans;Kava*;Middle Aged;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Sleep Wake Disorders/drug therapy
16131821;Administration, Oral;Animals;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chickens/metabolism*;Dose-Response Relationship, Drug;Female;Half-Life;Herb-Drug Interactions*;Oxytetracycline/blood;Oxytetracycline/pharmacokinetics*;Piper*
16125735;Animals;Antidepressive Agents/pharmacology*;Area Under Curve;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/pharmacokinetics;Herb-Drug Interactions;Hypericum;Injections, Intraperitoneal;Liver/drug effects*;Liver/enzymology;Male;Midazolam/pharmacokinetics;Perfusion;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Tolbutamide/pharmacokinetics
16117219;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy*;Nursing Assessment
16115117;Evidence-Based Medicine;Garlic*/adverse effects;Herb-Drug Interactions;Humans;Hypertension/prevention & control*;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Phytotherapy/methods*;Phytotherapy/standards;Phytotherapy/utilization;Treatment Outcome;United States
16114489;Anti-Bacterial Agents/isolation & purification;Anti-Bacterial Agents/pharmacology*;Apiaceae*;Cresols/isolation & purification;Cresols/pharmacology*;Drug Resistance, Bacterial;Herb-Drug Interactions;In Vitro Techniques;Microbial Sensitivity Tests;Monoterpenes/isolation & purification;Monoterpenes/pharmacology*;Oils, Volatile/isolation & purification;Oils, Volatile/pharmacology;Plant Oils/isolation & purification;Plant Oils/pharmacology*;Salmonella enteritidis/drug effects*;Salmonella typhimurium/drug effects*
16114078;Administration, Oral;Area Under Curve;Computer Simulation;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Humans;Injections, Intravenous;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics*;Plants, Medicinal*;Predictive Value of Tests
16108248;Anticoagulants*/agonists;Anticoagulants*/antagonists & inhibitors;Drug Interactions;Herb-Drug Interactions*;Humans;Panax;Salvia miltiorrhiza;Warfarin*/agonists;Warfarin*/antagonists & inhibitors
16100357;Antirheumatic Agents/adverse effects*;Drug Contamination*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*
16062162;Adrenal Cortex Hormones/therapeutic use;Analgesics, Opioid/therapeutic use;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/drug therapy*;Neoplasms/surgery;Practice Guidelines as Topic*;Preoperative Care
16046518;Beverages*;Biopsy;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Female;Follow-Up Studies;Graft Rejection/blood;Graft Rejection/pathology;Graft Rejection/prevention & control*;Herb-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Kidney Transplantation*;Middle Aged;Plant Extracts/therapeutic use*
16044851;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Dental Care for Chronically Ill*;Drug Interactions;Herb-Drug Interactions;Humans;Ibuprofen/pharmacology
16037651;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Dietary Supplements*/standards;Drug Labeling;European Union;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence*;Humans;Italy;Legislation, Drug*;Legislation, Food*;Minerals/standards;Minerals/therapeutic use;Plant Preparations*/adverse effects;Plant Preparations*/chemistry;Plant Preparations*/standards;Plant Preparations*/therapeutic use;Plants, Medicinal;Vitamins/standards;Vitamins/therapeutic use
16037648;Abortion, Spontaneous/chemically induced;Adolescent;Adult;Adverse Drug Reaction Reporting Systems/organization & administration;Adverse Drug Reaction Reporting Systems/statistics & numerical data*;Anaphylaxis/chemically induced;Anaphylaxis/epidemiology;Beverages/adverse effects;Child;Child, Preschool;Dietary Supplements/adverse effects*;Drug Hypersensitivity/epidemiology;Drug Hypersensitivity/etiology;Female;Government Agencies/organization & administration;Herb-Drug Interactions;Humans;Infant;Infant, Newborn;Italy;Male;Middle Aged;Pilot Projects;Plant Preparations/adverse effects*;Pregnancy;Pregnancy Complications/chemically induced;Self Medication;Telefacsimile
16010646;Complementary Therapies;Dietary Supplements;Herb-Drug Interactions*;Humans;Kidney Diseases/drug therapy*;Phytotherapy*;Warfarin/pharmacology*
16005588;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Kava/adverse effects*
16004184;Europe;Herb-Drug Interactions*;Humans;Legislation, Drug;Materia Medica/adverse effects*;Plant Preparations/adverse effects*;United States
15999084;Anticoagulants/adverse effects;Antioxidants/therapeutic use;Cardiovascular Diseases/prevention & control;Case Management/organization & administration;Chondroitin/therapeutic use;Clinical Trials as Topic*;Evidence-Based Medicine;Glucosamine/therapeutic use;Herb-Drug Interactions;Humans;National Institutes of Health (U.S.);Osteoarthritis/drug therapy;Phytotherapy/standards*;United States
15997009;Clinical Trials as Topic*;Herb-Drug Interactions*;Humans;Pediatrics;Pharmacokinetics
15984360;Aloe/adverse effects;Ephedra/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kava/adverse effects;Nurse Practitioners;Patient Acceptance of Health Care/psychology;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Patient Selection;Phytotherapy/adverse effects*;Phytotherapy/methods;Phytotherapy/nursing;Phytotherapy/psychology
15983535;Aged;Consumer Product Safety*;Dietary Supplements/utilization*;Drug Interactions;Female;Health Behavior;Health Services for the Aged/standards*;Herb-Drug Interactions;Humans;Male;Nonprescription Drugs/administration & dosage;Patient Satisfaction*;Plant Preparations/administration & dosage*;Surveys and Questionnaires
15974642;Administration, Oral;Aged;Allyl Compounds/chemistry;Caffeine/administration & dosage;Caffeine/blood;Caffeine/pharmacology;Chlorzoxazone/administration & dosage;Chlorzoxazone/blood;Chlorzoxazone/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Dietary Supplements*;Drug Administration Schedule;Female;Ginkgo biloba/chemistry;Herb-Drug Interactions;Humans;Hypericum/chemistry;Isoenzymes/antagonists & inhibitors;Isoenzymes/genetics;Isoenzymes/metabolism;Male;Midazolam/administration & dosage;Midazolam/blood;Midazolam/pharmacology;Panax/chemistry;Phenotype;Plant Preparations/administration & dosage;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Sulfides/chemistry
15960738;Aged;Arthroplasty, Replacement, Hip*;Ginkgo biloba*;Herb-Drug Interactions;Humans;Male;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Postoperative Hemorrhage/chemically induced*
15942431;Gastrointestinal Diseases/drug therapy*;Herb-Drug Interactions;Humans;Phytotherapy*
15936791;Administration, Oral;Animals;Area Under Curve;Asthenia/chemically induced;Chromatography, High Pressure Liquid;Half-Life;Herb-Drug Interactions*;Injections, Intravenous;Isoflavones/analysis;Isoflavones/chemistry;Male;Methotrexate/administration & dosage;Methotrexate/blood;Methotrexate/pharmacokinetics*;Molecular Structure;Piloerection/drug effects;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Plant Roots/chemistry*;Pueraria/chemistry*;Rats;Rats, Sprague-Dawley
15935039;Aged;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Cystitis/complications;Cystitis/drug therapy;Fruit;Herb-Drug Interactions*;Humans;Hypertension/complications;Hypertension/drug therapy;International Normalized Ratio;Male;Medical History Taking/methods*;Medication Errors/prevention & control;Phytotherapy/methods*;Plant Preparations;Vaccinium macrocarpon*;Warfarin/blood;Warfarin/therapeutic use*
15916450;Animals;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics*
15915310;Complementary Therapies/standards*;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Evidence-Based Medicine*;Food-Drug Interactions;Herb-Drug Interactions;Herbal Medicine/standards*;Humans;Practice Guidelines as Topic;Self Medication
15914127;Adult;Contraceptives, Oral, Synthetic/pharmacokinetics*;Contraceptives, Oral, Synthetic/pharmacology;Drug Interactions;Estrogens/pharmacokinetics;Estrogens/pharmacology;Ethinyl Estradiol/pharmacokinetics*;Ethinyl Estradiol/pharmacology;Female;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Metrorrhagia;Norethindrone/pharmacokinetics*;Norethindrone/pharmacology;Ovulation/drug effects*
15900291;Drug Contamination/legislation & jurisprudence;Drug Contamination/statistics & numerical data;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence*;Herbal Medicine/standards;Herbal Medicine/statistics & numerical data;Humans;Malaysia/ethnology;Plant Preparations/classification;Plant Preparations/therapeutic use*;Plants, Medicinal
15900287;Adult;Aryl Hydrocarbon Hydroxylases/drug effects*;Aryl Hydrocarbon Hydroxylases/genetics*;Caffeine/pharmacology;Capsules;Cimicifuga/chemistry;Cimicifuga/metabolism*;Dietary Supplements;Drug Administration Schedule;Female;Herb-Drug Interactions/physiology;Humans;Hydrastis/chemistry;Hydrastis/metabolism*;Kava/chemistry;Kava/metabolism*;Male;Midazolam/pharmacology;Patient Selection;Phenotype*;Time Factors;Valerian/chemistry*;Valerian/metabolism
15898829;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions*;Humans;Phytotherapy*/adverse effects;Plants, Medicinal/adverse effects;Plants, Medicinal/metabolism*
15884474;Anxiety/drug therapy*;Cimicifuga;Depression/drug therapy*;Evidence-Based Medicine;Ginkgo biloba;Herb-Drug Interactions;Humans;Hypericum;Kava;Nurse's Role;Patient Acceptance of Health Care/statistics & numerical data;Patient Education as Topic;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/nursing;Phytotherapy/standards;Sleep Wake Disorders/drug therapy*;Valerian
15856334;Adult;Aged;Demography;Dietary Supplements/classification;Dietary Supplements/utilization*;Female;Health Care Surveys;Herb-Drug Interactions;Hospitals, Community/utilization*;Humans;Illinois;Male;Middle Aged;Neoplasm Staging;Neoplasms/drug therapy;Neoplasms/pathology;Neoplasms/therapy*;Oncology Service, Hospital/utilization*;Self Care*;Surveys and Questionnaires
15835425;Communication*;Dietary Supplements/adverse effects*;Herb-Drug Interactions;Humans;Oral Health*;Vitamins/adverse effects
15834065;Antirheumatic Agents/adverse effects*;England;Herb-Drug Interactions*;Humans;Outpatient Clinics, Hospital;Phytotherapy/utilization*
15829016;Adolescent;Adult;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Ascorbic Acid/pharmacokinetics;Ascorbic Acid/therapeutic use*;Clinical Trials as Topic/standards;Drug Interactions*;Female;HIV Infections/drug therapy*;HIV-1/drug effects;Herb-Drug Interactions;Humans;Male;Middle Aged;Phytotherapy;Plant Extracts/pharmacokinetics;Plant Extracts/therapeutic use*
15824968;Animals;Blood Glucose/drug effects;Drugs, Chinese Herbal/pharmacology*;Fructose/pharmacology;Glucose Intolerance/drug therapy*;Glucose Tolerance Test;Herb-Drug Interactions;Hypoglycemic Agents/pharmacology;Insulin Resistance*;Male;Panax*;Rats;Rats, Wistar;Tolbutamide/pharmacology
15823059;Aged;Complementary Therapies;Drug Prescriptions*;Drug-Related Side Effects and Adverse Reactions*;Ginkgo biloba/adverse effects*;Herb-Drug Interactions*;Humans
15816268;Adolescent;Adult;Age Factors;Community Health Centers;Diabetes Mellitus/drug therapy*;Drug Prescriptions/statistics & numerical data*;Female;Gastrointestinal Diseases/drug therapy*;Health Care Surveys;Herb-Drug Interactions*;Humans;Hypertension/drug therapy*;Male;Middle Aged;Pharmacies;Pharmacy Service, Hospital;Phytotherapy/adverse effects;Phytotherapy/utilization*;Pilot Projects;Polypharmacy*;Self Medication/utilization*;Surveys and Questionnaires
15814041;Anticoagulants/antagonists & inhibitors*;Commiphora*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Phytotherapy/adverse effects;Phytotherapy/methods*;Plant Preparations/adverse effects;Plant Preparations/therapeutic use;Thrombosis/prevention & control;Warfarin/antagonists & inhibitors*
15807986;Animals;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Area Under Curve;Camellia sinensis;Clozapine/blood;Clozapine/pharmacokinetics*;Cytochrome P-450 CYP1A2/biosynthesis;Half-Life;Herb-Drug Interactions*;Liver/metabolism;Male;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Tea*
15801937;Administration, Oral;Adult;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Cross-Over Studies;Ginger/metabolism*;Ginkgo biloba/metabolism*;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Platelet Aggregation/drug effects;Protein Binding/drug effects;Warfarin/pharmacokinetics*;Warfarin/pharmacology
15794726;Adult;Aged;Animals;Child;Herb-Drug Interactions*;Humans;Middle Aged;Pharmaceutical Preparations/classification*;Plants, Medicinal/classification*;Risk Assessment
15779134;Acetaminophen/adverse effects;Aged;Analgesics, Non-Narcotic/adverse effects*;Anticoagulants/adverse effects*;Blood Coagulation/drug effects;Female;Ginger/adverse effects*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Warfarin/adverse effects
15742918;Aged;Herb-Drug Interactions;Humans;Hypericum;Male;Phytotherapy*/adverse effects;Plants, Medicinal*/adverse effects
15732155;Antineoplastic Agents/therapeutic use*;Benzamides;Herb-Drug Interactions*;Humans;Hypericum*;Imatinib Mesylate;Phytotherapy*;Piperazines/therapeutic use*;Pyrimidines/therapeutic use*
15703370;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Adult;African Americans;Asian Continental Ancestry Group;Cytochrome P-450 CYP3A/biosynthesis*;European Continental Ancestry Group;Female;Genotype;Herb-Drug Interactions/ethnology*;Hispanic Americans;Humans;Hypericum*;Male;Midazolam/blood;Midazolam/pharmacokinetics*;Middle Aged;Phenotype;Plant Preparations/pharmacology*;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics
15676159;Anticoagulants/pharmacology;Antihypertensive Agents/pharmacology;Biological Availability;Blood Coagulation/drug effects;Cardiotonic Agents/pharmacology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/blood;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/epidemiology;Clinical Trials as Topic;Herb-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology;Phytotherapy;Plant Preparations/pharmacology*;Plants, Medicinal*/metabolism;Platelet Aggregation Inhibitors/pharmacology;Risk Factors
15667753;Angelica;Cimicifuga;Drugs, Chinese Herbal/adverse effects*;Female;Herb-Drug Interactions;Hot Flashes/drug therapy*;Humans;Menopause*;Oenothera;Phytotherapy*;Plants, Medicinal*;Trifolium
15663295;Animals;Beverages*;Biological Availability;Bronchodilator Agents/blood;Cassia*;Chromatography, High Pressure Liquid/methods;Herb-Drug Interactions*;Male;Plant Preparations/pharmacology*;Rats;Rats, Wistar;Sapindaceae;Theophylline/blood*
15663291;Beverages/analysis;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/physiology*;Enzyme Inhibitors/analysis;Food-Drug Interactions/physiology*;Fruit/chemistry;Herb-Drug Interactions/physiology*;Humans
15660956;Anti-Allergic Agents/pharmacokinetics;Anti-Allergic Agents/pharmacology;Anti-Asthmatic Agents/pharmacokinetics;Anti-Asthmatic Agents/pharmacology;Anti-Infective Agents/pharmacokinetics;Anti-Infective Agents/pharmacology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology;Central Nervous System Agents/pharmacokinetics;Central Nervous System Agents/pharmacology;Clinical Trials as Topic;Contraceptives, Oral/pharmacokinetics;Contraceptives, Oral/pharmacology;Herb-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Immunosuppressive Agents/pharmacokinetics;Immunosuppressive Agents/pharmacology
15656716;Anxiety/drug therapy;Herb-Drug Interactions;Phytotherapy*/adverse effects;Sleep Initiation and Maintenance Disorders/drug therapy;Spasm/drug therapy;Valerian*/adverse effects;Valerian*/chemistry
15656714;Angelica sinensis*/adverse effects;Angelica sinensis*/chemistry;Cardiovascular Diseases/drug therapy;Dysmenorrhea/drug therapy;Female;Herb-Drug Interactions;Hot Flashes/drug therapy;Humans;Male;Nephrotic Syndrome/drug therapy;Phytotherapy*/adverse effects
15655860;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Herb-Drug Interactions*;Humans;Panax/adverse effects*;Warfarin/administration & dosage;Warfarin/adverse effects*
15647404;Drug Interactions*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Risk Factors;Stereoisomerism;Thrombosis/metabolism;Thrombosis/prevention & control;Warfarin/chemistry;Warfarin/metabolism;Warfarin/pharmacology*
15638066;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Plants, Medicinal*/adverse effects
15630483;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Platelets/drug effects;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/therapeutic use;Hemorrhage/chemically induced;Herb-Drug Interactions*;Humans;Plants, Medicinal/adverse effects*
15627040;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Anti-Retroviral Agents/metabolism*;Aryl Hydrocarbon Hydroxylases/metabolism;Cytochrome P-450 CYP3A;Fabaceae*;Herb-Drug Interactions*;Humans;Hypoxis*;Oxidoreductases, N-Demethylating/metabolism;Phytotherapy/methods*;Plant Extracts/adverse effects*;Receptors, Cytoplasmic and Nuclear/metabolism;Receptors, Steroid/metabolism;Verapamil/metabolism
15625927;Blood Glucose/metabolism*;Cinnamomum zeylanicum*/adverse effects;Complementary Therapies*/adverse effects;Contraindications;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Plants, Medicinal*/adverse effects
15617217;Dietary Supplements*/adverse effects;Dietary Supplements*/standards;Herb-Drug Interactions;Humans;Phytotherapy*/adverse effects;Phytotherapy*/standards;Self Medication/adverse effects;United States;United States Food and Drug Administration
15608563;Adult;Aryl Hydrocarbon Hydroxylases/blood;Aryl Hydrocarbon Hydroxylases/metabolism*;Asian Continental Ancestry Group;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Mixed Function Oxygenases/blood;Mixed Function Oxygenases/metabolism*;Omeprazole/analogs & derivatives*;Omeprazole/blood;Omeprazole/pharmacokinetics;Omeprazole/pharmacology*;Omeprazole/urine;Pharmacogenetics*;Plant Extracts/pharmacology;Time Factors
15581442;Drug Contamination;Drug Prescriptions/standards*;Drug and Narcotic Control;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Humans;Physician's Role*;Phytotherapy/adverse effects*;Phytotherapy/economics;Phytotherapy/standards*;Plant Preparations/adverse effects;Plant Preparations/economics;Plant Preparations/standards;United States
15570327;Beverages;Drug Labeling;Europe;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Humans;Kava/adverse effects*;Liver Failure/chemically induced*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use
15551196;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adenosine Triphosphate/metabolism;Amitriptyline/pharmacology;Animals;Antidepressive Agents/pharmacology;Brain/cytology;Bridged Bicyclo Compounds/pharmacology;Cells, Cultured;Dose-Response Relationship, Drug;Drug Interactions;Endothelial Cells/drug effects*;Fluoresceins/metabolism;Fluoxetine/pharmacology;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Leukemia;Models, Biological;Phloroglucinol/analogs & derivatives*;Phloroglucinol/pharmacology;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Quercetin/pharmacology;Swine;Terpenes/pharmacology
15523104;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Antioxidants/therapeutic use*;Combined Modality Therapy;Delivery of Health Care, Integrated;Diet;Dietary Supplements*;Female;Herb-Drug Interactions;Humans;Male;Micronutrients/administration & dosage;Neoplasms/mortality;Neoplasms/prevention & control*;Neoplasms/therapy*;Oxidative Stress/drug effects*;Radiotherapy, Adjuvant;Risk Assessment;Sensitivity and Specificity;Survival Analysis
15520476;Anti-HIV Agents/therapeutic use*;Complementary Therapies*;Focus Groups;HIV Infections/psychology;HIV Infections/therapy*;Health Knowledge, Attitudes, Practice;Herb-Drug Interactions*;Humans;Information Dissemination;Male;Patient Education as Topic*/methods;Phytotherapy
15508430;Area Under Curve;Cytochrome P-450 Enzyme System/pharmacokinetics*;Ginkgo biloba/metabolism*;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Liver/metabolism;Milk Thistle/metabolism*;Risk Factors
15503544;Echinacea/adverse effects;Ephedra/adverse effects;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Kava/adverse effects;Panax/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Serenoa
15500490;Adolescent;Ambulatory Surgical Procedures/methods*;Anesthesia/methods*;Child;Child, Preschool;Herb-Drug Interactions;Herbal Medicine/methods;Herbal Medicine/statistics & numerical data*;Humans;Infant;Surveys and Questionnaires
15493382;Chemistry, Pharmaceutical;Drug Contamination;Drug Overdose;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plants, Medicinal/adverse effects*
15477727;Dietary Supplements/adverse effects*;Food, Organic*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans
15467212;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;Animals;Apocynum*;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Cytochrome P-450 CYP3A;Herb-Drug Interactions;Hypericum;In Vitro Techniques;Intestinal Absorption;Male;Methylprednisolone/pharmacokinetics;Nifedipine/pharmacokinetics;Oxidoreductases, N-Demethylating/biosynthesis*;Plant Extracts/pharmacology;Rats;Rats, Wistar
15386721;Child;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Kava/adverse effects*;Male;Middle Aged;Pharmacoepidemiology*
15386186;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Phytotherapy*;Plant Extracts/metabolism*;Plant Extracts/pharmacokinetics;Plants, Medicinal*
15369000;Chondroitin;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Garlic;Ginger;Ginkgo biloba;Glucosamine;Herb-Drug Interactions*;Herbal Medicine;Humans;Hypericum;Kava;Orthopedics*;Panax;Perioperative Care;Phytotherapy/adverse effects;Valerian
15368996;Dose-Response Relationship, Drug;Drug Administration Schedule;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Herb-Drug Interactions;Herbal Medicine;Humans;Perioperative Care;Phytotherapy/adverse effects;Risk Factors
15350672;Animals;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2E1/drug effects;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/toxicity*;Enzyme Induction/drug effects;Gene Expression Regulation, Enzymologic/drug effects*;Health Surveys;Herb-Drug Interactions*;Humans;Korea;Male;Obesity/drug therapy;Plant Extracts/toxicity*;Rats;Rats, Sprague-Dawley
15341976;Child;Complementary Therapies*;Dietary Supplements;Herb-Drug Interactions;Humans;Mind-Body Therapies;Neoplasms/therapy*;Phytotherapy
15341178;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nurse's Role;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/nursing
15339595;Anti-Bacterial Agents/therapeutic use;Combined Modality Therapy;Drug Therapy, Combination;Herb-Drug Interactions;Humans;Medicine, Chinese Traditional*;Respiration, Artificial;Severe Acute Respiratory Syndrome/therapy*;Treatment Outcome
15339586;Antibiotics, Antineoplastic/pharmacology;Cell Proliferation/drug effects*;Chromatography, High Pressure Liquid;Daunorubicin/pharmacology;Drugs, Chinese Herbal/pharmacology*;Electrophoresis, Gel, Two-Dimensional;Female;Herb-Drug Interactions;Humans;Male;Neoplasms/drug therapy;Neoplasms/pathology;Plant Extracts/isolation & purification;Plant Extracts/pharmacology;Polygonaceae*;Tumor Cells, Cultured
15330011;Asthma/immunology*;Asthma/therapy*;Clinical Trials as Topic;Complementary Therapies*/classification;Herb-Drug Interactions;Humans;Hypersensitivity/immunology;Hypersensitivity/therapy;Phytotherapy/classification;Plant Preparations/classification;Plants, Medicinal/classification;United States
15316539;Attitude to Health;Complementary Therapies*/classification;Dental Care;Dentistry*;Herb-Drug Interactions;Humans;Nonprescription Drugs/therapeutic use;Phytotherapy/adverse effects;United States
15310261;Acupuncture Therapy;Complementary Therapies*;Herb-Drug Interactions*;Humans;Risk;Risk Management;Safety
15307350;Drug Monitoring;Herb-Drug Interactions;Humans;Nursing Assessment;Patient Acceptance of Health Care;Patient Education as Topic;Phytotherapy/adverse effects*;Phytotherapy/utilization
15303543;Animals;Antioxidants/adverse effects;Antioxidants/pharmacokinetics;Antioxidants/pharmacology*;Clinical Trials as Topic;Flavonoids/adverse effects;Flavonoids/pharmacokinetics;Flavonoids/pharmacology*;Herb-Drug Interactions;Humans;Phytotherapy/methods;Plants, Medicinal*
15270047;Herb-Drug Interactions;Humans;Nursing Assessment/methods;Phytotherapy/adverse effects*;Phytotherapy/nursing
15266321;Complementary Therapies/adverse effects*;Herb-Drug Interactions*;Humans;Neoplasms/therapy*;Phytotherapy/adverse effects;Plants, Medicinal/adverse effects
15266218;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Animals;Biological Transport;Cell Membrane Permeability;Cells, Cultured;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/genetics;Dose-Response Relationship, Drug;HIV Protease Inhibitors/pharmacokinetics*;Herb-Drug Interactions*;Humans;Male;Microsomes, Liver/metabolism;RNA, Messenger/biosynthesis;Rats;Rats, Sprague-Dawley;Ritonavir/pharmacokinetics*
15261327;Anesthesia*;Antidepressive Agents/adverse effects*;Cardiovascular Diseases/chemically induced;Herb-Drug Interactions*;Humans;Kava/adverse effects*;Perioperative Care;Plant Extracts/administration & dosage;Plant Extracts/adverse effects
15260917;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction/drug effects;Herb-Drug Interactions/genetics*;Humans;Hypericum/chemistry;Hypericum/drug effects;Hypericum/metabolism*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics*;Randomized Controlled Trials as Topic
15260514;Aged;Aged, 80 and over;Dietary Supplements/utilization*;Drug Utilization;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Pharmaceutical Preparations/administration & dosage;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Surveys and Questionnaires;United Kingdom
15234747;Anti-Anxiety Agents/adverse effects*;Anti-Anxiety Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacology;Cytochrome P-450 Enzyme System/drug effects;Enzyme Inhibitors/adverse effects*;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Kava*;Phytotherapy*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology
15231618;Area Under Curve;Clinical Trials as Topic/standards;Herb-Drug Interactions*;Humans;Hypericum/metabolism*;Observer Variation;Pharmacokinetics
15197212;Antineoplastic Agents/pharmacology*;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*;United States
15189680;False Positive Reactions;Herb-Drug Interactions*;Humans;Plant Preparations/urine*;Street Drugs/urine*;Substance Abuse Detection/methods*
15187203;Dietary Supplements*/adverse effects;Drug Utilization;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Primary Health Care*;Self Medication;Surveys and Questionnaires;Urologic Diseases*/chemically induced
15182880;Aged;Aged, 80 and over;Attitude to Health;Dose-Response Relationship, Drug;Female;Follow-Up Studies;Geriatric Assessment;Herb-Drug Interactions;Humans;Male;Patient Education as Topic*;Phytotherapy/methods*;Plants, Medicinal*;Risk Assessment;Treatment Outcome
15180581;Animals;Evidence-Based Medicine/methods*;Herb-Drug Interactions*;Herbal Medicine/classification;Humans;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Randomized Controlled Trials as Topic
15176651;Adult;Aged;Anti-Arrhythmia Agents/blood*;Antidiarrheals/blood*;Apocynaceae/chemistry*;Digitoxin/blood;Digoxin/blood;False Positive Reactions;Female;Glycosides/blood*;Half-Life;Herb-Drug Interactions;Humans;Male;Pilot Projects;Plant Extracts/blood;Plant Roots/chemistry
15145962;Beverages/adverse effects*;Citrus*;Dietary Supplements;Drug Interactions*;Drug Labeling/legislation & jurisprudence;Female;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Male;Pharmacogenetics;Sex Factors
15120451;Administration, Oral;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Biological Availability;Carrageenan;Diclofenac/administration & dosage;Diclofenac/blood;Diclofenac/pharmacokinetics;Diclofenac/pharmacology*;Edema/chemically induced;Edema/prevention & control;Fruit;Ginger*;Herb-Drug Interactions;Male;Medicine, Ayurvedic;Phytotherapy*;Piper*;Plant Extracts/pharmacology*;Rabbits;Rats;Rats, Wistar
15114493;Chemical and Drug Induced Liver Injury/etiology*;Herb-Drug Interactions;Humans;Kava*;Phytotherapy*;Plant Extracts/adverse effects*
15090899;Aged;Food-Drug Interactions/physiology*;Herb-Drug Interactions/physiology*;Humans;Nutritional Status/physiology
15089812;Analysis of Variance;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Cross-Over Studies;Herb-Drug Interactions;Humans;Hypericum*;International Normalized Ratio;Male;Panax*;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Prothrombin Time;Warfarin/analogs & derivatives*;Warfarin/blood;Warfarin/pharmacokinetics*;Warfarin/pharmacology;Warfarin/urine
15072439;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Herb-Drug Interactions*;Humans;Phytotherapy;Plants, Medicinal/metabolism*
15061327;Consumer Product Safety;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal*;United States;United States Food and Drug Administration
15056330;Aged;Attitude to Health;Community Health Nursing/methods;Complementary Therapies/utilization;Cross-Sectional Studies;Female;Health Behavior;Health Status;Herb-Drug Interactions;Humans;Phytotherapy/utilization*;Socioeconomic Factors;Turkey
15049433;Adult;Area Under Curve;Depressive Disorder/drug therapy;Female;Herb-Drug Interactions*;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Organ Transplantation;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Serotonin Uptake Inhibitors/therapeutic use
15037491;Dietary Supplements*;Drug Interactions*;Female;Health Surveys;Herb-Drug Interactions;Humans;Male;Middle Aged;Primary Health Care;United States
15022662;Attitude of Health Personnel*;Complementary Therapies/adverse effects;Complementary Therapies/utilization*;Family Practice;Female;Herb-Drug Interactions;Humans;Male;Medical History Taking;Middle Aged;Physician-Patient Relations;Self Medication/adverse effects
15018694;Aged;Aged, 80 and over;Alzheimer Disease/diagnosis;Alzheimer Disease/drug therapy*;Alzheimer Disease/psychology;Caregivers/education;Caregivers/psychology;Comorbidity;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/psychology;Dietary Supplements*/adverse effects;Drug Utilization/statistics & numerical data;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/therapeutic use*;Educational Status;Herb-Drug Interactions;Hospitals, Veterans;Humans;Male;Mental Status Schedule;Michigan;Patient Education as Topic;Phytotherapy/utilization*;Veterans/psychology*
15017578;Child;Child, Preschool;Herb-Drug Interactions;Humans;Phytotherapy/utilization*;Plant Preparations/therapeutic use*;Surgical Procedures, Operative/statistics & numerical data*;Surveys and Questionnaires
14999364;Acute Kidney Injury/chemically induced*;Cyclooxygenase 1;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/adverse effects*;Cyclooxygenase Inhibitors/pharmacokinetics;Herb-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Membrane Proteins;Nonprescription Drugs;Plant Preparations;Prostaglandin-Endoperoxide Synthases;Risk Factors
14991387;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects*;Attitude to Health;Female;Herb-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/psychology;Patient Compliance;Patient Education as Topic/methods;Phytotherapy/adverse effects*;Pilot Projects;Plants, Medicinal/adverse effects*;Professional-Patient Relations;Surveys and Questionnaires;Time Factors;Washington
14984852;Adolescent;Child;Child, Preschool;Complementary Therapies/utilization*;Data Collection;Female;Herb-Drug Interactions;Humans;Infant;Male;Phytotherapy/utilization*;Plant Preparations*;Surgical Procedures, Operative*
14980009;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Bridged Bicyclo Compounds;Flow Cytometry;Genes, MDR;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Mice;NIH 3T3 Cells;Perylene/analogs & derivatives*;Perylene/pharmacology*;Phloroglucinol/analogs & derivatives;Terpenes/pharmacology*
14766022;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/prevention & control*;Calcium Channel Blockers/administration & dosage;Carnitine/administration & dosage;Coenzymes;Dietary Supplements*/adverse effects;Digoxin/administration & dosage;Electrolytes/administration & dosage*;Electrolytes/adverse effects;Fatty Acids, Omega-3/administration & dosage;Free Radical Scavengers/administration & dosage;Glycosides/administration & dosage;Glycosides/adverse effects;Herb-Drug Interactions;Herbal Medicine*;Humans;Ubiquinone/administration & dosage;Ubiquinone/analogs & derivatives*;Vitamins/administration & dosage*
14765834;Anticoagulants/adverse effects*;Aortic Valve*;Heart Valve Diseases/complications;Heart Valve Diseases/etiology*;Heart Valve Prosthesis*;Herb-Drug Interactions*;Humans;Male;Middle Aged;Myocardial Infarction/etiology*;Plants, Medicinal/adverse effects*;Postoperative Complications/etiology*;Thrombosis/complications;Thrombosis/etiology*;Warfarin/adverse effects*
14749695;Administration, Oral;Adult;Area Under Curve;Caffeine/administration & dosage;Caffeine/pharmacokinetics;Cytochrome P-450 Enzyme System/drug effects*;Dextromethorphan/administration & dosage;Dextromethorphan/pharmacokinetics;Echinacea*;Female;Herb-Drug Interactions;Humans;Infusions, Intravenous;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Roots;Reference Values;Tolbutamide/administration & dosage;Tolbutamide/pharmacokinetics
14749688;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/adverse effects*
14702801;Dose-Response Relationship, Drug;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
14674921;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Drug Eruptions/etiology*;Drugs, Chinese Herbal/adverse effects*;Female;Herb-Drug Interactions;Humans;Japan;Middle Aged;Patch Tests;Plant Preparations/adverse effects*
14670163;Dietary Supplements/classification;Dietary Supplements/utilization*;Female;Herb-Drug Interactions;Hot Flashes/drug therapy;Humans;Isoflavones/classification;Isoflavones/therapeutic use;Menopause/drug effects;Physician-Patient Relations;Phytoestrogens;Phytotherapy/classification;Phytotherapy/utilization*;Plant Preparations/classification;Plant Preparations/therapeutic use;Treatment Outcome;Women's Health*
14664751;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions/physiology*;Humans;Neoplasms/drug therapy*;Neoplasms/enzymology*
14640772;Drug Prescriptions*;Herb-Drug Interactions*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*
14631731;Complementary Therapies/adverse effects*;Herb-Drug Interactions;Humans;Meningioma/drug therapy;Meningioma/surgery;Nutrition Therapy;Phytotherapy;Quality of Life
14596440;Dose-Response Relationship, Drug;Herb-Drug Interactions;Humans;Panax*;Phytotherapy*;Plant Preparations/pharmacology*
14595964;Drug Administration Schedule;Drug Interactions*;Food-Drug Interactions;Herb-Drug Interactions;Humans;Intestinal Absorption/drug effects;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism;Pharmacokinetics
14522595;Albendazole/administration & dosage;Albendazole/analogs & derivatives*;Albendazole/analysis;Albendazole/pharmacokinetics*;Animals;Anthelmintics/administration & dosage;Anthelmintics/analysis;Anthelmintics/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Drug Therapy, Combination;Herb-Drug Interactions;Injections, Intravenous;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Jejunum/drug effects*;Jejunum/metabolism;Male;Metabolic Clearance Rate/drug effects;Metabolic Clearance Rate/physiology;Panax*/chemistry;Perfusion;Plant Extracts/pharmacology*;Rats;Rats, Wistar
14506083;Aged;Geriatric Psychiatry/methods*;Herb-Drug Interactions;Humans;Mental Disorders/drug therapy*;Phytotherapy/adverse effects*;Plants, Medicinal*
14503986;Drugs, Chinese Herbal;Herb-Drug Interactions;Herbal Medicine/legislation & jurisprudence;Herbal Medicine/methods*;Humans;Phytotherapy/adverse effects*;Plant Preparations/adverse effects;Plant Preparations/toxicity;Risk Factors
12911685;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Isoenzymes/metabolism;Medicine, Kampo*;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology
12856855;Animals;Dose-Response Relationship, Drug;Drug Interactions*;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/toxicity;Herb-Drug Interactions;Humans
12832592;Depressive Disorder/drug therapy*;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy*
12784545;Animals;Antidepressive Agents/adverse effects*;Antidepressive Agents/pharmacokinetics;Central Nervous System Diseases/chemically induced;Dermatitis, Phototoxic/pathology;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Pharmacokinetics;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plant Extracts/pharmacokinetics
12635815;Animals;Cytochrome P-450 Enzyme System/metabolism*;Herb-Drug Interactions;Humans;Plants, Medicinal/chemistry*;Plants, Medicinal/metabolism*
12597263;Anticoagulants/pharmacology;Cardiovascular Agents/pharmacology*;Digoxin/pharmacology;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum;Hypertension/chemically induced;Hypokalemia/chemically induced;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/pharmacology
12568285;Animals;Blood Cell Count;Cassia/toxicity*;Diet;Drug Interactions;Eating/drug effects;Enteritis/chemically induced;Enteritis/pathology;Enzymes/blood;Growth/drug effects;Herb-Drug Interactions;Intestinal Mucosa/pathology;Male;Nerium/toxicity*;Rats;Rats, Wistar;Saudi Arabia;Weight Gain/drug effects
12472978;Analgesics/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anticoagulants/adverse effects;Aspirin/adverse effects;Dietary Supplements/adverse effects;Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/adverse effects*
12429683;Adolescent;Adult;Anti-Bacterial Agents*;Contraceptives, Oral*;Drug Interactions*;Female;Health Knowledge, Attitudes, Practice*;Herb-Drug Interactions;Humans;Hypericum*;Surveys and Questionnaires
12428996;Aged;Drug Interactions*;Drug Prescriptions;Drug-Related Side Effects and Adverse Reactions*;Female;Health Services for the Aged*;Herb-Drug Interactions;Hospitals, University;Humans;Male;Memory Disorders/drug therapy*;Nonprescription Drugs/adverse effects;Ontario;Plants, Medicinal/adverse effects*
12426769;Animals;Anticoagulants/adverse effects*;Drug Interactions;Food-Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal;Warfarin/adverse effects*
12424801;Albumins/metabolism;Binding, Competitive;Digoxin/analysis;Digoxin/blood;Digoxin/chemistry;Dose-Response Relationship, Drug;Drug Interactions*;Drugs, Chinese Herbal*;Enzyme Inhibitors/analysis;Enzyme Inhibitors/blood;Enzyme Inhibitors/chemistry;Enzyme Multiplied Immunoassay Technique;Herb-Drug Interactions;Humans;In Vitro Techniques;Medicine, Chinese Traditional;Phenanthrolines/antagonists & inhibitors*;Phenanthrolines/pharmacology;Plant Extracts/antagonists & inhibitors*;Plant Extracts/pharmacology;Salicylates/pharmacology*
12419960;Animals;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Drug Interactions/physiology;Drugs, Chinese Herbal/isolation & purification;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology;Female;Herb-Drug Interactions;Herbal Medicine;Medicine, Traditional;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Protein Binding/drug effects;Protein Binding/physiology;Rats;Rats, Sprague-Dawley
12404705;Adult;Cognition/drug effects*;Cognition/physiology;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Ginkgo biloba*;Herb-Drug Interactions;Humans;Male;Mathematics;Nootropic Agents/pharmacology*;Panax*;Plant Extracts/pharmacology;Psychomotor Performance/drug effects*;Psychomotor Performance/physiology
12397870;Animals;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Psychotropic Drugs/pharmacokinetics;Psychotropic Drugs/pharmacology
12392581;Contraceptives, Oral/metabolism;Cyclosporine/metabolism;Digoxin/metabolism;Drug Interactions*;HIV Protease Inhibitors/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism*;Plant Extracts/adverse effects;Plant Extracts/metabolism*;Serotonin Uptake Inhibitors/metabolism;Theophylline/metabolism;Warfarin/metabolism
12378978;Beverages/adverse effects*;Biological Availability;Biotransformation/drug effects*;Citrus/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Drug Interactions*;Garlic/adverse effects*;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Mixed Function Oxygenases/antagonists & inhibitors;Phytotherapy/adverse effects*;Substance P/antagonists & inhibitors
12362826;Controlled Clinical Trials as Topic;Drug Interactions*;Evidence-Based Medicine;Garlic/adverse effects;Garlic/metabolism;Ginkgo biloba/adverse effects;Ginkgo biloba/metabolism;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Panax/adverse effects;Panax/metabolism;Phytotherapy/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/metabolism;Plant Extracts/pharmacokinetics;Plants, Medicinal/adverse effects*;Plants, Medicinal/metabolism;Practice Guidelines as Topic;Valerian/adverse effects;Valerian/metabolism
12235448;Adult;Allyl Compounds/pharmacokinetics;Analysis of Variance;Cytochrome P-450 CYP2E1/genetics*;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions/genetics;Female;Ginkgo biloba/metabolism;Herb-Drug Interactions;Humans;Hypericum/metabolism;Male;Mixed Function Oxygenases/genetics*;Mixed Function Oxygenases/metabolism;Panax/metabolism;Phenotype;Phytotherapy/methods;Plant Preparations/administration & dosage*;Plant Preparations/pharmacokinetics;Predictive Value of Tests;Sex Factors;Sulfides/pharmacokinetics
12175708;Animals;Binding, Competitive/drug effects;CHO Cells;Cells, Cultured;Cricetinae;Cyclic AMP/metabolism;Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology;Herb-Drug Interactions;Humulus/chemistry*;Plant Extracts/pharmacology;Purinergic P1 Receptor Antagonists;Radioligand Assay;Receptor, Adenosine A2A;Receptors, Purinergic P1/drug effects*;Valerian/chemistry*
12169403;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Chromatography, High Pressure Liquid;Drug Synergism;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Injections, Intravenous;Male;Mice;Prothrombin Time;Rats;Rats, Wistar;Warfarin/administration & dosage;Warfarin/blood;Warfarin/pharmacokinetics*
12160480;Animals;Cytochrome P-450 Enzyme System/biosynthesis;Drug Interactions;Herb-Drug Interactions;Humans;Pharmacokinetics*;Phytotherapy*;Plant Extracts/adverse effects*;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Xenobiotics/metabolism
12125624;Anxiety/drug therapy;Depression/drug therapy;Drug Interactions;Female;HIV Infections/drug therapy;HIV Infections/psychology;HIV Protease Inhibitors/pharmacology*;HIV Seronegativity;Herb-Drug Interactions;Humans;Hypericum*;Indinavir/pharmacology*;Male
12125178;Alcoholic Beverages/adverse effects*;Biological Availability;Drug Interactions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Risk Factors
12125177;Drug Contamination;Drug Hypersensitivity/etiology;Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Switzerland
12110997;Antidepressive Agents/chemistry;Antidepressive Agents/pharmacology*;Biogenic Amines/metabolism;Biological Transport;Drug Evaluation, Preclinical;Flavonoids/chemistry;Flavonoids/pharmacology*;GTP-Binding Proteins/metabolism*;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Membrane Transport Proteins/metabolism*;Plant Extracts/chemistry;Radioligand Assay;Receptors, Biogenic Amine/drug effects*;Receptors, Biogenic Amine/metabolism
12100483;Amino Acid Sequence;Arabidopsis/drug effects;Arabidopsis/embryology;Arabidopsis/genetics*;Arabidopsis/metabolism*;Base Sequence;Cholestadienols/pharmacology;DNA, Plant/genetics;Enzyme Inhibitors/pharmacology;Gas Chromatography-Mass Spectrometry;Genes, Plant*;Herb-Drug Interactions;Methyltransferases/genetics;Models, Biological;Mutation;Oxidoreductases/antagonists & inhibitors;Oxidoreductases/genetics;Phenotype;Phytosterols/biosynthesis*;Steroid Isomerases/genetics
12020172;Clinical Trials as Topic;Databases, Bibliographic;Drug Interactions;Female;Herb-Drug Interactions;Humans;Male;Panax/adverse effects*
11995940;Animals;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Drug Interactions/physiology;Drugs, Chinese Herbal/pharmacokinetics*;Herb-Drug Interactions;Male;Paeonia/metabolism*;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Roots/metabolism;Rats;Rats, Sprague-Dawley
11883051;Dose-Response Relationship, Drug;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Self Medication
11849198;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;ATP-Binding Cassette, Sub-Family B, Member 1/blood;Analysis of Variance;Drug Interactions/physiology;Female;HIV Protease Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Hypericum/chemistry*;Lymphocytes/drug effects;Lymphocytes/metabolism;Male;Ritonavir/pharmacology;Single-Blind Method;Statistics, Nonparametric
11786229;Binding Sites;Carbohydrate Sequence;Deuterium Oxide;Drug Design;Galectin 1;Hemagglutinins/chemistry*;Herb-Drug Interactions;Lactose/analogs & derivatives;Lactose/chemistry*;Lectins/chemistry*;Magnetic Resonance Spectroscopy/methods*;Mistletoe;Models, Molecular;Molecular Conformation;Molecular Sequence Data;Plant Lectins;Plant Preparations*;Plant Proteins*;Ribosome Inactivating Proteins, Type 2;Solutions;Surface Properties;Toxins, Biological/chemistry;Xylose/chemistry*
11772128;Drug Interactions*;Drug Prescriptions*;Echinacea/adverse effects;Garlic/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kava/adverse effects;Panax/adverse effects;Phytotherapy/adverse effects*;Plant Extracts/adverse effects;Plant Preparations/adverse effects*;Plant Preparations/pharmacokinetics;Serenoa
11736868;Adult;Aged;Aged, 80 and over;Cycadopsida*;Databases as Topic;Drug Interactions*;Female;Herb-Drug Interactions;Humans;Magnoliopsida*;Male;Middle Aged;Phytotherapy*/adverse effects
11714999;Cardiovascular Agents/pharmacology*;Drug Interactions;Herb-Drug Interactions;Humans;Plants, Medicinal*
11695885;Cannabis;Clinical Trials as Topic;Drug Interactions*;Drug Synergism*;Flavonoids;Ginkgo biloba;Glycyrrhiza;Herb-Drug Interactions;Humans;Hypericum;Kava;Oils, Volatile;Panax;Phytotherapy*;Valerian
11556915;Anti-Infective Agents, Local/chemistry;Anti-Infective Agents, Local/pharmacology*;Candida albicans/drug effects;Escherichia coli/drug effects;Herb-Drug Interactions;Magnoliopsida/chemistry*;Microbial Sensitivity Tests;Monoterpenes*;Oils, Volatile/chemistry;Oils, Volatile/pharmacology;Plant Oils/chemistry;Plant Oils/pharmacology*;Plants, Medicinal/chemistry*;Pseudomonas aeruginosa/drug effects;Solubility;Staphylococcus aureus/drug effects;Tea/chemistry;Terpenes/chemistry;Trees/chemistry
11554427;Animals;Anticonvulsants/pharmacokinetics*;Anticonvulsants/pharmacology*;Biotransformation;Blood Proteins/metabolism;Carbamazepine/pharmacokinetics*;Carbamazepine/pharmacology*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;In Vitro Techniques;Liver/drug effects;Liver/enzymology;Male;Medicine, Kampo;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Protein Binding;Rats;Rats, Wistar
11542535;Animals;Capsicum/drug effects;Capsicum/growth & development*;Capsicum/metabolism;Capsicum/radiation effects;Carbon Dioxide/pharmacology*;Carbon Dioxide/toxicity;Cell Respiration/drug effects;Darkness;Drosophila melanogaster;Ecosystem;Environment, Controlled*;Hemiptera;Herb-Drug Interactions;Insecta/drug effects*;Insecta/physiology;Insecticides/pharmacology*;Light;Malathion/pharmacology*;Photosynthesis/drug effects;Plants, Medicinal*
11407242;Adult;Contraceptives, Oral, Combined/adverse effects;Depressive Disorder/drug therapy*;Drug Interactions;Female;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Nonprescription Drugs/adverse effects*;Plants, Medicinal*
11315759;Antidepressive Agents/adverse effects*;Clinical Trials as Topic;Contraindications;Dermatitis, Phototoxic/epidemiology;Dermatitis, Phototoxic/etiology;Drug Interactions;Epidemiologic Studies;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Incidence;Perylene/analogs & derivatives*;Perylene/pharmacology;Photosensitizing Agents/adverse effects;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Plants, Medicinal*/adverse effects;Radiation-Sensitizing Agents/pharmacology
11213066;Adult;Dietary Supplements*;Drug Interactions;Drugs, Chinese Herbal/pharmacology;Female;Graft Rejection/drug therapy;Graft Rejection/prevention & control;Herb-Drug Interactions;Humans;Kidney Transplantation/immunology;Pancreas Transplantation/immunology;Phytotherapy*
11212424;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects*;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Contraceptives, Oral/administration & dosage;Contraceptives, Oral/adverse effects;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects*;Plants, Medicinal*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects
11155496;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Depressive Disorder/drug therapy*;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Plants, Medicinal*;Risk Factors
11144706;Anticoagulants/pharmacology;Dietary Supplements;Drug Interactions;Drugs, Chinese Herbal/pharmacology*;Garlic/chemistry;Ginger/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions;Humans;Panax/chemistry;Plant Extracts/pharmacology;Plants, Medicinal;Warfarin/pharmacology*
11095377;Antiviral Agents/pharmacology;Contraceptives, Oral;Drug Interactions;Female;Hepatitis C/therapy;Herb-Drug Interactions;Humans;Hypericum*;Interferons/pharmacology;Male;Plants, Medicinal*;Pregnancy
11029865;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions;Humans;Pharmacists;Plants, Medicinal/adverse effects
10985130;Adverse Drug Reaction Reporting Systems;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Plants, Medicinal*;South Africa
10953464;Drug Interactions*;Herb-Drug Interactions;Humans;Pharmaceutical Preparations/administration & dosage*;Plants, Medicinal/adverse effects*
10917398;Contraceptives, Oral/adverse effects*;Drug Interactions;Estrogen Replacement Therapy/adverse effects*;Female;Herb-Drug Interactions;Humans;Magnoliopsida/adverse effects*;Middle Aged
10906369;Adverse Drug Reaction Reporting Systems;Anti-Ulcer Agents/adverse effects*;Cisapride/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Induction;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Mixed Function Oxygenases/metabolism*;Plants, Medicinal*;Product Surveillance, Postmarketing;Psychotropic Drugs/adverse effects*;Referral and Consultation*
10902065;Adult;Anticoagulants/adverse effects*;Complementary Therapies*;Herb-Drug Interactions;Humans;Magnoliopsida/adverse effects;Phytotherapy;Vitamins/adverse effects;Warfarin/adverse effects*
10872032;Cyclosporine/blood;Drug Interactions;Graft Rejection/blood;Herb-Drug Interactions;Humans;Hypericum*;Plant Extracts/adverse effects;Plant Extracts/pharmacology*;Plants, Medicinal*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacology;Tremor/chemically induced;Warfarin/pharmacology
10815528;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/chemistry;Hypericum/metabolism*;Plants, Medicinal*;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/chemistry;Serotonin Uptake Inhibitors/metabolism*
10800553;Anticoagulants/pharmacology;Antiviral Agents/pharmacology;Contraceptives, Oral/pharmacology;Drug Interactions;Enzyme Inhibitors/pharmacology;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Hypericum/enzymology;Plants, Medicinal*
10784267;Depression/therapy;Drug Interactions;Drug and Narcotic Control*;European Union;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Hypericum/therapeutic use;Ireland;Phytotherapy*;Plants, Medicinal*;United Kingdom;United States
10737289;Beverages/adverse effects*;Cardiovascular Agents/pharmacology*;Drug Interactions;Herb-Drug Interactions;Humans;Hypokalemia/etiology*;Phytotherapy;Plants, Medicinal/adverse effects*;Plants, Medicinal/therapeutic use;United States
10721388;Benzodiazepines/adverse effects;Beverages/adverse effects*;Calcium Channel Blockers/adverse effects;Cisapride/adverse effects;Citrus/adverse effects*;Cyclosporine/adverse effects;Cytochrome P-450 Enzyme Inhibitors;Drug Prescriptions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Terfenadine/adverse effects
10715935;Antidepressive Agents/adverse effects*;Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Plant Extracts/adverse effects*;Plants, Medicinal*
10702779;Adipose Tissue, Brown/drug effects;Adipose Tissue, Brown/metabolism*;Animals;Body Temperature Regulation/drug effects*;Caffeine/pharmacology*;Catechin/pharmacology;Central Nervous System Stimulants/pharmacology*;Culture Techniques;Ephedrine/pharmacology;Flavonoids*;Herb-Drug Interactions;Male;Norepinephrine/metabolism;Obesity/metabolism*;Oxygen Consumption;Phenols/pharmacology;Plant Extracts/pharmacology;Polymers/pharmacology;Rats;Rats, Sprague-Dawley;Sympathectomy;Sympathetic Nervous System/drug effects;Sympathetic Nervous System/physiology;Tea*
10682937;Animals;Antineoplastic Agents, Phytogenic/isolation & purification;Antineoplastic Agents, Phytogenic/pharmacology*;Cattle;Chromatography, High Pressure Liquid;Drug Interactions;Electron Transport Complex I;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Furans/isolation & purification;Furans/pharmacology*;Herb-Drug Interactions;Lactones/isolation & purification;Lactones/pharmacology*;Mitochondria, Heart/drug effects;Mitochondria, Heart/enzymology*;Multienzyme Complexes/antagonists & inhibitors*;NADH, NADPH Oxidoreductases/antagonists & inhibitors*;Phytotherapy;Plant Extracts/chemistry;Seeds/chemistry
10675182;Anticoagulants/therapeutic use;Drug Contamination;Drug Interactions*;Herb-Drug Interactions;Humans;Plants, Medicinal*
11122556;Aged;Dementia/therapy*;Drug Interactions*;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Kava/adverse effects;MEDLINE;Panax/adverse effects;Plants, Medicinal/adverse effects*;Valerian/adverse effects
10543025;Animals;Birth Weight/drug effects;Body Weight/drug effects;Carcinoma, Hepatocellular/genetics;Carcinoma, Hepatocellular/metabolism;Diet;Embryonic and Fetal Development/drug effects*;Estrogen Receptor alpha;Estrogen Receptor beta;Female;Genistein/toxicity*;Growth/drug effects*;Growth Inhibitors/toxicity*;Herb-Drug Interactions;Humans;Isoflavones/toxicity*;Litter Size/drug effects;Liver Neoplasms/genetics;Liver Neoplasms/metabolism;Male;Ovum/drug effects;Pregnancy;Rats;Rats, Sprague-Dawley;Receptors, Estrogen/agonists*;Receptors, Estrogen/genetics;Receptors, Estrogen/physiology;Sexual Maturation/drug effects;Soybeans;Transfection;Tumor Cells, Cultured
10533874;Anesthetics*;Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal/adverse effects*;Risk Factors;Surgical Procedures, Operative*
10531760;Adult;Aged;Anticoagulants/adverse effects*;Complementary Therapies*;Dietary Supplements/adverse effects*;Drug Interactions;Estrogens, Non-Steroidal/adverse effects*;Estrogens, Non-Steroidal/classification*;Estrogens, Non-Steroidal/therapeutic use;Female;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Isoflavones*;Male;Middle Aged;Panax/adverse effects;Phytoestrogens;Phytotherapy;Plant Preparations;Plants, Medicinal;Warfarin/adverse effects*
10499304;Animals;Drug Antagonism;Drug Interactions;Drug Synergism;Drugs, Chinese Herbal/history;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;History, Ancient;Humans;Medicine, Chinese Traditional*/history;Reproducibility of Results;Yin-Yang
10493330;Drug Interactions;Herb-Drug Interactions;Humans;Plants, Medicinal/adverse effects*
10447148;Aged;Aged, 80 and over;Antidepressive Agents/metabolism*;Antidepressive Agents/therapeutic use;Depressive Disorder/drug therapy;Drug Interactions;Ericales/adverse effects;Ericales/chemistry*;Female;Herb-Drug Interactions;Humans;Male;Middle Aged;Plants, Medicinal/adverse effects;Plants, Medicinal/chemistry*
10417980;Animals;Anisotropy;Biflavonoids*;Cell Line;Cell Membrane/metabolism;Chamomile;Dimerization;Diphenylhexatriene/analogs & derivatives*;Flavonoids/chemistry;Flavonoids/metabolism*;Fluorescent Dyes*;Herb-Drug Interactions;Liposomes/metabolism;Mice;Molecular Structure;Oils, Volatile/chemistry;Oils, Volatile/metabolism*;Phospholipids/metabolism;Plants, Medicinal;Spectrometry, Fluorescence
10394636;Abscisic Acid/pharmacology;Base Sequence;Cloning, Molecular;DNA Primers/genetics;DNA, Plant/genetics;Ethylenes/pharmacology;Fabaceae/drug effects;Fabaceae/enzymology*;Fabaceae/genetics;Gene Expression Regulation, Developmental/drug effects;Gene Expression Regulation, Plant/drug effects;Genes, Plant*/drug effects;Genes, Reporter;Glucuronidase/genetics;Glucuronidase/metabolism;Herb-Drug Interactions;Histocytochemistry;Indoleacetic Acids/pharmacology;Lyases/genetics*;Molecular Sequence Data;Plants, Genetically Modified;Plants, Medicinal*;Plants, Toxic;Promoter Regions, Genetic/drug effects;Tobacco/genetics
10381780;Animals;Calcium/metabolism;Calcium-Transporting ATPases/antagonists & inhibitors*;Calcium-Transporting ATPases/metabolism;Catechols;Cyclic AMP-Dependent Protein Kinases/metabolism;Dogs;Ellagic Acid/pharmacology*;Fatty Alcohols/pharmacology*;Herb-Drug Interactions;In Vitro Techniques;Kinetics;Microsomes/drug effects;Microsomes/enzymology;Muscle, Skeletal/drug effects;Muscle, Skeletal/enzymology;Muscle, Skeletal/ultrastructure;Myocardium/enzymology*;Myocardium/metabolism;Myocardium/ultrastructure;Phosphates/metabolism;Phosphorylation;Plants, Medicinal;Rabbits;Sarcoplasmic Reticulum/drug effects;Sarcoplasmic Reticulum/enzymology*
10375176;Analysis of Variance;Animals;Anticonvulsants/pharmacokinetics*;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacology;Carbamazepine/pharmacokinetics*;Drug Interactions;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Male;Medicine, Chinese Traditional;Phytotherapy;Protein Binding/drug effects;Rats;Rats, Wistar
10088878;Drug Interactions;Ephedrine/adverse effects;Ericales/adverse effects;Ginkgo biloba/adverse effects;Herb-Drug Interactions;Humans;Kava;Panax/adverse effects;Patient Education as Topic;Plant Extracts/adverse effects;Plants, Medicinal/adverse effects*;Teaching Materials;United States;United States Food and Drug Administration
9924842;Adult;Brazil;Drug Interactions;Fluoxetine/adverse effects;Herb-Drug Interactions;Humans;Male;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Serotonin Syndrome/chemically induced*;Serotonin Syndrome/psychology;Serotonin Uptake Inhibitors/adverse effects*
9818800;Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/pharmacology*;Plants, Medicinal/therapeutic use*
9565737;Age Factors;Animals;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus/chemistry*;Coumarins/chemistry;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavonoids/chemistry;Food-Drug Interactions*;Furocoumarins;Herb-Drug Interactions;Humans;Intestine, Small/drug effects;Intestine, Small/enzymology;Male;Mixed Function Oxygenases/metabolism;Risk Assessment;Sex Factors
9395786;Antiviral Agents/pharmacology*;CCAAT-Enhancer-Binding Proteins;DNA, Viral/metabolism;DNA-Binding Proteins/metabolism;Enhancer Elements, Genetic*;Hepatitis B virus/drug effects*;Hepatitis B virus/genetics;Herb-Drug Interactions;Humans;Nuclear Proteins/metabolism;Plants, Medicinal*;Simian virus 40/genetics;Transcription Factors/metabolism*;Tumor Cells, Cultured
9292409;Animals;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/drug therapy*;Benzoates*;Bridged-Ring Compounds*;Calcium Channels/drug effects;Glucosides/metabolism;Glucosides/pharmacology*;Glucosides/therapeutic use;Heart Atria/drug effects;Heart Atria/metabolism;Herb-Drug Interactions;In Vitro Techniques;Male;Monoterpenes;Myocardial Contraction/drug effects*;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Plants, Medicinal*/metabolism;Plants, Medicinal*/therapeutic use;Rats;Rats, Wistar;Sodium Channels/drug effects;Time Factors;Veratrine/metabolism;Veratrine/toxicity*
9260034;Anti-Anxiety Agents/metabolism;Beverages*;Biological Availability;Calcium Channel Blockers/metabolism;Central Nervous System Stimulants/metabolism;Citrus/metabolism*;Controlled Clinical Trials as Topic;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Estrogens/metabolism;Flavonoids/metabolism;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Immunosuppressive Agents/metabolism;In Vitro Techniques;Midazolam/metabolism;Mixed Function Oxygenases/metabolism
9050093;Animals;Anti-Anxiety Agents/pharmacology*;Carbolines/pharmacology*;Diazepam/pharmacology*;Drug Interactions;Ginkgo biloba;Herb-Drug Interactions;Male;Motor Activity/drug effects;Plant Extracts/pharmacology*;Rats;Rats, Wistar;Social Behavior*
8665388;Animals;Disease Vectors*;Drug Evaluation, Preclinical;Herb-Drug Interactions;Larva;Lethal Dose 50;Medicine, African Traditional*;Molluscacides*;Pest Control/methods;Plant Extracts*;Schistosoma haematobium/drug effects*;Schistosoma mansoni/drug effects*;Snails/parasitology*;Water Microbiology;Zimbabwe
7487701;Aged;Drug Combinations;Drugs, Chinese Herbal/adverse effects*;Herb-Drug Interactions;Humans;Male;Phenanthrolines/adverse effects*;Plant Extracts*;Salicylates/adverse effects*;Self Medication;Warfarin/adverse effects*;Warfarin/therapeutic use
7882725;Adolescent;Adult;Cell Communication/drug effects;Cell Fusion/drug effects;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Immunosuppressive Agents/pharmacology*;Lymphocytes/ultrastructure*;Macrophages/ultrastructure*;Male;Microscopy, Electron;Phagocytosis;Semen/cytology;Semen/drug effects*;Tripterygium
8202566;Animals;Erythrocytes/drug effects*;Erythrocytes/metabolism;Ginsenosides;Glucose/metabolism;Herb-Drug Interactions;In Vitro Techniques;Monosaccharide Transport Proteins/drug effects*;Monosaccharide Transport Proteins/metabolism;Panax*;Plants, Medicinal*;Saponins/pharmacology*;Sheep;Structure-Activity Relationship;Triterpenes/pharmacology*
8026706;Animals;Baclofen/metabolism;Bridged Bicyclo Compounds/metabolism;Bridged Bicyclo Compounds, Heterocyclic*;Carbohydrate Sequence;Flunitrazepam/metabolism;Ginsenosides;Herb-Drug Interactions;Ligands;Male;Molecular Sequence Data;Muscimol/metabolism;Panax;Plants, Medicinal;Rats;Rats, Sprague-Dawley;Receptors, GABA-A/drug effects;Receptors, GABA-A/metabolism*;Receptors, GABA-B/drug effects;Receptors, GABA-B/metabolism*;Saponins/pharmacology*;Sulfur Radioisotopes;Tritium
11537706;Cell Polarity/drug effects;Cell Polarity/physiology*;Colchicine/pharmacology;Cytochalasin D/pharmacology;Cytoskeleton/drug effects;Cytoskeleton/physiology*;Cytoskeleton/ultrastructure;Endoplasmic Reticulum/chemistry;Endoplasmic Reticulum/ultrastructure;Gravitation;Herb-Drug Interactions;Immunohistochemistry;Microscopy, Electron;Organelles/metabolism;Organelles/physiology;Organelles/ultrastructure*;Paclitaxel/pharmacology;Peptides/analysis;Peptides/physiology;Phalloidine/pharmacology;Plant Cells;Plant Physiological Phenomena;Plant Proteins/analysis;Plant Proteins/physiology;Plants/ultrastructure*;Plastids/chemistry;Plastids/physiology;Plastids/ultrastructure*;Rotation
8218717;Animals;Drug Interactions;Drug-Related Side Effects and Adverse Reactions*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal*
1509690;Animal Feed;Animals;Body Weight/drug effects*;Cassia*;Chickens;Drug Combinations;Female;Hematologic Tests;Herb-Drug Interactions;Liver Function Tests;Male;Plants, Medicinal*;Plants, Toxic*;Poultry Diseases/chemically induced*;Poultry Diseases/metabolism;Poultry Diseases/pathology
1357129;Adrenergic beta-Agonists/adverse effects;Albuterol/adverse effects;Albuterol/analogs & derivatives;Butylamines/adverse effects;Clozapine/adverse effects;Contraceptives, Oral/pharmacology;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions*;Flecainide/adverse effects;Herb-Drug Interactions;Humans;Medicine, East Asian Traditional;Noscapine/toxicity;Omeprazole/adverse effects;Parasympatholytics/adverse effects;Plants, Toxic;Salmeterol Xinafoate
1323854;Alginates/pharmacology;Animals;Dialysis;Dietary Fiber/pharmacology*;Herb-Drug Interactions;In Vitro Techniques;Intestines/drug effects;Niacin/pharmacology*;Pentoxifylline/pharmacology*;Psyllium/pharmacology;Rats;Viscosity
2052849;Animals;Biomphalaria/growth & development;Biomphalaria/parasitology*;Biomphalaria/physiology;Chemotaxis;Ecdysteroids;Ecdysterone/pharmacology*;Female;Herb-Drug Interactions;Host-Parasite Interactions/drug effects;Host-Parasite Interactions/physiology;Invertebrate Hormones/pharmacology;Invertebrate Hormones/physiology*;Oviposition/drug effects;Plant Extracts/pharmacology*;Schistosoma mansoni/drug effects;Schistosoma mansoni/physiology*
2001408;Adult;Cell Adhesion*/drug effects;Disulfides/pharmacology;Extracellular Matrix/physiology*;Fibronectins/pharmacology;Fibronectins/physiology*;Garlic;Herb-Drug Interactions;Humans;In Vitro Techniques;Kinetics;Luminescent Measurements;Luminol;N-Formylmethionine Leucyl-Phenylalanine/pharmacology;Neutrophils/cytology;Neutrophils/drug effects;Neutrophils/physiology*;Oligopeptides/pharmacology;Plant Extracts/pharmacology;Plants, Medicinal;Receptors, Immunologic/drug effects;Tetradecanoylphorbol Acetate/pharmacology
1793770;Animals;Herb-Drug Interactions;Humans;Phytotherapy*;Plant Extracts/adverse effects*;Plants, Medicinal*
2397548;Antihypertensive Agents*;Drug Compounding;Drug Interactions;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Humans;Hydralazine/administration & dosage;Hydralazine/pharmacology*;Hydrochlorothiazide/administration & dosage;Hydrochlorothiazide/pharmacology*
3390207;Animals;Cell Survival/drug effects;Colchicine/analogs & derivatives*;Colchicine/metabolism;Colchicine/pharmacology;Colchicum/analysis*;Guanosine Triphosphate/metabolism;Herb-Drug Interactions;Hydrolysis;Mice;Mitosis/drug effects*;Plants, Medicinal/analysis*;Structure-Activity Relationship;Tubulin/metabolism*
3434801;Agglutinins/analysis*;Carbohydrate Sequence;Chromatography, High Pressure Liquid;Concanavalin A/analysis*;Datura stramonium/analysis;Glycoside Hydrolases/metabolism*;Herb-Drug Interactions;Lectins/analysis*;Molecular Sequence Data;Oligosaccharides/analysis*;Phytohemagglutinins/analysis*;Plant Extracts/analysis;Plant Lectins;Plants, Medicinal;Plants, Toxic
493123;Cholesterol;DNA, Bacterial/metabolism*;DNA, Circular/metabolism;Deoxyribonucleases/pharmacology;Fabaceae/metabolism;Herb-Drug Interactions;Liposomes*/metabolism;Phosphatidylcholines;Plants, Medicinal;Plasmids;Protoplasts/metabolism*
418440;Animals;Body Temperature/drug effects;Cannabis*;Copper/pharmacology*;Drug Interactions;Drug Tolerance;Female;Herb-Drug Interactions;Hypnotics and Sedatives;Magnesium/pharmacology;Male;Mice;Penicillamine/pharmacology;Pentobarbital/pharmacology;Rats;Zinc/pharmacology
830703;Appetite/drug effects;Benzothiadiazines;Diuretics;Drug Administration Schedule;Drug Interactions;Folic Acid/metabolism;Food*;Glycyrrhiza;Herb-Drug Interactions;Humans;Hypertension/chemically induced;Hypokalemia/chemically induced;Intestinal Absorption/drug effects;Monoamine Oxidase Inhibitors/adverse effects;Pharmaceutical Preparations/metabolism*;Pharmaceutical Preparations/urine;Plants, Medicinal;Sodium/adverse effects;Sodium Chloride Symporter Inhibitors/adverse effects;Taste/drug effects;Tyramine/adverse effects;Vitamin D/metabolism
1238886;Animals;Cannabidiol/therapeutic use*;Cannabis/therapeutic use*;Dronabinol/therapeutic use*;Drug Synergism;Herb-Drug Interactions;Humans;Male;Morphine;Phytotherapy*;Rats;Substance Withdrawal Syndrome/drug therapy*
1202312;Aedes*;Alkaloids/analysis;Animals;Anthraquinones/analysis;Cardiac Glycosides/analysis;Flavonoids/analysis;Herb-Drug Interactions;Insecticides*/analysis;Larva;Minnesota;North Dakota;Phenols/analysis;Phytosterols/analysis;Plant Extracts;Saponins/analysis
1097148;Adult;Benzopyrans/administration & dosage;Benzopyrans/pharmacology;Cannabidiol/administration & dosage;Cannabidiol/pharmacology*;Cannabis/administration & dosage;Cannabis/pharmacology*;Clinical Trials as Topic;Dronabinol/administration & dosage;Dronabinol/pharmacology*;Drug Interactions;Eye/drug effects;Herb-Drug Interactions;Humans;Male;Phytotherapy;Pulse/drug effects;Time Factors;Time Perception/drug effects
234681;Benzothiadiazines;Diet;Diuretics;Drug-Related Side Effects and Adverse Reactions*;Food*;Glycyrrhiza;Herb-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Malabsorption Syndromes/chemically induced;Monoamine Oxidase Inhibitors/adverse effects;Nutritional Physiological Phenomena/drug effects*;Pharmaceutical Preparations/metabolism*;Plants, Medicinal;Potassium/metabolism;Sodium Chloride Symporter Inhibitors/adverse effects;Vitamins/adverse effects
4850601;Animals;Cannabis/administration & dosage;Cannabis/pharmacology*;Depression, Chemical;Dose-Response Relationship, Drug;Drug Combinations;Drug Interactions;Electroshock;Herb-Drug Interactions;Injections, Intraperitoneal;Male;Mice;Pentylenetetrazole/pharmacology;Phenobarbital/pharmacology;Phenytoin/pharmacology*;Phytotherapy;Seizures/chemically induced;Seizures/drug therapy*;Stimulation, Chemical
4300950;Acacia;Alcohols;Aluminum;Calcium Carbonate;Calcium Hydroxide;Chemistry, Pharmaceutical;Citrates;Herb-Drug Interactions;Hydroxides;Iron*;Kaolin;Lactose;Magnesium;Magnesium Oxide;Oxides;Pharmaceutical Vehicles*;Phosphates;Polyethylenes;Potassium Iodide;Silicon Dioxide;Sodium Chloride;Spectrum Analysis;Stearic Acids;Sulfates;Zinc
4389856;Anesthetics/pharmacology*;Benzothiadiazines/adverse effects;Cortisone/adverse effects;Drug Antagonism*;Ganglionic Blockers/adverse effects;Herb-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Plants, Medicinal;Preoperative Care*;Rauwolfia/adverse effects;Sympatholytics/adverse effects;Sympathomimetics/adverse effects;Tranquilizing Agents/adverse effects;Vasodilator Agents/adverse effects
29503428;Administration, Oral;Food Additives/adverse effects*;Food-Drug Interactions*;Humans;Inositol/analogs & derivatives;Magnesium Oxide;Solubility;Tablets/administration & dosage*
29345156;Adult;Animals;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics;Catechol O-Methyltransferase Inhibitors/administration & dosage;Catechol O-Methyltransferase Inhibitors/pharmacokinetics;Dose-Response Relationship, Drug;Drug Therapy, Combination;Food-Drug Interactions;Half-Life;Humans;Levodopa/administration & dosage;Levodopa/pharmacokinetics;Oxadiazoles/administration & dosage*;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics;Parkinson Disease/drug therapy*;Parkinson Disease/physiopathology
29220436;Computational Biology;Data Mining;Databases, Pharmaceutical*;Databases, Protein*;Food-Drug Interactions*;Humans;Plants, Edible*;User-Computer Interface
29191726;Basic Helix-Loop-Helix Transcription Factors/agonists*;Basic Helix-Loop-Helix Transcription Factors/antagonists & inhibitors*;Cell Line, Tumor;Cell Survival/drug effects;Cooking;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism;Food-Drug Interactions;Gene Expression Regulation/drug effects;Humans;Laurus;Myristica fragrans;Oils, Volatile/pharmacology*;Origanum;Plant Oils/pharmacology*;RNA, Messenger/genetics;RNA, Messenger/metabolism;Receptors, Aryl Hydrocarbon/agonists*;Receptors, Aryl Hydrocarbon/antagonists & inhibitors*;Spices/analysis*;Thymus Plant
29092729;Adult;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Benzopyrans/pharmacokinetics*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Propionates/pharmacokinetics*;Therapeutic Equivalency;Young Adult
29086063;Adolescent;Adult;Benzimidazoles/pharmacokinetics;Benzimidazoles/therapeutic use*;Biological Availability;Female;Food Analysis;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;Phenylurea Compounds/pharmacokinetics;Phenylurea Compounds/therapeutic use*;Proton Pump Inhibitors/therapeutic use*;Young Adult
29076384;Adolescent;Animals;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Child;Drug Monitoring;Food-Drug Interactions;Fusion Proteins, bcr-abl;Humans;Imatinib Mesylate/pharmacokinetics;Imatinib Mesylate/pharmacology;Imatinib Mesylate/therapeutic use*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Medication Adherence;Protein Kinase Inhibitors/pharmacokinetics;Protein Kinase Inhibitors/pharmacology;Protein Kinase Inhibitors/therapeutic use
28980319;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport;Catechin/chemistry;Cell Line;Cyclodextrins/chemistry*;Digoxin/administration & dosage;Digoxin/chemistry;Digoxin/pharmacokinetics;Food-Drug Interactions*;Intestinal Absorption;Intestine, Small/metabolism;Male;Quinidine/administration & dosage;Quinidine/chemistry;Quinidine/pharmacokinetics;Rats;Rats, Sprague-Dawley;Rhodamine 123/administration & dosage;Rhodamine 123/chemistry;Rhodamine 123/pharmacokinetics;Solubility;Swine;Tea/chemistry*
28948482;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacokinetics;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Fasting;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Hydrocodone/administration & dosage*;Hydrocodone/pharmacokinetics;Male;Naltrexone/administration & dosage*
28941798;Animals;Cytochrome P-450 Enzyme Inhibitors/toxicity*;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Food-Drug Interactions;Humans;Hydroxylation;Inhibitory Concentration 50;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Naphthoquinones/toxicity*;Rats;Rats, Sprague-Dawley
28933336;Adolescent;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Chromatography, Liquid/methods*;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Oxycodone/administration & dosage*;Oxycodone/adverse effects;Oxycodone/pharmacokinetics;Tablets;Tandem Mass Spectrometry/methods*;Therapeutic Equivalency;Young Adult
28892755;Binding Sites;Binding, Competitive;Blood Proteins/chemistry;Blood Proteins/metabolism*;Circular Dichroism;Flavonoids/chemistry;Flavonoids/metabolism*;Food-Drug Interactions;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Kinetics;Molecular Docking Simulation;Protein Binding;Protein Structure, Tertiary;Pyridines/chemistry;Pyridines/metabolism*;Rutin/chemistry;Rutin/metabolism;Serum Albumin/chemistry;Serum Albumin/metabolism;Spectrophotometry, Ultraviolet;Thermodynamics
28776077;Abiraterone Acetate/administration & dosage*;Abiraterone Acetate/adverse effects;Abiraterone Acetate/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Liberation;Food-Drug Interactions*;Humans;Male;Middle Aged;Solubility
28655386;Adult;Citrus;Female;Food-Drug Interactions*;Fruit and Vegetable Juices;Humans;Interferon-beta/adverse effects*;Multiple Sclerosis/drug therapy;Rhabdomyolysis/chemically induced*
28635328;Administration, Oral;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Azetidines/administration & dosage;Azetidines/pharmacology;Benzylamines/administration & dosage;Benzylamines/pharmacology;Diet;Dietary Supplements;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Stroke/etiology;Stroke/prevention & control;Thromboembolism/etiology;Thromboembolism/prevention & control*;Vitamin K/administration & dosage*;Vitamin K/antagonists & inhibitors;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacology
28622592;Animals;Ethanol/metabolism*;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/metabolism*;Humans
28622205;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy*;Caffeine/adverse effects;Caffeine/blood;Coffee/adverse effects*;Coffee/metabolism;Food-Drug Interactions/physiology*;Humans;Lithium/blood*;Lithium/therapeutic use*;Male;Middle Aged
28585857;Chronic Disease/drug therapy;Chronic Disease/therapy*;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Polypharmacy*
28450226;Acyl Coenzyme A/metabolism*;Alcohol Oxidoreductases/antagonists & inhibitors*;Alcohol Oxidoreductases/genetics;Alcohol Oxidoreductases/metabolism;Binding Sites;Binding, Competitive;Cell Line, Tumor;Drug Resistance, Neoplasm;Fatty Acids, Nonesterified/metabolism*;Food-Drug Interactions;Humans;Intestinal Mucosa/enzymology*;Mutation;Myristic Acid/metabolism;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism;Oxidoreductases/antagonists & inhibitors;Oxidoreductases/genetics;Oxidoreductases/metabolism;Palmitic Acid/metabolism;Palmitoyl Coenzyme A/metabolism;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Stearic Acids/metabolism;Sugar Alcohol Dehydrogenases/antagonists & inhibitors;Sugar Alcohol Dehydrogenases/genetics;Sugar Alcohol Dehydrogenases/metabolism
28414144;Beverages;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Intestinal Absorption/physiology;Intestines/metabolism*;Organic Anion Transporters/metabolism*;Pharmaceutical Preparations/metabolism*
28409410;Animals;Aorta/drug effects;Aorta/metabolism;Aorta/pathology;Atorvastatin Calcium/agonists*;Atorvastatin Calcium/therapeutic use;Biomarkers/blood;Biomarkers/metabolism;C-Reactive Protein/agonists;C-Reactive Protein/genetics;C-Reactive Protein/metabolism;Cardiotonic Agents/agonists;Cardiotonic Agents/therapeutic use;Chromium/agonists;Chromium/therapeutic use*;Combined Modality Therapy;Dietary Supplements*;Disease Models, Animal*;Food-Drug Interactions*;Gene Expression Regulation/drug effects;Heart Ventricles/drug effects;Heart Ventricles/metabolism;Heart Ventricles/pathology;Hyperlipidemias/diet therapy*;Hyperlipidemias/drug therapy;Hyperlipidemias/metabolism;Hyperlipidemias/pathology;Hypolipidemic Agents/chemistry;Hypolipidemic Agents/therapeutic use*;Lipoproteins, LDL/blood;Male;Octoxynol;Picolinic Acids/administration & dosage;Random Allocation;Rats, Sprague-Dawley;Serum Albumin, Human;Serum Amyloid P-Component/agonists;Serum Amyloid P-Component/genetics;Serum Amyloid P-Component/metabolism
28399577;Clinical Trials as Topic;Diarrhea/drug therapy*;Dietary Supplements*;Drug Interactions;Food-Drug Interactions;Humans;Nutrition Policy;Risk Factors;Zinc/administration & dosage*;Zinc/deficiency*;Zinc/pharmacokinetics
28349328;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pyridones/pharmacokinetics*;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tenofovir/pharmacokinetics;Triazoles/pharmacokinetics*
28339328;Administration, Oral;Adolescent;Adult;Antimetabolites, Antineoplastic/administration & dosage*;Child;Child, Preschool;Dairy Products;Drug Administration Schedule;Drug Monitoring/methods;Erythrocytes/metabolism;Female;Food-Drug Interactions;Humans;Male;Medication Adherence*;Mercaptopurine/administration & dosage*;Methyltransferases/genetics;Methyltransferases/metabolism;Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy*;Thioguanine/blood*;Thionucleotides/blood*;Young Adult
28286289;Administration, Oral;Adolescent;Adult;Animals;Biological Availability;Cell Line, Tumor;Cross-Over Studies;Drug Liberation;Fasting/blood;Fasting/metabolism*;Female;Food-Drug Interactions*;Gastrointestinal Tract/metabolism;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/chemistry;Hypnotics and Sedatives/pharmacokinetics*;Intestinal Absorption;Male;Milk;Models, Biological;Pyridines/blood;Pyridines/chemistry;Pyridines/pharmacokinetics*;Serum Albumin, Bovine;Software;Young Adult
28247011;Adult;Aged;Aged, 80 and over;Albumins/metabolism;BRCA1 Protein/genetics*;BRCA2 Protein/genetics*;Benzamides/administration & dosage;Benzamides/pharmacokinetics*;Benzamides/therapeutic use;Biological Availability;Body Weight;Fallopian Tube Neoplasms/drug therapy*;Fallopian Tube Neoplasms/genetics*;Female;Food-Drug Interactions;Heterozygote;Humans;Intestinal Absorption;Male;Middle Aged;Models, Biological;Mutation;Neoplasms/drug therapy*;Neoplasms/genetics*;Ovarian Neoplasms/drug therapy*;Ovarian Neoplasms/genetics*;Peritoneal Neoplasms/drug therapy*;Peritoneal Neoplasms/genetics*;Poly(ADP-ribose) Polymerase Inhibitors/pharmacokinetics*;Population;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use
28243685;Antitussive Agents/administration & dosage;Antitussive Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Chromatography, High Pressure Liquid/methods*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Male;Morphinans/administration & dosage;Morphinans/pharmacokinetics*;Tablets;Tandem Mass Spectrometry/methods*;Young Adult
28234656;Animals;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Mental Disorders/drug therapy;Mental Disorders/metabolism*;Nootropic Agents/pharmacokinetics*;Nootropic Agents/therapeutic use;Polypharmacy*;Psychotropic Drugs/pharmacokinetics*;Psychotropic Drugs/therapeutic use
28204912;Adolescent;Adult;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclin-Dependent Kinase 4/antagonists & inhibitors;Cyclin-Dependent Kinase 6/antagonists & inhibitors;Cyclin-Dependent Kinase Inhibitor Proteins/adverse effects;Cyclin-Dependent Kinase Inhibitor Proteins/pharmacokinetics*;Energy Intake;Fasting/metabolism;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Intestinal Absorption;Male;Meals;Middle Aged;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Young Adult
28196633;Animals;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Drug Interactions*;Food-Drug Interactions;Herbal Medicine/methods;Humans;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plants, Medicinal/chemistry;Vitamin K/antagonists & inhibitors
28191610;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Antithrombins/pharmacology;Antithrombins/therapeutic use;Atrial Fibrillation/drug therapy;Clinical Competence/standards*;Consensus;Dabigatran/pharmacology;Dabigatran/therapeutic use;Drug-Related Side Effects and Adverse Reactions;Factor Xa Inhibitors/therapeutic use;Food-Drug Interactions;Humans;Internal Medicine/methods*;Italy;Liver Diseases/etiology;Perioperative Period/methods;Pyrazoles/pharmacology;Pyrazoles/therapeutic use;Pyridines/pharmacology;Pyridines/therapeutic use;Pyridones/pharmacology;Pyridones/therapeutic use;Rivaroxaban/pharmacology;Rivaroxaban/therapeutic use;Stroke/drug therapy;Thiazoles/pharmacology;Thiazoles/therapeutic use;Time Factors;Venous Thromboembolism/prevention & control
28177427;Carbonated Beverages*;Drug Interactions;Drug Monitoring;Erlotinib Hydrochloride/administration & dosage*;Erlotinib Hydrochloride/pharmacokinetics;Food-Drug Interactions;Humans;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/pharmacokinetics;Proton Pump Inhibitors/administration & dosage*
28167545;Administration, Oral;Adult;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Body Mass Index;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Drug Dosage Calculations;Fasting;Female;Food-Drug Interactions*;Gram-Positive Bacterial Infections/drug therapy;Gram-Positive Bacterial Infections/microbiology;Healthy Volunteers;Humans;Linezolid/blood;Linezolid/pharmacokinetics*;Male;Models, Statistical*;Oxazolidinones/blood;Oxazolidinones/pharmacokinetics*;Patient Safety;Pyridones/blood;Pyridones/pharmacokinetics*
28163162;Administration, Oral;Biological Availability;Chemistry, Pharmaceutical/methods;Ciprofloxacin/metabolism*;Food-Drug Interactions/physiology*;Gastrointestinal Absorption/physiology*;Humans;Hydrogen-Ion Concentration;Malvaceae/adverse effects*;Postprandial Period;Solubility;Tablets/metabolism*;Viscosity
28142160;Acetaldehyde/blood;Adult;Attention;Cross-Over Studies;Double-Blind Method;Ethanol/administration & dosage;Ethanol/blood;Ethanol/metabolism*;Ethanol/pharmacology;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Orphan Drug Production;Tiopronin/administration & dosage;Tiopronin/adverse effects;Tiopronin/pharmacology*;Young Adult
28134229;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/therapeutic use*;Citrus paradisi;Food-Drug Interactions*;Fruit and Vegetable Juices*;Humans;Neoplasms/drug therapy*
28104136;Acute Disease;Calcineurin Inhibitors/adverse effects*;Creatinine/blood;Curcuma/adverse effects*;Edema/etiology;Food-Drug Interactions*;Humans;Liver Transplantation;Male;Middle Aged;Postoperative Complications/chemically induced*;Tacrolimus/adverse effects*;Tacrolimus/blood
28101841;Administration, Oral;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Biological Availability;Female;Food-Drug Interactions*;Humans;Ketoprofen/administration & dosage;Ketoprofen/blood;Ketoprofen/pharmacokinetics*;Male;Sex Characteristics*;Stereoisomerism*
28091956;Acetylcholinesterase/blood;Animals;Antioxidants/pharmacology*;Brain Chemistry/drug effects;Caffeine/pharmacology*;Central Nervous System Stimulants/pharmacology*;Cholinesterase Inhibitors/pharmacology*;Drug Interactions;Food-Drug Interactions;Free Radical Scavengers/pharmacology;In Vitro Techniques;Indans/pharmacology*;Iron Chelating Agents/pharmacology;Lipid Peroxidation/drug effects;Nootropic Agents/pharmacology*;Piperidines/pharmacology*;Rats
28077306;Animals;Anti-Anxiety Agents/pharmacology;Antidepressive Agents/pharmacology;Anxiety/psychology;Behavior, Animal/drug effects*;Brain/drug effects*;Brain/metabolism;Brain-Derived Neurotrophic Factor/metabolism*;Depression/psychology;Diet;Estradiol/adverse effects;Estradiol/pharmacology*;Female;Food-Drug Interactions*;Isoflavones/administration & dosage*;Maze Learning/drug effects;Motor Activity/drug effects;Ovariectomy;Rats, Sprague-Dawley
28073144;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Drug Labeling;Food-Drug Interactions*;Humans;Intestinal Absorption
28069114;Adult;Antioxidants/analysis;Antioxidants/metabolism*;Coffee/chemistry;Coffee/metabolism*;Female;Food, Fortified/analysis;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Nutritive Value/immunology*;Phenols/analysis;Phenols/metabolism*;Plant Extracts/analysis;Plant Extracts/metabolism;Soy Milk/chemistry;Soy Milk/metabolism*;Young Adult
28057550;Administration, Oral;Adult;Antirheumatic Agents/adverse effects;Antirheumatic Agents/blood;Antirheumatic Agents/pharmacokinetics*;Antirheumatic Agents/urine;Area Under Curve;Asian Continental Ancestry Group;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/urine;Platelet Membrane Glycoproteins/antagonists & inhibitors;Receptors, G-Protein-Coupled/antagonists & inhibitors;Young Adult
28050783;Animals;Azoxymethane/pharmacology*;Carcinogenesis/metabolism*;Carcinogens/pharmacology;Cell Transformation, Neoplastic/metabolism;Colon/drug effects;Colon/metabolism;Colon/pathology;Colonic Neoplasms*/metabolism;Colonic Neoplasms*/pathology;Complex Mixtures;Dextran Sulfate/pharmacology*;Diet, High-Fat*/adverse effects;Diet, High-Fat*/methods;Disease Models, Animal;Dose-Response Relationship, Drug;Food-Drug Interactions;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Lysophospholipids/pharmacology*;Rats;Soybeans*;Statistics as Topic
28043125;ATP Binding Cassette Transporter, Sub-Family G, Member 2/antagonists & inhibitors*;Animals;Biological Products/pharmacology*;Biological Transport/drug effects;Breast Neoplasms/diet therapy*;Breast Neoplasms/metabolism;Cell Line;DNA, Complementary/metabolism;Flavonoids/chemistry;Flavonoids/pharmacology;Food-Drug Interactions/physiology;Gallic Acid/analogs & derivatives;Gallic Acid/chemistry;Humans;Masoprocol/chemistry;Membrane Transport Proteins/metabolism;Multidrug Resistance-Associated Proteins/antagonists & inhibitors*;Neoplasm Proteins/antagonists & inhibitors*;Sf9 Cells
28032362;Animals;Cells, Cultured;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry*;Computer Simulation;Dogs;Estrone/analogs & derivatives;Estrone/metabolism;Flavanones/pharmacology;Flavones/pharmacology;Food-Drug Interactions*;Fruit and Vegetable Juices*/adverse effects;Furocoumarins/pharmacology;Hesperidin/pharmacology;Humans;Inhibitory Concentration 50;Models, Biological;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism
28028768;Absorption, Physiological;Achlorhydria/chemically induced;Achlorhydria/metabolism*;Achlorhydria/prevention & control;Administration, Oral;Adult;Atazanavir Sulfate/administration & dosage;Atazanavir Sulfate/pharmacokinetics*;Betaine/administration & dosage;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;Humans;Male;Middle Aged;Proton Pump Inhibitors/adverse effects;Proton Pump Inhibitors/pharmacokinetics*;Rabeprazole/adverse effects;Rabeprazole/pharmacokinetics*;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Young Adult
27939244;Animals;Anticholesteremic Agents/pharmacology;Atorvastatin Calcium/administration & dosage;Atorvastatin Calcium/pharmacology*;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Dietary Supplements*;Docosahexaenoic Acids/administration & dosage;Docosahexaenoic Acids/pharmacology*;Drug Combinations;Eicosapentaenoic Acid/administration & dosage;Eicosapentaenoic Acid/analogs & derivatives*;Eicosapentaenoic Acid/pharmacology*;Food-Drug Interactions;Gene Expression Regulation/drug effects;Hypercholesterolemia/drug therapy;Male;Metabolic Syndrome/blood;Metabolic Syndrome/metabolism*;Rats;Rats, Inbred Strains
27933871;Apigenin/pharmacology*;Arachidonic Acid/metabolism*;Cytochrome P450 Family 4/antagonists & inhibitors;Cytochrome P450 Family 4/metabolism*;Food-Drug Interactions;Humans;Hydroxyeicosatetraenoic Acids/metabolism;Hydroxylation;Inhibitory Concentration 50;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Microsomes/drug effects;Microsomes/metabolism;Polyphenols/pharmacology*;Vasoconstrictor Agents/pharmacology*
27914234;Administration, Oral;Aged;Biological Availability;Food-Drug Interactions*;Gastrointestinal Tract/metabolism*;Humans;Hydrogen-Ion Concentration*;Pharmacokinetics;Solubility
27909943;Chemistry, Pharmaceutical/methods;Computer Simulation;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/chemistry*;Delayed-Action Preparations/metabolism*;Drug Liberation/physiology;Food-Drug Interactions/physiology;Gastrointestinal Tract/metabolism;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology;Models, Biological;Pediatrics;Solubility;Valproic Acid/administration & dosage;Valproic Acid/chemistry*;Valproic Acid/metabolism*
27890698;Adult;Animals;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/metabolism;Cell Line, Tumor;Citrus*;Citrus paradisi*;Citrus sinensis*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Fruit and Vegetable Juices*/adverse effects;HEK293 Cells;Humans;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/metabolism;Mice;Rifampin/adverse effects;Rifampin/metabolism;Tacrolimus/adverse effects;Tacrolimus/metabolism*
27883269;Administration, Oral;Animals;Antimalarials/administration & dosage*;Antimalarials/pharmacokinetics;Area Under Curve;Biological Availability;Child, Preschool;Ethanolamines/administration & dosage*;Ethanolamines/pharmacokinetics;Female;Fluorenes/administration & dosage*;Fluorenes/pharmacokinetics;Food-Drug Interactions*;Humans;Infant;Malaria, Falciparum/drug therapy*;Male;Milk;Plant Oils/administration & dosage;Tablets;Time Factors;Treatment Outcome;Uganda;Zea mays
27863806;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects*;Antiviral Agents/blood*;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Hepatitis/drug therapy;Humans;Male;Middle Aged;Placebo Effect;Quinoxalines/administration & dosage;Quinoxalines/adverse effects*;Quinoxalines/blood*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects*;Sulfonamides/blood*
27639080;Administration, Oral;Adult;Appetite Stimulants/administration & dosage*;Appetite Stimulants/pharmacokinetics*;Appetite Stimulants/therapeutic use;Biological Availability;Cachexia/drug therapy;Cross-Over Studies;Drug Delivery Systems/methods;Drug Dosage Calculations;Eating;Fasting;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Megestrol Acetate/administration & dosage*;Megestrol Acetate/pharmacokinetics*;Megestrol Acetate/therapeutic use;Models, Biological*;Nanoparticles;Republic of Korea;Young Adult
27799203;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/chemistry;Antiviral Agents/therapeutic use*;Body Mass Index;Food-Drug Interactions;Glucuronides/administration & dosage;Glucuronides/chemistry;Glucuronides/therapeutic use*;HIV Infections/drug therapy;Healthy Volunteers;Humans;Male;Middle Aged;Young Adult
27785737;Adolescent;Adult;B-Lymphocytes/drug effects;Basophils/drug effects;Cohort Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;Syk Kinase/antagonists & inhibitors*;Tetraspanin 30/biosynthesis;Tetraspanin 30/drug effects;Vanadates/pharmacology;Young Adult
27530469;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antiviral Agents/administration & dosage*;Antiviral Agents/pharmacokinetics;Antiviral Agents/pharmacology;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Drug Interactions;Food-Drug Interactions*;Hepatitis C, Chronic/drug therapy*;Humans;Organic Anion Transporters/metabolism
27781421;Adolescent;Adult;Area Under Curve;Carbohydrate Metabolism/drug effects;Female;Food-Drug Interactions*;Humans;Hydrocortisone/blood;Male;Middle Aged;Organophosphates/pharmacokinetics*;Phenanthrenes/pharmacokinetics*;Receptors, Glucocorticoid/agonists*
27770845;Beverages;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*
27757923;Amiodarone*/chemistry;Amiodarone*/pharmacokinetics;Anti-Arrhythmia Agents/chemistry;Anti-Arrhythmia Agents/pharmacokinetics;Biological Availability;Calorimetry, Differential Scanning/methods;Drug Compounding/methods;Food-Drug Interactions;Freeze Drying/methods;Humans;Solubility;Spectroscopy, Fourier Transform Infrared/methods;X-Ray Diffraction/methods;beta-Cyclodextrins*/chemistry;beta-Cyclodextrins*/pharmacokinetics
27749255;Administration, Oral;Alcohol Drinking/adverse effects*;Alcohol Drinking/blood;Alcohol Drinking/metabolism;Alcoholic Beverages/adverse effects;Animals;Antioxidants/administration & dosage;Antioxidants/analysis;Antioxidants/chemistry;Antioxidants/pharmacokinetics*;Biological Availability;Dose-Response Relationship, Drug;Ethanol/adverse effects;Food-Drug Interactions*;Half-Life;Injections, Intravenous;Intestinal Absorption*;Kaempferols/administration & dosage;Kaempferols/agonists;Kaempferols/blood;Kaempferols/pharmacokinetics*;Male;Metabolic Clearance Rate;Random Allocation;Rats, Sprague-Dawley
27738922;Cholinergic Antagonists/adverse effects;Cholinergic Antagonists/metabolism*;Food-Drug Interactions/physiology*;Fruit and Vegetable Juices*;Humans;Treatment Outcome;Urinary Bladder, Overactive/drug therapy*;Urinary Bladder, Overactive/metabolism*
27720220;5-alpha Reductase Inhibitors/administration & dosage*;Adrenergic alpha-Antagonists/administration & dosage*;Alcoholic Beverages*;Drug Interactions;Food-Drug Interactions*;Humans;Male;Prostatic Hyperplasia/drug therapy
27719743;Adolescent;Adult;Aminobutyrates/pharmacokinetics*;Angiotensin Receptor Antagonists/pharmacokinetics*;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neprilysin/antagonists & inhibitors*;Tetrazoles/pharmacokinetics*;Valsartan/pharmacokinetics*
27709656;Area Under Curve;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Food-Drug Interactions*;Fruit and Vegetable Juices*;Humans
27704550;Administration, Oral;Adolescent;Beverages*;Biological Availability;Child;Child, Preschool;Dosage Forms;Drug Compounding;Food*;Food-Drug Interactions/physiology;Humans;Infant;Infant, Newborn;Pediatrics/methods*;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism
27693678;Administration, Oral;Area Under Curve;Biological Availability;Cross-Over Studies;Fasting;Female;Food-Drug Interactions;Gastric Juice/chemistry;Gastrointestinal Contents/drug effects*;Gastrointestinal Tract/drug effects*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;Healthy Volunteers;Humans;Hydrogen-Ion Concentration;Indinavir/administration & dosage*;Indinavir/chemistry;Indinavir/pharmacokinetics;Intestinal Absorption/drug effects*;Male;Membranes, Artificial;Micelles;Solubility;Tandem Mass Spectrometry
27654926;Colorectal Neoplasms/diet therapy;Colorectal Neoplasms/drug therapy;Colorectal Neoplasms/prevention & control;Colorectal Neoplasms/therapy;Combined Modality Therapy;Complementary Therapies*/trends;Dietary Supplements*;Evidence-Based Medicine*;Food-Drug Interactions;Gastritis/diet therapy;Gastritis/drug therapy;Gastritis/prevention & control;Gastritis/therapy;Gastrointestinal Agents/therapeutic use*;Gastrointestinal Diseases/diet therapy*;Gastrointestinal Diseases/drug therapy;Gastrointestinal Diseases/prevention & control;Gastrointestinal Diseases/therapy;Healthy Diet;Healthy Lifestyle;Helicobacter Infections/diet therapy;Helicobacter Infections/drug therapy;Helicobacter Infections/prevention & control;Helicobacter Infections/therapy;Humans;Inflammatory Bowel Diseases/diet therapy;Inflammatory Bowel Diseases/drug therapy;Inflammatory Bowel Diseases/prevention & control;Inflammatory Bowel Diseases/therapy;Nutritional Support*/trends
27638335;Clinical Trials as Topic*/methods;Drug Compounding;Food-Drug Interactions/physiology*;Humans;Models, Biological*;Receptors, Lysosphingolipid/physiology*;Thiazoles/chemistry;Thiazoles/pharmacokinetics*
27618606;Animals;Area Under Curve;Beverages;Chromatography, High Pressure Liquid;Female;Food-Drug Interactions*;Glycyrrhiza*;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/pharmacokinetics*;Punicaceae*;Rats;Rats, Sprague-Dawley;Reproducibility of Results
27592195;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/pharmacokinetics;Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage*;Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/pharmacokinetics*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;Humans;Individuality;Male;Retrospective Studies
27582329;Cell Line, Tumor;Cytochrome P-450 CYP3A/metabolism*;Food-Drug Interactions;Fruit and Vegetable Juices*;Humans;Hydroxytestosterones/antagonists & inhibitors*;Hydroxytestosterones/metabolism;Recombinant Proteins/metabolism;Vegetables
27581964;Animals;Clinical Trials as Topic;Drug Resistance, Neoplasm;Food-Drug Interactions;Humans;Kidney Function Tests;Thalidomide/adverse effects;Thalidomide/analogs & derivatives*;Thalidomide/chemistry;Thalidomide/pharmacokinetics;Thalidomide/pharmacology
27581475;Aged;Angiotensin Receptor Antagonists/adverse effects;Angiotensin Receptor Antagonists/therapeutic use*;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Diet;Feeding Behavior;Female;Food-Drug Interactions;Humans;Hyperkalemia/blood*;Hyperkalemia/etiology;Hypertension/blood;Hypertension/drug therapy*;Male;Middle Aged;Potassium/administration & dosage*;Potassium/blood;Potassium/pharmacology;Renin-Angiotensin System/drug effects*;Risk Factors
27558232;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use;Bridged Bicyclo Compounds, Heterocyclic/pharmacokinetics*;Bridged Bicyclo Compounds, Heterocyclic/therapeutic use;Cohort Studies;Dietary Fats/administration & dosage;Dietary Fats/metabolism*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism*;Lymphoma, Non-Hodgkin/drug therapy;Lymphoma, Non-Hodgkin/metabolism*;Male;Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors*;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use
27539539;Adult;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Fasting/physiology;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate;Middle Aged;Tetracyclines/pharmacokinetics*;Time Factors
27514506;Adult;Angiotensin II Type 1 Receptor Blockers/administration & dosage;Angiotensin II Type 1 Receptor Blockers/adverse effects;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Benzimidazoles/administration & dosage*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Chlorthalidone/administration & dosage*;Chlorthalidone/adverse effects;Chlorthalidone/pharmacokinetics;Cohort Studies;Dietary Fats/administration & dosage;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Oxadiazoles/administration & dosage*;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics;Tablets;Young Adult
27503364;Adult;Area Under Curve;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Double-Blind Method;Female;Food-Drug Interactions;Fruit and Vegetable Juices*;Furocoumarins/administration & dosage;Furocoumarins/pharmacology*;Healthy Volunteers;Humans;Male;Midazolam/pharmacokinetics*;Prospective Studies
27497726;Animals;Food*;Food Additives/chemistry;Food Additives/toxicity*;Food Safety*;Food-Drug Interactions*;Gastrointestinal Absorption/drug effects*;Humans;Nanoparticles/chemistry;Nanoparticles/toxicity*;Oxidative Stress/drug effects;Particle Size;Solubility;Surface Properties
27488574;Administration, Oral;Adult;Amphetamine*/administration & dosage;Amphetamine*/adverse effects;Amphetamine*/chemistry;Amphetamine*/pharmacokinetics;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/chemistry;Central Nervous System Stimulants/pharmacokinetics;Cross-Over Studies;Dosage Forms*;Drug Compounding/methods;Drug-Related Side Effects and Adverse Reactions*/diagnosis;Drug-Related Side Effects and Adverse Reactions*/etiology;Female;Food-Drug Interactions*;Half-Life;Humans;Isomerism;Male;Middle Aged;Therapeutic Equivalency
27481881;Adult;Aged;Area Under Curve;Arterial Pressure/drug effects*;Caffeine/administration & dosage;Caffeine/adverse effects;Caffeine/blood;Caffeine/pharmacokinetics*;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Coffee*/adverse effects;Cross-Over Studies;Felodipine/administration & dosage;Felodipine/blood;Felodipine/pharmacokinetics*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Vascular Resistance/drug effects;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*
27458288;Active Transport, Cell Nucleus/drug effects*;Administration, Oral;Adolescent;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Biopsy;Canada;Capsules;Disease Progression;Drug Administration Schedule;Drug Compounding;Fasting/blood;Female;Food-Drug Interactions;Humans;Hydrazines/administration & dosage*;Hydrazines/adverse effects;Hydrazines/pharmacokinetics;Male;Middle Aged;New York City;Pharmaceutical Solutions;Postprandial Period;Sarcoma/drug therapy*;Sarcoma/metabolism;Sarcoma/pathology;Soft Tissue Neoplasms/drug therapy*;Soft Tissue Neoplasms/metabolism;Soft Tissue Neoplasms/pathology;Tablets;Time Factors;Tomography, X-Ray Computed;Treatment Outcome;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/pharmacokinetics;Young Adult
27453391;Beverages/analysis;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*
27444380;Animals;Anticarcinogenic Agents/chemistry;Anticarcinogenic Agents/metabolism;Anticarcinogenic Agents/pharmacology*;Binding, Competitive;Catalytic Domain;Citrus paradisi/chemistry*;Cytochrome P-450 CYP1A1/antagonists & inhibitors*;Cytochrome P-450 CYP1A1/chemistry;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 Enzyme Inhibitors/chemistry;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P-450 Enzyme Inhibitors/pharmacology*;Flavanones/chemistry;Flavanones/metabolism;Flavanones/pharmacology;Food-Drug Interactions;Fruit and Vegetable Juices/analysis*;Furocoumarins/chemistry;Furocoumarins/metabolism;Furocoumarins/pharmacology;Humans;Ligands;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Models, Molecular*;Molecular Conformation;Molecular Docking Simulation;Molecular Dynamics Simulation;Rats;Rats, Wistar;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism
27444313;Acetamides*/administration & dosage;Acetamides*/adverse effects;Acetamides*/pharmacokinetics;Administration, Oral;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/adverse effects;Anti-Ulcer Agents/pharmacokinetics;Area Under Curve;Asian Continental Ancestry Group;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Monitoring;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Piperidines*/administration & dosage;Piperidines*/adverse effects;Piperidines*/pharmacokinetics;Pyridines*/administration & dosage;Pyridines*/adverse effects;Pyridines*/pharmacokinetics;Stomach Ulcer/drug therapy;Tablets;Tandem Mass Spectrometry
27435452;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Cytochrome P-450 CYP3A/metabolism;Drug Interactions*;Factor Xa Inhibitors/administration & dosage*;Factor Xa Inhibitors/adverse effects;Factor Xa Inhibitors/pharmacology;Food-Drug Interactions;Humans;Warfarin/administration & dosage;Warfarin/adverse effects
27422208;Animals;Drug Compounding;Food-Drug Interactions*;Humans;In Vitro Techniques;Stomach/drug effects*;Stomach/physiology
27418571;Adult;Benzhydryl Compounds/blood*;Benzhydryl Compounds/chemistry*;Cross-Over Studies;Diet, High-Fat*;Drug Compounding;Fasting/blood*;Female;Food-Drug Interactions/physiology*;Glucosides/blood*;Glucosides/chemistry*;Hot Temperature*/adverse effects;Humans;Male;Middle Aged;Tablets;Therapeutic Equivalency;Young Adult
27418392;Acrylates/chemistry*;Administration, Oral;Animals;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology*;Chemistry, Pharmaceutical*;Eating;Fasting;Food-Drug Interactions*;In Vitro Techniques;Male;Polymers/chemistry*;Rats;Rats, Wistar;Risedronate Sodium/chemistry;Risedronate Sodium/pharmacokinetics;Risedronate Sodium/pharmacology*;Stomach/drug effects*
27406858;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use;Case-Control Studies;Constipation/epidemiology;Constipation/etiology*;Cross-Sectional Studies;Energy Intake*;Feeding Behavior*;Female;Food-Drug Interactions;Healthy Diet*;Hospitals, Special;Humans;Italy/epidemiology;Levodopa/administration & dosage;Levodopa/adverse effects;Levodopa/therapeutic use;Male;Malnutrition/epidemiology;Malnutrition/etiology*;Middle Aged;Outpatient Clinics, Hospital;Parkinson Disease/drug therapy;Parkinson Disease/physiopathology*;Patient Compliance*;Prevalence;Risk;Severity of Illness Index
27402726;Administration, Oral;Aged;Area Under Curve;Biological Availability;Biphenyl Compounds/administration & dosage;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Infusions, Intravenous;Middle Aged;Postmenopause*
27348971;Animals;Area Under Curve;Blotting, Western;Capsaicin/administration & dosage;Capsaicin/pharmacology*;Chromatography, Liquid;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Glucuronosyltransferase/genetics*;Liver/drug effects;Liver/enzymology;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Polymerase Chain Reaction;Simvastatin/pharmacokinetics*;Tandem Mass Spectrometry;Up-Regulation/drug effects
27345284;Administration, Intravenous;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Nitriles/administration & dosage;Nitriles/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Stomach/chemistry;Triazoles/administration & dosage;Triazoles/pharmacokinetics*
27339904;Anti-Inflammatory Agents, Non-Steroidal/pharmacology;Antineoplastic Agents/pharmacology*;Antioxidants/metabolism;Apoptosis/drug effects*;Apoptosis Regulatory Proteins/agonists;Apoptosis Regulatory Proteins/genetics;Apoptosis Regulatory Proteins/metabolism;Ascorbic Acid/metabolism*;Carcinoma/diet therapy;Carcinoma/drug therapy;Carcinoma/metabolism;Colonic Neoplasms/diet therapy;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/metabolism;Combined Modality Therapy;Dietary Supplements;Drug Resistance, Neoplasm;Food-Drug Interactions;Gene Expression Regulation, Neoplastic/drug effects;HCT116 Cells;Humans;Osmolar Concentration;Oxidants/metabolism;Proto-Oncogene Proteins/agonists;Proto-Oncogene Proteins/genetics;Proto-Oncogene Proteins/metabolism;RNA Interference;Reactive Oxygen Species/agonists*;Reactive Oxygen Species/metabolism;Sulindac/pharmacology*;Tumor Suppressor Protein p53/agonists*;Tumor Suppressor Protein p53/antagonists & inhibitors;Tumor Suppressor Protein p53/genetics;Tumor Suppressor Protein p53/metabolism
27324506;Adult;Aminobutyrates/pharmacokinetics*;Angiotensin Receptor Antagonists/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Double-Blind Method;Food-Drug Interactions/physiology;Healthy Volunteers;Humans;Male;Neprilysin/pharmacokinetics*;Receptors, Angiotensin/metabolism;Tetrazoles/pharmacokinetics*;Valsartan/pharmacokinetics*;Young Adult
27322002;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacology*;Delayed-Action Preparations;Dosage Forms*;Food-Drug Interactions*;Humans;Nifedipine/administration & dosage;Nifedipine/pharmacology*;Solubility
27316629;Administration, Oral;Antineoplastic Agents/administration & dosage*;Food-Drug Interactions*;Humans;Plants, Edible*;Plants, Medicinal*
27310331;Administration, Oral;Adult;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Indoleacetic Acids/administration & dosage*;Indoleacetic Acids/adverse effects;Indoleacetic Acids/pharmacokinetics;Male;Middle Aged;Pyridines/administration & dosage*;Pyridines/adverse effects;Pyridines/pharmacokinetics;Receptors, Immunologic/antagonists & inhibitors*;Receptors, Prostaglandin/antagonists & inhibitors*
27310148;Acute Disease;Chronic Disease;Cluster Headache/drug therapy*;Cluster Headache/prevention & control;Drug Interactions*;Food-Drug Interactions;Humans;Secondary Prevention/methods;Time Factors;Xenobiotics/administration & dosage*;Xenobiotics/adverse effects;Xenobiotics/pharmacokinetics
27301503;Adult;Biological Availability;Citrus paradisi*/adverse effects;Connective Tissue Diseases/blood*;Connective Tissue Diseases/drug therapy;Drug Administration Schedule;Female;Food-Drug Interactions*;Fruit and Vegetable Juices*/adverse effects;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood*;Immunosuppressive Agents/therapeutic use;Male;Tacrolimus/administration & dosage;Tacrolimus/blood*;Tacrolimus/therapeutic use;Young Adult
27294349;Adult;Area Under Curve;Benzylamines/pharmacokinetics*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions/physiology*;Fruit and Vegetable Juices/adverse effects*;Half-Life;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate/physiology;Midazolam/pharmacokinetics*;Middle Aged;Naphthalenes/pharmacokinetics*;Punicaceae/adverse effects*
27292282;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Drug Stability;Factor Xa Inhibitors/pharmacokinetics*;Fasting;Female;Food-Drug Interactions*;Humans;Male;Pyrazoles/pharmacokinetics*;Pyridones/pharmacokinetics*;Tablets;Therapeutic Equivalency
27213447;Adult;Belgium;Biological Availability;Biomarkers/blood;Breakfast;Calcifediol/blood*;Cholecalciferol/administration & dosage*;Cholecalciferol/blood;Cholecalciferol/pharmacokinetics;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Dietary Supplements*;Female;Food-Drug Interactions*;Gastrointestinal Absorption;Humans;Male;Middle Aged;Postprandial Period;Young Adult
27183705;Administration, Oral*;Beverages;Biological Availability;Capsules;Chemistry, Pharmaceutical;Child;Dosage Forms;Food*;Food-Drug Interactions*;Humans;Pharmaceutical Vehicles;Surface Tension;Suspensions;Tablets;Taste;Viscosity
27178739;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics*;Body Fluids/chemistry;Body Fluids/metabolism;Catheterization;Cross-Over Studies;Delayed-Action Preparations;Drug Compounding;Duodenum/metabolism;Fasting;Female;Food-Drug Interactions;Gastrointestinal Tract/metabolism*;Healthy Volunteers;Humans;Intestinal Absorption;Jejunum/metabolism;Male;Stomach/metabolism;Triazoles/analysis;Triazoles/pharmacokinetics*;Young Adult
27173501;Aged, 80 and over;Antirheumatic Agents/adverse effects;Arthritis, Rheumatoid/drug therapy;Carbonated Beverages/adverse effects*;Electrocardiography;Female;Food-Drug Interactions;Humans;Hydroxychloroquine/adverse effects;Long QT Syndrome/chemically induced*;Muscle Cramp/drug therapy;Muscle Relaxants, Central/adverse effects*;Quinine/adverse effects*
27163498;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Humans;Intestinal Absorption*;Ketoprofen/administration & dosage*;Ketoprofen/pharmacokinetics;Male;Sex Factors;Young Adult
27163497;Administration, Oral;Adolescent;Adult;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Cytochrome P-450 Enzyme Inhibitors/administration & dosage*;Cytochrome P-450 Enzyme Inhibitors/adverse effects;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics;Dietary Fats;Fasting;Food-Drug Interactions*;Humans;Imidazoles/administration & dosage*;Imidazoles/adverse effects;Imidazoles/pharmacokinetics;Least-Squares Analysis;Male;Middle Aged;Naphthalenes/administration & dosage*;Naphthalenes/adverse effects;Naphthalenes/pharmacokinetics;Steroid 17-alpha-Hydroxylase/antagonists & inhibitors;Young Adult
27162173;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adamantane/pharmacology;Adolescent;Adult;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Janus Kinase Inhibitors/adverse effects;Janus Kinase Inhibitors/pharmacokinetics*;Janus Kinase Inhibitors/pharmacology*;Male;Middle Aged;Niacinamide/adverse effects;Niacinamide/analogs & derivatives*;Niacinamide/pharmacokinetics;Niacinamide/pharmacology;Young Adult
27155921;Administration, Oral;Animals;Atherosclerosis/blood;Atherosclerosis/etiology*;Atherosclerosis/metabolism;Biomarkers/blood;Choline/administration & dosage;Choline/metabolism*;Deuterium;Dietary Fats/metabolism;Environmental Pollutants/administration & dosage;Environmental Pollutants/toxicity*;Enzyme Induction/drug effects;Food-Drug Interactions;Liver/drug effects*;Liver/enzymology;Liver/metabolism;Male;Methylamines/administration & dosage;Methylamines/blood*;Methylamines/metabolism;Mice, Inbred C57BL;Oxygenases/chemistry;Oxygenases/genetics;Oxygenases/metabolism*;Phosphatidylcholines/administration & dosage;Phosphatidylcholines/metabolism;Polychlorinated Biphenyls/administration & dosage;Polychlorinated Biphenyls/toxicity*;Random Allocation;Up-Regulation/drug effects
27138025;Adolescent;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage*;Benzhydryl Compounds/pharmacokinetics;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Glucosides/administration & dosage*;Glucosides/pharmacokinetics;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/pharmacokinetics;Male;Metformin/administration & dosage*;Metformin/pharmacokinetics;Middle Aged;Tablets;Therapeutic Equivalency;Young Adult
27137147;Administration, Oral;Adult;Age Factors;Aged;Antiemetics/administration & dosage*;Antiemetics/adverse effects;Antiemetics/blood;Antiemetics/pharmacokinetics*;Cross-Over Studies;Fasting/blood;Female;Food-Drug Interactions*;Germany;Healthy Volunteers;Humans;Isoquinolines/administration & dosage*;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Male;Middle Aged;Postprandial Period;Pyridines/administration & dosage*;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Quinuclidines/administration & dosage*;Quinuclidines/adverse effects;Quinuclidines/blood;Quinuclidines/pharmacokinetics*;Young Adult
27137146;Administration, Oral;Adolescent;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biotransformation;Capsules;Cross-Over Studies;Delayed-Action Preparations;Drug Combinations;Drug Compounding;Fasting/blood;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Naltrexone/administration & dosage;Naltrexone/adverse effects;Naltrexone/analogs & derivatives;Naltrexone/blood;Naltrexone/pharmacokinetics*;Narcotic Antagonists/administration & dosage;Narcotic Antagonists/adverse effects;Narcotic Antagonists/blood;Narcotic Antagonists/pharmacokinetics*;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/blood;Oxycodone/pharmacokinetics*;Postprandial Period;Young Adult
27136912;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Breakfast;Cross-Over Studies;Dietary Fats/administration & dosage;Drug Administration Schedule;Fasting/blood;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Janus Kinase 2/antagonists & inhibitors*;Janus Kinase 2/metabolism;Janus Kinase Inhibitors/administration & dosage;Janus Kinase Inhibitors/adverse effects;Janus Kinase Inhibitors/blood;Janus Kinase Inhibitors/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Postprandial Period;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Tennessee;Young Adult
27136908;Administration, Oral;Adolescent;Adult;Area Under Curve;Belgium;Canagliflozin/administration & dosage*;Canagliflozin/adverse effects;Canagliflozin/blood;Canagliflozin/pharmacokinetics*;Cross-Over Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Kidney Tubules/drug effects*;Kidney Tubules/metabolism;Linear Models;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Sodium-Glucose Transporter 2/antagonists & inhibitors*;Sodium-Glucose Transporter 2/metabolism;Therapeutic Equivalency;United States;Young Adult
27120703;Acquired Immunodeficiency Syndrome/complications;Animals;Antitubercular Agents/pharmacokinetics*;Antitubercular Agents/therapeutic use;Drug Interactions;Drug Resistance, Multiple, Bacterial;Food-Drug Interactions;Global Health*;Half-Life;Humans;Medication Adherence;Public Health;Tissue Distribution;Tuberculosis, Multidrug-Resistant/drug therapy*;Tuberculosis, Multidrug-Resistant/epidemiology
27067239;Administration, Oral;Amiodarone/metabolism*;Biological Availability;Biopharmaceutics/methods;Chemistry, Pharmaceutical/methods;Danazol/metabolism*;Food-Drug Interactions;High-Throughput Screening Assays/methods;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Ivermectin/metabolism*;Models, Biological;Pharmaceutical Preparations/metabolism*;Solubility;Stomach/metabolism;Therapeutic Equivalency
27061460;Abiraterone Acetate/pharmacokinetics*;Adult;Animals;Bile/metabolism;Biological Availability;Duodenum/metabolism;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Postprandial Period;Rats;Solubility;Steroid Synthesis Inhibitors/pharmacokinetics;Stomach/metabolism;Young Adult
27061346;Antacids/adverse effects*;Antacids/chemistry;Deoxyribose/chemistry;Dietary Supplements/adverse effects*;Electron Spin Resonance Spectroscopy;Ferrous Compounds/adverse effects;Ferrous Compounds/chemistry;Food-Drug Interactions*;Humans;Hydrogen Peroxide/agonists;Hydrogen Peroxide/analysis;Hydrogen Peroxide/chemistry;Hydrogen-Ion Concentration;Hydroxyl Radical/agonists;Hydroxyl Radical/analysis;Hydroxyl Radical/chemistry;Iron, Dietary/adverse effects*;Lactates/adverse effects;Lactates/chemistry;Magnesium Compounds/adverse effects*;Magnesium Compounds/chemistry;Netherlands;Nonprescription Drugs/adverse effects;Osmolar Concentration;Peroxides/adverse effects*;Peroxides/chemistry;Reactive Oxygen Species/analysis;Reactive Oxygen Species/chemistry*;Self Care/adverse effects*;Self Medication/adverse effects
27052517;Animals;Anticholesteremic Agents/metabolism*;Biological Transport;Catechin/analogs & derivatives*;Catechin/metabolism;Female;Food-Drug Interactions*;HEK293 Cells;Humans;Organic Anion Transporters/metabolism;Rats;Rats, Sprague-Dawley;Simvastatin/analogs & derivatives;Simvastatin/metabolism*
27049053;Adult;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Mesalamine/adverse effects;Mesalamine/pharmacokinetics*;Spectrometry, Mass, Electrospray Ionization;Tablets, Enteric-Coated;Tandem Mass Spectrometry;Therapeutic Equivalency
27043608;Acetaldehyde/blood;Alanine Transaminase/blood;Alcohol Dehydrogenase/metabolism;Alcoholic Intoxication/therapy;Aldehyde Oxidoreductases/metabolism;Animals;Aspartate Aminotransferases/blood;Chemical and Drug Induced Liver Injury/prevention & control;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Fruit*/adverse effects;Functional Food*/adverse effects;Liver/drug effects;Liver/metabolism;Male;Malondialdehyde/metabolism;Mice;Superoxide Dismutase/metabolism
27039386;Administration, Oral;Adult;Aged;Angiogenesis Inhibitors/administration & dosage*;Angiogenesis Inhibitors/adverse effects;Angiogenesis Inhibitors/pharmacology;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gene Expression Regulation, Neoplastic/drug effects;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/pharmacology;Integrin alpha2/genetics;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Neoplasms/pathology;RNA, Messenger/metabolism;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacology;Treatment Outcome
27033456;ATP Binding Cassette Transporter, Sub-Family G, Member 2/biosynthesis;ATP Binding Cassette Transporter, Sub-Family G, Member 2/drug effects*;ATP Binding Cassette Transporter, Sub-Family G, Member 2/genetics;Antineoplastic Agents/pharmacology;Breast Neoplasms/drug therapy*;Breast Neoplasms/genetics;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Dose-Response Relationship, Drug;Doxorubicin/pharmacology;Drug Resistance, Multiple/drug effects*;Drug Resistance, Neoplasm/drug effects*;Female;Food-Drug Interactions;Gene Expression Regulation, Neoplastic;Genistein/toxicity*;Humans;MCF-7 Cells;MicroRNAs/genetics;MicroRNAs/metabolism;Mitoxantrone/pharmacology;Multidrug Resistance-Associated Proteins/biosynthesis;Multidrug Resistance-Associated Proteins/drug effects*;Multidrug Resistance-Associated Proteins/genetics;Neoplasm Proteins/biosynthesis;Neoplasm Proteins/drug effects*;Neoplasm Proteins/genetics;Phytoestrogens/toxicity*;Protein Biosynthesis;Protein Synthesis Inhibitors/pharmacology;Risk Assessment;Up-Regulation
27029823;Adult;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics;Bridged Bicyclo Compounds, Heterocyclic/blood*;Bridged Bicyclo Compounds, Heterocyclic/pharmacokinetics;Cross-Over Studies;Diet, Fat-Restricted*/methods;Diet, High-Fat*/methods;Dietary Fats/blood*;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors*;Sulfonamides/blood*;Sulfonamides/pharmacokinetics
27022718;Administration, Oral;Calibration;Chromatography, High Pressure Liquid/methods*;Drug Stability;Fasting;Female;Flavanones/administration & dosage*;Flavanones/blood*;Flavanones/pharmacokinetics;Flavonoids/blood*;Flavonoids/pharmacokinetics;Food-Drug Interactions*;Humans;Liquid-Liquid Extraction;Male;Reproducibility of Results;Sensitivity and Specificity;Spectrometry, Mass, Electrospray Ionization;Tablets;Tandem Mass Spectrometry/methods*
27019158;Administration, Oral;Adult;Antiviral Agents/administration & dosage*;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Healthy Volunteers;Hepacivirus/drug effects*;Hepacivirus/enzymology;Humans;Male;Metabolic Clearance Rate;Middle Aged;Oligopeptides/administration & dosage*;Oligopeptides/pharmacokinetics*;Omeprazole/administration & dosage*;Omeprazole/adverse effects;Protease Inhibitors/administration & dosage*;Protease Inhibitors/pharmacokinetics*;Proton Pump Inhibitors/administration & dosage*;Proton Pump Inhibitors/adverse effects;Risk Factors;Thiazoles/administration & dosage*;Thiazoles/pharmacokinetics*;Viral Nonstructural Proteins/antagonists & inhibitors*;Viral Nonstructural Proteins/metabolism;Young Adult
26995510;Adrenergic alpha-Agonists/therapeutic use*;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/therapeutic use*;Central Nervous System Stimulants/therapeutic use*;Depressive Disorder/drug therapy*;Dietary Supplements*;Dopamine Agonists/therapeutic use*;Double-Blind Method;Drug Interactions;Drug Resistance;Drug Therapy, Combination;Excitatory Amino Acid Antagonists/therapeutic use*;Fatty Acids, Omega-3/therapeutic use;Folic Acid/therapeutic use;Food-Drug Interactions;Humans;Ketamine/therapeutic use*;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/therapeutic use*;Randomized Controlled Trials as Topic;S-Adenosylmethionine/therapeutic use
26995271;Administration, Oral;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacology*;Humans;Intestinal Absorption/drug effects*;Neoplasms/metabolism*;Proton Pump Inhibitors/pharmacology*
26970526;Adult;Cross-Over Studies;Delayed-Action Preparations;Diet, High-Fat*/methods;Dietary Fats/administration & dosage;Dietary Fats/blood*;Drug Administration Schedule;Drug Compounding;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Piperidines/administration & dosage;Piperidines/blood*;Piperidines/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Pyrimidines/administration & dosage;Pyrimidines/blood*;Pyrimidines/pharmacokinetics;Pyrroles/administration & dosage;Pyrroles/blood*;Pyrroles/pharmacokinetics
26943820;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26934925;Administration, Oral;Animals;Bone Density Conservation Agents/pharmacokinetics*;Bone Density Conservation Agents/urine;Calcium/pharmacology*;Drinking Water;Food-Drug Interactions;Intestinal Absorption;Magnesium/pharmacology*;Male;Mineral Waters*;Rats, Wistar;Risedronate Sodium/pharmacokinetics*;Risedronate Sodium/urine
26932305;Adamantane/administration & dosage;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adult;Area Under Curve;Cross-Over Studies;Drug Combinations;Food-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/administration & dosage;Metformin/pharmacokinetics*;Nitriles/administration & dosage;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage;Pyrrolidines/pharmacokinetics*;Tablets;Therapeutic Equivalency
26929637;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Blood Coagulation/drug effects*;Drug Administration Schedule;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Medication Adherence;Patient Satisfaction;Patient Selection;Practice Guidelines as Topic;Recurrence;Risk Factors;Time Factors;Treatment Outcome;Venous Thromboembolism/blood;Venous Thromboembolism/diagnosis;Venous Thromboembolism/drug therapy*
26921120;Adolescent;Adult;Biopharmaceutics;Cell Membrane/metabolism;Computer Simulation;Fasting;Female;Food-Drug Interactions*;Gastric Emptying;Humans;Intestinal Absorption;Intestines/metabolism*;Ketoconazole/chemistry;Ketoconazole/pharmacokinetics;Male;Middle Aged;Triazoles/chemistry;Triazoles/pharmacokinetics;Young Adult
26918279;Aged;Anemia/chemically induced;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Japan;Leukopenia/chemically induced;Male;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy*;Neoplasms/metabolism*;Neoplasms/pathology;Neutropenia/chemically induced;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics;Pyrrolidines/pharmacology;Pyrrolidines/therapeutic use;Thymine/adverse effects;Thymine/pharmacokinetics;Thymine/pharmacology;Thymine/therapeutic use;Trifluridine/adverse effects;Trifluridine/pharmacokinetics*;Trifluridine/pharmacology*;Trifluridine/therapeutic use;Uracil/adverse effects;Uracil/analogs & derivatives*;Uracil/pharmacokinetics;Uracil/pharmacology;Uracil/therapeutic use
26902828;Antineoplastic Agents/pharmacokinetics*;Asian Continental Ancestry Group;Chemistry, Pharmaceutical;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/pharmacokinetics*;Protein Kinase Inhibitors/pharmacokinetics*
26895020;ATP-Binding Cassette Transporters/metabolism;Animals;Animals, Genetically Modified;Area Under Curve;Cytochrome P-450 CYP3A/metabolism;Drug Interactions;Enterocytes/enzymology;Food-Drug Interactions;Glucuronosyltransferase/metabolism;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology*;Intestinal Mucosa/metabolism;Metabolic Clearance Rate;Models, Animal;Models, Biological*;Pharmacokinetics;Sulfotransferases/metabolism
26872892;Aged;Aged, 80 and over;Area Under Curve;Biological Availability;Boron Compounds/adverse effects;Boron Compounds/pharmacokinetics*;Cross-Over Studies;Diet, High-Fat*;Female;Food-Drug Interactions;Glycine/adverse effects;Glycine/analogs & derivatives*;Glycine/pharmacokinetics;Humans;Intestinal Absorption;Lymphoma/metabolism*;Male;Meals*;Middle Aged;Neoplasms/metabolism*;Proteasome Inhibitors/adverse effects;Proteasome Inhibitors/pharmacokinetics*
26858332;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Carbonated Beverages*;Carcinoma, Non-Small-Cell Lung/blood;Carcinoma, Non-Small-Cell Lung/drug therapy*;Carcinoma, Non-Small-Cell Lung/pathology;Cross-Over Studies;Drug Monitoring;Erlotinib Hydrochloride/administration & dosage;Erlotinib Hydrochloride/blood;Erlotinib Hydrochloride/pharmacokinetics*;Esomeprazole/administration & dosage;Female;Food-Drug Interactions*;Gastrointestinal Absorption*;Humans;Hydrogen-Ion Concentration;Lung Neoplasms/blood;Lung Neoplasms/drug therapy*;Lung Neoplasms/pathology;Male;Middle Aged;Netherlands;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Proton Pump Inhibitors/administration & dosage
26854426;Animals;Biological Availability;Chemistry, Pharmaceutical;Drug Delivery Systems*;Emulsions;Ethylene Glycols/administration & dosage;Ethylene Glycols/chemistry;Fasting/metabolism;Food-Drug Interactions;Gastrointestinal Tract/metabolism;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/chemistry;HIV Protease Inhibitors/pharmacokinetics;Intestinal Absorption/drug effects;Linoleic Acids/administration & dosage;Linoleic Acids/chemistry;Male;Nelfinavir/administration & dosage*;Nelfinavir/blood;Nelfinavir/chemistry;Nelfinavir/pharmacokinetics;Permeability/drug effects;Polysorbates/administration & dosage;Polysorbates/chemistry;Rabbits;Rats;Solubility;Surface-Active Agents/administration & dosage;Surface-Active Agents/chemistry
26843482;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Antiphospholipid Syndrome/complications;Antiphospholipid Syndrome/drug therapy*;Antithrombins/administration & dosage;Antithrombins/adverse effects;Breast Feeding;Factor Xa Inhibitors/administration & dosage;Factor Xa Inhibitors/adverse effects;Female;Food-Drug Interactions/physiology;Hemorrhage/chemically induced;Humans;Kidney Diseases/complications;Liver Diseases/complications;Lupus Coagulation Inhibitor/blood;Pregnancy;Pregnancy Complications/drug therapy;Thrombosis/complications;Thrombosis/drug therapy;Vitamin K/antagonists & inhibitors
26843267;Biological Availability;Dietary Supplements*;Energy Metabolism/physiology*;Food-Drug Interactions;Humans;Intestinal Absorption;Malnutrition/metabolism;Micronutrients/metabolism*;Nutritional Requirements
26830519;Aged;Dietary Supplements/adverse effects*;Drug-Related Side Effects and Adverse Reactions/diagnosis;Drug-Related Side Effects and Adverse Reactions/metabolism;Female;Food-Drug Interactions*/physiology;Humans;Rhabdomyolysis/chemically induced*;Rhabdomyolysis/diagnosis*;Rhabdomyolysis/metabolism;Rosuvastatin Calcium/adverse effects*;Rosuvastatin Calcium/metabolism
26821227;Adipose Tissue/drug effects;Adipose Tissue/metabolism;Dexamethasone/adverse effects*;Docosahexaenoic Acids/pharmacology;Eicosapentaenoic Acid/pharmacology;Fatty Acids, Nonesterified/blood;Fish Oils/administration & dosage;Fish Oils/pharmacology*;Food-Drug Interactions;Glycerol/blood;Humans;Insulin Resistance*;Lipid Metabolism/drug effects;Lipolysis/drug effects*;Male;Oils/pharmacology;Paraffin/pharmacology;Young Adult
26821071;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Animals;Anthocyanins/administration & dosage*;Anthocyanins/metabolism;Dietary Supplements*;Dose-Response Relationship, Drug;Fluoresceins/administration & dosage*;Fluoresceins/metabolism;Food-Drug Interactions*/physiology;Humans;Swine;Verapamil/administration & dosage;Verapamil/metabolism
26801658;Aged;Combined Modality Therapy/adverse effects;Enteral Nutrition/adverse effects*;Fever/chemically induced*;Food-Drug Interactions;Humans;Levodopa/adverse effects*;Male;Substance Withdrawal Syndrome
26798646;Animals;Food*;Food-Drug Interactions*;Humans;Nutritional Physiological Phenomena*
26797810;Adolescent;Adult;Asian Continental Ancestry Group;China;Dose-Response Relationship, Drug;Drug Administration Schedule*;Female;Fibrosis/drug therapy;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Pyridones/administration & dosage*;Pyridones/adverse effects;Pyridones/blood;Pyridones/pharmacokinetics*;Sex Characteristics;Young Adult
26795834;Evidence-Based Nursing/organization & administration*;Food-Drug Interactions*;Humans;Nurse Practitioners*;Primary Care Nursing*
26775868;Administration, Oral;Adolescent;Adult;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Cinnarizine/administration & dosage*;Cinnarizine/blood;Cinnarizine/pharmacokinetics;Cross-Over Studies;Drug Delivery Systems*;Emulsions;Fasting;Food-Drug Interactions*;Gastric Emptying;Healthy Volunteers;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics;Humans;Intestinal Absorption;Male;Tablets;Young Adult
26755336;Adult;Bile/metabolism*;Biological Availability;Celecoxib/pharmacokinetics*;Diet, High-Fat/methods;Fasting/metabolism*;Food;Food-Drug Interactions/physiology;Gastrointestinal Tract/metabolism*;Humans;Models, Biological;Solubility
26748446;Adjuvants, Pharmaceutic*/chemistry;Adjuvants, Pharmaceutic*/pharmacology;Animals;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/chemistry*;Biological Availability;Delayed-Action Preparations;Dogs;Food-Drug Interactions*;Microscopy, Electron, Scanning;Phospholipids*/chemistry;Phospholipids*/pharmacology;Piperazines/administration & dosage;Piperazines/blood;Piperazines/chemistry*;Solubility;Spectroscopy, Fourier Transform Infrared;Technology, Pharmaceutical/methods*;Thiazoles/administration & dosage;Thiazoles/blood;Thiazoles/chemistry*;X-Ray Diffraction
26728536;Aged;Antibodies/pharmacology;Antibodies/therapeutic use;Bone Density/drug effects;Bone Density Conservation Agents*/pharmacology;Bone Density Conservation Agents*/therapeutic use;Bone Morphogenetic Proteins/immunology;Bone Resorption/prevention & control;Cathepsin K/antagonists & inhibitors;Clinical Trials as Topic;Diphosphonates*/pharmacology;Diphosphonates*/therapeutic use;Drug Discovery/trends*;Enzyme Inhibitors/pharmacology;Enzyme Inhibitors/therapeutic use;Female;Food-Drug Interactions;Genetic Markers/immunology;Humans;Osteogenesis/drug effects;Osteoporosis/drug therapy*;Osteoporosis/metabolism;Parathyroid Hormone-Related Protein*/pharmacology;Parathyroid Hormone-Related Protein*/therapeutic use
26725427;Administration, Oral;Animals;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/blood;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Food Deprivation;Food-Drug Interactions;Half-Life;Rats;Rifampin/administration & dosage;Rifampin/blood;Rifampin/pharmacokinetics*
26721731;Administration, Oral;Alcoholic Beverages;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/chemistry;Capsules;Citrus sinensis;Drug Liberation;Food-Drug Interactions*;Fruit and Vegetable Juices;Gastric Juice/metabolism*;Hydrodynamics;Hydrogen-Ion Concentration;Nifedipine/administration & dosage*;Nifedipine/chemistry;Solubility;Water/administration & dosage
26709596;Adolescent;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Urea/adverse effects;Urea/analogs & derivatives*;Urea/pharmacokinetics
26689566;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics;Aurora Kinase A/antagonists & inhibitors*;Azepines/administration & dosage*;Azepines/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism*;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/pharmacokinetics*;Pyrimidines/administration & dosage*;Pyrimidines/pharmacokinetics*
26677899;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chemistry, Pharmaceutical;Computer Simulation;Delayed-Action Preparations;Excipients/chemistry;Fasting;Food-Drug Interactions*;Gastric Absorption;Humans;Intestinal Absorption;Models, Biological*;Models, Chemical*;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/chemistry;Nifedipine/pharmacokinetics*;Numerical Analysis, Computer-Assisted;Postprandial Period;Solubility
26632187;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport;Caco-2 Cells;Dioxoles/pharmacology*;Drug Interactions*;Food-Drug Interactions;Humans;Intestinal Absorption/drug effects;Lignans/pharmacology*;Male;Plant Extracts/pharmacology;Rats, Wistar;Rhodamine 123/pharmacokinetics*;Seeds/chemistry*;Sesamum/chemistry*;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
26630906;Animals;Biological Availability;Biological Transport;Drug Interactions;Food-Drug Interactions;Humans;Intestinal Absorption;Intestines/metabolism;Liver/metabolism;Membrane Transport Proteins/metabolism*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
26604072;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Eating/physiology;Fasting;Food-Drug Interactions/physiology;Half-Life;Humans;Male;Middle Aged;Mineralocorticoid Receptor Antagonists/adverse effects*;Mineralocorticoid Receptor Antagonists/pharmacokinetics*;Mineralocorticoid Receptor Antagonists/therapeutic use;Naphthyridines/adverse effects*;Naphthyridines/pharmacokinetics*;Naphthyridines/therapeutic use;Pharmaceutical Solutions/adverse effects;Pharmaceutical Solutions/pharmacokinetics;Pharmaceutical Solutions/therapeutic use;Tablets/adverse effects;Tablets/pharmacokinetics;Tablets/therapeutic use;Young Adult
26590950;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Biotransformation;Cross-Over Studies;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/blood;Cyclooxygenase Inhibitors/chemistry;Cyclooxygenase Inhibitors/pharmacokinetics*;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/analysis;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Drug Compounding*;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Ketoprofen/administration & dosage;Ketoprofen/blood;Ketoprofen/chemistry;Ketoprofen/pharmacokinetics*;Male;Metabolic Clearance Rate;Molecular Structure;Sex Characteristics;Stereoisomerism;Tablets, Enteric-Coated;Young Adult
26589308;Biopharmaceutics/classification*;Carrier Proteins/metabolism;Drug Interactions;Environment;Food-Drug Interactions;Humans;Pharmaceutical Preparations/classification*;Pharmaceutical Preparations/metabolism;Pharmacogenetics;Pharmacokinetics*;Solubility;Tissue Distribution
26581327;Administration, Oral;Adolescent;Adult;Age Factors;Aged;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacology*;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage*;Double-Blind Method;Fasting;Female;Fluoroquinolones/blood;Fluoroquinolones/pharmacokinetics;Fluoroquinolones/pharmacology*;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Sex Factors;Young Adult
26566368;Cobicistat/adverse effects;Cobicistat/therapeutic use*;Cytochrome P-450 CYP3A Inhibitors/adverse effects;Cytochrome P-450 CYP3A Inhibitors/therapeutic use*;Darunavir/adverse effects;Darunavir/pharmacokinetics;Darunavir/therapeutic use*;Drug Combinations;Drug Interactions;Food-Drug Interactions;HIV Infections/diagnosis;HIV Infections/drug therapy*;HIV Infections/virology;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use*;Humans;Risk Factors;Treatment Outcome
26526067;Administration, Oral;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/metabolism;Antineoplastic Agents/toxicity*;Bacteria/drug effects;Bacteria/enzymology;Bacterial Proteins/antagonists & inhibitors;Bacterial Proteins/metabolism;Camptothecin/administration & dosage;Camptothecin/analogs & derivatives*;Camptothecin/metabolism;Camptothecin/toxicity;Cefixime/pharmacology;Diarrhea/chemically induced*;Diarrhea/metabolism;Diarrhea/microbiology;Diarrhea/prevention & control;Enzyme Inhibitors/pharmacology;Female;Flavonoids/pharmacology;Food-Drug Interactions;Fruit and Vegetable Juices;Gastrointestinal Microbiome;Gene Transfer Techniques;Glucuronidase/antagonists & inhibitors;Glucuronidase/metabolism;Hydrogen-Ion Concentration;Intestinal Absorption*;Intestines/drug effects*;Intestines/metabolism;Intestines/microbiology;Kinetics;Malus;Mice, Inbred C57BL;Oocytes;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Xenopus laevis
26502357;Adult;Aged;Castration/methods*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Gonadotropin-Releasing Hormone/antagonists & inhibitors*;Humans;Luteinizing Hormone/blood;Male;Middle Aged;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics;Phenylurea Compounds/therapeutic use*;Prostatic Neoplasms/drug therapy*;Pyrimidinones/adverse effects;Pyrimidinones/pharmacokinetics;Pyrimidinones/therapeutic use*;Testosterone/blood;Treatment Outcome;Young Adult
26478276;Administration, Oral;Animals;Antimalarials/administration & dosage*;Antimalarials/pharmacokinetics;Antimalarials/pharmacology;Biological Availability;Chemistry, Pharmaceutical/methods;Chloroquine/pharmacology;Disease Models, Animal;Drug Stability;Ethanolamines/administration & dosage*;Ethanolamines/pharmacokinetics;Ethanolamines/pharmacology;Fluorenes/administration & dosage*;Fluorenes/pharmacokinetics;Fluorenes/pharmacology;Food-Drug Interactions*;Malaria/drug therapy*;Male;Mice;Mice, Inbred C57BL;Solubility;Technology, Pharmaceutical/methods
26467069;Animals;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics;Anticholesteremic Agents/therapeutic use;Biological Availability;Flavonoids/administration & dosage*;Flavonoids/adverse effects;Flavonoids/pharmacology;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hypercholesterolemia/diet therapy;Hypercholesterolemia/drug therapy*
26457956;Adolescent;Antineoplastic Combined Chemotherapy Protocols/adverse effects;Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Child;Child, Preschool;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infant;Maintenance Chemotherapy;Male;Medication Adherence*;Mercaptopurine/administration & dosage*;Mercaptopurine/adverse effects;Mercaptopurine/pharmacokinetics;Methotrexate/administration & dosage*;Methotrexate/adverse effects;Methotrexate/pharmacokinetics;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy*;Risk Factors;Surveys and Questionnaires
26446005;Adolescent;Adult;Area Under Curve;Asian Continental Ancestry Group*;Cross-Over Studies;Diet, High-Fat/methods;Dietary Fats/metabolism*;Fasting/metabolism;Food-Drug Interactions/physiology*;Healthy Volunteers;Histamine H1 Antagonists, Non-Sedating/metabolism*;Humans;Loratadine/analogs & derivatives*;Loratadine/metabolism;Male;Phenotype*;Prevalence;Young Adult
26407124;Beverages*;Citrus paradisi/chemistry*;Demography;Diet*;Food*;Food-Drug Interactions*;Healthy Volunteers*;Humans;Male;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Therapeutic Equivalency;Young Adult
26391972;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Liberation;Food-Drug Interactions*;Humans;Mesalamine/administration & dosage*;Mesalamine/chemistry;Mesalamine/pharmacokinetics;Solubility
26382728;Administration, Oral;Adolescent;Adult;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Carbon Isotopes;Citrus paradisi/chemistry*;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food-Drug Interactions*;Fruit and Vegetable Juices*;Healthy Volunteers;Humans;Injections, Intravenous;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Time Factors;Young Adult
26375734;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Biopharmaceutics/classification*;Case-Control Studies;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/chemistry;Diclofenac/metabolism*;Female;Food-Drug Interactions/physiology*;Gastrointestinal Contents/drug effects;Gastrointestinal Contents/enzymology;Gastrointestinal Transit/drug effects;Gastrointestinal Transit/physiology*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Male
26369919;Aged;Anticonvulsants/administration & dosage*;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics;Biological Availability;Child;Delayed-Action Preparations;Drug Administration Schedule;Epilepsy/drug therapy*;Food-Drug Interactions;Humans;Medication Adherence*;Neuralgia, Postherpetic/drug therapy;Restless Legs Syndrome/drug therapy
26355866;Animals;Antineoplastic Agents/pharmacology*;Dietary Supplements*;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fishes*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Seafood*
26355864;Animals;Antineoplastic Agents/pharmacology*;Dietary Supplements*;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fishes*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Seafood*
26355863;Animals;Antineoplastic Agents/pharmacology*;Dietary Supplements*;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fishes*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Seafood*
26355003;Animals;Appetite Regulation/drug effects*;Appetite Stimulants/administration & dosage;Appetite Stimulants/pharmacology*;Chickens;Crosses, Genetic;Dietary Carbohydrates/administration & dosage;Dietary Proteins/administration & dosage*;Dose-Response Relationship, Drug;Energy Intake/drug effects;Food Preferences;Food-Drug Interactions*;Gene Expression Regulation, Developmental/drug effects*;Hypothalamus/drug effects*;Hypothalamus/growth & development;Hypothalamus/metabolism;Injections, Intraventricular;Neurons/drug effects;Neurons/metabolism;Neuropeptide Y/agonists;Neuropeptide Y/genetics;Neuropeptide Y/metabolism;Prolactin-Releasing Hormone/administration & dosage;Prolactin-Releasing Hormone/pharmacology*;Random Allocation;Rats;Weight Gain/drug effects
26352940;Acetaminophen/pharmacokinetics*;Adolescent;Adult;Cross-Over Studies;Female;Food-Drug Interactions;Gastric Emptying/physiology*;Humans;Male;Postprandial Period;Young Adult
26352868;Administration, Oral;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Medication Adherence;Thromboembolism/prevention & control*
26346860;Anticoagulants/adverse effects*;Databases, Bibliographic;Eating*;Food-Drug Interactions*;Humans;Recommended Dietary Allowances*;Soy Foods/adverse effects;Vegetables;Vitamin K/administration & dosage*;Vitamin K/adverse effects*;Warfarin/adverse effects*
26334219;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use*;Area Under Curve;Benzamides;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Organic Chemicals/administration & dosage;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Organic Chemicals/therapeutic use*;Pyrazines;Sulfonamides
26325166;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Capsules/metabolism;Capsules/pharmacokinetics;Cross-Over Studies;Eating;Fasting;Female;Food/adverse effects*;Food-Drug Interactions*;Healthy Volunteers;Humans;Indoles/metabolism*;Indoles/pharmacokinetics*;Pyrroles/metabolism*;Pyrroles/pharmacokinetics*;Young Adult
26304780;Antioxidants;Dietary Supplements;Digestion/drug effects;Food, Fortified*;Food-Drug Interactions;Gastrointestinal Tract/metabolism;Humans;Light;Nutritive Value/drug effects*;Onions/chemistry*;Phaseolus/metabolism*;Phenols/administration & dosage*;Plant Extracts/chemistry*
26294172;Administration, Oral;Area Under Curve;Asian Continental Ancestry Group;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food/adverse effects*;Food-Drug Interactions;Half-Life;Healthy Volunteers;Humans;Male;Tablets/administration & dosage;Tablets/pharmacokinetics;Triazoles/administration & dosage*;Triazoles/pharmacokinetics*
26293519;Adolescent;Adult;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/pharmacokinetics*;Biological Availability;Energy Intake;Fasting;Food;Food-Drug Interactions*;Humans;Male;Quinolines/pharmacokinetics*;Young Adult
26293237;Acetamides/administration & dosage*;Acetates/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Pyrazines/administration & dosage*;Pyrazines/pharmacokinetics*;Receptors, Epoprostenol/agonists*
26293236;Acetamides/administration & dosage*;Acetates/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Pyrazines/administration & dosage*;Pyrazines/pharmacokinetics*;Receptors, Epoprostenol/agonists*
26288994;Antifungal Agents/chemistry*;Biological Availability;Carbohydrates/chemistry;Drug Liberation*;Fats/chemistry;Food-Drug Interactions*;Hydrogen-Ion Concentration;Ketoconazole/chemistry*;Models, Biological*;Proteins/chemistry;Solubility
26283447;Administration, Oral;Animal Feed/analysis;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dogs;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions*;Half-Life;Male;Minocycline/administration & dosage;Minocycline/blood;Minocycline/pharmacokinetics*
26276738;Administration, Oral;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use*;Biological Availability;Cytostatic Agents;Eating;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Patient Education as Topic
26272586;Administration, Oral;Adult;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Receptor Protein-Tyrosine Kinases/antagonists & inhibitors;Sulfones/adverse effects;Sulfones/blood;Sulfones/pharmacokinetics*;Young Adult
26264792;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26264233;Chemistry, Pharmaceutical;Delayed-Action Preparations;Drug Administration Schedule;Drug Monitoring;Food-Drug Interactions;Graft Rejection/immunology;Graft Rejection/prevention & control;Graft Survival/drug effects;Humans;Immunosuppressive Agents/administration & dosage*;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/chemistry;Immunosuppressive Agents/pharmacokinetics;Liver Transplantation*/adverse effects;Medication Adherence;Practice Guidelines as Topic;Tacrolimus/administration & dosage*;Tacrolimus/adverse effects;Tacrolimus/chemistry;Tacrolimus/pharmacokinetics;Time Factors;Treatment Outcome
26242220;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Chemistry, Pharmaceutical;Cross-Over Studies;Diet, High-Fat/adverse effects;Drug Administration Schedule;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Neoplasm Metastasis/drug therapy;Neoplasms/blood;Neoplasms/drug therapy*;Phthalazines/adverse effects;Phthalazines/chemistry;Phthalazines/pharmacokinetics*;Phthalazines/therapeutic use;Piperazines/adverse effects;Piperazines/chemistry;Piperazines/pharmacokinetics*;Piperazines/therapeutic use;Poly(ADP-ribose) Polymerase Inhibitors/adverse effects;Poly(ADP-ribose) Polymerase Inhibitors/chemistry;Poly(ADP-ribose) Polymerase Inhibitors/pharmacokinetics*;Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use;Tablets
26234524;Administration, Oral;Animals;Dipeptidyl Peptidase 4/genetics;Dipeptidyl Peptidase 4/metabolism*;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage;Dipeptidyl-Peptidase IV Inhibitors/therapeutic use*;Dose-Response Relationship, Drug;Drug Therapy, Combination;Food-Drug Interactions;Glucagon-Like Peptide 1/agonists*;Glucagon-Like Peptide 1/blood;Glucose Intolerance/blood;Glucose Intolerance/drug therapy*;Glucose Intolerance/metabolism;Injections, Intraperitoneal;Insulin/agonists;Insulin/blood;Insulin/secretion;Insulin-Secreting Cells/drug effects;Insulin-Secreting Cells/secretion;Male;Mice, Inbred C57BL;Piperazines/administration & dosage;Piperazines/therapeutic use;Piperidines/administration & dosage;Piperidines/therapeutic use;Pyridines/administration & dosage;Pyridines/therapeutic use;Receptor, Serotonin, 5-HT1B/chemistry;Receptor, Serotonin, 5-HT1B/metabolism*;Serotonin 5-HT1 Receptor Agonists/administration & dosage;Serotonin 5-HT1 Receptor Agonists/therapeutic use*;Up-Regulation/drug effects*;Uracil/administration & dosage;Uracil/analogs & derivatives;Uracil/therapeutic use
26215636;Animals;Biological Availability;Computational Biology;Cross-Over Studies;Drug Compounding;Drug Liberation;Excipients/chemistry;Expert Systems;Fenofibrate/blood;Fenofibrate/chemistry;Fenofibrate/metabolism;Fenofibrate/pharmacokinetics*;Food-Drug Interactions;Hypolipidemic Agents/blood;Hypolipidemic Agents/chemistry;Hypolipidemic Agents/metabolism;Hypolipidemic Agents/pharmacokinetics*;Intestinal Absorption;Male;Olive Oil/chemistry*;Pharmaceutical Vehicles/chemistry*;Polyethylene Glycols/chemistry*;Polysorbates/chemistry*;Povidone/chemistry*;Random Allocation;Solubility;Surface-Active Agents/chemistry*;Sus scrofa
26213156;Adult;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics*;Area Under Curve;Beverages*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Stereoisomerism;Terfenadine/analogs & derivatives*;Terfenadine/chemistry;Terfenadine/pharmacokinetics;Young Adult
26210682;Adult;Aged;Aged, 80 and over;Biological Availability;Drug Administration Schedule;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Imidazolines/administration & dosage;Imidazolines/pharmacokinetics;Imidazolines/pharmacology*;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Postprandial Period;Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors*;Young Adult
26181186;Academic Medical Centers;Animals;Antineoplastic Agents/pharmacology*;Biomarkers/blood;Camptothecin/analogs & derivatives;Camptothecin/pharmacology;Cell Line, Tumor;Cisplatin/pharmacology;Dietary Supplements*;Dose-Response Relationship, Drug;Drug Resistance, Neoplasm*;Fatty Acids/blood*;Fish Oils/administration & dosage*;Fish Oils/pharmacokinetics;Fishes*;Food-Drug Interactions*;Health Care Surveys;Humans;Mice, Inbred BALB C;Neoplasms/blood;Neoplasms/drug therapy*;Neoplasms/pathology;Netherlands;Organoplatinum Compounds/pharmacology;Seafood*;Surveys and Questionnaires;Tumor Burden;Up-Regulation
26179237;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats;Drug Antagonism*;Energy Intake;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacokinetics;Quinazolinones/administration & dosage;Quinazolinones/pharmacokinetics*;Rabeprazole/administration & dosage;Rabeprazole/pharmacokinetics*;Young Adult
26149619;Animals;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/toxicity;Capsules;Chemistry, Pharmaceutical;Excipients;Food-Drug Interactions;Humans;Intestinal Absorption;Nifedipine/administration & dosage*;Nifedipine/pharmacokinetics;Nifedipine/toxicity;Solubility;Tablets
26140311;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26138369;Acetaminophen/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/pharmacokinetics*;Dipyrone/pharmacokinetics*;Food-Drug Interactions*;Humans
26135230;Administration, Oral;Area Under Curve;Biological Availability;Capsules/administration & dosage*;Capsules/chemistry*;Capsules/metabolism;Chemistry, Pharmaceutical/methods;Cross-Over Studies;Eating/physiology;Food;Food-Drug Interactions;Humans;Piperazines/administration & dosage*;Piperazines/chemistry*;Piperazines/metabolism;Thiazoles/administration & dosage*;Thiazoles/chemistry*;Thiazoles/metabolism
26133712;Administration, Oral;Amiodarone/administration & dosage;Amiodarone/analogs & derivatives*;Amiodarone/blood;Amiodarone/chemistry;Amiodarone/pharmacokinetics;Animals;Anti-Arrhythmia Agents/administration & dosage*;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/chemistry;Anti-Arrhythmia Agents/pharmacokinetics*;Castor Oil/analogs & derivatives;Castor Oil/chemistry;Dogs;Drug Delivery Systems*;Emulsions;Food-Drug Interactions*;Glycerides/chemistry;Glycerol/analogs & derivatives;Glycerol/chemistry;Intestinal Absorption;Male;Polyethylene Glycols/chemistry;Polysorbates/chemistry;Surface-Active Agents/chemistry
26119520;Animals;Binding, Competitive;Brain/drug effects*;Brain/metabolism;Dietary Supplements/adverse effects*;Dietary Supplements/classification;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions*;Humans;Kinetics;Male;Muscarinic Antagonists/adverse effects*;Muscarinic Antagonists/classification;Muscarinic Antagonists/metabolism;Protein Binding;Radioimmunoassay;Rats, Inbred WKY;Receptors, Muscarinic/drug effects*;Receptors, Muscarinic/metabolism;Risk Assessment;Risk Factors
26101174;4-Aminopyridine/adverse effects;4-Aminopyridine/analogs & derivatives*;4-Aminopyridine/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Eating/physiology*;Fasting/metabolism;Female;Food-Drug Interactions/physiology*;Half-Life;Healthy Volunteers;Humans;Male;Middle Aged;Phosphates/pharmacokinetics;Therapeutic Equivalency;Young Adult
26096139;Abiraterone Acetate/adverse effects;Abiraterone Acetate/blood;Abiraterone Acetate/pharmacokinetics*;Adult;Aged;Aged, 80 and over;Cytochrome P-450 Enzyme Inhibitors/adverse effects;Cytochrome P-450 Enzyme Inhibitors/blood;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics;Dietary Fats/pharmacology*;Drug Therapy, Combination;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Prednisone/adverse effects;Prostatic Neoplasms, Castration-Resistant/blood;Prostatic Neoplasms, Castration-Resistant/metabolism*
26095990;Cytochrome P-450 CYP3A Inhibitors/pharmacology*;Food-Drug Interactions*;Fruit and Vegetable Juices*/adverse effects;Humans;Organic Anion Transporters/antagonists & inhibitors*;Tea*/adverse effects
26056407;Attitude of Health Personnel;Attitude to Computers;Computer Simulation*;Computer-Assisted Instruction/methods*;Counseling*;Curriculum;Education, Pharmacy/methods*;Food-Drug Interactions;Health Knowledge, Attitudes, Practice;Humans;Medication Adherence*;Professional-Patient Relations*;Students, Pharmacy/psychology*;Surveys and Questionnaires;Teaching/methods*
26048185;Adult;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/blood*;Benzhydryl Compounds/therapeutic use;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food-Drug Interactions/physiology*;Glucosides/administration & dosage;Glucosides/adverse effects;Glucosides/blood*;Glucosides/therapeutic use;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood*;Hypoglycemic Agents/therapeutic use;Male;Metformin/administration & dosage;Metformin/adverse effects;Metformin/blood*;Metformin/therapeutic use;Middle Aged;Tablets;Therapeutic Equivalency;Young Adult
26048134;Adult;Aged;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Cross-Over Studies;Female;Food-Drug Interactions*;Gastrointestinal Absorption;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Phthalazines/pharmacokinetics*;Phthalazines/therapeutic use;Piperazines/pharmacokinetics*;Piperazines/therapeutic use
26047551;Antioxidants/chemistry;Antioxidants/pharmacology*;Bone Marrow Transplantation*;Catechin/analogs & derivatives*;Catechin/chemistry;Catechin/pharmacology;Food-Drug Interactions;Humans;Tea/chemistry*;Uric Acid/blood
26028419;Antacids;Drug Liberation*;Food Additives/adverse effects*;Food-Drug Interactions*;Immersion;Laxatives;Magnesium Oxide/chemistry*;Polysaccharides, Bacterial/adverse effects*;Solubility;Tablets;Time Factors
26026989;Animals;Antitussive Agents/pharmacokinetics*;Food-Drug Interactions;Humans;Intestines/metabolism*;Liver/metabolism*;Male;Mice;Noscapine/pharmacokinetics*
26022074;Animals;Antidepressive Agents/administration & dosage;Antidepressive Agents/therapeutic use*;Behavior, Animal/drug effects;CA1 Region, Hippocampal/drug effects;CA1 Region, Hippocampal/metabolism;CA1 Region, Hippocampal/pathology;Combined Modality Therapy;Depression/blood;Depression/metabolism;Depression/pathology;Depression/prevention & control*;Dietary Supplements*;Disease Models, Animal*;Estradiol/administration & dosage;Estradiol/analogs & derivatives*;Estradiol/therapeutic use;Estrogen Replacement Therapy;Estrogens/administration & dosage;Estrogens/blood;Estrogens/therapeutic use*;Fatty Acids, Omega-3/administration & dosage;Fatty Acids, Omega-3/therapeutic use*;Female;Food-Drug Interactions;Injections, Subcutaneous;Nerve Tissue Proteins/agonists;Nerve Tissue Proteins/antagonists & inhibitors;Nerve Tissue Proteins/genetics;Nerve Tissue Proteins/metabolism;Ovariectomy/adverse effects;Random Allocation;Rats, Wistar;Serotonergic Neurons/drug effects;Serotonergic Neurons/metabolism;Serotonergic Neurons/pathology;Serotonin/blood
26011141;Administration, Oral;Adult;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Phenytoin/administration & dosage;Phenytoin/analogs & derivatives*;Phenytoin/pharmacokinetics
26006702;Adult;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions*;Gonanes/blood;Gonanes/pharmacokinetics*;Humans;Intestinal Absorption;Molecular Structure;Young Adult
26004270;Animals;Antiviral Agents/pharmacokinetics;Antiviral Agents/pharmacology;Antiviral Agents/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;Genotype;Hepacivirus/drug effects;Hepacivirus/genetics;Hepatitis C/drug therapy*;Hepatitis C/virology;Humans;Oligopeptides/pharmacokinetics;Oligopeptides/pharmacology;Oligopeptides/therapeutic use*
25995169;Administration, Oral;Adult;Age Factors;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Asian Continental Ancestry Group/genetics*;China/epidemiology;Cross-Over Studies;Crown Ethers/administration & dosage;Crown Ethers/blood;Crown Ethers/pharmacokinetics*;Cytochrome P-450 CYP2C19/genetics*;Cytochrome P-450 CYP2C19/metabolism;Food-Drug Interactions*;Gastrointestinal Absorption*;Healthy Volunteers;Humans;Models, Biological*;Nonlinear Dynamics*;Pharmacogenetics;Polymorphism, Genetic*;Protein Binding;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Quinazolines/administration & dosage;Quinazolines/blood;Quinazolines/pharmacokinetics*;Serum Albumin/metabolism;Serum Albumin, Human;Young Adult
25994853;Adult;Aged;Carcinoma, Non-Small-Cell Lung/drug therapy;Carcinoma, Non-Small-Cell Lung/metabolism*;Cohort Studies;Cross-Over Studies;Erlotinib Hydrochloride;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Lung Neoplasms/drug therapy;Lung Neoplasms/metabolism*;Male;Middle Aged;Postprandial Period*;Protein Kinase Inhibitors/pharmacokinetics*;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*
25975016;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme Inhibitors/chemistry;Food*;Food-Drug Interactions;Humans;Isoenzymes/metabolism;Liver/drug effects;Liver/enzymology*;Pyrazoles/metabolism*;Pyrimidines/metabolism*
25963981;Adolescent;Adult;Antimalarials/adverse effects*;Antimalarials/pharmacokinetics*;Antimalarials/therapeutic use;Area Under Curve;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Artemisinins/therapeutic use;Biological Availability;Dietary Fats;Drug Combinations;Female;Follow-Up Studies;Food-Drug Interactions;Humans;Infant, Newborn;Malaria, Falciparum/drug therapy;Malaria, Falciparum/metabolism;Models, Statistical;Papua New Guinea/epidemiology;Pregnancy;Pregnancy Outcome;Pyrimethamine/adverse effects*;Pyrimethamine/pharmacokinetics*;Pyrimethamine/therapeutic use;Quinolines/adverse effects*;Quinolines/pharmacokinetics*;Quinolines/therapeutic use;Sulfadoxine/adverse effects*;Sulfadoxine/pharmacokinetics*;Sulfadoxine/therapeutic use;Young Adult
25963481;Acetates/administration & dosage*;Acetates/blood*;Administration, Oral;Adolescent;Adult;Aminopyridines/administration & dosage*;Aminopyridines/blood*;Biological Availability;Diacylglycerol O-Acyltransferase/antagonists & inhibitors*;Diacylglycerol O-Acyltransferase/blood*;Diet, High-Fat/methods;Dietary Fats/blood*;Dose-Response Relationship, Drug;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/blood;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Middle Aged;Young Adult
25947916;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Antioxidants/adverse effects;Antioxidants/pharmacology;Apoptosis/drug effects;Apoptosis Regulatory Proteins/metabolism;Breast Neoplasms/drug therapy*;Breast Neoplasms/metabolism;Cell Line, Tumor;Cell Proliferation/drug effects;Cell Survival/drug effects;Dose-Response Relationship, Drug;Doxorubicin/pharmacology*;Doxorubicin/therapeutic use;Female;Food-Drug Interactions;Humans;Luteolin/adverse effects*;Luteolin/pharmacology;MCF-7 Cells;Plant Extracts/adverse effects*;Plant Extracts/pharmacology;Proto-Oncogene Proteins c-bcl-2/metabolism;Reactive Oxygen Species/metabolism;Receptors, Estrogen/metabolism;Vegetables/chemistry
25933598;Animals;Area Under Curve;Computer Simulation*;Dogs;Fasting;Food-Drug Interactions*;Humans;Male;Models, Biological*;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Solubility;Species Specificity
25917876;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Biotransformation;Dose-Response Relationship, Drug;Drug Administration Schedule;Food-Drug Interactions;Humans;Male;Middle Aged;Phenylthiohydantoin/administration & dosage;Phenylthiohydantoin/analogs & derivatives*;Phenylthiohydantoin/blood;Phenylthiohydantoin/pharmacokinetics;Prostatic Neoplasms, Castration-Resistant/blood;Prostatic Neoplasms, Castration-Resistant/drug therapy*;Prostatic Neoplasms, Castration-Resistant/metabolism
25894658;Adult;Communication*;Dietary Supplements/adverse effects*;Female;Food-Drug Interactions*;Humans;Internet;Japan;Male;Middle Aged;Physicians*;Self Medication/adverse effects*;Surveys and Questionnaires;Trace Elements/administration & dosage;Vitamins/administration & dosage;Young Adult
25894564;Animals;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/chemistry;Blood Platelets/drug effects;Blood Platelets/metabolism;Cells, Cultured;Colony-Forming Units Assay;Dietary Supplements;Drug Evaluation, Preclinical;Enzyme Inhibitors/adverse effects*;Enzyme Inhibitors/chemistry;Food-Drug Interactions;Hematopoiesis/drug effects*;Humans;Leukocytes, Mononuclear/cytology;Leukocytes, Mononuclear/drug effects;Leukocytes, Mononuclear/metabolism;Leukocytes, Mononuclear/pathology;Macaca fascicularis;Male;Megakaryocytes/cytology;Megakaryocytes/drug effects*;Megakaryocytes/metabolism;Megakaryocytes/pathology;Mice;Molecular Structure;Niacin/metabolism*;Niacin/therapeutic use;Nicotinamide Phosphoribosyltransferase/antagonists & inhibitors*;Nicotinamide Phosphoribosyltransferase/genetics;Nicotinamide Phosphoribosyltransferase/metabolism;Pentosyltransferases/genetics;Pentosyltransferases/metabolism;Rats, Sprague-Dawley;Thrombocytopenia/chemically induced*;Thrombocytopenia/metabolism;Thrombocytopenia/prevention & control
25893430;Administration, Oral;Animals;Antineoplastic Agents, Hormonal/administration & dosage*;Antineoplastic Agents, Hormonal/pharmacokinetics;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Dogs;Emulsions;Food-Drug Interactions*;Male;Megestrol Acetate/administration & dosage*;Megestrol Acetate/chemistry;Megestrol Acetate/pharmacokinetics;Nanoparticles*;Random Allocation;Solubility;Tandem Mass Spectrometry
25880707;Adult;Blood Coagulation Tests;Drug Monitoring/methods;Factor Xa Inhibitors/blood;Factor Xa Inhibitors/pharmacokinetics*;Food-Drug Interactions*;Humans;Job Description;Male;Meals*;Medication Adherence;Personnel Staffing and Scheduling;Predictive Value of Tests;Pulmonary Embolism/blood;Pulmonary Embolism/diagnosis;Pulmonary Embolism/drug therapy*;Recurrence;Risk Factors;Rivaroxaban/blood;Rivaroxaban/pharmacokinetics*;Venous Thromboembolism/blood;Venous Thromboembolism/diagnosis;Venous Thromboembolism/drug therapy*;Venous Thrombosis/blood;Venous Thrombosis/diagnosis;Venous Thrombosis/drug therapy*
25850750;Acetamides/administration & dosage*;Acetamides/adverse effects;Acetamides/pharmacokinetics;Acetates/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Male;Pyrazines/administration & dosage*;Pyrazines/adverse effects;Pyrazines/pharmacokinetics*;Receptors, Epoprostenol/agonists*;Young Adult
25828628;Adult;Aged;Aged, 80 and over;Anticoagulants/adverse effects*;Anticoagulants/blood;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Diet/adverse effects;Drug Monitoring;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/therapeutic use;Female;Food-Drug Interactions*;Hematuria/chemically induced;Humans;International Normalized Ratio;Male;Middle Aged;Nutritional Status/drug effects*;Republic of Korea;Retrospective Studies;Vitamin K/adverse effects;Vitamin K/antagonists & inhibitors*;Vitamin K/blood;Vitamin K/therapeutic use;Vitamin K Deficiency/chemically induced*;Vitamin K Deficiency/prevention & control;Vitamin K Epoxide Reductases/antagonists & inhibitors;Vitamin K Epoxide Reductases/metabolism;Warfarin/adverse effects*;Warfarin/blood;Warfarin/pharmacokinetics;Warfarin/therapeutic use
25812749;Acetaldehyde Dehydrogenase Inhibitors/adverse effects*;Adult;Antitrichomonal Agents/adverse effects*;Disulfiram/adverse effects*;Food-Drug Interactions*;Humans;Male;Ornidazole/adverse effects*;Wine*
25807927;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects*;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Cross-Over Studies;Delayed-Action Preparations;Drug Therapy, Combination;Food-Drug Interactions;Glucuronates/blood;Glucuronates/metabolism;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/adverse effects*;Hydromorphone/analogs & derivatives;Hydromorphone/blood;Hydromorphone/metabolism;Hydromorphone/pharmacokinetics*;Male;Middle Aged;Young Adult
25792182;Food-Drug Interactions*;Humans
25791157;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Cyclooxygenase Inhibitors/adverse effects;Dietary Fiber/adverse effects;Dietary Fiber/therapeutic use;Dinoprostone/therapeutic use;Enterobacteriaceae;Food-Drug Interactions;Gastrointestinal Motility/drug effects;Intestinal Diseases/chemically induced*;Intestinal Diseases/pathology;Intestinal Diseases/prevention & control;Intestinal Mucosa/drug effects;Intestinal Mucosa/pathology;Intestine, Small/drug effects*;Intestine, Small/microbiology;Intestine, Small/pathology;Mice;Nitric Oxide/metabolism;Nitric Oxide Synthase/metabolism;Pre-Exposure Prophylaxis/methods;Prostaglandins/biosynthesis;Proton Pump Inhibitors/adverse effects;Rats
25784216;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Administration, Oral;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Aspirin/administration & dosage;Aspirin/pharmacokinetics*;Biological Availability;Dipyrone/administration & dosage;Dipyrone/pharmacokinetics*;Drug Liberation;Food-Drug Interactions*;Humans
25769525;Administration, Oral;Colon/physiology*;Fasting/physiology*;Food-Drug Interactions;Gastric Emptying;Gastrointestinal Transit;Humans;Intestine, Small/physiology*;Tablets/pharmacokinetics*
25762793;Antitubercular Agents/pharmacokinetics*;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Rifampin/pharmacokinetics*;Tuberculosis, Pulmonary/drug therapy*
25762792;Antitubercular Agents/pharmacokinetics*;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Rifampin/pharmacokinetics*;Tuberculosis, Pulmonary/drug therapy*
25748293;Administration, Oral;Adult;Aged;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Chromatography, Liquid;Diphosphonates/administration & dosage;Diphosphonates/adverse effects;Diphosphonates/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Middle Aged;Tablets;Tandem Mass Spectrometry/methods;Young Adult
25747454;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Administration, Oral;Adult;Biotransformation;Chemistry, Pharmaceutical;Cross-Over Studies;Drug Stability;Duodenum/metabolism*;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Intestinal Absorption*;Intestinal Secretions/metabolism;Male;Phosphorous Acids/administration & dosage;Phosphorous Acids/blood;Phosphorous Acids/pharmacokinetics*;Postprandial Period;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Technology, Pharmaceutical;Young Adult
25744000;Animals;Bone Density/drug effects;Bone Density Conservation Agents/pharmacology;Bone Density Conservation Agents/therapeutic use*;Bone Resorption/metabolism;Bone Resorption/pathology;Bone Resorption/prevention & control*;Bone and Bones/drug effects;Bone and Bones/metabolism;Bone and Bones/pathology;Calcium Channels/genetics;Calcium Channels/metabolism;Calcium, Dietary/metabolism;Calcium, Dietary/therapeutic use*;Cell Proliferation/drug effects;Cells, Cultured;Combined Modality Therapy;Food-Drug Interactions*;Male;Mice, Inbred C57BL;Osteoblasts/drug effects*;Osteoblasts/metabolism;Osteoblasts/pathology;Osteogenesis/drug effects*;Parathyroid Hormone/analogs & derivatives*;Parathyroid Hormone/pharmacology;Parathyroid Hormone/therapeutic use*;Peptide Fragments/pharmacology;Peptide Fragments/therapeutic use;Receptors, Calcium-Sensing/agonists;Receptors, Calcium-Sensing/genetics;Receptors, Calcium-Sensing/metabolism;Receptors, Parathyroid Hormone/agonists;Receptors, Parathyroid Hormone/genetics;Receptors, Parathyroid Hormone/metabolism;TRPV Cation Channels/agonists;TRPV Cation Channels/genetics;TRPV Cation Channels/metabolism;Up-Regulation/drug effects
25724156;Administration, Oral;Adult;Aged;Aged, 80 and over;Case-Control Studies;Cross-Over Studies;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/blood;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism*;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*
27140799;1-Deoxynojirimycin/administration & dosage;1-Deoxynojirimycin/adverse effects;1-Deoxynojirimycin/analogs & derivatives*;1-Deoxynojirimycin/blood;1-Deoxynojirimycin/pharmacokinetics;Administration, Oral;Adolescent;Adult;Aged;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Dietary Fats/administration & dosage;Drug Administration Schedule;Drug Compounding;Fasting/blood;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Male;Meals*;Metabolic Clearance Rate;Middle Aged;Pharmaceutical Solutions;Postprandial Period;Texas;Therapeutic Equivalency;Young Adult
25720525;Adult;Area Under Curve;Beverages/adverse effects;Citrus paradisi/adverse effects;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions;Fruit and Vegetable Juices/adverse effects*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Punicaceae/adverse effects*;Simvastatin/pharmacokinetics*;Young Adult
25712830;Administration, Oral;Animals;Biopharmaceutics/classification;Computer Simulation;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Intestinal Absorption;Mouth Mucosa/metabolism*
25694412;Drug Administration Schedule;Food-Drug Interactions;Humans;Hypothyroidism/drug therapy*;Quality of Life;Thyroxine/administration & dosage*;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use
25673087;Administration, Oral;Adult;Amidines/administration & dosage*;Amidines/blood;Amidines/pharmacokinetics*;Amidines/urine;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/urine;Antithrombins/blood;Antithrombins/pharmacokinetics*;Antithrombins/urine;Biomarkers, Pharmacological/blood;Biomarkers, Pharmacological/urine;Blood Coagulation/drug effects*;Cross-Over Studies;Dipeptides/administration & dosage*;Dipeptides/blood;Dipeptides/pharmacokinetics*;Dipeptides/urine;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions/physiology*;Healthy Volunteers;Humans;Male;Middle Aged;Young Adult
25668218;Animals;Computational Biology/methods*;Databases, Factual;Diet;Disease;Food-Drug Interactions*;Gene Expression Profiling;Humans;Mice;Models, Molecular*;Phytochemicals*
25658756;Administration, Oral;Age Factors;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Blood Coagulation/drug effects;Food-Drug Interactions;Hemorrhage/drug therapy;Humans;Liver Diseases/metabolism;Platelet Aggregation Inhibitors/adverse effects;Renal Insufficiency, Chronic/metabolism;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use
25656645;Binding Sites;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Hydrogen Bonding;Hydrophobic and Hydrophilic Interactions;Models, Molecular;Nifedipine/pharmacology*;Rutin/pharmacology*;Serum Albumin/chemistry*;Thermodynamics
25648347;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Area Under Curve;Benzimidazoles/administration & dosage*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Biological Availability;Capsules;Cross-Over Studies;Disease-Free Survival;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Protein-Tyrosine Kinases/antagonists & inhibitors;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Quinolones/therapeutic use;Tablets
25636978;Beverages;Dietary Supplements;Food-Drug Interactions*;Fruit;Humans;Internal Medicine*;Intestines/metabolism;Vegetables;Vitamins
25633078;Biological Availability;Biotransformation;Digestion/physiology*;Flavonoids/chemistry*;Flavonoids/metabolism;Flavonoids/pharmacokinetics*;Flavonoids/pharmacology;Food-Drug Interactions*;Gastrointestinal Absorption;Gastrointestinal Tract/metabolism*;Humans;Hydroxylation;Molecular Structure;Structure-Activity Relationship;Tissue Distribution
25615879;Administration, Oral;Animals;Biological Availability;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/analysis;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics;Calcium Compounds/chemistry*;Chemical Phenomena;Chemistry, Pharmaceutical;Drug Carriers/administration & dosage*;Drug Carriers/analysis;Drug Carriers/chemistry;Drug Carriers/pharmacokinetics;Drug Liberation;Drug Stability;Drug Storage;Emulsions;Food-Drug Interactions*;Intestinal Absorption;Male;Nifedipine/administration & dosage*;Nifedipine/analysis;Nifedipine/chemistry;Nifedipine/pharmacokinetics;Particle Size;Porosity;Powders;Rats, Wistar;Silicates/chemistry*;Silicon Dioxide/chemistry*;Surface Properties
25609481;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Drug Interactions;Food-Drug Interactions/physiology;Gastrointestinal Absorption/physiology;Humans;Hydrogen-Ion Concentration;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/pharmacokinetics
25573904;Administration, Oral;Adult;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage*;Fasting;Female;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Infant Formula/administration & dosage*;Male;Middle Aged;Powders;Ritonavir/blood;Ritonavir/pharmacokinetics*;Solutions;Therapeutic Equivalency;Water
25557052;Activation, Metabolic/drug effects;Beverages/adverse effects*;Blood Platelets/drug effects;Citrus paradisi/adverse effects*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/metabolism;Platelet Aggregation Inhibitors/pharmacokinetics;Platelet Aggregation Inhibitors/pharmacology;Prasugrel Hydrochloride/blood;Prasugrel Hydrochloride/metabolism;Prasugrel Hydrochloride/pharmacokinetics*;Prasugrel Hydrochloride/pharmacology;Prodrugs/metabolism*;Prodrugs/pharmacokinetics;Young Adult
25552402;Administration, Sublingual;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Healthy Volunteers;Heterocyclic Compounds, 4 or More Rings/administration & dosage;Heterocyclic Compounds, 4 or More Rings/blood;Heterocyclic Compounds, 4 or More Rings/pharmacokinetics*;Humans;Male;Middle Aged;Models, Biological;Young Adult
25549790;Animals;Biological Availability;Carbamates/chemistry*;Carbamates/pharmacokinetics;Food-Drug Interactions*;Hypoglycemic Agents/chemistry*;Hypoglycemic Agents/pharmacokinetics;Male;Nanoparticles*;Piperidines/chemistry*;Piperidines/pharmacokinetics;Rats;Rats, Wistar
25547640;Acetaminophen/pharmacokinetics*;Animals;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carbamazepine/pharmacokinetics;Citrus paradisi/adverse effects*;Diclofenac/pharmacokinetics;Eating;Food-Drug Interactions*;Male;Rats;Rats, Sprague-Dawley
25546166;Administration, Oral;Adolescent;Adult;Area Under Curve;Canagliflozin;Cross-Over Studies;Drug Combinations;Fasting/blood;Female;Food-Drug Interactions*;Glucosides/administration & dosage*;Glucosides/adverse effects;Glucosides/blood;Glucosides/pharmacokinetics*;Half-Life;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Male;Metabolic Clearance Rate;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/blood;Metformin/pharmacokinetics*;Middle Aged;Postprandial Period;Tablets;Therapeutic Equivalency;Thiophenes/administration & dosage*;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/pharmacokinetics*;Young Adult
25546165;Administration, Oral;Adolescent;Adult;Area Under Curve;Biotransformation;Capsules;China;Cross-Over Studies;Dietary Fats/administration & dosage;Fasting/blood;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics*;Postprandial Period;Salicylates/administration & dosage;Salicylates/blood;Salicylates/pharmacokinetics*;Therapeutic Equivalency;Young Adult
25541407;Adipokines/blood;Adipose Tissue/drug effects;Adipose Tissue/metabolism;Animals;Biomarkers/blood;Blood Glucose/drug effects*;Blood Glucose/metabolism;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/etiology;Diabetes Mellitus, Type 2/genetics;Diabetes Mellitus, Type 2/prevention & control*;Dichlorodiphenyl Dichloroethylene/pharmacology*;Dichlorodiphenyl Dichloroethylene/toxicity;Diet, Fat-Restricted;Diet, High-Fat*;Disease Models, Animal;Dyslipidemias/blood;Dyslipidemias/etiology;Dyslipidemias/prevention & control*;Environmental Pollutants/pharmacology*;Environmental Pollutants/toxicity;Fatty Liver/blood;Fatty Liver/etiology;Fatty Liver/prevention & control;Food-Drug Interactions;Glucose Intolerance/blood;Glucose Intolerance/etiology;Glucose Intolerance/prevention & control;Glucose Transporter Type 4/genetics;Glucose Transporter Type 4/metabolism;Hyperinsulinism/blood;Hyperinsulinism/etiology;Hyperinsulinism/prevention & control;Insecticides/pharmacology*;Insecticides/toxicity;Insulin/blood;Insulin Resistance;Lipids/blood*;Liver/drug effects;Liver/metabolism;Male;Mice, Inbred C57BL;Muscle, Skeletal/drug effects;Muscle, Skeletal/metabolism;RNA, Messenger/metabolism;Time Factors
25525635;Drug Interactions;Food-Drug Interactions;Humans;Lactones/adverse effects;Lactones/pharmacokinetics;Lactones/pharmacology;Lactones/therapeutic use*;Platelet Aggregation Inhibitors/therapeutic use*;Pyridines/adverse effects;Pyridines/pharmacokinetics;Pyridines/pharmacology;Pyridines/therapeutic use*;Receptor, PAR-1/antagonists & inhibitors*;Thrombosis/prevention & control*
25511575;Androstenes/pharmacokinetics*;Antineoplastic Agents/pharmacokinetics*;Clinical Trials as Topic;Computer Simulation*;Food-Drug Interactions;Gastrointestinal Absorption;Humans;Metabolic Clearance Rate;Models, Biological;Pyrimidines/pharmacokinetics*;Randomized Controlled Trials as Topic/methods*;Sampling Studies
25510602;Animals;Bile Acids and Salts/analysis;Fasting/metabolism;Food-Drug Interactions*;Humans;Ileum/metabolism;In Vitro Techniques;Intestinal Absorption*;Intestinal Secretions/metabolism*;Male;Permeability;Pharmaceutical Preparations/metabolism*;Phospholipids/analysis;Postprandial Period/physiology;Rats, Wistar;Solvents
25499666;Adult;Analysis of Variance;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/adverse effects*;Diclofenac/blood;Diclofenac/pharmacokinetics*;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Pennsylvania;Tablets;Young Adult
25486915;Administration, Oral;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use*;Dermatologic Surgical Procedures*;Dermatology;Dietary Supplements;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Humans;Platelet Aggregation Inhibitors/pharmacology*;Platelet Aggregation Inhibitors/therapeutic use*;Practice Guidelines as Topic;Risk Assessment
25486333;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Citrus paradisi;Cross-Over Studies;Dietary Supplements;Dosage Forms;Dose-Response Relationship, Drug;Female;Flavanones/administration & dosage*;Flavanones/pharmacology;Food-Drug Interactions;Humans;Male;Organic Anion Transporters/genetics;Polymorphism, Single Nucleotide;Propanolamines/blood;Propanolamines/pharmacokinetics*;Propanolamines/urine;Young Adult
25476894;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Carbamates/administration & dosage;Carbamates/adverse effects;Carbamates/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Antagonism;Famotidine/pharmacology;Female;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;raf Kinases/antagonists & inhibitors
25470100;Beverages/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Organic Anion Transporters/antagonists & inhibitors*;Psychotropic Drugs/antagonists & inhibitors*
25466133;Amines/chemistry*;Biogenic Amines/analysis;Chromatography, High Pressure Liquid;Fermentation*;Food-Drug Interactions;Histamine/analysis;Monoamine Oxidase Inhibitors/administration & dosage;Phenethylamines/analysis;Risk Assessment;Soy Foods/analysis*;Spain;Tyramine/analysis
25449994;Administration, Oral;Adult;Area Under Curve;Calcium Carbonate/pharmacology*;Cross-Over Studies;Dietary Supplements*;Drug Antagonism;Fasting;Female;Ferrous Compounds/pharmacology*;Food-Drug Interactions;HIV Integrase Inhibitors/pharmacokinetics*;Half-Life;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Male;Metabolic Clearance Rate
25438724;Administration, Oral;Adult;Biological Availability;Capsules;Cognition/drug effects;Cross-Over Studies;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Nicotinic Agonists/administration & dosage;Nicotinic Agonists/adverse effects;Nicotinic Agonists/pharmacokinetics*;Quinuclidines/administration & dosage;Quinuclidines/adverse effects;Quinuclidines/pharmacokinetics*;Receptors, Nicotinic;Sex Factors;Therapeutic Equivalency;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/pharmacokinetics*
25418395;Depression/complications;Depression/diagnosis;Diagnosis, Differential;Dietary Proteins/administration & dosage;Energy Intake;Food-Drug Interactions;Gastrointestinal Diseases/diagnosis;Gastrointestinal Diseases/etiology;Humans;Inflammation/diagnosis;Inflammation/etiology;Micronutrients/administration & dosage;Micronutrients/deficiency;Protein-Energy Malnutrition/diagnosis*;Protein-Energy Malnutrition/etiology;Weight Loss
25418056;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/genetics;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors*;ATP-Binding Cassette Transporters/genetics;ATP-Binding Cassette Transporters/metabolism;Animals;Antineoplastic Agents/chemistry;Antineoplastic Agents/metabolism*;Antineoplastic Agents/pharmacology;Beverages/analysis;Biological Transport/drug effects;Cell Line;Coumarins/analysis;Coumarins/chemistry;Coumarins/pharmacology;Dasatinib;Dogs;Flavonoids/analysis;Flavonoids/chemistry;Flavonoids/pharmacology;Food-Drug Interactions;Fruit/chemistry;Humans;Madin Darby Canine Kidney Cells;Membrane Transport Modulators/analysis;Membrane Transport Modulators/chemistry;Membrane Transport Modulators/pharmacology*;Neoplasm Proteins/antagonists & inhibitors*;Neoplasm Proteins/genetics;Neoplasm Proteins/metabolism;Phytochemicals/analysis;Phytochemicals/chemistry;Phytochemicals/pharmacology*;Protein Kinase Inhibitors/chemistry;Protein Kinase Inhibitors/metabolism*;Protein Kinase Inhibitors/pharmacology;Protein-Tyrosine Kinases/antagonists & inhibitors;Protein-Tyrosine Kinases/metabolism;Pyrimidines/antagonists & inhibitors;Pyrimidines/metabolism*;Pyrimidines/pharmacology;Recombinant Proteins/chemistry;Recombinant Proteins/metabolism;Sus scrofa;Thiazoles/antagonists & inhibitors;Thiazoles/metabolism*;Thiazoles/pharmacology
25417837;Administration, Oral;Animals;Animals, Inbred Strains;Beverages;Breakfast;Denmark;Dogs;Drug Evaluation, Preclinical/methods*;Drugs, Investigational/administration & dosage;Drugs, Investigational/chemistry;Drugs, Investigational/pharmacokinetics*;Energy Intake;Food-Drug Interactions*;Gastric Emptying/drug effects;Humans;Male;Models, Animal*;Oral Mucosal Absorption*;Solubility;Species Specificity;Swine;Swine, Miniature/physiology*
25417766;Acetaminophen/antagonists & inhibitors;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Acetaminophen/poisoning;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/chemistry;Analgesics, Non-Narcotic/pharmacokinetics*;Analgesics, Non-Narcotic/poisoning;Animals;Antipyretics/antagonists & inhibitors;Antipyretics/blood;Antipyretics/pharmacokinetics;Antipyretics/poisoning;Biological Availability;Biotransformation;Carbohydrate Conformation;Catalytic Domain;Chemical and Drug Induced Liver Injury/blood;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/prevention & control;Cytochrome P-450 CYP2E1/chemistry;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP2E1 Inhibitors/chemistry;Cytochrome P-450 CYP2E1 Inhibitors/metabolism;Cytochrome P-450 CYP2E1 Inhibitors/therapeutic use*;Databases, Protein;Dietary Supplements*;Female;Food-Drug Interactions*;Glucosamine/chemistry;Glucosamine/metabolism;Glucosamine/therapeutic use*;Humans;Ligands;Liver/drug effects;Liver/enzymology;Liver/metabolism*;Molecular Docking Simulation;Protein Conformation;Rats, Sprague-Dawley
25381051;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Biological Availability;Cohort Studies;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Leukemia, Lymphocytic, Chronic, B-Cell/blood;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy*;Leukemia, Lymphocytic, Chronic, B-Cell/metabolism;Lymphoma, Mantle-Cell/blood;Lymphoma, Mantle-Cell/drug therapy*;Lymphoma, Mantle-Cell/metabolism;Male;Middle Aged;Models, Biological*;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/therapeutic use;Protein-Tyrosine Kinases/antagonists & inhibitors*;Pyrazoles/administration & dosage;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrazoles/therapeutic use;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use
25377158;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Biotransformation;Dose-Response Relationship, Drug;Drugs, Investigational/administration & dosage;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Drugs, Investigational/therapeutic use;Female;Food-Drug Interactions;Half-Life;Humans;Hydroxylation;Intestinal Absorption;Male;Metabolic Clearance Rate;Methylation;Middle Aged;Models, Biological*;Neoplasms/blood;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/administration & dosage;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolines/therapeutic use;Receptor, Epidermal Growth Factor/antagonists & inhibitors*;Tablets
25365914;Administration, Oral;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism*
25361167;Animals;Brazil;Cytochrome P-450 Enzyme Inhibitors/chemistry*;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P-450 Enzyme System/chemistry*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Kinetics;Male;Propolis/chemistry*;Propolis/metabolism;Rats;Rats, Wistar
27129123;Administration, Oral;Adolescent;Adult;Amlodipine, Valsartan Drug Combination/administration & dosage*;Amlodipine, Valsartan Drug Combination/adverse effects;Amlodipine, Valsartan Drug Combination/blood;Amlodipine, Valsartan Drug Combination/pharmacokinetics*;Angiotensin II Type 1 Receptor Blockers/administration & dosage*;Angiotensin II Type 1 Receptor Blockers/adverse effects;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage;Drug Combinations;Drug Monitoring;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Hydrochlorothiazide/administration & dosage*;Hydrochlorothiazide/adverse effects;Hydrochlorothiazide/blood;Hydrochlorothiazide/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Tablets;Young Adult
27129119;Adolescent;Adult;Aged;Antiviral Agents/administration & dosage*;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Boronic Acids/administration & dosage*;Boronic Acids/adverse effects;Boronic Acids/pharmacokinetics*;Double-Blind Method;Female;Food-Drug Interactions;Genotype;Hepacivirus/drug effects*;Hepacivirus/enzymology;Hepacivirus/genetics;Hepatitis C, Chronic/blood;Hepatitis C, Chronic/diagnosis;Hepatitis C, Chronic/drug therapy*;Hepatitis C, Chronic/genetics;Humans;Interleukins/genetics;Male;Middle Aged;Phenotype;Protease Inhibitors/administration & dosage*;Protease Inhibitors/adverse effects;Protease Inhibitors/pharmacokinetics;RNA, Viral/blood;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*;Treatment Outcome;United States;Viral Load;Viral Nonstructural Proteins/antagonists & inhibitors*;Viral Nonstructural Proteins/metabolism;Young Adult
25350242;Aged;Angiotensin II Type 1 Receptor Blockers/adverse effects*;Angiotensin II Type 1 Receptor Blockers/therapeutic use;Biopsy;Celiac Disease/chemically induced*;Celiac Disease/diagnosis*;Celiac Disease/epidemiology*;Celiac Disease/pathology;Chronic Disease;Diagnosis, Differential;Diarrhea/chemically induced*;Diarrhea/epidemiology;Diarrhea/etiology*;Diarrhea/pathology;Female;Food-Drug Interactions;Humans;Ileum/drug effects;Ileum/pathology;Imidazoles/adverse effects*;Imidazoles/therapeutic use;Intestinal Mucosa/drug effects;Intestinal Mucosa/pathology;Tetrazoles/adverse effects*;Tetrazoles/therapeutic use
25344090;Abiraterone Acetate;Adult;Androstenes/administration & dosage;Androstenes/adverse effects;Androstenes/blood;Androstenes/pharmacokinetics*;Antineoplastic Agents, Hormonal/administration & dosage;Antineoplastic Agents, Hormonal/adverse effects;Antineoplastic Agents, Hormonal/blood;Antineoplastic Agents, Hormonal/pharmacokinetics*;Asian Americans;Cross-Over Studies;Cytochrome P-450 Enzyme Inhibitors/administration & dosage;Cytochrome P-450 Enzyme Inhibitors/adverse effects;Cytochrome P-450 Enzyme Inhibitors/blood;Cytochrome P-450 Enzyme Inhibitors/pharmacokinetics*;Dose-Response Relationship, Drug;European Continental Ancestry Group;Food-Drug Interactions*/ethnology;Half-Life;Humans;Japan/ethnology;Male;Meals;Metabolic Clearance Rate;Middle Aged;Prostatic Neoplasms/drug therapy;Prostatic Neoplasms/ethnology;Steroid 17-alpha-Hydroxylase/antagonists & inhibitors*;Tablets;United States;Young Adult
25337649;Animals;Anticonvulsants/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Humans;Intestinal Absorption;Membrane Transport Proteins/physiology*;Vigabatrin/pharmacokinetics*
25326286;Aldehyde Oxidase/antagonists & inhibitors*;Aldehyde Oxidase/metabolism*;Catechin/adverse effects;Catechin/analogs & derivatives;Catechin/metabolism;Cytochrome P-450 Enzyme System/metabolism;Diet/adverse effects*;Enzyme Inhibitors/metabolism;Food-Drug Interactions/physiology*;Guanine/analogs & derivatives;Guanine/metabolism;Humans;Ligands;Oxidation-Reduction;Quantitative Structure-Activity Relationship;Tea/adverse effects;Xenobiotics/metabolism
25312344;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions;Humans;Models, Biological*;Retrospective Studies;Therapeutic Equivalency
25288354;Chemistry, Pharmaceutical;Drug Stability;Enteral Nutrition/methods*;Food-Drug Interactions*;Gastrostomy/adverse effects;Gastrostomy/methods*;Humans;Intubation, Gastrointestinal/adverse effects;Intubation, Gastrointestinal/methods*;Prescription Drugs/administration & dosage*;Prescription Drugs/chemistry;Prescription Drugs/pharmacokinetics
25274605;Area Under Curve;Beverages;Citrus;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inhibitors/administration & dosage;Cytochrome P-450 CYP3A Inhibitors/blood;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics*;Drug Interactions*;Food-Drug Interactions;Humans;Models, Biological*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*;Predictive Value of Tests;Regression Analysis;Substrate Specificity
25268237;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Biological Availability;Computer Simulation;Fasting/physiology;Felodipine/blood;Felodipine/pharmacokinetics*;Food-Drug Interactions/physiology*;Gastric Emptying/physiology;Gastrointestinal Tract/physiopathology;Gastrointestinal Transit/physiology;Humans;Intestinal Absorption/physiology;Intestines/physiology;Models, Statistical*;Postprandial Period/physiology;Precision Medicine;Solubility;User-Computer Interface*
25253884;Adult;Beverages*;Biomarkers/blood;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Female;Food-Drug Interactions/physiology*;Forecasting;Humans;Loperamide/administration & dosage;Loperamide/blood*;Male;Microsomes/drug effects;Microsomes/enzymology;Middle Aged;Prospective Studies;Substrate Specificity/drug effects;Substrate Specificity/physiology;Young Adult
25251944;Dietary Supplements/adverse effects*;Drug-Related Side Effects and Adverse Reactions*/epidemiology;Drug-Related Side Effects and Adverse Reactions*/etiology;Food-Drug Interactions;Humans;Plant Preparations/adverse effects*;Plants, Medicinal*/adverse effects;Plants, Medicinal*/classification
25238825;Drug Interactions*;Enteral Nutrition*;Food-Drug Interactions*;Humans
25231186;Adamantane/analogs & derivatives;Adamantane/pharmacology;Adolescent;Adult;Appetite Regulation/drug effects;Cross-Over Studies;Dietary Fats/metabolism*;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Double-Blind Method;Energy Intake/drug effects;Energy Metabolism/drug effects*;Food-Drug Interactions*;Gastric Inhibitory Polypeptide/agonists*;Gastric Inhibitory Polypeptide/blood;Gastric Inhibitory Polypeptide/secretion;Glucagon/blood;Glucagon/secretion;Glucagon-Like Peptide 1/agonists*;Glucagon-Like Peptide 1/blood;Glucagon-Like Peptide 1/secretion;Humans;Hyperglycemia/blood;Hyperglycemia/metabolism;Hyperglycemia/prevention & control*;Insulin/blood;Insulin/secretion;Male;Middle Aged;Nitriles/pharmacology;Peptide Fragments/blood;Peptide Fragments/secretion;Peptide YY/blood;Peptide YY/secretion;Postprandial Period;Pyrrolidines/pharmacology;Young Adult
25224876;Adult;Aged;Analgesics/pharmacokinetics*;Area Under Curve;Benzenesulfonates/pharmacokinetics*;Chromatography, High Pressure Liquid;Colonoscopy;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Least-Squares Analysis;Male;Middle Aged;Pain/drug therapy;Tandem Mass Spectrometry
25224007;Adolescent;Adult;Anti-HIV Agents/therapeutic use;Antitubercular Agents/pharmacokinetics*;Antitubercular Agents/therapeutic use;Area Under Curve;Comorbidity;Diabetes Mellitus/drug therapy;Diabetes Mellitus/epidemiology;Diabetes Mellitus/pathology;Dietary Fats/metabolism;Dietary Fats/pharmacokinetics*;Drug Administration Schedule;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/epidemiology;HIV Infections/pathology;Humans;Hypoglycemic Agents/therapeutic use;Isoniazid/pharmacokinetics*;Isoniazid/therapeutic use;Male;Middle Aged;Peru/epidemiology;Rifampin/pharmacokinetics*;Rifampin/therapeutic use;Sex Factors;Treatment Outcome;Tuberculosis, Pulmonary/drug therapy*;Tuberculosis, Pulmonary/epidemiology;Tuberculosis, Pulmonary/pathology
25213388;Adult;Child;Cyclosporine/adverse effects;Cyclosporine/pharmacokinetics;Cyclosporine/therapeutic use*;Dermatitis, Atopic/drug therapy;Disease Susceptibility;Drug Administration Schedule;Drug Interactions;Female;Food-Drug Interactions;Humans;Hypertension/chemically induced;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics;Immunosuppressive Agents/therapeutic use*;Infection/etiology;Kidney Diseases/chemically induced;Kidney Diseases/diagnosis;Neoplasms/etiology;Practice Guidelines as Topic;Pregnancy;Pregnancy Complications/drug therapy;Pregnancy Complications/prevention & control;Psoriasis/drug therapy;Quality of Life;Skin Diseases/drug therapy*
25207548;Adult;Citrus paradisi*;Female;Food-Drug Interactions*;Fruit and Vegetable Juices*;Humans;Male;Phenylpropionates/adverse effects;Phenylpropionates/pharmacokinetics*;Pyridazines/adverse effects;Pyridazines/pharmacokinetics*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
25204404;Adult;Aged;Aged, 80 and over;Androstenes/blood;Androstenes/pharmacokinetics*;Androstenes/therapeutic use;Antineoplastic Agents/therapeutic use;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Double-Blind Method;Fasting/metabolism;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;Models, Biological*;Prostatic Neoplasms, Castration-Resistant/drug therapy;Prostatic Neoplasms, Castration-Resistant/metabolism*;Steroid 17-alpha-Hydroxylase/antagonists & inhibitors;Taxoids/therapeutic use;Young Adult
25199774;Administration, Oral;Adult;Aged;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics;Antifungal Agents/therapeutic use*;Female;Food-Drug Interactions;Gastrointestinal Absorption;Humans;Leukemia/microbiology;Liver/pathology;Male;Middle Aged;Mycoses/complications;Mycoses/drug therapy*;Mycoses/prevention & control*;Suspensions/adverse effects;Tablets/adverse effects;Triazoles/adverse effects;Triazoles/pharmacokinetics;Triazoles/therapeutic use*
25193431;Administration, Oral;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Biological Availability;Capsules;Cross-Over Studies;Dietary Fats/adverse effects*;Female;Food Analysis/methods;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasm Staging;Neoplasms*/drug therapy;Neoplasms*/pathology;Quinolones/administration & dosage;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Therapeutic Equivalency;Treatment Outcome
25186833;Adolescent;Adult;Biological Availability;Clinical Trials, Phase I as Topic;Dose-Response Relationship, Drug;Factor Xa Inhibitors/administration & dosage;Factor Xa Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Models, Biological*;Nonlinear Dynamics;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Sex Factors;Thiazoles/administration & dosage;Thiazoles/pharmacokinetics*;Young Adult
25173560;Animals;Antineoplastic Agents/chemistry;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/pharmacology*;Catechin/analogs & derivatives*;Catechin/metabolism;Drug Synergism;Food-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/metabolism;Tea/metabolism*
27129014;Adult;Area Under Curve;Belgium;Cross-Over Studies;Drug Compounding;Fasting/blood;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Metabolic Clearance Rate;Middle Aged;Models, Biological;Postprandial Period;Proton Pump Inhibitors/administration & dosage*;Proton Pump Inhibitors/adverse effects;Proton Pump Inhibitors/chemistry;Proton Pump Inhibitors/pharmacokinetics*;Rabeprazole/administration & dosage*;Rabeprazole/adverse effects;Rabeprazole/chemistry;Rabeprazole/pharmacokinetics*;Tablets;Therapeutic Equivalency;United States;Young Adult
27129006;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Darunavir/administration & dosage*;Darunavir/adverse effects;Darunavir/blood;Darunavir/pharmacokinetics*;Fasting/blood;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Healthy Volunteers;Humans;Male;Metabolic Clearance Rate;Middle Aged;Netherlands;Pharmaceutical Solutions;Postprandial Period;Ritonavir/administration & dosage*;Tablets;Young Adult
25170252;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Analgesics/administration & dosage;Analgesics/pharmacokinetics;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/administration & dosage;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Oxycodone/administration & dosage;Oxycodone/pharmacokinetics*;Tablets;Young Adult
25165009;Administration, Oral;Animals;Area Under Curve;Biological Availability;Chromatography, Reverse-Phase/methods;Drug Stability;Fasting/blood;Female;Food-Drug Interactions*;Ginkgo biloba*/chemistry;Ginkgolides/administration & dosage*;Ginkgolides/blood;Ginkgolides/isolation & purification;Ginkgolides/pharmacokinetics*;Half-Life;Lactones/administration & dosage*;Lactones/blood;Lactones/isolation & purification;Lactones/pharmacokinetics*;Male;Plant Extracts/administration & dosage*;Plant Extracts/blood;Plant Extracts/isolation & purification;Plant Extracts/pharmacokinetics*;Postprandial Period;Rats, Sprague-Dawley;Reproducibility of Results;Sex Factors;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry
25148900;Angiotensin-Converting Enzyme Inhibitors/adverse effects*;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Angiotensin-Converting Enzyme Inhibitors/therapeutic use;Drug Interactions;Food-Drug Interactions;Humans;Hyperkalemia/chemically induced;Hypotension/chemically induced;Kidney Function Tests;Renal Insufficiency/chemically induced;Renal Insufficiency, Chronic/drug therapy*;Renal Insufficiency, Chronic/physiopathology;Renin-Angiotensin System/drug effects*
25142999;Adult;Cytochrome P-450 CYP3A Inducers/adverse effects*;Cytochrome P-450 CYP3A Inhibitors/blood;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics*;Dietary Supplements/adverse effects*;Drug Combinations;Female;Food-Drug Interactions*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Immunologic Factors/adverse effects;Lopinavir/blood;Lopinavir/pharmacokinetics*;Male;Maryland;Metabolic Clearance Rate;National Institute of Allergy and Infectious Diseases (U.S.);Nootropic Agents/adverse effects;Panax/adverse effects*;Plant Roots/adverse effects;Ritonavir/blood;Ritonavir/pharmacokinetics*;United States;Young Adult
25118080;Cheese/adverse effects*;Food-Drug Interactions*;Humans;Male;Monoamine Oxidase Inhibitors/adverse effects*;Myocardial Infarction/chemically induced*;Phenelzine/adverse effects*;Young Adult
25112306;Anticoagulants/pharmacology*;Food-Drug Interactions*;Fruit/chemistry*;Humans;International Normalized Ratio;Warfarin/pharmacology*
25078976;Adult;Analgesics/administration & dosage;Analgesics/adverse effects;Analgesics/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Energy Intake/physiology;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pregabalin;Therapeutic Equivalency;Time Factors;Young Adult;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/pharmacokinetics
25055080;Animals;Antioxidants/metabolism;Antioxidants/pharmacology*;Aorta/metabolism;Camellia sinensis*;Diet;Diet, High-Fat;Dietary Fats/metabolism;Dietary Fats/pharmacology*;Duodenum/metabolism;Ferrous Compounds/pharmacology;Food-Drug Interactions;Gene Expression/drug effects*;Iron/metabolism;Iron/pharmacology*;Lactates/pharmacology;Liver/metabolism;Male;Mice, Inbred C57BL;Mitogen-Activated Protein Kinase 1/genetics;Mitogen-Activated Protein Kinase 1/metabolism;Myocardium/metabolism*;NF-kappa B/genetics;NF-kappa B/metabolism;Plant Extracts/pharmacology*;Polymerase Chain Reaction;RNA, Messenger/genetics;RNA, Messenger/metabolism;Tea;Trace Elements/pharmacology
25051813;Alcoholic Beverages/adverse effects;Beverages/adverse effects*;Food-Drug Interactions;Humans;Quinine/adverse effects*
25044357;Benzilates/blood;Benzilates/chemistry;Benzilates/pharmacokinetics*;Biological Availability;Computer Simulation;Dose-Response Relationship, Drug;Fasting/metabolism*;Food-Drug Interactions*;Gastric Emptying/drug effects;Gastrointestinal Absorption/drug effects*;Humans;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Models, Biological*;Nortropanes/blood;Nortropanes/chemistry;Nortropanes/pharmacokinetics*;Solubility;Time Factors;Urological Agents/blood;Urological Agents/chemistry;Urological Agents/pharmacokinetics*
25030115;Chemistry, Pharmaceutical;Colloids;Danazol/chemistry*;Digestion;Drug Carriers*;Drug Stability;Emulsions;Fasting;Food-Drug Interactions;Humans;Intestinal Secretions/enzymology;Kinetics;Lipids/chemistry*;Lipolysis;Nanoparticles;Oils/chemistry*;Postprandial Period;Solubility;Solvents/chemistry;Technology, Pharmaceutical/methods;Water/chemistry
25029747;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications*;Benzimidazoles/therapeutic use;Dabigatran;Food-Drug Interactions;Humans;Morpholines/therapeutic use;Pyrazoles/therapeutic use;Pyridones/therapeutic use;Rivaroxaban;Stroke/etiology;Stroke/prevention & control*;Thiophenes/therapeutic use;Warfarin/therapeutic use;beta-Alanine/analogs & derivatives;beta-Alanine/therapeutic use
25026202;Chromatography, Liquid;Citrus/chemistry*;Food-Drug Interactions*;Fruit/chemistry;Furocoumarins/analysis*;Humans;Mass Spectrometry;Methoxsalen/analogs & derivatives*;Methoxsalen/analysis;Plant Extracts/chemistry*;Plant Extracts/standards
25008160;Centers for Disease Control and Prevention (U.S.);Dose-Response Relationship, Radiation;Drug Interactions;Evidence-Based Medicine*/methods;Food-Drug Interactions;Humans;Iodine Radioisotopes/administration & dosage;Iodine Radioisotopes/adverse effects*;Iodine Radioisotopes/pharmacokinetics;Iodine Radioisotopes/therapeutic use;Radionuclide Imaging;Radiopharmaceuticals/administration & dosage;Radiopharmaceuticals/adverse effects*;Radiopharmaceuticals/pharmacokinetics;Radiopharmaceuticals/therapeutic use;Sodium Iodide/administration & dosage;Sodium Iodide/adverse effects*;Sodium Iodide/pharmacokinetics;Sodium Iodide/therapeutic use;Thyroid Diseases/diagnostic imaging;Thyroid Diseases/metabolism;Thyroid Diseases/physiopathology;Thyroid Diseases/radiotherapy*;Thyroid Gland/diagnostic imaging;Thyroid Gland/metabolism;Thyroid Gland/physiopathology;Thyroid Gland/radiation effects*;Thyrotropin/blood;Tissue Distribution;Toxicology/methods;United States
24990113;Administration, Oral;Adult;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Fasting/metabolism;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Pyrazoles/adverse effects;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Therapeutic Equivalency;Young Adult
24982396;Administration, Oral;Adult;Aniline Compounds/administration & dosage*;Aniline Compounds/adverse effects*;Aniline Compounds/pharmacokinetics;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Biological Availability;Biopharmaceutics/ethics*;Biopharmaceutics/methods;Cohort Studies;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Neoplasms/drug therapy;Neoplasms/metabolism;Risk Assessment;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects*;Sulfonamides/pharmacokinetics
27128838;Adolescent;Adult;Anti-Inflammatory Agents/administration & dosage;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents/blood;Anti-Inflammatory Agents/pharmacokinetics*;Antioxidants/administration & dosage;Antioxidants/adverse effects;Antioxidants/pharmacokinetics*;Drug Monitoring;Fasting/blood;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Models, Biological;Oleanolic Acid/administration & dosage;Oleanolic Acid/adverse effects;Oleanolic Acid/analogs & derivatives*;Oleanolic Acid/blood;Oleanolic Acid/pharmacokinetics;Postprandial Period;Risk Assessment;Wisconsin;Young Adult
24973432;Color;Diltiazem/poisoning*;Drug Overdose*;Fat Emulsions, Intravenous/poisoning*;Female;Food-Drug Interactions;Hemolysis;Humans;Hyperlipidemias/chemically induced;Middle Aged;Off-Label Use;Plasma;Poisoning/blood;Tetrazoles/poisoning;Valine/analogs & derivatives;Valine/poisoning;Valsartan
24970101;Absorption;Animals;Chemistry, Pharmaceutical/methods;Diffusion;Drug Delivery Systems*;Food-Drug Interactions*;Humans;Osmolar Concentration;Particle Size;Permeability;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/chemistry;Pharmacopoeias as Topic;Solubility;Tablets
24966255;Aged;Anticoagulants*/pharmacology;Dietary Supplements;Drug Interactions*;Female;Flavonoids/pharmacology;Food-Drug Interactions;Fruit/chemistry*;Humans;International Normalized Ratio;Quercetin*/pharmacology;Vitis/chemistry*;Warfarin*/pharmacology
24965573;Adolescent;Adult;Azetidines*/adverse effects;Azetidines*/blood;Azetidines*/pharmacokinetics;Azetidines*/pharmacology;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Janus Kinase 1/antagonists & inhibitors;Janus Kinase 2/antagonists & inhibitors;Male;Middle Aged;Protein Kinase Inhibitors*/adverse effects;Protein Kinase Inhibitors*/blood;Protein Kinase Inhibitors*/pharmacokinetics;Protein Kinase Inhibitors*/pharmacology;STAT3 Transcription Factor/antagonists & inhibitors;Sulfonamides*/adverse effects;Sulfonamides*/blood;Sulfonamides*/pharmacokinetics;Sulfonamides*/pharmacology;Young Adult
24952640;Community Pharmacy Services*;Databases, Factual;Food-Drug Interactions*;Greece;Humans;Internet*;Pharmaceutical Services*;Pharmacists*;Software
24938126;Calcineurin Inhibitors/metabolism*;Cooking*;Diet*;Flavonoids/metabolism*;Food-Drug Interactions*;Humans
24935561;Analgesics/blood;Analgesics/pharmacokinetics;Analgesics/pharmacology;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacology;Cross-Over Studies;Dose-Response Relationship, Drug;Fluoroquinolones/adverse effects;Fluoroquinolones/blood;Fluoroquinolones/pharmacokinetics;Fluoroquinolones/pharmacology;Food-Drug Interactions;Humans;Long QT Syndrome/chemically induced*;Long QT Syndrome/metabolism*;Models, Biological*;Morpholines/blood;Morpholines/pharmacokinetics;Morpholines/pharmacology;Pyrazoles/blood;Pyrazoles/pharmacokinetics;Pyrazoles/pharmacology
24918555;Acne Vulgaris/drug therapy*;Acne Vulgaris/pathology;Adolescent;Adult;Child;Dermatologic Agents/administration & dosage;Dermatologic Agents/adverse effects;Dermatologic Agents/therapeutic use*;Double-Blind Method;Drugs, Generic/administration & dosage;Drugs, Generic/adverse effects;Drugs, Generic/therapeutic use*;Female;Food-Drug Interactions;Humans;Isotretinoin/administration & dosage;Isotretinoin/adverse effects;Isotretinoin/therapeutic use*;Male;Middle Aged;Severity of Illness Index;Treatment Outcome;Young Adult
24903351;Adult;Animals;Anti-Allergic Agents/blood;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics;Anti-Allergic Agents/urine;Area Under Curve;Beverages*;Cross-Over Studies;Eating;Female;Food-Drug Interactions*;Fruit*;Histamine H1 Antagonists, Non-Sedating/blood;Histamine H1 Antagonists, Non-Sedating/chemistry;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics;Histamine H1 Antagonists, Non-Sedating/urine;Humans;Intestinal Absorption;Male;Malus*;Oocytes/metabolism;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;RNA, Complementary/genetics;Stereoisomerism;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/chemistry;Terfenadine/pharmacokinetics;Terfenadine/urine;Xenopus laevis;Young Adult
24898424;Administration, Oral;Beverages*/adverse effects;Biological Availability;Citrus paradisi/adverse effects;Citrus paradisi/metabolism*;Food-Drug Interactions/physiology*;Forecasting;Humans;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*
24875052;Deamino Arginine Vasopressin/administration & dosage;Deamino Arginine Vasopressin/chemistry;Drug Delivery Systems*;Eating;Excipients;Fasting/metabolism*;Fatty Acids/chemistry;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/chemistry;Lipase/chemistry;Lipids/chemistry*;Lipolysis;Oleic Acid/chemistry;Peptides/administration & dosage*;Proteins/administration & dosage*
24852093;Administration, Oral;Biological Availability;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/metabolism;Delayed-Action Preparations;Drug Carriers/chemistry*;Drug Delivery Systems/trends;Drug Stability;Emulsions;Food-Drug Interactions;Humans;Lipids/chemistry*;Nanoparticles/chemistry*;Solutions;Suspensions
24834535;Benzodiazepines/administration & dosage;Beverages/adverse effects*;Calcium Channel Blockers/administration & dosage;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage
24818771;Adult;Diet, High-Fat;Fasting/metabolism;Ferric Compounds/chemistry;Food-Drug Interactions*;Gastrointestinal Transit;Humans;Hypromellose Derivatives/chemistry*;Hypromellose Derivatives/pharmacokinetics*;Intestine, Large/metabolism;Intestine, Small/metabolism;Magnetic Phenomena;Male;Molecular Weight;Postprandial Period;Solubility;Stomach/metabolism;Tablets
24817647;Angiogenesis Inhibitors/administration & dosage;Angiogenesis Inhibitors/metabolism;Angiogenesis Inhibitors/pharmacokinetics*;Angiogenesis Inhibitors/pharmacology;Animals;Benzofurans/administration & dosage;Benzofurans/metabolism;Benzofurans/pharmacokinetics*;Benzofurans/pharmacology;Bile/chemistry;Biological Availability;Caco-2 Cells;Cells, Cultured;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical;Drug Interactions;Drugs, Investigational/administration & dosage;Drugs, Investigational/metabolism;Drugs, Investigational/pharmacokinetics*;Drugs, Investigational/pharmacology;Female;Food-Drug Interactions;Humans;Inactivation, Metabolic;Intestinal Absorption*;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism*;Models, Biological*;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/metabolism;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/pharmacology;Quinazolines/administration & dosage;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Quinazolines/pharmacology;Random Allocation;Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors*
24817413;Animals;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Arrhythmias, Cardiac/chemically induced;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics;Drug Interactions;Food-Drug Interactions;Hepacivirus/drug effects*;Hepacivirus/enzymology;Hepatitis C/diagnosis;Hepatitis C/drug therapy*;Hepatitis C/enzymology;Humans;Oligopeptides/adverse effects;Oligopeptides/pharmacokinetics*;Proline/adverse effects;Proline/analogs & derivatives*;Proline/pharmacokinetics;Risk Assessment;Risk Factors;Serine Proteinase Inhibitors/adverse effects;Serine Proteinase Inhibitors/pharmacokinetics*
24813475;Cardiovascular Diseases/prevention & control;Cognition/drug effects;Diet;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;United States
24813412;Beverages/adverse effects*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Male;Punicaceae/adverse effects*;Risk Factors
24810181;Administration, Oral;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Biological Availability;Circadian Rhythm*;Cross-Over Studies;Drug Administration Schedule;Fatigue/chemically induced;Fatigue/physiopathology;Female;Food-Drug Interactions*;Half-Life;Hand-Foot Syndrome/physiopathology;Humans;Hypertension/chemically induced;Hypertension/physiopathology;Indazoles/adverse effects;Indazoles/blood;Indazoles/pharmacokinetics*;Indazoles/therapeutic use;Male;Neoplasms/blood;Neoplasms/drug therapy;Phenylurea Compounds/adverse effects;Phenylurea Compounds/blood;Phenylurea Compounds/pharmacokinetics*;Phenylurea Compounds/therapeutic use;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/therapeutic use;Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors*;Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors*;Severity of Illness Index
24802019;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/pharmacology;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Deoxycytidine/administration & dosage;Deoxycytidine/adverse effects;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacokinetics;Diet, High-Fat;Drug Administration Schedule;Emtricitabine;Food-Drug Interactions*;Half-Life;Humans;Male;Phosphorous Acids/administration & dosage;Phosphorous Acids/pharmacology*;Young Adult
24798770;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics;Cross-Over Studies;Dideoxynucleosides/administration & dosage;Dideoxynucleosides/blood;Dideoxynucleosides/pharmacokinetics*;Dietary Fats;Drug Combinations;Female;Food-Drug Interactions*;Heterocyclic Compounds, 3-Ring/administration & dosage;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Lamivudine/administration & dosage;Lamivudine/blood;Lamivudine/pharmacokinetics*;Male;Therapeutic Equivalency;Vaginal Creams, Foams, and Jellies;Young Adult
24791577;Analysis of Variance;Antihypertensive Agents/therapeutic use*;Blood Pressure/drug effects*;Body Mass Index;China;Cohort Studies;Factor Analysis, Statistical;Female;Follow-Up Studies;Food-Drug Interactions/physiology*;Health Surveys/methods;Health Surveys/statistics & numerical data;Humans;Hypertension/complications;Hypertension/drug therapy*;Male;Middle Aged;Obesity/complications;Riboflavin/administration & dosage*
27128606;Administration, Oral;Adolescent;Adult;Area Under Curve;Atrioventricular Block/chemically induced;Atrioventricular Block/physiopathology;Australia;Biological Availability;Bradycardia/chemically induced;Bradycardia/physiopathology;Cross-Over Studies;Drug Compounding;Female;Food-Drug Interactions;Half-Life;Healthy Volunteers;Heart Rate/drug effects;Humans;Indoles/administration & dosage;Indoles/adverse effects;Indoles/pharmacokinetics*;Linear Models;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Oxadiazoles/administration & dosage;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics*;Receptors, Lysosphingolipid/drug effects*;Receptors, Lysosphingolipid/metabolism;Single-Blind Method;Young Adult
24768728;Administration, Oral;Age Factors;Animals;Chemistry, Pharmaceutical;Child;Child, Preschool;Delayed-Action Preparations;Drug Carriers*;Drug Stability;Excipients/chemistry;Food-Drug Interactions;Humans;Hypnotics and Sedatives/administration & dosage*;Hypnotics and Sedatives/chemistry*;Infant;Kinetics;Lipids/chemistry*;Melatonin/administration & dosage*;Melatonin/chemistry*;Milk/chemistry;Particle Size;Solubility;Technology, Pharmaceutical/methods;Yogurt
24757719;Antineoplastic Agents/pharmacokinetics*;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Indoles/pharmacokinetics*;Male;Melanoma/metabolism*;Protein Kinase Inhibitors/pharmacokinetics*;Sulfonamides/pharmacokinetics*
24756141;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Labeling;Drug Therapy;Food-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/enzymology;Neoplasms/metabolism;Risk Factors
24755124;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Combinations;Female;Food-Drug Interactions*;Humans;Hypoglycemic Agents/administration & dosage*;Linagliptin;Male;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/chemistry;Metformin/pharmacokinetics;Middle Aged;Purines/administration & dosage*;Purines/adverse effects;Purines/chemistry;Purines/pharmacokinetics;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/chemistry;Quinazolines/pharmacokinetics;Solubility;Tablets
24752831;Adult;Anticholesteremic Agents/administration & dosage*;Anticholesteremic Agents/pharmacokinetics;Anticholesteremic Agents/pharmacology;Area Under Curve;Asian Continental Ancestry Group;Azetines/administration & dosage*;Azetines/pharmacokinetics;Azetines/pharmacology;Cholesterol, LDL/blood*;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Female;Fluorobenzenes/administration & dosage*;Fluorobenzenes/pharmacokinetics;Fluorobenzenes/pharmacology;Food-Drug Interactions;Half-Life;Humans;Male;Young Adult
24751672;Administration, Oral;Atenolol/administration & dosage;Atenolol/chemistry;Atenolol/metabolism*;Atenolol/pharmacokinetics;Food/adverse effects*;Food-Drug Interactions*;Furosemide/administration & dosage;Furosemide/chemistry;Furosemide/metabolism*;Furosemide/pharmacokinetics;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects*;Metformin/administration & dosage;Metformin/chemistry;Metformin/metabolism*;Metformin/pharmacokinetics;Permeability;Reproducibility of Results;Solubility;Viscosity
24739447;Adrenergic beta-Antagonists/pharmacokinetics*;Catechin/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Nadolol/pharmacokinetics*;Tea/chemistry*
24734908;Administration, Oral;Adolescent;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/pharmacokinetics;Male;Naphthalenes/administration & dosage*;Naphthalenes/adverse effects;Naphthalenes/pharmacokinetics;Receptors, Immunologic/antagonists & inhibitors*;Receptors, Prostaglandin/antagonists & inhibitors*;Young Adult
24730660;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Drug Interactions;Drug Monitoring;Food-Drug Interactions;Global Health;HIV Infections/drug therapy*;Humans;Patient Compliance;Pharmacogenetics;Quality of Life*
24723311;Aged;Aged, 80 and over;Cohort Studies;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Male;Middle Aged;Patient Education as Topic/methods*;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/therapeutic use*;Treatment Failure
24721651;Animals;Diet*;Diuretics/pharmacology*;Food-Drug Interactions*;Homeostasis/drug effects;Large-Conductance Calcium-Activated Potassium Channels/metabolism*;Mice;Mice, Knockout;Potassium/metabolism*
24713083;Acculturation;Aged;Aging*;Alcohol Drinking/epidemiology*;Alcohol Drinking/ethnology;Alcohol Drinking/psychology;Alcoholic Beverages/adverse effects;Alcoholism/epidemiology*;Alcoholism/ethnology;Alcoholism/psychology;Boston/epidemiology;Cohort Studies;Contraindications;Cross-Sectional Studies;Ethanol;Female;Food-Drug Interactions;Health Surveys;Hispanic Americans;Humans;Longitudinal Studies;Male;Middle Aged;Patient Compliance;Prevalence;Puerto Rico/ethnology;Risk;Sex Factors;Urban Health*/ethnology
24703329;Age Factors;Constipation/diet therapy*;Dietary Supplements;European Union;Female;Food-Drug Interactions;Humans;Laxatives/adverse effects;Laxatives/therapeutic use;Legislation, Drug/organization & administration;Legislation, Food*/organization & administration;Plants, Medicinal/adverse effects*;Pregnancy
24676073;Adolescent;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Enteral Nutrition*;Female;Food-Drug Interactions*;Humans;Intensive Care Units;Male;Middle Aged;Retrospective Studies;Young Adult
24670091;Administration, Oral;Biological Availability;Capsules/chemistry;Chemical Precipitation;Chemistry, Pharmaceutical;Crystallization;Drug Delivery Systems/methods*;Drug Stability;Drug Storage;Emulsions/chemistry*;Emulsions/pharmacokinetics;Food-Drug Interactions;In Vitro Techniques;Intestinal Absorption;Particle Size;Solubility;Surface-Active Agents/chemistry;Technology, Pharmaceutical/methods*;Triglycerides/chemistry
24670024;Acetaldehyde Dehydrogenase Inhibitors/adverse effects*;Administration, Intravenous;Adult;Alcoholic Beverages/adverse effects*;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Cephalosporins/administration & dosage;Cephalosporins/adverse effects*;Disulfiram/adverse effects*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Retrospective Studies
24660518;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Clinical Competence*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Hospitals, Teaching/manpower;Hospitals, Teaching/standards;Humans;Nursing Care/standards*;Nursing Staff, Hospital/standards;Nutritive Value;Patient Education as Topic/standards*;Potassium/physiology*;Southeastern United States
24657141;Chemistry, Pharmaceutical;Digestion;Duodenum/metabolism;Food-Drug Interactions*;Humans;Hydrochlorothiazide/chemistry*;Hydrophobic and Hydrophilic Interactions;Models, Biological*;Solubility;Stomach/metabolism*;Tablets
24637348;Administration, Oral;Animals;Biopharmaceutics/methods*;Chemistry, Pharmaceutical;Excipients/chemistry*;Food-Drug Interactions*;Gastrointestinal Motility;Gastrointestinal Tract/metabolism*;Humans;Intestinal Absorption*;Models, Animal;Models, Biological;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Reproducibility of Results;Species Specificity
24619146;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics;Benzodiazepines/adverse effects;Benzodiazepines/pharmacokinetics;Biotransformation;Checklist;Comorbidity;Dose-Response Relationship, Drug;Drug Information Services;Drug Interactions*;Drug Monitoring;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Humans;Inactivation, Metabolic;Metabolic Clearance Rate/physiology;Polypharmacy;Prescription Drugs/adverse effects*;Prescription Drugs/pharmacokinetics;Substance-Related Disorders/blood;Xenobiotics/adverse effects*;Xenobiotics/pharmacokinetics
24618639;Animals;Area Under Curve;Brain Chemistry;Drug Evaluation, Preclinical;Food-Drug Interactions;Glucuronosyltransferase/blood;Isoenzymes/blood;Male;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Rats;Rats, Sprague-Dawley;Soybeans/chemistry*;Valproic Acid/analogs & derivatives*;Valproic Acid/blood;Valproic Acid/pharmacokinetics*;gamma-Aminobutyric Acid/metabolism
24615728;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics;Asian Continental Ancestry Group;Beverages;Carbamates/blood;Carbamates/pharmacokinetics*;Cobicistat;Cross-Over Studies;Deoxycytidine/analogs & derivatives*;Deoxycytidine/blood;Deoxycytidine/pharmacokinetics;Dietary Proteins/pharmacology*;Drug Combinations;Emtricitabine;Food-Drug Interactions*;Humans;Male;Middle Aged;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Quinolones/blood;Quinolones/pharmacokinetics*;Tenofovir;Thiazoles/blood;Thiazoles/pharmacokinetics*;Young Adult
24598049;Acaricides/administration & dosage;Acaricides/blood;Acaricides/pharmacokinetics;Administration, Oral;Animals;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/blood;Antiparasitic Agents/pharmacokinetics*;Area Under Curve;Body Weight;Dogs/metabolism*;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions*;Gastrointestinal Absorption;Insecticides/administration & dosage;Insecticides/blood;Insecticides/pharmacokinetics;Isoxazoles/administration & dosage;Isoxazoles/blood;Isoxazoles/pharmacokinetics*;Male;Safety;Tablets
24594059;Adult;Aged;Antitubercular Agents/pharmacokinetics*;Arylamine N-Acetyltransferase/genetics;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Tuberculosis/drug therapy*
24583387;Amlodipine/pharmacology;Animals;Antihypertensive Agents/pharmacology*;Blood Pressure;Food-Drug Interactions*;Heart/drug effects;Indapamide/pharmacology;Kidney/drug effects;Kidney/metabolism;Liver/drug effects;Liver/metabolism;Male;Nutritional Status*;Perindopril/pharmacology;Rats;Rats, Inbred SHR;Spleen/drug effects;Spleen/metabolism
24583386;Biological Availability;Dietary Supplements/adverse effects;Food-Drug Interactions*;Fruit/chemistry;Humans;Intestinal Absorption/drug effects;Intestines/drug effects;Intestines/metabolism;Nutritional Status;Pharmaceutical Preparations/metabolism;Pharmacokinetics;Risk Factors;Vegetables/chemistry
24582998;Calcium, Dietary/administration & dosage;Dietary Fats/administration & dosage;Dietary Fiber/administration & dosage;Dietary Proteins/administration & dosage;Energy Intake;Evidence-Based Practice*;Food-Drug Interactions*;Humans;Medicaid;Medicare;Motor Activity;Nutrition Assessment;Nutritionists*;Phosphorus, Dietary/administration & dosage;Renal Insufficiency, Chronic/diagnosis;Renal Insufficiency, Chronic/diet therapy*;Renal Insufficiency, Chronic/drug therapy;Sodium, Dietary/administration & dosage;United States
24553283;Adrenergic beta-Antagonists/pharmacokinetics*;Catechin/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Nadolol/pharmacokinetics*;Tea/chemistry*
24552005;Citrus paradisi*;Drug-Related Side Effects and Adverse Reactions/etiology*;Food-Drug Interactions*;Humans
24549825;Animals;Beverages*;Binding Sites/physiology;Cells, Cultured;Citrus paradisi/metabolism*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Oocytes;Organic Anion Transporters/metabolism*;Pravastatin/metabolism*;Pravastatin/pharmacology;Substrate Specificity;Terfenadine/analogs & derivatives*;Terfenadine/metabolism;Terfenadine/pharmacology;Xenopus laevis
24548978;Adolescent;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Phenylurea Compounds/administration & dosage;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics*;Protein Kinase Inhibitors/pharmacokinetics*;Quinolines/administration & dosage;Quinolines/adverse effects;Quinolines/pharmacokinetics*
24535888;Administration, Oral;Adolescent;Adult;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Humans;Male;Middle Aged;Nitroimidazoles/administration & dosage*;Nitroimidazoles/adverse effects;Nitroimidazoles/pharmacokinetics;Prodrugs;Suspensions;Tablets;Trypanocidal Agents/administration & dosage*;Trypanocidal Agents/adverse effects;Trypanocidal Agents/pharmacokinetics;Trypanosomiasis, African/drug therapy;Young Adult
24517573;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism;Antioxidants/adverse effects;Antioxidants/metabolism;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Aryl Hydrocarbon Hydroxylases/metabolism;Curcumin/adverse effects*;Curcumin/metabolism;Cytochrome P-450 CYP2C9/chemistry;Cytochrome P-450 CYP2C9/metabolism*;Cytochrome P-450 CYP2C9 Inhibitors/adverse effects;Cytochrome P-450 CYP2C9 Inhibitors/metabolism;Cytochrome P-450 Enzyme Inhibitors/adverse effects*;Cytochrome P-450 Enzyme Inhibitors/metabolism;Cytochrome P450 Family 2;Diclofenac/metabolism;Dietary Supplements/adverse effects*;Food-Drug Interactions;Humans;Kinetics;Male;Metabolic Detoxication, Phase I;Microsomes, Liver/enzymology*;Microsomes, Liver/metabolism;NADP/metabolism;Rats, Sprague-Dawley;Species Specificity;Steroid 16-alpha-Hydroxylase/antagonists & inhibitors*;Steroid 16-alpha-Hydroxylase/metabolism
24495314;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting/blood;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Male;Metabolic Clearance Rate;Metformin/administration & dosage;Metformin/adverse effects;Metformin/blood;Metformin/pharmacokinetics*;Piperidones/administration & dosage;Piperidones/adverse effects;Piperidones/blood;Piperidones/pharmacokinetics*;Postprandial Period;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Republic of Korea;Sex Factors;Tablets;Young Adult
24490434;Dietary Supplements*;Evidence-Based Medicine;Food-Drug Interactions;Humans;Nutritional Status;Primary Prevention/methods*;Randomized Controlled Trials as Topic;Research Design
24488324;Adult;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Crown Ethers/administration & dosage*;Crown Ethers/adverse effects;Crown Ethers/blood;Crown Ethers/pharmacokinetics*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics*;Xenograft Model Antitumor Assays;Young Adult
24453847;Drug Therapy/methods*;Food-Drug Interactions*;Humans;Nutritive Value*;Parenteral Nutrition Solutions/adverse effects;Parenteral Nutrition Solutions/pharmacokinetics*;Parenteral Nutrition Solutions/therapeutic use*;Parenteral Nutrition, Home*
24447534;Administration, Oral;Aged;Cross-Over Studies;Diet, High-Fat/adverse effects*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Male;Middle Aged;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Piperazines/pharmacokinetics*;Purines/pharmacokinetics;Sildenafil Citrate;Sulfones/pharmacokinetics*;Tablets/adverse effects*;Therapeutic Equivalency
24442773;Animals;Chemistry, Pharmaceutical*;Dogs;Food-Drug Interactions*;Humans;Solubility
24442146;Animals;Bile/metabolism;Biomarkers/blood;Biomarkers/urine;Chemical and Drug Induced Liver Injury/etiology*;Chemical and Drug Induced Liver Injury/metabolism;Chemical and Drug Induced Liver Injury/pathology;Citric Acid Cycle;Diet, High-Fat*;Disease Models, Animal;Fatty Acids, Nonesterified/metabolism;Food-Drug Interactions*;Gas Chromatography-Mass Spectrometry;Liver/metabolism;Liver/pathology;Male;Metabolomics/methods;Mitochondria, Liver/metabolism;Non-alcoholic Fatty Liver Disease/etiology*;Non-alcoholic Fatty Liver Disease/metabolism;Non-alcoholic Fatty Liver Disease/pathology;Rats, Sprague-Dawley;Risk Factors;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Valproic Acid*
24435225;Alkalies/chemistry;Food-Drug Interactions*;Models, Chemical*;Permeability;Solubility
24419562;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/pharmacology;Adult;Area Under Curve;Blood Pressure/drug effects;Catechin/pharmacokinetics*;Cross-Over Studies;Female;Food-Drug Interactions*;HEK293 Cells;Humans;Inhibitory Concentration 50;Intestines/metabolism;Male;Nadolol/pharmacokinetics*;Nadolol/pharmacology;Organic Anion Transporters/metabolism;Tea/chemistry*;Young Adult
24399453;Administration, Oral;Adult;Asian Continental Ancestry Group*/ethnology;Cohort Studies;Dose-Response Relationship, Drug;Fasting/metabolism*;Fatigue/chemically induced;Fatigue/diagnosis;Follow-Up Studies;Food-Drug Interactions/physiology*;Humans;Male;Piperazines/adverse effects*;Piperazines/pharmacokinetics*;Piperidines/adverse effects*;Piperidines/pharmacokinetics*;Postprandial Period/drug effects;Postprandial Period/physiology*;Young Adult
24383939;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Blood Coagulation/drug effects;Diet;Food-Drug Interactions;Humans;Male;Taiwan;Vegetables;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage*;Warfarin/adverse effects
24382706;Animals;Area Under Curve;Benzamides/administration & dosage;Benzamides/pharmacokinetics;Biological Availability;Caco-2 Cells;Capsules;Cell Membrane Permeability;Chemistry, Pharmaceutical/methods*;Delayed-Action Preparations/chemistry*;Drug Carriers;Enzyme Activators/administration & dosage;Enzyme Activators/pharmacokinetics;Excipients;Female;Food-Drug Interactions;Humans;Hypromellose Derivatives;Male;Methylcellulose/analogs & derivatives;Models, Biological;Solubility;Sulfones/administration & dosage;Sulfones/pharmacokinetics;Swine/physiology*;Swine, Miniature/physiology*;Tablets
24374975;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Melanoma/drug therapy;Melanoma/genetics;Melanoma/metabolism*;Middle Aged;Mutation;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Proto-Oncogene Proteins B-raf/antagonists & inhibitors;Proto-Oncogene Proteins B-raf/genetics;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
24374821;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Anti-HIV Agents/urine;Dose-Response Relationship, Drug;Fasting/metabolism;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/urine;Single-Blind Method;Thymidine/adverse effects;Thymidine/analogs & derivatives*;Thymidine/blood;Thymidine/pharmacokinetics;Thymidine/urine;Young Adult
24374798;Administration, Oral;Aged;Aged, 80 and over;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/blood;Antimetabolites, Antineoplastic/chemistry;Antimetabolites, Antineoplastic/pharmacokinetics*;Azacitidine/administration & dosage;Azacitidine/blood;Azacitidine/chemistry;Azacitidine/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Delayed-Action Preparations/pharmacokinetics;Female;Food-Drug Interactions*;Hematologic Neoplasms/metabolism;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Stomach/chemistry;Tablets
24371039;Animals;Cell Line;Cell Line, Tumor;Cell Membrane/drug effects*;Cell Membrane/metabolism;Cell Membrane/secretion;Dose-Response Relationship, Drug;Enteroendocrine Cells/drug effects*;Enteroendocrine Cells/metabolism;Enteroendocrine Cells/secretion;Food-Drug Interactions*;Glucagon-Like Peptide 1/secretion*;Glucose/metabolism*;Grape Seed Extract/pharmacology*;Linoleic Acid/metabolism*;Membrane Potential, Mitochondrial;Membrane Potentials;Mice;Proanthocyanidins/pharmacology*;Proline/metabolism*;Time Factors
24346280;Adult;Aged;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/pharmacokinetics;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics;Receptor, ErbB-2/metabolism
24343538;Amantadine/administration & dosage;Amantadine/adverse effects;Amantadine/therapeutic use;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/classification;Antiparkinson Agents/therapeutic use*;Cardiovascular Diseases/chemically induced;Catechol O-Methyltransferase;Catechol O-Methyltransferase Inhibitors;Clinical Trials as Topic;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/classification;Dopamine Agonists/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/therapeutic use;Food-Drug Interactions;Humans;Indans/administration & dosage;Indans/adverse effects;Indans/pharmacology;Indans/therapeutic use*;Indoles/therapeutic use;Levodopa/administration & dosage;Levodopa/therapeutic use;Mental Disorders/chemically induced;Mental Disorders/prevention & control;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Multicenter Studies as Topic;Parkinson Disease/drug therapy*;Serotonin Syndrome/etiology;Serotonin Syndrome/prevention & control;Treatment Outcome
24338453;Administration, Oral;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Blood Coagulation/drug effects*;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Treatment Outcome;Venous Thrombosis/blood;Venous Thrombosis/diagnosis;Venous Thrombosis/drug therapy*
24332774;Aged;Antiparkinson Agents/therapeutic use*;Food-Drug Interactions*;Humans;Levodopa/therapeutic use*;Male;Parkinson Disease/drug therapy*;Plants, Medicinal;Vicia faba/adverse effects*
24325365;Adult;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Models, Biological;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/pharmacokinetics*;Succinates/administration & dosage;Succinates/pharmacokinetics*;Tandem Mass Spectrometry;Young Adult
24316176;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Artemisia annua*;Artemisinins/administration & dosage;Artemisinins/pharmacokinetics*;Biological Availability;Capsules;Dietary Supplements;Digestion;Edible Grain;Flavonoids/administration & dosage;Flavonoids/pharmacokinetics*;Food-Drug Interactions;Intestines/metabolism;Malaria/drug therapy;Malaria/metabolism;Plant Leaves*;Plant Oils;Stomach/metabolism;Sucrose
24303901;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Biological Transport/drug effects;Biological Transport/physiology;Cell Line, Tumor;Citrus paradisi*;Doxorubicin/metabolism;Doxorubicin/pharmacology;Food-Drug Interactions/physiology*;Freeze Drying/methods;Humans;Male;Pharmaceutical Preparations/metabolism*;Plant Extracts/isolation & purification;Plant Extracts/metabolism*;Plant Extracts/pharmacology;Rabbits
24301077;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Arthritis, Rheumatoid/drug therapy;Biological Availability;Biopharmaceutics;Caco-2 Cells;Chemistry, Pharmaceutical;Excipients;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Piroxicam/administration & dosage*;Piroxicam/pharmacokinetics;Piroxicam/therapeutic use;Rats;Solubility;Stereoisomerism;Therapeutic Equivalency;Tissue Distribution
24292052;Adult;Beverages*;Celiprolol/blood;Celiprolol/pharmacokinetics*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Food-Drug Interactions;Humans;Male;Midazolam/blood;Midazolam/pharmacokinetics*;Organic Anion Transporters/antagonists & inhibitors*;Young Adult
24272966;Administration, Oral;Adult;Blood Glucose/analysis;Cross-Over Studies;Dietary Carbohydrates/pharmacology*;Dietary Fats/pharmacology*;Double-Blind Method;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Insulin/blood;Male;Middle Aged;Ribose/adverse effects;Ribose/pharmacokinetics*;Ribose/pharmacology*;Solutions;Uric Acid/blood;Young Adult
24262730;Adult;Anemia, Iron-Deficiency/complications;Anemia, Iron-Deficiency/etiology*;Female;Food;Food-Drug Interactions*;Humans;Iron/administration & dosage;Iron/pharmacokinetics*;Iron/therapeutic use;Pica/complications*;Polyphenols/chemistry;Trace Elements/administration & dosage;Trace Elements/therapeutic use;Vitis/adverse effects*;Vitis/chemistry
24259961;Analgesics, Opioid/adverse effects;Exocrine Pancreatic Insufficiency/etiology;Exocrine Pancreatic Insufficiency/metabolism;Exocrine Pancreatic Insufficiency/physiopathology;Food-Drug Interactions;Gastrointestinal Motility;Humans;Intestinal Absorption*/drug effects;Intestines/drug effects;Intestines/metabolism*;Intestines/microbiology;Intestines/physiopathology;Life Style;Malnutrition/etiology;Malnutrition/metabolism;Malnutrition/physiopathology;Nutritional Status;Pancreatitis, Chronic/complications;Pancreatitis, Chronic/diagnosis;Pancreatitis, Chronic/metabolism*;Pancreatitis, Chronic/physiopathology;Pancreatitis, Chronic/therapy;Pharmacokinetics*;Polypharmacy
24256019;Cytochrome P-450 Enzyme Inhibitors;Drug Interactions;Fibric Acids/adverse effects;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hypolipidemic Agents/adverse effects*;Rhabdomyolysis/chemically induced
24252529;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Anti-HIV Agents/therapeutic use;Anti-Infective Agents/pharmacokinetics;Anticonvulsants/pharmacokinetics;Contraceptives, Oral/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism*;Cytochrome P-450 CYP3A Inducers/pharmacokinetics*;Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics;Drug Interactions;Food-Drug Interactions;Gastrointestinal Agents/pharmacokinetics;HIV Infections/drug therapy;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Intestinal Absorption;Nitriles/administration & dosage;Nitriles/blood;Nitriles/pharmacokinetics*;Nitriles/therapeutic use;Proton Pump Inhibitors/pharmacokinetics;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Reverse Transcriptase Inhibitors/therapeutic use;Rilpivirine
24252527;Adenine/administration & dosage;Adenine/analogs & derivatives;Adult;Aged;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/pharmacology*;Anti-HIV Agents/therapeutic use;Biological Availability;Child;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inducers/pharmacology;Cytochrome P-450 CYP3A Inhibitors/pharmacology;Deoxycytidine/administration & dosage;Deoxycytidine/analogs & derivatives;Drug Administration Routes;Drug Combinations;Drug Interactions;Drug Therapy, Combination;Emtricitabine;Food-Drug Interactions;HIV Infections/drug therapy;HIV Reverse Transcriptase/antagonists & inhibitors*;HIV-1/drug effects*;HIV-1/enzymology;Half-Life;Humans;Intestinal Absorption;Molecular Structure;Nanoparticles;Nitriles/administration & dosage;Nitriles/pharmacokinetics;Nitriles/pharmacology*;Nitriles/therapeutic use;Organophosphonates/administration & dosage;Proton Pump Inhibitors/pharmacology;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics;Pyrimidines/pharmacology*;Pyrimidines/therapeutic use;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/pharmacology;Reverse Transcriptase Inhibitors/therapeutic use;Rilpivirine;Tenofovir
24242999;Administration, Oral;Adolescent;Adult;Aged;Antimalarials*/administration & dosage;Antimalarials*/adverse effects;Antimalarials*/blood;Antimalarials*/pharmacokinetics;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Heterocyclic Compounds, 1-Ring*/administration & dosage;Heterocyclic Compounds, 1-Ring*/adverse effects;Heterocyclic Compounds, 1-Ring*/blood;Heterocyclic Compounds, 1-Ring*/pharmacokinetics;Humans;Male;Middle Aged;Peroxides*/administration & dosage;Peroxides*/adverse effects;Peroxides*/blood;Peroxides*/pharmacokinetics;Spiro Compounds*/administration & dosage;Spiro Compounds*/adverse effects;Spiro Compounds*/blood;Spiro Compounds*/pharmacokinetics;Young Adult
24239996;Administration, Intravenous;Administration, Oral;Animals;Biological Availability;Biopharmaceutics/methods;Capsules;Chemistry, Pharmaceutical;Cinnarizine/administration & dosage*;Cinnarizine/blood;Cinnarizine/chemistry;Cinnarizine/pharmacokinetics*;Dietary Proteins/administration & dosage;Dogs;Drug Carriers*;Fasting/blood;Food-Drug Interactions*;Intestinal Absorption;Male;Nanotechnology;Postprandial Period;Solubility;Tablets;Technology, Pharmaceutical/methods
24224449;Adult;Aged;Antineoplastic Agents/therapeutic use;Antioxidants/analysis*;Ascorbic Acid/administration & dosage*;Carcinoma, Non-Small-Cell Lung/blood*;Carcinoma, Non-Small-Cell Lung/drug therapy*;Dietary Supplements;Female;Food-Drug Interactions;Humans;Lung Neoplasms/blood*;Lung Neoplasms/drug therapy*;Male;Middle Aged;Vitamin A/administration & dosage;Vitamin A/blood;Vitamin E/administration & dosage;Vitamin E/blood;Vitamins/blood*
24219078;Administration, Oral*;Drug Compounding;Drug Stability;Female;Food*;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Humans;Pediatric Nursing*;Practice Patterns, Nurses'*;Scotland;Surveys and Questionnaires
24216238;Child;Drug Industry;Europe;Excipients;Food-Drug Interactions;Government Regulation;Guidelines as Topic*;Humans;Legislation, Drug*
24166743;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Carrier Proteins/genetics;Carrier Proteins/metabolism*;Digoxin*;Drug Interactions;Food-Drug Interactions;Humans;Pharmaceutical Preparations/metabolism
24166669;Animals;Caffeic Acids/pharmacology*;Citrus paradisi;DNA, Complementary/genetics;Food-Drug Interactions;Kidney/drug effects;Kidney/metabolism*;Male;Organic Anion Transport Protein 1/antagonists & inhibitors*;Organic Anion Transport Protein 1/genetics;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/genetics;Pharmaceutical Preparations/metabolism;Rats;Rats, Wistar;Xenopus laevis
24152604;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/pharmacokinetics*;Cross-Over Studies;Female;Food-Drug Interactions*;Glucosides/administration & dosage;Glucosides/adverse effects;Glucosides/pharmacokinetics*;Healthy Volunteers;Humans;Male;Middle Aged;Sodium-Glucose Transporter 2/antagonists & inhibitors*;Young Adult
24142299;Adenine/administration & dosage;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Cross-Over Studies;Deoxycytidine/administration & dosage;Deoxycytidine/adverse effects;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacokinetics;Drug Combinations;Emtricitabine;Fasting/metabolism;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/metabolism*;Humans;Male;Middle Aged;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Organophosphonates/administration & dosage;Organophosphonates/adverse effects;Organophosphonates/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Rilpivirine;Tablets;Tenofovir;Young Adult
24132705;Administration, Oral;Adult;Amlodipine/administration & dosage*;Amlodipine/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Female;Food;Food-Drug Interactions*;Humans;Imidazoles/pharmacokinetics;Losartan/administration & dosage*;Losartan/pharmacokinetics*;Male;Tablets/administration & dosage;Tablets/pharmacokinetics;Tetrazoles/pharmacokinetics;Young Adult
24126567;Administration, Oral;Adult;Area Under Curve;Benzimidazoles/administration & dosage*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Bridged Bicyclo Compounds/administration & dosage*;Bridged Bicyclo Compounds/adverse effects;Bridged Bicyclo Compounds/pharmacokinetics;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics;Calcium Channels, L-Type/drug effects*;Calcium Channels, T-Type/drug effects*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Humans;Male;Prospective Studies;Young Adult
24123095;Administration, Oral;Adult;Breakfast;Coffee/adverse effects*;Cohort Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Hormone Replacement Therapy*;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Hypothyroidism/metabolism;Intestinal Absorption;Italy;Male;Middle Aged;Thyrotropin/blood;Thyroxine/administration & dosage*;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use;Time Factors;Triiodothyronine/blood
24120730;Aspartame/pharmacology;Cell Line, Tumor;Cells, Cultured;Cyclamates/pharmacology;Cytochrome P-450 CYP1A1/genetics;Cytochrome P-450 CYP1A1/metabolism*;Food-Drug Interactions*;Hepatocytes/drug effects;Hepatocytes/metabolism;Humans;Receptors, Aryl Hydrocarbon/metabolism*;Receptors, Glucocorticoid/metabolism*;Saccharin/pharmacology;Sweetening Agents/pharmacology*;Thiazines/pharmacology
24117531;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Lactams/pharmacokinetics*;Male;Meals;Neuropeptides/pharmacology*;Omeprazole/pharmacology;Ranitidine/pharmacology;Ritonavir/pharmacokinetics*;Sulfonamides/pharmacokinetics*;Young Adult
24099279;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food-Drug Interactions;Healthy Volunteers;Hydrogen-Ion Concentration;Indazoles/pharmacokinetics*;Proton Pump Inhibitors/adverse effects*;Rabeprazole/adverse effects*;Solubility;Sulfonamides/pharmacokinetics*
24090732;Administration, Oral;Animals;Area Under Curve;Dogs;Fasting/metabolism*;Food-Drug Interactions*;Gastric Acid/secretion;Gastric Emptying/drug effects;Gastric Mucosa/drug effects;Gastric Mucosa/metabolism;Gastric Mucosa/secretion;Humans;Hydrogen-Ion Concentration;Male;Models, Animal;Pentagastrin/administration & dosage*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/blood;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Reproducibility of Results;Species Specificity
24087843;Animals;Anticarcinogenic Agents/administration & dosage*;Anticarcinogenic Agents/pharmacokinetics;Antineoplastic Agents/administration & dosage;Antineoplastic Combined Chemotherapy Protocols/administration & dosage*;Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics;Chemoprevention;Diet;Disease Models, Animal;Drug Evaluation, Preclinical;Food-Drug Interactions*;Humans;Isothiocyanates/administration & dosage*;Isothiocyanates/chemistry;Isothiocyanates/pharmacokinetics;Neoplasms/drug therapy;Neoplasms/prevention & control;Randomized Controlled Trials as Topic
24067745;Adult;Area Under Curve;Beverages/adverse effects*;Biotransformation/drug effects*;Citrus paradisi/adverse effects*;Confidence Intervals;Cross-Over Studies;Female;Food-Drug Interactions*;Genotype;Half-Life;Humans;Male;Platelet Aggregation Inhibitors/metabolism*;Platelet Function Tests;Receptors, Purinergic P2Y12/genetics;Ticlopidine/analogs & derivatives*;Ticlopidine/metabolism;Young Adult
24063896;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Antiviral Agents/chemistry;Antiviral Agents/pharmacology*;Antiviral Agents/therapeutic use;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Therapy, Combination;Food-Drug Interactions;Genotype;Hepacivirus/drug effects;Hepacivirus/enzymology;Hepacivirus/genetics;Hepatitis C/drug therapy;Humans;Inactivation, Metabolic;Interferons/administration & dosage;Interferons/therapeutic use;Interleukins/genetics;Intestinal Absorption;Oligopeptides/chemistry;Oligopeptides/pharmacology*;Oligopeptides/therapeutic use;Polyethylene Glycols/administration & dosage;Polyethylene Glycols/therapeutic use;Protease Inhibitors/chemistry;Protease Inhibitors/pharmacology*;Protease Inhibitors/therapeutic use;Ribavirin/administration & dosage;Ribavirin/therapeutic use;Viral Nonstructural Proteins/antagonists & inhibitors*;Virus Replication/drug effects
24062180;Adolescent;Adult;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Healthy Volunteers;Humans;Male;Middle Aged;PPAR alpha/agonists*;Phenylpropionates/adverse effects;Phenylpropionates/pharmacokinetics*;Phenylpropionates/pharmacology;Placebos;Pyrroles/adverse effects;Pyrroles/pharmacokinetics*;Pyrroles/pharmacology;Sex Factors;Young Adult
24060671;Administration, Oral;Biopharmaceutics/methods;Chemistry, Pharmaceutical;Computer Simulation;Fasting/blood;Food-Drug Interactions*;Gastrointestinal Motility;Gastrointestinal Tract/physiology;Humans;Intestinal Absorption;Models, Biological*;Nifedipine/administration & dosage*;Nifedipine/blood;Nifedipine/chemistry;Nifedipine/classification;Nifedipine/pharmacokinetics*;Permeability;Postprandial Period;Reproducibility of Results;Solubility;Technology, Pharmaceutical/methods
24056057;Biological Availability;Chemistry, Pharmaceutical/methods*;Computer Simulation;Diclofenac/blood*;Diclofenac/chemistry*;Dosage Forms;Fasting;Female;Food-Drug Interactions;Gastric Emptying;Gastrointestinal Transit;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology;Kinetics;Male;Pharmaceutical Preparations;Software;Solubility;Tablets/pharmacokinetics;Tablets, Enteric-Coated/chemistry*;Technology, Pharmaceutical/methods*
24056027;Administration, Oral;Animals;Biological Availability;Chemistry, Pharmaceutical;Cinnarizine/administration & dosage;Cinnarizine/chemistry;Cinnarizine/pharmacokinetics*;Computer Simulation;Dogs;Drug Carriers*;Excipients/chemistry;Fasting/metabolism*;Food-Drug Interactions*;Hydrogen-Ion Concentration;Intestines/metabolism*;Lipolysis*;Models, Biological;Nanotechnology;Postprandial Period*;Reproducibility of Results;Solubility;Stomach/metabolism*;Tablets;Technology, Pharmaceutical/methods
24053714;Animals;Biological Availability;Food*;Food-Drug Interactions*;Functional Food*;Humans;Pharmaceutical Preparations/administration & dosage*
24051217;Administration, Oral;Biopharmaceutics/instrumentation;Biopharmaceutics/methods*;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/chemistry*;Diclofenac/metabolism;Equipment Design;Food-Drug Interactions*;Gastric Emptying*;Humans;Peristalsis*;Postprandial Period*;Pressure;Solubility;Stomach/physiology*;Tablets;Time Factors
24048240;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/therapeutic use;Food-Drug Interactions*;Humans
24040848;Absorption;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat/methods;Eating/physiology*;Fasting/physiology;Food;Food-Drug Interactions*;Humans;Male;Tablets/adverse effects;Tablets/metabolism;Tablets/pharmacokinetics;Tamoxifen/adverse effects;Tamoxifen/analogs & derivatives*;Tamoxifen/metabolism;Tamoxifen/pharmacokinetics;Young Adult
24036846;Administration, Oral;Adult;Antacids/adverse effects*;Antacids/therapeutic use;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Calcium Carbonate/adverse effects*;Calcium Carbonate/therapeutic use;Calcium, Dietary/adverse effects;Calcium, Dietary/therapeutic use;Cross-Over Studies;Dietary Supplements/adverse effects*;Female;Food-Drug Interactions*;Gastric Mucosa/drug effects;Gastric Mucosa/metabolism;Gastritis/chemically induced;Gastritis/prevention & control;Half-Life;Humans;Intestinal Absorption;Male;Protein-Tyrosine Kinases/administration & dosage;Protein-Tyrosine Kinases/adverse effects;Protein-Tyrosine Kinases/blood;Protein-Tyrosine Kinases/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/blood;Pyrimidines/pharmacokinetics*
24036239;Benzilates/chemistry*;Biopharmaceutics/methods;Chemistry, Pharmaceutical;Diffusion;Food-Drug Interactions*;Gastric Juice/chemistry;Gastrointestinal Motility*;Gastrointestinal Tract/physiology*;Humans;Hydrodynamics;Kinetics;Models, Chemical;Nortropanes/chemistry*;Osmolar Concentration;Postprandial Period*;Solubility;Tablets, Enteric-Coated;Technology, Pharmaceutical/methods;Viscosity;Water/chemistry*
24030706;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use*;Consumer Health Information/methods*;Dabigatran;Drug Interactions;Fibrinolytic Agents/administration & dosage;Fibrinolytic Agents/adverse effects;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions;Humans;Patient Safety;Perception*;Social Media*;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/therapeutic use
24021514;Administration, Oral;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/physiology;Mental Disorders/blood;Mental Disorders/drug therapy*;Randomized Controlled Trials as Topic;Thyrotropin/blood;Thyroxine/administration & dosage*;Thyroxine/adverse effects;Thyroxine/pharmacokinetics*
24014143;Adult;Cross-Over Studies;Female;Food-Drug Interactions/physiology*;Humans;Isoindoles/administration & dosage*;Isoindoles/blood*;Lurasidone Hydrochloride;Male;Middle Aged;Schizophrenia/blood*;Schizophrenia/drug therapy*;Thiazoles/administration & dosage*;Thiazoles/blood*
24013073;ATP Binding Cassette Transporter, Sub-Family B/genetics;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Biological Availability;Capsaicin/pharmacology*;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Dexamethasone/pharmacology;Dietary Supplements;Dose-Response Relationship, Drug;Food-Drug Interactions*;Ketoconazole/pharmacology;Male;Rats, Sprague-Dawley
24003188;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
24003187;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23994640;Administration, Oral;Biopharmaceutics/methods*;Dosage Forms;Fasting/metabolism;Food-Drug Interactions;Humans;Intestinal Absorption;Intestinal Secretions/chemistry;Intestinal Secretions/metabolism*;Intestine, Small/metabolism*;Models, Biological*;Permeability;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*;Postprandial Period;Solubility
23989967;Administration, Oral;Adolescent;Biological Availability;Child;Cross-Over Studies;Deamino Arginine Vasopressin/administration & dosage*;Deamino Arginine Vasopressin/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Freeze Drying*;Humans;Male;Metabolic Clearance Rate/physiology;Nocturnal Enuresis/blood*;Nocturnal Enuresis/drug therapy*;Tablets;Therapeutic Equivalency
23979737;Administration, Oral;Adult;Antitubercular Agents/blood;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage*;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Nitroimidazoles/blood;Nitroimidazoles/pharmacokinetics*
23955148;Administration, Oral;Animals;Cross-Over Studies;Dogs;Food-Drug Interactions*;Humans;In Vitro Techniques;Models, Biological*;Pharmacokinetics;Solubility
23939880;Adult;Bile Acids and Salts/metabolism;Body Fluids/metabolism*;Eating;Fasting/metabolism;Female;Food-Drug Interactions;Gastrointestinal Contents;HIV Protease Inhibitors/metabolism*;Humans;Hydrogen-Ion Concentration;Intestines/metabolism*;Male;Micelles;Postprandial Period;Ritonavir/metabolism;Solubility;Young Adult
23939537;Administration, Sublingual;Adult;Area Under Curve;Cross-Over Studies;Diet, High-Fat*;Fasting/blood*;Female;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Middle Aged;Pyridines/administration & dosage;Pyridines/blood;Pyridines/pharmacokinetics*;Solubility;Tablets;Young Adult
23934742;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Clinical Trials as Topic;Depression/drug therapy*;Depression/enzymology;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase/metabolism*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Tyramine/pharmacology
23928870;Adult;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Cytochrome P-450 CYP2C9/genetics;Cytochrome P-450 CYP2C9/metabolism;Female;Food-Drug Interactions/genetics*;Genotype*;Humans;Male;Middle Aged;Pharmacogenetics/methods;Polymorphism, Single Nucleotide*;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Vitamin K Epoxide Reductases/genetics*;Vitamin K Epoxide Reductases/metabolism;Warfarin/administration & dosage*;Warfarin/adverse effects
23927483;Adolescent;Adult;Analysis of Variance;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Energy Intake;Epoprostenol/analogs & derivatives*;Epoprostenol/pharmacokinetics;Female;Food;Food-Drug Interactions*;Half-Life;Healthy Volunteers;Humans;Male;Middle Aged;Nutritive Value;Tandem Mass Spectrometry;Young Adult
23926628;Adverse Drug Reaction Reporting Systems;Angiotensin II Type 1 Receptor Blockers/therapeutic use;Angiotensin-Converting Enzyme Inhibitors/therapeutic use;Anti-Arrhythmia Agents/therapeutic use;Beverages*;Cardiotonic Agents/therapeutic use;Cardiovascular Agents/therapeutic use*;Cardiovascular Diseases/drug therapy*;Dietary Supplements*;Drug Interactions;Food;Food-Drug Interactions*;Humans;Vitamins*
23926058;Administration, Oral;Adolescent;Adult;Chemistry, Pharmaceutical;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions*/physiology;Humans;Male;Middle Aged;Organophosphates/administration & dosage*;Organophosphates/pharmacokinetics*;Oxazoles/administration & dosage*;Oxazoles/pharmacokinetics*;Prodrugs/administration & dosage*;Prodrugs/chemistry;Prodrugs/pharmacokinetics*;Young Adult
23917982;Critical Care/methods;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions*;Humans;Intensive Care Units;Nutritional Support/adverse effects;Nutritional Support/methods;Parenteral Nutrition/adverse effects;Parenteral Nutrition/methods*
23893461;Administration, Oral;Adult;Aged;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Diet, High-Fat;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;MAP Kinase Kinase 1/antagonists & inhibitors;MAP Kinase Kinase 2/antagonists & inhibitors;Male;Middle Aged;Neoplasms/metabolism*;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Pyridones/blood;Pyridones/pharmacokinetics*;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*
23888935;Adult;Analysis of Variance;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Body Mass Index;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Ethnic Groups;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Imidazoles/pharmacokinetics*;Male;Middle Aged;Pyridazines/pharmacokinetics*;Sex Characteristics;Tandem Mass Spectrometry;Young Adult
23888632;Citrus paradisi*;Evidence-Based Medicine;Food-Drug Interactions*;United Kingdom
23878024;Adult;Animals;Anti-Allergic Agents/blood;Anti-Allergic Agents/pharmacokinetics*;Beverages*/analysis;COS Cells;Cercopithecus aethiops;Citrus paradisi*;Coumarins/analysis;Cross-Over Studies;Estrone/analogs & derivatives;Estrone/metabolism;Female;Flavonoids/analysis;Food-Drug Interactions*;Fruit;HEK293 Cells;Humans;Male;Middle Aged;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics;Young Adult
23870611;Administration, Oral;Adult;Asian Continental Ancestry Group;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Tolerance;Food*;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Succinates/administration & dosage;Succinates/pharmacokinetics*;Tablets, Enteric-Coated
23849436;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Phenoxyacetates/adverse effects;Phenoxyacetates/pharmacokinetics*;Tablets
23832397;Administration, Oral;Adult;Aged;Aged, 80 and over;Aurora Kinase A/antagonists & inhibitors*;Cohort Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Middle Aged;Neoplasm Metastasis;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Norbornanes/administration & dosage*;Norbornanes/adverse effects;Norbornanes/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Pyrimidines/administration & dosage*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics;Treatment Outcome;Young Adult
27024600;Beverages;Citrus paradisi*;Food-Drug Interactions*;Heart;Humans
23794501;Animals;Beverages/analysis*;Citrus paradisi/chemistry*;Citrus sinensis/chemistry*;Estrone/analogs & derivatives;Estrone/pharmacokinetics;Flavonoids/chemistry;Flavonoids/isolation & purification;Flavonoids/metabolism;Food-Drug Interactions*;Gene Expression;Intestinal Absorption/drug effects;Malus/chemistry*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Xenopus
23789936;Administration, Oral;Aged;Aged, 80 and over;Biological Availability;Capsules;Disease Progression;Dose-Response Relationship, Drug;Dyspnea/chemically induced;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glycine/administration & dosage;Glycine/adverse effects;Glycine/analogs & derivatives*;Glycine/blood;Glycine/pharmacokinetics;Glycine/therapeutic use;Humans;Male;Middle Aged;Myelodysplastic Syndromes/blood;Myelodysplastic Syndromes/drug therapy*;Myelodysplastic Syndromes/enzymology;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Protein Kinase Inhibitors/therapeutic use*;Remission Induction;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/blood;Sulfones/pharmacokinetics;Sulfones/therapeutic use*;Treatment Outcome;Urologic Diseases/chemically induced
23789798;Administration, Oral;Administration, Topical;Adult;Airway Obstruction/prevention & control;Algorithms;Deglutition Disorders/physiopathology*;Dosage Forms*;Drug Prescriptions*;Food-Drug Interactions;Guideline Adherence;Hospitals, Urban/organization & administration;Humans;Pharmaceutical Preparations/classification;Pharmacy Service, Hospital*;Powders;Practice Guidelines as Topic*
23773634;Antirheumatic Agents/adverse effects*;Antirheumatic Agents/pharmacokinetics;Arthritis, Rheumatoid/drug therapy*;Arthritis, Rheumatoid/enzymology;Calcineurin/metabolism;Calcineurin Inhibitors;Citrus paradisi;Enzyme Inhibitors/adverse effects;Folic Acid/adverse effects;Folic Acid/metabolism;Food-Drug Interactions*;Fruit/adverse effects;Humans;Isoniazid/adverse effects;Methotrexate/adverse effects;Risk Factors;Seafood/adverse effects
23773631;Animals;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents/therapeutic use*;Dietary Proteins/adverse effects;Dietary Supplements*/adverse effects;Food-Drug Interactions;Humans;Meat/adverse effects;Plant Preparations/therapeutic use*;Rheumatic Diseases/drug therapy*;Rheumatic Diseases/epidemiology;Rheumatic Diseases/immunology;Risk Factors;Treatment Outcome;Vitamin D/adverse effects;Vitamin D/therapeutic use*;Vitamin D Deficiency/drug therapy*;Vitamin D Deficiency/epidemiology;Vitamin D Deficiency/immunology
23757819;Aged;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Middle Aged
23750707;Animals;Benzilates/metabolism;Benzilates/pharmacokinetics*;Bile Acids and Salts/metabolism*;Caco-2 Cells;Cattle;Food-Drug Interactions;Glycochenodeoxycholic Acid/pharmacology;Humans;Intestinal Absorption/drug effects;Magnetic Resonance Spectroscopy;Male;Nortropanes/metabolism;Nortropanes/pharmacokinetics*;Rats;Rats, Wistar;Taurodeoxycholic Acid/pharmacology
23745231;Acne Vulgaris/drug therapy*;Administration, Oral;Dermatologic Agents/administration & dosage*;Dermatologic Agents/pharmacokinetics;Dermatologic Agents/therapeutic use;Food-Drug Interactions;Humans;Isotretinoin/administration & dosage*;Isotretinoin/pharmacokinetics;Isotretinoin/therapeutic use;Tablets
23740680;Drug-Related Side Effects and Adverse Reactions/etiology;Food;Food-Drug Interactions/physiology*;Humans;Medicine, Ayurvedic*;Treatment Outcome
23736966;Adolescent;Adult;Calcineurin Inhibitors*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/adverse effects;Cyclosporine/pharmacokinetics*;Diet, Fat-Restricted*;Diet, High-Fat*;Double-Blind Method;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics*;Fasting/metabolism;Female;Food-Drug Interactions*;Healthy Volunteers;Humans;Male;Middle Aged;Young Adult
23735880;Adult;Anthocyanins/chemistry;Anthocyanins/toxicity*;Cell Survival/drug effects;Cytochrome P-450 CYP1A1/metabolism*;Dietary Supplements;Enzyme Inhibitors/toxicity;Female;Food-Drug Interactions;Gene Expression Regulation, Enzymologic/drug effects;Glucosides/chemistry;Glucosides/toxicity;Hep G2 Cells;Hepatocytes/drug effects*;Hepatocytes/metabolism;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Middle Aged;Protein Binding;Receptors, Aryl Hydrocarbon/drug effects*;Receptors, Aryl Hydrocarbon/metabolism;Signal Transduction/drug effects
23720136;Administration, Oral;Adult;Biological Availability;Breakfast;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Sucrose;Fasting/metabolism*;Female;Food, Formulated*;Food-Drug Interactions*;HIV Reverse Transcriptase/antagonists & inhibitors;Humans;Male;Meals;Middle Aged;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Proteins/administration & dosage;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/pharmacokinetics*;Rilpivirine;Young Adult
23719876;Anti-Retroviral Agents/administration & dosage*;Anti-Retroviral Agents/pharmacokinetics;Biological Availability*;Dosage Forms;Enteral Nutrition/methods;Enteral Nutrition/standards*;Food-Drug Interactions*;Humans;Intubation, Gastrointestinal
23715233;Antihypertensive Agents*/administration & dosage;Antihypertensive Agents*/adverse effects;Antihypertensive Agents*/therapeutic use;Colombia;Comorbidity;Cross-Sectional Studies;Culture;Drug Administration Schedule;Drug Interactions;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Humans;Hypertension/complications;Hypertension/drug therapy;Hypertension/physiopathology;Hypertension/psychology*;Male;Medication Adherence*/statistics & numerical data;Middle Aged;Patient Education as Topic;Patient Medication Knowledge*/statistics & numerical data;Physician-Patient Relations;Socioeconomic Factors;Urban Population
23711557;Adult;Anticoagulants/therapeutic use*;Cardiovascular Nursing/standards*;Drug Interactions;Europe;Female;Food-Drug Interactions;Health Care Surveys;Health Knowledge, Attitudes, Practice*;Humans;International Normalized Ratio/nursing;Male;Middle Aged;Self Administration;Thrombosis/drug therapy;Thrombosis/nursing*;Thrombosis/prevention & control;Warfarin/therapeutic use
23710968;Food*;Food-Drug Interactions/physiology*;Humans;Nutritional Status/physiology;Pharmaceutical Preparations/metabolism*
23706685;Biotransformation/genetics;Carrier Proteins/genetics;Carrier Proteins/metabolism;Clinical Trials as Topic/methods;Confounding Factors (Epidemiology);Cytochrome P-450 Enzyme System/genetics;Dose-Response Relationship, Drug;Drug Evaluation, Preclinical/methods;Drug Interactions*;Food-Drug Interactions;Humans;Intestinal Absorption;Intestines/metabolism;Kidney/metabolism;Patient Selection;Pharmacokinetics;Plant Preparations/pharmacokinetics;Research Design*
23696038;Beverages/analysis;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood*;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/metabolism*;Citrus paradisi*/metabolism;Computer Simulation;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Models, Biological;Nifedipine/administration & dosage;Nifedipine/blood*;Nifedipine/chemistry;Nifedipine/metabolism*;Solubility
23686349;Absorption;Animals;Biological Transport;Drug Interactions;Food-Drug Interactions;Genotype;Humans;Membrane Transport Modulators/metabolism;Membrane Transport Modulators/pharmacology*;Membrane Transport Proteins/drug effects*;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism;Permeability;Phenotype
23680730;Administration, Oral;Animals;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/chemistry*;Anti-Bacterial Agents/pharmacokinetics;Biological Availability;Cephalexin/blood;Cephalexin/chemistry*;Cephalexin/pharmacokinetics;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Dogs;Drug Compounding;Drug Delivery Systems*;Fasting/metabolism;Female;Food-Drug Interactions;Intestinal Absorption;Male;Tablets
23677858;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Adrenergic beta-Antagonists/pharmacokinetics;Adrenergic beta-Antagonists/therapeutic use;Adult;Area Under Curve;Beverages/adverse effects*;Blood Pressure/drug effects;Citrus paradisi*;Cross-Over Studies;Drug Interactions;Food-Drug Interactions;Half-Life;Heart Rate/drug effects;Humans;Itraconazole/pharmacokinetics;Itraconazole/pharmacology*;Male;Nadolol/pharmacokinetics*;Nadolol/pharmacology*;Rifampin/pharmacokinetics;Rifampin/pharmacology*;Young Adult
23674575;Disease Management*;Food-Drug Interactions*;Humans
23673492;Animals;Anti-Anxiety Agents/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Beverages*;Buspirone/pharmacokinetics;Caco-2 Cells;Calcium Channel Blockers/pharmacokinetics;Carbamazepine/pharmacokinetics;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Drug Evaluation, Preclinical;Drug Interactions*;Flurbiprofen/pharmacokinetics;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/pharmacokinetics;Hypoglycemic Agents/pharmacokinetics;Midazolam/pharmacokinetics;Nitrendipine/pharmacokinetics;Punicaceae/chemistry*;Tolbutamide/pharmacokinetics;Triazolam/pharmacokinetics
23669408;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/metabolism;Biotransformation;Canthaxanthin/adverse effects;Canthaxanthin/metabolism;Carotenoids/adverse effects;Carotenoids/metabolism*;Cryptoxanthins;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2C8;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/adverse effects;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/metabolism*;Food-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors;Isoenzymes/metabolism;Kinetics;Lutein/adverse effects;Lutein/metabolism;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism*;Xanthophylls/adverse effects;Xanthophylls/metabolism;Xenobiotics/metabolism*;Zeaxanthins
23665448;Absorption;Administration, Oral;Adult;Biopharmaceutics/methods*;Biopharmaceutics/trends;Chemistry, Pharmaceutical/methods;Chemistry, Pharmaceutical/trends;Child;Computer Simulation;Drug Delivery Systems;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Pediatrics;Permeability;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemical synthesis;Solubility;Technology, Pharmaceutical/methods*;Technology, Pharmaceutical/trends
23637051;Adolescent;Benzoates/administration & dosage*;Beverages*;Blood Transfusion;Child;Child, Preschool;Female;Food*;Food-Drug Interactions*;Hematologic Diseases/therapy;Hemosiderosis/drug therapy*;Hemosiderosis/etiology;Humans;Iron Chelating Agents/administration & dosage*;Male;Triazoles/administration & dosage*
23636154;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Drug Interactions*;Drug Monitoring;Female;Food-Drug Interactions;Humans;Internet;Male;Middle Aged;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects*;Patient Education as Topic/methods*;Prescription Drugs/administration & dosage;Prescription Drugs/adverse effects*;Sex Factors;Surveys and Questionnaires;United States
23634851;Animals;Carcinogenesis/drug effects;Carcinogenesis/metabolism;Carcinogens/metabolism*;Chemoprevention;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Diet;Disease Models, Animal;Food-Drug Interactions/physiology;Humans;Inactivation, Metabolic/physiology;Phytochemicals/pharmacology*
23612358;Alcoholic Beverages;Chemistry, Pharmaceutical;Delayed-Action Preparations/administration & dosage;Drug Delivery Systems;Food;Food-Drug Interactions*;Gastrointestinal Tract/physiology*;Humans;Pharmaceutical Preparations/administration & dosage
23611558;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages;Cyclosporine/pharmacology;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Dietary Supplements*;Everolimus;Fish Oils/administration & dosage;Food;Food-Drug Interactions*;Fruit/chemistry;Humans;Immunosuppression;Immunosuppressive Agents/pharmacology*;Patient Education as Topic;Plants, Medicinal/chemistry;Sirolimus/analogs & derivatives;Sirolimus/pharmacology;Tacrolimus/pharmacology;Transplantation*
23588449;Aged;Anticoagulants/pharmacology*;Chronic Disease;Coumarins/pharmacology*;Diet*;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Vitamin K/administration & dosage*
23588433;Adrenergic alpha-Antagonists;Adrenergic beta-Antagonists;Antihypertensive Agents*/pharmacokinetics;Antihypertensive Agents*/pharmacology;Calcium Channel Blockers;Citrus paradisi;Diet;Diuretics;Food-Drug Interactions*;Humans
23558602;Adult;Area Under Curve;Capsules;Delayed-Action Preparations;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Omeprazole/administration & dosage;Omeprazole/pharmacokinetics*;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacokinetics*;Tablets, Enteric-Coated;Time Factors;Young Adult
23556334;Analysis of Variance;Antifungal Agents/administration & dosage;Antifungal Agents/blood*;Antifungal Agents/pharmacokinetics*;Area Under Curve;Calibration;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/pharmacology*;Food-Drug Interactions;Humans;Indicators and Reagents;Limit of Detection;Mass Spectrometry;Quality Control;Reproducibility of Results;Triazoles/administration & dosage;Triazoles/blood*;Triazoles/pharmacokinetics*
23553850;Adult;Aged;Aged, 80 and over;Anilides/administration & dosage;Anilides/adverse effects;Anilides/pharmacokinetics*;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasm Staging;Neoplasms/drug therapy*;Neoplasms/pathology*;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Treatment Outcome
23550055;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23550054;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23536972;Administration, Oral;Animals;Area Under Curve;Dogs;Eating*;Fasting;Food-Drug Interactions*;Intestinal Absorption;Male;Models, Theoretical;Succinates/administration & dosage*;Succinates/blood;Succinates/metabolism;Succinates/pharmacokinetics*
23529727;Administration, Oral;Adult;Amidohydrolases/antagonists & inhibitors*;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/administration & dosage*;Humans;Male;Tablets;Treatment Outcome;Young Adult
23520584;Adolescent;Adult;Aged;Bacterial Infections/classification;Bacterial Infections/immunology;Bacterial Infections/prevention & control*;Child, Preschool;Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage*;Female;Food-Drug Interactions/immunology*;Humans;Immunization Schedule;Infant, Newborn;Male;Mass Vaccination*/methods;Mass Vaccination*/organization & administration;Mass Vaccination*/trends;Meningococcal Vaccines/administration & dosage*;Organizational Innovation;Pneumococcal Vaccines/administration & dosage*;Pregnancy;Vaccines, Conjugate/administration & dosage*;Viral Vaccines/administration & dosage*;Virus Diseases/classification;Virus Diseases/immunology;Virus Diseases/prevention & control*
23503449;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/metabolism*;Food-Drug Interactions/physiology*;Humans;Male;Suspensions;Taiwan/epidemiology;Triazoles/administration & dosage*;Triazoles/pharmacokinetics*;Young Adult
23501043;Aged;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Glucagon-Like Peptide 2/administration & dosage*;Glucagon-Like Peptide 2/pharmacology;Humans;Infusions, Subcutaneous;Intestinal Absorption/drug effects;Male;Middle Aged;Short Bowel Syndrome/drug therapy*;Short Bowel Syndrome/physiopathology
23497885;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/chemistry*;ATP-Binding Cassette Transporters/metabolism;Biological Transport;Cell Line;Dietary Supplements/analysis;Down-Regulation*;Food-Drug Interactions;Humans;Neoplasm Proteins/chemistry*;Neoplasm Proteins/metabolism;Plant Extracts/chemistry*;Protein Binding
23497763;Acetanilides/administration & dosage;Acetanilides/adverse effects;Acetanilides/blood;Acetanilides/pharmacokinetics*;Administration, Oral;Adrenergic beta-Agonists/administration & dosage;Adrenergic beta-Agonists/adverse effects;Adrenergic beta-Agonists/blood;Adrenergic beta-Agonists/pharmacokinetics*;Adult;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Reference Values;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*
23495418;Cardiovascular Agents/adverse effects*;Citrus paradisi*;Food-Drug Interactions*;Humans
23480875;Administration, Oral;Adult;Animals;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Combinations;Ethanolamines/pharmacokinetics*;Female;Fluorenes/pharmacokinetics*;Food-Drug Interactions;Humans;Male;Milk*;Plant Oils/pharmacology*;Uganda;Zea mays*
23478684;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/therapeutic use;Beverages;Biological Availability;Citrus paradisi;Diet;Dietary Fiber;Feeding Behavior;Food-Drug Interactions/physiology*;Humans;Plants, Medicinal
23466046;Animals;Deficiency Diseases/chemically induced*;Deficiency Diseases/diet therapy;Deficiency Diseases/epidemiology;Deficiency Diseases/prevention & control;Dietary Supplements;Food-Drug Interactions*;Humans;Micronutrients/administration & dosage;Micronutrients/deficiency;Micronutrients/metabolism*;Micronutrients/therapeutic use;Prescription Drugs/adverse effects*;Risk
23458226;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics*;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/blood;Food-Drug Interactions*;Half-Life;Humans;Infusions, Intravenous;Intestinal Absorption*;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Models, Statistical;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/blood;Morpholines/chemistry;Morpholines/pharmacokinetics*;Postprandial Period;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/chemistry;Thiophenes/pharmacokinetics*;Young Adult
23456771;Abnormalities, Drug-Induced/physiopathology;Abnormalities, Drug-Induced/prevention & control;Adult;Animals;Anticonvulsants/administration & dosage*;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics;Biotransformation;Body Temperature;Child;Circadian Rhythm/physiology;Drug Chronotherapy*;Drug Delivery Systems;Epilepsy/drug therapy;Epilepsy/physiopathology;Epilepsy/prevention & control;Epilepsy/therapy;Food-Drug Interactions;Gene Expression Regulation;Humans;Hydrocortisone/secretion;Intestinal Absorption;Melatonin/secretion;Melatonin/therapeutic use;Mice;Phototherapy;Prospective Studies;Randomized Controlled Trials as Topic;Retrospective Studies;Sleep Stages/physiology
23447089;Administration, Oral;Animals;Area Under Curve;Chromatography, Liquid;Dietary Fats;Dogs;Fluorobenzenes/administration & dosage;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Models, Biological*;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Tandem Mass Spectrometry;Tissue Distribution
23444432;Beverages*;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Pharmacokinetics*
23444431;Beverages*;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Pharmacokinetics*
23442116;Arsenic/pharmacokinetics*;Bile Acids and Salts/chemistry;Bile Acids and Salts/metabolism*;Computer Simulation;Digestion;Fatty Acids/chemistry;Fatty Acids/metabolism*;Food-Drug Interactions*;Gastrointestinal Tract/metabolism*;Humans;Hydrogen-Ion Concentration;Models, Biological;Oryza/chemistry;Reference Standards;Risk Assessment;Soil Pollutants/pharmacokinetics*;Trace Elements/analysis
23434923;Administration, Oral;Animals;Buffers;Calibration;Chromatography, High Pressure Liquid;Dogs;Drug Evaluation, Preclinical;Fasting*;Food-Drug Interactions;Gastric Juice/drug effects;Gastrointestinal Contents/chemistry;Gastrointestinal Tract/drug effects*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/physiology;Osmolar Concentration;Phospholipids/chemistry;Solubility;Surface Tension
23420518;Administration, Oral;Antineoplastic Agents*/administration & dosage;Antineoplastic Agents*/chemistry;Antineoplastic Agents*/pharmacokinetics;Biological Availability;Drug Stability;Food-Drug Interactions;Humans;Solubility
23419230;Administration, Cutaneous;Administration, Oral;Caregivers/education;Cognitive Therapy;Combined Modality Therapy;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Food-Drug Interactions;Humans;Medication Adherence*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Motivational Interviewing;Patient Education as Topic;Treatment Failure
23417765;Administration, Oral;Adolescent;Adult;Asian Continental Ancestry Group*;Eating/drug effects;Eating/physiology*;Female;Food-Drug Interactions/physiology*;Humans;Male;Piperazines/administration & dosage*;Piperazines/blood*;Piperazines/pharmacokinetics;Piperidines/administration & dosage*;Piperidines/blood*;Piperidines/pharmacokinetics;Young Adult
23412805;Adult;Aged;Aged, 80 and over;Antineoplastic Agents, Hormonal/therapeutic use*;Aryl Hydrocarbon Hydroxylases/genetics;Aryl Hydrocarbon Hydroxylases/metabolism;Breast Neoplasms/drug therapy*;Breast Neoplasms/metabolism;Breast Neoplasms/pathology;Coffee*;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2C8;Female;Food-Drug Interactions*;Genotype;Humans;Middle Aged;Receptors, Estrogen/metabolism*;Tamoxifen/therapeutic use*
23405822;Aged;Aged, 80 and over;Food-Drug Interactions*;Humans;Long-Term Care;Middle Aged;Nursing Homes;Risk Assessment
23402972;Animals;Body Fluids/drug effects*;Body Fluids/metabolism;Caco-2 Cells;Food*;Food-Drug Interactions;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/chemistry;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/administration & dosage;Indinavir/chemistry;Indinavir/pharmacokinetics*;Intestinal Absorption/drug effects*;Intestines/drug effects*;Intestines/metabolism;Male;Mice;Solubility
23399607;Citrus paradisi;Diabetes Mellitus, Type 2/drug therapy*;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Male;Middle Aged;Musculoskeletal Pain/chemically induced*;Myositis/chemically induced*;Quality of Life;Simvastatin/adverse effects*;Simvastatin/therapeutic use
23384079;Dietary Supplements*;Food-Drug Interactions;Humans;Preventive Medicine;Science*
23373097;Beverages;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
23362039;Aging*;Alcohol Drinking/adverse effects;Alcohol Drinking/epidemiology*;Alcoholism/epidemiology;Australia/epidemiology;Binge Drinking/epidemiology;Disease Susceptibility;Europe/epidemiology;Food-Drug Interactions;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/therapeutic use*;North America/epidemiology;Patient Compliance;Prevalence;Substance-Related Disorders/epidemiology
23356842;Animals;Area Under Curve;Beverages*;Ciprofloxacin/pharmacology*;Citrus paradisi*;Cytochrome P-450 CYP1A2 Inhibitors;Drug Interactions;Food-Drug Interactions;Intestinal Absorption/physiology;Male;Permeability;Rats;Rats, Wistar;Riluzole/pharmacokinetics*
23340477;Food Labeling*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Patient Safety*;Protein Kinase Inhibitors/therapeutic use*;Protein-Tyrosine Kinases/antagonists & inhibitors*
23331476;Beverages/adverse effects;Blood Glucose/analysis;Caffeine/adverse effects*;Diabetes Mellitus, Type 1/blood;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 1/metabolism;Diabetes Mellitus, Type 2/blood*;Diabetes Mellitus, Type 2/metabolism;Diabetes, Gestational/blood;Diabetes, Gestational/metabolism;Evidence-Based Medicine*;Female;Food-Drug Interactions;Humans;Hyperglycemia/chemically induced*;Hyperinsulinism/chemically induced;Hypoglycemia/chemically induced;Hypoglycemic Agents/therapeutic use;Insulin/therapeutic use;Insulin Resistance*;Male;Pregnancy;Randomized Controlled Trials as Topic
23329786;Diarrhea/etiology;Diarrhea/pathology;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Intubation, Gastrointestinal/adverse effects;Nutritional Status;Osmolar Concentration;Pharmaceutical Preparations/administration & dosage*
23297175;Beverages*;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/adverse effects;Furocoumarins/analysis;Humans;Organic Anion Transporters/metabolism;Pharmacokinetics*
23282066;Animals;Beverages;Citrus paradisi;Cytochrome P-450 CYP3A/metabolism*;Food-Drug Interactions;Humans;Hydroxylation;Kinetics;Male;Mice;Mice, Inbred BALB C;Microsomes/metabolism;Midazolam/blood;Midazolam/pharmacokinetics*;Models, Animal;Oxidoreductases, N-Demethylating/metabolism;Rats;Rats, Sprague-Dawley;Species Specificity;Tandem Mass Spectrometry;Triazolam/blood;Triazolam/pharmacokinetics*
23279674;Adrenergic beta-Antagonists/adverse effects;Angiotensin Receptor Antagonists/adverse effects;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Antihypertensive Agents/adverse effects*;Calcium Channel Blockers/adverse effects;Food-Drug Interactions;Humans;Hypertension/drug therapy;Risk Factors;Sodium Chloride Symporter Inhibitors/adverse effects;Trace Elements/deficiency;Trace Elements/metabolism*;Zinc/deficiency;Zinc/metabolism*
23278367;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Eating;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Organophosphonates/adverse effects;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Phosphorous Acids/adverse effects;Phosphorous Acids/blood;Phosphorous Acids/pharmacokinetics*;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Tenofovir
24937393;Acetylcholine/pharmacology;Animals;Carbachol/pharmacology;Cholinergic Agonists/pharmacology;Diet*;Dose-Response Relationship, Drug;Food-Drug Interactions;Gastrointestinal Motility*/drug effects;Gastrointestinal Transit;Honey*;Ileum/drug effects;Ileum/physiology*;Male;Muscle, Smooth/drug effects;Muscle, Smooth/physiology*;Rats, Wistar
23264447;Absorption;Animals;Beverages*;Binding Sites;Binding, Competitive;Biological Transport;Citrus paradisi*;Citrus sinensis*;Estrone/analogs & derivatives*;Estrone/metabolism;Food-Drug Interactions*;Fruit;Kinetics;Malus*;Oocytes;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Terfenadine/analogs & derivatives*;Terfenadine/metabolism;Xenopus laevis
23248072;Adolescent;Adult;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacology*;Antiparkinson Agents/urine;Catechol O-Methyltransferase/metabolism;Catechol O-Methyltransferase Inhibitors*;Cross-Over Studies;Double-Blind Method;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacology*;Enzyme Inhibitors/urine;Erythrocytes/drug effects;Erythrocytes/enzymology;Food-Drug Interactions;Humans;Male;Middle Aged;Models, Biological;Oxadiazoles/blood;Oxadiazoles/pharmacology*;Oxadiazoles/urine;Young Adult
23230999;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Doxylamine/administration & dosage;Doxylamine/adverse effects;Doxylamine/analogs & derivatives*;Doxylamine/pharmacokinetics;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics*;Tablets, Enteric-Coated;Young Adult
23220613;Administration, Oral;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Capsaicin/administration & dosage*;Capsaicin/pharmacokinetics;Capsicum/chemistry;Chromatography, Liquid;Cytochrome P-450 CYP3A/metabolism;Dexamethasone/administration & dosage;Female;Food-Drug Interactions*;Ketoconazole/administration & dosage;Mass Spectrometry;Rats;Rats, Sprague-Dawley;Simvastatin/administration & dosage;Simvastatin/pharmacokinetics*
23211396;Administration, Oral;Adult;Azepines/pharmacokinetics*;Benzamides/pharmacokinetics*;Cross-Over Studies;Factor Xa Inhibitors*;Food-Drug Interactions*;Humans;Male
23200637;Adult;Beverages*;Cytochromes/blood;Food-Drug Interactions*;Fruit;Heart Transplantation;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacology*;Male;Punicaceae*;Tacrolimus/blood;Tacrolimus/pharmacology*
23190017;Administration, Oral;Adolescent;Adult;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors*;Male;Middle Aged;Oxazines/administration & dosage;Oxazines/pharmacokinetics*;Pharmaceutical Solutions;Prodrugs;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/pharmacokinetics*;Protein-Tyrosine Kinases/antagonists & inhibitors*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Suspensions;Syk Kinase;Tablets;Young Adult
23184849;Acute Kidney Injury/chemically induced;Beverages/adverse effects*;Biological Availability;Breast Neoplasms/chemically induced;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Fruit/metabolism;Furocoumarins/metabolism;Humans;Metabolic Detoxication, Phase I*;Pharmaceutical Preparations/metabolism;Rhabdomyolysis/chemically induced;Risk Factors;Torsades de Pointes/chemically induced
23184666;Adolescent;Adult;Analysis of Variance;Area Under Curve;Arrhythmias, Cardiac/chemically induced*;Arrhythmias, Cardiac/diagnosis;Arrhythmias, Cardiac/physiopathology;Biotransformation;Caffeine/administration & dosage;Caffeine/adverse effects*;Chi-Square Distribution;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Drug Interactions;Electrocardiography;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heart Rate/drug effects*;Hematologic Agents/administration & dosage;Hematologic Agents/adverse effects*;Hematologic Agents/blood;Hematologic Agents/pharmacokinetics*;Humans;Hydroxylation;Intestinal Absorption;London;Male;Metabolic Clearance Rate;Postprandial Period;Quinazolines/administration & dosage;Quinazolines/adverse effects*;Quinazolines/blood;Quinazolines/pharmacokinetics*;Young Adult
23167572;Adolescent;Adult;Antiprotozoal Agents/administration & dosage;Antiprotozoal Agents/chemistry;Antiprotozoal Agents/pharmacokinetics*;China;Chromatography, High Pressure Liquid/methods*;Cross-Over Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Humans;Male;Ornidazole/administration & dosage;Ornidazole/chemistry;Ornidazole/pharmacokinetics*;Stereoisomerism;Young Adult
23165864;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P-450 CYP2C19;Female;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Male;Sex Characteristics;Thalidomide/adverse effects;Thalidomide/pharmacokinetics*
23157216;Aged;Food-Drug Interactions*;Humans;Nutritional Status;Polypharmacy*
23156527;Economics, Pharmaceutical;Folic Acid/metabolism;Food-Drug Interactions*;Humans;Minerals/metabolism;Pharmacokinetics;Trace Elements/metabolism;Vitamin D/metabolism;Vitamin K/metabolism
23146039;Amodiaquine/analogs & derivatives;Amodiaquine/metabolism*;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Chromatography, High Pressure Liquid;Cytochrome P-450 Enzyme Inhibitors*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Honey*;Inhibitory Concentration 50;Kinetics;Recombinant Proteins/metabolism
23146034;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A Inhibitors*;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Furocoumarins/pharmacology*;Hep G2 Cells;Humans;Ketoconazole/pharmacology;Models, Biological*;NADPH-Ferrihemoprotein Reductase/antagonists & inhibitors*;Nifedipine/metabolism*;Plant Extracts/pharmacology;RNA, Messenger/metabolism
23139017;Animals;Biopharmaceutics/classification*;Computer Simulation*;Dogs;Drug Discovery*;Food-Drug Interactions*;Humans;Mice;Rats
23132664;Animals;Beverages*;Citrus paradisi*;Citrus sinensis*;Dose-Response Relationship, Drug;Estrone/analogs & derivatives*;Estrone/metabolism;Flavanones/pharmacology;Flavonoids/pharmacology*;Food-Drug Interactions*;Fruit;Hesperidin/pharmacology;Humans;Kinetics;Least-Squares Analysis;Malus*;Models, Biological;Nonlinear Dynamics;Oocytes;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Osmolar Concentration;Phlorhizin/pharmacology;Quercetin/pharmacology;Xenopus laevis
23126367;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adenosine/analogs & derivatives*;Adenosine/pharmacokinetics;Adult;Area Under Curve;Beverages*;Blood Platelets;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/pharmacokinetics*;Purinergic P2Y Receptor Antagonists/pharmacokinetics*;Young Adult
23117668;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Benzimidazoles/therapeutic use;Blood Coagulation/drug effects*;Blood Coagulation Tests;Dabigatran;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring*;Food-Drug Interactions;Hemostasis/drug effects;Humans;Morpholines/adverse effects;Morpholines/pharmacokinetics;Morpholines/therapeutic use;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics;Pyrazoles/therapeutic use;Pyridones/adverse effects;Pyridones/pharmacokinetics;Pyridones/therapeutic use;Rivaroxaban;Switzerland;Thiophenes/adverse effects;Thiophenes/pharmacokinetics;Thiophenes/therapeutic use;Thromboembolism/blood;Thromboembolism/drug therapy*;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
23104241;Administration, Oral;Adult;Anticonvulsants/adverse effects;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood*;Antipsychotic Agents/pharmacokinetics;Antipsychotic Agents/therapeutic use*;Caffeine/adverse effects;Case-Control Studies;Central Nervous System Stimulants/adverse effects;Chi-Square Distribution;Chromatography, High Pressure Liquid;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/blood*;Clozapine/pharmacokinetics;Clozapine/therapeutic use*;Cross-Sectional Studies;Drug Interactions;Drug Monitoring/methods;Drug Resistance*;Female;Food-Drug Interactions;Humans;Least-Squares Analysis;Logistic Models;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Psychiatric Status Rating Scales;Risk Factors;Schizophrenia/blood;Schizophrenia/diagnosis;Schizophrenia/drug therapy*;Schizophrenic Psychology;Spectrophotometry, Ultraviolet;Treatment Failure;Valproic Acid/adverse effects
23102570;Antineoplastic Agents/therapeutic use*;Energy Drinks/adverse effects*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*
23101976;Absorption;Acetaldehyde/metabolism;Alcohol Dehydrogenase/classification;Alcohol Dehydrogenase/genetics;Alcohol Dehydrogenase/metabolism;Alcoholism/metabolism;Cytochrome P-450 CYP2E1/metabolism;Electron Transport;Ethanol/blood;Ethanol/metabolism*;Female;Food-Drug Interactions;Humans;Kinetics;Liver/metabolism;Male;NAD/metabolism;Oxidation-Reduction;Tissue Distribution
23097095;Coffee/adverse effects*;Drug Carriers/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Thyroxine/pharmacokinetics*
23065939;Algorithms;Food-Drug Interactions*;Intestinal Absorption*;Intestines/metabolism;Micelles;Models, Biological*;Molecular Dynamics Simulation;Pharmaceutical Preparations/metabolism
23065713;Flavanones/chemistry*;Food-Drug Interactions*;Glucosides/chemistry*;Glucuronosyltransferase/metabolism*;Glycyrrhiza/chemistry;Humans;Hymecromone/metabolism;Isoenzymes/metabolism;Kinetics
23052407;Administration, Oral;Adolescent;Adult;Biological Availability;Breakfast;Cannabidiol/administration & dosage;Cannabidiol/blood;Cannabidiol/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage;Dronabinol/administration & dosage;Dronabinol/blood;Dronabinol/pharmacokinetics*;Drug Combinations;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged;Mouth Mucosa/metabolism*;Oral Sprays;Young Adult
23047652;Adult;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Beverages*;Cytochrome P-450 CYP2C9;Female;Fluconazole/pharmacology;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Humans;In Vitro Techniques;Inhibitory Concentration 50;Male;Middle Aged;Plant Extracts/pharmacology;Punicaceae/chemistry*;Young Adult
23033114;Administration, Oral;Animals;Beverages*;Biological Availability;Food-Drug Interactions*;Fruit*;Humans;Organic Anion Transporters/metabolism*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism
23027198;Adolescent;Adult;Aged;Antifungal Agents/administration & dosage;Antifungal Agents/therapeutic use*;Biological Availability;Chromatography, High Pressure Liquid;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Diseases/metabolism;Hematopoietic Stem Cell Transplantation;Humans;Immunosuppressive Agents/adverse effects;Leukemia, Myeloid, Acute/metabolism*;Male;Middle Aged;Multivariate Analysis;Myelodysplastic Syndromes/metabolism*;Prospective Studies;Spectrophotometry, Ultraviolet;Tacrolimus/adverse effects;Triazoles/administration & dosage;Triazoles/therapeutic use*;Young Adult
23010558;Adult;Aged;Benzamides/administration & dosage;Benzamides/adverse effects;Benzamides/pharmacokinetics;Benzamides/therapeutic use*;Blood Glucose/analysis;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Administration Schedule;Enzyme Activators/administration & dosage;Enzyme Activators/adverse effects;Enzyme Activators/pharmacokinetics;Enzyme Activators/therapeutic use*;Fasting;Female;Food-Drug Interactions*;Glucokinase/metabolism;Half-Life;Humans;Hyperglycemia/prevention & control*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/therapeutic use*;Male;Metabolic Clearance Rate;Middle Aged;Postprandial Period;Single-Blind Method;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics;Sulfones/therapeutic use*
22998389;Animals;Antioxidants/adverse effects;Antioxidants/metabolism*;Antioxidants/therapeutic use;Biotransformation;Dietary Supplements*/adverse effects;Enzyme Induction;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/therapeutic use;Flavonoids/adverse effects;Flavonoids/metabolism*;Flavonoids/therapeutic use;Food-Drug Interactions;Glutathione Transferase/antagonists & inhibitors;Glutathione Transferase/biosynthesis*;Glutathione Transferase/chemistry;Glutathione Transferase/metabolism;Humans;Liver/drug effects;Liver/enzymology;Liver/metabolism;Xenobiotics/pharmacokinetics
22951241;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects*;Anxiety Disorders/diagnosis;Anxiety Disorders/drug therapy;Anxiety Disorders/psychology;Bipolar Disorder/diagnosis;Bipolar Disorder/drug therapy;Bipolar Disorder/psychology;Comorbidity;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Medication Adherence;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Primary Health Care*;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology
22951239;Administration, Cutaneous;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Risk Factors;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Tyramine/administration & dosage;Tyramine/adverse effects
22951238;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Serotonin Agents/administration & dosage;Serotonin Agents/adverse effects;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Sympathomimetics/administration & dosage;Sympathomimetics/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects
22951237;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Cross-Cultural Comparison;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy;Depressive Disorder, Major/psychology;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;General Practice;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Practice Guidelines as Topic;Referral and Consultation;Risk Factors;Secondary Prevention;Treatment Outcome
22956350;Administration, Oral;Asian Continental Ancestry Group;Febuxostat;Female;Food-Drug Interactions;Gout Suppressants/administration & dosage;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics*;Humans;Indicators and Reagents;Male;Sex Characteristics;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Xanthine Oxidase/antagonists & inhibitors;Young Adult
22955172;Administration, Oral;Adult;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;European Continental Ancestry Group;Food-Drug Interactions*;Half-Life;Humans;Japan;Male;Stereoisomerism;Thalidomide/administration & dosage;Thalidomide/analogs & derivatives*;Thalidomide/pharmacokinetics;Time Factors;Young Adult
22953828;2-Pyridinylmethylsulfinylbenzimidazoles/chemistry*;Animals;Cattle;Food-Drug Interactions*;Protein Binding;Serum Albumin, Bovine/chemistry;Serum Albumin, Bovine/metabolism;Spectrum Analysis/methods*
22951980;Acetates/pharmacokinetics*;Adult;Anti-Asthmatic Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Prospective Studies;Quinolines/pharmacokinetics*;Young Adult
22950522;Administration, Oral;Adolescent;Adult;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors*;Male;Methotrexate/administration & dosage;Middle Aged;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics*;Protein-Serine-Threonine Kinases/antagonists & inhibitors*;Young Adult
22943970;Administration, Oral;Adult;Area Under Curve;Blood Glucose/drug effects;Dipeptidyl Peptidase 4/drug effects;Dipeptidyl Peptidase 4/metabolism;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics;Dipeptidyl-Peptidase IV Inhibitors/pharmacology;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Glucagon-Like Peptide 1/blood;Glucagon-Like Peptide 1/drug effects;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/pharmacology;Insulin/blood;Linear Models;Male;Piperazines/administration & dosage*;Piperazines/pharmacokinetics;Piperazines/pharmacology;Republic of Korea;Young Adult
22943633;Adult;Anthocyanins/analysis;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Beverages/adverse effects*;Beverages/analysis;Blueberry Plants/adverse effects*;Blueberry Plants/chemistry;Buspirone/pharmacokinetics*;Citrus paradisi/adverse effects;Citrus paradisi/chemistry;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Female;Fluconazole/pharmacology;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Furocoumarins/analysis;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Middle Aged;Phenols/analysis
22943121;Animals;Depression/drug therapy*;Depression/physiopathology;Drug Design*;Drug Interactions;Food-Drug Interactions;Heart Failure/drug therapy;Heart Failure/physiopathology;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neurodegenerative Diseases/drug therapy;Neurodegenerative Diseases/physiopathology;Parkinson Disease/drug therapy;Parkinson Disease/physiopathology
22943117;Administration, Oral;Animals;Chronic Disease;Dermatologic Agents/administration & dosage*;Dermatologic Agents/pharmacokinetics;Dermatologic Agents/pharmacology;Drug Interactions;Eczema/drug therapy*;Eczema/pathology;Food-Drug Interactions;Hand Dermatoses/drug therapy;Hand Dermatoses/pathology;Humans;Tretinoin/administration & dosage*;Tretinoin/pharmacokinetics;Tretinoin/pharmacology
22940371;Adolescent;Adult;Beverages;Citrus/chemistry*;Citrus paradisi/chemistry*;Colchicine/adverse effects;Colchicine/pharmacokinetics*;Drug Labeling;Female;Food-Drug Interactions*;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics;Humans;Male;Middle Aged;Time Factors;Young Adult
22937625;Adult;Beverages/adverse effects*;Child;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
22932947;Adult;Antithyroid Agents/administration & dosage;Antithyroid Agents/blood;Antithyroid Agents/pharmacokinetics;Antithyroid Agents/therapeutic use;Capsules;Chemistry, Pharmaceutical;Coffee/adverse effects*;Cross-Over Studies;Drug Carriers/administration & dosage;Drug Carriers/pharmacokinetics*;Drug Carriers/therapeutic use;Female;Food-Drug Interactions*;Gels;Goiter, Nodular/drug therapy;Hormone Replacement Therapy;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy;Hypothyroidism/metabolism;Intestinal Absorption*;Male;Middle Aged;Neoplasm Recurrence, Local/drug therapy;Thyroid Gland/drug effects;Thyroid Gland/secretion;Thyroid Nodule/drug therapy;Thyrotropin/blood;Thyrotropin/secretion;Thyroxine/administration & dosage;Thyroxine/blood;Thyroxine/pharmacokinetics*;Thyroxine/therapeutic use
22931521;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Clinical Trials as Topic;Drug Discovery;Drug Interactions;Food-Drug Interactions;Glomerular Filtration Rate;Humans;Inactivation, Metabolic;Kidney Diseases/complications*;Kidney Diseases/metabolism;Thromboembolism/blood;Thromboembolism/complications;Thromboembolism/drug therapy*;Treatment Outcome
22927137;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Alkaloids/administration & dosage*;Animals;Benzodioxoles/administration & dosage*;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Diltiazem/analogs & derivatives;Diltiazem/blood;Diltiazem/metabolism;Diltiazem/pharmacokinetics*;Food-Drug Interactions;Gene Expression/drug effects;Hep G2 Cells;Humans;Male;Piperidines/administration & dosage*;Polyunsaturated Alkamides/administration & dosage*;Rats;Rats, Sprague-Dawley;Receptors, Steroid/metabolism*
22926611;Antipsychotic Agents/pharmacokinetics*;Antipsychotic Agents/therapeutic use;Caffeine/isolation & purification;Caffeine/pharmacology*;Carbonated Beverages;Clozapine/pharmacokinetics*;Clozapine/therapeutic use;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Schizophrenia, Paranoid/drug therapy;Young Adult
22908106;Child, Preschool;Congenital Hypothyroidism/blood;Congenital Hypothyroidism/drug therapy*;Female;Food-Drug Interactions*;Humans;Infant, Newborn;Lactose Intolerance;Soy Milk/administration & dosage*;Thyrotropin/blood;Thyroxine/administration & dosage*
22897361;Biological Availability*;Cacao/metabolism;Citrus/metabolism;Coffee/metabolism;Fatty Acids, Unsaturated/pharmacokinetics;Fish Oils/pharmacokinetics;Food*;Food Industry;Food-Drug Interactions/physiology;Humans;Intestinal Absorption/physiology;Plant Preparations/pharmacokinetics;Tea/metabolism
22893357;Acute-Phase Reaction/chemically induced;Aged;Bone Density/drug effects*;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/adverse effects;Bone Density Conservation Agents/pharmacology*;Bone Remodeling/drug effects;Calcium, Dietary/administration & dosage;Calcium, Dietary/pharmacology*;Diphosphonates/administration & dosage;Diphosphonates/adverse effects;Diphosphonates/pharmacology*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions/physiology*;Hip Joint/physiopathology;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacology*;Lumbar Vertebrae/physiopathology;Middle Aged;Osteoporosis, Postmenopausal/blood;Osteoporosis, Postmenopausal/drug therapy;Osteoporosis, Postmenopausal/physiopathology;Randomized Controlled Trials as Topic;Vitamin D/analogs & derivatives*;Vitamin D/blood
22892338;Aged;Animals;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/toxicity*;Biotransformation;Citrus paradisi;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Diclofenac/metabolism;Diclofenac/pharmacokinetics;Diclofenac/toxicity*;Female;Food-Drug Interactions;Glutathione/metabolism;Humans;In Vitro Techniques;Intestinal Diseases/chemically induced*;Intestinal Diseases/pathology*;Intestinal Mucosa/drug effects;Intestinal Mucosa/pathology;Intestine, Small/enzymology*;Intestine, Small/pathology*;Male;Mice;Mice, Knockout;Microsomes/drug effects;Microsomes/enzymology;Middle Aged;Ulcer/chemically induced;Ulcer/pathology
22884524;Animals;Arylsulfotransferase/physiology;Beverages;Biological Transport;Citrus paradisi;Cytochrome P-450 CYP3A/physiology;Food-Drug Interactions*;Glucuronosyltransferase/physiology;Humans;Intestines/metabolism*
22877817;Food-Drug Interactions*;Humans;Hydroxybenzoates/pharmacology*;Inhibitory Concentration 50;Organic Anion Transporters/classification;Organic Anion Transporters/drug effects*
22874769;Adenocarcinoma/diet therapy;Adenocarcinoma/drug therapy*;Adenocarcinoma/metabolism;Antineoplastic Agents/pharmacology*;Antineoplastic Agents/therapeutic use;Apoptosis/drug effects*;Camptothecin/analogs & derivatives;Camptothecin/pharmacology;Camptothecin/therapeutic use;Cell Line, Tumor;Cell Survival/drug effects;Colonic Neoplasms/diet therapy;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/metabolism;Combined Modality Therapy;Dietary Supplements;Drug Resistance, Neoplasm*;Emulsions;Fatty Acids, Omega-3/metabolism;Fatty Acids, Omega-3/therapeutic use;Fish Oils/metabolism*;Fish Oils/therapeutic use;Fluorouracil/pharmacology;Fluorouracil/therapeutic use;Food-Drug Interactions;Humans;Membrane Potential, Mitochondrial/drug effects;Mitochondria/drug effects*;Mitochondria/metabolism;Organoplatinum Compounds/pharmacology;Organoplatinum Compounds/therapeutic use;bcl-2-Associated X Protein/metabolism
22866966;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control;Drug Interactions;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Medication Adherence;Pharmacogenetics*
22856466;Animals;Biomarkers/metabolism;Cell Proliferation/drug effects;Cell Shape/drug effects;Dietary Supplements/adverse effects;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Epithelial Cells/pathology;Estrogen Replacement Therapy/methods*;Female;Flax/adverse effects;Flax/chemistry*;Food-Drug Interactions*;Hyperplasia;Menopause*/metabolism;Ovariectomy/adverse effects;Phytoestrogens/adverse effects;Phytoestrogens/therapeutic use*;Powders;Proliferating Cell Nuclear Antigen/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Seeds/adverse effects;Seeds/chemistry*;Uterus/drug effects*;Uterus/metabolism;Uterus/pathology
22849770;Adult;Area Under Curve;Blood Pressure/drug effects;Cyclopropanes/administration & dosage;Cyclopropanes/pharmacokinetics;Cyclopropanes/pharmacology*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Enalapril/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Male;Midazolam/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/pharmacokinetics;Pyridines/pharmacology*;Renin/antagonists & inhibitors*;Time Factors;Young Adult
22833934;Administration, Oral;Biological Availability*;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Solubility;Technology, Pharmaceutical*
22829430;Adult;Dietary Supplements/adverse effects*;Female;Follow-Up Studies;Food-Drug Interactions;Humans;Lung Neoplasms/blood*;Lung Neoplasms/mortality*;Male;Middle Aged;Nutrition Surveys;Proportional Hazards Models;Risk Factors;United States/epidemiology;Vitamin A/blood*;Vitamin D/analogs & derivatives*;Vitamin D/blood;beta Carotene/blood
22818558;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Dabigatran;Drug Contamination;Drug Monitoring/methods*;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Heparin/administration & dosage;Heparin/adverse effects*;Humans;Hypersensitivity/etiology;Hypersensitivity/prevention & control;Injections, Subcutaneous/adverse effects;Necrosis/etiology;Necrosis/prevention & control;Osteoporosis/chemically induced;Osteoporosis/prevention & control;Skin Diseases/chemically induced;Skin Diseases/prevention & control;Subcutaneous Tissue/drug effects;Thrombocytopenia/chemically induced;Thrombocytopenia/prevention & control;Warfarin*/administration & dosage;Warfarin*/adverse effects;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*
22792553;Aged;Chronic Disease/drug therapy*;Chronic Disease/epidemiology;Combined Modality Therapy;Comorbidity;Drug Interactions;Drug Therapy, Combination;Evidence-Based Medicine;Family Practice*;Female;Food-Drug Interactions;Guideline Adherence;Humans;Specialization*;Switzerland
22788578;Animals;Anticarcinogenic Agents/adverse effects;Cardiotonic Agents/adverse effects*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/adverse effects*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Stilbenes/adverse effects*;Vasodilator Agents/adverse effects;Wine/adverse effects;Wine/analysis
22782559;Benzilates;Biopharmaceutics/methods*;Buffers;Chemistry, Pharmaceutical;Computer Simulation;Food;Food-Drug Interactions*;Galactans/chemistry;Gastrointestinal Tract/metabolism*;Humans;Hypromellose Derivatives;Mannans/chemistry;Methylcellulose/analogs & derivatives;Methylcellulose/chemistry;Models, Biological*;Nortropanes/chemistry*;Nortropanes/pharmacokinetics;Permeability;Plant Gums/chemistry;Solubility;Tablets;Viscosity
22773284;Antibody Formation/drug effects;Antibody Formation/immunology;Breast Feeding*;Child Development/physiology*;Communicable Diseases/immunology*;Drug Contamination;Environmental Pollutants/adverse effects;Food-Drug Interactions/immunology;Health Promotion;Humans;Immunity, Cellular/drug effects;Immunity, Cellular/immunology;Infant, Newborn;Infection Control/methods*;Milk, Human/immunology*;Nervous System/growth & development;Vaccination/methods;Vaccines*/classification;Vaccines*/immunology;Vaccines*/pharmacology
22769968;Adsorption;Cyclic GMP/physiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/physiopathology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/physiopathology;Hearing/drug effects;Heart/drug effects;Heart/physiopathology;Heart Diseases/chemically induced;Heart Diseases/physiopathology;Humans;Nervous System Diseases/chemically induced;Nervous System Diseases/physiopathology;Nitric Oxide/physiology;Phosphodiesterase 5 Inhibitors/adverse effects*;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Reproduction/drug effects;Tissue Distribution
22759198;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Double-Blind Method;Factor Xa Inhibitors*;Fasting;Fibrinolytic Agents/pharmacokinetics*;Fibrinolytic Agents/pharmacology;Food-Drug Interactions/physiology*;Half-Life;Humans;Male;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology;Pyridones/pharmacokinetics*;Pyridones/pharmacology;Time Factors;Young Adult
22759078;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adolescent;Adult;Antimalarials/adverse effects*;Antimalarials/pharmacokinetics*;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Peroxides/adverse effects*;Peroxides/pharmacokinetics*;Young Adult
22735461;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Energy Intake;Factor Xa Inhibitors*;Fasting;Food-Drug Interactions*;Humans;Male;Partial Thromboplastin Time/statistics & numerical data;Prothrombin Time/statistics & numerical data;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Pyridones/pharmacology*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Pyrrolidines/pharmacology*
22718404;Administration, Oral;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Anticoagulants/classification;Anticoagulants/economics;Anticoagulants/therapeutic use;Atrial Fibrillation/complications*;Cross-Sectional Studies;Drug Interactions;Factor Xa Inhibitors;Food-Drug Interactions;Humans;Medication Adherence;Middle Aged;Patient Preference*;Prescription Fees;Stroke/etiology;Stroke/prevention & control*;Thrombophilia/drug therapy*;Thrombophilia/etiology;Time Factors;Vitamin K/antagonists & inhibitors
22717418;Adolescent;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naltrexone/pharmacology;Narcotic Antagonists/pharmacology;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
22717215;Biological Availability;Dietary Supplements/adverse effects;Dietetics*;Energy Metabolism/drug effects;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Nutritional Status;Pharmacokinetics;Risk Factors
22715076;Circadian Rhythm;Drug Chronotherapy;Drug Therapy, Combination;Food-Drug Interactions*;General Practice;Germany;Humans;Pharmacokinetics;Risk Factors
22697192;Administration, Cutaneous;Adult;Adverse Drug Reaction Reporting Systems/statistics & numerical data;Aged;Depressive Disorder/drug therapy*;Drug Eruptions/etiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Female;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Selegiline/administration & dosage*;Selegiline/adverse effects;Self-Injurious Behavior/chemically induced;Tyramine/adverse effects*;United States
22669570;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Sirolimus/adverse effects;Sirolimus/analogs & derivatives*;Sirolimus/pharmacokinetics;Stomatitis/chemically induced;Time Factors;Tonsillitis/chemically induced;Young Adult
22668071;Animals;Capsaicin/pharmacology*;Capsicum*;Cholinesterase Inhibitors/pharmacokinetics*;Food-Drug Interactions*;Galantamine/pharmacokinetics*;Rats;Sensory System Agents/pharmacology*
22660441;Adult;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacology*;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacology*;Blood Pressure/drug effects*;Circadian Rhythm;Cross-Over Studies;Diet, High-Fat;Food-Drug Interactions;Humans;Male;Middle Aged;Models, Biological*;Pyrimidines/blood;Pyrimidines/pharmacology*;Tetrazoles/blood;Tetrazoles/pharmacology*;Young Adult
22652546;Administration, Oral;Caco-2 Cells;Chemical Precipitation;Computer Simulation*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Male;Models, Biological*;Permeability;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism;Solubility
22650326;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group*;China;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Least-Squares Analysis;Linear Models;Male;Metabolic Clearance Rate;Models, Biological;Postprandial Period;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/blood;Quinolones/pharmacokinetics*;Young Adult
22649154;Animals;Antioxidants/metabolism;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Antioxidants/therapeutic use*;Atherosclerosis/metabolism;Atherosclerosis/physiopathology;Atherosclerosis/prevention & control*;Atherosclerosis/therapy;Combined Modality Therapy;Dietary Supplements;Disease Progression;Evidence-Based Medicine*;Food-Drug Interactions;Humans;Oxidative Stress/drug effects
22648626;Animals;CCAAT-Enhancer-Binding Protein-beta/genetics*;CCAAT-Enhancer-Binding Protein-beta/metabolism;Capsaicin/pharmacology*;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions;Gene Expression Regulation/drug effects;Hep G2 Cells;Humans;Inactivation, Metabolic;Liver/drug effects;Liver/metabolism;Male;Nifedipine/analogs & derivatives;Nifedipine/blood;Nifedipine/pharmacokinetics;Promoter Regions, Genetic/drug effects;Proto-Oncogene Proteins c-akt/genetics;Proto-Oncogene Proteins c-akt/metabolism;Rats;Rats, Sprague-Dawley;Receptors, Steroid/genetics*;Receptors, Steroid/metabolism;Signal Transduction/drug effects;TRPV Cation Channels/metabolism;Up-Regulation
22648492;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Drug Administration Schedule;Drug Design*;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use;Humans;Time Factors;Venous Thromboembolism/drug therapy*;Venous Thromboembolism/pathology;Vitamin K/antagonists & inhibitors
22645121;Brain Injuries/therapy;Calcium/blood;Enteral Nutrition/methods;Evidence-Based Medicine*;Food-Drug Interactions;Humans;Hypocalcemia/diagnosis;Hypocalcemia/drug therapy;Hypocalcemia/physiopathology;Insulin/administration & dosage;Obesity/diet therapy;Pancreatitis/physiopathology;Pancreatitis/therapy;Phosphorus/administration & dosage;Renal Insufficiency, Chronic/drug therapy;Research*;Treatment Outcome;Warfarin/administration & dosage
22644797;Adult;Aged;Cross-Over Studies;Diarrhea/chemically induced;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Energy Intake*;Fasting;Fatigue/chemically induced;Female;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Indazoles/adverse effects;Indazoles/pharmacokinetics*;Male;Middle Aged;Nausea/chemically induced;Tablets;Young Adult
22634362;Alcoholic Intoxication/metabolism;Alcoholic Intoxication/prevention & control*;Animals;Anxiety/etiology;Anxiety/prevention & control*;Behavior, Animal/drug effects;Brain/drug effects*;Brain/metabolism;Dietary Supplements;Disease Models, Animal;Dose-Response Relationship, Drug;Ethanol/antagonists & inhibitors*;Ethanol/pharmacokinetics;Ethanol/poisoning;Exploratory Behavior/drug effects;Female;Food-Drug Interactions;Locomotion/drug effects;Male;Neurons/drug effects*;Neurons/metabolism;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/therapeutic use*;Taurine/administration & dosage;Taurine/therapeutic use*;Time Factors;Tissue Distribution/drug effects;Zebrafish
22615291;Adolescent;Adult;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Suspensions;Tablets;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
22585285;Administration, Oral;Adult;Antidiuretic Hormone Receptor Antagonists;Asian Continental Ancestry Group;Benzazepines/administration & dosage;Benzazepines/blood;Benzazepines/pharmacokinetics*;Benzazepines/urine;Cross-Over Studies;Diuretics/administration & dosage;Diuretics/blood;Diuretics/pharmacokinetics*;Diuretics/urine;European Continental Ancestry Group;Fasting/metabolism*;Food-Drug Interactions;Humans;Male;Middle Aged;Urine;Young Adult
22581486;Administration, Oral;Animals;Biological Availability;Cell Membrane Permeability;Dose-Response Relationship, Drug;Drug Discovery/methods*;Food-Drug Interactions;Humans;Intestinal Absorption;Models, Biological*;Mouth Mucosa/metabolism*;Nonlinear Dynamics;Permeability;Pharmaceutical Preparations*/administration & dosage;Pharmaceutical Preparations*/chemistry;Pharmaceutical Preparations*/metabolism;Solubility
22574741;Adrenergic beta-Antagonists/pharmacokinetics*;Adult;Atenolol/pharmacokinetics*;Beverages*;Cross-Over Studies;Food-Drug Interactions*;Genotype;Humans;Male;Malus*;Middle Aged;Organic Anion Transporters/genetics;Polymorphism, Single Nucleotide
22566187;Animals;Beverages;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Humans;Liver/drug effects;Liver/enzymology;Male;Midazolam/metabolism;Partial Thromboplastin Time;Polyphenols/pharmacology*;Psidium/chemistry*;Rats;Rats, Sprague-Dawley;Warfarin/pharmacology*
22554162;Drug Stability;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Humans;Nurses*;Pediatric Nursing*/education
22546295;Animals;Barium/pharmacokinetics;Biological Availability;Cellulose/chemistry;Cellulose/pharmacokinetics;Delayed-Action Preparations/chemistry;Delayed-Action Preparations/pharmacokinetics;Diagnostic Imaging;Dogs;Drug Compounding;Energy Intake;Fasting;Food-Drug Interactions;Gastric Emptying*;Hypromellose Derivatives;Lactose/chemistry;Lactose/pharmacokinetics;Male;Metformin/blood;Metformin/chemistry;Metformin/pharmacokinetics*;Methylcellulose/analogs & derivatives;Methylcellulose/chemistry;Methylcellulose/pharmacokinetics;Solubility;Stearic Acids/chemistry;Stearic Acids/pharmacokinetics
22543167;Administration, Oral;Animals;Benzoates/pharmacokinetics*;Bridged-Ring Compounds/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Eating;Female;Food-Drug Interactions;Glucosides/pharmacokinetics*;Male;Monoterpenes;Rats;Rats, Sprague-Dawley;Sex Factors
22530414;Anticoagulants/adverse effects*;Beverages/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;International Normalized Ratio;Punicaceae/adverse effects*;Warfarin/adverse effects*
22530306;Animals;Area Under Curve;Beverages*;Calibration;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Half-Life;Indicators and Reagents;Isoenzymes/metabolism;Limit of Detection;Male;Mass Spectrometry;Pharmaceutical Preparations/metabolism;Rats;Rats, Wistar;Reference Standards;Regression Analysis
22530299;Algorithms;Area Under Curve;Beverages*;Citrus paradisi*;Data Interpretation, Statistical;Dihydropyridines/chemistry;Dihydropyridines/pharmacology*;Food-Drug Interactions*;Least-Squares Analysis;Models, Statistical;Quantitative Structure-Activity Relationship;Regression Analysis
22528540;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Ascorbic Acid/administration & dosage;Ascorbic Acid/adverse effects*;Dietary Supplements/adverse effects*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypervitaminosis A/chemically induced*;Vitamin A/administration & dosage;Vitamin A/adverse effects*;Vitamin E/administration & dosage;Vitamin E/adverse effects*;beta Carotene/administration & dosage;beta Carotene/adverse effects*
22527288;Adolescent;Adult;Aged;Aged, 80 and over;Ascorbic Acid/administration & dosage;Ascorbic Acid/blood*;Diet;Dietary Supplements*;Female;Folic Acid/administration & dosage;Folic Acid/blood*;Food-Drug Interactions;Gene Expression Regulation;Genotype;Humans;Male;Methylenetetrahydrofolate Reductase (NADPH2)/genetics*;Methylenetetrahydrofolate Reductase (NADPH2)/metabolism;Middle Aged;Nutritional Status*;Polymorphism, Single Nucleotide;Risk Factors;Surveys and Questionnaires;Young Adult
22522225;Administration, Oral;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Drug Combinations;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Lopinavir/administration & dosage;Lopinavir/blood;Lopinavir/pharmacokinetics*;Male;Postprandial Period;Ritonavir/administration & dosage;Ritonavir/blood;Ritonavir/pharmacokinetics*;Sex Factors;Therapeutic Equivalency;Uruguay;Young Adult
22514335;Animals;Benzo(a)pyrene/adverse effects;Charcoal/metabolism*;Clinical Trials as Topic;Coffee*;Food-Drug Interactions*;Humans;Inactivation, Metabolic;Male;Meat/adverse effects;Methylcholanthrene/adverse effects;Mice;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Polycyclic Aromatic Hydrocarbons/adverse effects;Rats;Smoking/adverse effects;Smoking/metabolism*
22504108;Cardiotonic Agents/pharmacology*;Contraindications;Critical Care/methods*;Enteral Nutrition*;Food-Drug Interactions*;Gastrointestinal Tract/blood supply;Gastrointestinal Tract/drug effects;Hemodynamics;Humans;Vasoconstrictor Agents/pharmacology*
22499231;Animals;Beverages*/analysis;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Enzyme Induction;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Food-Drug Interactions;Fruit*/chemistry;Fruit*/growth & development;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Thailand;Up-Regulation
22495943;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/therapeutic use*;Arthroplasty, Replacement, Hip;Arthroplasty, Replacement, Knee;Atrial Fibrillation/blood;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Factor Xa Inhibitors;Food-Drug Interactions;Formularies, Hospital*;Humans;Prothrombin/antagonists & inhibitors;Stroke/blood;Stroke/prevention & control;Thromboembolism/blood;Thromboembolism/etiology;Thromboembolism/prevention & control*
22490669;Blotting, Western;Cell Line, Tumor;Cytochrome P-450 CYP1A1/physiology*;Cytochrome P-450 CYP1A2/physiology;Food-Drug Interactions;Genes, Reporter/drug effects;Hepatocytes/drug effects*;Humans;Intestinal Neoplasms/pathology;Liver Neoplasms/pathology;Male;Middle Aged;Mineral Waters*;Real-Time Polymerase Chain Reaction;Receptors, Aryl Hydrocarbon/physiology*;Signal Transduction/drug effects;Transcription, Genetic/drug effects
22480286;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Benzimidazoles*/pharmacokinetics;Benzimidazoles*/therapeutic use;Clinical Trials as Topic;Dabigatran;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Molecular Structure;Stroke/blood;Stroke/prevention & control*;Thromboembolism/blood;Thromboembolism/prevention & control*;Treatment Outcome;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
22465646;Abdominal Pain/etiology;Citrus paradisi*;Colectomy;Electrocardiography;Female;Food-Drug Interactions*;Humans;Intestines/surgery;Ischemia/chemically induced*;Ischemia/surgery;Middle Aged;Multiple Organ Failure/complications;Piperidines/adverse effects*;Serotonin Agents/adverse effects*;Shock/drug therapy;Shock/etiology;Splanchnic Circulation/physiology*;Tryptamines/adverse effects*
22456303;Administration, Oral;Adolescent;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;GABA Agonists/administration & dosage*;GABA Agonists/adverse effects;GABA Agonists/blood;GABA Agonists/pharmacokinetics*;Humans;Linear Models;Male;Middle Aged;Phosphinic Acids/administration & dosage*;Phosphinic Acids/adverse effects;Phosphinic Acids/blood;Phosphinic Acids/pharmacokinetics*;Propylamines/administration & dosage*;Propylamines/adverse effects;Propylamines/blood;Propylamines/pharmacokinetics*;Young Adult
22456294;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adult;Analysis of Variance;Area Under Curve;Asian Continental Ancestry Group*;Biomarkers/blood;Blood Glucose/drug effects*;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/ethnology;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Administration Schedule;Drug Monitoring;Eating*;Feeding Behavior*;Female;Food-Drug Interactions*;Glucagon-Like Peptide 1/blood;Humans;Intestinal Absorption;Japan/epidemiology;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Postprandial Period;Pyrrolidines/administration & dosage*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Treatment Outcome
22420652;Acetaminophen/adverse effects;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Biological Availability;Fasting;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/prevention & control*;Humans;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects;Nonprescription Drugs/pharmacokinetics
22420520;Biological Availability;Food-Drug Interactions*;Humans;Long-Term Care*;Pharmacokinetics
22417366;Biological Availability;Biological Transport*;Citrus/metabolism;Citrus paradisi/metabolism;Citrus sinensis/metabolism;Food-Drug Interactions*;Fruit/metabolism*;Humans;Inactivation, Metabolic*;Malus/metabolism;Medicine, Traditional;Morus/metabolism;Nutritive Value;Plant Extracts/pharmacokinetics*;Punicaceae/metabolism;Risk Factors;Vegetables/metabolism*;Vitis/metabolism
22417333;Beverages/analysis*;Citrus paradisi/chemistry*;Food Storage/methods*;Food-Drug Interactions;Fruit/chemistry;Furocoumarins/analysis*;Linear Models
22394605;1-Methyl-4-phenylpyridinium/pharmacokinetics;Apigenin/pharmacology;Atorvastatin Calcium;Biological Transport/drug effects;Flavanones/blood;Flavanones/pharmacology;Flavonoids/blood;Flavonoids/pharmacology*;Food-Drug Interactions;HEK293 Cells;Hepatocytes/metabolism*;Heptanoic Acids/pharmacokinetics;Humans;Inhibitory Concentration 50;Kaempferols/blood;Kaempferols/pharmacology;Metformin/pharmacokinetics;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/metabolism;Organic Cation Transporter 1/antagonists & inhibitors*;Organic Cation Transporter 1/metabolism;Pyrroles/pharmacokinetics;Quercetin/blood;Quercetin/pharmacology;Rutin/blood;Rutin/pharmacology;Solute Carrier Organic Anion Transporter Family Member 1B3;Solute Carrier Organic Anion Transporter Family Member 1b1;Sulfobromophthalein/pharmacokinetics;Tritium/pharmacokinetics
22390368;Administration, Oral;Aged;Asian Continental Ancestry Group;Delayed-Action Preparations;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/blood;Dopamine Agonists/pharmacokinetics;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Levodopa/administration & dosage;Male;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism*;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics
22375877;Animals;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Aryl Hydrocarbon Hydroxylases/drug effects;Capsaicin*/administration & dosage;Capsaicin*/analogs & derivatives;Capsaicin*/chemistry;Capsaicin*/pharmacology;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP2E1/drug effects;Cytochrome P-450 CYP2E1 Inhibitors;Cytochrome P-450 CYP3A Inhibitors*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Inhibitory Concentration 50;Liver/enzymology;Male;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology*;Molecular Structure;Rats;Rats, Wistar
22365344;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
22356441;Administration, Oral;Animals;Anti-HIV Agents/chemistry;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/pharmacology*;Dietary Fats/administration & dosage;Dogs;Food-Drug Interactions;HIV-1/drug effects*;HIV-1/physiology;Haplorhini;Humans;Organophosphates/chemistry;Organophosphates/pharmacokinetics;Organophosphates/pharmacology*;Piperazines/chemistry;Piperazines/pharmacokinetics;Piperazines/pharmacology*;Prodrugs/chemistry;Prodrugs/pharmacokinetics;Prodrugs/pharmacology*;Rats;Solubility;Virus Attachment/drug effects*
22349808;Administration, Oral;Adult;Area Under Curve;Capsules;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Female;Food-Drug Interactions*;Headache/chemically induced;Humans;Male;Metabolic Clearance Rate;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Young Adult
22344702;Amino Acid Substitution;Apoenzymes/metabolism;Beverages*;Binding Sites;Chromatography, Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/chemistry;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A Inhibitors*;Electrophoresis, Polyacrylamide Gel;Escherichia coli/genetics;Food-Drug Interactions*;Furocoumarins/metabolism*;Furocoumarins/pharmacology*;Glutathione/metabolism;Humans;Mutagenesis, Site-Directed;Plasmids;Protein Binding;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry
22336488;Administration, Oral;Adolescent;Adult;Benzoates/administration & dosage;Benzoates/blood;Benzoates/pharmacokinetics*;Benzoates/pharmacology;Biological Availability;Calcium/metabolism*;Cross-Over Studies;Female;Food*;Food-Drug Interactions*;Humans;Hydrazines/administration & dosage;Hydrazines/blood;Hydrazines/pharmacokinetics*;Hydrazines/pharmacology;Male;Middle Aged;Powders;Pyrazoles/administration & dosage;Pyrazoles/blood;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology;Receptors, Thrombopoietin/agonists;Suspensions;Tablets;Time Factors;Young Adult
22331950;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Prostatic Neoplasms/drug therapy*
22331942;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Prostatic Neoplasms/drug therapy*
22324070;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control;Dabigatran;Drug Approval*;Drug Interactions;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Humans;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/therapeutic use;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/therapeutic use;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/therapeutic use;Pyridones/administration & dosage;Pyridones/adverse effects;Pyridones/therapeutic use;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use*
22309266;Animals;Antibiotics, Antineoplastic/pharmacokinetics*;Area Under Curve;Creatine Kinase/blood;Diet, Protein-Restricted*;Doxorubicin/pharmacokinetics*;Drug Combinations;Epirubicin/pharmacokinetics*;Food-Drug Interactions;Heart/drug effects*;Humans;Injections, Intraperitoneal;Male;Models, Animal;Myocytes, Cardiac/drug effects;Myocytes, Cardiac/metabolism;Protein-Energy Malnutrition/metabolism*;Random Allocation;Rats;Risk Factors
22309265;Administration, Oral;Adult;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Blood Pressure/drug effects;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;KATP Channels/metabolism*;Male;Propylamines/administration & dosage;Propylamines/adverse effects;Propylamines/pharmacokinetics*;Sex Factors;Young Adult
22308076;Animals;Beverages;Citrus paradisi/chemistry*;Drug Synergism;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Intestinal Absorption;Intestines/drug effects;Lopinavir/administration & dosage;Lopinavir/pharmacokinetics*;Male;Microsomes/drug effects;Rats;Rats, Wistar;Ritonavir/administration & dosage;Ritonavir/chemistry*
22300396;Adult;Aged;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Biological Availability;Drug Interactions;Female;Food-Drug Interactions;Gastrointestinal Transit;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Models, Biological*;Nevirapine/administration & dosage;Nevirapine/pharmacokinetics*;Nonlinear Dynamics;Regression Analysis;South Africa;Young Adult
22294059;Area Under Curve;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Data Interpretation, Statistical;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/adverse effects;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dihydropyridines/administration & dosage*;Dihydropyridines/blood;Dihydropyridines/chemistry;Dihydropyridines/pharmacokinetics*;Drug Administration Schedule;Drug Labeling*;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Pilot Projects;Stereoisomerism;Therapeutic Equivalency;Time Factors
22286159;Adult;Aged;Aryl Hydrocarbon Hydroxylases/metabolism;Beverages*;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP2B6;Cytochrome P-450 CYP3A/metabolism;Female;Food-Drug Interactions*;Humans;Ketamine/administration & dosage;Ketamine/analogs & derivatives;Ketamine/blood;Ketamine/pharmacokinetics*;Male;Middle Aged;Oxidoreductases, N-Demethylating/metabolism;Young Adult
22271001;Animals;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Dogs;Eating;Fasting/metabolism;Female;Food-Drug Interactions*;Intestinal Absorption;Male;Tablets;Time Factors
22265646;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
22232462;Administration, Oral;Adult;Antinematodal Agents/administration & dosage;Antinematodal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Macrolides/administration & dosage;Macrolides/pharmacokinetics;Male;Middle Aged;Young Adult
22231999;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Atrial Fibrillation/drug therapy;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Vaccinium macrocarpon/adverse effects*;Warfarin/metabolism;Warfarin/therapeutic use*
22230932;Amlodipine/pharmacology;Antihypertensive Agents/pharmacology*;Biological Availability;Copper/pharmacokinetics;Digestion;Fagopyrum/chemistry*;Food-Drug Interactions*;Indapamide/pharmacology;Iron/pharmacokinetics;Magnesium/pharmacokinetics;Pancreatin/metabolism;Pepsin A/metabolism;Perindopril/pharmacology;Spectrophotometry, Atomic;Trace Elements/pharmacokinetics*;Zinc/pharmacokinetics
22217686;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Breast Neoplasms/drug therapy*;Drug Administration Schedule;Drug Interactions;Drug-Related Side Effects and Adverse Reactions/diagnosis*;Female;Food-Drug Interactions;Humans;Hungary;Medication Adherence*;Molecular Targeted Therapy*
22216470;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
22213574;Amyloid Precursor Protein Secretases/antagonists & inhibitors*;Animals;Area Under Curve;Biological Availability;Biopharmaceutics;Cell Line;Chemistry, Pharmaceutical;Dogs;Food-Drug Interactions*;Nanoparticles/chemistry*;Protease Inhibitors/chemistry*;Protease Inhibitors/pharmacokinetics*;Pyrazoles/chemistry*;Pyrazoles/pharmacokinetics;Quinolines/chemistry*;Quinolines/pharmacokinetics;Solubility;Suspensions;X-Ray Diffraction
22206795;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/urine;Area Under Curve;Biotransformation;Cross-Over Studies;Double-Blind Method;Feces/chemistry;Female;Food-Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate;Metabolomics;Middle Aged;Models, Biological;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/urine;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/urine;Quinazolines/administration & dosage;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolines/urine;United Kingdom;Young Adult
22199125;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics*;Animals;Base Sequence;Brassica*;Chromatography, Liquid;DNA Primers;Food-Drug Interactions*;Glucuronosyltransferase/genetics;Male;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Real-Time Polymerase Chain Reaction
22183173;Administration, Oral;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats/metabolism*;Fasting;Female;Food-Drug Interactions*;HIV Integrase Inhibitors/blood;HIV Integrase Inhibitors/pharmacokinetics*;Half-Life;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Intestinal Absorption;Male;Middle Aged;Tandem Mass Spectrometry
22167571;Administration, Oral;Biological Availability;Boswellia*;Cathepsin G/metabolism;Computer Simulation;Cross-Over Studies;Eicosanoids/blood;Fasting/physiology;Food-Drug Interactions*;Humans;Male;Meals;Models, Biological;Plant Extracts/administration & dosage*;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Platelet Aggregation/drug effects;Triterpenes/administration & dosage;Triterpenes/blood;Triterpenes/pharmacokinetics*
22167566;Adenosine A2 Receptor Antagonists/administration & dosage;Adenosine A2 Receptor Antagonists/blood;Adenosine A2 Receptor Antagonists/pharmacokinetics*;Administration, Oral;Adult;Biological Availability;Capsules;Cross-Over Studies;Diet, High-Fat*;Energy Intake;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
22162540;Adult;Biological Availability;Breakfast;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics;Fasting/metabolism;Food-Drug Interactions*;Humans;Male;Tablets;Therapeutic Equivalency;Trimetazidine/administration & dosage;Trimetazidine/blood;Trimetazidine/pharmacokinetics*;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*;Young Adult
22149151;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/analogs & derivatives*;Diclofenac/pharmacokinetics;Dietary Fats;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Republic of Korea;Therapeutic Equivalency;Young Adult
22108488;Dietary Supplements*/adverse effects;Food-Drug Interactions;Humans;Preventive Medicine
22137263;ATP Binding Cassette Transporter 1;ATP-Binding Cassette Transporters/genetics;ATP-Binding Cassette Transporters/metabolism;Adenocarcinoma/diet therapy;Adenocarcinoma/drug therapy*;Adenocarcinoma/metabolism;Antineoplastic Agents/agonists;Antineoplastic Agents/pharmacology*;Antineoplastic Agents, Phytogenic/agonists;Antineoplastic Agents, Phytogenic/metabolism;Carotenoids/agonists;Carotenoids/metabolism*;Cell Line, Tumor;Cell Proliferation/drug effects;Cholesterol/metabolism;Dietary Supplements;Food-Drug Interactions;Gene Expression Regulation, Neoplastic/drug effects;Humans;Hydrocarbons, Fluorinated/agonists;Hydrocarbons, Fluorinated/pharmacology*;Liver X Receptors;Male;Neoplasm Proteins/agonists;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/genetics;Neoplasm Proteins/metabolism;Orphan Nuclear Receptors/agonists*;Orphan Nuclear Receptors/antagonists & inhibitors;Orphan Nuclear Receptors/genetics;Orphan Nuclear Receptors/metabolism*;Osmolar Concentration;PPAR gamma/antagonists & inhibitors;PPAR gamma/genetics;PPAR gamma/metabolism;Prostatic Neoplasms/diet therapy;Prostatic Neoplasms/drug therapy*;Prostatic Neoplasms/metabolism;RNA Interference;RNA, Messenger/metabolism;RNA, Small Interfering;Sulfonamides/agonists;Sulfonamides/pharmacology*
22137030;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antioxidants/administration & dosage;Antioxidants/analysis;Antioxidants/therapeutic use*;Dietary Supplements*;Fatty Acids, Omega-3/therapeutic use;Fish Oils/therapeutic use*;Food-Drug Interactions*;Gene Expression Regulation/drug effects;Haptoglobins/genetics;Haptoglobins/metabolism;Hepatic Insufficiency/etiology;Hepatic Insufficiency/prevention & control;Injections, Intraperitoneal;Liver/drug effects*;Liver/metabolism;Liver/pathology;Liver/physiopathology;Male;NF-kappa B/genetics;NF-kappa B/metabolism;Oxidative Stress/drug effects;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Reperfusion Injury/metabolism;Reperfusion Injury/pathology;Reperfusion Injury/physiopathology;Reperfusion Injury/prevention & control*;Triiodothyronine/administration & dosage;Triiodothyronine/blood;Triiodothyronine/therapeutic use*;Tumor Necrosis Factor-alpha/genetics;Tumor Necrosis Factor-alpha/metabolism
22133697;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Dopamine Antagonists/administration & dosage*;Dopamine Antagonists/adverse effects;Dopamine Antagonists/pharmacokinetics*;Dopamine D2 Receptor Antagonists;Dose-Response Relationship, Drug;Evidence-Based Medicine;Food-Drug Interactions;Humans;Patient Selection;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/diagnosis;Psychotic Disorders/drug therapy*;Psychotic Disorders/metabolism;Psychotic Disorders/psychology;Receptors, Dopamine D2/metabolism;Risk Assessment;Thiazoles/administration & dosage*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Treatment Outcome
22129569;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group*;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/blood;Cardiovascular Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Republic of Korea;Tetrazoles/administration & dosage*;Tetrazoles/adverse effects;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Therapeutic Equivalency;Young Adult
22129380;Animals;Antioxidants/administration & dosage;Antioxidants/analysis;Beverages/adverse effects;Beverages/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Flavonoids/administration & dosage;Flavonoids/analysis;Food-Drug Interactions;Fruit*/chemistry;Functional Food*/adverse effects;Functional Food*/analysis;Humans;Phenols/administration & dosage;Phenols/analysis;Punicaceae*/chemistry
22128201;Adenosine Diphosphate;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/genetics;Breakfast;Cross-Over Studies;Cytochrome P-450 CYP2C19;Diet, High-Fat;Food-Drug Interactions*;Genotype;Humans;Male;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/administration & dosage*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/blood;Ticlopidine/pharmacokinetics;Young Adult
22124880;Adult;Amides/adverse effects;Amides/blood;Amides/metabolism;Amides/pharmacokinetics*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics*;Beverages/adverse effects*;Beverages/analysis;Biological Transport/drug effects;Citrus paradisi/chemistry*;Cross-Over Studies;Flavanones/analysis;Flavanones/pharmacology;Food-Drug Interactions*;Fruit/chemistry;Fumarates/adverse effects;Fumarates/blood;Fumarates/metabolism;Fumarates/pharmacokinetics*;HEK293 Cells;Half-Life;Humans;Intestinal Mucosa/enzymology*;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Recombinant Proteins/antagonists & inhibitors;Recombinant Proteins/metabolism;Renin/antagonists & inhibitors;Terfenadine/analogs & derivatives;Terfenadine/metabolism;Young Adult
22123127;Animals;Beverages*;Citrus*;Citrus paradisi/metabolism;Curcuma/metabolism*;Food-Drug Interactions/physiology*;Ginger/metabolism*;Male;Plant Extracts/metabolism*;Rats;Rats, Sprague-Dawley;Tacrolimus/metabolism*
22122815;Adolescent;Adult;Antidepressive Agents, Second-Generation/administration & dosage*;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics;Area Under Curve;Biological Availability;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/blood;Trazodone/administration & dosage*;Trazodone/adverse effects;Trazodone/pharmacokinetics
22120090;Adult;Antidiuretic Hormone Receptor Antagonists*;Area Under Curve;Arginine Vasopressin/blood;Asian Continental Ancestry Group;Benzazepines/blood;Benzazepines/pharmacokinetics*;Benzazepines/pharmacology;Benzazepines/urine;Cross-Over Studies;Diuretics/blood;Diuretics/pharmacokinetics*;Diuretics/pharmacology;Diuretics/urine;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Humans;Male;Potassium/blood;Sodium/blood;Young Adult
22114852;Animals;Clinical Trials as Topic/methods;Contraceptive Agents/administration & dosage;Contraceptive Agents/pharmacokinetics;Contraceptives, Postcoital/administration & dosage*;Contraceptives, Postcoital/pharmacokinetics*;Drug Interactions/physiology;Female;Food-Drug Interactions/physiology;Humans;Norpregnadienes/administration & dosage*;Norpregnadienes/pharmacokinetics*;Receptors, Progesterone/physiology;Unsafe Sex/drug effects;Unsafe Sex/physiology
22101410;Administration, Oral;Animals;Area Under Curve;Beverages*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Half-Life;Male;Nitrendipine/pharmacokinetics*;Punicaceae/chemistry*;Rabbits;Time Factors
22085278;Animals;Beverages;Biological Transport;Caco-2 Cells;Cimetidine/pharmacokinetics*;Dietary Supplements;Food-Drug Interactions*;Fruit/chemistry;Humans;Intestinal Absorption*;Jejunum/metabolism;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Swine;Vegetables/chemistry;Verapamil
22058101;4-Aminopyridine/administration & dosage;4-Aminopyridine/adverse effects;4-Aminopyridine/pharmacokinetics*;Adolescent;Adult;Analysis of Variance;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Fasting/physiology;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Multiple Sclerosis/drug therapy*;Potassium Channel Blockers/administration & dosage;Potassium Channel Blockers/adverse effects;Potassium Channel Blockers/pharmacokinetics;Prospective Studies;Sex Factors;Walking/physiology;Young Adult
22057852;Administration, Oral;Adult;Aged;Aged, 80 and over;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Drug Administration Schedule;Eating;Fasting;Fatigue/chemically induced;Female;Food*;Food-Drug Interactions;Histone Deacetylase Inhibitors/administration & dosage;Histone Deacetylase Inhibitors/adverse effects;Histone Deacetylase Inhibitors/pharmacokinetics*;Humans;Hydroxamic Acids/administration & dosage;Hydroxamic Acids/adverse effects;Hydroxamic Acids/pharmacokinetics*;Indoles;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Treatment Outcome;Vomiting/chemically induced
22040889;Adult;Area Under Curve;Ascorbic Acid/blood;Ascorbic Acid/pharmacokinetics*;Ascorbic Acid/urine;Beverages;Dose-Response Relationship, Drug;Flavonoids/pharmacology;Food-Drug Interactions*;Fruit/chemistry*;Humans;Intestinal Absorption*;Japan;Male;Malpighiaceae/chemistry*;Plant Preparations/chemistry;Plant Preparations/pharmacology*;Reference Values;Vitamins/blood;Vitamins/pharmacokinetics*;Vitamins/urine;Young Adult
22039822;Area Under Curve;Beverages;Calcium Channel Blockers/chemistry*;Calcium Channel Blockers/pharmacology*;Citrus paradisi*;Cytochrome P-450 CYP3A/chemistry;Cytochrome P-450 CYP3A/metabolism;Dihydropyridines/chemistry*;Dihydropyridines/pharmacology*;Food-Drug Interactions*;Humans;Intestines/metabolism;Quantitative Structure-Activity Relationship
22031686;Adult;Aged;Calcium Channel Blockers/adverse effects;Citrus paradisi/adverse effects*;Cross-Sectional Studies;Drug-Related Side Effects and Adverse Reactions*;Emergency Medical Services;Female;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Male;Middle Aged;Pharmacovigilance;Risk
22031621;Adult;Biological Availability;Cross-Over Studies;Female;Food;Food-Drug Interactions*;Humans;Male;Middle Aged;Piperidines/administration & dosage*;Piperidines/blood;Piperidines/pharmacokinetics*;Pyrroles/administration & dosage*;Pyrroles/blood;Pyrroles/pharmacokinetics*;Receptor, Epidermal Growth Factor/antagonists & inhibitors;Receptor, ErbB-2/antagonists & inhibitors;Triazines/administration & dosage*;Triazines/blood;Triazines/pharmacokinetics*;Vascular Endothelial Growth Factor A/antagonists & inhibitors
22029224;Adult;Benzilates/blood*;Benzilates/pharmacokinetics*;Calibration;Chemistry, Pharmaceutical;Cholinergic Antagonists/blood*;Cholinergic Antagonists/pharmacokinetics*;Chromatography, High Pressure Liquid;Delayed-Action Preparations;Female;Food-Drug Interactions;Half-Life;Humans;Male;Quality Control;Reference Standards;Reproducibility of Results;Sex Characteristics;Solutions;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Young Adult
22020317;Administration, Oral;Adult;Aged;Aged, 80 and over;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics*;Antimetabolites, Antineoplastic/therapeutic use;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Oxonic Acid/administration & dosage;Oxonic Acid/adverse effects;Oxonic Acid/pharmacokinetics*;Oxonic Acid/therapeutic use;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacology*;Proton Pump Inhibitors/therapeutic use;Tegafur/administration & dosage;Tegafur/adverse effects;Tegafur/pharmacokinetics*;Tegafur/therapeutic use;Treatment Outcome
22016977;Contraindications;Documentation*;Drug Administration Schedule;Drug Compounding/standards*;Drug Dosage Calculations;Drug Prescriptions/standards;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/standards*;Female;Food-Drug Interactions;Humans;Pregnancy;Terminology as Topic
22001672;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Cell Line, Tumor;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/toxicity*;Food-Drug Interactions*;Humans;Limonins/toxicity*;Microsomes, Liver;Tandem Mass Spectrometry
23251982;Drug Administration Routes*;Drug Interactions;Enteral Nutrition*;Food-Drug Interactions;United Kingdom
21973269;Administration, Oral;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/pharmacology;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Carbonated Beverages;Cross-Over Studies;Drug Interactions;Esomeprazole/administration & dosage;Esomeprazole/pharmacology;Female;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Male;Triazoles/administration & dosage;Triazoles/blood;Triazoles/chemistry;Triazoles/pharmacokinetics*;Young Adult
21967645;Adenosine/analogs & derivatives*;Adenosine/pharmacokinetics;Administration, Oral;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage;Female;Food-Drug Interactions*;Humans;Least-Squares Analysis;Male;Middle Aged;Purinergic P2Y Receptor Antagonists/pharmacokinetics*;Time Factors;Young Adult
21961887;Absorption/physiology;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Age Factors;Antipyretics/administration & dosage;Antipyretics/pharmacokinetics*;Area Under Curve;Biological Availability;Child;Child, Preschool;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Fasting;Food-Drug Interactions;Humans;Infant;Male;Suspensions/administration & dosage;Suspensions/pharmacokinetics*;Therapeutic Equivalency;Young Adult
21959701;Acenocoumarol/administration & dosage;Administration, Oral;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Case-Control Studies;Diet*;Female;Food-Drug Interactions;Humans;International Normalized Ratio/statistics & numerical data*;Male;Middle Aged;Retrospective Studies;Seasons;Single Person;Spouses*;Vitamin K/administration & dosage*;Vitamins/administration & dosage*;Warfarin/administration & dosage
23256289;Alcohol Drinking/adverse effects;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Aripiprazole;Combined Modality Therapy;Depressive Disorder/drug therapy;Dietary Supplements/adverse effects*;Food*;Food-Drug Interactions*;Humans;Male;Malnutrition/chemically induced*;Malnutrition/diagnosis;Malnutrition/prevention & control;Middle Aged;Piperazines/adverse effects;Piperazines/therapeutic use;Prescription Drugs/adverse effects*;Quinolones/adverse effects;Quinolones/therapeutic use
21942630;ATP-Binding Cassette Transporters/metabolism;Animals;Biological Transport;Carrier Proteins/metabolism*;Diet;Drug Design;Drug Interactions*;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Models, Animal;Multidrug Resistance-Associated Proteins/metabolism;Pharmaceutical Preparations/metabolism;Pharmacogenetics;Polymorphism, Genetic
21936891;Animals;Atherosclerosis/prevention & control;Cholesterol/blood;Cholesterol/metabolism;Cholesterol, Dietary/adverse effects;Cholesterol, HDL/blood*;Cholic Acid/adverse effects;Combined Modality Therapy;Dietary Supplements*;Fluorobenzenes/antagonists & inhibitors*;Fluorobenzenes/therapeutic use;Food-Drug Interactions*;Globulins/isolation & purification;Globulins/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hypercholesterolemia/blood;Hypercholesterolemia/diet therapy*;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Lipoproteins/metabolism;Liver/metabolism;Male;Pyrimidines/antagonists & inhibitors*;Pyrimidines/therapeutic use;Rats;Rats, Wistar;Risk Factors;Rosuvastatin Calcium;Soybean Proteins/isolation & purification;Soybean Proteins/therapeutic use*;Sulfonamides/antagonists & inhibitors*;Sulfonamides/therapeutic use;Triglycerides/metabolism
21931020;Abiraterone Acetate;Androstadienes/administration & dosage;Androstadienes/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics*;Drug Labeling/standards;Food-Drug Interactions*;Humans;Male;Prostatic Neoplasms/drug therapy*;Prostatic Neoplasms/metabolism;United States;United States Food and Drug Administration
21910510;Administration, Oral;Adult;Angiotensin I/blood;Angiotensin II/blood;Angiotensin II Type 1 Receptor Blockers/adverse effects*;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Angiotensin II Type 1 Receptor Blockers/urine;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Biphenyl Compounds/adverse effects*;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Biphenyl Compounds/urine;Blood Pressure/drug effects;Dizziness/chemically induced;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Pyrimidines/adverse effects*;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/urine;Renin/blood;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Tetrazoles/urine;Young Adult
21909143;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation*;Humans;Myocardial Infarction/blood;Myocardial Infarction/drug therapy*;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Platelet Count;Thrombocytopenia/blood;Thrombocytopenia/drug therapy*;Thrombosis/blood;Thrombosis/drug therapy*;Transplantation, Homologous
21898126;1-Deoxynojirimycin/administration & dosage;1-Deoxynojirimycin/analogs & derivatives*;Blood Glucose/metabolism;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Dipeptidyl-Peptidase IV Inhibitors/therapeutic use*;Drug Administration Schedule;Drug Therapy, Combination;Female;Food-Drug Interactions;Glucagon/blood;Glucagon-Like Peptide 1/blood*;Humans;Hypoglycemic Agents/therapeutic use*;Insulin/blood;Male;Middle Aged;Postprandial Period;Pyrazines/administration & dosage*;Sitagliptin Phosphate;Triazoles/administration & dosage*
21896619;Addison Disease/blood*;Addison Disease/drug therapy;Adult;Aged;Beverages*;Citrus paradisi/physiology*;Cortisone/analogs & derivatives*;Cortisone/metabolism;Cortisone/therapeutic use;Female;Food-Drug Interactions/physiology*;Glycyrrhiza/physiology*;Humans;Hydrocortisone/biosynthesis;Hydrocortisone/blood*;Male;Middle Aged;Up-Regulation/physiology
21874525;Administration, Oral;Animals;Biological Availability;Blood Glucose/drug effects;Chenodeoxycholic Acid/analogs & derivatives;Cholic Acids/administration & dosage;Cholic Acids/pharmacokinetics*;Chromatography, High Pressure Liquid/methods;Diabetes Mellitus, Experimental/drug therapy*;Diabetes Mellitus, Experimental/metabolism;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 1/metabolism;Drug Therapy, Combination;Food-Drug Interactions;Gliclazide/administration & dosage;Gliclazide/pharmacokinetics*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Injections, Intravenous;Male;Probiotics/pharmacology*;Random Allocation;Rats;Rats, Wistar
21872931;Administration, Oral;Adolescent;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Anti-HIV Agents/therapeutic use;Biological Availability;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions*;HIV Infections/blood;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1/isolation & purification*;Humans;Male;Medication Adherence;Middle Aged;Nevirapine/administration & dosage;Nevirapine/blood;Nevirapine/pharmacokinetics*;Nevirapine/therapeutic use;Young Adult
21856591;Adult;Carica/adverse effects*;Food-Drug Interactions;Goiter, Nodular/surgery;Humans;Hypothyroidism/complications*;Hypothyroidism/drug therapy*;Intestinal Absorption;Male;Thyroidectomy;Thyrotropin/blood;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*;Triiodothyronine/blood
21853290;Adolescent;Adult;Antidiuretic Hormone Receptor Antagonists;Benzazepines/blood;Benzazepines/pharmacokinetics*;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Diuretics/blood;Diuretics/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Young Adult
21852006;Adolescent;Adult;Beverages/adverse effects;Caffeine/adverse effects;Caffeine/blood*;Coffee*/adverse effects;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Warfarin/blood*
21843611;Acetaminophen/administration & dosage*;Acetaminophen/chemistry;Administration, Oral;Capsules;Carrageenan/chemistry;Excipients/chemistry*;Fasting;Food-Drug Interactions;Humans;Hypromellose Derivatives;In Vitro Techniques;Methylcellulose/analogs & derivatives*;Methylcellulose/chemistry;Models, Biological*;Polysaccharides, Bacterial/chemistry;Radionuclide Imaging/methods;Solubility
21831129;Acute Coronary Syndrome/drug therapy*;Acute Coronary Syndrome/physiopathology;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Thrombosis/prevention & control*;Vitamin K/antagonists & inhibitors
21819239;Administration, Oral;Anticoagulants/pharmacology*;Antithrombins/adverse effects;Antithrombins/therapeutic use*;Factor Xa Inhibitors;Food-Drug Interactions;Hemostatics/metabolism;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Pharmacogenetics;Prothrombin/antagonists & inhibitors;Thrombin/therapeutic use;Thrombosis/drug therapy;Vitamin K/antagonists & inhibitors;Warfarin/adverse effects;Warfarin/therapeutic use*
21819160;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Cross-Over Studies;Delayed-Action Preparations;Dipeptides/administration & dosage;Dipeptides/adverse effects;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Combinations;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/administration & dosage;Metformin/adverse effects;Metformin/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
21812328;Antioxidants/analysis;Beverages/adverse effects*;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Female;Flavanones/analysis;Food-Drug Interactions/physiology*;Forecasting;Furocoumarins/analysis;Humans;In Vitro Techniques;Linear Models;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Models, Statistical;Oxidation-Reduction;Testosterone/metabolism
21805622;Esterification;Flavones/chemistry;Flavones/metabolism;Flavonoids/chemistry*;Flavonoids/metabolism*;Flavonols/chemistry;Flavonols/metabolism;Food-Drug Interactions;Free Radical Scavengers/chemistry*;Free Radical Scavengers/metabolism*;Glucosides/chemistry;Glucosides/metabolism;Glycosylation;Hydrogenation;Hydroxylation;Kinetics;Methylation;Milk Proteins/metabolism*;Polyphenols/chemistry;Polyphenols/metabolism;Protein Binding;Stilbenes/chemistry*;Stilbenes/metabolism*;Structure-Activity Relationship
21803422;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Linagliptin;Male;Middle Aged;Purines/adverse effects;Purines/pharmacokinetics*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Tandem Mass Spectrometry;Young Adult
21803144;Computer Simulation*;Drug Compounding*;Drugs, Generic*/chemistry;Drugs, Generic*/pharmacokinetics;Food-Drug Interactions*;Humans;Pharmaceutical Preparations*/metabolism;Therapeutic Equivalency;United States;United States Food and Drug Administration
21797170;Antineoplastic Agents/metabolism;Antineoplastic Agents/pharmacology*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Nutritional Status*;Oxidoreductases/metabolism
21796375;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Diet*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy;Neoplasms/metabolism*
21793725;Anticarcinogenic Agents/pharmacology*;Antioxidants/pharmacology*;Apoptosis/drug effects;Beverages/analysis;Chemoprevention;Food-Drug Interactions;Fruit/chemistry;Humans;Inflammation/drug therapy;Neoplasms/drug therapy;Phytotherapy*;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Punicaceae/chemistry*
21733905;Adolescent;Antifungal Agents/pharmacokinetics*;Antifungal Agents/therapeutic use;Enteral Nutrition/adverse effects*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation/methods;Humans;Male;Mycoses/prevention & control;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Suspensions;Triazoles/pharmacokinetics*;Triazoles/therapeutic use;Voriconazole
21732691;2-Pyridinylmethylsulfinylbenzimidazoles;Animals;Benzimidazoles/chemistry*;Binding Sites;Cattle;Flavonoids/chemistry*;Food-Drug Interactions*;Molecular Structure;Protein Binding;Serum Albumin, Bovine/chemistry*;Sulfoxides/chemistry*
21724950;Aged;Alanine/administration & dosage;Alanine/analogs & derivatives*;Alanine/blood;Alanine/pharmacokinetics;Alanine/pharmacology;Amyloid Precursor Protein Secretases/antagonists & inhibitors*;Amyloid beta-Peptides/blood;Azepines/administration & dosage*;Azepines/blood;Azepines/pharmacokinetics;Azepines/pharmacology;Biological Availability;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Drug Administration Schedule;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Nootropic Agents/administration & dosage*;Nootropic Agents/blood;Nootropic Agents/pharmacokinetics;Nootropic Agents/pharmacology;Patient Dropouts;Peptide Fragments/blood;Tablets
21721019;Animals;Arylsulfotransferase/biosynthesis*;Arylsulfotransferase/genetics;Caffeine/administration & dosage*;Caffeine/adverse effects;Central Nervous System Stimulants/administration & dosage;Enzyme Induction*;Female;Food-Drug Interactions;Intestinal Mucosa/enzymology*;Intestinal Mucosa/metabolism;Intestine, Small/enzymology*;Intestine, Small/metabolism;Liver/enzymology*;Liver/metabolism;Male;Organ Specificity;Phosphodiesterase Inhibitors/administration & dosage;Purinergic P1 Receptor Antagonists/administration & dosage;RNA, Messenger/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Sex Characteristics;Sulfotransferases/biosynthesis*;Sulfotransferases/genetics
21720234;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Carbonated Beverages/adverse effects*;Cola*/adverse effects;Food-Drug Interactions/physiology*;Humans;Lithium/blood*;Lithium/therapeutic use;Male;Middle Aged
21718067;Animals;Cattle;Dietary Supplements/analysis*;Food-Drug Interactions*;Glycosylation;Hemoglobins/chemistry*;Hydrophobic and Hydrophilic Interactions;Hydroxylation;Models, Biological;Molecular Structure;Polyphenols/chemistry*;Protein Binding;Structure-Activity Relationship
21715058;Acenocoumarol/adverse effects*;Acenocoumarol/pharmacokinetics;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Ethanol/pharmacokinetics;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food Labeling;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Internet;Legislation, Drug;Patient Education as Topic;Spain;United States;United States Food and Drug Administration;Vitamin K/antagonists & inhibitors;Vomiting/etiology
21712497;Administration, Oral;Area Under Curve;Biological Availability;Capsules/administration & dosage;Confidence Intervals;Cross-Over Studies;Deglutition Disorders;Female;Food-Drug Interactions*;Humans;Male;Malus*;Middle Aged;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Therapeutic Equivalency;Yogurt*
21705359;Antihypertensive Agents/therapeutic use;Blood Pressure/physiology;Cost-Benefit Analysis;Diet/adverse effects;Diet, Sodium-Restricted/methods;Dose-Response Relationship, Drug;Food-Drug Interactions;Health Promotion/economics;Health Promotion/methods;Heart Failure/etiology*;Heart Failure/physiopathology;Heart Failure/prevention & control;Humans;Hypertension/etiology*;Hypertension/physiopathology;Hypertension/prevention & control;Hypertrophy, Left Ventricular/etiology;Hypertrophy, Left Ventricular/physiopathology;Life Style;Obesity/prevention & control;Risk Factors;Sodium Chloride, Dietary/adverse effects*;Ventricular Dysfunction, Left/etiology;Ventricular Dysfunction, Left/physiopathology;Weight Loss
21704241;Administration, Oral;Adolescent;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage;Fasting;Female;Fenofibrate/administration & dosage;Fenofibrate/adverse effects;Fenofibrate/analogs & derivatives*;Fenofibrate/pharmacokinetics;Food-Drug Interactions*;Humans;Male;Prodrugs;Tablets;Therapeutic Equivalency;Young Adult
21704240;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cholesterol Ester Transfer Proteins/antagonists & inhibitors;Cross-Over Studies;Dietary Fats/administration & dosage*;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Sulfhydryl Compounds/administration & dosage;Sulfhydryl Compounds/adverse effects;Sulfhydryl Compounds/pharmacokinetics*;Time Factors;Young Adult
21697612;Acyclovir/analogs & derivatives;Acyclovir/metabolism;Animals;Caffeic Acids/pharmacology*;Chlorogenic Acid/pharmacology;Coffee/chemistry;Estrone/analogs & derivatives;Estrone/metabolism;Food-Drug Interactions*;Fruit/chemistry;Humans;Inhibitory Concentration 50;Methotrexate/metabolism;Oocytes/drug effects;Oocytes/metabolism;Organic Anion Transport Protein 1/antagonists & inhibitors*;Organic Anion Transport Protein 1/genetics;Organic Anion Transporters, Sodium-Independent/antagonists & inhibitors*;Organic Anion Transporters, Sodium-Independent/genetics;Quinic Acid/pharmacology;RNA, Complementary/pharmacology;Vegetables/chemistry;Xenopus laevis;p-Aminohippuric Acid/metabolism
21692829;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use;Beverages;Carcinoma, Squamous Cell/drug therapy;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Esophageal Neoplasms/drug therapy;Female;Food-Drug Interactions*;Humans;Middle Aged;Taxoids/pharmacokinetics*;Taxoids/therapeutic use
21692649;Administration, Intranasal/methods*;Animals;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Brain/metabolism*;Cattle;Cefotaxime/pharmacokinetics*;Food-Drug Interactions/physiology*;Humans;Male;Meningitis, Bacterial/metabolism;Rats;Rats, Sprague-Dawley
21691746;Adolescent;Adult;Aniline Compounds/administration & dosage*;Aniline Compounds/adverse effects;Aniline Compounds/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Proto-Oncogene Proteins c-abl/antagonists & inhibitors;Quinolines/administration & dosage*;Quinolines/adverse effects;Quinolines/pharmacokinetics;Tandem Mass Spectrometry;Tissue Distribution;Young Adult;src-Family Kinases/antagonists & inhibitors
21682192;ATP Binding Cassette Transporter, Sub-Family B/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Flavonoids/adverse effects;Food-Drug Interactions*;Furocoumarins/adverse effects;Humans;Intestinal Absorption/drug effects*;Intestines/metabolism*
21680781;Adult;Alleles;China;Cross-Over Studies;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism*;Dietary Supplements*;Enzyme Induction;Food-Drug Interactions;Gene Frequency;Genetic Association Studies;Half-Life;Humans;Male;Metabolic Detoxication, Phase I;Midazolam/analogs & derivatives;Midazolam/blood;Midazolam/pharmacokinetics*;Polymorphism, Single Nucleotide*;Quercetin/metabolism*;Young Adult
21676011;Adult;Body Temperature/drug effects*;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Middle Aged;TRPV Cation Channels/antagonists & inhibitors*;Young Adult
21675289;Analgesics/pharmacology;Analgesics/therapeutic use;Capsaicin/metabolism;Capsaicin/pharmacology*;Capsaicin/therapeutic use;Capsicum*;Food-Drug Interactions;Humans;Pain/drug therapy;Substance P/antagonists & inhibitors;Substance P/metabolism*
21674263;Area Under Curve;Biological Availability;Dopamine Antagonists/pharmacokinetics*;Dopamine Antagonists/pharmacology;Excipients/chemistry*;Fasting;Food-Drug Interactions;Humans;Piperazines/pharmacokinetics*;Piperazines/pharmacology;Solubility;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology
21671821;Administration, Oral;Animals;Delayed-Action Preparations/pharmacokinetics;Drug Combinations;Drug Delivery Systems*;Food-Drug Interactions;Gastric Emptying;Humans;Stomach/physiology*;Technology, Pharmaceutical*
21666065;Acetaminophen/metabolism;Acetaminophen/pharmacokinetics*;Acetaminophen/urine;Adult;Alleles;Cross-Over Studies;Diet;Female;Food-Drug Interactions*;Fruit*;Genotype;Glucuronides/metabolism;Glucuronosyltransferase/genetics*;Glucuronosyltransferase/metabolism;Half-Life;Humans;Male;Polymorphism, Genetic;Saliva/metabolism;Vegetables*
21663428;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacokinetics;Central Nervous System Stimulants/therapeutic use*;Child;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/pharmacokinetics;Methylphenidate/therapeutic use*;Treatment Outcome
21650079;Biological Availability;Chemistry, Pharmaceutical/standards;Drug Design;Drug Interactions;Drugs, Generic/pharmacokinetics;Drugs, Generic/standards*;Europe;European Union;Food-Drug Interactions;Guidelines as Topic;Therapeutic Equivalency*;United States;United States Food and Drug Administration
21633025;Administration, Oral;Adolescent;Adult;Aminoquinolines/pharmacokinetics*;Amphotericin B/pharmacokinetics*;Antiprotozoal Agents/pharmacokinetics*;Area Under Curve;Cohort Studies;Cross-Over Studies;Fasting;Female;Food;Food-Drug Interactions*;Half-Life;Humans;India;Leishmaniasis, Visceral/drug therapy*;Leishmaniasis, Visceral/pathology;Male;Middle Aged;Prospective Studies;Young Adult
21628600;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use*;Brain/drug effects*;Brain/enzymology;Dietary Proteins/adverse effects;Dietary Proteins/metabolism*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypertension/etiology;Hypertension/prevention & control;Indans/adverse effects;Indans/therapeutic use*;Monoamine Oxidase/metabolism*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/enzymology;Patient Safety;Risk Assessment;Risk Factors;Treatment Outcome;Tyramine/adverse effects;Tyramine/metabolism*
21617593;Beverages*;Food-Drug Interactions*;Fruit*;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics*;Humans;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
21615244;Animals;Biological Availability;Caco-2 Cells;Female;Food;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Male;Models, Animal;Pharmaceutical Preparations/metabolism*;Predictive Value of Tests;Rats;Rats, Wistar;Regression Analysis
21610201;Adolescent;Adult;Area Under Curve;Benzofurans/adverse effects*;Benzofurans/pharmacokinetics;Benzofurans/pharmacology;Blood Glucose/drug effects*;C-Peptide/secretion;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Insulin/secretion;Male;Middle Aged;Receptors, G-Protein-Coupled/agonists*;Sulfones/adverse effects*;Sulfones/pharmacokinetics;Sulfones/pharmacology;Young Adult
21607954;Acetamides/blood;Acetamides/pharmacokinetics;Acetamides/urine;Adult;Animals;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Antiviral Agents/urine;Area Under Curve;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Milk*;Oseltamivir/blood;Oseltamivir/pharmacokinetics*;Oseltamivir/urine;Reference Values
21593283;Administration, Oral;Adrenergic beta-1 Receptor Antagonists/administration & dosage;Adrenergic beta-1 Receptor Antagonists/pharmacokinetics*;Adult;Area Under Curve;Atenolol/administration & dosage;Atenolol/pharmacokinetics;Beverages;Celiprolol/administration & dosage;Celiprolol/pharmacokinetics*;Citrus paradisi/chemistry;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Organic Anion Transporters/genetics*;Pharmacogenetics;Polymorphism, Genetic;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives;Terfenadine/pharmacokinetics;Young Adult
21553459;Citrus paradisi*/chemistry;Food-Drug Interactions*;Humans
21551317;Adult;Analysis of Variance;Area Under Curve;Benzilates/administration & dosage;Benzilates/blood;Benzilates/chemistry;Benzilates/pharmacokinetics*;Biological Availability;Biotransformation;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Fasting/blood;Female;Food-Drug Interactions*;Germany;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Muscarinic Antagonists/administration & dosage;Muscarinic Antagonists/blood;Muscarinic Antagonists/chemistry;Muscarinic Antagonists/pharmacokinetics*;Oxidation-Reduction;Postprandial Period;Young Adult
21548660;Adult;Area Under Curve;Benzopyrans/adverse effects;Benzopyrans/blood;Benzopyrans/metabolism;Benzopyrans/pharmacokinetics*;Biotransformation/physiology;Cross-Over Studies;Dopamine beta-Hydroxylase/antagonists & inhibitors;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacokinetics;Food Deprivation/physiology;Food-Drug Interactions/physiology*;Humans;Imidazoles/adverse effects;Imidazoles/blood;Imidazoles/metabolism;Imidazoles/pharmacokinetics*;Male;Therapeutic Equivalency;Young Adult
21545633;Antimetabolites, Antineoplastic;Biological Transport/drug effects;Carbonated Beverages/adverse effects*;Cola/adverse effects*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Kidney/metabolism;Liver/metabolism;Lymphoma/drug therapy;Lymphoma/urine;Male;Methotrexate/pharmacokinetics*;Methotrexate/therapeutic use;Middle Aged;Urine/chemistry
21544521;Animal Feed/adverse effects;Animals;Behavior, Animal/drug effects*;Body Temperature/drug effects;Body Weight/drug effects*;Dietary Fats*/administration & dosage;Dietary Fats*/adverse effects;Dopamine Agonists/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Male;Quinpirole/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, Dopamine/metabolism*;Yawning/drug effects
21535728;Allyl Compounds/administration & dosage;Allyl Compounds/adverse effects*;Animals;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Dietary Supplements/adverse effects*;Food-Drug Interactions;Garlic/chemistry;Half-Life;Male;Metabolic Clearance Rate;Nifedipine/blood;Nifedipine/pharmacokinetics*;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Roots/chemistry;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects*;Random Allocation;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Sulfides/administration & dosage;Sulfides/adverse effects*;Time Factors;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*
21532276;Administration, Oral;Alendronate/administration & dosage;Alendronate/pharmacokinetics*;Alendronate/urine;Animals;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/pharmacokinetics*;Bone Density Conservation Agents/urine;Calcium/analysis;Food-Drug Interactions;Male;Mineral Waters/adverse effects*;Mineral Waters/analysis;Rats;Rats, Wistar;Time Factors
21527341;Administration, Oral;Adolescent;Adult;Area Under Curve;Chemical Precipitation;Computer Simulation;Cross-Over Studies;Fasting/metabolism*;Food-Drug Interactions*;Gastric Emptying;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;Humans;Intestinal Absorption/physiology;Intestine, Small/metabolism*;Male;Models, Biological;Nelfinavir/administration & dosage;Nelfinavir/pharmacokinetics*;Solubility;Tablets/administration & dosage;Tablets/pharmacokinetics;Young Adult
21517925;Administration, Oral;Adult;Asian Continental Ancestry Group;China;Chromatography, Liquid/methods*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Isoindoles/administration & dosage;Isoindoles/adverse effects;Isoindoles/pharmacokinetics*;Male;Tablets;Tandem Mass Spectrometry/methods*;Young Adult
21511277;Antidiuretic Agents/pharmacokinetics;Antidiuretic Agents/pharmacology*;Antidiuretic Agents/therapeutic use*;Chemistry, Pharmaceutical;Child;Deamino Arginine Vasopressin/pharmacokinetics;Deamino Arginine Vasopressin/pharmacology*;Deamino Arginine Vasopressin/therapeutic use*;Female;Food-Drug Interactions*;Humans;Male;Nocturnal Enuresis/drug therapy*;Tablets;Therapeutic Equivalency
21501216;Aged;Analysis of Variance;Anticholesteremic Agents/blood*;Anticholesteremic Agents/therapeutic use;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cohort Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Heptanoic Acids/blood*;Heptanoic Acids/therapeutic use;Humans;Lipid Metabolism/drug effects;Lipid Metabolism Disorders/blood;Lipid Metabolism Disorders/drug therapy*;Male;Middle Aged;Pyrroles/blood*;Pyrroles/therapeutic use;Time Factors
21500482;Beverages/analysis*;Citrus paradisi/chemistry*;Flavanones/analysis;Flavonoids/analysis*;Food-Drug Interactions;Fruit/chemistry;Humans
21497708;Administration, Oral;Adult;Area Under Curve;Beverages*;Chromatography, High Pressure Liquid;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Female;Food-Drug Interactions*;Humans;Japan;Male;Metabolic Clearance Rate;Midazolam/blood;Midazolam/pharmacokinetics*;Midazolam/urine;Punicaceae/chemistry*;Tandem Mass Spectrometry;Young Adult
21490128;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Availability;Cytochrome P-450 CYP3A/metabolism*;Drug Design;Drug Interactions;Drug Synergism;Food-Drug Interactions;Humans;Mice;Mice, Knockout;Mice, Transgenic;Models, Animal;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism*
21474786;Administration, Oral;Adult;Androgens/administration & dosage*;Androgens/blood;Androgens/pharmacokinetics*;Biotransformation;Chromatography, Liquid;Cross-Over Studies;Dihydrotestosterone/blood;Drug Administration Schedule;Emulsions;Estradiol/blood;Fasting/blood;Food-Drug Interactions;Humans;Hypogonadism/blood;Hypogonadism/drug therapy*;Male;Middle Aged;Postprandial Period;Tandem Mass Spectrometry;Testosterone/administration & dosage;Testosterone/analogs & derivatives*;Testosterone/blood;Testosterone/pharmacokinetics;Treatment Outcome;United States
21474406;Administration, Oral;Aged;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hospital Units*;Humans;Inpatients/psychology*;International Normalized Ratio;Knowledge;Middle Aged;Patient Education as Topic*;Physical and Rehabilitation Medicine*;Prospective Studies;Rehabilitation*;Self Medication;Surveys and Questionnaires;Vitamin K/antagonists & inhibitors
21473341;Diet*;Food-Drug Interactions*;Humans;Patient Education as Topic*;United Kingdom
21457137;Acetates;Animals;Area Under Curve;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Food-Drug Interactions*;Fruit;Male;Plant Extracts/pharmacology*;Rabbits;Verapamil/pharmacokinetics*
21453201;Animals;Clinical Trials as Topic/methods;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions/chemically induced*;Drug-Related Side Effects and Adverse Reactions/metabolism;Drug-Related Side Effects and Adverse Reactions/prevention & control;Food-Drug Interactions/physiology;Humans;Indans/adverse effects;Indans/pharmacokinetics;Indans/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Serotonin Agents/adverse effects;Serotonin Agents/pharmacokinetics;Serotonin Agents/therapeutic use;Treatment Outcome
21443600;Administration, Oral;Adolescent;Adult;Biological Availability;Cross-Over Studies;Dermatologic Agents/administration & dosage;Dermatologic Agents/adverse effects;Dermatologic Agents/blood*;Fasting/blood;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Tretinoin/administration & dosage;Tretinoin/adverse effects;Tretinoin/blood*;Young Adult
21441285;Animals;Anti-Inflammatory Agents, Non-Steroidal/toxicity*;Disease Models, Animal;Dose-Response Relationship, Drug;Enterocytes/drug effects;Enterocytes/pathology;Escherichia coli/metabolism*;Female;Food-Drug Interactions;Gastric Mucosa/drug effects;Gastric Mucosa/microbiology;Gastric Mucosa/pathology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/microbiology;Gastrointestinal Tract/pathology*;Indomethacin/toxicity*;Probiotics/administration & dosage*;Swine
21435141;Adolescent;Adult;Benzhydryl Compounds;Biological Availability;Diet;Dietary Fats*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Glucosides/administration & dosage;Glucosides/pharmacokinetics*;Humans;Male;Middle Aged;Sodium-Glucose Transporter 2/antagonists & inhibitors*;Young Adult
21434835;ATP Binding Cassette Transporter, Sub-Family B/drug effects;Alkaloids/pharmacokinetics*;Benzodioxoles/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Piper nigrum/chemistry*;Piperidines/pharmacokinetics*;Polyunsaturated Alkamides/pharmacokinetics*
21432599;Attention Deficit Disorder with Hyperactivity/diagnosis;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/therapeutic use*;Child;Cross-Over Studies;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/therapeutic use*;Female;Food Deprivation;Food-Drug Interactions*;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/therapeutic use*;Single-Blind Method
21422239;Administration, Oral;Adolescent;Adult;Biological Availability;Blood Cell Count;Butyrates/administration & dosage;Butyrates/adverse effects*;Butyrates/analysis;Butyrates/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Fetal Hemoglobin/analysis;Food-Drug Interactions;Half-Life;Hematinics/administration & dosage;Hematinics/adverse effects*;Hematinics/analysis;Hematinics/pharmacokinetics*;Humans;Male;Metabolic Clearance Rate;Plasma/chemistry;Reticulocytes/drug effects;Urine/chemistry;Young Adult
21398067;Animal Feed*/analysis;Animals;Antineoplastic Agents/analysis;Antineoplastic Agents/blood;Antineoplastic Agents/metabolism*;Antineoplastic Agents/urine;Biotransformation;Carbon Radioisotopes/metabolism;Chromatography, High Pressure Liquid/instrumentation;Chromatography, High Pressure Liquid/methods;Dogs;Feces/chemistry;Female;Food-Drug Interactions*;Humans;Magnetic Resonance Spectroscopy;Male;Mass Spectrometry/instrumentation;Mass Spectrometry/methods;Molecular Structure;Pyrrolidines/analysis;Pyrrolidines/blood;Pyrrolidines/metabolism*;Pyrrolidines/urine;Rats;Species Specificity
21372392;Administration, Oral;Caco-2 Cells;Dose-Response Relationship, Drug;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption*;Permeability;Pharmaceutical Preparations/analysis*;Postprandial Period;Solubility;Technology, Pharmaceutical/methods*;Tetrazoles/pharmacokinetics*;Water
21364039;Anticoagulants/metabolism;Anticoagulants/pharmacology*;Beverages*;Drug Interactions;Female;Food-Drug Interactions*;Fruit*;Humans;International Normalized Ratio;Middle Aged;Vaccinium macrocarpon*;Warfarin/metabolism;Warfarin/pharmacology*
21359645;Administration, Oral;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Food/adverse effects*;Food-Drug Interactions*;Humans;Warfarin*/adverse effects;Warfarin*/pharmacokinetics;Warfarin*/therapeutic use
21356148;Adult;Aged;Anticholesteremic Agents/administration & dosage*;Cholesterol/blood;Female;Follow-Up Studies;Food, Fortified*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hypercholesterolemia/drug therapy;Linear Models;Longitudinal Studies;Male;Margarine/analysis*;Middle Aged;Multivariate Analysis;Phytosterols/administration & dosage*;Retrospective Studies;Surveys and Questionnaires
21355446;Adenine/administration & dosage;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/pharmacokinetics;Adult;Blood Cell Count;Blood Chemical Analysis;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Middle Aged;Organophosphonates/administration & dosage;Organophosphonates/adverse effects;Organophosphonates/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/pharmacokinetics*;Spectrometry, Fluorescence;Tablets;Tenofovir;Therapeutic Equivalency;Young Adult
21349922;Administration, Oral;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Beverages;Biological Availability;Citrus paradisi/chemistry;Female;Food-Drug Interactions;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology*;Intestine, Small/drug effects;Intestine, Small/enzymology*;Lovastatin/administration & dosage;Lovastatin/pharmacokinetics*;Mice;Mice, Knockout;NADPH-Ferrihemoprotein Reductase/genetics;NADPH-Ferrihemoprotein Reductase/metabolism;NADPH-Ferrihemoprotein Reductase/physiology*
21341419;Caffeine/pharmacokinetics;Citrus paradisi;Dairy Products;Food-Drug Interactions*;Humans;Vitamin K/pharmacokinetics;Vitamins/pharmacokinetics
21301274;Beverages/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Vaccinium macrocarpon*;Warfarin/adverse effects*
21298205;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics;Anti-Arrhythmia Agents/therapeutic use*;Beverages*;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/metabolism;Citrus paradisi*;Food-Drug Interactions;Humans
21268318;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
21257798;Adolescent;Adult;Area Under Curve;Biological Availability;Double-Blind Method;Female;Food-Drug Interactions;Humans;Janus Kinases/antagonists & inhibitors;Male;Middle Aged;Neutropenia/chemically induced;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology*;STAT3 Transcription Factor/blood;Young Adult
21254874;Animals;Beverages*/adverse effects;Beverages*/analysis;Citrus paradisi*/adverse effects;Citrus paradisi*/chemistry;Food-Drug Interactions*;Humans;Pharmacokinetics*
21248612;Administration, Oral;Adolescent;Adult;Antifibrinolytic Agents/administration & dosage;Antifibrinolytic Agents/adverse effects;Antifibrinolytic Agents/therapeutic use*;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions;Humans;Menorrhagia/drug therapy*;Middle Aged;Tablets;Time Factors;Tranexamic Acid/administration & dosage;Tranexamic Acid/adverse effects;Tranexamic Acid/therapeutic use;Treatment Outcome;Young Adult
21238588;Administration, Oral;Animals;Anticoagulants*/administration & dosage;Anticoagulants*/blood;Anticoagulants*/pharmacokinetics;Area Under Curve;Biological Availability;Drug Delivery Systems;Duodenum/metabolism*;Fasting/metabolism;Female;Food-Drug Interactions*;Haplorhini;Naphthalenes/blood;Naphthalenes/pharmacokinetics*;Propionates/blood;Propionates/pharmacokinetics*;Solubility;Tablets, Enteric-Coated;Time Factors
21235125;Anti-Allergic Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacokinetics;Antimalarials/pharmacokinetics;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus paradisi/adverse effects*;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Risk Factors
21219314;Animals;Anticonvulsants*;Behavior, Animal/drug effects;Cell Death/drug effects;Convulsants*;Cyclooxygenase 2/metabolism;Cyclooxygenase 2 Inhibitors/pharmacology*;Diet;Dose-Response Relationship, Drug;Eating;Extinction, Psychological/drug effects;Food-Drug Interactions;Immunohistochemistry;Kainic Acid/pharmacology;Kindling, Neurologic/drug effects*;Lactones/pharmacology*;Male;Mice;Pentylenetetrazole*;Seizures/chemically induced;Seizures/prevention & control*;Sulfones/pharmacology*
21207216;Absorption/physiology*;Algorithms;Anticonvulsants/chemistry;Anticonvulsants/pharmacokinetics;Capsules;Carbamazepine/chemistry;Carbamazepine/pharmacokinetics;Chemistry, Pharmaceutical;Computer Simulation;Dosage Forms;Drug Design*;Fasting/metabolism;Food-Drug Interactions;Humans;Intestinal Absorption/physiology;Models, Biological*;Models, Statistical*;Pharmacokinetics;Quality Improvement*;Solubility;Suspensions;Tablets;Therapeutic Equivalency
21204914;Adult;Amides/blood*;Antihypertensive Agents/blood*;Beverages*;Citrus sinensis*;Female;Food-Drug Interactions*;Fumarates/blood*;Humans;Male;Malus*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/physiology;Renin/blood;Young Adult
21194458;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Critical Care*;Drug Monitoring;Food-Drug Interactions;Humans;Hypoalbuminemia/drug therapy;Hypoalbuminemia/therapy;Parenteral Nutrition*/adverse effects
21189136;Administration, Oral;Animals;Biological Availability;Biological Transport;Biotransformation;Food-Drug Interactions*;Humans;Intestinal Absorption;Intestinal Mucosa/enzymology;Intestinal Mucosa/metabolism;Intestines/enzymology;Intestines/metabolism*;Membrane Transport Proteins/metabolism*;Pharmaceutical Preparations/administration & dosage;Pharmacokinetics*;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics;Research Design
21185864;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy*;Clinical Trials as Topic;Food-Drug Interactions;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Thromboembolism/drug therapy*;Thromboembolism/etiology;Thromboembolism/prevention & control;Venous Thrombosis/complications;Venous Thrombosis/drug therapy*;Venous Thrombosis/prevention & control;Warfarin/therapeutic use
21173898;Administration, Oral;Calcium Carbonate/blood;Calcium Carbonate/therapeutic use;Calcium Citrate/blood;Calcium Citrate/therapeutic use;Calcium Gluconate/blood;Calcium Gluconate/therapeutic use;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Therapy, Combination;Food-Drug Interactions;Half-Life;Hormone Replacement Therapy/methods*;Humans;Hypocalcemia/blood;Hypocalcemia/drug therapy*;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Infusions, Intravenous;Iodine/administration & dosage;Iodine/blood;Parathyroid Diseases/blood;Parathyroid Diseases/surgery*;Parathyroid Hormone/blood;Parathyroid Hormone/therapeutic use;Parathyroidectomy*;Postoperative Complications/blood;Postoperative Complications/drug therapy*;Recombinant Proteins/therapeutic use;Thyroid Diseases/blood;Thyroid Diseases/surgery*;Thyroid Neoplasms/blood;Thyroid Neoplasms/surgery*;Thyroidectomy*;Thyrotropin/blood;Thyroxine/blood;Thyroxine/therapeutic use;Treatment Outcome;Triiodothyronine/blood;Triiodothyronine/therapeutic use;Vitamin D/blood;Vitamin D/therapeutic use
21163558;Antioxidants/analysis;Combined Modality Therapy;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/diet therapy*;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/enzymology;Dyslipidemias/prevention & control;Female;Food-Drug Interactions*;Glyburide/adverse effects;Glyburide/therapeutic use*;Glycated Hemoglobin A/analysis;Humans;Hyperglycemia/prevention & control;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Oxidoreductases/blood;Sesame Oil/adverse effects;Sesame Oil/therapeutic use*;Severity of Illness Index
21162177;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/metabolism*;Beverages/adverse effects;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Food-Drug Interactions*;Fruit;Health Knowledge, Attitudes, Practice*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Patient Education as Topic
21155809;Animals;Biological Availability;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Food/standards*;Food-Drug Interactions*;Humans;Legislation, Food
21148046;Administration, Oral;Adult;Biological Availability;Biotransformation;Body Mass Index;Cytochrome P-450 CYP3A/metabolism*;Female;Flavonoids/analysis;Food-Drug Interactions;Half-Life;Honey*/analysis;Humans;Injections, Intravenous;Intestines/enzymology*;Liver/enzymology*;Male;Metabolic Clearance Rate;Midazolam/administration & dosage;Midazolam/analogs & derivatives;Midazolam/blood;Midazolam/pharmacokinetics;Midazolam/urine;Single-Blind Method;Young Adult
21147941;Administration, Cutaneous;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Blood Pressure/drug effects*;Cheese;Depressive Disorder, Major/drug therapy;Feeding Behavior;Food-Drug Interactions;Humans;Hypertension/chemically induced*;Hypertension/prevention & control;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Myocardium;Risk Factors;Selegiline/adverse effects;Selegiline/pharmacokinetics;Selegiline/therapeutic use*;Tyramine
21142260;Animals;Beverages;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 Enzyme System/adverse effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
21138349;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biological Transport/drug effects;Darunavir;Drug Interactions;Food-Drug Interactions*;Garlic/chemistry;Garlic/metabolism*;HIV Protease Inhibitors/pharmacokinetics*;Hep G2 Cells;Humans;Liver/drug effects;Liver/metabolism;Models, Biological;Multidrug Resistance-Associated Proteins/metabolism;Permeability;Plant Extracts/pharmacokinetics*;Saquinavir/pharmacokinetics*;Sulfonamides/pharmacokinetics*
21125816;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Calibration;Chromatography, High Pressure Liquid;Cross-Over Studies;Fasting/metabolism;Female;Food-Drug Interactions;Ganciclovir/pharmacokinetics;Guanine/administration & dosage;Guanine/adverse effects;Guanine/analogs & derivatives*;Guanine/pharmacokinetics;Humans;Male;Mass Spectrometry;Reproducibility of Results;Tablets;Young Adult
21124269;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Antioxidants/administration & dosage*;Antioxidants/adverse effects;Beverages/adverse effects*;Food-Drug Interactions*;Gastrointestinal Hemorrhage/etiology;Gastrointestinal Hemorrhage/prevention & control;Health Knowledge, Attitudes, Practice;Humans;Vaccinium macrocarpon*;Warfarin/administration & dosage*;Warfarin/adverse effects
21120480;Adult;Aged;Area Under Curve;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Magnetic Resonance Imaging;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/pathology;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Quinazolines/therapeutic use*;Tomography, X-Ray Computed;Treatment Outcome;Young Adult
21118913;Adenine/analogs & derivatives*;Adenine/pharmacology;Adenine/therapeutic use;Chemoprevention;Deoxycytidine/analogs & derivatives*;Deoxycytidine/pharmacology;Deoxycytidine/therapeutic use;Drug Interactions;Emtricitabine;Female;Food-Drug Interactions;HIV Infections/drug therapy;HIV Infections/prevention & control*;Humans;Male;Organophosphonates/pharmacology;Organophosphonates/therapeutic use*;Tenofovir
21098692;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical/methods;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions*;Humans;Hydromorphone/administration & dosage*;Hydromorphone/adverse effects;Hydromorphone/chemistry;Hydromorphone/pharmacokinetics*;Male;Naltrexone/administration & dosage;Therapeutic Equivalency
21085831;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Pregnancy Complications/drug therapy;Tuberculosis/drug therapy*;Tuberculosis, Multidrug-Resistant/drug therapy
21085830;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Brazil;Chemical and Drug Induced Liver Injury;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Risk Factors;Tuberculosis/drug therapy*;Tuberculosis/metabolism
21073557;Biomedical Research/history;Cheese;Drug Interactions*/genetics;Drug Therapy/history*;Food-Drug Interactions*;History, 20th Century;Humans
21058190;Antineoplastic Agents, Phytogenic/metabolism*;Cell Adhesion;Cell Cycle/drug effects*;Cell Line, Tumor;Cell Proliferation/drug effects;Cell Survival/drug effects;Cyclin B1/metabolism;Food-Drug Interactions;G2 Phase/drug effects;Humans;Microtubules/drug effects;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Neoplasms/prevention & control;Nocodazole/antagonists & inhibitors*;Nocodazole/pharmacology;Osmolar Concentration;Paclitaxel/antagonists & inhibitors*;Paclitaxel/pharmacology;Quercetin/metabolism*;Time Factors;Tubulin/metabolism;Tubulin Modulators/antagonists & inhibitors*;Tubulin Modulators/pharmacology;Tumor Suppressor Protein p53/genetics;Tumor Suppressor Protein p53/metabolism
21055466;Carbamates/administration & dosage*;Carbamates/pharmacokinetics*;Fasting;Food-Drug Interactions;Gastrointestinal Tract/metabolism*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Magnetic Resonance Imaging;Organophosphates/administration & dosage*;Organophosphates/pharmacokinetics*;Postprandial Period;Solubility;Sulfonamides/administration & dosage*;Sulfonamides/pharmacokinetics*;Tablets
21048420;Antipsychotic Agents*/chemistry;Catechin/analogs & derivatives*;Catechin/chemistry;Dimethyl Sulfoxide;Food-Drug Interactions*;Hydrogen;Magnetic Resonance Spectroscopy;Models, Molecular;Molecular Conformation;Risperidone*/chemistry;Solubility;Solutions;Tea*;Water
21039758;Administration, Oral;Anti-Allergic Agents/pharmacokinetics*;Beverages*;Biological Availability;Citrus*;Citrus paradisi*;Food-Drug Interactions/physiology*;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics*;Humans;Organic Anion Transporters/metabolism;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
22834058;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Atrial Fibrillation/drug therapy*;Diet;Dose-Response Relationship, Drug;Food-Drug Interactions*;Health Behavior;Health Education;Humans;Risk Factors;Vegetables*;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage*;Warfarin/adverse effects
20980999;Administration, Oral;Adult;Aged;Cohort Studies;Cross-Over Studies;Dietary Fats/metabolism*;Fatigue/chemically induced;Female;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects*;Pyrimidines/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects*;Sulfonamides/pharmacokinetics*
20974993;Acetates/administration & dosage;Acetates/blood;Acetates/pharmacokinetics*;Adolescent;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/blood;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Asthma/drug therapy*;Asthma/metabolism;Asthma/physiopathology;Beverages*;Citrus paradisi*;Citrus sinensis*;Cross-Over Studies;Female;Florida;Food-Drug Interactions*;Fruit;Heterozygote;Homozygote;Humans;Isotonic Solutions;Leukotriene Antagonists/administration & dosage;Leukotriene Antagonists/blood;Leukotriene Antagonists/pharmacokinetics*;Male;Models, Biological;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Phenotype;Polymorphism, Genetic;Quinolines/administration & dosage;Quinolines/blood;Quinolines/pharmacokinetics*
20972517;Beverages;Cardiovascular Diseases/drug therapy*;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/metabolism;Diabetes Mellitus/drug therapy*;Flavanones/pharmacology;Food-Drug Interactions*/physiology;Humans;Intestines/metabolism;Metabolic Syndrome/drug therapy*;Metabolic Syndrome/metabolism;Phytotherapy*
20970282;Aged, 80 and over;Amiodarone/adverse effects*;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/therapy;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Electric Countershock;Electrocardiography;Emergency Service, Hospital;Female;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced;Torsades de Pointes/therapy
20959524;Adult;Benzothiazoles/administration & dosage;Benzothiazoles/adverse effects*;Benzothiazoles/analysis;Benzothiazoles/pharmacokinetics*;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects*;Dopamine Agonists/analysis;Dopamine Agonists/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Plasma/chemistry;Urine/chemistry
20952061;Antineoplastic Agents/economics*;Antineoplastic Agents/therapeutic use;Benzamides;Beverages*;Citrus*;Drug Costs*;Food-Drug Interactions*;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Piperazines/economics*;Piperazines/therapeutic use;Pyrimidines/economics*;Pyrimidines/therapeutic use
20949341;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats;Drug-Related Side Effects and Adverse Reactions;Fasting;Feeding Behavior*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Morphine/administration & dosage;Morphine/pharmacology*;Naltrexone/administration & dosage;Naltrexone/pharmacokinetics*
20928982;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/history*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Drug Monitoring;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/drug therapy;History, 20th Century;History, 21st Century;Humans;International Normalized Ratio;Mixed Function Oxygenases/antagonists & inhibitors;Patient Education as Topic;Thrombophilia/drug therapy;Thrombosis/prevention & control;Vitamin K/metabolism;Vitamin K/therapeutic use;Vitamin K Epoxide Reductases;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/history*;Warfarin/pharmacokinetics;Warfarin/therapeutic use
20926751;Adenosine A1 Receptor Antagonists/administration & dosage;Adenosine A1 Receptor Antagonists/adverse effects;Adenosine A1 Receptor Antagonists/blood;Adenosine A1 Receptor Antagonists/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Aged;Biological Availability;Cross-Over Studies;Diuretics/administration & dosage;Diuretics/adverse effects;Diuretics/blood;Diuretics/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Sex Characteristics;Xanthines/administration & dosage;Xanthines/adverse effects;Xanthines/blood;Xanthines/pharmacokinetics*;Young Adult
20883117;Aged;Amitriptyline/administration & dosage;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Amitriptyline/therapeutic use;Animals;Delayed-Action Preparations;Drug Administration Schedule;Food-Drug Interactions;Humans;Muscle Relaxants, Central/administration & dosage;Muscle Relaxants, Central/pharmacokinetics*;Muscle Relaxants, Central/therapeutic use;Randomized Controlled Trials as Topic;Spasm/drug therapy*
20869315;Antacids/adverse effects;Anti-Infective Agents/adverse effects;Anticonvulsants/adverse effects;Antiemetics/adverse effects;Antineoplastic Agents/adverse effects;Child;Complementary Therapies/adverse effects;Drug Interactions*;Food-Drug Interactions;Humans;Neoplasms/drug therapy*
20864621;Administration, Oral;Adolescent;Adult;Biotransformation;Cytochrome P-450 CYP2D6/metabolism;Dizziness/chemically induced;Double-Blind Method;Drug Administration Schedule;Electrocardiography;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Female;Food-Drug Interactions*;Glucosyltransferases/antagonists & inhibitors*;Heart Rate/drug effects;Humans;Intestinal Absorption;Male;Models, Biological;Nausea/chemically induced;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine;Vomiting/chemically induced;Young Adult
20854805;Antineoplastic Agents/antagonists & inhibitors*;Antineoplastic Agents/pharmacology;Apoptosis/drug effects;Carcinoma, Non-Small-Cell Lung/drug therapy*;Cell Line, Tumor;Cell Survival/drug effects;Drug Interactions;Enzyme Activation/drug effects;Flavonoids/pharmacology*;Food-Drug Interactions;Free Radical Scavengers/pharmacology*;Humans;Indoles/antagonists & inhibitors*;Indoles/pharmacology;JNK Mitogen-Activated Protein Kinases/metabolism;MAP Kinase Signaling System/drug effects;Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors;Osmolar Concentration;Phosphorylation/drug effects;Protein Kinase Inhibitors/pharmacology;Reactive Oxygen Species/metabolism*
20852003;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Acetamides/therapeutic use;Adult;Biological Availability;Capsules;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/therapeutic use;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/therapeutic use;Male;Orexin Receptors;Reaction Time/drug effects;Receptors, G-Protein-Coupled/antagonists & inhibitors*;Receptors, Neuropeptide/antagonists & inhibitors*;Tablets;Task Performance and Analysis;Therapeutic Equivalency;Wakefulness/drug effects;Young Adult
20736331;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Drug Labeling/standards*;Fasting;Food;Food-Drug Interactions*;Humans;Intestinal Absorption;Pharmaceutical Preparations/administration & dosage*
20736327;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Drug Delivery Systems;Drug Labeling/standards*;Drug Labeling/statistics & numerical data;Fasting;Food;Food-Drug Interactions*;Humans;Intestinal Absorption;Pharmaceutical Preparations/administration & dosage*;United States;United States Food and Drug Administration
20717876;Beverages;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Fruit;Humans;Intestines/drug effects*;Intestines/enzymology;Microsomes/drug effects;Midazolam/metabolism*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Recombinant Proteins;Triterpenes/isolation & purification;Triterpenes/pharmacology*;Vaccinium macrocarpon/chemistry*
20701327;Animals;Biological Availability;Chemistry, Pharmaceutical/instrumentation;Chemistry, Pharmaceutical/methods*;Dosage Forms;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Pharmacokinetics*;Solubility
20694287;Dietary Fiber*;Food-Drug Interactions*;Humans
20686214;Aged;Aged, 80 and over;Child, Preschool;Day Care, Medical/statistics & numerical data*;Drug Interactions;Drug Utilization;Food, Organic/utilization*;Food-Drug Interactions;Humans;Japan/epidemiology;Nonprescription Drugs*;Parents*;Schools, Nursery/statistics & numerical data*;Self Medication;Surveys and Questionnaires
20678294;Appetite/drug effects;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Gastrointestinal Diseases/etiology;Humans;Nutrition Assessment;Nutritional Status*
20664534;Adult;Amides/pharmacokinetics*;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Female;Food-Drug Interactions;Fumarates/pharmacokinetics*;Half-Life;Humans;Male;Organic Anion Transporters/antagonists & inhibitors*;Renin/antagonists & inhibitors;Young Adult
20662310;1-Naphthylisothiocyanate;Administration, Oral;Animals;Biological Availability;Carbon Tetrachloride;Cholestasis/chemically induced;Cholestasis/metabolism*;Food-Drug Interactions;Immunosuppressive Agents/pharmacokinetics*;Intestinal Absorption/physiology*;Male;Rats;Rats, Sprague-Dawley;Ribonucleosides/pharmacokinetics*
20660294;Administration, Oral;Bone Density Conservation Agents/administration & dosage*;Bone Density Conservation Agents/pharmacokinetics;Bone Resorption/drug therapy;Calcitonin/administration & dosage*;Calcitonin/pharmacokinetics;Food-Drug Interactions;Gastric Emptying/drug effects;Humans;Osteoporosis/drug therapy*;Osteoporosis/metabolism;Peptide Fragments/administration & dosage;Peptide Fragments/pharmacokinetics;Tablets/administration & dosage;Tablets/pharmacokinetics
20653797;Antiparkinson Agents/therapeutic use*;Catechol O-Methyltransferase Inhibitors;Dopamine Agonists/therapeutic use;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/therapeutic use;Parkinson Disease/drug therapy*;Practice Guidelines as Topic
20653361;Animals;Antifungal Agents/therapeutic use*;Azoles/therapeutic use*;Disease Management;Drug Interactions*/physiology;Food-Drug Interactions*/physiology;Humans;Mycoses/drug therapy*;Mycoses/etiology;Transplantation*/adverse effects
20652662;Adult;Cheese/adverse effects*;Chest Pain/drug therapy;Chest Pain/etiology;Chest Pain/physiopathology;Electrocardiography;Female;Food-Drug Interactions*;Heart/drug effects;Heart/physiopathology;Humans;Injections, Intravenous;Monoamine Oxidase Inhibitors/adverse effects*;Morphine/therapeutic use;Myocardial Infarction/blood;Myocardial Infarction/chemically induced*;Myocardial Infarction/physiopathology;Nitroprusside/therapeutic use;Phenelzine/adverse effects*;Treatment Outcome;Troponin I/blood;Vasodilator Agents/therapeutic use
20642557;Aged;Aged, 80 and over;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Cardiovascular Diseases/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Prothrombin Time*;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacology*;Warfarin/therapeutic use
20630973;Aged;Anticoagulants/adverse effects*;Brassica/adverse effects*;Diet/adverse effects;Dyspnea/chemically induced;Female;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Pulmonary Embolism/drug therapy;Recurrence;Vitamin K Deficiency/etiology*;Warfarin/adverse effects*
20628041;Antiparkinson Agents/adverse effects*;Carbidopa/administration & dosage;Drug Therapy, Combination;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Intensive Care Units;Length of Stay;Levodopa/adverse effects*;Male;Middle Aged;Neuroleptic Malignant Syndrome/etiology*;Parkinson Disease/drug therapy
20584229;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects*;Benzimidazoles/metabolism;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dabigatran;Drug Interactions;Food-Drug Interactions;Humans;Morpholines/administration & dosage;Morpholines/adverse effects*;Morpholines/metabolism;Pyrazoles/administration & dosage;Pyrazoles/adverse effects*;Pyrazoles/metabolism;Pyridones/administration & dosage;Pyridones/adverse effects*;Pyridones/metabolism;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects*;Thiophenes/metabolism;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/metabolism
20576487;Absorption;Administration, Oral;Chemistry, Pharmaceutical;Computer Simulation*;Fasting;Female;Food-Drug Interactions;Forecasting;Gastric Emptying;Humans;Intestinal Absorption*;Male;Models, Biological*;Morpholines/administration & dosage;Morpholines/blood;Morpholines/chemistry;Morpholines/pharmacokinetics*;Nanoparticles*;Permeability;Postprandial Period;Randomized Controlled Trials as Topic;Software;Solubility
20566446;Adolescent;Adult;Area Under Curve;Biological Availability;Child;Child, Preschool;Female;Food-Drug Interactions*;Humans;Male;Middle Aged
20554023;Absorption;Administration, Oral;Animals;Chemistry, Pharmaceutical;Computer Simulation*;Dogs;Eating;Fasting;Food-Drug Interactions;Gastrointestinal Transit;Intestinal Absorption;Models, Biological*;Particle Size;Permeability;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/chemistry;Platelet Aggregation Inhibitors/pharmacokinetics*;Reproducibility of Results;Solubility;Tetrazoles/administration & dosage;Tetrazoles/blood;Tetrazoles/chemistry;Tetrazoles/pharmacokinetics*
20550762;Antacids/pharmacology*;Antitubercular Agents/administration & dosage;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Clinical Trials as Topic;Drug Interactions;Food-Drug Interactions*;Humans
20538908;Anticoagulants/therapeutic use*;Drug Monitoring;Enteral Nutrition*;Food, Formulated*/analysis;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Middle Aged;Thromboembolism/prevention & control;Treatment Outcome;Vitamin K/administration & dosage*;Vitamin K/therapeutic use;Warfarin/therapeutic use*
20538051;Administration, Oral;Animals;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Circadian Rhythm*;Diet*;Drug Administration Schedule;Eating*;Food-Drug Interactions*;Male;Milk;Nifedipine/administration & dosage*;Nifedipine/blood;Nifedipine/pharmacokinetics*;Oleic Acid/administration & dosage;Rats;Rats, Sprague-Dawley;Sodium Chloride, Dietary/administration & dosage;Taurocholic Acid/administration & dosage
20534818;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/urine;Area Under Curve;Asian Continental Ancestry Group;Blood Coagulation/drug effects*;Body Mass Index;Chromatography, Liquid;Cross-Over Studies;Dietary Fats*;European Continental Ancestry Group;Factor Xa Inhibitors*;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Models, Biological;Partial Thromboplastin Time;Prothrombin Time;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Pyridines/urine;Tandem Mass Spectrometry;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazoles/urine;Young Adult
20529767;Antineoplastic Agents/therapeutic use;Benzamides;Drug Eruptions/prevention & control;Drug Interactions;Drug Resistance, Neoplasm;Erythropoietin/therapeutic use;Fertility/drug effects;Food-Drug Interactions;France;Granulocyte Colony-Stimulating Factor/therapeutic use;Heart Diseases/chemically induced;Heart Diseases/prevention & control;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Metabolic Diseases/chemically induced;Metabolic Diseases/prevention & control;Neutropenia/chemically induced;Neutropenia/prevention & control;Piperazines/therapeutic use;Protein Kinase Inhibitors/adverse effects*;Protein-Tyrosine Kinases/antagonists & inhibitors;Pyrimidines/adverse effects*;Pyrimidines/therapeutic use;Recombinant Proteins
20520305;Fabaceae/adverse effects*;Fabaceae/metabolism;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Hypertension/metabolism;Levodopa/adverse effects;Levodopa/metabolism;Tyramine/adverse effects;Tyramine/metabolism
20512335;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Beverages/adverse effects;Biological Availability;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drug Labeling;Female;Food-Drug Interactions*;Humans;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Midazolam/metabolism;Middle Aged;Neoplasms/drug therapy;Neoplasms/pathology;Pyrroles/administration & dosage;Pyrroles/pharmacokinetics*
20511734;Administration, Oral;Adolescent;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Biomedical Research;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Drug Evaluation;Drug Monitoring;Drugs, Investigational/administration & dosage;Drugs, Investigational/pharmacokinetics*;Energy Intake;Fasting/physiology;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/pharmacokinetics*;Postprandial Period/physiology;Psychotic Disorders/blood*;Psychotic Disorders/drug therapy;Schizophrenia/blood*;Schizophrenia/drug therapy;Thiazoles/administration & dosage;Thiazoles/pharmacokinetics*;Treatment Outcome;Young Adult
20503933;ATP Binding Cassette Transporter, Sub-Family B/biosynthesis;ATP Binding Cassette Transporter, Sub-Family B/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antineoplastic Agents/pharmacology;Antioxidants/pharmacology*;Blotting, Western;Cell Line, Tumor;Cell Survival/drug effects;Drug Resistance, Neoplasm/drug effects*;Fluoresceins/pharmacology;Food-Drug Interactions;Glutathione Transferase/biosynthesis;Glutathione Transferase/metabolism;Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism;Humans;Kaempferols/pharmacology*;Multidrug Resistance-Associated Proteins/metabolism;Reverse Transcriptase Polymerase Chain Reaction
20503932;Animals;Area Under Curve;Beverages;Calcium Channel Blockers/pharmacokinetics*;Citrus paradisi/chemistry*;Felodipine/pharmacokinetics*;Food-Drug Interactions*;Humans;MEDLINE;Publication Bias*
20495471;Age Factors;Anti-Bacterial Agents/therapeutic use;Beverages*;Evidence-Based Medicine;Female;Food-Drug Interactions;Fruit;Humans;Male;Phytotherapy*;Recurrence;Sex Factors;Treatment Outcome;Urinary Tract Infections/microbiology;Urinary Tract Infections/therapy*;Vaccinium macrocarpon*;Women's Health
20492299;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Alkaloids/pharmacology*;Animals;Benzodioxoles/pharmacology*;Biological Availability;Chromatography, High Pressure Liquid;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Gastric Emptying/drug effects;Half-Life;Histamine H1 Antagonists, Non-Sedating/administration & dosage;Histamine H1 Antagonists, Non-Sedating/blood;Histamine H1 Antagonists, Non-Sedating/pharmacokinetics*;Intestinal Absorption/drug effects*;Male;Piper nigrum/chemistry*;Piperidines/pharmacology*;Polyunsaturated Alkamides/pharmacology*;Rats;Rats, Sprague-Dawley;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics
20490472;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;Confounding Factors (Epidemiology);Cross-Over Studies;Drug Administration Schedule;Eating*;Fasting*;Female;Food-Drug Interactions;Humans;Male;Piperazines/administration & dosage*;Piperazines/blood;Piperazines/pharmacology*;Piperidines/administration & dosage*;Piperidines/blood;Piperidines/pharmacology*;Postprandial Period;Reference Values;Research Design;Time Factors
20486464;Biotransformation;Drug Therapy;Europe;Fasting;Food-Drug Interactions;Guidelines as Topic*;Humans;Patient Selection;Pharmaceutical Preparations/analysis;Pharmaceutical Preparations/metabolism*;Pharmaceutical Preparations/standards*;Pharmacokinetics*;Solubility;Therapeutic Equivalency*
20484610;Adult;Amines/administration & dosage;Amines/adverse effects;Amines/blood;Amines/pharmacokinetics*;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Anticonvulsants/administration & dosage;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/administration & dosage;Cyclohexanecarboxylic Acids/adverse effects;Cyclohexanecarboxylic Acids/blood;Cyclohexanecarboxylic Acids/pharmacokinetics*;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gastric Emptying/drug effects;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Stomach/metabolism*;Young Adult;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/blood;gamma-Aminobutyric Acid/pharmacokinetics*
20481649;Animals;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Antifungal Agents/pharmacology;Area Under Curve;Biological Availability;Drug Interactions;Drug Resistance, Fungal;Food-Drug Interactions;Fungi/drug effects;Humans;Mycoses/drug therapy*;Mycoses/microbiology;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Triazoles/pharmacology
20472816;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Amiodarone/analogs & derivatives*;Amiodarone/pharmacokinetics;Amiodarone/pharmacology;Amiodarone/therapeutic use;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/pharmacology;Anti-Arrhythmia Agents/therapeutic use;Atrial Fibrillation/drug therapy*;Biological Availability;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Drug Interactions;Food-Drug Interactions;Half-Life;Humans
20458565;Food-Drug Interactions;Pharmacokinetics;Pharmacology*;Solubility
20457591;Adolescent;Adult;Cross-Over Studies;Dietary Fats/administration & dosage*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/blood;HIV Integrase Inhibitors/pharmacokinetics*;Humans;Male;Middle Aged;Pyrrolidinones/adverse effects;Pyrrolidinones/blood;Pyrrolidinones/pharmacokinetics*;Raltegravir Potassium;Young Adult
20457501;Animals;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Caseins/metabolism*;Cattle;Ciprofloxacin/chemistry;Ciprofloxacin/pharmacokinetics*;Food-Drug Interactions*;Milk/adverse effects*;Solubility;Tablets
20449528;Beverages;Citrus paradisi;Fatty Acids;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hyperlipidemias/blood;Hyperlipidemias/drug therapy*;Phytosterols
20432867;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Bacteria/metabolism;Bifidobacterium;Drug Interactions;Food-Drug Interactions;Humans;Intestines/metabolism;Intestines/microbiology;Lactobacillus rhamnosus;Probiotics/administration & dosage*;Probiotics/adverse effects;Vitamin K/biosynthesis;Vitamin K/metabolism;Warfarin/administration & dosage*
20422948;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions;Humans;Itraconazole/administration & dosage;Itraconazole/pharmacokinetics*;Male;Reference Standards;Reproducibility of Results;Tandem Mass Spectrometry;Therapeutic Equivalency;Young Adult
20406214;Administration, Oral;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Beverages*;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Oxycodone/administration & dosage;Oxycodone/blood;Oxycodone/pharmacokinetics*
20400647;Adult;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Beverages/analysis*;Biological Availability;Biotransformation;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Itraconazole/adverse effects;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/chemistry;Itraconazole/pharmacokinetics*;Male;Miconazole/blood;Miconazole/chemistry;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Young Adult
20384552;Animals;Antiparkinson Agents/pharmacokinetics*;Antiparkinson Agents/pharmacology;Dietary Fiber/pharmacology;Dietary Proteins/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Levodopa/pharmacokinetics*;Levodopa/pharmacology;Parkinson Disease/drug therapy
20374180;Amlodipine/administration & dosage*;Amlodipine/blood*;Beverages/adverse effects;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/blood;Hypertension/drug therapy*;Hypertension/physiopathology;Japan;Male;Middle Aged;Nifedipine/administration & dosage*;Nifedipine/blood*
20372991;Adult;Area Under Curve;Azithromycin/administration & dosage*;Azithromycin/blood;Azithromycin/pharmacokinetics*;Biological Availability;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Dosage Forms;Fasting;Female;Food-Drug Interactions*;Humans;Male;Molecular Structure
20221896;Administration, Oral;Aminoquinolines/administration & dosage;Aminoquinolines/chemistry;Aminoquinolines/pharmacokinetics*;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/chemistry;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamates/administration & dosage;Carbamates/chemistry;Carbamates/pharmacokinetics*;Cholesterol Ester Transfer Proteins/antagonists & inhibitors*;Chromatography, High Pressure Liquid;Dogs;Food-Drug Interactions;Half-Life;Injections, Intravenous;Intestinal Absorption/physiology*;Intestines/metabolism*;Lipids/chemistry;Lymphatic System/metabolism*;Male;Mass Spectrometry;Molecular Weight;Quinolines/administration & dosage;Quinolines/chemistry;Quinolines/pharmacokinetics*;Solubility;Triglycerides/chemistry
20208387;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis*;Drug Evaluation/methods*;Drug Interactions*;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology;Food-Drug Interactions;Humans;Intestines/drug effects;Intestines/enzymology;Intestines/metabolism*;Models, Statistical*
20206791;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Biopterin/administration & dosage;Biopterin/analogs & derivatives*;Biopterin/blood;Biopterin/pharmacokinetics;Cross-Over Studies;Dietary Fats/administration & dosage*;Energy Intake;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Models, Biological;Postprandial Period;Solubility;Tablets;Young Adult
20197487;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Tablets;Tandem Mass Spectrometry;Young Adult
20183991;Belgium;Biological Availability;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/analysis;Capsules;Chromatography, High Pressure Liquid;Delayed-Action Preparations;Drug Utilization;Food-Drug Interactions;Nifedipine/administration & dosage*;Nifedipine/analysis;Reproducibility of Results;Solubility;Spectrophotometry, Ultraviolet;Tablets
20180933;Acute Disease;Africa;Antimalarials*/administration & dosage;Antimalarials*/pharmacokinetics;Artemisinins*/administration & dosage;Artemisinins*/pharmacokinetics;Biological Availability;Child;Child, Preschool;Diet;Drug Combinations;Ethanolamines/administration & dosage;Ethanolamines/pharmacokinetics*;Female;Fluorenes/administration & dosage;Fluorenes/pharmacokinetics*;Food-Drug Interactions*;Humans;Malaria, Falciparum/blood;Malaria, Falciparum/drug therapy*;Male;Time Factors
20166442;Administration, Oral;Area Under Curve;Asian Continental Ancestry Group;China;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Fluorobenzenes/administration & dosage;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions;Half-Life;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sex Factors;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Young Adult
20160155;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Adult;Beverages;China;Chromatography, High Pressure Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/genetics*;Cytochrome P-450 CYP3A Inhibitors;DNA/genetics;Ethnic Groups;Female;Food-Drug Interactions;Genotype;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Phenotype;Polymorphism, Genetic;Reverse Transcriptase Polymerase Chain Reaction;Young Adult
20150522;Adamantane/analogs & derivatives*;Adamantane/blood;Adamantane/pharmacokinetics;Adult;Area Under Curve;Cross-Over Studies;Dietary Fats*;Dipeptides/blood;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/blood;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
20147618;Administration, Oral;Adult;Analgesics/blood;Analgesics/pharmacokinetics*;Analgesics/urine;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Anticonvulsants/urine;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Half-Life;Humans;Metabolic Clearance Rate;Middle Aged;Pregabalin;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/blood;gamma-Aminobutyric Acid/pharmacokinetics;gamma-Aminobutyric Acid/urine
20144318;Adult;Diabetes Mellitus, Type 2/genetics*;Diabetes Mellitus, Type 2/metabolism*;Diet*;Food-Drug Interactions/genetics;Genetic Predisposition to Disease;Humans;Metabolic Syndrome/genetics;Nutrigenomics*;Research Design
20140680;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Caco-2 Cells;Cardiovascular Agents/analysis;Cardiovascular Agents/pharmacokinetics*;Cell Membrane Permeability;Dietary Supplements*/analysis;Food-Drug Interactions*;Garlic/chemistry*;Humans;Hypoglycemic Agents/analysis;Hypoglycemic Agents/pharmacokinetics*;Intestinal Absorption;Intestine, Small/metabolism;Male;Monocarboxylic Acid Transporters/metabolism;Multidrug Resistance-Associated Proteins/metabolism;Organic Anion Transporters/metabolism;Peptide Transporter 1;Plant Extracts*/chemistry;Plant Roots/chemistry*;Rats;Rats, Wistar;Symporters/metabolism;Transcytosis
20137869;Adolescent;Alcoholic Intoxication/psychology;Alcoholism/psychology;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Computer Simulation;Decision Making*;Eating;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Humans
20137768;Adolescent;Adult;Area Under Curve;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Liquid/methods;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/adverse effects;Nifedipine/pharmacokinetics*;Osmosis;Tablets;Tandem Mass Spectrometry/methods;Therapeutic Equivalency;Young Adult
20137764;Adult;Amines/pharmacokinetics;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamates/adverse effects;Carbamates/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/pharmacokinetics;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prodrugs;Young Adult;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/pharmacokinetics
20132652;Amino Acids, Aromatic/pharmacokinetics;Binding, Competitive;Chronotherapy;Diet, Mediterranean;Diet, Protein-Restricted*;Food-Drug Interactions;Humans;Levodopa/pharmacokinetics;Levodopa/therapeutic use;Parkinson Disease/diet therapy*
20110012;Adolescent;Adult;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benzothiazoles/administration & dosage*;Benzothiazoles/adverse effects;Benzothiazoles/pharmacokinetics*;Biological Availability;Body Mass Index;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dietary Fats;Food-Drug Interactions;Humans;Male;Reproducibility of Results;Young Adult
20101064;Administration, Oral;Adult;Area Under Curve;Benzoxazines/administration & dosage*;Benzoxazines/blood;Benzoxazines/pharmacokinetics*;Biological Availability;Capsules;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Reverse Transcriptase Inhibitors/administration & dosage*;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Taste;Therapeutic Equivalency
20095789;Aldehyde Oxidase/antagonists & inhibitors;Aldehyde Oxidase/metabolism*;Animals;Drug Interactions;Flavonoids/metabolism*;Flavonoids/pharmacology;Flavonoids/therapeutic use;Food-Drug Interactions;Humans;Metalloproteins/antagonists & inhibitors;Metalloproteins/metabolism*;Molybdenum/metabolism*;Oxidation-Reduction;Phytotherapy;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Structure-Activity Relationship;Xanthine Oxidase/antagonists & inhibitors;Xanthine Oxidase/metabolism*;Xenobiotics/metabolism
20081065;Administration, Oral;Adolescent;Adult;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics*;Area Under Curve;Bleeding Time;Dose-Response Relationship, Drug;Factor Xa/metabolism;Factor Xa Inhibitors*;Food-Drug Interactions;Half-Life;Humans;International Normalized Ratio;Male;Middle Aged;Partial Thromboplastin Time;Prothrombin Time;Pyridines/adverse effects*;Pyridines/pharmacokinetics*;Single-Blind Method;Tablets;Thiazoles/adverse effects*;Thiazoles/pharmacokinetics*;Young Adult
20067711;Animals;Biotransformation;Clinical Trials as Topic/standards;Dietary Supplements*;Dosage Forms;Food-Drug Interactions*;Functional Food*;Humans;Pharmacokinetics;Risk Assessment
20065263;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Arecaceae/chemistry*;Beverages/adverse effects*;Blood Coagulation/drug effects;Fatty Acids/adverse effects;Food-Drug Interactions*;Fruit/chemistry*;Humans;United States;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
20053516;Animals;Anti-Infective Agents/chemistry*;Anti-Infective Agents/metabolism;Biological Availability;Calcium/chemistry;Caseins/chemistry;Chromatography, High Pressure Liquid;Ciprofloxacin/chemistry*;Ciprofloxacin/metabolism;Food-Drug Interactions*;Hydrogen-Ion Concentration;Kinetics;Lipids/chemistry;Milk/adverse effects*;Reproducibility of Results;Solid Phase Extraction;Solubility;Spectrometry, Mass, Electrospray Ionization;Tablets
20044363;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects*;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Practice Guidelines as Topic*;Prescription Drugs*
21819799;Adult;Anticonvulsants/poisoning*;Benzodiazepines/poisoning*;Beverages/poisoning*;Codeine/poisoning;Fatal Outcome;Food-Drug Interactions*;Humans;Male;Morphine/poisoning;Papaver/chemistry*;Plant Extracts;Seeds/chemistry;Thebaine/poisoning
20040339;Administration, Oral;Adult;Area Under Curve;Cimetidine/pharmacokinetics;Cimetidine/pharmacology;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacokinetics;Histamine H2 Antagonists/pharmacology;Humans;Hypoglycemic Agents/pharmacology;Male;Metformin/pharmacokinetics;Metformin/pharmacology;Middle Aged;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Uracil/adverse effects;Uracil/analogs & derivatives*;Uracil/pharmacokinetics;Young Adult
20029019;Anticoagulants/therapeutic use*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Hematoma/diagnosis;Hematoma/etiology*;Humans;International Normalized Ratio;Middle Aged;Punicaceae/adverse effects*;Warfarin/therapeutic use*
20001610;Anti-HIV Agents/chemistry;Anti-HIV Agents/therapeutic use*;Benzoxazines/adverse effects;Benzoxazines/chemistry;Benzoxazines/metabolism;Benzoxazines/pharmacokinetics;Benzoxazines/therapeutic use*;Chemistry, Pharmaceutical;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1;Humans;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/chemistry;Reverse Transcriptase Inhibitors/metabolism;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*
19948946;Adolescent;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Beverages;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions*;Fusion Proteins, bcr-abl/metabolism;Headache/chemically induced;Humans;Male;Middle Aged;Protein-Tyrosine Kinases/metabolism;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Vomiting/chemically induced;Young Adult
19947351;Antineoplastic Agents/pharmacology*;Antioxidants/pharmacology*;DNA Damage/drug effects;Dietary Supplements*;Edible Grain;Food-Drug Interactions/physiology*;Fruit;Humans;Neoplasms/drug therapy*;Oxidative Stress/drug effects;Vegetables
19945772;Adenocarcinoma/drug therapy;Adenocarcinoma/pathology;Adenocarcinoma/physiopathology*;Antimetabolites, Antineoplastic/pharmacology;Apoptosis*;Cell Count;Cell Cycle;Cell Survival*;Colorectal Neoplasms/drug therapy;Colorectal Neoplasms/pathology;Colorectal Neoplasms/physiopathology*;Drug Combinations;Fat Emulsions, Intravenous/administration & dosage*;Fat Emulsions, Intravenous/chemistry;Fatty Acids/analysis;Fish Oils/chemistry;Fluorouracil/pharmacology;Food-Drug Interactions;HT29 Cells;Humans;Osmolar Concentration;Phospholipids/administration & dosage;Phospholipids/chemistry;S Phase/drug effects*;Sorbitol/administration & dosage;Sorbitol/chemistry;Soybean Oil/chemistry;Triglycerides/administration & dosage;Triglycerides/chemistry
19925488;Adult;Anaphylaxis/etiology*;Anaphylaxis/immunology;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Exercise*;Female;Food-Drug Interactions;Humans;Immunoglobulin E/analysis;Male;Skin Tests;Wheat Hypersensitivity/complications*;Wheat Hypersensitivity/immunology
19925256;Adult;Alginates/administration & dosage*;Alginates/pharmacokinetics;Antacids/administration & dosage*;Antacids/pharmacokinetics;Chemistry, Pharmaceutical/instrumentation*;Chemistry, Pharmaceutical/methods;Cross-Over Studies;Drug Combinations;Food-Drug Interactions/physiology;Gastroesophageal Reflux/diagnostic imaging;Gastroesophageal Reflux/drug therapy;Glucuronic Acid/administration & dosage;Glucuronic Acid/pharmacokinetics;Hexuronic Acids/administration & dosage;Hexuronic Acids/pharmacokinetics;Humans;Male;Radionuclide Imaging;Stomach/diagnostic imaging*;Stomach/drug effects;Stomach/metabolism*;Young Adult
19924121;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Dietary Fats;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions*;Fusion Proteins, bcr-abl/administration & dosage;Fusion Proteins, bcr-abl/pharmacokinetics*;Humans;Leukocyte Count;Male;Middle Aged;Protein-Tyrosine Kinases/administration & dosage;Protein-Tyrosine Kinases/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*;Solubility;Young Adult
19922894;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/pharmacokinetics*;Female;Food-Drug Interactions;Gelatin;Humans;Intestinal Absorption;Male;Young Adult
19908637;Anti-Bacterial Agents/pharmacology*;Food-Drug Interactions*;Humans
19902529;Antioxidants/metabolism*;Circular Dichroism;Dietary Supplements;Food-Drug Interactions*;Humans;Magnetic Resonance Spectroscopy;Protein Binding;Quercetin/metabolism*;Serum Albumin/metabolism*;Warfarin/metabolism*
19895490;Anti-Bacterial Agents/pharmacology*;Bacillus subtilis/drug effects;Dietary Carbohydrates;Dietary Fats;Dietary Proteins;Drug Synergism;Edetic Acid/pharmacology*;Escherichia coli/drug effects;Food Microbiology*;Food Preservatives/pharmacology;Food-Drug Interactions*;Laurates/pharmacology*;Microbial Sensitivity Tests;Monoglycerides/pharmacology*;Nisin/pharmacology*;Propionates/pharmacology;Pyrones/pharmacology*;Sodium Lactate/pharmacology;Staphylococcus aureus/drug effects
19881206;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/metabolism;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/metabolism;Benzoates/administration & dosage;Benzoates/metabolism;Camptothecin/administration & dosage;Camptothecin/adverse effects;Camptothecin/analogs & derivatives;Camptothecin/metabolism;Coumaric Acids;Cyclohexanes/administration & dosage;Cyclohexanes/metabolism*;Drug Interactions;Flavonoids;Food-Drug Interactions;Functional Food;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/metabolism*;Intestinal Absorption*;Monocarboxylic Acid Transporters/physiology;Phenols;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/metabolism;Polyphenols
19891943;Absorptiometry, Photon;Accidental Falls/prevention & control;Aged;Algorithms;Biomarkers/blood;Bone Density*;Bone Density Conservation Agents/therapeutic use*;Calcium/therapeutic use*;Congresses as Topic;Diphosphonates/therapeutic use;Drug Interactions;Drug Therapy, Combination;Estrogen Replacement Therapy/methods;Female;Food-Drug Interactions;Hip Fractures/diagnosis;Hip Fractures/physiopathology;Hip Fractures/prevention & control*;Humans;Life Style;Mass Screening/methods;Middle Aged;Osteoporosis, Postmenopausal/blood;Osteoporosis, Postmenopausal/complications;Osteoporosis, Postmenopausal/diagnosis*;Osteoporosis, Postmenopausal/physiopathology;Osteoporosis, Postmenopausal/prevention & control*;Osteoporotic Fractures/blood;Osteoporotic Fractures/diagnosis*;Osteoporotic Fractures/etiology;Osteoporotic Fractures/physiopathology;Osteoporotic Fractures/prevention & control*;Osteoprotegerin/blood;Practice Guidelines as Topic;RANK Ligand/blood;Risk Assessment;Risk Factors;Treatment Outcome;Vitamin D/therapeutic use*
19843830;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Influenza Vaccines/adverse effects*;Influenza Vaccines/pharmacokinetics;Intracranial Hemorrhages/chemically induced*;Intracranial Hemorrhages/metabolism;Warfarin/adverse effects*;Warfarin/pharmacokinetics
19830413;Administration, Oral;Adolescent;Adult;Beverages*;Biological Availability;Body Mass Index;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Fruit*;Half-Life;Humans;Jordan;Male;Phosphodiesterase 5 Inhibitors*;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/blood;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/administration & dosage;Piperazines/blood;Piperazines/pharmacokinetics*;Purines/administration & dosage;Purines/blood;Purines/pharmacokinetics;Sildenafil Citrate;Statistics as Topic;Sulfones/administration & dosage;Sulfones/blood;Sulfones/pharmacokinetics*;Young Adult
19822208;Administration, Oral;Dosage Forms*;Electromagnetic Phenomena;Ferrosoferric Oxide/chemistry;Food-Drug Interactions;Humans;Imaging, Three-Dimensional/methods*;Magnetic Resonance Imaging/methods*;Particle Size;Stomach*;Technology, Pharmaceutical/methods;Time Factors
19804821;Animals;Biological Availability;Cross-Over Studies;Flavonols/administration & dosage*;Flavonols/blood;Flavonols/pharmacokinetics*;Food-Drug Interactions/physiology*;Male;Quercetin/administration & dosage*;Quercetin/blood;Quercetin/pharmacokinetics*;Simvastatin/blood;Simvastatin/pharmacokinetics*;Swine
19789373;Beverages*;Biological Availability;Clinical Trials as Topic;Food-Drug Interactions*;Fruit*;Humans;Organic Anion Transporters/metabolism*;Pharmacokinetics*
19779132;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Adrenergic beta-1 Receptor Antagonists;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*/adverse effects;Biological Transport/drug effects;Cell Culture Techniques;Cell Membrane Permeability/drug effects;Citrus paradisi/chemistry*;Dose-Response Relationship, Drug;Flavanones/adverse effects;Flavanones/isolation & purification;Food-Drug Interactions*;Humans;Intestinal Absorption*;LLC-PK1 Cells;Oocytes/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/biosynthesis;Propanolamines/pharmacokinetics*;Rats;Rats, Wistar;Species Specificity;Swine;Transfection;Xenopus laevis
19766437;Absorption;Anticoagulants/adverse effects*;Anticoagulants/metabolism*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Drug Overdose;Female;Food-Drug Interactions;Humans;Middle Aged;Phenindione/adverse effects;Phenindione/analogs & derivatives*;Phenindione/metabolism;Severity of Illness Index;Vitamin K/antagonists & inhibitors*
19749487;Animals;Catalysis;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/physiology*;Environment;Food-Drug Interactions;Humans;Liver/enzymology;Oxidation-Reduction;Pharmaceutical Preparations/metabolism*;Pharmacogenetics;Polymorphism, Genetic;Species Specificity;Substrate Specificity
19746411;Animals;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Data Interpretation, Statistical;Dogs;Drug Combinations;Drug Evaluation, Preclinical;Food-Drug Interactions;HIV Infections/drug therapy;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;Humans;Lopinavir;Models, Biological;Pyrimidinones/administration & dosage;Pyrimidinones/pharmacokinetics*;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Tablets;Therapeutic Equivalency
19730804;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/metabolism;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Colitis, Ulcerative/drug therapy;Crohn Disease/drug therapy;Double-Blind Method;Drug Administration Schedule;Drug Monitoring;Food-Drug Interactions;Humans;Japan;Male;Mesalamine/administration & dosage;Mesalamine/metabolism;Mesalamine/pharmacokinetics*;Metabolic Clearance Rate;Middle Aged;Safety*;Tablets;Time Factors
19728565;Adolescent;Adult;Amodiaquine/administration & dosage;Amodiaquine/adverse effects;Amodiaquine/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Spectrometry, Mass, Electrospray Ionization;Young Adult
19721907;Anticholesteremic Agents/pharmacology*;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control*;Diet*;Follow-Up Studies;Food-Drug Interactions;Humans;Hypercholesterolemia/complications;Hypercholesterolemia/etiology*;Male;Middle Aged;Olive Oil;Plant Oils*;Risk Factors;Simvastatin/pharmacology*;Sunflower Oil
19721898;Antineoplastic Agents/pharmacology*;Food-Drug Interactions*;Humans
19694738;Administration, Oral;Adult;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/pharmacokinetics*;Cytochrome P-450 CYP2C9;Diclofenac/administration & dosage;Diclofenac/pharmacokinetics*;Drug Monitoring;Epidemiologic Methods;Female;Food-Drug Interactions/physiology;Humans;Male;Microsomes, Liver/metabolism*;Plant Extracts/metabolism*;Vaccinium macrocarpon/metabolism*;Young Adult
19694184;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Beverages/analysis*;Budesonide/administration & dosage*;Budesonide/pharmacokinetics*;Capsules;Chromatography, High Pressure Liquid;Citrus paradisi*;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Injections, Intravenous;Male;Mass Spectrometry;Young Adult
19682087;Administration, Oral;Animals;Biological Availability;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Male;Omeprazole/blood;Omeprazole/pharmacokinetics*;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics;Rats;Rats, Wistar;Seeds/metabolism;Soybeans*
19669631;Administration, Oral;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/pharmacokinetics*;Antipsychotic Agents/pharmacology;Biological Availability;Bipolar Disorder/drug therapy;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Monitoring;Energy Intake*;Food-Drug Interactions*;Humans;Injections, Intramuscular;Intestinal Absorption;Piperazines/administration & dosage*;Piperazines/pharmacokinetics*;Piperazines/pharmacology;Safety;Schizophrenia/drug therapy;Thiazoles/administration & dosage*;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology;Treatment Outcome
19667002;Drug Incompatibility;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
19663740;ATP-Binding Cassette Transporters/metabolism;Absorption;Amino Acid Transport Systems/metabolism;Animals;Brain/metabolism;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans;Membrane Transport Proteins/physiology*;Pharmaceutical Preparations/metabolism;Pharmaceutical Preparations/urine;Pharmacokinetics;RNA, Messenger/biosynthesis;RNA, Messenger/genetics;Subcellular Fractions/metabolism;Tissue Distribution
19663632;Animals;Biological Availability;Cytochrome P-450 Enzyme System/metabolism;Dietary Fats/pharmacology*;Fatty Acids/pharmacology;Food-Drug Interactions;Humans;Isoenzymes/metabolism;Lipids/pharmacology*;Lipoproteins/physiology*;Pharmaceutical Preparations/metabolism*
19663519;Adolescent;Adult;Age Factors;Aged;Dosage Forms;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Evaluation;Electrocardiography/drug effects;Female;Food-Drug Interactions;Glycation End Products, Advanced/antagonists & inhibitors*;Humans;Male;Middle Aged;Pyridinium Compounds/administration & dosage*;Pyridinium Compounds/adverse effects;Pyridinium Compounds/pharmacokinetics;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics;Therapeutic Equivalency
19660444;Animals;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology*;Area Under Curve;Blood Pressure;Dose-Response Relationship, Drug;Electrocardiography;Electrolytes/urine;Female;Food-Drug Interactions*;Garlic*;Hydrochlorothiazide/pharmacokinetics;Hydrochlorothiazide/pharmacology*;Rats;Rats, Wistar
19660002;Adult;Aged;Area Under Curve;Cross-Over Studies;Erectile Dysfunction/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphodiesterase Inhibitors/therapeutic use;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Sulfonamides;Young Adult
19646718;Adult;Atrial Fibrillation/chemically induced;Autoimmune Diseases/epidemiology;Comorbidity;Contraindications;Dose-Response Relationship, Drug;Drug Interactions;Estrogens/pharmacokinetics;Estrogens/physiology;Female;Food-Drug Interactions;Gastritis/epidemiology;Heart Diseases/epidemiology;Hormone Replacement Therapy*;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/drug effects;Male;Middle Aged;Osteoporosis/chemically induced;Pregnancy;Pregnancy Complications/epidemiology;Thyrotropin/blood;Thyroxine/administration & dosage;Thyroxine/adverse effects;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*
19644845;Adult;Female;Food;Food-Drug Interactions/physiology;Gastric Juice/metabolism*;Humans;Male;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Satiation/physiology*;Solubility;Stomach/metabolism*
19637955;Anticoagulants/pharmacokinetics*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Middle Aged;Punicaceae/adverse effects*;Venous Thrombosis/drug therapy;Warfarin/pharmacokinetics*
19634639;Animals;Anti-Bacterial Agents/pharmacokinetics;Beverages;Biological Availability;Fluoroquinolones/pharmacokinetics*;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/physiology*;Kinetics;Milk
19627745;Adult;Anti-Allergic Agents/therapeutic use;Child;Dietary Sucrose/adverse effects;Food/adverse effects*;Food Additives/adverse effects;Food Hypersensitivity/diet therapy;Food Hypersensitivity/drug therapy;Food Hypersensitivity/epidemiology;Food Hypersensitivity/etiology;Food-Drug Interactions;Foodborne Diseases/epidemiology;Foodborne Diseases/etiology;Humans;Lactose Intolerance/diagnosis;Lactose Intolerance/diet therapy;Lactose Intolerance/drug therapy;Lactose Intolerance/epidemiology;Metabolism, Inborn Errors/complications;Prevalence;beta-Galactosidase/therapeutic use
19619649;Administration, Oral;Amoxicillin/blood;Amoxicillin/pharmacokinetics;Amoxicillin-Potassium Clavulanate Combination/pharmacokinetics;Chemistry, Pharmaceutical/methods;Dosage Forms*;Drug Delivery Systems;Electromagnetic Phenomena;Female;Food-Drug Interactions;Gastrointestinal Motility;Gastrointestinal Tract/physiology*;Humans;Imaging, Three-Dimensional/methods*;Male;Molecular Probe Techniques*;Molecular Probes*/chemistry;Solubility;Tablets, Enteric-Coated/analysis;Tablets, Enteric-Coated/chemistry;Technology, Pharmaceutical/methods*
19617468;Administration, Oral;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics;Area Under Curve;Drug Administration Schedule;Food-Drug Interactions;Gastric Mucosa/metabolism;Humans;Mycoses/drug therapy*;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics
19601724;Animals;Anti-Allergic Agents*/administration & dosage;Anti-Allergic Agents*/adverse effects;Anti-Allergic Agents*/pharmacokinetics;Anti-Allergic Agents*/therapeutic use;Carrier Proteins/metabolism;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Diet*;Dose-Response Relationship, Drug;Drug Interactions*;Drug Therapy, Combination;Food-Drug Interactions;Humans;Models, Biological
19594405;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Food-Drug Interactions;Humans;Oxidation-Reduction;Polymorphism, Genetic*;Xenobiotics/metabolism*
19591515;Administration, Oral;Adolescent;Adult;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/pharmacokinetics*;Cross-Over Studies;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged
19589874;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Acridines/pharmacology;Administration, Oral;Animals;Biological Transport/physiology*;Caco-2 Cells;Colchicine/pharmacokinetics*;Drug Interactions;Epithelium/drug effects;Epithelium/physiology;Food-Drug Interactions;Humans;Ileum/drug effects;Ileum/pathology;Indoles/administration & dosage;Indoles/pharmacology;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Intestine, Small/drug effects;Intestine, Small/pathology;Intestine, Small/physiology;Jejunum/drug effects;Jejunum/pathology;Male;Multidrug Resistance-Associated Proteins/physiology*;Oxotremorine/analogs & derivatives;Oxotremorine/pharmacokinetics;Oxotremorine/pharmacology;Permeability;Rats;Rats, Wistar;Tetrahydroisoquinolines/pharmacology;Verapamil/administration & dosage;Verapamil/pharmacology;p-Aminohippuric Acid/pharmacokinetics;p-Aminohippuric Acid/pharmacology
19585717;Arrhythmias, Cardiac/chemically induced*;Clinical Trials as Topic;Drug Approval;Drug Interactions;Exercise Tolerance/drug effects;Food-Drug Interactions;France;Humans;Intermittent Claudication/drug therapy*;Mortality;Pentoxifylline/administration & dosage;Pentoxifylline/adverse effects;Pentoxifylline/therapeutic use;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/therapeutic use;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use;Randomized Controlled Trials as Topic;Risk;Tetrazoles/administration & dosage;Tetrazoles/adverse effects*;Tetrazoles/therapeutic use;Walking
19585468;Anthocyanins/pharmacology*;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/pharmacology*;Fluvoxamine/pharmacology;Food-Drug Interactions;Fruit/chemistry;Humans;Inhibitory Concentration 50;Luminescent Measurements;Proanthocyanidins/pharmacology
19581528;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Neoplasms/drug therapy*;Neoplasms/pathology;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*;Reference Values;Risk Assessment
19572422;Adult;Aged;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacology;Anti-HIV Agents/therapeutic use;Child;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Fasting;Female;Food-Drug Interactions;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;HIV Infections/drug therapy*;HIV Integrase Inhibitors/administration & dosage;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/pharmacokinetics;HIV Integrase Inhibitors/pharmacology*;HIV Integrase Inhibitors/therapeutic use;Humans;Inactivation, Metabolic;Intestinal Absorption;Male;Microsomes, Liver/enzymology;Polypharmacy;Pregnancy;Pregnancy Complications, Infectious/drug therapy;Pyrrolidinones/administration & dosage;Pyrrolidinones/adverse effects;Pyrrolidinones/pharmacokinetics;Pyrrolidinones/pharmacology*;Pyrrolidinones/therapeutic use;Raltegravir Potassium
19559560;Animals;Butylene Glycols/metabolism*;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Estradiol/metabolism;Estradiol/pharmacology*;Female;Flax/metabolism*;Food-Drug Interactions;Insulin-Like Growth Factor I/analysis;Insulin-Like Growth Factor I/metabolism;Intestine, Small/enzymology;Intestine, Small/metabolism;Lignans/metabolism*;Liver/enzymology;Liver/metabolism;Organ Size;Ovariectomy;Phytoestrogens/metabolism*;RNA/chemistry;RNA/genetics;Random Allocation;Reverse Transcriptase Polymerase Chain Reaction/veterinary;Sheep/metabolism*;Stomach/enzymology;Stomach/metabolism;Thyroxine/analysis;Thyroxine/metabolism;Triiodothyronine/analysis;Triiodothyronine/metabolism
19553405;Adult;Aged;Aged, 80 and over;Anticoagulants/pharmacokinetics*;Beverages/adverse effects*;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacokinetics*
19548857;Animals;Food-Drug Interactions/physiology;HIV Infections/drug therapy;HIV Infections/enzymology;HIV Reverse Transcriptase/antagonists & inhibitors*;HIV Reverse Transcriptase/metabolism;Humans;Nitriles/chemistry*;Nitriles/pharmacokinetics;Nitriles/therapeutic use*;Pyrimidines/chemistry*;Pyrimidines/pharmacokinetics;Pyrimidines/therapeutic use*;Reverse Transcriptase Inhibitors/chemistry*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*;Rilpivirine
19480806;Dietetics/education;Enteral Nutrition/adverse effects;Enteral Nutrition/methods;Enteral Nutrition/standards;Evidence-Based Medicine;Feeding Behavior;Food Preservation/standards;Food Service, Hospital/standards;Food, Formulated/adverse effects;Food, Formulated/standards;Food-Drug Interactions;Humans;Malnutrition/diagnosis;Malnutrition/prevention & control;Malnutrition/therapy;Mass Screening/methods;Mass Screening/standards;Medical Records/standards;Nutrition Assessment;Nutritional Support/standards*;Parenteral Nutrition/adverse effects;Parenteral Nutrition/methods;Parenteral Nutrition/standards;Parenteral Nutrition Solutions/administration & dosage;Parenteral Nutrition Solutions/chemistry;Parenteral Nutrition Solutions/standards;Patient Care Planning;Quality Assurance, Health Care;Risk Factors;Spain;Surveys and Questionnaires
19476741;Adjuvants, Immunologic/pharmacology;Adjuvants, Immunologic/therapeutic use;Animals;Diabetes Mellitus/therapy;Food-Drug Interactions;Grifola*/chemistry;Humans;Neoplasms/therapy;beta-Glucans/analysis
19473600;Adolescent;Adult;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/blood;Benzhydryl Compounds/pharmacokinetics*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Muscarinic Antagonists/adverse effects;Muscarinic Antagonists/blood;Muscarinic Antagonists/pharmacokinetics*
19465123;Adult;Animals;Biological Availability;Celecoxib;Cross-Over Studies;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Milk/metabolism*;Models, Biological*;Predictive Value of Tests;Pyrazoles/chemistry;Pyrazoles/pharmacokinetics*;Solubility;Sulfonamides/chemistry;Sulfonamides/pharmacokinetics*
19458055;Abdominal Pain/chemically induced;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Diarrhea/chemically induced;Drug Administration Schedule;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Organoplatinum Compounds/administration & dosage;Organoplatinum Compounds/adverse effects;Organoplatinum Compounds/pharmacokinetics*;Vomiting/chemically induced
19446149;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Area Under Curve;Benzoates/administration & dosage;Benzoates/adverse effects;Benzoates/pharmacokinetics*;Biological Availability;Calcium, Dietary/pharmacology;Capsules;Cross-Over Studies;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions*;Humans;Hydrazines/administration & dosage;Hydrazines/adverse effects;Hydrazines/pharmacokinetics*;Magnesium/pharmacology;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Receptors, Thrombopoietin/agonists;Tablets;Young Adult
19445995;Adult;Antitussive Agents/pharmacokinetics*;Antitussive Agents/urine;Beverages*/analysis;Biotransformation;Calibration;Chromatography, High Pressure Liquid;Citrus paradisi*/chemistry;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Dextromethorphan/pharmacokinetics*;Dextromethorphan/urine;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Indicators and Reagents;Male;Middle Aged;Reproducibility of Results;Tandem Mass Spectrometry;Young Adult
19439487;Administration, Oral;Animals;Animals, Newborn;Antiviral Agents/administration & dosage;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Biological Transport;Brain/metabolism;Caco-2 Cells;Caseins/metabolism;Dipeptides/pharmacology;Female;Food-Drug Interactions*;HeLa Cells;Humans;Intestinal Absorption*/drug effects;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism*;Male;Milk/metabolism*;Oseltamivir/administration & dosage;Oseltamivir/blood;Oseltamivir/pharmacokinetics*;Peptide Transporter 1;Rats;Rats, Wistar;Symporters/antagonists & inhibitors;Symporters/genetics;Symporters/metabolism*;Temperature;Transfection
19398716;Abdominal Pain/chemically induced;Aged;Aged, 80 and over;Biotransformation;Dose-Response Relationship, Drug;Female;Fever/chemically induced;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glutathione/administration & dosage;Glutathione/adverse effects;Glutathione/analogs & derivatives*;Glutathione/pharmacokinetics;Glutathione/therapeutic use;Humans;Male;Maximum Tolerated Dose;Middle Aged;Myelodysplastic Syndromes/drug therapy*;Neutropenia/chemically induced;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/therapeutic use*;Tablets
19373300;Antidepressive Agents/adverse effects*;Beverages;Drug Interactions;Food-Drug Interactions;Humans;Isocarboxazid/adverse effects;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Phenelzine/adverse effects;Risk Factors;Serotonin Syndrome/chemically induced;Tranylcypromine/adverse effects
19369574;Administration, Oral;Adult;Cross-Over Studies;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Purines/administration & dosage*;Ribavirin/administration & dosage;Ribavirin/pharmacokinetics*
19357792;Anthocyanins/administration & dosage;Anthocyanins/pharmacology*;Cytochrome P-450 CYP2D6 Inhibitors*;Flavonoids/administration & dosage;Flavonoids/pharmacology*;Food-Drug Interactions;Fruit/chemistry;Humans;Inhibitory Concentration 50;Luminescent Measurements/methods;Phenols/administration & dosage;Phenols/pharmacology*;Polyphenols;Vegetables/chemistry
19356393;Adult;Amitriptyline/administration & dosage;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Humans;Male;Muscle Relaxants, Central/administration & dosage;Muscle Relaxants, Central/pharmacokinetics*;Tablets;Young Adult
19328861;Aged;Antacids/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biotransformation;Double-Blind Method;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Linear Models;Male;Middle Aged;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Therapeutic Equivalency
19319690;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/metabolism;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Algorithms;Biological Transport, Active;Caco-2 Cells;Calcium Channel Blockers/pharmacology;Cell Membrane Permeability/drug effects;Dose-Response Relationship, Drug;Drug Interactions;Epithelial Cells/metabolism*;Food-Drug Interactions;Histamine H2 Antagonists/metabolism*;Humans;Intestines/cytology;Intestines/metabolism*;Kinetics;Multidrug Resistance-Associated Proteins/antagonists & inhibitors;Multidrug Resistance-Associated Proteins/metabolism;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/metabolism;Nizatidine/metabolism*;Spectrophotometry, Ultraviolet;Verapamil/pharmacology
19318633;Calcium/pharmacology;Clinical Trials as Topic;Folic Acid/pharmacology;Food-Drug Interactions;Humans;Micronutrients/pharmacology*;Neoplasms/prevention & control*;Research Design;Selenium/pharmacology;Trace Elements/pharmacology;Treatment Failure;Vitamin B 12/pharmacology;Vitamin B 6/pharmacology;Vitamin D/pharmacology;Vitamin E/pharmacology;Vitamins/pharmacology;beta Carotene/pharmacology
19293342;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Ghrelin/agonists*;Human Growth Hormone/metabolism;Humans;Indoles;Insulin-Like Growth Factor I/metabolism;Male;Oligopeptides/adverse effects;Oligopeptides/pharmacokinetics*;Oligopeptides/pharmacology*;Tryptophan/analogs & derivatives
19284184;Aluminum/toxicity;Autistic Disorder/chemically induced*;Autistic Disorder/metabolism;Cadmium/toxicity;Child;Child Welfare;Cytokines/metabolism;Environmental Pollutants/toxicity*;Fluorides/toxicity;Food Additives/toxicity*;Food-Drug Interactions;Glutamic Acid/metabolism;Humans;Immune System Diseases/metabolism;Lead/toxicity;Metals, Heavy/toxicity*;Mitochondria/metabolism;Neurotoxins/toxicity*;Risk Factors
19281729;Administration, Oral;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Middle Aged;Neoplasms/drug therapy*;Therapeutic Equivalency;Topotecan/adverse effects;Topotecan/pharmacokinetics*;Topotecan/therapeutic use*
19277401;Anticoagulants/administration & dosage*;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Half-Life;Humans;International Normalized Ratio;Medication Adherence;Oligosaccharides/administration & dosage*;Secondary Prevention;Thromboembolism/drug therapy*;Thromboembolism/economics;Thromboembolism/prevention & control;Warfarin/administration & dosage*
19267186;Diet;Duodenum/physiology*;Female;Food-Drug Interactions;Gastrointestinal Contents/chemistry*;Humans;Linear Models;Male;Models, Biological;Pharmaceutical Preparations/analysis*;Pharmaceutical Preparations/chemistry;Postprandial Period*;Solubility;Time Factors
19255348;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Patient Education as Topic/methods*;Practice Guidelines as Topic*;Rheumatic Heart Disease/drug therapy;Therapeutic Equivalency;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
19253346;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Azetidines/administration & dosage;Azetidines/pharmacology;Benzylamines/administration & dosage;Benzylamines/pharmacology;Biological Availability;Blood Coagulation/drug effects;Drug Design;Factor Xa Inhibitors;Food-Drug Interactions*;Humans;Rats;Thrombin/antagonists & inhibitors;Vitamin K/antagonists & inhibitors;Vitamin K/pharmacokinetics*;Vitamin K Deficiency/blood
19243357;2-Pyridinylmethylsulfinylbenzimidazoles/blood;2-Pyridinylmethylsulfinylbenzimidazoles/pharmacokinetics*;Adolescent;Adult;Cross-Over Studies;Delayed-Action Preparations;Dexlansoprazole;Dietary Fats/pharmacokinetics*;Fasting;Female;Food-Drug Interactions*;Humans;Lansoprazole;Male;Middle Aged;Proton Pump Inhibitors/blood;Proton Pump Inhibitors/pharmacokinetics*;Young Adult
19243207;Adult;Amitriptyline/administration & dosage;Amitriptyline/adverse effects;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Antidepressive Agents, Tricyclic/administration & dosage;Antidepressive Agents, Tricyclic/adverse effects;Antidepressive Agents, Tricyclic/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Sample Size;Young Adult
19226652;Animals;Area Under Curve;Caco-2 Cells;Fasting;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption*;Male;Permeability;Pharmaceutical Preparations/metabolism*;Postprandial Period/physiology;Rats;Rats, Wistar;Solubility
19225452;Biological Transport, Active/drug effects;Biological Transport, Active/physiology;Food-Drug Interactions/physiology*;Humans;Metabolic Networks and Pathways/drug effects;Metabolic Networks and Pathways/physiology;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism*;Pharmaceutical Preparations/standards;Practice Guidelines as Topic/standards*;Transplantation/physiology*
19222985;Chronic Disease;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/psychology;Drug Interactions;Drug Resistance;Electroconvulsive Therapy;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Risk Factors
19206053;Adult;Aged;Arrhythmias, Cardiac/chemically induced;Biological Availability;Biotransformation;Citrus paradisi/metabolism;Drug Interactions;Female;Food-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Intestinal Absorption;Male;Membrane Transport Proteins/physiology*;Middle Aged;Muscular Diseases/chemically induced;Pharmacokinetics*;Xenobiotics/pharmacokinetics
19188677;Adult;Aged;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Solubility
19184451;Adenocarcinoma/pathology;Animals;Cell Line, Tumor/metabolism;Chemical Precipitation;Chemistry, Pharmaceutical;Colonic Neoplasms/pathology;Computer Simulation*;Dogs;Eating;Fasting;Female;Food-Drug Interactions*;Gastrointestinal Contents;Gastrointestinal Tract/physiology;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Models, Biological*;Morpholines/pharmacokinetics;Pharmacokinetics*;Solubility;Species Specificity;Theophylline/pharmacokinetics
19178019;Antineoplastic Agents/pharmacology;Antioxidants/adverse effects;Antioxidants/therapeutic use;Breast Neoplasms/nursing*;Diet*;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Humans
19169898;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use;Critical Illness;Female;Food-Drug Interactions*;Half-Life;Humans;Infant, Newborn;Male;Netilmicin/pharmacokinetics*;Netilmicin/therapeutic use;Parenteral Nutrition*;Prospective Studies;Sepsis/drug therapy;Tissue Distribution
19167586;Administration, Oral;Adolescent;Adrenergic alpha-2 Receptor Agonists;Adrenergic alpha-Agonists/administration & dosage;Adrenergic alpha-Agonists/adverse effects;Adrenergic alpha-Agonists/pharmacokinetics*;Adult;Area Under Curve;Asthenia/chemically induced;Biological Availability;Blood Pressure/drug effects;Capsules;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions;Half-Life;Humans;Male;Malus*;Middle Aged;Young Adult
19166632;Cardiovascular Diseases/immunology;Cardiovascular Diseases/therapy;Complementary Therapies*;Dietary Supplements;Fatty Acids, Omega-3/administration & dosage;Food-Drug Interactions*;Glutamine/administration & dosage;Humans;Models, Immunological;Neoplasms/immunology;Neoplasms/therapy
19160441;Administration, Oral;Antibiotics, Antitubercular/administration & dosage*;Antibiotics, Antitubercular/chemistry;Antibiotics, Antitubercular/pharmacokinetics*;Antibiotics, Antitubercular/therapeutic use;Biological Availability;Dosage Forms;Drug Approval;Drug Stability;Excipients;Food-Drug Interactions;Humans;Leprostatic Agents/administration & dosage*;Leprostatic Agents/chemistry;Leprostatic Agents/pharmacokinetics*;Leprostatic Agents/therapeutic use;Permeability;Rifampin/administration & dosage*;Rifampin/chemistry;Rifampin/pharmacokinetics*;Rifampin/therapeutic use;Solubility;Therapeutic Equivalency
19133704;Administration, Oral;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/pharmacokinetics*;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Postprandial Period;Randomized Controlled Trials as Topic;Young Adult
19126824;Aged;Female;Food-Drug Interactions/physiology*;Humans;International Normalized Ratio/methods;Tea/adverse effects*;Tea/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19116375;Animals;Body Weight;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Eating/drug effects;Food-Drug Interactions;Glucose Tolerance Test;Hypothalamus, Middle/drug effects;Hypothalamus, Middle/metabolism*;Hypothalamus, Middle/pathology;I-kappa B Kinase/metabolism;Injections, Intraventricular;Insulin/blood;Insulin/pharmacology*;Insulin Resistance/physiology*;Leptin/blood;Lipid Metabolism/drug effects;Obesity/blood;Obesity/metabolism*;Obesity/pathology;Rats;Rats, Long-Evans;Satiety Response/physiology;Signal Transduction/drug effects
19088792;Adolescent;Adult;Athletic Performance/physiology*;Caffeine/administration & dosage;Caffeine/pharmacology*;Canada;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacology*;Coffee*;Diet/methods*;Female;Food-Drug Interactions/physiology;Humans;Male;Middle Aged;Motor Activity/physiology*;Sports*;Young Adult
19075617;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/physiology*;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Citrus paradisi;Food-Drug Interactions*;Humans;Multidrug Resistance-Associated Proteins/physiology;Neoplasm Proteins/physiology
19075045;Administration, Oral;Adult;African Americans/genetics;African Americans/statistics & numerical data;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/adverse effects;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Carbonated Beverages*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Eating;European Continental Ancestry Group/genetics;European Continental Ancestry Group/statistics & numerical data;Fasting;Female;Food-Drug Interactions*;Gastric Mucosa/drug effects*;Gastric Mucosa/metabolism;Humans;Hydrogen-Ion Concentration/drug effects;Intestinal Absorption/drug effects;Male;Middle Aged;Omeprazole/administration & dosage;Omeprazole/adverse effects;Omeprazole/blood;Omeprazole/pharmacokinetics;Suspensions;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
19062482;Animals;Beverages*;Blood Glucose/drug effects;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/drug therapy*;Drug Synergism;Food-Drug Interactions;Fruit*;Insulin/pharmacokinetics;Insulin/pharmacology*;Male;Morinda*;Phytotherapy/methods*;Random Allocation;Rats;Rats, Sprague-Dawley
19058474;Aged;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Beverages/adverse effects;Fatal Outcome;Flavonoids/adverse effects;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced*;Humans;Male;Pericardial Effusion/chemically induced*;Phytotherapy/adverse effects;Vaccinium macrocarpon/adverse effects*;Vaccinium macrocarpon/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19053875;Acetaminophen/pharmacokinetics*;Animals;Beverages;Citrus paradisi*;Fluorescence Polarization Immunoassay;Food-Drug Interactions*;Half-Life;Mice;Mice, Inbred BALB C;Models, Animal;Plant Preparations/pharmacology*
19053852;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/drug effects;Antioxidants/pharmacology;Beverages;Caco-2 Cells;Colonic Neoplasms/metabolism*;Food-Drug Interactions/physiology*;Gene Expression Regulation/drug effects;Humans;Hydrolyzable Tannins/isolation & purification;Hydrolyzable Tannins/pharmacology*;Intestinal Mucosa/drug effects;Metabolic Detoxication, Phase I;Naphthols/pharmacokinetics;Neoplasm Proteins/drug effects;Plant Preparations*;Punicaceae*;Sulfotransferases/drug effects
19052281;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
19048359;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Animals;Beverages/adverse effects*;Caco-2 Cells;Cell Polarity;Citrus paradisi*/chemistry;Colchicine/administration & dosage;Colchicine/metabolism*;Dose-Response Relationship, Drug;Flavanones/isolation & purification;Flavanones/pharmacology;Food-Drug Interactions*;Fruit;Furocoumarins/isolation & purification;Furocoumarins/pharmacology;Humans;Ileum/drug effects;Ileum/metabolism*;Intestinal Absorption*/drug effects;Jejunum/drug effects;Jejunum/metabolism*;Male;Permeability;Quinidine/pharmacology;Rats;Rats, Wistar;Risk Assessment;Time Factors;Tubulin Modulators/administration & dosage;Tubulin Modulators/metabolism*;Verapamil/pharmacology
19033220;Brain Injuries/metabolism*;Brain Injuries/therapy*;Energy Intake/physiology;Energy Metabolism/physiology*;Enteral Nutrition/methods*;Enteral Nutrition/standards;Food-Drug Interactions;Humans;Nutrition Assessment;Nutritional Requirements*;Water-Electrolyte Balance/physiology*
19032767;Adult;Africa South of the Sahara;Antimalarials/administration & dosage*;Artemisinins/administration & dosage*;Child;Diet*;Dietary Fats/administration & dosage*;Dietary Fats/analysis;Drug Combinations;Ethanolamines/administration & dosage*;Feeding Behavior;Fluorenes/administration & dosage*;Food-Drug Interactions*;Humans;Infant;Malaria, Falciparum/drug therapy*;Randomized Controlled Trials as Topic
19026256;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/agonists;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Cross-Over Studies;Dietary Fats/metabolism*;Drug Administration Schedule;Energy Intake/physiology*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/blood*;Psychotic Disorders/drug therapy;Schizophrenia/blood*;Schizophrenia/drug therapy;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Young Adult
19014838;Adult;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chemistry, Pharmaceutical;Clarithromycin/administration & dosage*;Clarithromycin/adverse effects;Clarithromycin/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions;Half-Life;Humans;Jordan;Male;Metabolic Clearance Rate;Tablets;Therapeutic Equivalency
19014837;Adolescent;Adult;Area Under Curve;Blood Glucose/analysis;Chromatography, High Pressure Liquid;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Glucagon-Like Peptide 1/blood;Half-Life;Humans;Insulin/blood;Korea;Male;Metabolic Clearance Rate;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Organic Chemicals/pharmacology*;Piperidones;Pyrimidines;Young Adult
19000367;Administration, Oral;Amiodarone/analogs & derivatives*;Amiodarone/pharmacokinetics*;Animals;Area Under Curve;Bile Acids and Salts/administration & dosage;Cholesterol/administration & dosage;Dietary Fats/administration & dosage*;Food-Drug Interactions;Intestines/metabolism*;Lecithins/administration & dosage;Lipase/administration & dosage;Male;Peanut Oil;Plant Oils/administration & dosage;Rats;Rats, Sprague-Dawley;Soybean Oil/administration & dosage;Triglycerides/administration & dosage
18998611;Acetaminophen/adverse effects*;Acetaminophen/pharmacokinetics;Acetaminophen/therapeutic use;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/pharmacokinetics;Analgesics, Non-Narcotic/therapeutic use;Arthritis/drug therapy;Food-Drug Interactions;Humans;Wine/adverse effects*
18997138;Aged;Anticoagulants*;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin*
18990540;Adult;Aged;Anemia, Pernicious/diagnosis;Anemia, Pernicious/drug therapy;Drug-Related Side Effects and Adverse Reactions;Food*;Food-Drug Interactions;Humans;Intestinal Absorption/physiology;Malabsorption Syndromes/complications*;Malabsorption Syndromes/diagnosis;Malabsorption Syndromes/drug therapy;Syndrome;Vitamin B 12/metabolism*;Vitamin B 12/therapeutic use;Vitamin B 12 Deficiency/diagnosis;Vitamin B 12 Deficiency/drug therapy;Vitamin B 12 Deficiency/etiology;Vitamin B Complex/metabolism*;Vitamin B Complex/therapeutic use
18989993;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Data Interpretation, Statistical;Dibenzazepines/administration & dosage;Dibenzazepines/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Stereoisomerism;Tablets;Therapeutic Equivalency;Young Adult
18988456;Biological Availability*;Biopharmaceutics/classification*;Biopharmaceutics/methods;Chemistry, Pharmaceutical;Dosage Forms;Drug Interactions;Food-Drug Interactions*;Humans;Models, Theoretical;Permeability;Pharmaceutical Preparations/classification*;Pharmacology, Clinical/methods;Predictive Value of Tests;Solubility;Technology, Pharmaceutical/methods*;Therapeutic Equivalency
18955941;Antidepressive Agents/adverse effects;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/therapeutic use*;Brain/drug effects;Cheese/adverse effects;Depressive Disorder/blood;Depressive Disorder/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/therapeutic use*;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/therapeutic use;Tyramine/adverse effects;Tyramine/metabolism
18955043;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adenosine Triphosphatases/drug effects*;Adenosine Triphosphatases/metabolism;Antibiotics, Antineoplastic/metabolism;Citrus/chemistry*;Daunorubicin/metabolism;Fluoresceins/metabolism;Food-Drug Interactions*;Humans;KB Cells
18951015;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Antineoplastic Agents/therapeutic use*;Biological Availability;Biomarkers, Tumor;Clinical Protocols;Clinical Trials, Phase I as Topic/methods*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Maximum Tolerated Dose;Neoplasms/drug therapy*
18926963;Acenocoumarol/administration & dosage*;Administration, Oral;Adult;Age Factors;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Drug Interactions;Educational Status;Family Practice;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Hemorrhage/chemically induced*;Hemorrhage/prevention & control;Humans;Male;Medicine;Middle Aged;Patient Care Team*;Residence Characteristics;Specialization;Surveys and Questionnaires;Young Adult
18855612;Animals;Beverages*;Biological Availability;Citrus paradisi*;Food-Drug Interactions*;Humans;Intestines/metabolism*
18832020;Amino Acids/metabolism;Animals;Antifungal Agents/chemistry*;Antifungal Agents/pharmacokinetics;Bile/chemistry;Biological Availability;Dietary Carbohydrates/metabolism;Dietary Fats/metabolism;Dietary Proteins/metabolism;Food-Drug Interactions*;Gastric Juice/metabolism;Intestinal Secretions/metabolism;Itraconazole/chemistry*;Itraconazole/pharmacokinetics;Milk/metabolism;Solubility
18826865;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Capsules;Chromatography, High Pressure Liquid;Citrus sinensis*;Cross-Over Studies;Delayed-Action Preparations;Diltiazem/administration & dosage;Diltiazem/pharmacokinetics*;Diltiazem/pharmacology;Drug Administration Schedule;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Vitis*
18823217;Administration, Oral;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Fasting*;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Pyridazines/administration & dosage;Pyridazines/pharmacokinetics*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics*;Young Adult
18793577;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/pharmacokinetics*;Therapeutic Equivalency
18793575;Adult;Area Under Curve;Chromatography, Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Endothelin A Receptor Antagonists;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Tandem Mass Spectrometry
18771009;Beverages*;Citrus paradisi*;Color;Cytochrome P-450 CYP3A/metabolism;Data Interpretation, Statistical;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/analysis;Furocoumarins/pharmacokinetics;Furocoumarins/pharmacology;Hot Temperature;Oxidation-Reduction;Pharmacokinetics;Testosterone/metabolism
18768996;Antineoplastic Agents*/adverse effects;Antineoplastic Agents*/pharmacokinetics;Antineoplastic Agents*/pharmacology;Antineoplastic Agents*/therapeutic use;Breast Neoplasms*/drug therapy;Breast Neoplasms*/pathology;Drug Resistance, Neoplasm;Female;Food-Drug Interactions;Humans;Neoplasm Metastasis;Protein Kinase Inhibitors*/adverse effects;Protein Kinase Inhibitors*/pharmacokinetics;Protein Kinase Inhibitors*/pharmacology;Protein Kinase Inhibitors*/therapeutic use;Quinazolines*/adverse effects;Quinazolines*/pharmacokinetics;Quinazolines*/pharmacology;Quinazolines*/therapeutic use;Receptor, ErbB-2/metabolism
18758149;Food, Organic*;Food-Drug Interactions*;Glyburide*/pharmacokinetics;Hypoglycemic Agents*/pharmacokinetics;Metformin*/pharmacokinetics
18752268;Adrenergic alpha-1 Receptor Antagonists*;Adult;Azepines/blood;Azepines/chemistry;Azepines/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Drug Carriers/chemistry*;Fasting;Food-Drug Interactions*;Gastrointestinal Tract/diagnostic imaging*;Gastrointestinal Transit/physiology;Humans;Hypromellose Derivatives;Male;Methylcellulose/analogs & derivatives*;Methylcellulose/chemistry;Middle Aged;Postprandial Period;Quinolines/blood;Quinolines/chemistry;Quinolines/pharmacokinetics*;Radioisotopes;Radionuclide Imaging;Samarium
18727015;Anthocyanins/metabolism;Anthocyanins/pharmacology*;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Food-Drug Interactions
18724493;Drug Industry*;Drug Interactions;Drug Labeling*;Food-Drug Interactions;HIV Protease Inhibitors/therapeutic use*;Humans;Saquinavir/therapeutic use*
18721117;Biological Availability;Clinical Trials as Topic;Delayed-Action Preparations;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/pharmacokinetics;Renal Insufficiency/complications
18717508;Analgesics, Opioid/therapeutic use*;Chronic Disease;Clinical Trials as Topic;Delayed-Action Preparations;Drug Interactions;Follow-Up Studies;Food-Drug Interactions;Humans;Oxymorphone/adverse effects;Oxymorphone/pharmacokinetics;Oxymorphone/pharmacology;Oxymorphone/therapeutic use*;Pain/drug therapy*
18691989;Antidepressive Agents/chemistry*;Beverages;Drug Stability;Duloxetine Hydrochloride;Food*;Food-Drug Interactions;Fruit;Tablets, Enteric-Coated;Thiophenes/chemistry*
18690864;Administration, Topical;Animals;Clinical Trials as Topic/ethics;Data Interpretation, Statistical;Drugs, Generic;Food-Drug Interactions;Humans;Pharmacokinetics;Therapeutic Equivalency*
18675344;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Emulsions;Fasting/metabolism;Food-Drug Interactions;Freeze Drying;Griseofulvin/administration & dosage;Griseofulvin/chemistry;Griseofulvin/pharmacokinetics*;Humans;Intestinal Absorption;Male;Postprandial Period;Powders;Tablets
18671458;Administration, Oral;Adult;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Deoxycytidine/administration & dosage;Deoxycytidine/analogs & derivatives*;Deoxycytidine/blood;Deoxycytidine/pharmacokinetics;Dietary Fats/administration & dosage*;Fasting/metabolism;Food-Drug Interactions*;Humans;Male;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tandem Mass Spectrometry
18666368;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus paradisi*;Cytochrome P-450 CYP3A/physiology;Felodipine/pharmacokinetics;Food-Drug Interactions*;Humans
18663908;Beverages*;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Psychotropic Drugs/pharmacokinetics;Psychotropic Drugs/pharmacology*
18641203;Adult;Biological Availability;Catechin/administration & dosage;Catechin/analogs & derivatives*;Catechin/chemistry;Catechin/pharmacokinetics;Dietary Fats/pharmacokinetics;Dose-Response Relationship, Drug;Female;Flavonoids/administration & dosage;Flavonoids/chemistry*;Flavonoids/pharmacokinetics*;Food;Food-Drug Interactions;Humans;Ileostomy;Male;Molecular Structure;Tea/chemistry
18624679;Animals;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions*;Food-Drug Interactions;Humans;Intestines/enzymology;Intestines/metabolism*;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
18607579;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Benzofurans/administration & dosage*;Benzofurans/blood;Benzofurans/pharmacokinetics;Biological Availability;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions*;Half-Life;Humans;Male;Niflumic Acid/blood;Niflumic Acid/pharmacokinetics*;Postprandial Period;Prodrugs/administration & dosage*;Prodrugs/pharmacokinetics;Pyridines/administration & dosage*;Pyridines/blood;Pyridines/pharmacokinetics;Young Adult
18589558;Adolescent;Adult;Aged;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Fasting/physiology;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*;Tandem Mass Spectrometry;Therapeutic Equivalency
18585670;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Biological Availability;Drug Therapy, Combination;Fasting;Female;Food-Drug Interactions*;Humans;Male;Meat*;Middle Aged;Ovum*;Quinolines/administration & dosage;Quinolines/pharmacokinetics*;Vegetables*;Vietnam;Volunteers
18579105;Animals;Anticarcinogenic Agents/pharmacology*;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Antioxidants/pharmacology*;Area Under Curve;Bile/chemistry;Bile/metabolism;Biological Transport/drug effects;Camptothecin/analogs & derivatives*;Camptothecin/pharmacokinetics;Catechin/analogs & derivatives*;Catechin/pharmacology;Chromatography, High Pressure Liquid;Contraindications;Dietary Supplements;Food-Drug Interactions*;Glucuronides/pharmacokinetics*;Injections, Intravenous;Male;Rats;Rats, Sprague-Dawley;Specific Pathogen-Free Organisms
18552451;Blood Pressure/drug effects;Carbolines/administration & dosage*;Carbolines/adverse effects;Carbolines/pharmacokinetics;Carbolines/pharmacology;Cyclic GMP/metabolism;Erectile Dysfunction/drug therapy*;Food-Drug Interactions;Humans;Male;Muscle Relaxation/drug effects;Muscle, Smooth/metabolism;Penis/blood supply;Penis/metabolism;Phosphodiesterase 5 Inhibitors*;Phosphodiesterase Inhibitors/administration & dosage*;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics;Phosphodiesterase Inhibitors/pharmacology;Randomized Controlled Trials as Topic;Tadalafil
18551467;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Folic Acid/administration & dosage;Folic Acid/pharmacokinetics*;Food-Drug Interactions*;Humans;Immunoassay;Luminescent Measurements;Male;Middle Aged;Tea/chemistry*;Vitamin B Complex/administration & dosage;Vitamin B Complex/pharmacokinetics*
18551249;Animals;Biological Availability*;Food-Drug Interactions;Humans;Intestinal Absorption;Therapeutic Equivalency*
18543582;Blood Glucose/analysis;Chlorpropamide/blood;Chlorpropamide/pharmacokinetics*;Chlorpropamide/therapeutic use;Chromatography, High Pressure Liquid;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Diet;Dietary Carbohydrates*;Drug Administration Schedule;Food-Drug Interactions*;Humans;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/therapeutic use;Middle Aged;Nigeria;Postprandial Period;Time Factors
18538461;Animals;Botulinum Toxins, Type A/chemistry;Botulinum Toxins, Type A/isolation & purification*;Botulinum Toxins, Type A/pharmacokinetics*;Dose-Response Relationship, Drug;Electrophoresis, Polyacrylamide Gel;Food-Drug Interactions;Injections, Intraperitoneal;Intubation, Gastrointestinal;Lethal Dose 50;Mass Spectrometry;Mice
18500565;Drug Design*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations*/administration & dosage;Pharmaceutical Preparations*/chemistry;Pharmaceutical Preparations*/metabolism;Pharmacokinetics
18488812;2-Pyridinylmethylsulfinylbenzimidazoles/administration & dosage*;2-Pyridinylmethylsulfinylbenzimidazoles/pharmacokinetics*;Adolescent;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Proton Pump Inhibitors/administration & dosage*;Proton Pump Inhibitors/pharmacokinetics*;Reproducibility of Results
18484490;Administration, Oral;Administration, Rectal;Alendronate/administration & dosage;Alendronate/chemistry;Alendronate/pharmacokinetics*;Animals;Biological Availability;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/chemistry;Bone Density Conservation Agents/pharmacokinetics*;Chemical Phenomena;Chemistry, Pharmaceutical;Chemistry, Physical;Diffusion;Food-Drug Interactions;Intestinal Absorption/physiology*;Isotope Labeling;Male;Rabbits;Solubility;Technetium/chemistry
18479171;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacokinetics*;Dideoxynucleosides/administration & dosage;Dideoxynucleosides/pharmacokinetics*;Drug Combinations;Drug Interactions;Food-Drug Interactions;Humans;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tissue Distribution
18471347;Adamantane/administration & dosage;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adolescent;Adult;Cross-Over Studies;Diabetes Mellitus, Type 2/drug therapy;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Dipeptidyl-Peptidase IV Inhibitors/therapeutic use;Drug Combinations;Female;Food-Drug Interactions*;Humans;Male;Metformin/administration & dosage*;Metformin/pharmacokinetics*;Middle Aged;Nitriles/administration & dosage*;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage*;Pyrrolidines/pharmacokinetics*
18465212;Adult;Colon/physiology*;Drug Delivery Systems*;Fasting/physiology;Food-Drug Interactions/physiology*;Gastric Emptying/physiology;Gastrointestinal Transit/physiology*;Humans;Hydrogen-Ion Concentration;Ileum/physiology*;Indium Radioisotopes;Kinetics;Male;Polymethacrylic Acids;Tablets, Enteric-Coated;Technetium/pharmacokinetics
18449511;Administration, Oral;Animals;Biological Availability;Biotransformation;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacology*;Drug Interactions;Food-Drug Interactions;Hesperidin/administration & dosage*;Hesperidin/pharmacokinetics*;Intestinal Absorption/drug effects;Male;Models, Biological;Rats;Rats, Sprague-Dawley;Verapamil/administration & dosage*;Verapamil/analogs & derivatives;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/pharmacology
18446504;Animals;Antiparasitic Agents/metabolism;Antiparasitic Agents/pharmacokinetics;Antiparasitic Agents/therapeutic use;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Ivermectin/metabolism;Ivermectin/pharmacokinetics*;Ivermectin/therapeutic use;Parasitic Diseases/drug therapy;Parasitic Diseases/metabolism
18438069;Beverages*;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Humans;Hypertension/chemically induced*;Hypertension/etiology;Rhabdomyolysis/chemically induced*;Rhabdomyolysis/etiology;Tea/adverse effects*
18421804;Beverages*;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*
18382075;Aged;Aged, 80 and over;Biological Availability;Female;Food-Drug Interactions*;Health Status*;Humans;Intestinal Absorption;Male;Nutritional Status/drug effects*;Nutritional Status/physiology*;Pharmaceutical Preparations/administration & dosage*;Pharmacokinetics
18415673;Administration, Oral;Animals;Atorvastatin Calcium;Caffeine/administration & dosage;Caffeine/pharmacology*;Coffee*;Food-Drug Interactions*;Heptanoic Acids/pharmacology*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Myocardial Infarction/pathology;Myocardial Infarction/physiopathology;Myocardial Infarction/prevention & control*;Myocardial Reperfusion Injury/pathology;Myocardial Reperfusion Injury/physiopathology;Myocardial Reperfusion Injury/prevention & control*;Myocardium/metabolism;Myocardium/pathology;Pyrroles/pharmacology*;Rats
18407914;Adsorption;Biological Availability;Enteral Nutrition/adverse effects*;Food-Drug Interactions;Gastrostomy/instrumentation*;Humans;In Vitro Techniques;Iodine Radioisotopes;Thyroxine/pharmacokinetics*
18401778;Cellulose/analogs & derivatives;Cellulose/chemistry;Chemistry, Pharmaceutical;Delayed-Action Preparations;Excipients/chemistry*;Food-Drug Interactions*;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/chemistry;Models, Biological;Neural Networks (Computer)*;Starch/analogs & derivatives;Starch/chemistry;Tablets;Time Factors
18400708;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Area Under Curve;Beverages/analysis;Caco-2 Cells;Citrus/chemistry;Citrus paradisi/chemistry*;Cross-Over Studies;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Enzyme Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions;Fruit/chemistry;Furocoumarins/pharmacology*;Humans;Male;Middle Aged
18399711;2-Pyridinylmethylsulfinylbenzimidazoles/pharmacology;Animals;Anti-Ulcer Agents/pharmacology;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Benzimidazoles/pharmacokinetics*;Benzimidazoles/pharmacology*;Biological Availability;Dabigatran;Drug Interactions;Food-Drug Interactions;Humans;Liver Diseases/metabolism;Prodrugs/pharmacokinetics*;Prodrugs/pharmacology*;Pyridines/pharmacokinetics*;Pyridines/pharmacology*;Thrombin/antagonists & inhibitors*
18386838;Animals;Area Under Curve;Biological Availability;Dogs;Drug Delivery Systems*;Food-Drug Interactions*;Intestine, Small/metabolism*;Male;Pharmacokinetics;Solubility;Tablets
18380401;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food Handling;Food-Drug Interactions*;Furocoumarins/pharmacokinetics;Hot Temperature;Humans;In Vitro Techniques;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Testosterone/metabolism
18380396;Adult;Beverages*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Food-Drug Interactions*;Furocoumarins/blood*;Humans;Male;Mass Spectrometry;Radiation-Sensitizing Agents/metabolism*;Reference Standards
18380391;Beverages/adverse effects*;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Glycyrrhiza/chemistry;Humans;Hypertension/diagnosis;Hypertension/etiology*;Tea/adverse effects*
18370856;Animals;Carrier Proteins/metabolism;Dietary Supplements*;Drug Interactions;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Mixed Function Oxygenases/metabolism;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
18363537;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dietary Carbohydrates/administration & dosage;Dietary Proteins/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacokinetics*
18348745;Attitude of Health Personnel;Communication;Dietary Supplements/utilization*;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice;Humans;Patient Education as Topic;Prevalence;United States;United States Food and Drug Administration
18348469;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cephalosporins/administration & dosage;Cephalosporins/blood;Cephalosporins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Diet*;Diet, Fat-Restricted;Diet, Vegetarian;Dietary Fats/administration & dosage;Fasting;Food-Drug Interactions*;Humans;Male;Tablets
18344215;Animals;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Beverages;Celiprolol/pharmacokinetics*;Chromatography, Liquid;Citrus sinensis/chemistry*;Food-Drug Interactions*;Hesperidin/pharmacology*;Intestinal Absorption;Male;Rats;Rats, Wistar;Spectrometry, Mass, Electrospray Ionization
18343098;Bile Acids and Salts/chemistry*;Capsules;Cholestyramine Resin/chemistry*;Cross-Linking Reagents/chemistry;Food-Drug Interactions*;Gelatin/chemistry*;Humans;Hydrogen-Ion Concentration;Intestine, Small;Models, Biological*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Predictive Value of Tests;Solubility;Stomach*;Taurocholic Acid/chemistry
18327703;Administration, Oral;Animals;Atorvastatin Calcium;Blood Pressure/drug effects;Caffeine/administration & dosage;Caffeine/pharmacology*;Coffee*;Disease Models, Animal;Food-Drug Interactions*;Heart Rate/drug effects;Heptanoic Acids/pharmacology*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Male;Myocardial Infarction/pathology;Myocardial Infarction/physiopathology;Myocardial Infarction/prevention & control*;Myocardial Reperfusion Injury/pathology;Myocardial Reperfusion Injury/physiopathology;Myocardial Reperfusion Injury/prevention & control*;Myocardium/metabolism;Myocardium/pathology*;Phosphorylation;Proto-Oncogene Proteins c-akt/metabolism;Pyrroles/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, Purinergic P1/drug effects;Receptors, Purinergic P1/metabolism
18294110;Anticoagulants/administration & dosage;Anticoagulants/therapeutic use*;Antifibrinolytic Agents/administration & dosage*;Drug Administration Schedule;Drug Resistance*;Enteral Nutrition*;Female;Food-Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Retrospective Studies;Vitamin K/administration & dosage*;Warfarin/administration & dosage;Warfarin/therapeutic use*
18285619;Administration, Oral;Adult;Area Under Curve;Biological Availability;Blood Pressure/drug effects;Capsules;Cross-Over Studies;Dextroamphetamine/administration & dosage;Dextroamphetamine/adverse effects;Dextroamphetamine/chemistry;Dextroamphetamine/metabolism;Dextroamphetamine/pharmacokinetics*;Eating/physiology*;Fasting/physiology*;Female;Flushing/chemically induced;Food-Drug Interactions;Half-Life;Headache/chemically induced;Humans;Hyperkinesis/chemically induced;Lisdexamfetamine Dimesylate;Lysine/chemistry;Lysine/metabolism;Male;Metabolic Clearance Rate;Molecular Structure;Tachycardia/chemically induced
18281442;Adolescent;Adult;Area Under Curve;Benzoates/administration & dosage;Benzoates/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Eating/physiology*;Female;Food;Food-Drug Interactions;Humans;Intestinal Absorption;Iron Chelating Agents/administration & dosage;Iron Chelating Agents/pharmacokinetics*;Iron Overload/metabolism*;Male;Middle Aged;Spectrophotometry, Ultraviolet;Triazoles/administration & dosage;Triazoles/pharmacokinetics*
18272698;Aged;Enteral Nutrition/adverse effects*;Food-Drug Interactions/physiology*;Humans;Levodopa/adverse effects*;Levodopa/pharmacokinetics;Male;Parkinson Disease/metabolism;Parkinson Disease/therapy
18258749;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dibenzazepines/administration & dosage;Dibenzazepines/blood;Dibenzazepines/pharmacokinetics*;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions*;Half-Life;Humans;Male
18249530;Carbon Dioxide/chemistry;Chemical Phenomena;Chemistry, Physical;Delayed-Action Preparations;Excipients/chemistry*;Food-Drug Interactions;Magnetic Resonance Imaging;Polyvinyls/chemistry*;Propranolol/administration & dosage;Propranolol/chemistry;Stomach;Tablets*;Viscosity;Water/chemistry
18246623;Anticoagulants/chemistry*;Beverages;Food-Drug Interactions*;Vaccinium macrocarpon/chemistry*;Warfarin/chemistry*
18237050;Beverages*;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Glycyrrhiza/chemistry;Humans;Hypertension/diagnosis;Hypertension/etiology*;Tea/adverse effects*;Tea/chemistry
18199522;Administration, Oral;Biological Availability;Biological Transport;Dietary Fats/metabolism*;Food-Drug Interactions*;Forecasting;Gastrointestinal Tract/metabolism;Humans;Models, Biological;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/classification;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Solubility
18195466;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Area Under Curve;Beverages;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Domperidone/blood;Domperidone/pharmacokinetics*;Dopamine Antagonists/blood;Dopamine Antagonists/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Intestinal Absorption;Male;Quinidine/pharmacology*;Rats;Rats, Wistar
18178070;Administration, Oral;Adult;Area Under Curve;Biological Availability;Drug Delivery Systems/methods;Emulsions;Fasting/metabolism*;Food-Drug Interactions*;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male
18176118;Administration, Oral;Adult;Aged;Algorithms;Area Under Curve;Creatine Kinase/blood;Cross-Over Studies;Dose-Response Relationship, Drug;Erlotinib Hydrochloride;Exanthema/chemically induced;Fasting;Food-Drug Interactions*;Glossitis/chemically induced;Hematuria/chemically induced;Humans;Liver/drug effects;Liver/enzymology;Male;Middle Aged;Molecular Structure;Patient Dropouts/statistics & numerical data;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Quinazolines/chemistry;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Receptor, Epidermal Growth Factor/antagonists & inhibitors*;Time Factors;gamma-Glutamyltransferase/blood
18176062;Antihypertensive Agents/chemistry;Antihypertensive Agents/pharmacokinetics*;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chemical Phenomena;Chemistry, Physical;Citrus paradisi*;Dihydropyridines/chemistry;Dihydropyridines/pharmacokinetics*;Food-Drug Interactions*;Humans;Structure-Activity Relationship
18175757;Bone Density/drug effects;Bone Density Conservation Agents/administration & dosage*;Calcium, Dietary/administration & dosage*;Diet;Dietary Proteins/pharmacology;Dietary Supplements;Estriol/metabolism*;Estrogens/blood;Estrogens/metabolism*;Estrogens/urine;Female;Food-Drug Interactions;Humans;Steroids/administration & dosage
18174962;Animals;Controlled Clinical Trials as Topic;Cyclohexanes/adverse effects;Cyclohexanes/pharmacology*;Cyclohexanes/therapeutic use;Drug Interactions;Drug Resistance, Viral;Drug Therapy, Combination;Female;Food-Drug Interactions;HIV Fusion Inhibitors/adverse effects;HIV Fusion Inhibitors/pharmacology*;HIV Fusion Inhibitors/therapeutic use;HIV Infections/drug therapy*;HIV-1/drug effects;Humans;Male;Triazoles/adverse effects;Triazoles/pharmacology*;Triazoles/therapeutic use
18172627;Administration, Oral;Adult;Antifungal Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Female;Food-Drug Interactions*;Humans;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Pharmaceutical Solutions;Sex Factors
18162024;Adolescent;Adult;Aged;Aged, 80 and over;Depressive Disorder, Major/drug therapy*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Duloxetine Hydrochloride;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Outpatients;Serotonin Uptake Inhibitors/administration & dosage*;Serotonin Uptake Inhibitors/adverse effects;Thiophenes/administration & dosage*;Thiophenes/adverse effects;Treatment Outcome
18084364;Citrus/adverse effects;Citrus paradisi/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Pharmaceutical Preparations/metabolism*;Punicaceae/adverse effects;Vitis/adverse effects
18082510;Aged;Alcohol Drinking;Coronary Disease/mortality;Coronary Disease/prevention & control;Coronary Disease/therapy*;Cross-Sectional Studies;Ethanol/administration & dosage*;Fatty Acids, Omega-3/administration & dosage*;Fatty Acids, Omega-3/blood*;Female;Fish Oils/administration & dosage;Fish Oils/blood;Follow-Up Studies;Food-Drug Interactions*;Humans;Linear Models;Male;Middle Aged;Multivariate Analysis;Probability;Reference Values;Survival Rate;Treatment Outcome
18082281;Administration, Oral;Animals;Biological Availability;Biological Transport;Drug Carriers/chemistry*;Drug Stability;Food-Drug Interactions;Injections, Intravenous;Lecithins/chemistry*;Lymph/metabolism;Lymphatic Vessels;Male;Mice;Mice, Inbred BALB C;Mice, Inbred C57BL;Mice, Knockout;Molecular Structure;Mouth Mucosa/metabolism*;Phospholipases A2/genetics;Phospholipases A2/physiology;Postprandial Period;Prodrugs*/administration & dosage;Prodrugs*/pharmacokinetics;Rats;Rats, Wistar;Triglycerides/chemistry*;Valproic Acid/administration & dosage;Valproic Acid/analogs & derivatives*;Valproic Acid/blood;Valproic Acid/pharmacokinetics
18074548;Anaphylaxis/chemically induced;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Arrhythmias, Cardiac/chemically induced;Citrus paradisi;Cystitis/chemically induced;Drug Interactions;Food-Drug Interactions;Histamine/physiology;Histamine H1 Antagonists/adverse effects*;Histamine H1 Antagonists/pharmacology;Humans;Seizures/chemically induced*;Sleep Wake Disorders/chemically induced*
18074531;Adrenergic beta-Antagonists/adverse effects*;Arrhythmias, Cardiac/chemically induced*;Calcium Channel Blockers/adverse effects*;Citrus paradisi;Coronary Vasospasm/chemically induced;Depression/chemically induced;Depression, Chemical;Drug Interactions;Food-Drug Interactions;Heart Rate/drug effects;Humans;Lipid Metabolism Disorders/chemically induced;Myocardial Contraction/drug effects;Sympathetic Nervous System/physiopathology
18069906;Attention Deficit Disorder with Hyperactivity/drug therapy;Depression/drug therapy;Food-Drug Interactions;Humans;Narcolepsy/drug therapy;Parkinson Disease/drug therapy;Phenylketonurias/drug therapy;Stress, Physiological/drug therapy;Tyrosine/adverse effects;Tyrosine/pharmacokinetics;Tyrosine/therapeutic use*
18057881;Animals;Anti-Arrhythmia Agents/pharmacology*;Beverages*;Citrus paradisi;Delayed Rectifier Potassium Channels/antagonists & inhibitors;Dose-Response Relationship, Drug;ERG1 Potassium Channel;Electrocardiography/drug effects;Ether-A-Go-Go Potassium Channels/antagonists & inhibitors*;Ether-A-Go-Go Potassium Channels/metabolism;Female;Flavanones/pharmacology*;Food-Drug Interactions*;In Vitro Techniques;Oocytes/metabolism;Patch-Clamp Techniques;Xenopus
18057745;Animals;Antifungal Agents/administration & dosage;Antifungal Agents/chemistry*;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Biopharmaceutics;Drug Delivery Systems;Emulsions;Excipients;Food-Drug Interactions;Griseofulvin/administration & dosage;Griseofulvin/chemistry*;Griseofulvin/pharmacokinetics*;Male;Particle Size;Rats;Rats, Sprague-Dawley;Solubility;Solvents
18056195;Animals;Camptothecin/analogs & derivatives*;Camptothecin/pharmacology;Camptothecin/toxicity;Colonic Neoplasms/drug therapy*;Colonic Neoplasms/metabolism;Diarrhea/chemically induced*;Diarrhea/prevention & control;Diet;Fatty Acids, Omega-3/administration & dosage*;Female;Food-Drug Interactions*;Glutamine/administration & dosage*;Oligosaccharides/administration & dosage*;Probiotics/administration & dosage;Rats
18045784;Animals;Antimetabolites, Antineoplastic/pharmacokinetics*;Biological Availability;Cattle;Clinical Trials as Topic;Food-Drug Interactions;Humans;Mercaptopurine/pharmacokinetics*;Milk/enzymology*;Patient Education as Topic;Xanthine Oxidase/pharmacology*
18044447;Animals;Anti-Infective Agents/pharmacology*;Capsules;Colony Count, Microbial;Consumer Product Safety;Dose-Response Relationship, Drug;Emulsions;Escherichia coli O157/drug effects*;Escherichia coli O157/growth & development;Eugenol/pharmacology*;Food Microbiology;Food Preservation/methods*;Food-Drug Interactions;Humans;Lipids;Listeria monocytogenes/drug effects*;Listeria monocytogenes/growth & development;Micelles;Microbial Sensitivity Tests;Milk/chemistry;Milk/microbiology*;Time Factors
18042957;Adult;Cohort Studies;Cross-Sectional Studies;Diet;Diet Records;Dietary Supplements/adverse effects;Dietary Supplements/economics*;Dietary Supplements/utilization*;Dietetics;Drug Interactions*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/psychology*;Health Knowledge, Attitudes, Practice;Humans;Male;Middle Aged;Risk Factors
18042475;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;China;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Fluorobenzenes/administration & dosage*;Fluorobenzenes/adverse effects;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions;Hospitals, University;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Mass Spectrometry;Pyrimidines/administration & dosage*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sex Factors;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
18035186;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacology;Antiparkinson Agents/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indans/administration & dosage;Indans/adverse effects;Indans/pharmacology;Indans/therapeutic use*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/adverse effects;Neuroprotective Agents/pharmacology;Neuroprotective Agents/therapeutic use*;Parkinson Disease/drug therapy*;Selegiline/administration & dosage;Selegiline/adverse effects;Selegiline/pharmacology;Selegiline/therapeutic use
18024885;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*
18024884;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Quinazolines/administration & dosage;Quinazolines/pharmacokinetics*
18024883;Antineoplastic Agents/administration & dosage*;Biological Availability;Drug Administration Schedule;Drug Labeling*;Food-Drug Interactions;Humans;Quinazolines/administration & dosage*;Quinazolines/economics;Quinazolines/pharmacokinetics
18024021;Animals;Anticholesteremic Agents/administration & dosage*;Anticholesteremic Agents/pharmacokinetics;Biological Availability;Caprylates/chemistry;Chemistry, Pharmaceutical;Cholesterol Ester Transfer Proteins/antagonists & inhibitors;Dogs;Emulsions;Excipients/chemistry;Food-Drug Interactions*;Glycerides/chemistry;Male;Polyethylene Glycols/chemistry;Polysorbates/chemistry;Quinolines/administration & dosage*;Quinolines/pharmacokinetics;Surface-Active Agents/chemistry*;Triacetin/chemistry;Triglycerides/chemistry
18007569;Absorption;Administration, Oral;Adolescent;Adult;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*
17995858;Antioxidants/analysis*;Antioxidants/chemistry;Biphenyl Compounds/chemistry;Dose-Response Relationship, Drug;Fabaceae/chemistry*;Fabaceae/standards*;Ferric Compounds/chemistry;Flavonoids/analysis;Flavonoids/chemistry;Food Handling/methods*;Food-Drug Interactions;Free Radical Scavengers;Hydrazines/chemistry;Nutritive Value;Phenols/analysis*;Phenols/chemistry;Picrates;Reactive Oxygen Species/metabolism;Solvents/chemistry*;Tannins/analysis;Tannins/chemistry
17995709;Calibration;Chemistry Techniques, Analytical/methods;Chemistry Techniques, Analytical/standards*;Clinical Laboratory Techniques/standards*;Flour/analysis;Folic Acid/analysis;Folic Acid/isolation & purification*;Food Analysis/methods*;Food-Drug Interactions;Infant Food/analysis;Lactobacillus casei/metabolism*;Meat Products/analysis;Pronase/metabolism;Regression Analysis;Reproducibility of Results;Sensitivity and Specificity;Vegetables/chemistry;alpha-Amylases/metabolism;gamma-Glutamyl Hydrolase/metabolism
17982397;Administration, Oral;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/pharmacokinetics*
17978552;Anencephaly/prevention & control;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/pharmacokinetics;Benzodiazepines/administration & dosage;Benzodiazepines/pharmacokinetics;Biomedical Research*;Dietary Supplements;Female;Folic Acid/administration & dosage;Food-Drug Interactions;Health Promotion;Humans;Male;Patient Education as Topic;Pharmaceutical Services*;Pharmacies*;Pharmacists;Pharmacokinetics;Pregnancy;Sex Characteristics;Smoking;Spinal Dysraphism/prevention & control
17976262;Benzoic Acid/metabolism*;Biological Transport;Blotting, Western;Caco-2 Cells;Dose-Response Relationship, Drug;Flavanones/administration & dosage;Flavanones/pharmacology;Flavonoids/administration & dosage;Flavonoids/pharmacology*;Food-Drug Interactions;Gene Expression Regulation/drug effects*;Humans;Inhibitory Concentration 50;Lactic Acid/metabolism;Monocarboxylic Acid Transporters/antagonists & inhibitors*;Quercetin/administration & dosage;Quercetin/pharmacology;Reverse Transcriptase Polymerase Chain Reaction;Silymarin/administration & dosage;Silymarin/pharmacology;Symporters/antagonists & inhibitors*
17971226;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacology;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
17967158;Aged;Animals;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Medication Errors/adverse effects;Polypharmacy*
17966839;Adult;Aged;Analysis of Variance;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics*;Farnesyltranstransferase/antagonists & inhibitors;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*
17958008;Beverages/adverse effects;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
17955954;Animals;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Food-Drug Interactions*;Humans;Plant Preparations/adverse effects*
17953718;Adult;Antacids/blood;Antacids/pharmacokinetics*;Antacids/pharmacology;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/blood;Dietary Fats/pharmacokinetics*;Drug Interactions/physiology*;Fasting;Febuxostat;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology
17937879;Epilepsy/diet therapy*;Epilepsy/metabolism;Food-Drug Interactions;Humans;Ketone Bodies/biosynthesis*
17919554;Aged;Anticoagulants/adverse effects*;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Beverages*;Blood Coagulation Disorders/blood;Blood Coagulation Disorders/chemically induced*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
17916059;Antidepressive Agents, Second-Generation/therapeutic use*;Anxiety Disorders/drug therapy*;Biological Availability;Citalopram/adverse effects;Citalopram/pharmacokinetics;Citalopram/therapeutic use*;Depressive Disorder, Major/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans
17910207;Adolescent;Child;Dietary Supplements*;Drug Interactions;Food;Food-Drug Interactions;Humans;Inositol/therapeutic use;Mental Disorders;Minerals;Mood Disorders/therapy;Psychopharmacology*;United States;Vitamins/therapeutic use
17906160;Adult;Area Under Curve;China;Female;Food-Drug Interactions*;Humans;Male;Pulmonary Fibrosis/drug therapy;Pyridones/administration & dosage*;Pyridones/blood;Pyridones/pharmacokinetics*;Pyridones/therapeutic use;Sex Factors
17880476;Brazil;Chemistry, Pharmaceutical;Clinical Nursing Research;Clinical Protocols/standards*;Critical Care/methods;Drug Therapy/nursing;Drug-Related Side Effects and Adverse Reactions;Education, Nursing, Continuing;Enteral Nutrition/adverse effects;Enteral Nutrition/instrumentation;Enteral Nutrition/nursing*;Equipment Failure/statistics & numerical data;Evidence-Based Medicine;Female;Food, Formulated/adverse effects;Food-Drug Interactions;Heart Diseases/therapy;Humans;Infusion Pumps/adverse effects;Intubation, Gastrointestinal/adverse effects;Intubation, Gastrointestinal/instrumentation;Intubation, Gastrointestinal/nursing*;Male;Nursing Assessment/standards;Nursing Evaluation Research;Nursing Staff, Hospital/education;Patient Care Planning/standards*;Risk Factors;Therapeutic Irrigation/methods;Therapeutic Irrigation/nursing*;Therapeutic Irrigation/standards
17875111;Aged;Aspirin/adverse effects*;Aspirin/pharmacokinetics;Beverages;Citrus*;Food-Drug Interactions*;Humans;Male;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics;Purpura/chemically induced;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics
17720777;1-Deoxynojirimycin/administration & dosage;1-Deoxynojirimycin/analogs & derivatives*;1-Deoxynojirimycin/blood;1-Deoxynojirimycin/pharmacokinetics;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Glucosyltransferases/antagonists & inhibitors*;Half-Life;Humans;Male;Middle Aged;Sex Factors
17712849;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Animals;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics;Biological Availability;Cyclodextrins/administration & dosage*;Cyclodextrins/blood;Cyclodextrins/chemistry;Cyclodextrins/pharmacokinetics*;Food-Drug Interactions;Injections, Intravenous;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/chemistry;Itraconazole/pharmacokinetics*;Male;Rats;Rats, Sprague-Dawley;Solubility;beta-Cyclodextrins/administration & dosage;beta-Cyclodextrins/blood;beta-Cyclodextrins/chemistry;beta-Cyclodextrins/pharmacokinetics
17697908;Adolescent;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyproheptadine/administration & dosage;Cyproheptadine/analogs & derivatives*;Cyproheptadine/pharmacokinetics;Female;Food-Drug Interactions*;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/pharmacokinetics*;Humans;Loratadine/analogs & derivatives;Loratadine/blood;Loratadine/pharmacokinetics;Male;Tablets
17695563;Atherosclerosis/prevention & control*;Beverages*;Citrus paradisi*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*
17691921;Adult;Beverages/analysis;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;DNA/genetics;DNA/isolation & purification;Felodipine/adverse effects;Felodipine/pharmacokinetics*;Felodipine/pharmacology*;Food-Drug Interactions*;Furocoumarins/chemistry;Furocoumarins/pharmacology*;Genotype;Heart Rate/drug effects;Humans;Hydroxylation;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Molecular Sequence Data;Polymorphism, Genetic;Testosterone/metabolism
17691590;Adult;Anemia, Iron-Deficiency/drug therapy;Beverages;Citrus sinensis*;Cross-Over Studies;Data Interpretation, Statistical;Erythrocytes/metabolism;Female;Ferric Compounds/pharmacokinetics*;Food-Drug Interactions*;Hemoglobins/metabolism;Humans;Iron/blood;Iron/pharmacokinetics*;Iron Radioisotopes;Male;Tea*;Transferrin/metabolism
17691585;Acetaminophen/chemistry;Anaerobiosis;Ascorbic Acid/chemistry;Aspartic Acid/chemistry;Beverages;Calcium Phosphates/chemistry;Citrus sinensis;Drug Interactions;Ferric Compounds/chemistry*;Food-Drug Interactions;Hydrogen-Ion Concentration;Indicators and Reagents;Methyldopa/chemistry;Salicylic Acid/chemistry;Spectrophotometry, Ultraviolet;Tetracycline/chemistry
17688173;Adult;Anti-Infective Agents/chemistry;Anti-Infective Agents/metabolism*;Anti-Infective Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Calcium Carbonate/adverse effects;Chemistry, Pharmaceutical;Ciprofloxacin/chemistry;Ciprofloxacin/metabolism*;Ciprofloxacin/pharmacokinetics*;Citrus*;Cross-Over Studies;Drug Monitoring;Female;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Linear Models;Male;Metabolic Clearance Rate;Nigeria;Solubility;Spectrophotometry, Ultraviolet;Tablets;Time Factors;Vitis*
17640157;Depressive Disorder/drug therapy;Diet;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Tyramine/metabolism
17656620;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Confidence Intervals;Cross-Over Studies;Dietary Fats*;Dipeptidyl-Peptidase IV Inhibitors*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Models, Statistical;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*
17655512;Absorption;Administration, Oral;Adult;Alprazolam/chemistry;Alprazolam/pharmacokinetics*;Anti-Anxiety Agents/chemistry;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Tablets;Tandem Mass Spectrometry
17653140;Administration, Oral;Adolescent;Adult;Aged;Aged, 80 and over;Animals;Biological Availability;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Kidney/metabolism;Male;Middle Aged;Piperidines/blood;Piperidines/pharmacokinetics*;Receptors, Opioid, mu/antagonists & inhibitors;Surgical Procedures, Operative
17639625;Aged;Aspirin/administration & dosage*;Beverages*;Citrus paradisi*;Fibrinolytic Agents/administration & dosage*;Food-Drug Interactions*;Humans
17631915;Amygdala/drug effects;Amygdala/metabolism*;Animals;Behavior, Animal/drug effects;Calcitonin Gene-Related Peptide/metabolism;Cell Count;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Early Growth Response Protein 1/metabolism*;Food-Drug Interactions/radiation effects;Hyperalgesia/chemically induced;Hyperalgesia/metabolism*;Male;Morphine/administration & dosage*;Naloxone;Narcotics/administration & dosage*;Pain Measurement;Proto-Oncogene Proteins c-fos/metabolism*;Rats;Rats, Wistar;Reaction Time/drug effects;Tyrosine 3-Monooxygenase/metabolism
17617289;Adult;Asthenia/chemically induced;Biological Availability;Capsules;Clonidine/administration & dosage;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dietary Fats*;Dosage Forms;Female;Food-Drug Interactions;Humans;Male;Muscle Relaxants, Central/administration & dosage*;Muscle Relaxants, Central/adverse effects;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics*;Tablets
17612708;Administration, Cutaneous;Antidepressive Agents*/adverse effects;Antidepressive Agents*/pharmacology;Antidepressive Agents*/therapeutic use;Depression/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors*/adverse effects;Monoamine Oxidase Inhibitors*/pharmacology;Monoamine Oxidase Inhibitors*/therapeutic use;Selegiline*/adverse effects;Selegiline*/pharmacology;Selegiline*/therapeutic use
17604610;Administration, Oral;Animals;Area Under Curve;Chlorobenzenes/blood;Chlorobenzenes/metabolism;Chlorobenzenes/pharmacokinetics*;Chylomicrons/chemistry;Chylomicrons/metabolism;DDT;Diazepam/blood;Diazepam/metabolism;Diazepam/pharmacokinetics*;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions;Injections, Intravenous;Intestinal Absorption/drug effects;Lipoproteins/chemistry*;Lipoproteins/metabolism;Lipoproteins, VLDL/chemistry;Lipoproteins, VLDL/metabolism;Lymph/chemistry;Lymph/metabolism;Male;Peanut Oil;Plant Oils/administration & dosage;Plant Oils/metabolism;Postprandial Period;Protein Binding;Rats;Rats, Wistar;Triglycerides/blood;Triglycerides/metabolism
17571254;Adult;Area Under Curve;Biological Availability;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Dietary Fats*;Emulsions;Fasting;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Reference Values;Sex Factors;Therapeutic Equivalency
17549313;Aspirin/pharmacology*;Blood Platelets/drug effects*;Blood Platelets/enzymology;Cyclooxygenase 1/metabolism*;Cyclooxygenase Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Gallic Acid/pharmacology*;Humans;In Vitro Techniques;Platelet Aggregation/drug effects*;Salicylic Acid/pharmacology;Thromboxane B2/metabolism
17545920;Animals;Antineoplastic Agents, Hormonal/pharmacology;Apoptosis/drug effects;Bone Density/drug effects*;Bone Density Conservation Agents/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/pathology;Cell Line, Tumor;Cell Proliferation/drug effects;Combined Modality Therapy;Food-Drug Interactions*;Lignans/pharmacology*;Mice;Mice, Nude;Ovariectomy;Premenopause;Seeds;Sesamum*;Tamoxifen/antagonists & inhibitors*;Tumor Burden/drug effects;Xenograft Model Antitumor Assays
17542349;Administration, Oral;Adolescent;Adult;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Organic Chemicals/administration & dosage;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/pharmacokinetics*
17542018;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Caco-2 Cells;Citrus paradisi*;Dose-Response Relationship, Drug;Flavanones/pharmacology;Food-Drug Interactions*;Furocoumarins/pharmacology;Humans;Intestinal Absorption/drug effects*;Intestinal Mucosa/drug effects*;Intestinal Mucosa/metabolism;Membrane Transport Modulators/pharmacology*;Permeability;Propanolamines/metabolism*
17530235;Citrus paradisi*;Drug Overdose;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage*;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/pharmacokinetics;Liver Transplantation;Middle Aged;Tacrolimus/administration & dosage*;Tacrolimus/adverse effects*;Tacrolimus/pharmacokinetics
17510891;Amphetamines/administration & dosage;Amphetamines/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Delayed-Action Preparations;Drug Administration Schedule;Food-Drug Interactions;Gastric Emptying;Gastrointestinal Transit*;Humans;Models, Biological;Models, Statistical*;Monte Carlo Method;Solubility
17510152;European Union;Food, Organic/standards*;Food-Drug Interactions;Foods, Specialized/standards*;Humans;Legislation, Drug;Marketing;Product Surveillance, Postmarketing
17500086;Drug Interactions;Drug Storage;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Humans;Patient Education as Topic*;Pharmaceutical Preparations*/administration & dosage;Pharmacists*
17499891;Child;Child, Preschool;Environmental Exposure/adverse effects*;Food-Drug Interactions;Humans;Lead Poisoning/blood*;Lead Poisoning/etiology*;Nutritional Status*;Public Health*;Trace Elements/administration & dosage;Vitamins/administration & dosage
17495279;Adolescent;Adult;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Fasting;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Piperidines/administration & dosage*;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Psychotic Disorders;Serotonin 5-HT2 Receptor Agonists*;Tablets;Therapeutic Equivalency;Urea/administration & dosage;Urea/adverse effects;Urea/analogs & derivatives*;Urea/blood;Urea/pharmacokinetics
17468508;Animals;Attitude of Health Personnel;Catechin;Diet;Eating;Food-Drug Interactions;Humans;Hypertension/prevention & control;Milk/adverse effects*;Milk Proteins/adverse effects;Postprandial Period;Swine;Swine, Miniature;Tea*;Vasodilation
17463218;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats;Fasting;Food;Food-Drug Interactions*;Gastric Emptying;Humans;Male;Mass Spectrometry;Middle Aged;Nucleic Acid Synthesis Inhibitors;Rifamycins/administration & dosage;Rifamycins/adverse effects*;Rifamycins/blood;Rifamycins/pharmacokinetics*;Therapeutic Equivalency
17452418;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/blood;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Animals;Beverages/analysis*;Caco-2 Cells;Citrus paradisi*;Dose-Response Relationship, Drug;Enalapril/administration & dosage;Enalapril/pharmacokinetics;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Esterases/antagonists & inhibitors*;Esterases/metabolism;Flavanones/pharmacology;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Food-Drug Interactions*;Fruit;Humans;Hydrolysis;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;In Vitro Techniques;Intestinal Absorption/drug effects;Kaempferols/pharmacology;Lovastatin/administration & dosage;Lovastatin/pharmacokinetics;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Nitrophenols/metabolism;Rats;Rats, Sprague-Dawley
17443397;Administration, Oral;Adult;Carbamates/administration & dosage;Carbamates/blood;Carbamates/chemistry;Carbamates/pharmacokinetics*;Cross-Over Studies;Duodenum/metabolism*;Fasting/metabolism;Feasibility Studies;Female;Food-Drug Interactions*;Gastric Juice/metabolism*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/chemistry;HIV Protease Inhibitors/pharmacokinetics*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption*;Intestinal Secretions/metabolism*;Male;Organophosphates/administration & dosage;Organophosphates/blood;Organophosphates/chemistry;Organophosphates/pharmacokinetics*;Postprandial Period;Solubility;Sulfonamides/administration & dosage;Sulfonamides/blood;Sulfonamides/chemistry;Sulfonamides/pharmacokinetics*;Tablets
17438537;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Area Under Curve;Beverages*;Carrier Proteins/metabolism;Citrus paradisi*;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Organic Anion Transporters/metabolism
17425628;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Eating*;Esomeprazole/administration & dosage;Esomeprazole/blood;Esomeprazole/pharmacokinetics*;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged
17414499;Aged;Aging/pathology;Aging/physiology*;Drug Prescriptions;Food-Drug Interactions*;Geriatric Assessment;Health Status*;Humans;Nutrition Assessment;Nutritional Status*;Risk Factors
17397270;Animals;Biotin/pharmacology;Biotin/therapeutic use*;Candidiasis, Vulvovaginal/drug therapy;Dermatitis/drug therapy;Diabetes Mellitus/drug therapy;Dyslipidemias/drug therapy;Female;Food-Drug Interactions;Foot Diseases/drug therapy;Foot Diseases/veterinary;Hoof and Claw;Humans;Male;Multiple Carboxylase Deficiency/drug therapy;Nail Diseases/drug therapy
17392996;Adrenergic beta-Antagonists/pharmacology;Anti-Arrhythmia Agents/pharmacology;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Cardiovascular Agents/pharmacokinetics;Cardiovascular Agents/pharmacology*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy;Cardiovascular Diseases/physiopathology;Citrus paradisi*;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology
17392729;Adult;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages*;Clonidine/analogs & derivatives*;Clonidine/pharmacokinetics;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Midazolam/pharmacokinetics*;Stereoisomerism;Vaccinium macrocarpon*;Warfarin/chemistry;Warfarin/pharmacokinetics*
17392396;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Animals;Beverages*;Caco-2 Cells;Cell Membrane Permeability/drug effects;Citrus paradisi*;Enalapril/pharmacokinetics;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Esterases/antagonists & inhibitors*;Esterases/metabolism;Food-Drug Interactions*;Fruit;Humans;Hydrolysis;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/drug effects;Intestines/enzymology;Liver/drug effects;Liver/enzymology;Lovastatin/pharmacokinetics;Male;Nitrophenols/metabolism;Nitrophenols/pharmacology;Rats;Rats, Sprague-Dawley;Subcellular Fractions/drug effects;Subcellular Fractions/enzymology;Swine
17389562;Acyl Coenzyme A/antagonists & inhibitors;Citrus paradisi/metabolism*;Drug-Related Side Effects and Adverse Reactions;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacokinetics;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
17389557;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Darunavir;Drug Combinations;Fasting;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Seronegativity;Half-Life;Humans;Male;Middle Aged;Ritonavir/administration & dosage;Ritonavir/adverse effects;Ritonavir/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
17389552;Adolescent;Adult;Area Under Curve;Circadian Rhythm;Codon, Nonsense/antagonists & inhibitors*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Immunoblotting;Male;Oxadiazoles/administration & dosage;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics*
17385020;Area Under Curve;Food-Drug Interactions*;Pharmacokinetics*
17368832;Anticoagulants/antagonists & inhibitors*;Food-Drug Interactions*;Humans;International Normalized Ratio;Tea/adverse effects*;Vegetables*;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
17357375;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects*;Drug Interactions;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/pharmacokinetics*;Histamine H1 Antagonists/pharmacology;Humans;Solute Carrier Organic Anion Transporter Family Member 1b1/drug effects
17346019;Alcohol Drinking/adverse effects*;Alcohol Drinking/epidemiology;Alcohol Drinking/metabolism;Alcohol Drinking/prevention & control*;Alcoholic Beverages/analysis;Attitude to Health;Ethanol/analysis;Food-Drug Interactions;Health Behavior;Health Knowledge, Attitudes, Practice;Health Promotion/organization & administration*;Helping Behavior;Humans;Life Style*;Nurse's Role/psychology*;Patient Education as Topic/organization & administration;Social Support;United Kingdom/epidemiology
17331342;Administration, Oral;Animals;Area Under Curve;Chelating Agents/administration & dosage*;Chelating Agents/pharmacokinetics*;Clioquinol/administration & dosage*;Clioquinol/pharmacokinetics*;Cricetinae;Female;Food-Drug Interactions;Tissue Distribution
17328583;Adolescent;Adult;Aged;Antacids/pharmacology;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Azithromycin/administration & dosage;Azithromycin/adverse effects;Azithromycin/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacology;Drug Interactions;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Humans;Male;Microspheres;Middle Aged;Sample Size
17322161;Anticoagulants/adverse effects*;Aryl Hydrocarbon Hydroxylases;Beverages;Clinical Trials as Topic;Cytochrome P-450 CYP2C9;Drug Monitoring;Female;Flavonoids;Food-Drug Interactions*;Hemorrhage/chemically induced;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Vitamin K Deficiency;Warfarin/adverse effects*;Warfarin/pharmacokinetics*
17322140;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Beverages*;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP3A/metabolism*;Food-Drug Interactions;GABA Modulators/administration & dosage;GABA Modulators/metabolism;GABA Modulators/pharmacokinetics;Humans;Injections, Intravenous;Male;Metabolic Clearance Rate;Microsomes, Liver/metabolism;Midazolam/administration & dosage;Midazolam/metabolism;Midazolam/pharmacokinetics*;Punicaceae/chemistry*;Triazolam/analogs & derivatives;Triazolam/metabolism
17306733;Diet*;Female;Food-Drug Interactions;Genetic Predisposition to Disease;Genomics*;Humans;Male;Nutritional Physiological Phenomena/genetics*;Nutritional Status/genetics;Population Surveillance;Quality Control;Risk Assessment
17300625;Absorption;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Biological Availability;Cross-Over Studies;Dietary Supplements;Dose-Response Relationship, Drug;Drug Combinations;Ethanolamines/administration & dosage;Ethanolamines/pharmacokinetics*;Fasting;Female;Fluorenes/administration & dosage;Fluorenes/pharmacokinetics*;Food-Drug Interactions;Humans;Malaria, Falciparum/prevention & control;Male;Middle Aged;Soy Milk/administration & dosage*
17296276;Administration, Oral;Animals;Brain/metabolism;Chylomicrons/blood;Chylomicrons/metabolism*;DDT/administration & dosage;DDT/blood;DDT/pharmacokinetics*;DDT/toxicity;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Facial Muscles/drug effects;Food-Drug Interactions*;Hyperlipidemias/blood;Hyperlipidemias/etiology;Hyperlipidemias/metabolism*;Infusions, Intravenous;Male;Peanut Oil;Plant Oils/administration & dosage;Plant Oils/adverse effects*;Postprandial Period;Protein Binding;Rats;Rats, Wistar;Tremor/chemically induced;Triglycerides/blood;Triglycerides/metabolism*
17286787;Adult;Area Under Curve;Benzodiazepines/pharmacokinetics*;Benzodiazepines/pharmacology*;Biological Availability;Cross-Over Studies;Diazepam/pharmacokinetics*;Diazepam/pharmacology*;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/pharmacology*;Male;Nitrazepam/pharmacokinetics*;Nitrazepam/pharmacology*;Psychomotor Performance/drug effects
17270055;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/blood;Hydromorphone/pharmacokinetics*;Male;Middle Aged;Naltrexone/administration & dosage;Narcotic Antagonists/administration & dosage
17269967;Adult;Aged;Aged, 80 and over;Arthritis, Psoriatic/drug therapy*;Caffeine/pharmacology*;Dermatologic Agents/administration & dosage;Dermatologic Agents/pharmacokinetics*;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Methotrexate/administration & dosage;Methotrexate/pharmacokinetics*;Middle Aged;Psoriasis/drug therapy*
17269895;Animals;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Humans;Intestine, Small/metabolism*;Models, Biological;Prognosis
17253885;Biotransformation;Contraceptives, Oral/pharmacokinetics*;Contraceptives, Oral/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/pharmacology;Ethinyl Estradiol/pharmacokinetics*;Ethinyl Estradiol/pharmacology;Food-Drug Interactions;Glucuronides/metabolism;Glucuronosyltransferase/antagonists & inhibitors;Glucuronosyltransferase/metabolism*;Humans;Isoenzymes/metabolism;Membrane Transport Proteins/metabolism;Models, Biological;Oxidation-Reduction;Progestins/pharmacology;Sulfotransferases/antagonists & inhibitors;Sulfotransferases/metabolism*;Sulfuric Acid Esters/metabolism
17253883;Anti-Bacterial Agents/pharmacology*;Area Under Curve;Biological Availability;Biotransformation;Carbamates/administration & dosage;Carbamates/pharmacokinetics*;Carbamates/pharmacology;Cyclohexanes/administration & dosage;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Drug Administration Schedule;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Intestinal Absorption;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/pharmacokinetics;Phenylalanine/pharmacology;Piperidines/administration & dosage;Piperidines/pharmacokinetics*;Piperidines/pharmacology;Postprandial Period
17250919;Animals;Biological Availability;Etidronic Acid/administration & dosage;Etidronic Acid/analogs & derivatives*;Etidronic Acid/blood;Etidronic Acid/chemistry;Etidronic Acid/pharmacokinetics;Food-Drug Interactions*;Gastrointestinal Transit;Infusions, Intravenous;Intestinal Absorption*;Intestinal Mucosa/metabolism;Male;Molecular Structure;Naphthalenes/administration & dosage;Naphthalenes/blood;Naphthalenes/chemistry;Naphthalenes/pharmacokinetics*;Propionates/administration & dosage;Propionates/blood;Propionates/chemistry;Propionates/pharmacokinetics*;Rats;Rats, Wistar;Risedronate Sodium;Trientine/administration & dosage;Trientine/blood;Trientine/chemistry;Trientine/pharmacokinetics*
17245831;Food-Drug Interactions;Humans;Hypertension/etiology;Indans/adverse effects;Indans/therapeutic use*;Melanoma/chemically induced;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Neuroprotective Agents/adverse effects;Neuroprotective Agents/therapeutic use*;Parkinson Disease/drug therapy*;Skin Neoplasms/chemically induced
17233779;Adult;Aged;Dose-Response Relationship, Drug;Double-Blind Method;Erectile Dysfunction/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Patient Satisfaction;Penile Erection/drug effects;Phosphodiesterase Inhibitors/administration & dosage*;Piperazines/administration & dosage*;Purines/administration & dosage;Sildenafil Citrate;Sulfones/administration & dosage*;Treatment Outcome;Vasodilator Agents/administration & dosage*
17224848;Adult;Area Under Curve;Biological Availability;Capsules;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gelatin/chemistry;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;Humans;Lopinavir;Male;Metabolic Clearance Rate;Middle Aged;Pyrimidinones/administration & dosage;Pyrimidinones/pharmacokinetics*;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Tablets
17220050;Adult;Area Under Curve;Biological Availability;Calibration;Cross-Over Studies;Electrocardiography/drug effects;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/pharmacokinetics*;Ticlopidine/administration & dosage;Ticlopidine/analogs & derivatives*;Ticlopidine/pharmacokinetics
17215845;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Adult;Aged;Aged, 80 and over;Beverages/adverse effects*;Biological Availability;Blotting, Western;Carrier Proteins/biosynthesis*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Female;Fluorescent Antibody Technique;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Humans;Immunohistochemistry;Intestines/metabolism*;Male;Middle Aged;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Pharmaceutical Preparations/metabolism*;RNA/biosynthesis;RNA/genetics;Reverse Transcriptase Polymerase Chain Reaction;Terfenadine/analogs & derivatives;Terfenadine/blood
17212251;Aged;Diuretics/adverse effects*;Food-Drug Interactions;Humans;Minerals/adverse effects*;Salts/adverse effects*;Sodium/deficiency*;Sodium Chloride, Dietary/administration & dosage
17209212;Dietary Supplements;Evidence-Based Medicine;Food-Drug Interactions*;Genetic Predisposition to Disease;Humans;Minerals/administration & dosage*;Neoplasms/etiology;Neoplasms/genetics;Neoplasms/prevention & control*;Nutritional Status;Randomized Controlled Trials as Topic;Vitamins/administration & dosage*
17207418;Administration, Oral;Animals;Biological Availability;Drug Administration Schedule;Food-Drug Interactions/physiology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/metabolism;Glucosamine/administration & dosage;Glucosamine/analogs & derivatives*;Glucosamine/blood;Glucosamine/pharmacokinetics;Male;Rats;Rats, Sprague-Dawley
17187315;Animals;Beverages;Cytochrome P-450 Enzyme System/biosynthesis;Drug Interactions*;Enzyme Induction;Food-Drug Interactions;Humans
17176169;Food-Drug Interactions;Tetrahydrofolates/pharmacology;Tetrahydrofolates/therapeutic use*
17146730;Acetamides/administration & dosage*;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting/blood;Female;Food-Drug Interactions;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Netherlands;Pilot Projects;Postprandial Period;Treatment Outcome;Tubulin Modulators/administration & dosage*;Tubulin Modulators/adverse effects;Tubulin Modulators/blood;Tubulin Modulators/pharmacokinetics*
17143047;Aged;Aging/blood*;Anticoagulants/administration & dosage*;Anticoagulants/therapeutic use;Antifibrinolytic Agents/administration & dosage*;Blood Coagulation/drug effects*;Diet;Food-Drug Interactions*;Humans;Phenprocoumon/administration & dosage;Thrombosis/prevention & control;Vitamin K/administration & dosage*;Warfarin/administration & dosage
17137219;Aldosterone/blood;Animals;Cardiomegaly/physiopathology;Diet, Sodium-Restricted;Echocardiography;Fibrosis/physiopathology;Food-Drug Interactions*;Heart/drug effects;Male;Mineralocorticoid Receptor Antagonists/pharmacology*;Mineralocorticoid Receptor Antagonists/therapeutic use;Myocardial Infarction/physiopathology*;Rats;Rats, Wistar;Sodium Chloride/administration & dosage;Sodium Chloride/pharmacology*;Spironolactone/analogs & derivatives*;Spironolactone/pharmacology;Spironolactone/therapeutic use;Ventricular Remodeling/drug effects*
17132763;ATP-Binding Cassette, Sub-Family B, Member 1/physiology;Animals;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors*;Beverages*;Biological Availability;Cytochrome P-450 CYP2C9;Food-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics*;Male;Punicaceae*;Rats;Rats, Wistar;Tolbutamide/antagonists & inhibitors*;Tolbutamide/pharmacokinetics*
17126638;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Beverages*;Cross-Over Studies;Double-Blind Method;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Prospective Studies;Prothrombin Time*;Time Factors;Vaccinium macrocarpon*;Warfarin/therapeutic use*
17126626;Adolescent;Adult;Dietary Supplements*/adverse effects;Dietary Supplements*/statistics & numerical data;Dietary Supplements*/utilization;Drug Prescriptions/statistics & numerical data;Female;Food-Drug Interactions*;Health Behavior*;Health Knowledge, Attitudes, Practice*;Humans;Interviews as Topic;Male;Middle Aged;Minerals/administration & dosage*;Minerals/adverse effects;Nutrition Surveys;Prevalence;Socioeconomic Factors;United States;Vitamins/administration & dosage*;Vitamins/adverse effects
17126621;Advertising as Topic/legislation & jurisprudence*;Advertising as Topic/methods;Advertising as Topic/standards;Community Participation;Drug Industry;Drug Prescriptions*;Food-Drug Interactions*;Guidelines as Topic;Health Knowledge, Attitudes, Practice;Humans;Legislation, Drug*;Mass Media;Patient Education as Topic;United States;United States Food and Drug Administration
17116021;Administration, Oral;Anticonvulsants/pharmacokinetics*;Carbamates/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Design;Drugs, Investigational;Food-Drug Interactions;Humans;Neurotransmitter Agents/pharmacokinetics*;Placebos
17112309;Aged;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug-Related Side Effects and Adverse Reactions/etiology;Food-Drug Interactions*;Humans
17112297;Area Under Curve;Biological Availability;Computer Simulation;Cross-Over Studies;Fasting/physiology;Food-Drug Interactions/physiology*;Humans;Hydrophobic and Hydrophilic Interactions;Intestinal Absorption/physiology;Models, Biological*;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism;Pharmacokinetics*;Software;Solubility
17101740;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Clinical Trials as Topic;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Molecular Structure;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry
17094172;Adult;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/urine;Beverages;Cross-Over Studies;Diclofenac/pharmacokinetics*;Diclofenac/urine;Female;Flowers;Food-Drug Interactions*;Hibiscus*;Humans;Kidney/drug effects*;Kidney/metabolism;Male;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use
17077528;Animals;Area Under Curve;Beverages/analysis*;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Chromatography, High Pressure Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Duodenum/drug effects;Duodenum/metabolism;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/chemistry;Furocoumarins/pharmacology;Hot Temperature*;Hydroxytestosterones/analysis;Hydroxytestosterones/metabolism;Intubation, Gastrointestinal;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Molecular Structure;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics;Rats;Rats, Wistar;Time Factors
17075867;Animals;Atazanavir Sulfate;Biological Availability;Dietary Fats*;Dogs;Drug Evaluation, Preclinical/methods*;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Models, Animal*;Oligopeptides/pharmacokinetics;Pentagastrin/pharmacology*;Pravastatin/pharmacokinetics;Pyridines/pharmacokinetics
17065027;Administration, Oral;Adult;Anti-HIV Agents/therapeutic use*;Antiretroviral Therapy, Highly Active;Capsules;Clinical Trials as Topic;Cohort Studies;Didanosine/therapeutic use*;Fasting;Female;Food*;Food-Drug Interactions*;HIV*/isolation & purification;HIV Infections/drug therapy*;HIV Infections/virology;Humans;Male;Patient Compliance;Proportional Hazards Models;Retrospective Studies;Risk Factors;Spain;Treatment Failure;Viral Load
17053894;Administration, Oral;Adult;Algorithms;Analysis of Variance;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics;Area Under Curve;Biological Availability;Bread*;Capsules;Chromatography, High Pressure Liquid/methods;Cluster Analysis;Cross-Over Studies;Dose-Response Relationship, Drug;Eating/physiology*;Female;Food-Drug Interactions;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Oryza*;Retrospective Studies;Software*;Time Factors
17046222;Attitude to Health;Diet Records*;Diet Surveys;Diet, Fat-Restricted;Diet, Reducing;Energy Intake*;Evaluation Studies as Topic;Feeding Behavior;Female;Food, Genetically Modified*;Food-Drug Interactions*;Humans;Male;Nutrition Assessment;Sensitivity and Specificity;Surveys and Questionnaires
16995870;Adult;Beverages*;Citrus*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/metabolism*;Drug Interactions;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/metabolism*;Male
16989032;Bacteriuria/prevention & control;Double-Blind Method;Female;Food-Drug Interactions;Fruit;Humans;Phytotherapy;Plant Preparations*/therapeutic use;Randomized Controlled Trials as Topic;Self Care/methods;Urinary Tract Infections*/prevention & control;Urinary Tract Infections*/therapy;Vaccinium macrocarpon*;Warfarin
16988211;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Anticholesteremic Agents/pharmacokinetics;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Atorvastatin Calcium;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Disorders of Excessive Somnolence/chemically induced;Dose-Response Relationship, Drug;Drug Combinations;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heptanoic Acids/adverse effects;Heptanoic Acids/pharmacokinetics*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/pharmacokinetics*;Tablets;Therapeutic Equivalency
16988203;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Administration, Oral;Adult;Aminopyridines/administration & dosage;Aminopyridines/blood;Aminopyridines/metabolism;Aminopyridines/pharmacokinetics*;Area Under Curve;Benzamides/administration & dosage;Benzamides/blood;Benzamides/metabolism;Benzamides/pharmacokinetics*;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclopropanes/administration & dosage;Cyclopropanes/blood;Cyclopropanes/metabolism;Cyclopropanes/pharmacokinetics;Dietary Fats/administration & dosage*;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Half-Life;Headache/diagnosis;Headache/epidemiology;Humans;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
16945054;Anticoagulants/adverse effects*;Beverages*;Food-Drug Interactions;Humans;International Normalized Ratio;Vaccinium macrocarpon*;Warfarin/adverse effects*
16909484;Administration, Cutaneous;Depression/drug therapy*;Drug Approval;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Selegiline/administration & dosage*
16903052;Animal Feed/adverse effects;Animal Feed/analysis*;Animals;Chironomidae/growth & development*;Ecosystem;Food-Drug Interactions;Geologic Sediments/chemistry*;Larva/growth & development*;Water Pollutants, Chemical/toxicity*
16900909;Alcoholic Beverages/adverse effects*;Analgesics, Opioid/adverse effects*;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Intestinal Absorption;Oxycodone/adverse effects*;Patient Education as Topic
16872553;Animals;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Drug Interactions;Food-Drug Interactions*;Furocoumarins/pharmacology;Humans;In Vitro Techniques;Intestines/metabolism;Male;Microsomes/metabolism;Microsomes, Liver/metabolism;Nifedipine/pharmacokinetics*;Oxidation-Reduction;Rats;Rats, Wistar;Vaccinium macrocarpon*
16871472;Adult;Alprazolam/therapeutic use;Animals;Antidepressive Agents, Second-Generation/therapeutic use;Antidepressive Agents, Tricyclic/adverse effects*;Anxiety/complications;Anxiety/drug therapy;Clomipramine/adverse effects*;Drug Eruptions/pathology*;Female;Food-Drug Interactions*;Gadus morhua*;Humans;Hypnotics and Sedatives/therapeutic use;Meat/adverse effects*;Obsessive-Compulsive Disorder/complications;Obsessive-Compulsive Disorder/drug therapy;Paroxetine/therapeutic use;Urticaria/chemically induced*;Urticaria/pathology*
16870316;Animals;Antibiotics, Antineoplastic/toxicity*;Blood Pressure/drug effects;Deoxyguanosine/analogs & derivatives;Deoxyguanosine/metabolism;Doxorubicin/toxicity*;Food-Drug Interactions*;Hypertension/chemically induced*;Hypertension/enzymology;Hypertension/pathology;Immunoenzyme Techniques;Kidney/drug effects*;Kidney/enzymology;Kidney/pathology;Male;Nitric Oxide Synthase Type III/metabolism*;Oxidative Stress*;Rats;Rats, Sprague-Dawley;Sodium, Dietary/administration & dosage*;Up-Regulation
16863482;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Interactions;Food-Drug Interactions*;Gastric Acid/secretion;Gastric Acidity Determination;Gastric Mucosa/drug effects*;Gastric Mucosa/metabolism;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Histamine H2 Antagonists/pharmacology*;Humans;Intestinal Absorption/drug effects;Male;Pilot Projects;Ranitidine/pharmacology*;Reference Values;Saquinavir/blood;Saquinavir/pharmacokinetics*;Scotland
16863458;Animals;Drug Interactions;Food-Drug Interactions;Humans;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/metabolism;Immunosuppressive Agents/therapeutic use*;Mycophenolic Acid/adverse effects;Mycophenolic Acid/analogs & derivatives*;Mycophenolic Acid/metabolism;Mycophenolic Acid/therapeutic use;Organ Transplantation*;Transplantation Immunology
16863430;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Animals;Biological Availability;Cytochrome P-450 CYP3A/physiology*;Drug Design;Drug Interactions;Food-Drug Interactions;Humans;Intestines/metabolism;Liver/metabolism;Pharmaceutical Preparations/metabolism*;Pharmacogenetics
16863427;ATP Binding Cassette Transporter, Sub-Family G, Member 2;ATP-Binding Cassette Transporters/analysis;ATP-Binding Cassette Transporters/antagonists & inhibitors;ATP-Binding Cassette Transporters/genetics;ATP-Binding Cassette Transporters/physiology*;Absorption;Area Under Curve;Blood-Brain Barrier;Drug Interactions*;Food-Drug Interactions;Humans;Neoplasm Proteins/analysis;Neoplasm Proteins/antagonists & inhibitors;Neoplasm Proteins/genetics;Neoplasm Proteins/physiology*;Pharmacokinetics*;Polymorphism, Genetic
16862703;Anticholesteremic Agents/metabolism;Atorvastatin Calcium;Beverages*;Cytochrome P-450 CYP3A Inhibitors*;Female;Food-Drug Interactions*;Heptanoic Acids/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Punicaceae*;Pyrroles/metabolism
16856145;Administration, Oral;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Blood Pressure/drug effects*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Therapy, Combination;Female;Food-Drug Interactions*;Heart Rate/drug effects*;Humans;Indans/administration & dosage;Indans/adverse effects*;Levodopa/administration & dosage;Levodopa/adverse effects;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Parkinson Disease/drug therapy*;Risk Factors;Tyramine*/administration & dosage
16855078;Administration, Cutaneous;Administration, Oral;Adolescent;Adult;Blood Pressure/drug effects*;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Heart Rate/drug effects;Humans;Hypertension/chemically induced*;Hypertension/physiopathology;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Reference Values;Selegiline/administration & dosage;Selegiline/adverse effects*;Time Factors;Tranylcypromine/administration & dosage;Tranylcypromine/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects*
16850557;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism
16850428;Algorithms;Biopharmaceutics;Body Fluids/chemistry;Caco-2 Cells;Chromatography, High Pressure Liquid;Danazol/administration & dosage;Danazol/chemistry;Danazol/pharmacokinetics;Electric Conductivity;Emulsions;Estrogen Antagonists/administration & dosage;Estrogen Antagonists/chemistry;Estrogen Antagonists/pharmacokinetics;Food-Drug Interactions*;Humans;Intestinal Absorption;Permeability;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Polyethylene Glycols;Predictive Value of Tests;Solubility
16815131;Adult;Antiretroviral Therapy, Highly Active/adverse effects;Diabetes, Gestational/diet therapy*;Dietetics/organization & administration*;Female;Food-Drug Interactions;HIV Infections/complications;HIV Infections/therapy*;Home Care Services/organization & administration*;Humans;Maternal Nutritional Physiological Phenomena;Nutrition Therapy*;Nutritional Sciences/education;Patient Care Team;Patient Education as Topic;Pregnancy;Pregnancy Complications, Infectious/therapy*;Pregnancy Outcome;Prenatal Nutritional Physiological Phenomena;United States
16814135;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/therapeutic use;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/drug therapy*;Intestines/enzymology
16808323;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Area Under Curve;Beverages*;Biological Availability*;Citrus paradisi*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*
16804094;Animals;Beverages*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism;Punicaceae*
16803818;Anti-Anxiety Agents/administration & dosage*;Benzodiazepines/administration & dosage*;Citrus paradisi;Conscious Sedation/methods*;Food-Drug Interactions*;Humans
16802061;Anti-Anxiety Agents;Beverages*;Calcium Channel Blockers*;Citrus paradisi*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors
16789588;Depressive Disorder/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use
16773618;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Combined Modality Therapy;Cross-Over Studies;Diet, Protein-Restricted*/adverse effects;Drug Therapy, Combination;Female;Food-Drug Interactions*;Humans;Levodopa/administration & dosage;Levodopa/adverse effects*;Male;Middle Aged;Neurologic Examination*;Parkinson Disease/diet therapy*;Parkinson Disease/physiopathology;Patient Satisfaction;Pilot Projects;Postprandial Period*/physiology;Single-Blind Method
16772772;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Drug Synergism;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Hypoprothrombinemias/chemically induced*;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
16758223;Adolescent;Adult;Alcohol Drinking/adverse effects;Antioxidants/therapeutic use;Biomarkers;Case-Control Studies;Child;Controlled Clinical Trials as Topic;Dermatologic Agents/administration & dosage;Dermatologic Agents/therapeutic use;Diet, Vegetarian;Energy Intake;Fasting;Fatty Acids, Omega-3/therapeutic use;Female;Fish Oils;Food-Drug Interactions;Glutens/adverse effects;Homocysteine/blood;Humans;Male;Methotrexate/administration & dosage;Methotrexate/therapeutic use;Nutritional Status*;Psoriasis/blood;Psoriasis/diet therapy*;Psoriasis/drug therapy;Psoriasis/etiology;Psoriasis/metabolism;Sex Factors;Vitamin D/therapeutic use
16756539;Enteral Nutrition*;Food-Drug Interactions*;Humans
16755036;Animals;Beverages/radiation effects*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Citrus paradisi/radiation effects;Drug Interactions;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/pharmacology*;Furocoumarins/radiation effects;Male;Nifedipine/blood;Nifedipine/pharmacokinetics*;Rats;Rats, Wistar;Ultraviolet Rays*
16741856;Anticoagulants/pharmacology*;Drug Resistance;Female;Food-Drug Interactions*;Humans;Lettuce*;Middle Aged;Warfarin/pharmacology*
16732136;Administration, Cutaneous;Animals;Depressive Disorder/drug therapy*;Diet*;Food-Drug Interactions;Guinea Pigs;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/pharmacokinetics*;Selegiline/administration & dosage*;Selegiline/pharmacokinetics*;Tyramine/metabolism*
16722829;Adult;Antimalarials/pharmacokinetics*;Beverages*;Citrus paradisi*;Female;Food-Drug Interactions;Humans;Male;Primaquine/pharmacokinetics*;Sex Characteristics
16715357;Animals;Bile Acids and Salts/analysis;Buffers;Dipyridamole/chemistry*;Dogs;Duodenum*;Fasting;Female;Food-Drug Interactions*;Gastrointestinal Contents/chemistry*;Humans;Hydrogen-Ion Concentration;Jejunum*;Ketoconazole/chemistry*;Lipids/analysis;Male;Polyethylene Glycols;Solubility;Species Specificity;Vitamin K/administration & dosage
16702731;Adult;Bayes Theorem;Beverages;Citrus paradisi/chemistry*;Female;Food-Drug Interactions*;Half-Life;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Liver Transplantation/physiology*;Phosphoric Monoester Hydrolases/metabolism;Tacrolimus/blood;Tacrolimus/pharmacokinetics*
16699355;Anticoagulants/therapeutic use*;Cross-Sectional Studies;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Heart Valve Prosthesis Implantation*/adverse effects;Humans;International Normalized Ratio;Male;Middle Aged;Patient Education as Topic/methods;Population Surveillance;Thromboembolism/etiology;Thromboembolism/prevention & control;Vitamin K/metabolism;Warfarin/therapeutic use*
16674636;Blood Platelets/physiology*;Diet*;Food-Drug Interactions*;Humans;Platelet Function Tests/methods;Preoperative Care/methods;Research Design
16669846;Administration, Oral;Adult;Area Under Curve;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Dihydropyridines/blood;Dihydropyridines/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Stereoisomerism;Time Factors
16669845;Beverages*;Biological Availability;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Dihydropyridines/pharmacokinetics*;Enzyme Inhibitors/pharmacokinetics;Food-Drug Interactions*;Herbal Medicine;Humans;Intestines/drug effects;Intestines/enzymology;Liver/drug effects;Liver/enzymology;Stereoisomerism
16638738;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Factor Xa Inhibitors;Fasting/metabolism;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacology;Humans;Intestinal Absorption/drug effects;Magnesium Hydroxide/pharmacology;Male;Morpholines/adverse effects;Morpholines/blood;Morpholines/pharmacokinetics*;Morpholines/pharmacology;Prothrombin Time;Ranitidine/pharmacology*;Rivaroxaban;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/pharmacokinetics*;Thiophenes/pharmacology
16628990;Anticoagulants/pharmacology*;Dietary Supplements*;Fish Oils;Food-Drug Interactions*;Fruit;Humans;Seaweed;Soy Milk;Tea;Warfarin/pharmacology*
16613116;Beverages/adverse effects*;Food-Drug Interactions*;Humans;Vaccinium macrocarpon/adverse effects*;Warfarin/adverse effects*
16584288;Administration, Oral;Adult;Biological Availability;Capsules;Delayed-Action Preparations;Dietary Fats/pharmacology;Fasting/metabolism;Female;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male
16569183;Enteral Nutrition*/adverse effects;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pharmacy Service, Hospital;Prospective Studies
16562361;Anti-Retroviral Agents/adverse effects;Anti-Retroviral Agents/classification;Anti-Retroviral Agents/therapeutic use*;CD4 Lymphocyte Count;Food-Drug Interactions;HIV Infections/drug therapy*;Hepatitis C/drug therapy;Humans;Sweden
16552571;Acetylglucosaminidase/blood;Animals;Antioxidants/administration & dosage;Antioxidants/chemistry;Antioxidants/metabolism;Catalase/metabolism;Cell Survival/drug effects;Cisplatin/toxicity*;Creatine/blood;Female;Food-Drug Interactions;Glutathione Peroxidase/metabolism;Humans;Kidney/drug effects*;Kidney/metabolism;Kidney/pathology;Kidney Diseases/chemically induced*;Kidney Diseases/physiopathology;Kidney Diseases/prevention & control;Lipid Peroxidation/drug effects;Male;Rats;Rats, Wistar;Spirulina/chemistry;Spirulina/physiology*;Superoxide Dismutase/metabolism;Tumor Cells, Cultured;Urea/blood
16520665;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Middle Aged;Protein-Tyrosine Kinases/antagonists & inhibitors*;Protein-Tyrosine Kinases/metabolism;Pyrroles/adverse effects;Pyrroles/blood;Pyrroles/pharmacokinetics*
16518091;Adrenergic alpha-1 Receptor Antagonists;Adrenergic alpha-Antagonists/administration & dosage;Adrenergic alpha-Antagonists/pharmacokinetics*;Adult;Aged;Aging/metabolism;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Food-Drug Interactions;Guanosine Triphosphate/physiology;Humans;Indoles/administration & dosage;Indoles/metabolism;Indoles/pharmacokinetics*;Kidney Diseases/metabolism;Male;Orosomucoid/metabolism;Protein Binding
16513449;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adolescent;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Vaccinium macrocarpon*
16513448;Adolescent;Adult;Area Under Curve;Benzodiazepines/pharmacokinetics;Beverages*;Chromatography, Liquid;Citrus paradisi*;Cytochrome P-450 CYP3A/metabolism*;Female;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Liver/drug effects;Liver/enzymology;Male;Mass Spectrometry;Middle Aged;Ritonavir/pharmacokinetics*
16512094;Anti-Bacterial Agents/adverse effects;Antifungal Agents/adverse effects;Atorvastatin Calcium;Azoles/adverse effects;Citrus paradisi/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dental Care for Chronically Ill*;Drug Interactions;Food-Drug Interactions;Heptanoic Acids/adverse effects;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Macrolides/adverse effects;Pravastatin/adverse effects;Pyrroles/adverse effects;Rhabdomyolysis/chemically induced;Simvastatin/adverse effects
16505889;Beverages;Food-Drug Interactions*;Humans;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Punicaceae*
16502765;Adolescent;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Fasting/blood;Female;Fenofibrate/administration & dosage;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/administration & dosage;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male;Nanostructures;Reference Values;Tablets
16490807;Adsorption;Adult;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Carbon/pharmacology*;Cross-Over Studies;Dietary Fats;Drug Administration Schedule;Drug Interactions;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Agents/pharmacology*;Humans;Imidazoles/blood;Imidazoles/pharmacokinetics*;Losartan/blood;Losartan/pharmacokinetics*;Male;Oxides/pharmacology*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Time Factors
16490805;Administration, Oral;Adult;Antiemetics/administration & dosage;Antiemetics/blood;Antiemetics/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Monitoring;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Middle Aged;Morpholines/administration & dosage;Morpholines/blood;Morpholines/pharmacokinetics*;Neurokinin-1 Receptor Antagonists*
16490803;Absorption;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/pharmacology;Drug Monitoring;Energy Intake;Fasting;Female;Food;Food-Drug Interactions*;Humans;Male;Nucleosides/administration & dosage;Nucleosides/blood;Nucleosides/pharmacokinetics*;Pyrimidinones/administration & dosage;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Thymidine/analogs & derivatives
16454693;Animals;Cytochrome P-450 Enzyme System/biosynthesis*;Cytochrome P-450 Enzyme System/genetics*;Diet*;Dietary Fats/pharmacology;Enzyme Induction/physiology;Food-Drug Interactions;Humans;Liver Diseases/metabolism;Nutritional Physiological Phenomena;Oxidation-Reduction;Vitamin A Deficiency/metabolism;Vitamin E/physiology
16430569;Analgesics, Opioid/pharmacokinetics*;Anesthetics/pharmacokinetics*;Animals;Biotransformation;Cytochrome P-450 Enzyme System/physiology*;Drug Interactions;Enzyme Induction/physiology;Enzyme Inhibitors/pharmacology;Food-Drug Interactions/physiology;Humans;Liver/enzymology*;Smoking/metabolism
16430312;Administration, Oral;Adult;Anticoagulants*/administration & dosage;Anticoagulants*/pharmacokinetics;Anticoagulants*/pharmacology;Area Under Curve;Azetidines*/administration & dosage;Azetidines*/pharmacokinetics;Azetidines*/pharmacology;Benzylamines*/administration & dosage;Benzylamines*/pharmacokinetics;Benzylamines*/pharmacology;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Food-Drug Interactions;Humans;Japan;Male;Metabolic Clearance Rate;Thrombin/antagonists & inhibitors*
16425970;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics;Chromatography, High Pressure Liquid;Clinical Chemistry Tests;Cross-Over Studies;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage;Eating/drug effects;European Union;Fasting;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Hydrogen-Ion Concentration;Male;Mass Spectrometry;Nifedipine/adverse effects;Nifedipine/blood;Nifedipine/pharmacokinetics*;Solubility;Tablets;Technology, Pharmaceutical/methods;Time Factors
16416305;Adult;Analysis of Variance;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism;Benzodiazepines/blood;Benzodiazepines/metabolism;Benzodiazepines/pharmacokinetics*;Beverages*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/metabolism;Hypnotics and Sedatives/pharmacokinetics*;Male;Metabolic Clearance Rate;Time Factors;Triazolam/blood;Triazolam/metabolism;Triazolam/pharmacokinetics*
16415112;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;In Vitro Techniques;Microsomes, Liver/enzymology;Midazolam/metabolism;Morus*;Vitis*
16413247;Adult;Algorithms;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Antifungal Agents/blood;Antifungal Agents/pharmacology*;Area Under Curve;Beverages;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Female;Fluconazole/blood;Fluconazole/pharmacology*;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Tea*;Vaccinium macrocarpon*;Vitis*
16412477;Adult;Animals;Beverages;Biological Availability;Blotting, Western;Carrier Proteins/metabolism;Citrus sinensis/chemistry*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Intestines/drug effects;Intestines/metabolism;Male;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Organic Anion Transporters, Sodium-Independent/biosynthesis;Organic Anion Transporters, Sodium-Independent/genetics;Pravastatin/pharmacokinetics*;RNA, Messenger/biosynthesis;RNA, Messenger/genetics;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Polymerase Chain Reaction;Simvastatin/pharmacokinetics
16398269;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Algorithms;Animals;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/pharmacokinetics;Antitubercular Agents/administration & dosage;Antitubercular Agents/pharmacokinetics;Beverages*;Calcium Channel Blockers/pharmacology;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Dose-Response Relationship, Drug;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;Ileum/drug effects;Ileum/metabolism;In Vitro Techniques;Indinavir/administration & dosage;Indinavir/pharmacokinetics;Intestinal Absorption/drug effects*;Male;Paclitaxel/administration & dosage;Paclitaxel/pharmacokinetics;Permeability;Pharmaceutical Preparations/metabolism*;Rats;Rats, Sprague-Dawley;Rifampin/administration & dosage;Rifampin/pharmacokinetics;Verapamil/pharmacology
16393464;Administration, Oral;Aniline Hydroxylase/metabolism;Animals;Chlorzoxazone/administration & dosage;Chlorzoxazone/blood;Chlorzoxazone/pharmacokinetics*;Cytochrome P-450 CYP1A1/metabolism;Cytochrome P-450 CYP2B1/metabolism;Cytochrome P-450 CYP2E1/biosynthesis*;Cytochrome P-450 CYP3A/metabolism;Fasting/metabolism*;Food-Drug Interactions;Injections, Intravenous;Liver/enzymology;Male;Muscle Relaxants, Central/administration & dosage;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics;Rats;Rats, Sprague-Dawley
16380358;Animals;Biological Availability;Citrus paradisi/chemistry*;Food-Drug Interactions*;Humans;Pharmacokinetics*
16365957;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/metabolism;Humans;Male;Piperazines/blood;Purines;Sildenafil Citrate;Sulfones;Vasodilator Agents/blood
16358638;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Drug Administration Schedule;Food-Drug Interactions;Gluconeogenesis/drug effects;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Insulin/administration & dosage;Insulin/adverse effects;Insulin/analogs & derivatives*;Insulin/blood;Insulin/pharmacokinetics;Insulin Lispro;Receptor, Insulin/drug effects
16357446;Antitubercular Agents/adverse effects*;Antitubercular Agents/therapeutic use;Cheese*;Fish Products*;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*;Isoniazid/therapeutic use;Risk Factors;Tuberculosis/drug therapy;Wine*
16337049;Anticoagulants/pharmacology*;Aspirin/pharmacology;Azetidines/pharmacology;Benzylamines/pharmacology;Calcium Channel Blockers/pharmacology*;Food Additives/adverse effects*;Food-Drug Interactions*;Honey/adverse effects*;Humans;Soy Foods/adverse effects*
16327247;Administration, Oral;Animals;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/pharmacokinetics*;Biological Availability;Food-Drug Interactions*;Levodopa/administration & dosage;Levodopa/pharmacokinetics*;Male;Musa*;Rats;Rats, Wistar
16326816;Animals;Area Under Curve;Beverages*/adverse effects;Biological Availability;Carbamazepine/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors*/adverse effects;Food-Drug Interactions*;Fruit*;Male;Metabolic Clearance Rate;Rats;Rats, Wistar
16325363;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Antiretroviral Therapy, Highly Active;Clinical Trials as Topic/methods;Clinical Trials as Topic/statistics & numerical data;Cohort Studies;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/epidemiology;HIV Infections/psychology;Humans;Interdisciplinary Communication;Outcome Assessment (Health Care);Patient Care Team;Physician-Patient Relations;Treatment Refusal*/statistics & numerical data
16321619;Administration, Oral;Adult;Alfentanil/administration & dosage;Alfentanil/pharmacokinetics*;Algorithms;Anesthetics, Intravenous/administration & dosage;Anesthetics, Intravenous/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cytochrome P-450 CYP3A/biosynthesis*;Cytochrome P-450 CYP3A Inhibitors*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Injections, Intravenous;Liver/enzymology;Liver/metabolism;Midazolam/administration & dosage;Midazolam/pharmacokinetics*
16306299;Biological Availability;Drug Administration Routes;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions/physiology*;Humans;Pharmaceutical Preparations/administration & dosage*
16305592;Acebutolol/analogs & derivatives;Acebutolol/blood*;Acebutolol/urine;Adrenergic beta-Antagonists/blood*;Adrenergic beta-Antagonists/urine;Adult;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/urine;Antihypertensive Agents/therapeutic use;Beverages*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Hemodynamics/drug effects;Humans;Male
16305298;Dietary Supplements/adverse effects;Drug Evaluation/methods*;Food-Drug Interactions*;Humans;Intestinal Absorption;Nutritional Status;Pharmaceutical Services;Pharmacokinetics
16302488;Biological Availability;Cytochrome P-450 Enzyme System/metabolism;Enzyme Induction;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism;Pharmacokinetics;Risk Factors;Time Factors
16297483;Animals;Antifungal Agents/administration & dosage*;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics;Area Under Curve;Biological Availability;Capsules;Chemical Phenomena;Chemistry, Pharmaceutical;Chemistry, Physical;Emulsions;Ethylene Glycols;Food-Drug Interactions;Hydrochloric Acid;Intestinal Absorption;Itraconazole/administration & dosage*;Itraconazole/chemistry;Itraconazole/pharmacokinetics;Male;Oils;Particle Size;Poloxamer;Rats;Rats, Sprague-Dawley;Solubility;Surface-Active Agents;Tocopherols;alpha-Tocopherol/analogs & derivatives
16296740;Animals;Attention Deficit Disorder with Hyperactivity/drug therapy*;Attention Deficit Disorder with Hyperactivity/physiopathology;Biological Availability;Chemistry, Pharmaceutical;Clinical Trials as Topic;Delayed-Action Preparations;Dopamine Agents/therapeutic use*;Food-Drug Interactions*;Humans;Methylphenidate/chemistry;Methylphenidate/pharmacokinetics;Methylphenidate/therapeutic use*;Sex Factors
16291715;Administration, Oral;Adult;Antidepressive Agents, Second-Generation/administration & dosage;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics*;Biological Availability;Citalopram/administration & dosage;Citalopram/adverse effects;Citalopram/pharmacokinetics*;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics*
16291710;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Didanosine/adverse effects;Didanosine/blood;Didanosine/pharmacokinetics*;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Male;Organophosphonates/adverse effects;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tenofovir
16288258;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans
16272810;Animals;Beverages;Chromatography, High Pressure Liquid;Citrus*/chemistry;Food-Drug Interactions*;Furocoumarins/analysis;Male;Nifedipine/pharmacokinetics*;Rats;Rats, Wistar
16272808;Beverages/analysis*;Chromatography, High Pressure Liquid/instrumentation;Chromatography, High Pressure Liquid/methods*;Citrus/chemistry*;Food-Drug Interactions;Furocoumarins/analysis*
16268317;Citrus paradisi/adverse effects;Drug Interactions*;Drug Therapy/nursing*;Food-Drug Interactions;Humans;Hypericum/adverse effects
16267709;Drug Administration Routes;Enteral Nutrition/instrumentation;Enteral Nutrition/methods*;Food-Drug Interactions*;Humans;Intubation, Gastrointestinal/instrumentation;Intubation, Gastrointestinal/methods*;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic;Practice Patterns, Physicians'
16265911;Adult;Dietary Supplements*;Drug Interactions;Drug Labeling;Female;Food Additives*/adverse effects;Food-Drug Interactions;Humans;Legislation, Drug;Legislation, Food;Male;Plant Structures*/adverse effects;Plants, Medicinal*/adverse effects;Russia;Safety
16260103;Absorption;Beverages*/toxicity;Biological Transport/drug effects;Caco-2 Cells;Carbon Radioisotopes;Cell Membrane Permeability/drug effects;Cell Survival/drug effects;Citrus*/classification;Food-Drug Interactions*;Humans;Mannitol/metabolism;Propranolol/metabolism
16247711;Adult;Animals;Body Fluids/chemistry*;Chemical Phenomena;Chemistry, Physical;Chromatography, High Pressure Liquid;Dogs;Female;Food-Drug Interactions*;Humans;Intestines/chemistry;Intestines/metabolism;Kinetics;Lipids/chemistry;Male;Molecular Weight;Pharmaceutical Preparations/chemistry*;Solubility;Thermodynamics
16239358;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adenine/urine;Administration, Oral;Adult;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Antiviral Agents/urine;Dietary Fats/pharmacology;Double-Blind Method;Food-Drug Interactions;Humans;Male;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Organophosphonates/urine;Organophosphorus Compounds/blood;Organophosphorus Compounds/pharmacokinetics*;Organophosphorus Compounds/urine;Prodrugs/pharmacokinetics*
16239022;Clinical Trials as Topic*;Dietary Supplements/adverse effects*;Evidence-Based Medicine*;Fibrinolytic Agents/adverse effects*;Food, Organic/adverse effects*;Food-Drug Interactions*;Humans;Plants, Medicinal/adverse effects*;Risk Assessment/methods*;Risk Factors
16236039;Adult;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacokinetics*;Food-Drug Interactions/physiology;Heptanoic Acids/pharmacokinetics*;Humans;Male;Pyrroles/pharmacokinetics*;Quinolines/pharmacokinetics*
16213057;Adult;Algorithms;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics;Colon/metabolism;Cross-Over Studies;Delayed-Action Preparations*;Felodipine/administration & dosage;Felodipine/blood;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Gastric Emptying;Gastrointestinal Transit/physiology;Humans;Magnetics;Male;Solubility;Spectrophotometry, Ultraviolet;Stomach/metabolism*
16207645;Dietary Supplements*;Drug Interactions*;Drug Prescriptions;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice;Humans;United States
16199918;Calcium Channel Blockers/adverse effects*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions*;Humans
16198665;3',5'-Cyclic-GMP Phosphodiesterases;Aryl Hydrocarbon Hydroxylases/genetics*;Beverages;Citrus paradisi;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 5;Cytochrome P-450 CYP2C9;Food-Drug Interactions;Genotype;Humans;Male;Phosphodiesterase Inhibitors/blood;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphoric Diester Hydrolases/metabolism;Piperazines/blood;Piperazines/pharmacokinetics*;Purines;Sildenafil Citrate;Sulfones/blood
16193318;1-Methyl-4-phenylpyridinium/metabolism*;Caco-2 Cells;Caffeine/pharmacology;Catechin/analogs & derivatives;Catechin/pharmacology;Corticosterone/pharmacology;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism;Organic Cation Transport Proteins/metabolism*;Plant Extracts/pharmacology*;Quinolines/pharmacology;Tea*;Theophylline/pharmacology;Tritium
16192747;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/therapeutic use;Anticonvulsants/pharmacokinetics;Anticonvulsants/therapeutic use;Antifungal Agents/adverse effects;Antifungal Agents/therapeutic use*;Clinical Trials as Topic;Cross Infection/prevention & control*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Monitoring;Echinocandins;Food-Drug Interactions;Humans;Immunocompromised Host;Intensive Care Units;Lipopeptides;Liver/drug effects;Liver/enzymology;Mycoses/drug therapy*;Mycoses/prevention & control;Peptides, Cyclic/adverse effects;Peptides, Cyclic/therapeutic use*;Polypharmacy;Pyrimidines/adverse effects;Pyrimidines/therapeutic use*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use;Triazoles/adverse effects;Triazoles/therapeutic use*;Voriconazole
16190498;Anticoagulants*;Food-Drug Interactions*;Humans;International Normalized Ratio;Phytotherapy/adverse effects*;Urinary Tract Infections/prevention & control*;Vaccinium macrocarpon*;Warfarin*
16187969;Administration, Oral;Adolescent;Adult;Antacids/administration & dosage;Antacids/pharmacokinetics*;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use;Biological Availability;Bismuth/pharmacokinetics*;Bismuth/therapeutic use;Cross-Over Studies;Drug Combinations;Food-Drug Interactions*;Helicobacter Infections/drug therapy*;Helicobacter pylori*;Humans;Male;Metronidazole/pharmacokinetics;Metronidazole/therapeutic use;Middle Aged;Tetracycline/pharmacokinetics;Tetracycline/therapeutic use
16181450;Antioxidants/therapeutic use;Cholecalciferol/therapeutic use;Diet/adverse effects*;Fatty Acids, Unsaturated/therapeutic use;Food-Drug Interactions;Glutens/adverse effects;Humans;Oxidative Stress;Psoriasis/diet therapy*;Psoriasis/drug therapy;Psoriasis/etiology*;Vitamin B 12/therapeutic use
16169713;Acetaminophen/administration & dosage;Acetaminophen/chemistry*;Acetaminophen/pharmacokinetics;Administration, Oral;Adult;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/chemistry*;Analgesics, Non-Narcotic/pharmacokinetics;Biological Availability;Dialysis Solutions/chemistry;Diffusion;Fasting;Female;Food;Food-Drug Interactions*;Gastrointestinal Tract/metabolism;Humans;Hydrogen-Ion Concentration;In Vitro Techniques;Intestinal Absorption;Male;Models, Biological*;Saliva/chemistry;Saliva/metabolism;Solubility;Tablets*
16164493;Adult;Aged;Area Under Curve;Blood Specimen Collection;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Estradiol/adverse effects;Estradiol/analogs & derivatives*;Estradiol/pharmacokinetics;Female;Food-Drug Interactions;Hormones/blood;Humans;Mass Spectrometry;Middle Aged;Postmenopause/physiology*;Selective Estrogen Receptor Modulators/adverse effects*;Selective Estrogen Receptor Modulators/pharmacokinetics*
16161934;Beverages*;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions/genetics;Food-Drug Interactions*;Humans;Microsomes, Liver/metabolism*;Pharmaceutical Preparations/metabolism*;Polymorphism, Genetic
16120075;Adult;Beverages;Biological Availability;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Thyroxine/blood;Thyroxine/pharmacokinetics*
16119275;Animals;Antirheumatic Agents/pharmacokinetics*;Beverages*;Biological Transport;Food-Drug Interactions*;Fruit*;Humans;Intestinal Absorption;Intestines/metabolism;Methotrexate/pharmacokinetics*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism
16100300;Adult;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Female;Food-Drug Interactions*;Humans;Ibuprofen/analogs & derivatives*;Ibuprofen/chemistry;Ibuprofen/pharmacokinetics*;Intestinal Absorption;Lysine/analogs & derivatives*;Lysine/pharmacokinetics;Male;Middle Aged;Pharmaceutic Aids;Povidone;Solubility;Tablets;Therapeutic Equivalency
16078151;Adrenergic beta-Agonists/chemistry*;Algorithms;Arylsulfotransferase/chemistry*;Autoradiography;Beverages*;Biological Availability;Citrus;Food-Drug Interactions*;Humans;Isoenzymes/chemistry;Kinetics;Recombinant Proteins/chemistry;Ritodrine/chemistry*;Sulfotransferases/chemistry*;Tea
16076481;Animals;Blood Coagulation/drug effects*;Blood Coagulation/physiology*;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Dietary Supplements/classification*;Evidence-Based Medicine;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/classification;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Hemorrhage/prevention & control;Humans;Risk Assessment/methods;Risk Factors
16055224;Adolescent;Adrenergic beta-Antagonists/administration & dosage*;Adrenergic beta-Antagonists/pharmacokinetics*;Adult;Algorithms;Animals;Area Under Curve;Biological Availability;Biological Transport, Active/physiology;Biotransformation;Caco-2 Cells;Cross-Over Studies;Drug Delivery Systems*;Excipients;Female;Food-Drug Interactions;Humans;In Vitro Techniques;Intestinal Absorption;Lactose/analogs & derivatives;Male;Methylcellulose/analogs & derivatives;Middle Aged;Oxazines;Polyethylene Glycols;Propranolol/administration & dosage*;Propranolol/pharmacokinetics*;Rats
16054195;Dietary Supplements*;Fibrinolytic Agents/administration & dosage*;Food-Drug Interactions*;Hemostasis/drug effects*;Hemostasis/physiology*;Humans
16052730;Animals;Calcium/pharmacokinetics*;Dietary Fiber/administration & dosage*;Food-Drug Interactions;Humans;Intestinal Absorption/physiology*;Milk*
16048354;ATP Binding Cassette Transporter, Sub-Family B/antagonists & inhibitors;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Animals;Beverages*;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Enzyme Inhibitors/chemistry;Enzyme Inhibitors/pharmacology;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/chemistry;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
16048029;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Benzodiazepines/metabolism;Beverages/adverse effects;Biological Availability;Calcium Channel Blockers/metabolism;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Intestinal Absorption/drug effects
16043212;Coumarins/administration & dosage;Coumarins/adverse effects;Coumarins/pharmacokinetics;Dietary Supplements*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Pharmacogenetics/methods;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
16035690;Animals;Bleeding Time;Clinical Trials as Topic;Drug Evaluation, Preclinical;Evidence-Based Medicine;Food-Drug Interactions;Garlic*/adverse effects;Garlic*/chemistry;Garlic*/physiology;Humans;Hyperlipidemias/prevention & control;Hypertension/prevention & control;Infection Control;Neoplasms/prevention & control;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/standards;Research Design/standards
15999499;Adult;Alcohol Drinking*;Erectile Dysfunction/drug therapy;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Sulfones/adverse effects;Sulfones/pharmacokinetics;Triazines/adverse effects;Triazines/pharmacokinetics;Vardenafil Dihydrochloride
15998360;Adolescent;Adult;Albendazole/pharmacokinetics*;Anthelmintics/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Diet*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Mexico
15991880;Adult;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dibenzazepines/adverse effects;Dibenzazepines/blood;Dibenzazepines/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged
15988577;Animals;Atorvastatin Calcium;Blood Glucose/metabolism;Diabetes Mellitus, Type 1/prevention & control*;Female;Food-Drug Interactions;Heptanoic Acids/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Mice;Mice, Inbred C57BL;Mice, Inbred NOD;Pyrroles/therapeutic use*
15983823;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Atenolol/blood;Atenolol/pharmacokinetics*;Atenolol/urine;Beverages*;Biological Availability;Blood Pressure/drug effects;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Heart Rate/drug effects;Humans;Male;Metabolic Clearance Rate
15980352;Adolescent;Adult;Benzoates*/administration & dosage;Benzoates*/adverse effects;Benzoates*/metabolism;Benzoates*/pharmacokinetics;CCR5 Receptor Antagonists*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;HIV Fusion Inhibitors*/administration & dosage;HIV Fusion Inhibitors*/adverse effects;HIV Fusion Inhibitors*/metabolism;HIV Fusion Inhibitors*/pharmacokinetics;Humans;Male;Middle Aged;Piperazines;Spiro Compounds*/administration & dosage;Spiro Compounds*/adverse effects;Spiro Compounds*/metabolism;Spiro Compounds*/pharmacokinetics
15978308;Administration, Oral;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Enteral Nutrition;Female;Food, Formulated;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Piracetam/analogs & derivatives*;Piracetam/pharmacokinetics
15954427;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Anemia, Aplastic/drug therapy;Autoimmune Diseases/drug therapy;Behcet Syndrome/drug therapy;Calcineurin Inhibitors;Cyclosporine*/administration & dosage;Cyclosporine*/adverse effects;Cyclosporine*/pharmacokinetics;Cyclosporine*/pharmacology;Drug Interactions;Drug Monitoring;Drug Therapy, Combination;Food-Drug Interactions;Graft Rejection/drug therapy;Humans;Immunosuppressive Agents*/administration & dosage;Immunosuppressive Agents*/adverse effects;Immunosuppressive Agents*/pharmacokinetics;Immunosuppressive Agents*/pharmacology;Kidney Transplantation
15951007;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Evidence-Based Medicine;Fatty Acids, Omega-3/adverse effects*;Fatty Acids, Omega-3/therapeutic use*;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Humans;Thrombosis/prevention & control*
15928257;Anticoagulants/administration & dosage*;Anticoagulants/therapeutic use;Diet, Reducing*;Dietary Carbohydrates*;Dietary Proteins*;Drug Monitoring;Food-Drug Interactions;Humans;Vitamin K/administration & dosage;Warfarin/administration & dosage*;Warfarin/therapeutic use
15917540;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/physiology;Female;Food-Drug Interactions;Humans;Male;Quinolines/administration & dosage;Quinolines/pharmacokinetics*
15911722;Anticoagulants/pharmacology*;Clinical Trials as Topic;Food-Drug Interactions*;Humans;Warfarin/pharmacology*
15911222;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Binding, Competitive;Biological Transport/drug effects;Caco-2 Cells;Cell Membrane Permeability/drug effects;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Organic Cation Transport Proteins/metabolism*;Propanolamines/pharmacokinetics*;Radioligand Assay
15903127;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Blotting, Western;Citrus paradisi*;Duodenum/metabolism;Food-Drug Interactions*;Genes, MDR/genetics;Humans;Male;Propanolamines/blood;Propanolamines/pharmacokinetics*;Propanolamines/urine;RNA, Messenger/analysis
15898148;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Azetidines/adverse effects;Azetidines/therapeutic use*;Benzylamines;Drug Approval;Elapid Venoms/chemistry;Food-Drug Interactions;Humans;Liver Failure/chemically induced*;Prodrugs/adverse effects;Prodrugs/therapeutic use*;Thrombosis/prevention & control*;United States;United States Food and Drug Administration
15889002;Absorption;Dietary Fiber/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
15885459;Acetaminophen/administration & dosage;Acetaminophen/blood*;Animals;Dogs;Fasting/metabolism;Food-Drug Interactions/physiology*;Gastric Emptying/drug effects;Gastric Emptying/physiology*;Gastrointestinal Contents*/drug effects;Male;Milk/metabolism*;Predictive Value of Tests;Solubility;Time Factors
15854203;Animals;Anticholesteremic Agents/metabolism;Anticholesteremic Agents/therapeutic use*;Anticholesteremic Agents/toxicity;Clinical Trials as Topic;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/toxicity;Hypercholesterolemia/drug therapy*;Intestinal Absorption;Liver/metabolism;Quinolines/metabolism;Quinolines/therapeutic use*;Quinolines/toxicity;Treatment Outcome
15832116;Administration, Oral;Deglutition Disorders/drug therapy*;Deglutition Disorders/nursing;Delayed-Action Preparations;Drug Administration Schedule;Enteral Nutrition/adverse effects;Food-Drug Interactions;Humans;Intestinal Absorption
15831782;Adolescent;Adult;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Antiviral Agents/urine;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Monosaccharides/blood;Monosaccharides/pharmacokinetics*;Monosaccharides/urine;Prodrugs/pharmacokinetics*;Triazoles/blood;Triazoles/pharmacokinetics*;Triazoles/urine
15831779;2-Pyridinylmethylsulfinylbenzimidazoles;Absorption;Administration, Oral;Adult;Aged;Aged, 80 and over;Area Under Curve;Arthroplasty, Replacement, Hip*;Benzimidazoles/pharmacokinetics*;Benzimidazoles/pharmacology;Cross-Over Studies;Dabigatran;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Middle Aged;Omeprazole/analogs & derivatives*;Omeprazole/pharmacology;Proton Pump Inhibitors;Pyridines/pharmacokinetics*;Sulfoxides/pharmacology;Thrombin/antagonists & inhibitors*
15831778;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/adverse effects;Hydromorphone/pharmacokinetics*;Male
15824753;Aged;Aging/physiology;Anticoagulants/administration & dosage*;Anticoagulants/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases/genetics*;Blood Proteins/metabolism;Body Weight/physiology;Cytochrome P-450 CYP2C9;Demography;Drug Interactions;Female;Food-Drug Interactions;Genotype;Heart Valve Prosthesis;Humans;International Normalized Ratio;Male;Polymorphism, Genetic/genetics*;Regression Analysis;Serum Albumin/metabolism;Stereoisomerism;Warfarin/administration & dosage*;Warfarin/pharmacokinetics*
15823765;Administration, Oral;Adult;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Area Under Curve;Cross-Over Studies;Drug Combinations;Food-Drug Interactions;Half-Life;Humans;Ibuprofen/pharmacokinetics*;Ibuprofen/therapeutic use;Intestinal Absorption;Male;Metabolic Clearance Rate;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Oxycodone/therapeutic use;Pain, Postoperative/drug therapy;Tablets;Therapeutic Equivalency
15811168;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi/chemistry;Citrus paradisi/metabolism*;Drinking;Food-Drug Interactions*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Half-Life;Humans;Nifedipine/analogs & derivatives;Nifedipine/pharmacokinetics*;Nifedipine/pharmacology;Time Factors
15807982;Biological Availability;Biopharmaceutics/classification*;Biopharmaceutics/legislation & jurisprudence;Drug Approval/legislation & jurisprudence;Drug Evaluation, Preclinical/methods;Food-Drug Interactions;Guidelines as Topic;Humans;Intestinal Absorption;Solubility;Technology, Pharmaceutical/legislation & jurisprudence
15785395;Beverages*;Citrus/chemistry*;Cyclosporine/blood;Cyclosporine/pharmacology*;Food Labeling;Food-Drug Interactions*;Humans;Lung Transplantation
15785394;Adult;Beverages*;Citrus/chemistry;Contraindications;Cyclosporine/blood;Cyclosporine/pharmacology*;Diet;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/analysis;Furocoumarins/blood;Furocoumarins/pharmacology*;Humans;Lung Transplantation*;Male;Transplantation
15776510;Anticholesteremic Agents/metabolism*;Atorvastatin Calcium;Beverages/adverse effects;Citrus paradisi/adverse effects;Citrus paradisi/metabolism*;Food-Drug Interactions*;Heptanoic Acids/metabolism*;Humans;Pyrroles/metabolism*
15762767;Adolescent;Aging/metabolism;Animals;Biotransformation;Female;Food-Drug Interactions;Humans;Indoles/pharmacokinetics*;Indoles/therapeutic use;Kidney Diseases/metabolism;Liver Diseases/metabolism;Male;Migraine Disorders/complications;Migraine Disorders/drug therapy*;Migraine Disorders/metabolism*;Receptor, Serotonin, 5-HT1B/metabolism*;Serotonin Receptor Agonists/pharmacokinetics*;Serotonin Receptor Agonists/therapeutic use;Sex Characteristics;Tissue Distribution;Tryptamines
15761758;Beverages;Citrus paradisi;Dietary Supplements;Food-Drug Interactions*;Humans;Pharmacokinetics;Pharmacopoeias as Topic/standards*;Spain
15755790;Aged;Dietary Carbohydrates/administration & dosage*;Dietary Carbohydrates/blood;Dietary Proteins/administration & dosage*;Dietary Proteins/blood;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Warfarin/administration & dosage*;Warfarin/blood
15752382;Administration, Oral;Aged;Androstadienes/pharmacokinetics*;Antineoplastic Agents/pharmacokinetics*;Aromatase Inhibitors/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Fasting/metabolism*;Female;Food-Drug Interactions/physiology*;Humans;Middle Aged
15741841;Administration, Oral;Adult;Bicycling/physiology;Blood Glucose/metabolism;Breath Tests;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/metabolism*;Exercise/physiology*;Fatty Acids, Nonesterified/blood;Food-Drug Interactions/physiology*;Fructose/administration & dosage*;Fructose/metabolism*;Humans;Lactic Acid/blood;Male;Oxidation-Reduction;Oxygen Consumption/physiology;Physical Endurance/physiology;Polysaccharides/administration & dosage*;Polysaccharides/metabolism*
15735611;Administration, Oral;Adult;Area Under Curve;Biological Availability;Citrus paradisi/physiology*;Cross-Over Studies;Drinking;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Organic Anion Transporters/chemistry;Organic Anion Transporters/metabolism*;Peptides/chemistry;Peptides/metabolism*;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics*;Water/metabolism;Water/pharmacology
15734296;Adolescent;Adult;Biological Availability;Cross-Over Studies;Danazol/blood*;Danazol/pharmacokinetics;Dietary Fats/pharmacokinetics*;Drinking/physiology*;Eating/physiology*;Food-Drug Interactions/physiology*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Humans;Male;Solubility
15706008;Adult;Antitubercular Agents/therapeutic use*;Bacteriological Techniques;Cholesterol/blood;Cholesterol/deficiency*;Colony Count, Microbial;Combined Modality Therapy;Drug Administration Schedule;Drug Therapy, Combination;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Male;Mexico;Middle Aged;Mycobacterium tuberculosis/drug effects*;Sputum/microbiology;Treatment Outcome;Tuberculosis, Pulmonary/blood;Tuberculosis, Pulmonary/diet therapy*;Tuberculosis, Pulmonary/microbiology
15683768;Animals;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Camelus/metabolism*;Chromatography, High Pressure Liquid/veterinary;Cross-Over Studies;Food-Drug Interactions*;Intestinal Absorption;Phenylbutazone/blood;Phenylbutazone/pharmacokinetics*;Poaceae*
15682573;Anticoagulants/agonists;Benzodiazepines/agonists;Beverages/adverse effects*;Calcium Channel Blockers/blood;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Food-Drug Interactions*;Humans;Warfarin/agonists
15673597;Animals;Anticonvulsants/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages*;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Oxidoreductases, N-Demethylating/metabolism*;Punicaceae*;Rats;Rats, Wistar;Spectrophotometry, Ultraviolet
15661483;Acquired Immunodeficiency Syndrome/complications*;Acquired Immunodeficiency Syndrome/drug therapy;Acquired Immunodeficiency Syndrome/epidemiology;Africa South of the Sahara/epidemiology;Antiviral Agents/therapeutic use;Botswana/epidemiology;Food-Drug Interactions;HIV Infections/complications*;HIV Infections/drug therapy;HIV Infections/epidemiology;Humans;Nutrition Disorders/complications*;Nutrition Disorders/epidemiology;Nutritional Physiological Phenomena*;South Africa/epidemiology;Uganda/epidemiology
15658364;Biomarkers/blood;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/blood*;Immunosuppressive Agents/pharmacokinetics;Reference Values;Specimen Handling;Tacrolimus/administration & dosage;Tacrolimus/adverse effects*;Tacrolimus/blood*;Tacrolimus/pharmacokinetics
15658363;Aging/metabolism;Biomarkers/blood;Chromatography, High Pressure Liquid;Cyclosporine/administration & dosage;Cyclosporine/adverse effects;Cyclosporine/blood*;Dosage Forms;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Immunoassay/methods;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/blood*;Kidney Diseases/metabolism;Liver Diseases/metabolism;Specimen Handling
15658353;ATP-Binding Cassette, Sub-Family B, Member 1;Anti-Allergic Agents/administration & dosage*;Anti-Allergic Agents/adverse effects;Anti-Allergic Agents/blood*;Anti-Allergic Agents/pharmacokinetics;Aryl Hydrocarbon Hydroxylases;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Specimen Handling;Spectrophotometry
15658352;Aging/metabolism;Asthma/drug therapy;Asthma/metabolism;Biomarkers/blood;Bronchodilator Agents/administration & dosage*;Bronchodilator Agents/blood*;Bronchodilator Agents/pharmacokinetics;Bronchodilator Agents/poisoning;Dosage Forms;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Half-Life;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Placental Lactogen;Reference Values;Smoking/adverse effects;Specimen Handling;Theophylline/administration & dosage*;Theophylline/blood*;Theophylline/poisoning
15658346;Anti-Inflammatory Agents, Non-Steroidal/blood*;Antirheumatic Agents/blood*;Aspirin/blood*;Aspirin/poisoning;Biomarkers/blood;Chromatography, High Pressure Liquid;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Salicylic Acid/blood*;Salicylic Acid/poisoning;Specimen Handling
15658338;Aging/metabolism;Anticonvulsants/administration & dosage;Anticonvulsants/adverse effects;Anticonvulsants/blood*;Anticonvulsants/poisoning;Biomarkers/blood;Chromatography, Gas;Chromatography, High Pressure Liquid;Clonazepam/administration & dosage;Clonazepam/adverse effects;Clonazepam/blood*;Clonazepam/poisoning;Diazepam/administration & dosage;Diazepam/adverse effects;Diazepam/blood*;Diazepam/poisoning;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Nitrazepam/administration & dosage;Nitrazepam/adverse effects;Nitrazepam/blood*;Nitrazepam/poisoning;Reference Values;Specimen Handling;Treatment Refusal
15647414;Administration, Oral;Adult;Area Under Curve;Capsules;Cross-Over Studies;Delayed-Action Preparations*;Didanosine/administration & dosage;Didanosine/metabolism;Didanosine/pharmacokinetics*;Drug Administration Schedule;Drug Interactions*;Drug Therapy, Combination;Female;Food-Drug Interactions;Half-Life;Healthy Volunteers;Humans;Indinavir/administration & dosage;Indinavir/pharmacokinetics*;Indinavir/pharmacology;Male;Reproducibility of Results;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Ritonavir/pharmacology;Therapeutic Equivalency
15645735;Arteriosclerosis/etiology;Arteriosclerosis/prevention & control;Body Weight;Citrus paradisi/adverse effects;Diet, Protein-Restricted/methods;Exercise Therapy/methods;Exercise Therapy/standards;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Kidney Failure, Chronic/complications*;Kidney Failure, Chronic/therapy*;Kidney Transplantation*;Life Style*;Metabolic Syndrome/complications*;Metabolic Syndrome/therapy;Water-Electrolyte Imbalance/etiology;Water-Electrolyte Imbalance/prevention & control
15643550;Adult;Area Under Curve;Biological Availability;Boswellia*;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats*;Eating*;Food-Drug Interactions;Humans;Male;Phytotherapy*;Plant Extracts/pharmacokinetics;Postprandial Period;Reference Values
15640499;Consumer Behavior;Flavonoids/adverse effects*;Food-Drug Interactions;Humans;Phenols/adverse effects*;Polyphenols;Taste/drug effects*;Thiourea/pharmacology;Wine*
15635366;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Blood Pressure/drug effects*;Cheese;Depression/drug therapy;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Nutrition Policy*;Tyramine/administration & dosage*;United States
15635350;Adolescent;Adult;Analysis of Variance;Child;Child Development/drug effects;Child Nutritional Physiological Phenomena;Child, Preschool;Chronic Disease/therapy*;Dietary Supplements/adverse effects*;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Food-Drug Interactions*;Humans;Male;Parents;Physician-Patient Relations;Prevalence;Prognosis;Surveys and Questionnaires;Treatment Outcome
15635347;Aged;Dietary Supplements/adverse effects;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Nutrition Surveys;Prevalence
15635346;Aged;Aged, 80 and over;Cohort Studies;Diet;Diet Records;Dietary Supplements/adverse effects;Dietary Supplements/statistics & numerical data;Dietary Supplements/utilization*;Female;Food-Drug Interactions*;Humans;Linear Models;Male;Middle Aged;Nutrition Surveys;Retrospective Studies;Risk Factors;United States
15635342;Child;Child Health Services;Chronic Disease/therapy;Communication;Complementary Therapies/adverse effects*;Complementary Therapies/methods*;Complementary Therapies/standards;Complementary Therapies/utilization;Dietary Supplements/utilization*;Disabled Children/statistics & numerical data*;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Professional-Family Relations*;Treatment Outcome
15621963;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/blood*;Atorvastatin Calcium;Beverages;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Heptanoic Acids/adverse effects;Heptanoic Acids/blood*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/blood*;Rhabdomyolysis/blood*;Rhabdomyolysis/etiology
15605125;Absorption;Animals;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Butter*;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Cross-Over Studies;Food-Drug Interactions*;Male;Phenytoin/blood;Phenytoin/pharmacokinetics*;Rabbits
15595979;Beverages/history*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/history;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;History, 20th Century;Humans
15592332;Adult;Area Under Curve;Biological Availability;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology*;Capsules;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Delayed-Action Preparations;Felodipine/pharmacokinetics;Felodipine/pharmacology*;Female;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/pharmacology*;Humans;Male;Spectrophotometry, Ultraviolet
15577230;Administration, Oral;Animals;Dietary Supplements*;Food-Drug Interactions/physiology*;Ginkgo biloba*;Male;Nifedipine/administration & dosage;Nifedipine/pharmacokinetics*;Plant Extracts/metabolism;Plant Leaves;Rats;Rats, Wistar
15577221;Administration, Oral;Adult;Dietary Supplements*;Food-Drug Interactions/physiology*;Ginkgo biloba*;Humans;Male;Middle Aged;Nifedipine/administration & dosage;Nifedipine/metabolism*;Plant Extracts/administration & dosage;Plant Extracts/metabolism;Plant Leaves
15576015;Adult;Appetite Depressants/metabolism;Appetite Depressants/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclobutanes/metabolism;Cyclobutanes/pharmacokinetics*;Dietary Fats/pharmacology*;Fasting/metabolism*;Food-Drug Interactions*;Humans;Male;Middle Aged;Pilot Projects
15571938;Adult;Adverse Drug Reaction Reporting Systems/classification;Adverse Drug Reaction Reporting Systems/organization & administration;Critical Care/methods*;Critical Care/standards;Critical Illness/therapy*;Drug Information Services/organization & administration;Food-Drug Interactions*;Humans;Incidence;Information Dissemination;Intestinal Absorption;Monitoring, Physiologic;Nurse's Role;Nutritional Status;Nutritional Support/methods*;Nutritional Support/standards;Pharmacy and Therapeutics Committee/organization & administration;Primary Prevention
15570603;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Animals;Area Under Curve;Beverages/adverse effects*;Biological Availability;Citrus;Food-Drug Interactions/physiology*;Fruit*;Histamine H1 Antagonists/pharmacokinetics*;Intestinal Absorption;Male;Malus;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism;Rats;Rats, Sprague-Dawley;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
15568891;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Drug Resistance, Multiple;Food-Drug Interactions*;Gastrointestinal Tract/metabolism;Humans;Intestinal Absorption
15561855;Adolescent;Adult;Aged;Aged, 80 and over;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use*;Area Under Curve;Bronchitis/drug therapy;Bronchitis/microbiology;Community-Acquired Infections/drug therapy*;Community-Acquired Infections/metabolism*;Drug Interactions;Female;Fluoroquinolones/pharmacokinetics*;Fluoroquinolones/therapeutic use*;Food-Drug Interactions;Humans;Male;Mass Spectrometry;Middle Aged;Models, Biological;Pneumonia/drug therapy;Pneumonia/microbiology;Population;Reproducibility of Results;Respiratory Tract Infections/drug therapy*;Respiratory Tract Infections/metabolism*;Sinusitis/drug therapy;Sinusitis/microbiology
15542101;Animals;Antimalarials/administration & dosage*;Antimalarials/therapeutic use;Artemisinins/administration & dosage*;Artemisinins/therapeutic use;Beverages;Citrus paradisi*;Cytochrome P-450 Enzyme System/metabolism;Cytochromes b5/metabolism;Food-Drug Interactions*;Liver/enzymology*;Liver/parasitology;Liver/pathology;Liver Function Tests;Male;Mice;Mice, Inbred Strains;Models, Animal;Schistosomiasis mansoni/drug therapy*;Schistosomiasis mansoni/enzymology;Schistosomiasis mansoni/pathology;Sesquiterpenes/administration & dosage*;Sesquiterpenes/therapeutic use
15536460;Administration, Oral;Adult;Alfentanil/administration & dosage*;Alfentanil/pharmacology;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacology;Anti-Bacterial Agents/pharmacokinetics;Antibiotics, Antitubercular/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Biological Availability;Citrus/chemistry;Cross-Over Studies;Cytochrome P-450 CYP3A;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Liver/enzymology*;Male;Mass Spectrometry;Oxidoreductases, N-Demethylating/metabolism*;Pupil/drug effects*;Rifampin/pharmacokinetics;Troleandomycin/pharmacokinetics
15531381;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Blotting, Western;Cell Line, Transformed;Cell Survival/drug effects;Citrus*;Dose-Response Relationship, Drug;Electrophoresis, Polyacrylamide Gel;Flavanones/pharmacology;Fluoresceins/metabolism;Food-Drug Interactions;Humans;Kaempferols/pharmacology;Kidney Tubules, Proximal/cytology;Kidney Tubules, Proximal/drug effects*;Kidney Tubules, Proximal/metabolism;Plant Extracts/pharmacology*;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction
15531008;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacology;Fasting*;Female;Fenofibrate/administration & dosage;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/administration & dosage;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male;Middle Aged;Randomized Controlled Trials as Topic;Tablets
15525560;Administration, Oral;Adult;Aminosalicylic Acid/administration & dosage;Antacids/metabolism*;Antitubercular Agents/administration & dosage;Beverages*;Biological Availability;Citrus sinensis;Clofazimine/blood;Clofazimine/pharmacokinetics*;Cross-Over Studies;Cycloserine/administration & dosage;Dietary Fats;Drug Combinations;Drug Interactions;Ethionamide/administration & dosage;Food*;Food-Drug Interactions;Humans;Leprostatic Agents/blood;Leprostatic Agents/pharmacokinetics*;Pyridoxine/administration & dosage
15510379;Diabetes Mellitus/drug therapy*;Drug Interactions;Drug Labeling;Drug Therapy, Combination;Food-Drug Interactions*;Humans;Pharmacies;United States
15509187;Adult;Allylamine/analogs & derivatives*;Allylamine/pharmacology*;Area Under Curve;Colesevelam Hydrochloride;Cross-Over Studies;Drug Administration Schedule;Drug Interactions;Female;Fenofibrate/blood;Fenofibrate/pharmacokinetics*;Food-Drug Interactions;Half-Life;Humans;Hypolipidemic Agents/blood;Hypolipidemic Agents/pharmacokinetics*;Male;Time Factors
15508534;Food-Drug Interactions*;Humans;International Normalized Ratio;Soy Milk*;Warfarin*
15504753;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Algorithms;Antineoplastic Agents, Phytogenic/pharmacokinetics;Beverages*;Biological Transport, Active/drug effects;Caco-2 Cells;Calcium Channel Blockers/pharmacology;Citrus/chemistry*;Cyclosporine/pharmacology;Food-Drug Interactions;HIV Protease Inhibitors/pharmacokinetics;Humans;Immunosuppressive Agents/pharmacology;Membrane Transport Proteins/genetics;Membrane Transport Proteins/metabolism*;Multidrug Resistance-Associated Proteins/genetics;Multidrug Resistance-Associated Proteins/metabolism*;Plant Extracts/chemistry;Propionates/pharmacology;Quinolines/pharmacology;Saquinavir/pharmacokinetics;Transfection;Verapamil/pharmacology;Vinblastine/pharmacokinetics
15497788;Acenocoumarol/adverse effects;Acenocoumarol/pharmacokinetics*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Routes;Enteral Nutrition/adverse effects*;Food, Formulated;Food-Drug Interactions*;Humans
15488686;Absorption/drug effects;Administration, Oral;Animals;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Area Under Curve;Biological Availability*;Capsules/administration & dosage;Capsules/chemistry;Capsules/pharmacokinetics;Chemistry, Pharmaceutical/methods*;Clinical Trials, Phase I as Topic;Clinical Trials, Phase II as Topic;Dogs;Drug Administration Schedule;Drug Evaluation, Preclinical;Fasting/metabolism;Food-Drug Interactions;Humans;Male;Models, Animal;Morpholines/metabolism;Morpholines/pharmacology*;Morpholines/therapeutic use;Nanostructures/chemistry*;Nausea/chemically induced;Nausea/prevention & control;Substance P/antagonists & inhibitors;Substance P/metabolism;Substance P/pharmacology;Tablets/administration & dosage;Tablets/chemistry;Tablets/pharmacokinetics;Technology, Pharmaceutical/methods;Technology, Pharmaceutical/trends;Upper Gastrointestinal Tract/drug effects;Upper Gastrointestinal Tract/metabolism;Vomiting/chemically induced;Vomiting/prevention & control
15482171;Acetamides/chemistry;Acetamides/pharmacokinetics;Acetamides/pharmacology*;Acetamides/therapeutic use;Animals;Anti-Bacterial Agents/pharmacology*;Anti-Bacterial Agents/therapeutic use;Bacteria/drug effects;Clinical Trials as Topic;Food-Drug Interactions;Humans;Linezolid;Methicillin Resistance;Oxazolidinones/chemistry;Oxazolidinones/pharmacokinetics;Oxazolidinones/pharmacology*;Oxazolidinones/therapeutic use;Pneumonia/drug therapy
15475676;Adaptation, Psychological;Adult;Aged;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/adverse effects;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Therapy, Combination;Feeding Behavior/psychology;Female;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/psychology;Health Knowledge, Attitudes, Practice;Homosexuality, Male/psychology;Humans;Male;Middle Aged;Personality Inventory/statistics & numerical data;Psychometrics;Statistics as Topic;Stress, Psychological/complications;Treatment Refusal/psychology*
15459052;Drug Administration Schedule;Fasting*;Food-Drug Interactions;Humans;Islam*;Pharmaceutical Preparations/administration & dosage*
15456329;Adolescent;Adult;Aged;Animals;Anti-Inflammatory Agents, Non-Steroidal*/metabolism;Anti-Inflammatory Agents, Non-Steroidal*/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use;Arthritis, Rheumatoid/drug therapy*;Butanones*/metabolism;Butanones*/pharmacokinetics;Butanones*/therapeutic use;Child;Child, Preschool;Clinical Trials as Topic;Cyclooxygenase Inhibitors*/adverse effects;Cyclooxygenase Inhibitors*/therapeutic use;Drug Interactions;Food-Drug Interactions;Humans;Middle Aged;Osteoarthritis/drug therapy*;Stomach Diseases/chemically induced*
15451546;Administration, Oral;Adult;Biological Availability;Bornanes/administration & dosage*;Bornanes/blood;Bornanes/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacokinetics*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Tablets, Enteric-Coated
15449971;Beverages*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/pharmacokinetics*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy*;Citrus paradisi*;Food-Drug Interactions*;Humans
15387721;Animals;Diabetes Complications/drug therapy;Diosmin/therapeutic use*;Food-Drug Interactions;Hemorrhoids/drug therapy;Humans;Lymphedema/drug therapy;Neoplasms/prevention & control;Varicose Veins/drug therapy;Venous Insufficiency/drug therapy
15384254;Administration, Oral;Animals;Body Weight/drug effects;Diet;Dose-Response Relationship, Drug;Female;Fetal Resorption/chemically induced;Fetal Weight/drug effects;Food Deprivation;Food-Drug Interactions;Insecticides/administration & dosage;Insecticides/toxicity*;Maternal Exposure*;Methyl Parathion/administration & dosage;Methyl Parathion/toxicity*;Placenta/drug effects*;Placenta/pathology;Pregnancy;Rats;Rats, Wistar
15383641;Adult;Anticoagulants*/metabolism;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Area Under Curve;Arthroplasty, Replacement, Hip*;Arthroplasty, Replacement, Knee*;Azetidines*/metabolism;Azetidines*/pharmacokinetics;Azetidines*/therapeutic use;Benzylamines;Biological Availability;Clinical Trials as Topic;Food-Drug Interactions;Half-Life;Humans;Male;Venous Thrombosis/drug therapy*
15381495;Anticoagulants/administration & dosage*;Food-Drug Interactions*;Humans;International Normalized Ratio;Vegetables/chemistry;Vitamin K/administration & dosage*;Vitamin K/antagonists & inhibitors;Warfarin/administration & dosage*
15355126;Adult;Aged;Animals;Anti-Inflammatory Agents*/pharmacokinetics;Anti-Inflammatory Agents*/pharmacology;Anti-Inflammatory Agents*/therapeutic use;Area Under Curve;Biological Availability;Budesonide*/pharmacokinetics;Budesonide*/pharmacology;Budesonide*/therapeutic use;Capsules;Crohn Disease/drug therapy*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Randomized Controlled Trials as Topic;Rats
15354763;Appetite/drug effects;Ethanol/pharmacology;Food-Drug Interactions*;Humans;Nutritional Status/drug effects
15346578;Anti-Allergic Agents/adverse effects;Dietary Supplements;Drug Interactions*;Food-Drug Interactions;Polypharmacy*;Terfenadine/adverse effects
15332505;Administration, Oral;Animals;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Carbonated Beverages*;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Ibuprofen/pharmacokinetics*;Male;Rabbits
15329598;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/pharmacology*;Antibiotics, Antitubercular/pharmacology;Antiemetics/pharmacology;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Chromatography, High Pressure Liquid;Citrus;Cross-Over Studies;Cytochrome P-450 CYP3A;Drug Interactions;Female;Fentanyl/administration & dosage;Fentanyl/analogs & derivatives*;Fentanyl/blood;Fentanyl/pharmacokinetics*;Fentanyl/pharmacology*;Food-Drug Interactions;Half-Life;Humans;Intestines/enzymology*;Liver/enzymology*;Male;Oxidoreductases, N-Demethylating/metabolism*;Pupil/drug effects;Rifampin/pharmacology;Spectrometry, Mass, Electrospray Ionization;Troleandomycin/pharmacology
15315110;Absorption;Beverages;Citrus paradisi;Ethanol/pharmacology;Fatty Acids/pharmacology;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*
15311686;Adjuvants, Immunologic/administration & dosage;Adjuvants, Immunologic/therapeutic use*;Adolescent;Adult;Aged;B-Lymphocytes/drug effects;B-Lymphocytes/immunology;B-Lymphocytes/radiation effects;Benzimidazoles/administration & dosage;Benzimidazoles/therapeutic use*;Child;Combined Modality Therapy;Diet Therapy/methods;Food-Drug Interactions*;Humans;Middle Aged;Psoriasis*/diet therapy;Psoriasis*/drug therapy;Psoriasis*/immunology;Radioactive Pollutants/adverse effects*;Radioisotopes;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;T-Lymphocytes/radiation effects;Treatment Outcome;Ukraine
15309441;Animals;Antineoplastic Agents/administration & dosage*;Apoptosis;Caspase 3;Caspases/metabolism;Colonic Neoplasms/chemically induced;Colonic Neoplasms/epidemiology;Colonic Neoplasms/prevention & control*;Cyclooxygenase 2;Dietary Fats, Unsaturated/administration & dosage*;Disease Models, Animal;Dose-Response Relationship, Drug;Fatty Acids, Unsaturated/analysis;Fatty Acids, Unsaturated/blood;Food-Drug Interactions*;Gene Expression Regulation;Gene Expression Regulation, Enzymologic;Genes, bcl-2;Incidence;Intestinal Mucosa/enzymology;Intestinal Mucosa/pathology;Isoenzymes/metabolism;Liver/chemistry;Male;Olive Oil;Plant Oils/administration & dosage;Plant Oils/chemistry;Prostaglandin-Endoperoxide Synthases/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Soybean Oil/administration & dosage;Soybean Oil/chemistry;Sulindac/administration & dosage*
15291376;Angiotensin II Type 1 Receptor Blockers;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Antihypertensive Agents/therapeutic use;Blood Pressure/drug effects;Clinical Trials as Topic;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypertension/drug therapy*;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Imidazoles/therapeutic use;Olmesartan Medoxomil;Patient Compliance;Receptor, Angiotensin, Type 1/metabolism;Tetrazoles/administration & dosage;Tetrazoles/adverse effects;Tetrazoles/pharmacokinetics*;Tetrazoles/therapeutic use
15230341;Adult;Area Under Curve;Biological Availability;Cefaclor/administration & dosage*;Cefaclor/pharmacokinetics*;Cephalosporins/administration & dosage*;Cephalosporins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diet, Fat-Restricted;Diet, Vegetarian;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Linear Models;Male;Oryza;Triticum
15211967;Acenocoumarol/pharmacokinetics;Acenocoumarol/therapeutic use*;Aged;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Monitoring, Physiologic;Protein Binding
15206993;Adult;Anticholesteremic Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Simvastatin/analogs & derivatives*;Simvastatin/metabolism;Simvastatin/pharmacokinetics*
15206986;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Male;Middle Aged;Muscarinic Antagonists/pharmacokinetics*;Quinuclidines/pharmacokinetics*;Solifenacin Succinate;Tetrahydroisoquinolines/pharmacokinetics*
15187690;Anticoagulants/pharmacology*;Food-Drug Interactions;Humans;Tea/chemistry*;Vitamin K/pharmacology*;Warfarin/pharmacology*
15179411;Adult;Area Under Curve;Beverages*;Caco-2 Cells;Citrus paradisi/metabolism*;Confidence Intervals;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Felodipine/pharmacokinetics;Female;Food-Drug Interactions/physiology*;Furocoumarins/pharmacokinetics*;Humans;Male;Plant Extracts/pharmacokinetics
15175418;Acetylcholine;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Animals;Blood Vessels/drug effects*;Blood Vessels/physiology;Food-Drug Interactions;Lisinopril/pharmacology;Prostaglandins/physiology;Rats;Rats, Wistar;Sodium/urine;Sodium, Dietary/pharmacology*;Vasodilation/drug effects*;Vasodilation/physiology
15158901;Animals;Dogs;Food-Drug Interactions/physiology*;Solubility/drug effects;Tablets/chemistry*;Tablets/pharmacokinetics
15151167;Acetaminophen/pharmacokinetics*;Adult;Beverages*;Food-Drug Interactions/physiology;Hibiscus*;Humans;Male;Plant Extracts/isolation & purification;Plant Extracts/pharmacokinetics;Water/metabolism
15142337;Animals;Chemical Phenomena;Chemistry, Physical;Dietary Sucrose;Fasting;Food*;Food, Formulated;Food-Drug Interactions;Hydrogen-Ion Concentration;Milk/chemistry;Pectins/chemistry;Pharmacokinetics;Postprandial Period*;Solubility;Stomach/chemistry*;United States;United States Food and Drug Administration;Viscosity;Vitamin K/chemistry
15134377;Adult;Alcohol Drinking/metabolism*;Cholesterol, HDL/blood*;Cholesterol, LDL/blood*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Glutathione Peroxidase/metabolism;Humans;Male;Oxidative Stress/drug effects*;Postprandial Period*;Time Factors;Wine*
15132100;Anticholesteremic Agents/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Rhabdomyolysis/chemically induced*;Simvastatin/adverse effects*
15124981;Adult;Area Under Curve;CDC2-CDC28 Kinases/antagonists & inhibitors;Cross-Over Studies;Cyclin E/antagonists & inhibitors;Cyclin-Dependent Kinase 2;Dose-Response Relationship, Drug;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Food-Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Purines/blood;Purines/pharmacokinetics*;Purines/urine;Stereoisomerism;Tissue Distribution
15121498;Administration, Oral;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Diet*;Drug Monitoring;Food-Drug Interactions*;Humans;Phenprocoumon/pharmacology;Vitamin K/chemistry;Vitamin K/pharmacology*;Warfarin/pharmacology
15121490;Administration, Oral;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Case-Control Studies;Cross-Over Studies;Diet*;Drug Monitoring;Female;Food-Drug Interactions*;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Observation;Phenprocoumon/pharmacology;Prospective Studies;Vitamin K/pharmacology*;Warfarin/pharmacology
15118259;Animals;Arteriosclerosis/drug therapy;Arteriosclerosis/prevention & control;Cholesterol/biosynthesis;Cholesterol, VLDL/secretion;Citrus paradisi;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Drug Therapy, Combination;Fenofibrate/therapeutic use;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Quinolines/chemistry;Quinolines/pharmacokinetics;Quinolines/pharmacology*;Quinolines/therapeutic use;Receptors, LDL/metabolism;Triglycerides/metabolism
15100064;Carbolines/adverse effects;Carbolines/therapeutic use*;Drug Interactions;Erectile Dysfunction/drug therapy*;Food-Drug Interactions;Humans;Imidazoles/adverse effects;Imidazoles/therapeutic use*;Male;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/therapeutic use*;Piperazines/adverse effects;Piperazines/therapeutic use*;Purines;Sildenafil Citrate;Sulfones;Tadalafil;Triazines;Vardenafil Dihydrochloride
15098799;2-Hydroxypropyl-beta-cyclodextrin;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Cyclodextrins;Female;Food-Drug Interactions*;Humans;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Pharmaceutical Solutions;beta-Cyclodextrins*
15049723;Drug Interactions;Fluorobenzenes/pharmacokinetics;Fluorobenzenes/pharmacology;Fluorobenzenes/therapeutic use*;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*;Hyperlipidemias/drug therapy*;Metabolic Clearance Rate;Pyrimidines/pharmacokinetics;Pyrimidines/pharmacology;Pyrimidines/therapeutic use*;Randomized Controlled Trials as Topic;Rosuvastatin Calcium;Sulfonamides/pharmacokinetics;Sulfonamides/pharmacology;Sulfonamides/therapeutic use*
15036167;Adult;Aged;Area Under Curve;Dietary Proteins/blood*;Female;Food-Drug Interactions/physiology*;Humans;Levodopa/blood*;Levodopa/therapeutic use;Male;Middle Aged;Parkinson Disease/blood*;Parkinson Disease/drug therapy*;Statistics, Nonparametric
15035576;Aged*;Food-Drug Interactions*;Humans;Patient Education as Topic*;Patient Selection*
15033405;Chemistry, Pharmaceutical;Contraceptives, Oral, Combined/administration & dosage*;Contraceptives, Oral, Combined/adverse effects;Contraceptives, Postcoital/administration & dosage*;Contraceptives, Postcoital/adverse effects;Female;Food-Drug Interactions;Humans;Nausea/chemically induced;Norethindrone/administration & dosage;Randomized Controlled Trials as Topic
15017321;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/metabolism;Aryl Hydrocarbon Hydroxylases/genetics;Community Health Nursing/methods;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring/methods;Drug Monitoring/nursing;Food-Drug Interactions;Home Care Services;Humans;International Normalized Ratio;Liver/metabolism;Metabolic Clearance Rate;Patient Education as Topic/methods;Prothrombin Time;Vitamin K*/administration & dosage;Vitamin K*/adverse effects;Warfarin*/administration & dosage;Warfarin*/adverse effects;Warfarin*/metabolism
15011605;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/adverse effects;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage;Ritonavir/adverse effects
15011592;Acquired Immunodeficiency Syndrome/drug therapy*;Drug Synergism;Drug Therapy, Combination;Food-Drug Interactions/physiology*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/pharmacokinetics;Humans;Multicenter Studies as Topic;Nelfinavir/administration & dosage*;Nelfinavir/pharmacokinetics;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage*;Ritonavir/pharmacokinetics
15001969;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Biological Availability;Celiprolol/antagonists & inhibitors*;Celiprolol/blood;Celiprolol/pharmacokinetics*;Celiprolol/urine;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Receptors, Adrenergic, beta/metabolism;Statistics, Nonparametric
14986824;DNA Methylation*;Diet*;Female;Food-Drug Interactions;Gene Expression Regulation*;Humans;Maternal Nutritional Physiological Phenomena;Neoplasms/genetics*;Pregnancy;S-Adenosylhomocysteine/metabolism;S-Adenosylmethionine/metabolism;Schizophrenia/genetics*
14980003;Animals;Antimalarials/adverse effects;Antimalarials/blood;Antimalarials/metabolism*;Blood Proteins/metabolism*;Electrocardiography/drug effects;Fasting;Food-Drug Interactions;Lipoproteins/metabolism*;Long QT Syndrome/chemically induced*;Long QT Syndrome/metabolism;Phenanthrenes/adverse effects;Phenanthrenes/blood;Phenanthrenes/metabolism*;Postprandial Period;Protein Binding;Rabbits
14979675;Administration, Oral;Animals;Area Under Curve;Beverages;Citrus*;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Dogs/metabolism*;Food-Drug Interactions;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male
14973309;Administration, Oral;Adult;Antiviral Agents/adverse effects;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics;Antiviral Agents/urine;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Dietary Fats;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Ribavirin/adverse effects;Ribavirin/analogs & derivatives*;Ribavirin/blood;Ribavirin/pharmacokinetics*;Ribavirin/urine;Time Factors
14765835;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Beverages*;Food-Drug Interactions*;Humans;Male;Reference Values;Vaccinium macrocarpon*;Warfarin/blood;Warfarin/pharmacology*
14765833;Anticoagulants/administration & dosage;Anticoagulants/metabolism*;Anticoagulants/pharmacology;Anticoagulants/therapeutic use;Continental Population Groups*;Cytochrome P-450 Enzyme System/genetics;Food-Drug Interactions;Humans;Warfarin/administration & dosage;Warfarin/metabolism*;Warfarin/pharmacology;Warfarin/therapeutic use
14758049;Administration, Oral;Adult;Drug Administration Schedule;Drug Combinations;Female;Food-Drug Interactions;Humans;Lopinavir;Male;Middle Aged;Models, Biological;Postprandial Period;Protease Inhibitors/blood;Protease Inhibitors/pharmacokinetics*;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Ritonavir/pharmacokinetics*;Time Factors
14748822;Administration, Oral;Adolescent;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Male;Middle Aged;Tablets;Triazoles/blood;Triazoles/pharmacokinetics*
14747426;Adult;Area Under Curve;Biological Availability;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/chemistry;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Dexmethylphenidate Hydrochloride*;Fasting;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Methylphenidate/analogs & derivatives*;Methylphenidate/blood;Methylphenidate/chemistry;Methylphenidate/pharmacokinetics*;Postprandial Period;Stereoisomerism;Therapeutic Equivalency
14735231;Administration, Oral;Animals;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbonated Beverages*;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Hydrogen-Ion Concentration;Male;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/pharmacokinetics*;Rabbits
14734983;Food-Drug Interactions*;Humans;Infusions, Intravenous/adverse effects*;Infusions, Intravenous/nursing;Injections, Intravenous/adverse effects*;Injections, Intravenous/nursing;Parenteral Nutrition, Total/adverse effects*;Parenteral Nutrition, Total/nursing
14706809;Animals;Biological Transport/genetics;Food-Drug Interactions/genetics;Genomics*/methods;Humans;Intestinal Absorption/genetics*;Membrane Transport Proteins/biosynthesis;Membrane Transport Proteins/genetics*;Oligonucleotide Array Sequence Analysis/methods*;Pharmaceutical Preparations/metabolism*
14684645;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Fatal Outcome;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced;Heart Diseases/chemically induced;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Male;Pericardium;Vaccinium macrocarpon*;Warfarin/adverse effects*
14679681;Aged;Aged, 80 and over;Anticoagulants/adverse effects*;Food-Drug Interactions*;Garlic/adverse effects*;Humans;International Normalized Ratio;Male;Phenindione/adverse effects*;Phenindione/analogs & derivatives*
14679360;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Beverages*;Biological Availability;Calcium Channel Blockers/metabolism;Central Nervous System Agents/metabolism;Citrus paradisi/chemistry;Citrus paradisi/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Intestinal Absorption/drug effects;Pharmacokinetics
14675888;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects*;Diagnosis, Differential;Electrocardiography;Food-Drug Interactions;Heart Block/chemically induced*;Heart Block/diagnosis*;Heart Block/physiopathology;Honey/adverse effects*;Humans;Male;Middle Aged;Verapamil/administration & dosage;Verapamil/adverse effects*
14672861;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Environmental Exposure/adverse effects*;Female;Food-Drug Interactions*;Humans;Lead Poisoning/etiology*;New South Wales;Nutritional Status*;Pregnancy;Pregnancy Complications/etiology;Public Health;Trace Elements/administration & dosage;Vitamins/administration & dosage
14653226;Adult;Benzodiazepines/administration & dosage;Benzodiazepines/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Tolerance;Fasting;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Random Allocation;Therapeutic Equivalency;Time Factors
14644581;Delayed-Action Preparations/metabolism;Dietary Fats/metabolism*;Drug Evaluation, Preclinical/methods;Food-Drug Interactions/physiology*;Polysaccharides/metabolism*;Solubility/drug effects
14641551;ATP Binding Cassette Transporter, Sub-Family B/physiology;Beverages*;Biological Availability;Food-Drug Interactions/physiology*;Fruit*;Humans;Organic Anion Transporters/antagonists & inhibitors;Pharmacokinetics
14629735;Acetaminophen/chemistry*;Adsorption;Analgesics, Non-Narcotic/chemistry*;Charcoal/chemistry*;Chromatography, High Pressure Liquid;Food*;Food-Drug Interactions;Hydrogen-Ion Concentration;Ice Cream;Surface Properties;Yogurt
14616409;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Voriconazole
14606933;Administration, Oral;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions/physiology;Half-Life;Humans;Male;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/analogs & derivatives*;Tacrolimus/pharmacokinetics*
14587961;Administration, Oral;Animals;Anti-Ulcer Agents/pharmacokinetics;Anti-Ulcer Agents/pharmacology*;Anti-Ulcer Agents/therapeutic use;Clinical Trials as Topic;Drug Interactions;Food-Drug Interactions;Gastric Acid/secretion;Humans;Injections, Intravenous;Peptic Ulcer/drug therapy*;Peptic Ulcer/physiopathology;Proton Pump Inhibitors*;Proton Pumps/metabolism
14585065;Antihypertensive Agents/pharmacokinetics*;Antihypertensive Agents/therapeutic use;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions*;Food-Drug Interactions;Humans;Hypertension/drug therapy*;Risk Factors
14576716;Adult;Adverse Drug Reaction Reporting Systems;Age Factors;Aged;California;Diet*;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Educational Status;Female;Food-Drug Interactions;Health Maintenance Organizations/statistics & numerical data*;Humans;Male;Middle Aged;Nutrition Surveys;Risk Factors;Sex Factors
14574774;Depressive Disorder/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use*;Netherlands;Phenelzine/adverse effects;Phenelzine/therapeutic use;Secondary Prevention;Time Factors;Tranylcypromine/adverse effects;Tranylcypromine/therapeutic use
14572860;Antitubercular Agents/administration & dosage*;Antitubercular Agents/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Drug Evaluation, Preclinical/methods;Food-Drug Interactions/physiology*;Oils/pharmacokinetics;Rifampin/administration & dosage*;Rifampin/pharmacokinetics*
14571304;Age Factors;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/pharmacology;Azetidines/pharmacokinetics*;Azetidines/pharmacology;Clinical Trials as Topic;Drug Interactions;Ethnic Groups;Ezetimibe;Food-Drug Interactions;Humans;Intestinal Absorption;Sex Factors
14571284;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Carbamazepine/administration & dosage;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Honey*;Humans;Male
14564940;Adult;Animals;Area Under Curve;Ascorbic Acid/administration & dosage;Ascorbic Acid/blood;Ascorbic Acid/pharmacokinetics;Biological Availability;Cross-Over Studies;Dairy Products*;Deficiency Diseases/blood;Deficiency Diseases/prevention & control*;Dietary Supplements*;Female;Folic Acid/administration & dosage;Folic Acid/blood;Folic Acid/pharmacokinetics;Food-Drug Interactions;Humans;Intestinal Absorption;Iron, Dietary/administration & dosage;Iron, Dietary/blood;Iron, Dietary/pharmacokinetics;Micronutrients/administration & dosage;Micronutrients/blood;Micronutrients/pharmacokinetics*;Middle Aged;Zinc/administration & dosage;Zinc/blood;Zinc/pharmacokinetics
14558393;Dietary Supplements*/adverse effects;Drug Interactions;Food-Drug Interactions;Humans;Physician-Patient Relations
14533574;Drug Interactions*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Nurse's Role;Patient Education as Topic;Phytotherapy/adverse effects*;Preoperative Care/methods*;Preoperative Care/nursing;Surgery, Plastic/nursing;Time Factors
14531725;Administration, Oral;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Atorvastatin Calcium;Biological Availability;Clinical Trials as Topic;Drug Interactions;Food-Drug Interactions;Gastrointestinal Tract/metabolism;Heptanoic Acids/administration & dosage;Heptanoic Acids/pharmacokinetics*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Liver/metabolism;Pyrroles/administration & dosage;Pyrroles/pharmacokinetics*
14531721;Beverages;Biological Availability;Biological Transport;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Drug Carriers/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
14531370;Adolescent;Adult;Aged;Anesthetics/administration & dosage;Anesthetics/adverse effects;Anesthetics/metabolism;Dietary Supplements*/adverse effects;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Preanesthetic Medication/adverse effects;Surveys and Questionnaires
14527091;Analysis of Variance;Area Under Curve;Biological Availability;Cefaclor/blood;Cefaclor/pharmacokinetics*;Cross-Over Studies;Diet, Vegetarian*;Dietary Fats/blood;Dietary Fats/pharmacokinetics*;Fasting/blood;Fasting/metabolism*;Food-Drug Interactions/physiology*;Humans;Male;Statistics, Nonparametric
14527090;Adult;Area Under Curve;Biological Availability;Food-Drug Interactions/physiology*;Fruit/metabolism;Humans;Ibuprofen/blood*;Ibuprofen/pharmacokinetics*;Male;Plant Extracts/pharmacokinetics;Tamarindus*
14518700;Adult;Cross-Over Studies;Drug Administration Schedule;Drug Therapy, Combination;Fasting;Food*;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/adverse effects*;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Indinavir/pharmacokinetics;Indinavir/therapeutic use;Kidney Diseases/chemically induced;Kidney Diseases/prevention & control*;Middle Aged;Ritonavir/administration & dosage*;Ritonavir/adverse effects;Ritonavir/pharmacokinetics;Ritonavir/therapeutic use
14517193;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Antiparasitic Agents/therapeutic use*;Cohort Studies;Dose-Response Relationship, Drug;Double-Blind Method;Eating;Fasting;Food-Drug Interactions;Humans;Macrolides/adverse effects;Macrolides/pharmacokinetics*;Macrolides/therapeutic use*;Male;Middle Aged;Nausea/chemically induced;Onchocerciasis/drug therapy*;Treatment Outcome;Vomiting/chemically induced
14506878;Adaptation, Physiological*;Animals;Antimalarials/pharmacology*;Antimalarials/therapeutic use;Biological Evolution;Drug Resistance;Erythrocytes/metabolism;Erythrocytes/parasitology;Food-Drug Interactions;Genotype;Humans;Malaria/drug therapy*;Malaria/prevention & control;Oxidation-Reduction;Plant Extracts/pharmacology;Plant Extracts/therapeutic use;Plasmodium/drug effects*;Plasmodium/genetics
13679966;Cross Reactions;Dermatitis, Allergic Contact/diagnosis;Dermatitis, Allergic Contact/immunology;Food-Drug Interactions/immunology*;Humans;Latex Hypersensitivity/diagnosis*;Latex Hypersensitivity/immunology*
12973820;Administration, Oral;Adolescent;Adult;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy;Biological Availability*;Capsules;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics*;Dietary Fats/administration & dosage;Dietary Fats/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food*;Food-Drug Interactions/physiology;Humans;Male;Methylphenidate/administration & dosage*;Methylphenidate/blood;Methylphenidate/pharmacokinetics*;Middle Aged;Time Factors
12971031;Adult;Animals;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Beverages;Calcium, Dietary/administration & dosage*;Citrus;Cross-Over Studies;Edible Grain;Fasting;Female;Food, Fortified*;Food-Drug Interactions*;Humans;Levofloxacin*;Male;Middle Aged;Milk;Ofloxacin/administration & dosage;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Therapeutic Equivalency
12952002;Aged;Food-Drug Interactions;Humans;Intestinal Absorption;Prevalence;Vitamin B 12*/blood;Vitamin B 12*/therapeutic use;Vitamin B 12 Deficiency/epidemiology*
12951947;Area Under Curve;Diet;Food-Drug Interactions*;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use*;Humans;Nelfinavir/administration & dosage;Nelfinavir/pharmacokinetics;Nelfinavir/therapeutic use*
12951939;Advisory Committees*;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/therapeutic use*;Atazanavir Sulfate;Dose-Response Relationship, Drug;Food-Drug Interactions;HIV Infections/drug therapy;Humans;Oligopeptides/administration & dosage;Oligopeptides/therapeutic use*;Pyridines/administration & dosage;Pyridines/therapeutic use*;United States;United States Food and Drug Administration
12945511;Clinical Competence;Diet;Dietary Supplements;Food Preferences*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice;Humans;Long-Term Care/standards*;Nutritional Sciences/education;Patient Care Team/standards*
12936882;Absorption;Alendronate/administration & dosage*;Alendronate/pharmacokinetics;Drug Interactions;Food-Drug Interactions;Humans;Water Supply/standards*
12936879;Absorption;Beverages*/adverse effects*;Citrus paradisi*/adverse effects;Food-Drug Interactions/physiology*;Humans
12921244;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Digoxin/pharmacokinetics*;Female;Food-Drug Interactions*;Genes, MDR;Genotype;Humans;Intestines/metabolism*;Male
12920426;Adult;Antidepressive Agents, Second-Generation/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Fluvoxamine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male
12875233;Animals;Biological Availability;Digestive System/metabolism;Dosage Forms;Drug Combinations;Food-Drug Interactions;Humans;Intestinal Absorption;Mefenamic Acid/pharmacokinetics*;Phenytoin/pharmacokinetics*;Sulpiride/pharmacokinetics*
12875231;Anti-Anxiety Agents/metabolism*;Anti-Bacterial Agents/pharmacology;Anticonvulsants/pharmacology;Antifungal Agents/pharmacology;Azoles/pharmacology;Benzodiazepines;Calcium Channel Blockers/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/physiology*;Drug Interactions;Food-Drug Interactions;Humans;Macrolides;Rifampin/pharmacology
12860494;Adult;Area Under Curve;Blood Glucose/analysis;Cross-Over Studies;Cyclohexanes/adverse effects;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Double-Blind Method;Food-Drug Interactions*;Gastric Emptying/drug effects*;Half-Life;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Insulin/blood;Male;Middle Aged;Phenylalanine/adverse effects;Phenylalanine/analogs & derivatives;Phenylalanine/pharmacokinetics*;Phenylalanine/pharmacology;Time Factors
12852456;Administration, Oral;Animals;Antimalarials/blood*;Antimalarials/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Stability;Food-Drug Interactions;Half-Life;Indicators and Reagents;Male;Primaquine/analogs & derivatives*;Primaquine/blood;Primaquine/metabolism*;Primaquine/pharmacokinetics*;Rabbits;Reproducibility of Results;Spectrophotometry, Ultraviolet
12851659;Administration, Oral;Animals;Anticonvulsants/administration & dosage;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Honey*;Male;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/pharmacokinetics*;Rabbits;Time Factors
12844325;Age Factors;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Clinical Trials as Topic;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Ergolines/administration & dosage*;Ergolines/blood;Ergolines/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Kidney Diseases/metabolism;Levodopa/pharmacokinetics;Liver Diseases/metabolism;Male;Selegiline/pharmacokinetics;Sex Factors
12838962;Animals;Drug Carriers*;Drug Delivery Systems*;Food-Drug Interactions;Humans;Prodrugs;United States;United States Food and Drug Administration
12834283;Animals;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Blotting, Western;Catechin/analogs & derivatives*;Catechin/pharmacology;Cell Line;Cyclooxygenase Inhibitors/pharmacology;Dinoprostone/biosynthesis*;Drug Synergism;Food Analysis;Food-Drug Interactions;Genistein/pharmacology;Indicators and Reagents;Indomethacin/pharmacology;Interferon-gamma/pharmacology;Isothiocyanates/chemistry;Isothiocyanates/pharmacology;Lipopolysaccharides/pharmacology;Macrophages/drug effects;Macrophages/metabolism*;Mice;Protein Biosynthesis;Spectrophotometry, Infrared;Sulfonamides/pharmacology;Tumor Necrosis Factor-alpha/biosynthesis*
12831515;Capsules;Chemistry, Pharmaceutical;Crystallization;Dietary Proteins/pharmacology;Food-Drug Interactions/physiology;Hydrogen-Ion Concentration;Indinavir/chemistry*;Ritonavir/chemistry*
12830268;Anticoagulants/administration & dosage;Anticoagulants/antagonists & inhibitors*;Drug Monitoring;Food-Drug Interactions*;Humans;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/antagonists & inhibitors*
12826982;Food-Drug Interactions/genetics*;Humans;Nonprescription Drugs/metabolism*
12820815;Animals;Anti-Ulcer Agents/chemistry*;Beverages*;Capsules;Citrus sinensis;Dairy Products*;Drug Stability;Esomeprazole/chemistry*;Food-Drug Interactions*;Gastric Acid/chemistry;Hydrochloric Acid/chemistry;Malus;Milk;Yogurt
12811362;Adult;Area Under Curve;Beverages*;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Citrus*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Furocoumarins/pharmacology*;Half-Life;Humans;Male;Middle Aged;NADP/metabolism;Radiation-Sensitizing Agents/pharmacology*;Wine*
12807517;11-beta-Hydroxysteroid Dehydrogenases;Adult;Aldosterone/blood;Beverages/adverse effects*;Citrus paradisi*;Depression, Chemical;Edema/etiology*;Edema/metabolism;Female;Food-Drug Interactions*;Humans;Hydroxysteroid Dehydrogenases/antagonists & inhibitors*;Hydroxysteroid Dehydrogenases/metabolism;Mineralocorticoids/metabolism*;Potassium/blood;Renin/blood
12792988;Aflatoxin B1/metabolism;Aflatoxin B1/toxicity*;Animals;Cytochrome P-450 Enzyme System/metabolism;Dietary Sucrose/administration & dosage*;Food-Drug Interactions*;Glutathione Transferase/metabolism;Isoenzymes;Liver/drug effects*;Liver/enzymology;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Mutagenesis/drug effects*;Mutagens/metabolism;Mutagens/toxicity*;Rats;Rats, Inbred F344;Salmonella typhimurium/drug effects;Salmonella typhimurium/genetics
12787947;Adult;Catha/chemistry*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacology*;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Food-Drug Interactions;Humans;Lipid Peroxidation/drug effects*;Male;Malondialdehyde/blood;Mastication;Middle Aged;Plant Leaves/chemistry*;Plant Preparations/pharmacology*;Postprandial Period;Smoking;Triglycerides/blood
12771601;APACHE;Administration, Oral;Adolescent;Adult;Aged;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Critical Illness*;Cross-Over Studies;Drug Monitoring/methods;Enteral Nutrition/methods*;Female;Fluoroquinolones*;Food-Drug Interactions;Humans;Infusions, Intravenous;Intubation, Gastrointestinal/methods*;Male;Middle Aged;Prospective Studies
12769668;Animals;Catechin/pharmacology;Enzymes/metabolism*;Food-Drug Interactions;Gallic Acid/analogs & derivatives*;Gallic Acid/pharmacology*;Humans;Mixed Function Oxygenases/metabolism;Pharmaceutical Preparations/metabolism*
12756216;Brassica*;Caco-2 Cells/enzymology;Caco-2 Cells/metabolism;Chromatography, Liquid;Enterocytes/enzymology;Enterocytes/metabolism;Enterocytes/secretion;Food-Drug Interactions;Gene Expression;Glucuronides/secretion;Glucuronosyltransferase/biosynthesis;Glutathione/analogs & derivatives;Glutathione/secretion;Glutathione Transferase/biosynthesis;Humans;Intestinal Absorption;Isothiocyanates;Jejunum/enzymology;Jejunum/metabolism*;Jejunum/secretion;Mass Spectrometry;Onions*;Plant Extracts/pharmacokinetics;Plant Stems;Plant Tubers;Quercetin/analogs & derivatives;Quercetin/pharmacokinetics*;Quercetin/secretion;RNA, Messenger/biosynthesis;Reverse Transcriptase Polymerase Chain Reaction;Thiocyanates/pharmacokinetics*;beta-Glucosidase/biosynthesis
12751908;Alcohol Dehydrogenase/metabolism;Animals;Dogs;Ethanol/blood;Ethanol/pharmacokinetics*;Food*;Food-Drug Interactions*;Gastric Emptying;Intestinal Absorption;Intestine, Small/enzymology;Monte Carlo Method;Stomach/enzymology;Stomach/metabolism
12751275;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Area Under Curve;Beverages*;Calcium, Dietary/pharmacology*;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Levofloxacin*;Male;Ofloxacin/administration & dosage;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Therapeutic Equivalency
12749182;Administration, Oral;Beverages*;Biological Availability;Citrus paradisi;Estradiol/administration & dosage;Estradiol/analogs & derivatives*;Estradiol/pharmacokinetics*;Estrogens, Conjugated (USP)/administration & dosage;Estrogens, Conjugated (USP)/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Progesterone/administration & dosage;Progesterone/pharmacokinetics*
12743672;Administration, Oral;Adult;Analysis of Variance;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Area Under Curve;Azetidines/adverse effects;Azetidines/pharmacokinetics*;Azetidines/pharmacology*;Benzylamines;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycine/analogs & derivatives*;Glycine/blood;Half-Life;Humans;Male;Metabolic Clearance Rate;Partial Thromboplastin Time;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/pharmacology;Prothrombin Time;Thrombin/antagonists & inhibitors*
12723461;Administration, Oral;Adult;Area Under Curve;Biomarkers;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Half-Life;Humans;Hydrogen-Ion Concentration;Imidazoles/administration & dosage;Imidazoles/pharmacokinetics*;Imidazoles/pharmacology;Male;Mitogen-Activated Protein Kinases/antagonists & inhibitors*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Pyridines/pharmacology;p38 Mitogen-Activated Protein Kinases
12711572;American Heart Association*;Docosahexaenoic Acids/administration & dosage*;Eicosapentaenoic Acid;Fatty Acids, Unsaturated/administration & dosage*;Food-Drug Interactions;Guidelines as Topic*;Heart Diseases/diet therapy*;Humans;United States
12708244;Anticoagulants/pharmacokinetics*;Blood Coagulation/drug effects;Cardiovascular Diseases/drug therapy;Cardiovascular Diseases/metabolism;Feeding Behavior*;Food-Drug Interactions*;Humans;International Normalized Ratio
12706777;Administration, Oral;Age Distribution;Aged;Aged, 80 and over;Asthenia/etiology;Carrier Proteins/metabolism*;Cohort Studies;Confusion/etiology;Diagnosis, Differential;Female;Food-Drug Interactions*;France/epidemiology;Humans;Malabsorption Syndromes/complications*;Malabsorption Syndromes/drug therapy;Malabsorption Syndromes/epidemiology;Malabsorption Syndromes/metabolism;Male;Middle Aged;Peripheral Nervous System Diseases/etiology;Retrospective Studies;Schilling Test*;Sex Distribution;Vitamin B 12/metabolism*;Vitamin B 12/therapeutic use*;Vitamin B 12 Deficiency/complications*;Vitamin B 12 Deficiency/diagnosis;Vitamin B 12 Deficiency/drug therapy*;Vitamin B 12 Deficiency/epidemiology
12698990;Administration, Oral;Adult;Area Under Curve;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/analogs & derivatives*;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Chemistry, Pharmaceutical;Chromatography, High Pressure Liquid;Cross-Over Studies;Dibenzazepines/blood;Fasting;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Tablets;Therapeutic Equivalency
12698987;Absorption;Acetaminophen/metabolism;Acetaminophen/pharmacokinetics*;Administration, Oral;Algorithms;Area Under Curve;Energy Intake*;Food;Food-Drug Interactions*;Gastric Emptying;Humans;Models, Biological;Postprandial Period
12693698;Administration, Oral;Animals;Area Under Curve;Diltiazem/administration & dosage;Diltiazem/blood;Diltiazem/pharmacokinetics*;Food-Drug Interactions;Half-Life;Honey*;Infusions, Intravenous;Rabbits
12691040;Beverages*;Citrus*;Food-Drug Interactions*;HIV Seronegativity;Humans;Male;Piperazines/pharmacology*;Purines;Sildenafil Citrate;Sulfones
12680887;Administration, Oral;Adult;Anti-Anxiety Agents/administration & dosage;Anti-Anxiety Agents/pharmacokinetics*;Anti-Anxiety Agents/pharmacology;Benzodiazepines*;Cross-Over Studies;Eating/physiology*;Fasting/physiology;Fatigue/chemically induced;Food-Drug Interactions/physiology*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/pharmacology;Male;Psychomotor Performance/drug effects;Thinking/drug effects;Time Factors
12674742;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Biotransformation/genetics*;Drug Interactions/genetics;Drug Resistance, Multiple/genetics*;Food-Drug Interactions/genetics;Gene Expression Regulation/physiology;Humans;Intestinal Absorption/genetics*;Metabolic Clearance Rate/genetics*;Pharmacokinetics*;Risk Factors
12661783;Amphetamines/administration & dosage*;Amphetamines/pharmacokinetics;Area Under Curve;Attention Deficit Disorder with Hyperactivity/drug therapy*;Biological Availability;Central Nervous System Stimulants/administration & dosage*;Central Nervous System Stimulants/pharmacokinetics;Delayed-Action Preparations;Drug Administration Schedule*;Eating*;Food-Drug Interactions*;Humans;United States
12653694;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Asthma/complications;Drug Eruptions/drug therapy;Drug Eruptions/etiology*;Food-Drug Interactions/physiology;Humans;Urticaria/chemically induced*;Urticaria/complications;Urticaria/drug therapy
12652372;Anti-HIV Agents/therapeutic use;Antiretroviral Therapy, Highly Active;Delivery of Health Care, Integrated;Food-Drug Interactions;HIV Infections/diet therapy*;HIV Infections/drug therapy;HIV Infections/mortality;Humans;Mass Screening;Nutrition Assessment;Nutritional Physiological Phenomena*;Reproducibility of Results;Treatment Outcome
12648028;Administration, Oral;Adult;Age Factors;Aged;Area Under Curve;Azetidines/pharmacokinetics;Azetidines/pharmacology*;Benzylamines;Biological Availability;Cross-Over Studies;Female;Fibrinolytic Agents/pharmacokinetics;Fibrinolytic Agents/pharmacology*;Food-Drug Interactions;Glycine/analogs & derivatives*;Glycine/blood;Glycine/pharmacokinetics;Glycine/urine;Humans;Infusions, Intravenous;Injections, Subcutaneous;Male;Metabolic Clearance Rate;Middle Aged;Prodrugs/pharmacokinetics;Prodrugs/pharmacology*;Thrombin/antagonists & inhibitors*
12648026;Age Factors;Biological Availability;Breast Neoplasms/drug therapy;Breast Neoplasms/prevention & control;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Kidney Diseases/physiopathology;Liver Diseases/metabolism;Liver Diseases/physiopathology;Osteoporosis/drug therapy;Osteoporosis/prevention & control;Selective Estrogen Receptor Modulators/adverse effects;Selective Estrogen Receptor Modulators/pharmacokinetics*;Selective Estrogen Receptor Modulators/therapeutic use
12638395;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/adverse effects;Cyclooxygenase Inhibitors/pharmacokinetics*;Dietary Fats;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors*;Male;Membrane Proteins;Middle Aged;Prostaglandin-Endoperoxide Synthases;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics*;Tablets;Time Factors
12638394;3',5'-Cyclic-GMP Phosphodiesterases;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 5;Dietary Fats/administration & dosage*;Drug Administration Schedule;Erectile Dysfunction/drug therapy;Food-Drug Interactions;Half-Life;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphoric Diester Hydrolases/metabolism*;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Postprandial Period;Sulfones;Time Factors;Triazines;Vardenafil Dihydrochloride
12634980;Administration, Oral;Aged;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/genetics;Case-Control Studies;Cytochrome P-450 CYP2C9;Dose-Response Relationship, Drug;Drug Interactions;Drug Overdose;Female;Food-Drug Interactions;Genotype;Hemorrhage/chemically induced;Humans;Inpatients;International Normalized Ratio;Male;Mutation;Polymorphism, Genetic;Prospective Studies;Risk Factors;Vitamin K/administration & dosage
12622202;Animals;Anticonvulsants/pharmacokinetics*;Area Under Curve;Carbamazepine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Honey*;Rabbits
12619247;Aged;Aging/physiology;Drug Interactions;Education, Continuing;Emergency Medical Services/organization & administration*;Food-Drug Interactions;Geriatric Assessment*;Humans;Medical History Taking*;Polypharmacy*;Self Administration;United States
12611563;Animals;Arthritis, Rheumatoid/therapy;Asthma/therapy;Cardiomyopathies/therapy;Disease Progression;Food-Drug Interactions;HIV Infections/prevention & control;Humans;Hypothyroidism/therapy;Infertility, Male/therapy;Liver Diseases/blood;Male;Neoplasms/prevention & control;Selenium/adverse effects;Selenium/deficiency;Selenium/therapeutic use*
12611197;Beverages/adverse effects*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
12603801;Adolescent;Causality;Chi-Square Distribution;Child;Child, Preschool;Confidence Intervals;Direct Service Costs;Drug Interactions;Drug Utilization Review*;Drug-Related Side Effects and Adverse Reactions*;Emergency Service, Hospital/economics;Emergency Service, Hospital/utilization*;Female;Food-Drug Interactions;Hospital Costs;Hospitals, Pediatric/utilization;Hospitals, Teaching/utilization;Humans;Male;Medication Errors;Patient Admission/economics;Patient Admission/statistics & numerical data*;Pharmaceutical Preparations/administration & dosage;Probability;Risk Assessment;Risk Factors;Self Medication/adverse effects*;Statistics, Nonparametric;Victoria/epidemiology
12592204;Anti-Infective Agents/blood*;Beverages;Ciprofloxacin/blood*;Citrus sinensis;Food-Drug Interactions*
12578152;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Food-Drug Interactions*;Humans;Ketolides*;Macrolides*;Male;Middle Aged
12554070;Animals;Beverages;Citrus paradisi;Flavanones/pharmacology;Food-Drug Interactions;Furocoumarins/pharmacology*;Hepatocytes/drug effects;Hepatocytes/enzymology;Hepatocytes/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;In Vitro Techniques;Liver/drug effects*;Liver/metabolism;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Rats;Simvastatin/metabolism*
12551706;Adult;Antiparkinson Agents/adverse effects;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benserazide/adverse effects;Benserazide/blood;Benserazide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food*;Food-Drug Interactions;Half-Life;Humans;Levodopa/adverse effects;Levodopa/blood;Levodopa/pharmacokinetics*;Male;Time Factors;Tyrosine/analogs & derivatives*;Tyrosine/blood
12543606;Beverages*;Citrus paradisi*;Food-Drug Interactions*;Humans;Hypolipidemic Agents/metabolism
12520633;Adolescent;Adult;Anti-Infective Agents/pharmacokinetics*;Beverages*;Calcium*;Citrus sinensis*;Female;Fluoroquinolones*;Food, Fortified*;Food-Drug Interactions*;Humans;Male;Therapeutic Equivalency
12520629;Administration, Oral;Adolescent;Adult;Biological Availability;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Sex Factors;Sodium Oxybate/administration & dosage;Sodium Oxybate/adverse effects;Sodium Oxybate/pharmacokinetics*;Solutions
12520628;Aged;Biological Availability;Cross-Over Studies;Estradiol Congeners/pharmacokinetics*;Estrogen Replacement Therapy;Ethinyl Estradiol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Norethindrone/pharmacokinetics*;Progesterone Congeners/pharmacokinetics*;Tablets
12516078;Animals;Biological Availability;Drug Evaluation, Preclinical/methods;Drug Evaluation, Preclinical/standards;Fasting/physiology*;Food*;Food-Drug Interactions;Gastric Acid/physiology*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Hydrogen-Ion Concentration;Macaca fascicularis;Male;Species Specificity;Technology, Pharmaceutical/methods*;Technology, Pharmaceutical/standards
12512484;Administration, Oral;Drug Therapy/nursing*;Enteral Nutrition/nursing;Food-Drug Interactions;Gastrostomy/nursing*;Humans;Pharmaceutical Preparations/administration & dosage*
12494789;Buffers*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration*;Models, Biological;Pharmaceutical Preparations/metabolism
12492049;Biological Availability;Carbamates;Dietary Fats/administration & dosage;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/metabolism*;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Humans;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use;Vitamin E/administration & dosage
12463728;Adult;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Benzodiazepines*;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Fasting;Food-Drug Interactions*;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Time Factors
12452752;Aged;Anticoagulants/administration & dosage;Anticoagulants/pharmacology;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Soybean Proteins/administration & dosage*;Soybean Proteins/pharmacology*;Soybeans*;Warfarin/administration & dosage*;Warfarin/pharmacology*
12451428;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood*;Calcium Channel Blockers/pharmacology;Citrus paradisi*;Cross-Over Studies;Diltiazem/administration & dosage;Diltiazem/blood*;Diltiazem/pharmacology;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Time Factors
12437338;Animals;Arsenates/administration & dosage;Arsenates/chemistry;Arsenates/metabolism;Arsenicals/administration & dosage;Arsenicals/chemistry;Arsenicals/metabolism*;Arsenites/administration & dosage;Arsenites/chemistry;Arsenites/metabolism;Bile/metabolism*;Food-Drug Interactions;Injections, Intravenous;Male;Organometallic Compounds/pharmacokinetics*;Rabbits;Selenic Acid;Selenium Compounds/administration & dosage;Selenium Compounds/chemistry;Selenium Compounds/metabolism*;Sodium Selenite/administration & dosage;Sodium Selenite/chemistry;Sodium Selenite/metabolism
12435624;Adult;Area Under Curve;Cross-Over Studies;Drug Administration Schedule;Food-Drug Interactions*;Humans;Nelfinavir/administration & dosage;Nelfinavir/pharmacokinetics*;Reference Values;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/pharmacokinetics*
12434565;Adolescent;Adult;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Mexico;Middle Aged;Ranitidine/blood;Ranitidine/pharmacokinetics*
12432966;Adult;Amphetamine/administration & dosage;Amphetamine/blood;Amphetamine/pharmacokinetics*;Amphetamines/administration & dosage;Amphetamines/blood;Amphetamines/pharmacokinetics*;Analysis of Variance;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/metabolism*;Fasting/metabolism*;Female;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged
12429467;Animals;Area Under Curve;Biological Availability;Diabetes Mellitus, Experimental/blood;Diabetes Mellitus, Experimental/metabolism*;Eating/physiology;Food-Drug Interactions/physiology*;Male;Rats;Rats, Sprague-Dawley;Tungsten Compounds/administration & dosage;Tungsten Compounds/blood;Tungsten Compounds/pharmacokinetics*
12426515;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Female;Food-Drug Interactions*;Humans;Male;Phenanthrenes/pharmacokinetics*;Phenanthrenes/pharmacology*
12410622;Antioxidants/administration & dosage*;Antioxidants/adverse effects;Biomarkers;Cardiovascular Diseases/mortality;Cardiovascular Diseases/prevention & control;Cohort Studies;Dietary Supplements;Feeding Behavior;Food-Drug Interactions;Fruit*;Humans;Lung Neoplasms/mortality;Lung Neoplasms/prevention & control;Oxidative Stress;Randomized Controlled Trials as Topic;Smoking*/adverse effects;Smoking*/metabolism;Vegetables*;Vitamin A/administration & dosage;Vitamin A/adverse effects;beta Carotene/administration & dosage*;beta Carotene/adverse effects;beta Carotene/pharmacokinetics
12406936;Beverages;Biological Availability;Cardiovascular Agents/pharmacokinetics*;Citrus paradisi*;Food-Drug Interactions*;Humans
12395977;Adolescent;Adult;Aged;Area Under Curve;Beverages;Citrus paradisi*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Male;Middle Aged;Time Factors;Water/administration & dosage
12389876;Antineoplastic Agents/economics;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Benzamides;Clinical Trials as Topic;Drug Interactions;Drug Resistance, Neoplasm;Food-Drug Interactions;Gastrointestinal Neoplasms/drug therapy;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Patient Education as Topic;Piperazines/economics;Piperazines/pharmacology;Piperazines/therapeutic use*;Pyrimidines/economics;Pyrimidines/pharmacology;Pyrimidines/therapeutic use*;Sarcoma/drug therapy;Stromal Cells
12389073;Administration, Oral;Adult;Aged;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carcinoma, Small Cell/drug therapy;Chromatography, High Pressure Liquid;Citrus paradisi/adverse effects*;Cross-Over Studies;Etoposide/administration & dosage;Etoposide/adverse effects;Etoposide/blood;Etoposide/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Infusions, Intravenous;Lung Neoplasms/drug therapy;Male;Middle Aged;Pilot Projects
12387000;Diabetes Mellitus, Type 2/diet therapy*;Dietary Fiber/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Diglycerides/analysis;Food, Organic*/adverse effects;Food, Organic*/analysis;Food-Drug Interactions;Glycoside Hydrolase Inhibitors;Humans;Hypercholesterolemia/diet therapy;Hyperglycemia/diet therapy;Hypertension/drug therapy
12386129;Administration, Oral;Animals;Antinematodal Agents/pharmacokinetics*;Area Under Curve;Benzimidazoles/pharmacokinetics;Biotransformation;Drug Synergism;Feces/chemistry;Fenbendazole/pharmacokinetics*;Food-Drug Interactions;Horses/metabolism*;Injections, Intravenous;Intestinal Absorption;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Pesticide Synergists/pharmacology;Piperonyl Butoxide/pharmacology;Stereoisomerism;Sulfates/metabolism;Sulfides/metabolism;Sulfoxides/metabolism
12371493;Animals;Food*;Food-Drug Interactions*;Geologic Sediments/chemistry*;Insecta/growth & development*;Species Specificity;Water Pollutants, Chemical/toxicity*
12371301;Anticholesteremic Agents/pharmacokinetics*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 Enzyme System/metabolism;Drug Synergism*;Food-Drug Interactions*;Humans;Simvastatin/pharmacokinetics*
12369444;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Aging/metabolism;Anti-Ulcer Agents/pharmacokinetics*;Benzimidazoles/pharmacokinetics*;Biological Availability;Child;Clinical Trials as Topic;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Omeprazole/analogs & derivatives;Rabeprazole
12363433;Animal Feed*;Animals;Biological Availability;Digestive System Physiological Phenomena*;Food-Drug Interactions*;Gastrointestinal Transit;Humans;Intestinal Absorption;Solubility;Species Specificity;Veterinary Drugs/administration & dosage;Veterinary Drugs/chemistry;Veterinary Drugs/pharmacokinetics*
12362932;Adult;Beverages;Chromatography, High Pressure Liquid;Citrus*;Citrus paradisi;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions*;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/blood*;Indinavir/pharmacokinetics*;Male
12362927;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Ivermectin/administration & dosage;Ivermectin/adverse effects;Ivermectin/pharmacokinetics*;Male;Middle Aged;Mydriasis/chemically induced;Pupil/drug effects
12362923;Adolescent;Adult;Aged;Butyrophenones/blood;Butyrophenones/pharmacokinetics;Butyrophenones/pharmacology;Butyrophenones/therapeutic use*;Child;Double-Blind Method;Female;Food-Drug Interactions*;Histamine H1 Antagonists/pharmacokinetics;Histamine H1 Antagonists/pharmacology;Histamine H1 Antagonists/therapeutic use*;Humans;Male;Middle Aged;Piperidines/blood;Piperidines/pharmacokinetics;Piperidines/pharmacology;Piperidines/therapeutic use*;Rhinitis, Allergic, Seasonal/blood;Rhinitis, Allergic, Seasonal/drug therapy*;Severity of Illness Index;Treatment Outcome
12235449;Adult;Aryl Hydrocarbon Hydroxylases*;Chlorzoxazone/pharmacokinetics;Cytochrome P-450 CYP2E1/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Europe;European Continental Ancestry Group*/genetics;Female;Food-Drug Interactions/physiology;Humans;Los Angeles;Male;Mexican Americans*/genetics;Midazolam/pharmacokinetics;Middle Aged;Oxidoreductases, N-Demethylating/metabolism*;Statistics, Nonparametric
12207630;Adult;Aged;Biological Availability;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/metabolism*;Hypnotics and Sedatives/pharmacokinetics;Intestines/metabolism;Liver Cirrhosis/enzymology;Male;Midazolam/analogs & derivatives*;Midazolam/blood;Midazolam/metabolism*;Midazolam/pharmacokinetics;Middle Aged
12187774;Biomarkers/urine;Child;Copper/urine*;Drug Administration Schedule;Food-Drug Interactions*;Hepatolenticular Degeneration/drug therapy*;Hepatolenticular Degeneration/genetics;Hepatolenticular Degeneration/urine;Humans;Male;Nuclear Family;Penicillamine/administration & dosage*
12171043;Anti-HIV Agents/adverse effects;Anti-HIV Agents/therapeutic use*;Food-Drug Interactions*;HIV Infections/drug therapy*;Humans
12171042;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;HIV Infections/drug therapy*;Humans
12165187;Adverse Drug Reaction Reporting Systems;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions*;Food-Drug Interactions;Humans;Iatrogenic Disease*;Internet;Interprofessional Relations;Plant Preparations/adverse effects*
12162471;Adolescent;Adult;Area Under Curve;Capsules/administration & dosage;Capsules/pharmacokinetics;Carbamates;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/physiology;Food-Drug Interactions;Health;Humans;Male;Middle Aged;Organophosphates/administration & dosage;Organophosphates/adverse effects;Organophosphates/blood;Organophosphates/pharmacokinetics*;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Suspensions/administration & dosage;Suspensions/pharmacokinetics;Tablets/administration & dosage;Tablets/pharmacokinetics
12161974;Citrus*;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics*
12154747;Alcohol Drinking;Anti-HIV Agents/therapeutic use*;Diet;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/psychology;Humans;Patient Compliance*
12139218;Adult;Albendazole/administration & dosage;Albendazole/pharmacokinetics*;Anthelmintics/administration & dosage;Anthelmintics/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Cimetidine/administration & dosage*;Citrus*;Drug Interactions;Food-Drug Interactions*;Histamine H2 Antagonists/administration & dosage*;Humans;Male
12136744;Adult;Area Under Curve;Capsules;Chemistry, Pharmaceutical;Dietary Fats/pharmacokinetics*;Food-Drug Interactions*;Humans;Male;Middle Aged;Saquinavir/blood*;Saquinavir/pharmacokinetics;Statistics, Nonparametric
12115838;Administration, Oral;Animals;Anti-HIV Agents/pharmacology*;Biological Availability;Chemistry, Pharmaceutical;Dogs;Female;Food-Drug Interactions*;Models, Animal;Particle Size;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolinones;Solubility;Tablets/chemistry;Water/chemistry
12115809;Administration, Oral;Animals;Antimalarials/administration & dosage;Antimalarials/chemistry;Antimalarials/pharmacokinetics*;Area Under Curve;Biological Availability;Blood Proteins/metabolism;Cholesterol/blood;Chromatography, High Pressure Liquid;Dietary Fats/pharmacology;Food-Drug Interactions*;Hyperlipidemias/metabolism;Injections, Intravenous;Lipid Metabolism;Lipids/blood*;Lipoproteins/blood*;Male;Peanut Oil;Phenanthrenes/administration & dosage;Phenanthrenes/chemistry;Phenanthrenes/pharmacokinetics*;Plant Oils/pharmacology;Poloxamer/pharmacology;Protein Binding;Rats;Rats, Sprague-Dawley;Stereoisomerism;Triglycerides/blood
12098841;Acetaminophen/administration & dosage*;Acetaminophen/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Analgesics, Non-Narcotic/administration & dosage*;Analgesics, Non-Narcotic/pharmacokinetics*;Analysis of Variance;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Excipients*;Fasting;Food-Drug Interactions;Humans;Male;Middle Aged;Sodium Bicarbonate*;Solubility;Tablets;Therapeutic Equivalency
12095536;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adolescent;Adult;Antitussive Agents/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases*;Beverages/adverse effects*;Biological Availability;Biotransformation;Citrus*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dealkylation;Dextromethorphan/pharmacokinetics*;Digestive System/enzymology;Digestive System/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Membrane Proteins/metabolism;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Oxidoreductases, N-Demethylating/metabolism;Phenotype;Reproducibility of Results
12093316;Anti-Infective Agents/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Antihypertensive Agents/pharmacokinetics;Antineoplastic Agents/pharmacokinetics;Biological Availability;Dietary Fats;Dietary Fiber;Food-Drug Interactions*;Humans;Practice Guidelines as Topic
12085854;Aged;Beverages/adverse effects;Citrus;Drug Interactions*;Female;Food-Drug Interactions;Humans;Polypharmacy*
12064015;Adenine/administration & dosage;Adenine/adverse effects;Adenine/analogs & derivatives;Adenine/pharmacokinetics;Adenine/therapeutic use*;Drug Interactions;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/nursing;Humans;Organophosphonates*;Organophosphorus Compounds/administration & dosage;Organophosphorus Compounds/adverse effects;Organophosphorus Compounds/pharmacokinetics;Organophosphorus Compounds/therapeutic use*;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*;Tenofovir
12055962;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/pharmacology;Anti-HIV Agents/therapeutic use*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Food-Drug Interactions;HIV Infections/drug therapy*;Humans
12053901;Animals;Diet*;Disease Models, Animal;Food-Drug Interactions;Hepatitis/complications;Hepatitis/diet therapy*;Hyperlipidemias/complications;Hyperlipidemias/diet therapy*;Obesity/complications;Obesity/diet therapy*;Rats;Rats, Sprague-Dawley;Ursodeoxycholic Acid/pharmacology*
12051573;Administration, Oral;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects*;Antiparasitic Agents/pharmacokinetics*;Area Under Curve;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Thiazoles/administration & dosage;Thiazoles/adverse effects*;Thiazoles/blood;Thiazoles/pharmacokinetics*
12047482;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacokinetics*;Fasting;Food-Drug Interactions*;Gas Chromatography-Mass Spectrometry;Humans;Male;Nifedipine/blood;Nifedipine/pharmacokinetics*;Osmosis;Solubility;Therapeutic Equivalency
12040751;Adult;Calcium Channel Blockers/pharmacokinetics*;Citrus*/chemistry;Flavanones*;Flavonoids/analysis;Food-Drug Interactions*;Humans;Male;Nifedipine/pharmacokinetics*;Nisoldipine/pharmacokinetics*
12037939;Biological Availability;Food-Drug Interactions*;Humans;Pharmacokinetics
12017348;Administration, Oral;Aged;Area Under Curve;Dietary Fats/administration & dosage;Dietary Fats/pharmacology;Dose-Response Relationship, Drug;Fasting;Feces/chemistry;Food-Drug Interactions;Health;Heterocyclic Compounds, 3-Ring/administration & dosage*;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Heterocyclic Compounds, 3-Ring/urine;Humans;Male;Middle Aged;Pyrimidinones/administration & dosage*;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Pyrimidinones/urine
12015791;Animals;Aryl Hydrocarbon Hydroxylases*;Beverages;Biological Availability;Citrus;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Delayed-Action Preparations/pharmacokinetics;Diet;Drug Evaluation, Preclinical/methods*;Food*;Food-Drug Interactions;Humans;Oxidoreductases, N-Demethylating/antagonists & inhibitors;Oxidoreductases, N-Demethylating/metabolism;Pharmacokinetics*
12015789;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Fasting/blood;Food-Drug Interactions;Gliclazide/administration & dosage;Gliclazide/blood;Gliclazide/pharmacokinetics*;Half-Life;Humans;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Infusions, Intravenous;Tablets
12014354;Aged;Aged, 80 and over;Anacardiaceae*/adverse effects;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Disorders/chemically induced;Food-Drug Interactions*;Fruit/adverse effects;Humans;International Normalized Ratio/adverse effects;Male;Middle Aged;Warfarin/adverse effects;Warfarin/therapeutic use*
12009003;Adolescent;Adult;Anticonvulsants/adverse effects*;Anticonvulsants/therapeutic use;Biotin/blood;Calcium/blood;Carnitine/blood;Carnitine/deficiency;Dietetics;Edema/chemically induced;Folic Acid/blood;Food-Drug Interactions*;Humans;Middle Aged;Seizures/drug therapy*;Serum Albumin/analysis;Serum Albumin/drug effects*;Valproic Acid/adverse effects*;Valproic Acid/therapeutic use;Weight Gain/drug effects
12004838;Anticholesteremic Agents/pharmacology;Beverages/adverse effects*;Calcium Channel Blockers/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans
12001345;Animals;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics;Anticonvulsants/therapeutic use*;Bromides/adverse effects;Bromides/pharmacokinetics;Bromides/therapeutic use*;Dog Diseases/drug therapy*;Dogs;Dose-Response Relationship, Drug;Drug Monitoring/veterinary;Epilepsy/drug therapy;Epilepsy/veterinary*;Food-Drug Interactions;Phenobarbital/adverse effects;Phenobarbital/pharmacokinetics;Phenobarbital/therapeutic use*;Potassium Compounds/adverse effects;Potassium Compounds/pharmacokinetics;Potassium Compounds/therapeutic use*
11998345;Administration, Oral;Drug Administration Schedule;Food-Drug Interactions*;Guidelines as Topic;Humans;Pharmaceutical Preparations/administration & dosage*
11996327;Adolescent;Adrenergic alpha-1 Receptor Antagonists;Adrenergic alpha-Antagonists/blood;Adrenergic alpha-Antagonists/pharmacokinetics*;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Fasting/metabolism*;Food*;Food-Drug Interactions*;Heterocyclic Compounds, 3-Ring/blood;Heterocyclic Compounds, 3-Ring/pharmacokinetics*;Humans;Male;Middle Aged;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*
11991343;African Continental Ancestry Group;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Male;Middle Aged;Nifedipine/pharmacokinetics*
11981235;Activities of Daily Living*;Adult;Aged;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Drug Evaluation/methods;Drug Evaluation/statistics & numerical data;Drug Therapy, Combination;Female;Food-Drug Interactions/physiology;Humans;Levodopa/blood;Levodopa/pharmacokinetics*;Male;Middle Aged;Motor Skills/drug effects;Motor Skills/physiology*;Parkinson Disease/blood*;Parkinson Disease/metabolism;Parkinson Disease/physiopathology
11976834;Aged;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dihydrouracil Dehydrogenase (NADP);Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Enzyme Inhibitors/pharmacology*;Female;Fluorouracil/pharmacokinetics*;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption;Male;Middle Aged;Models, Biological;Oxidoreductases/antagonists & inhibitors;Population;Therapeutic Equivalency;Uracil/analogs & derivatives*;Uracil/pharmacology*
11971644;Ammonia/toxicity*;Animals;Chlorella/drug effects*;Chlorella/growth & development;Daphnia/drug effects*;Daphnia/growth & development;Dose-Response Relationship, Drug;Food Deprivation;Food-Drug Interactions;Lethal Dose 50;Population Growth;Water Pollutants/toxicity*
11971236;Dietary Supplements/adverse effects*;Food-Drug Interactions;Germany;Humans;Kava/adverse effects*;Liver Diseases/etiology*;United States;United States Food and Drug Administration
11966676;Amlodipine/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Citrus*;Food-Drug Interactions*;Humans
11962300;Chemical Precipitation;Enteral Nutrition/adverse effects;Enteral Nutrition/instrumentation;Enteral Nutrition/methods;Enteral Nutrition/nursing*;Equipment Failure;Evidence-Based Medicine;Food-Drug Interactions;Humans;Intubation, Gastrointestinal/adverse effects;Intubation, Gastrointestinal/instrumentation;Intubation, Gastrointestinal/methods;Intubation, Gastrointestinal/nursing*;Maintenance;Nursing Evaluation Research;Therapeutic Irrigation/instrumentation;Therapeutic Irrigation/methods;Therapeutic Irrigation/nursing*
11959616;Adult;Anthelmintics/administration & dosage*;Anthelmintics/pharmacokinetics;Beverages*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Praziquantel/administration & dosage*;Praziquantel/pharmacokinetics
11959608;Administration, Oral;Adult;Beverages*;Carbamates;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/pharmacokinetics;Humans;Male;Sulfonamides/administration & dosage*;Sulfonamides/pharmacokinetics*
11959071;Acute Disease;Adult;Antidepressive Agents/adverse effects*;Cheese*;Delirium/blood;Delirium/chemically induced*;Delirium/therapy;Food-Drug Interactions;Humans;Hypericum/adverse effects*;Hypertension/blood;Hypertension/chemically induced*;Hypertension/therapy;Male;Monoamine Oxidase Inhibitors/adverse effects*
11957745;Animals;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl CoA Reductases/adverse effects;Hydroxymethylglutaryl CoA Reductases/pharmacokinetics*
11956673;Adult;Beverages*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/urine;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavanones*;Flavonoids/blood;Flavonoids/pharmacokinetics;Flavonoids/urine;Food-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Mixed Function Oxygenases/metabolism;Smoking/blood*;Stereoisomerism;Verapamil/adverse effects;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/urine
11953660;Biological Availability;Enteral Nutrition;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Pharmacokinetics;Treatment Outcome
11953654;Aging/physiology*;Antioxidants/therapeutic use;Chronic Disease/therapy*;Food-Drug Interactions;Humans;Kidney Failure, Chronic/complications;Kidney Failure, Chronic/therapy;Nutrition Disorders/etiology;Nutrition Disorders/therapy*;Nutritional Requirements;Nutritional Support/methods*;Parenteral Nutrition;Quality of Life;Treatment Outcome
11936572;Adult;Analysis of Variance;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics;Area Under Curve;Beverages*;Calcium/pharmacokinetics*;Ciprofloxacin/blood*;Ciprofloxacin/pharmacokinetics;Citrus/metabolism*;Cross-Over Studies;Female;Food, Fortified*/adverse effects;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Statistics, Nonparametric;Therapeutic Equivalency
11936569;Female;Food, Fortified*/adverse effects;Food, Fortified*/statistics & numerical data;Food-Drug Interactions/physiology*;Humans;Male;United States;United States Food and Drug Administration/legislation & jurisprudence*
11936567;Administration, Oral;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Didanosine/administration & dosage;Didanosine/adverse effects;Didanosine/blood*;Dietary Fats/blood;Fasting/blood;Female;Food-Drug Interactions/physiology*;Humans;Male;Microspheres;Tablets, Enteric-Coated
11927211;Aged;Aged, 80 and over;Alcohol Drinking;Anticoagulants/pharmacokinetics*;Body Mass Index;Case-Control Studies;Coumarins/pharmacokinetics*;Feeding Behavior*;Female;Food-Drug Interactions;Humans;International Normalized Ratio;Life Style*;Male;Middle Aged;Risk Factors
11923060;Adult;Analysis of Variance;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Chemistry, Pharmaceutical;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/metabolism*;Dosage Forms;Drug Industry;European Union;Fasting/blood*;Food-Drug Interactions/physiology*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/blood*
11920750;Animals;Antimalarials/blood;Antimalarials/chemistry*;Antimalarials/pharmacokinetics*;Area Under Curve;Chemical Phenomena;Chemistry, Physical;Chromatography, High Pressure Liquid;Dogs;Food-Drug Interactions;Intestinal Absorption/physiology*;Lymph/chemistry;Lymphatic System/metabolism*;Male;Models, Molecular;Phenanthrenes/blood;Phenanthrenes/chemistry*;Phenanthrenes/pharmacokinetics*;Postprandial Period/physiology*;Solubility;Spectrophotometry, Ultraviolet;Spectroscopy, Fourier Transform Infrared
11920745;Administration, Oral;Animals;Area Under Curve;Dogs;Food-Drug Interactions/physiology*;Infusions, Intravenous;Liver/metabolism;Mass Spectrometry;Mineralocorticoid Receptor Antagonists/administration & dosage*;Mineralocorticoid Receptor Antagonists/pharmacokinetics*;Portal Vein;Spironolactone/administration & dosage*;Spironolactone/analogs & derivatives*;Spironolactone/pharmacokinetics*;Spironolactone/pharmacology
11920267;Administration, Oral;Adult;Aged;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/pharmacokinetics*;Antimetabolites, Antineoplastic/toxicity;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy;Lymphoma, Non-Hodgkin/drug therapy;Male;Middle Aged;Prospective Studies;Treatment Outcome;Vidarabine Phosphate/administration & dosage;Vidarabine Phosphate/analogs & derivatives;Vidarabine Phosphate/pharmacokinetics*;Vidarabine Phosphate/toxicity
11906463;Administration, Oral;Adult;Animals;Chickens;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/blood;Food-Drug Interactions/physiology;Humans;Immunoenzyme Techniques;Male;Middle Aged;Muramidase/administration & dosage*;Muramidase/blood*;Rabbits
11904862;Aged;Cost-Benefit Analysis;Dietary Proteins/administration & dosage*;Dietary Proteins/analysis;Dietary Proteins/economics;Drug Therapy/nursing*;Energy Intake*;Food, Formulated*/analysis;Food, Formulated*/economics;Food-Drug Interactions;Humans;Medication Systems, Hospital;Nurse's Role;Nursing Assessment;Nutrition Assessment;Patient Care Team;Patient Selection;Pharmacists;Program Evaluation;Protein-Energy Malnutrition/complications;Protein-Energy Malnutrition/diagnosis;Protein-Energy Malnutrition/economics;Protein-Energy Malnutrition/therapy*;Skilled Nursing Facilities
11899948;Administration, Oral;Area Under Curve;Biological Availability;Estrogen Receptor Modulators/administration & dosage;Estrogen Receptor Modulators/blood;Estrogen Receptor Modulators/pharmacokinetics*;Fasting;Female;Food-Drug Interactions;Humans;Middle Aged;Norpregnenes/administration & dosage;Norpregnenes/metabolism;Norpregnenes/pharmacokinetics*;Postmenopause/blood;Postmenopause/metabolism
11897422;Administration, Oral;Adult;Bronchodilator Agents/blood;Cross-Over Studies;Digestive System/diagnostic imaging*;Digestive System/metabolism;Food-Drug Interactions/physiology;Gastrointestinal Transit/physiology*;Humans;Linear Models;Male;Monitoring, Physiologic/instrumentation;Monitoring, Physiologic/methods*;Predictive Value of Tests;Radionuclide Imaging;Theophylline/administration & dosage*;Theophylline/blood*;Time Factors
11886184;Aniline Compounds/toxicity*;Animals;Carbamates/toxicity*;Chlorpyrifos/toxicity*;Daphnia/drug effects*;Food Deprivation*;Food-Drug Interactions;Insecticides/toxicity*;No-Observed-Adverse-Effect Level;Phenylcarbamates*;Reproduction/drug effects
11865964;Adult;Analysis of Variance;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacokinetics;Eating/physiology*;Endothelin Receptor Antagonists*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Receptors, Endothelin/physiology;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
11865159;Anticonvulsants/pharmacokinetics;Capsules;Delayed-Action Preparations/pharmacokinetics;Food-Drug Interactions*;Humans;Phenytoin/pharmacokinetics*
11860217;Administration, Oral;Animals;Beverages*;Biological Availability;Citrus*/enzymology;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Food-Drug Interactions*/immunology;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics;Male;Rats;Rats, Sprague-Dawley
11849912;Adult;Anti-Anxiety Agents/administration & dosage*;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/chemistry;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Bornanes/administration & dosage*;Bornanes/blood;Bornanes/chemistry;Bornanes/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Fasting/physiology;Food-Drug Interactions*;Gastric Juice/physiology;Humans;Hydrogen-Ion Concentration;Male;Solubility;Tablets, Enteric-Coated
11837383;Adult;Aged;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Isoquinolines/administration & dosage;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/pharmacology*;Kinetics;Male;Middle Aged;Peptidyl-Dipeptidase A/blood;Tetrahydroisoquinolines*
11831543;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions;Half-Life;Humans;Lovastatin/administration & dosage;Lovastatin/pharmacokinetics*;Male;Single-Blind Method
11823754;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Calibration;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions/physiology*;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Purines;Quality Control;Sildenafil Citrate;Sulfones
11823753;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carrier Proteins/metabolism;Citrus;Double-Blind Method;Female;Flavonoids/metabolism;Food-Drug Interactions/physiology*;Fruit*;HeLa Cells;Histamine H1 Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Malus;Membrane Transport Proteins*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Dependent;Symporters;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
11816871;Adult;Beverages/adverse effects*;Citrus*;Clozapine/adverse effects;Clozapine/analogs & derivatives*;Clozapine/pharmacokinetics*;Clozapine/therapeutic use;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Psychiatric Status Rating Scales;Schizophrenia/blood*;Schizophrenia/drug therapy
11810949;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements*;Food-Drug Interactions*;Garlic*;HIV Infections/drug therapy*;HIV Infections/enzymology;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics;Humans;Saquinavir/blood*;Saquinavir/pharmacokinetics
11796879;Aged;Antihypertensive Agents/adverse effects;Benzopyrans/adverse effects;Beverages;Citrus/adverse effects;Coffee/adverse effects;Diabetes Mellitus, Type 2/complications*;Diabetic Nephropathies/complications*;Ethanolamines/adverse effects;Food-Drug Interactions;Humans;Hyperkalemia/etiology*;Hyperkalemia/therapy;Male;Nebivolol
11794001;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Analysis of Variance;Area Under Curve;Double-Blind Method;Food-Drug Interactions*;Humans;Hydromorphone/administration & dosage*;Hydromorphone/blood;Hydromorphone/pharmacokinetics*;Male;Middle Aged
11791889;Adult;Antifungal Agents/pharmacology;Antipsychotic Agents/blood*;Antipsychotic Agents/therapeutic use;Beverages*;Citrus*;Clozapine/blood*;Clozapine/therapeutic use;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Enzyme Inhibitors/pharmacology;Food-Drug Interactions;Humans;Ketoconazole/pharmacology;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Mixed Function Oxygenases/physiology;Schizophrenia/blood*;Schizophrenia/drug therapy
11782897;Binding Sites;Carbonates/chemistry;Carbonates/metabolism*;Dose-Response Relationship, Drug;Food;Food-Drug Interactions/physiology;Iron Compounds/chemistry;Iron Compounds/metabolism*;Magnesium Compounds/chemistry;Magnesium Compounds/metabolism*;Metals/chemistry;Metals/metabolism;Phosphates/metabolism*
11777752;Adult;Analysis of Variance;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/metabolism;Drug Administration Schedule;Fasting/blood*;Food-Drug Interactions/physiology*;Humans;Isosorbide Dinitrate/administration & dosage;Isosorbide Dinitrate/analogs & derivatives;Isosorbide Dinitrate/blood;Isosorbide Dinitrate/pharmacokinetics*;Male;Middle Aged;Tablets;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics
11768859;Clinical Trials as Topic;Dose-Response Relationship, Drug;Drug Therapy, Combination;Female;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/therapeutic use;Humans;Indinavir/administration & dosage*;Indinavir/therapeutic use;Male;Ritonavir/administration & dosage*;Ritonavir/therapeutic use;United States
11766777;Anti-Bacterial Agents/analysis;Anti-Bacterial Agents/therapeutic use;Anticonvulsants/analysis*;Anticonvulsants/therapeutic use;Capsules;Carbohydrates/analysis*;Cathartics/analysis;Cathartics/therapeutic use;Chemistry, Pharmaceutical;Child;Drug Therapy, Combination;Energy Intake*;Epilepsy/complications;Epilepsy/diet therapy*;Epilepsy/drug therapy*;Food-Drug Interactions;Humans;Ketosis/etiology*;Tablets
11763808;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Diet;Female;Food-Drug Interactions*;Hemostatics/administration & dosage;Hemostatics/adverse effects*;Hemostatics/therapeutic use;Humans;International Normalized Ratio;Seaweed/chemistry*;Vitamin K/administration & dosage;Vitamin K/adverse effects*;Vitamin K/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects*;Warfarin/therapeutic use
11762562;Adult;Breath Tests;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Energy Intake;Ethanol/blood;Ethanol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
11757132;Adolescent;Anti-Infective Agents/adverse effects*;Caffeine/adverse effects*;Enoxacin/adverse effects*;Female;Food-Drug Interactions*;Humans;Psychoses, Substance-Induced/etiology*;Urinary Tract Infections/drug therapy*
11745911;Acetamides/administration & dosage;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacokinetics;Fasting/physiology;Female;Food-Drug Interactions/physiology*;Humans;Injections, Intravenous;Linezolid;Male;Middle Aged;Oxazolidinones/administration & dosage;Oxazolidinones/blood;Oxazolidinones/pharmacokinetics*
11724078;Adult;Aminosalicylic Acid/administration & dosage*;Aminosalicylic Acid/adverse effects;Aminosalicylic Acid/pharmacokinetics*;Antacids/pharmacology;Antitubercular Agents/administration & dosage*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Cross-Over Studies;Dietary Fats/pharmacology;Double-Blind Method;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions;Half-Life;Humans;Male;Powders;Therapeutic Equivalency
11723297;Adolescent;Adult;Cimetidine/administration & dosage;Cimetidine/adverse effects;Dietary Carbohydrates/administration & dosage;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Synergism;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Neurocysticercosis/diagnosis;Neurocysticercosis/drug therapy*;Praziquantel/administration & dosage*;Praziquantel/adverse effects
11722289;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Biological Availability;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions;Drug Resistance, Multiple;Food-Drug Interactions;Humans;Intestinal Absorption;Pharmaceutical Preparations/metabolism*;Protein Binding;Xenobiotics/metabolism*
11718495;Administration, Oral;Adult;Aminosalicylic Acid/pharmacology;Antacids/pharmacology*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Clofazimine/pharmacology;Cross-Over Studies;Cycloserine/administration & dosage;Cycloserine/adverse effects;Cycloserine/pharmacokinetics*;Dietary Fats/pharmacology*;Drug Interactions;Electrophoresis, Capillary;Ethionamide/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male
11711263;Administration, Oral;Adult;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacokinetics;Cefmenoxime/administration & dosage;Cefmenoxime/analogs & derivatives*;Cefmenoxime/pharmacokinetics;Ceftizoxime/administration & dosage;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics*;Cross-Over Studies;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Milk/metabolism*;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics*;Time Factors;Urine/chemistry;Water/administration & dosage;Water/metabolism*
11711262;Administration, Oral;Adult;Age Factors*;Aged;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/pharmacokinetics;Ceftizoxime/administration & dosage*;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics*;Diet*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Prodrugs/administration & dosage*;Prodrugs/pharmacokinetics*;Urine/chemistry
11694644;Complementary Therapies/adverse effects;Complementary Therapies/standards*;Dietary Supplements/standards;Drug Interactions;Food-Drug Interactions;Humans;Neoplasms/therapy*;Phytotherapy;Plants, Medicinal/adverse effects;Quality Control;Research/organization & administration*;Research/trends;Research Support as Topic/trends;Treatment Outcome
11693087;Adjuvants, Immunologic/therapeutic use;Anti-HIV Agents*/administration & dosage;Anti-HIV Agents*/adverse effects;Anti-HIV Agents*/classification;Anti-HIV Agents*/therapeutic use;Developing Countries;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;HIV Infections*/complications;HIV Infections*/drug therapy;Hepatitis B/complications;Hepatitis C/complications;Humans;Patient Advocacy
11692301;Aged;Aging/immunology*;Appetite Stimulants/therapeutic use;Dietary Supplements;Food-Drug Interactions;Humans;Infection/diet therapy*;Infection/etiology;Infection/immunology*;Nutrition Disorders/complications;Nutrition Disorders/diagnosis;Nutrition Disorders/epidemiology;Randomized Controlled Trials as Topic;Risk Factors
11684410;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/pharmacokinetics;Adult;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Analysis of Variance;Area Under Curve;Caffeine/administration & dosage;Caffeine/blood;Caffeine/pharmacokinetics;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/pharmacokinetics;Cross-Over Studies;Drug Implants/administration & dosage;Drug Implants/pharmacokinetics;Fasting/blood;Female;Food-Drug Interactions/physiology;Gastric Emptying/physiology*;Humans;Male;Reproducibility of Results;Tablets, Enteric-Coated/administration & dosage;Tablets, Enteric-Coated/pharmacokinetics*
11681271;Area Under Curve;Drug Interactions;Food-Drug Interactions;Humans;Pharmacokinetics*
11673746;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Digoxin/pharmacokinetics*;Food-Drug Interactions*;Genotype;Humans;Polymorphism, Genetic
11605310;Acetaminophen/administration & dosage;Acetaminophen/adverse effects*;Acetaminophen/blood;Adult;Aged;Alanine Transaminase/metabolism;Alcoholism/complications*;Alcoholism/metabolism;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/blood;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury*;Cytochrome P-450 CYP2E1/metabolism;Diagnosis, Differential;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Liver/drug effects*;Liver/enzymology;Liver/metabolism*;Liver Diseases/blood;Liver Diseases/enzymology;Liver Function Tests;Treatment Outcome
11603643;Cardiovascular Diseases/therapy;Chronic Disease/therapy*;Dietary Supplements;Evidence-Based Medicine;Food, Organic*/adverse effects;Food, Organic*/standards;Food-Drug Interactions*;Humans;Safety;Treatment Outcome
11595840;Blood Glucose/metabolism;False Negative Reactions;Fluorodeoxyglucose F18*/metabolism;Food-Drug Interactions*;Humans;Lung Neoplasms/diagnostic imaging*;Lung Neoplasms/metabolism;Male;Middle Aged;Radiopharmaceuticals*/metabolism;Solitary Pulmonary Nodule/diagnostic imaging*;Solitary Pulmonary Nodule/metabolism;Tomography, Emission-Computed*
11587491;Adolescent;Adult;Area Under Curve;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacokinetics*;Chromatography, Gas;Cross-Over Studies;Delayed-Action Preparations;Electrochemistry;Female;Food-Drug Interactions*;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/pharmacokinetics*;Middle Aged;Stereoisomerism
11576693;Animals;Drug Carriers;Food-Drug Interactions*;Humans;Intestinal Absorption/physiology*;Intestines/metabolism*;Pharmaceutical Preparations/metabolism*;Rats
11572503;Administration, Oral;Beverages/adverse effects*;Biological Availability;Child;Citrus/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Flavoring Agents/administration & dosage;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/adverse effects*;Hypnotics and Sedatives/pharmacokinetics;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/enzymology;Liver/enzymology;Midazolam/administration & dosage;Midazolam/adverse effects*;Midazolam/pharmacokinetics;Mixed Function Oxygenases/antagonists & inhibitors;Taste/drug effects
11570093;Beverages;Citrus*;Drug Therapy, Combination;Food-Drug Interactions*;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Humans;Ritonavir/administration & dosage;Ritonavir/pharmacokinetics*;Ritonavir/therapeutic use;Saquinavir/administration & dosage;Saquinavir/pharmacokinetics*;Saquinavir/therapeutic use
11570085;Anti-HIV Agents/blood*;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use;Female;Food-Drug Interactions*;Garlic*;HIV Infections/blood*;HIV Infections/drug therapy;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use;Humans;Male;Plants, Medicinal*;Saquinavir/blood*;Saquinavir/pharmacokinetics;Saquinavir/therapeutic use
11563410;Administration, Oral;Adult;Analysis of Variance;Biological Availability;Blood Glucose/metabolism;Cross-Over Studies;Cyclohexanes/blood;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology*;Cyclohexanes/urine;Dietary Fats/pharmacokinetics*;Fasting/physiology;Food-Drug Interactions*;Humans;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology*;Hypoglycemic Agents/urine;Insulin/blood;Male;Phenylalanine/analogs & derivatives;Phenylalanine/blood;Phenylalanine/pharmacokinetics*;Phenylalanine/pharmacology*;Phenylalanine/urine
11563408;Administration, Oral;Adult;Analysis of Variance;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacokinetics*;Confidence Intervals;Cross-Over Studies;Fasting/blood;Food-Drug Interactions*;Ganciclovir/administration & dosage;Ganciclovir/pharmacokinetics*;HIV Seropositivity/blood;HIV Seropositivity/metabolism*;Humans;Least-Squares Analysis;Male;Middle Aged
11552202;Adult;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Biological Availability;Dietary Proteins/adverse effects;Drug Evaluation;Drug Monitoring;Drug Resistance;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food, Formulated/analysis;Food-Drug Interactions*;Humans;Male;Warfarin/blood;Warfarin/pharmacology*
11549099;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Adolescent;Adult;Aged;Aged, 80 and over;Aging/metabolism;Area Under Curve;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/adverse effects;Bronchodilator Agents/pharmacokinetics*;Carboxylic Acids;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclohexanecarboxylic Acids;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Nitriles;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
11531805;Adolescent;Adult;Anaphylaxis/etiology*;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Brachyura;Decapoda (Crustacea);Exercise*;Food Hypersensitivity/etiology*;Food-Drug Interactions*;Humans;Male;Middle Aged;Shellfish/adverse effects;Triticum/adverse effects
11525609;Antioxidants/administration & dosage;Antioxidants/adverse effects;Chemotherapy, Adjuvant;Dietary Supplements/adverse effects*;Food-Drug Interactions;Humans;Micronutrients/adverse effects*;Neoplasm Metastasis/drug therapy*;Neoplasms/drug therapy*;Neoplasms/pathology
11524779;Ethanol;Food-Drug Interactions/physiology*;Humans;Pharmacokinetics*
11524464;Adolescent;Adult;Aged;Analysis of Variance;Anticonvulsants/blood*;Anticonvulsants/pharmacokinetics;Area Under Curve;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption*/physiology;Male;Middle Aged;Phenytoin/blood*;Phenytoin/pharmacokinetics;Therapeutic Equivalency
11510376;Animal Feed;Animals;Anti-Bacterial Agents/administration & dosage*;Cat Diseases/diagnosis*;Cats;Drug Resistance, Microbial;Food-Drug Interactions;Hydrogen-Ion Concentration;Urinalysis;Urinary Tract Infections/diagnosis;Urinary Tract Infections/veterinary*
11509975;Animals;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/metabolism;Anti-Ulcer Agents/pharmacokinetics;Antioxidants/metabolism;Antioxidants/pharmacokinetics;Biological Availability;Carbohydrates/pharmacology*;Citrus/therapeutic use;Drugs, Chinese Herbal;Feces/chemistry;Flavanones*;Flavonoids/blood;Flavonoids/metabolism*;Flavonoids/pharmacokinetics;Food-Drug Interactions;Honey*;Phytotherapy;Rabbits;Sensitivity and Specificity
11509110;Anemia, Iron-Deficiency/prevention & control;Avitaminosis/prevention & control;Embryonic and Fetal Development;Female;Folic Acid Deficiency/prevention & control;Food-Drug Interactions;Humans;Infant, Low Birth Weight;Infant, Newborn;Iodine/deficiency;Magnesium Deficiency/prevention & control;Maternal Welfare*;Micronutrients*;Pregnancy;Pregnancy Complications/prevention & control*;Zinc/deficiency
11509108;Ascorbic Acid/metabolism;Biological Availability;Calcium/metabolism;Child;Child, Preschool;Copper/metabolism;Dietary Supplements*;Food, Fortified*;Food-Drug Interactions*;Humans;Infant;Intestinal Absorption;Iron/metabolism;Manganese/metabolism;Micronutrients/metabolism*;Zinc/metabolism
11488783;Area Under Curve;Beverages;Citrus*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacokinetics*;Flavonoids/metabolism;Food-Drug Interactions*;Furocoumarins/metabolism;Humans;Omeprazole/analogs & derivatives;Omeprazole/metabolism;Omeprazole/pharmacokinetics*
11478464;Diet/standards;Dietary Supplements;Food, Organic/adverse effects;Food, Organic/standards*;Food-Drug Interactions;Health Promotion;Humans;Preventive Medicine;Quality Control;Safety;Treatment Outcome
11476118;Beverages/adverse effects*;Citrus*;Food-Drug Interactions*;Humans;Public Health
11452240;Adult;Area Under Curve;Beverages*;Cisapride/analogs & derivatives*;Cisapride/blood;Cisapride/pharmacokinetics*;Cisapride/pharmacology;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Food-Drug Interactions;Gastrointestinal Agents/blood;Gastrointestinal Agents/pharmacokinetics*;Gastrointestinal Agents/pharmacology;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Reference Values;Wine*
11451032;Adult;Colloids;Dietary Fats/pharmacokinetics;Digestive System/metabolism*;Drug Carriers/pharmacokinetics*;Drug Monitoring/methods*;Female;Food-Drug Interactions/physiology;Humans;Liposomes/pharmacokinetics*;Magnetic Resonance Imaging/methods*;Male;Statistics, Nonparametric
11426073;Adult;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/therapeutic use;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Depression/complications;Depression/drug therapy*;Drug Interactions;Female;Fluoxetine/adverse effects;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions;HIV Infections/complications;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/therapeutic use
11422012;Administration, Oral;Adolescent;Area Under Curve;Child;Child, Preschool;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions/physiology*;Genetic Variation;Guanine Nucleotides/analysis*;Guanine Nucleotides/blood;Half-Life;Humans;Infant;Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy;Thioguanine/administration & dosage;Thioguanine/pharmacokinetics*;Thioguanine/therapeutic use;Time Factors
11417077;Animal Feed*;Animals;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dietary Proteins/administration & dosage;Dietary Proteins/adverse effects;Food-Drug Interactions*;Hydrogen-Ion Concentration;Intestinal Absorption;Minerals/administration & dosage;Minerals/adverse effects;Veterinary Drugs/pharmacokinetics*
11405898;Anti-Bacterial Agents/administration & dosage;Anti-Infective Agents, Local/therapeutic use;Bandages*;Burns/therapy;Food-Drug Interactions;Honey*;Humans;Length of Stay;Surgical Wound Infection/therapy;Wound Healing;Wounds and Injuries/therapy*
11405288;Animals;Area Under Curve;Calcium Channel Blockers/pharmacokinetics*;Citrus/chemistry*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions/physiology*;Furocoumarins/pharmacology;Male;Nifedipine/pharmacokinetics*;Rats;Rats, Wistar
11396348;Animals;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
11393692;Administration, Oral;Anti-Bacterial Agents/blood*;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid/methods;Clarithromycin/standards;Food-Drug Interactions;Humans;Mass Spectrometry;Minocycline/administration & dosage;Minocycline/blood*;Minocycline/pharmacokinetics*;Reference Standards;Tablets;Therapeutic Equivalency
11366377;AIDS-Related Opportunistic Infections/drug therapy*;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects*;Drug Interactions*;Drug Resistance, Microbial;Drug Therapy, Combination;Food-Drug Interactions;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/adverse effects*;Humans;Reverse Transcriptase Inhibitors/administration & dosage;Reverse Transcriptase Inhibitors/adverse effects*
11365556;Child;Child Nutritional Physiological Phenomena*;Child Welfare;Child, Preschool;Dietary Supplements;Eating;Energy Intake;Female;Fluid Therapy;Food Handling;Food-Drug Interactions;HIV Infections/complications*;HIV Infections/epidemiology;HIV Infections/therapy;Humans;Infant;Infant, Newborn;Male;Nutrition Disorders/complications*;Nutrition Disorders/diet therapy*;Nutritional Requirements*;United States/epidemiology
11361049;Adult;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Dietary Fats;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Half-Life;Headache/chemically induced;Humans;Least-Squares Analysis;Male;Metabolic Clearance Rate;Middle Aged;Quinoxalines/adverse effects;Quinoxalines/blood;Quinoxalines/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*
11345788;Food-Drug Interactions*;Humans;Nutritional Sciences/education*;United States
11341034;Animal Feed;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/therapeutic use*;Dietary Supplements;Food-Drug Interactions*;Injections, Intraperitoneal;Inulin/administration & dosage;Inulin/therapeutic use*;Liver Neoplasms, Experimental/diet therapy*;Liver Neoplasms, Experimental/drug therapy*;Male;Mice;Mice, Inbred Strains;Neoplasm Transplantation;Oligosaccharides/administration & dosage;Oligosaccharides/therapeutic use*;Treatment Outcome
11334062;Cyclosporine/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/adverse effects*;Intestinal Absorption/drug effects*;Nutritional Status/drug effects;Organ Transplantation*;Pharmacokinetics;Postoperative Complications;Treatment Outcome
11334060;Cardiovascular Diseases/etiology*;Cardiovascular Diseases/prevention & control;Diabetes Complications;Food-Drug Interactions;Humans;Hyperlipidemias/complications;Hypertension/complications;Immunosuppressive Agents/adverse effects*;Obesity/complications;Organ Transplantation/adverse effects*;Risk Factors;Weight Gain*
11332259;Adult;Antihypertensive Agents/adverse effects*;Diagnostic Errors*;Female;Food-Drug Interactions*;Glycyrrhiza/adverse effects*;Humans;Hydrochlorothiazide/adverse effects;Hypertension/chemically induced*;Hypertension/diagnosis;Hypertension/drug therapy;Hypokalemia/etiology;Medical History Taking;Muscle Cramp;Netherlands;Plants, Medicinal*;Tea/adverse effects*
11327750;Education, Continuing;Enteral Nutrition*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Pharmacokinetics;Risk Factors;Treatment Outcome
11324121;Dental Care*;Dietary Supplements*;Drug Interactions;Food-Drug Interactions;Humans;Plants, Medicinal*
11322025;Anticonvulsants/pharmacokinetics*;Carbamazepine/pharmacokinetics*;Citrus*;Food-Drug Interactions*;Humans;Male;Middle Aged
11304900;Adult;Anti-HIV Agents/therapeutic use*;Beverages*;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;Gastric Juice/metabolism*;Gastric Juice/secretion;HIV Infections/drug therapy;HIV Infections/metabolism*;Half-Life;Humans;Hydrogen-Ion Concentration;Indinavir/pharmacokinetics*;Indinavir/pharmacology;Male;Middle Aged;Models, Biological;Time Factors
11303053;Adult;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Celecoxib;Cross-Over Studies;Dietary Fats/pharmacology;Dogs;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/physiology*;Male;Pyrazoles;Sulfonamides/administration & dosage;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
11288420;Anticoagulants/pharmacokinetics;Critical Care*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Monoamine Oxidase Inhibitors/pharmacokinetics;Nutritional Support
11286323;Adult;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/pharmacokinetics*;Biological Availability;Cresols/administration & dosage;Cresols/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Phenylpropanolamine*;Tolterodine Tartrate;Urinary Bladder Diseases/metabolism*
11264638;Antifungal Agents/administration & dosage;Antifungal Agents/pharmacokinetics*;Aspergillosis/prevention & control;Carbonated Beverages*;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Drug Interactions;Food-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Itraconazole/administration & dosage;Itraconazole/pharmacokinetics*;Lung Diseases, Fungal/prevention & control;Lung Transplantation*;Opportunistic Infections/prevention & control;Retrospective Studies
11233298;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/therapeutic use;Carbamates;Clinical Trials as Topic;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Protease Inhibitors*/administration & dosage;HIV Protease Inhibitors*/pharmacology;Humans;Mixed Function Oxygenases/metabolism;Sulfonamides*/administration & dosage;Sulfonamides*/pharmacology
11231102;ATP-Binding Cassette, Sub-Family B, Member 1/pharmacokinetics*;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*;Biological Availability;Caco-2 Cells/metabolism;Citrus*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Male;Propanolamines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Stereoisomerism
11230998;Animals;Cyclooxygenase 1;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/pharmacology*;Eating/drug effects*;Eating/physiology;Female;Food-Drug Interactions*;Glutathione/drug effects;Glutathione/metabolism;Glutathione Peroxidase/drug effects;Glutathione Peroxidase/metabolism;Glutathione Reductase;Intestinal Mucosa/drug effects*;Intestinal Mucosa/metabolism;Intestinal Mucosa/pathology;Isoenzymes/antagonists & inhibitors;Male;Membrane Proteins;NADH, NADPH Oxidoreductases/drug effects;NADH, NADPH Oxidoreductases/metabolism;Oxidative Stress/drug effects*;Oxidative Stress/physiology;Piroxicam/pharmacology*;Prostaglandin-Endoperoxide Synthases;Rats;Rats, Wistar;Superoxide Dismutase/drug effects;Superoxide Dismutase/metabolism;Thiazines/pharmacology*;Thiazoles/pharmacology*;Ulcer/chemically induced*
11223799;Aged;Aged, 80 and over;Algorithms;Coronary Disease/epidemiology;Coronary Disease/nursing*;Coronary Disease/therapy;Female;Food-Drug Interactions;Humans;Hyperlipidemias/prevention & control;Male;Middle Aged;Nutrition Assessment*;Patient Education as Topic;United States/epidemiology
11216183;Anti-Ulcer Agents/adverse effects*;Anti-Ulcer Agents/pharmacokinetics;Arrhythmias, Cardiac/chemically induced*;Aryl Hydrocarbon Hydroxylases*;Beverages;Cisapride/adverse effects*;Cisapride/pharmacokinetics;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Oxidoreductases, N-Demethylating/drug effects;Oxidoreductases, N-Demethylating/metabolism
11214778;Adult;Area Under Curve;Beverages*;Biotransformation;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Stereoisomerism;Verapamil/pharmacokinetics*;Verapamil/pharmacology
11210400;Adolescent;Adult;Chemistry, Pharmaceutical;Cholinergic Antagonists/chemistry;Cholinergic Antagonists/metabolism;Cholinergic Antagonists/pharmacokinetics;Cross-Over Studies;Delayed-Action Preparations;Female;Food;Food-Drug Interactions*;Humans;Male;Mandelic Acids/chemistry;Mandelic Acids/metabolism;Mandelic Acids/pharmacokinetics*
11210399;Adolescent;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/chemistry;Anticonvulsants/pharmacokinetics;Area Under Curve;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/chemistry;Carbamazepine/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Food;Food-Drug Interactions*;Humans;Male;Middle Aged
11210398;Administration, Oral;Adult;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*
11206038;3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors*;Aged;Area Under Curve;Beverages*;Chromatography, High Pressure Liquid;Citrus/chemistry*;Food-Drug Interactions*;Half-Life;Humans;Male;Phosphodiesterase Inhibitors/blood*;Piperazines/blood*;Purines;Reproducibility of Results;Sildenafil Citrate;Spectrophotometry, Ultraviolet;Sulfones
11204334;Biological Availability;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Administration Schedule;Drug Synergism;Food-Drug Interactions*;Humans;Intestinal Mucosa/metabolism;Intestine, Small/metabolism;Liver/metabolism;Metabolic Diseases/etiology*;Metabolic Diseases/metabolism
11204333;Biological Availability;Food-Drug Interactions*/physiology;Humans;Malabsorption Syndromes/etiology*
11201303;Administration, Oral;Animals;Antimalarials/blood;Antimalarials/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cytochrome P-450 Enzyme Inhibitors;Female;Flavonoids/pharmacology*;Food-Drug Interactions*;Half-Life;Least-Squares Analysis;Quinine/administration & dosage;Quinine/blood;Quinine/pharmacokinetics*;Rats;Rats, Wistar
11185672;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions;Glyburide/pharmacokinetics*;Humans;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/pharmacokinetics*;Tablets
11185412;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Dietary Fats/pharmacology*;Female;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Middle Aged;Naphthyridines/administration & dosage;Naphthyridines/pharmacokinetics*
11180034;Administration, Oral;Adult;Antihypertensive Agents/pharmacokinetics*;Beverages*/analysis;Biological Availability;Caco-2 Cells/drug effects;Caco-2 Cells/enzymology;Citrus*/chemistry;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;DNA, Complementary/genetics;Enzyme Activation/drug effects;Enzyme Inhibitors/analysis;Enzyme Inhibitors/pharmacology;Felodipine/pharmacokinetics*;Female;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/pharmacology*;Humans;Male;Methoxsalen/analogs & derivatives*;Methoxsalen/analysis;Methoxsalen/pharmacology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/genetics;Mixed Function Oxygenases/metabolism
11170036;Administration, Oral;Animals;Food-Drug Interactions;Gastrointestinal Transit*;Injections, Intravenous;Intestinal Absorption*;Male;Radionuclide Imaging;Rats;Rats, Wistar;Theophylline/pharmacokinetics*
11155630;Creativity;Decision Support Systems, Clinical*;Efficiency, Organizational;Food-Drug Interactions;Hospitals, Community/organization & administration*;Humans;Indiana;Joint Commission on Accreditation of Healthcare Organizations;Medical Errors/prevention & control*;Multi-Institutional Systems/organization & administration;Parenteral Nutrition, Total;Risk Management*;Systems Integration;United States
11150014;Adult;Benzoates/adverse effects*;Female;Food Preservatives/adverse effects*;Food-Drug Interactions;Humans;Rhinitis, Allergic, Perennial/chemically induced*
11142666;Acrylic Resins;Analysis of Variance;Anti-Infective Agents, Local/antagonists & inhibitors*;Cetylpyridinium/antagonists & inhibitors*;Chlorhexidine/antagonists & inhibitors*;Dentifrices/pharmacokinetics;Drug Antagonism;Food-Drug Interactions;Humans;Mouthwashes/pharmacology*;Silicic Acid;Silicon Dioxide*;Sodium Fluoride*;Spectrophotometry;Tea/adverse effects;Tooth Discoloration/etiology;Toothpastes/pharmacology*
11141164;Beverages/adverse effects*;Citrus*;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced*
11135611;Ascorbic Acid/administration & dosage*;Ascorbic Acid/adverse effects;Ascorbic Acid/blood;Ascorbic Acid/pharmacokinetics;Biological Availability;Citrus*;Food-Drug Interactions;Humans;Intestinal Absorption
11125872;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors;Absorption;Administration, Inhalation;Adult;Benzamides/blood;Benzamides/pharmacokinetics*;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 4;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Phosphodiesterase Inhibitors/blood;Phosphodiesterase Inhibitors/pharmacokinetics*;Pilot Projects;Pyridines/blood;Pyridines/pharmacokinetics*;Sex Factors
11105574;Animals;Area Under Curve;Citrus*;Cyclosporine/pharmacokinetics;Cyclosporine/poisoning*;Food-Drug Interactions;Swine
11093663;Bornanes/blood*;Bornanes/pharmacokinetics;Calibration;Chromatography, Liquid/methods*;Food-Drug Interactions;Humans;Mass Spectrometry/methods*;Reproducibility of Results;Robotics;Serotonin Agents/blood*
11078178;Age Factors;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Blood Pressure/drug effects*;Blood Pressure/physiology*;Calcium Channel Blockers/pharmacology;Double-Blind Method;Enalapril/pharmacology*;Female;Food-Drug Interactions/physiology;Humans;Hypertension/physiopathology*;Isradipine/pharmacology*;Male;Middle Aged;Patient Compliance;Sex Factors;Sodium Chloride, Dietary/administration & dosage*;Sodium Chloride, Dietary/adverse effects*;Time Factors
11072877;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;Administration, Oral;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Bacillus subtilis/drug effects;Biological Availability;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Intestinal Absorption;Mice;Pharmaceutical Vehicles/administration & dosage;Pharmaceutical Vehicles/pharmacology;Poloxamer/pharmacology*;Serum Bactericidal Test;Stomach/metabolism;Tobramycin/administration & dosage;Tobramycin/blood;Tobramycin/pharmacokinetics*
11069440;Administration, Oral;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Amlodipine/pharmacology*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Middle Aged;Placebos;Pulse;Stereoisomerism
11064378;Animals;Antifungal Agents/pharmacokinetics*;Biological Availability;Caco-2 Cells;Cell Membrane Permeability;Dogs;Echinocandins;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption;Peptides, Cyclic/pharmacokinetics*
11061578;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Administration Schedule;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hypolipidemic Agents/pharmacokinetics;Male;Mixed Function Oxygenases/metabolism*;Reference Values;Simvastatin/administration & dosage;Simvastatin/blood;Simvastatin/pharmacokinetics*;Time Factors
11056327;Animals;Antineoplastic Agents/pharmacology*;Antineoplastic Agents, Hormonal/antagonists & inhibitors*;Antineoplastic Agents, Hormonal/therapeutic use;Female;Flavones*;Flavonoids/pharmacology*;Food-Drug Interactions;Mammary Neoplasms, Experimental/drug therapy*;Mice;Tamoxifen/antagonists & inhibitors*;Tamoxifen/therapeutic use
11054613;Animals;Anti-Arrhythmia Agents/pharmacology*;Anti-Arrhythmia Agents/therapeutic use;Atrial Fibrillation/drug therapy;Atrial Flutter/drug therapy;Clinical Trials as Topic;Drug Administration Schedule;Electrophysiology;Food-Drug Interactions;Heart Conduction System/drug effects*;Humans;Phenethylamines/administration & dosage;Phenethylamines/adverse effects;Phenethylamines/pharmacology*;Phenethylamines/therapeutic use*;Potassium Channel Blockers*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/pharmacology*;Sulfonamides/therapeutic use*;Tachycardia/complications;Tachycardia/drug therapy*;Tachycardia/physiopathology;Ventricular Dysfunction/complications
11049012;Adult;Anti-Inflammatory Agents/blood*;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Hydrocortisone/blood;Male;Methylprednisolone/blood*
11012470;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Anti-Ulcer Agents/administration & dosage*;Anti-Ulcer Agents/pharmacology*;Cross-Over Studies;Enzyme Inhibitors/administration & dosage*;Enzyme Inhibitors/pharmacology*;Female;Food-Drug Interactions*;Gastric Acid/metabolism*;Gastric Acidity Determination;Humans;Lansoprazole;Male;Manometry;Middle Aged;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives;Omeprazole/pharmacology;Proton Pump Inhibitors*
11002903;Alcohol Drinking/genetics*;Alcohol Drinking/psychology;Animals;Behavior, Addictive/genetics*;Behavior, Addictive/psychology;Breeding;Conditioning, Operant;Food-Drug Interactions;Rats;Rats, Inbred Lew;Rats, Long-Evans;Research Design
10997154;Alkaline Phosphatase/blood;Animal Feed*;Animals;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Calorimetry, Indirect/veterinary;Cholesterol/blood;Diet, Fat-Restricted/veterinary;Diet, Protein-Restricted/veterinary;Dogs/physiology*;Erythrocyte Count/veterinary;Female;Fluorescence Polarization/veterinary;Food-Drug Interactions*;Half-Life;Hematocrit/veterinary;Hemoglobins/analysis;Phenobarbital/blood;Phenobarbital/pharmacokinetics*;Prospective Studies;Random Allocation;Seizures/prevention & control;Seizures/veterinary;Serum Albumin/analysis
10994829;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Beverages/adverse effects*;Beverages/analysis;Biological Availability;Calcium Channel Blockers/metabolism;Citrus/adverse effects*;Citrus/chemistry;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Dose-Response Relationship, Drug;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Immunosuppressive Agents/metabolism;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Psychotropic Drugs/metabolism;Tacrolimus/metabolism;Terfenadine/metabolism
10994537;Acute Disease;Adult;Anticoagulants/adverse effects*;Drug Interactions;Drug and Narcotic Control;Female;Food-Drug Interactions;Garlic/adverse effects*;Ginkgo biloba/adverse effects*;Hematoma, Subdural/chemically induced;Humans;Medical History Taking;Nursing Assessment;Phytotherapy*;Plants, Medicinal*;Warfarin/adverse effects*
10993569;Aged;Anticoagulants/administration & dosage*;Bacteria, Anaerobic/drug effects*;Bacteria, Anaerobic/growth & development;Diet;Female;Food-Drug Interactions;Gastritis, Atrophic/drug therapy;Gastritis, Atrophic/microbiology*;Humans;Hydrogen-Ion Concentration;Intestines/microbiology*;Male;Middle Aged;Vitamin K/antagonists & inhibitors*;Vitamin K/biosynthesis;Vitamin K 1/administration & dosage;Vitamin K 1/deficiency;Vitamin K Deficiency/chemically induced;Warfarin/administration & dosage*
10991886;Adult;Antiplatyhelmintic Agents/administration & dosage;Antiplatyhelmintic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Diet;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Middle Aged;Praziquantel/administration & dosage;Praziquantel/pharmacokinetics*;Tablets
10963958;Amines/chemistry;Amines/metabolism;Amines/toxicity*;DNA/drug effects;DNA Damage/drug effects;Escherichia coli/drug effects;Escherichia coli/enzymology;Escherichia coli/genetics;Food Preservatives/chemistry;Food Preservatives/metabolism;Food Preservatives/toxicity*;Food-Drug Interactions*;HeLa Cells/drug effects;Humans;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Mutagenicity Tests;Mutagens/chemistry;Mutagens/metabolism;Mutagens/toxicity*;Plasmids/drug effects;Plasmids/genetics;SOS Response (Genetics)/drug effects;Salmonella typhimurium/drug effects;Salmonella typhimurium/genetics;Salmonella typhimurium/metabolism;Sorbic Acid/chemistry;Sorbic Acid/metabolism;Sorbic Acid/toxicity*
10963462;Anticoagulants*;Clinical Competence*;Food-Drug Interactions*;Health Personnel/education*;Health Personnel/standards;Humans;Surveys and Questionnaires;Treatment Outcome;Vitamin K*;Warfarin*
10959308;Beverages*;Citrus*;Food-Drug Interactions*;Humans
10959278;Drug Interactions*;Food-Drug Interactions*;Humans
10954962;Clinical Trials as Topic;Diabetes Mellitus, Type 2/drug therapy*;Drug Therapy, Combination;Food-Drug Interactions;Humans;Hypoglycemic Agents/therapeutic use*;Insulin Resistance;Thiazoles/pharmacology*;Thiazoles/therapeutic use;Thiazolidinediones*;United States
10954012;Administration, Oral;Adult;Appetite/drug effects;Blood Glucose/drug effects;Blood Glucose/metabolism;Calorimetry, Indirect;Cholecystokinin/blood;Cross-Over Studies;Double-Blind Method;Energy Metabolism/drug effects;Epinephrine/blood;Food-Drug Interactions;Fructose/pharmacology;Gastric Inhibitory Polypeptide/blood;Glucagon/blood;Glucagon-Like Peptide 1;Hexoses/blood;Hexoses/pharmacokinetics;Hexoses/pharmacology*;Humans;Male;Norepinephrine/blood;Peptide Fragments/blood;Protein Precursors/blood;Stereoisomerism;Sweetening Agents/pharmacokinetics;Sweetening Agents/pharmacology;Uric Acid/blood*;Uric Acid/urine
10945313;Aged;Aged, 80 and over;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacology*;Area Under Curve;Beverages;Blood Pressure/drug effects*;Citrus*;Diastole/drug effects;Felodipine/administration & dosage;Felodipine/analogs & derivatives*;Felodipine/blood;Felodipine/pharmacology*;Female;Food-Drug Interactions;Half-Life;Heart Rate/drug effects;Humans;Male;Posture;Reference Values;Systole/drug effects;Time Factors
10928402;Administration, Oral;Enteral Nutrition*;Food, Formulated;Food-Drug Interactions*;Humans;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*;Professional Practice;Prospective Studies;Randomized Controlled Trials as Topic;Retrospective Studies
10913925;Adult;Analgesics, Non-Narcotic/administration & dosage*;Analgesics, Non-Narcotic/pharmacokinetics*;Clodronic Acid/administration & dosage*;Clodronic Acid/pharmacokinetics*;Cross-Over Studies;Drug Administration Schedule;Eating*;Food-Drug Interactions;Humans;Intestinal Absorption
10907671;Adult;Alprazolam/blood;Alprazolam/pharmacokinetics*;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Anxiety Disorders/metabolism;Beverages*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Food-Drug Interactions*;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/metabolism*;Psychomotor Performance/physiology;Smoking/metabolism;Statistics, Nonparametric
10899384;Analgesics, Opioid/pharmacology*;Animals;Body Weight/drug effects;Diet;Female;Food-Drug Interactions*;Male;Morphine/pharmacology*;Pain*;Pain Measurement;Rats;Rats, Long-Evans;Saccharin/pharmacology*;Sex Characteristics*;Sucrose/pharmacology*;Taste
10896460;Anti-Bacterial Agents/pharmacology;Anticonvulsants/pharmacology;Biological Availability;Contraceptives, Oral, Combined/pharmacokinetics*;Contraceptives, Oral, Hormonal/pharmacokinetics*;Drug Interactions;Ethinyl Estradiol/pharmacokinetics;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Liver/metabolism;Prodrugs/pharmacokinetics;Progestins/pharmacokinetics
10892988;Administration, Oral;Animals;Antifungal Agents/administration & dosage;Antifungal Agents/blood*;Antifungal Agents/pharmacokinetics;Beverages*;Citrus*;Drug Administration Schedule;Food-Drug Interactions*;Male;Mice;Mice, Inbred ICR;Pyrimidines/administration & dosage;Pyrimidines/blood*;Pyrimidines/pharmacokinetics;Triazoles/administration & dosage;Triazoles/blood*;Triazoles/pharmacokinetics;Voriconazole
10890261;Administration, Oral;Aged;Beverages*;Chromatography, High Pressure Liquid;Citrus*/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/blood;Depression/blood;Depression/drug therapy*;Female;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes/drug effects;Microsomes/metabolism;Middle Aged;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/blood;Prospective Studies;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacokinetics*;Sertraline/administration & dosage;Sertraline/analogs & derivatives;Sertraline/antagonists & inhibitors;Sertraline/metabolism;Sertraline/pharmacokinetics*;Treatment Outcome
10888309;Adult;Amoxicillin/pharmacokinetics*;Capsules;Cross-Linking Reagents;Cross-Over Studies;Digestive System/diagnostic imaging;Digestive System/metabolism*;Excipients;Food-Drug Interactions;Gelatin;Humans;Male;Penicillins/pharmacokinetics*;Radionuclide Imaging;Therapeutic Equivalency
10883418;Biological Availability;Contraceptives, Oral, Synthetic/adverse effects;Contraceptives, Oral, Synthetic/pharmacokinetics;Cross-Over Studies;Dietary Fats/metabolism*;Estradiol/adverse effects;Estradiol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Norgestrel/adverse effects;Norgestrel/analogs & derivatives*;Norgestrel/pharmacokinetics*;Postmenopause/metabolism*;Women's Health
10872652;Anticholesteremic Agents/pharmacology*;Area Under Curve;Beverages;Citrus/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Liver/enzymology;Lovastatin/pharmacology*;Mixed Function Oxygenases/antagonists & inhibitors*
10872589;Beverages/analysis*;Calibration;Chromatography, High Pressure Liquid;Citrus*;Coumarins/analysis*;Coumarins/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Mass Spectrometry;Mixed Function Oxygenases/metabolism;Reproducibility of Results;Substrate Specificity
10859150;Aryl Hydrocarbon Hydroxylases*;Beverages*;Citrus*;Coumarins/pharmacokinetics;Coumarins/pharmacology*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacokinetics;Enzyme Inhibitors/pharmacology*;Food-Drug Interactions;Humans;Microsomes, Liver/enzymology;Oxidoreductases, N-Demethylating/antagonists & inhibitors*
10851844;Adverse Drug Reaction Reporting Systems;Drug Interactions*;Drug Therapy, Combination;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans
10832939;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/therapeutic use*;Disease*;Drug Interactions;Drug Monitoring;Fever/physiopathology;Food-Drug Interactions;Heart Failure/physiopathology;Humans;Liver Diseases/physiopathology;Safety;Thyroid Diseases/physiopathology;Warfarin/administration & dosage;Warfarin/therapeutic use*
10798570;Body Composition/drug effects;Body Composition/physiology*;Body Water/drug effects;Body Water/metabolism;Central Nervous System Depressants/blood*;Ethanol/blood*;Food-Drug Interactions*;Gastric Emptying/drug effects;Gastric Emptying/physiology;Humans;Sex Factors
10798569;Alcoholic Beverages*;Animals;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Gastric Emptying/drug effects*;Gastric Emptying/physiology;Humans;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Male;Rats
10798565;Biological Availability;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*
10798564;Alcohol Drinking/metabolism*;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Dose-Response Relationship, Drug;Ethanol/blood;Ethanol/pharmacokinetics*;Food-Drug Interactions*;Humans;Male
10790445;Alcoholic Beverages*;Analysis of Variance;Bisphenol A-Glycidyl Methacrylate/chemistry;Corn Oil/chemistry;Dental Bonding*;Dentin-Bonding Agents/chemistry*;Dietary Fats;Ethanol/chemistry;Food*;Food-Drug Interactions;Humans;Lactic Acid/chemistry;Materials Testing;Orthodontic Brackets*;Resin Cements/chemistry*;Statistics, Nonparametric;Water/chemistry
10772438;Anti-Bacterial Agents/pharmacology*;Antineoplastic Agents/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Drug Interactions;Erythromycin/pharmacology;Food-Drug Interactions;Humans;Tylosin/analogs & derivatives;Tylosin/pharmacology
10768303;Adolescent;Age Factors;Aged;Anticonvulsants/pharmacokinetics*;Anticonvulsants/pharmacology;Anticonvulsants/therapeutic use;Biological Availability;Child;Child, Preschool;Drug Interactions;Epilepsy/drug therapy*;Epilepsy/metabolism;Food-Drug Interactions;Fructose/analogs & derivatives*;Fructose/pharmacokinetics;Fructose/pharmacology;Fructose/therapeutic use;Half-Life;Humans;Intestinal Absorption;Patient Compliance;Pharmacokinetics;Tissue Distribution
10759694;Adult;Amiodarone/analogs & derivatives;Amiodarone/blood;Amiodarone/pharmacokinetics*;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases*;Beverages*;Biotransformation;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Electrocardiography/drug effects;Food-Drug Interactions*;Half-Life;Humans;Male;Oxidoreductases, N-Demethylating/metabolism
10741622;Adult;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Nisoldipine/adverse effects;Nisoldipine/blood;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology*;Reference Values;Time Factors;Vasodilator Agents/pharmacology
10740993;Aged;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Beverages*;Citrus*;Female;Fluoxetine/adverse effects*;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions*;Humans
10732665;Cheese/adverse effects*;Cheese/analysis;Diet*;Food/adverse effects*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects
10718785;Administration, Oral;Adult;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Eating;Fasting;Food-Drug Interactions;Humans;Hydantoins;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Imidazolidines*;Male;Piperazines/adverse effects;Piperazines/pharmacokinetics*
10709801;Area Under Curve;Data Interpretation, Statistical*;Food-Drug Interactions;Half-Life;Humans;Mathematics;Pharmacokinetics*
10702965;Adult;Area Under Curve;Beverages*;Bronchodilator Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Male;Theophylline/pharmacokinetics*
10688276;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Animals;Beverages;Biological Transport, Active;Citrus;Diet*;Digestive System/metabolism*;Flavonoids/metabolism;Food-Drug Interactions;Humans;Pharmaceutical Preparations/metabolism*
10683873;Antimalarials/chemistry;Antimalarials/pharmacokinetics*;Bile Acids and Salts/chemistry*;Caco-2 Cells;Excipients*;Food-Drug Interactions*;Humans;Micelles;Pectins/chemistry*;Permeability;Quinine/chemistry;Quinine/pharmacokinetics*
10681346;Animals;Antifungal Agents/administration & dosage*;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Dogs;Dose-Response Relationship, Drug;Food-Drug Interactions;Macaca fascicularis;Male;Mice;Rabbits;Rats;Triazoles/administration & dosage*;Triazoles/blood;Triazoles/pharmacokinetics*
10681341;Adult;Animals;Antimalarials/pharmacokinetics*;Antimalarials/therapeutic use*;Area Under Curve;Artemisinins*;Biological Availability;Child;Double-Blind Method;Drug Therapy, Combination;Electrocardiography;Ethanolamines/pharmacokinetics*;Ethanolamines/therapeutic use*;Fluorenes/pharmacokinetics*;Fluorenes/therapeutic use*;Food-Drug Interactions;Humans;Malaria, Falciparum/drug therapy*;Plasmodium falciparum/isolation & purification;Prospective Studies;Sesquiterpenes/therapeutic use;Treatment Outcome
10664901;Cardiovascular Agents/pharmacology*;Databases as Topic;Drug Interactions;Food-Drug Interactions;Guidelines as Topic;Humans;Internet;Psychotropic Drugs/pharmacology*
10651665;Adult;Erythromycin/administration & dosage*;Erythromycin/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions/physiology*;Gastrointestinal Motility/drug effects*;Humans;Infusions, Intravenous;Intestine, Small/drug effects*;Male;Manometry;Time Factors
10644077;Adamantane/analogs & derivatives;Adamantane/chemistry;Adamantane/pharmacokinetics;Anti-Bacterial Agents/chemistry;Anti-Bacterial Agents/pharmacokinetics;Antimalarials/chemistry;Antimalarials/pharmacokinetics;Atovaquone;Biopharmaceutics*;Chemical Phenomena;Chemistry, Physical;Chromans/chemistry;Chromans/pharmacokinetics;Chromatography, High Pressure Liquid;Food-Drug Interactions;Lactams*;Naphthoquinones/chemistry;Naphthoquinones/pharmacokinetics;Phenylurea Compounds/chemistry;Phenylurea Compounds/pharmacokinetics;Platelet Aggregation Inhibitors/chemistry;Platelet Aggregation Inhibitors/pharmacokinetics;Predictive Value of Tests;Prodrugs/chemistry;Prodrugs/pharmacokinetics;Solubility*;Solvents;Spectrophotometry, Ultraviolet;Thiazoles/chemistry;Thiazoles/pharmacokinetics;Thiazolidinediones*
10640644;Animals;Delayed-Action Preparations;Dogs;Fasting;Food-Drug Interactions;Hydrogels/chemistry;Hydrogels/pharmacokinetics*;Microscopy, Electron, Scanning;Porosity;Stomach/physiology*;Time Factors
11122551;Aging/physiology*;Anorexia;Body Composition;Bone Diseases, Metabolic;Dietary Supplements;Food-Drug Interactions;Geriatric Assessment;Humans;Nutritional Physiological Phenomena*;Quality of Life
10616954;Animals;Biological Availability;Curcumin/administration & dosage*;Diet*;Ferula*;Food-Drug Interactions;Humans;Medicine, Ayurvedic*;Medicine, East Asian Traditional*;Nepal;Phytotherapy;Plants, Medicinal*;Plants, Toxic*
10610011;AIDS-Related Opportunistic Infections/metabolism;AIDS-Related Opportunistic Infections/prevention & control;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects*;Antifungal Agents/pharmacokinetics*;Atovaquone;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects*;Naphthoquinones/pharmacokinetics*;Pneumonia, Pneumocystis/prevention & control;Trimethoprim, Sulfamethoxazole Drug Combination/pharmacokinetics
10606837;Adult;Area Under Curve;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Computer Simulation;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Enzyme Inhibitors/pharmacokinetics*;Felodipine/pharmacokinetics*;Food-Drug Interactions*;Gastrointestinal Transit/physiology;Humans;Intestines/metabolism;Liver/metabolism;Male;Metabolic Clearance Rate;Mixed Function Oxygenases/antagonists & inhibitors;Models, Biological
10604039;Administration, Oral;Animals;Bile/metabolism;Biotransformation;Blood Proteins/metabolism;Dogs;Feces/chemistry;Female;Food-Drug Interactions;Injections, Intravenous;Intestinal Absorption;Lymph/metabolism;Macaca fascicularis;Male;Nootropic Agents/pharmacokinetics*;Piperidines/pharmacokinetics*;Proline/analogs & derivatives*;Proline/pharmacokinetics;Protein Binding;Rats;Rats, Sprague-Dawley;Sex Characteristics
10594469;Adult;Aging;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Digestive System/metabolism;Doxazosin/administration & dosage*;Doxazosin/adverse effects;Doxazosin/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Male;Sex Characteristics;Therapeutic Equivalency
10584969;3-Hydroxybutyric Acid/metabolism;Anticonvulsants/metabolism*;Anticonvulsants/therapeutic use;Carnitine/metabolism*;Carnitine/therapeutic use;Dietary Fats/metabolism*;Dietary Fats/therapeutic use;Energy Metabolism/physiology*;Epilepsy/diet therapy;Epilepsy/metabolism*;Fatty Acids/urine;Food-Drug Interactions;Glucagon/blood;Humans;Insulin/blood;Ketone Bodies/metabolism*;Ketosis/chemically induced;Oxidation-Reduction;Patient Selection
10583024;Absorption;Adolescent;Adult;Age Factors;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Etidronic Acid/administration & dosage;Etidronic Acid/adverse effects;Etidronic Acid/analogs & derivatives*;Etidronic Acid/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Humans;Male;Risedronate Sodium;Sex Factors;Time Factors
10579471;Administration, Oral;Adult;Beverages*;Chromatography, High Pressure Liquid;Cisapride/blood;Cisapride/pharmacokinetics*;Cisapride/pharmacology;Citrus*;Cross-Over Studies;Electrocardiography/drug effects;Food-Drug Interactions;Gastrointestinal Agents/blood;Gastrointestinal Agents/pharmacokinetics*;Gastrointestinal Agents/pharmacology;Humans;Male;Time Factors
10579146;Adult;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Patient Dropouts;Sirolimus/blood;Sirolimus/pharmacokinetics*;Time Factors
10573471;Adolescent;Anticonvulsants/administration & dosage;Anticonvulsants/economics*;Anticonvulsants/therapeutic use;Child;Child, Preschool;Cost-Benefit Analysis;Dietary Fats/administration & dosage*;Dose-Response Relationship, Drug;Drug Costs*;Epilepsy/diet therapy*;Epilepsy/drug therapy;Epilepsy/economics*;Female;Follow-Up Studies;Food-Drug Interactions;Humans;Infant;Ketosis*/etiology;Ketosis*/metabolism;Male;Patient Dropouts;Prospective Studies;Treatment Outcome
10548035;Food-Drug Interactions*;Humans
10546925;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/blood;Antimalarials/pharmacokinetics*;Antiprotozoal Agents/administration & dosage;Antiprotozoal Agents/blood;Antiprotozoal Agents/pharmacokinetics*;Artemisinins*;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Male;Reference Values;Sesquiterpenes/administration & dosage;Sesquiterpenes/blood;Sesquiterpenes/pharmacokinetics*;Time Factors
10546919;Adult;Analysis of Variance;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/blood*;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Lovastatin/administration & dosage;Lovastatin/blood*;Male;Reference Values
10542738;Drug Monitoring;Drug Therapy/nursing;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Intestinal Absorption;Metabolic Clearance Rate;Patient Education as Topic
10538657;Boston;Cost Savings;Decision Support Systems, Clinical*;Drug Interactions;Food-Drug Interactions;Hospitals, General/standards;Hospitals, Teaching/standards;Humans;Hypersensitivity/prevention & control;Iatrogenic Disease/prevention & control*;Medication Errors/prevention & control;Unnecessary Procedures;User-Computer Interface
10511919;Age Factors;Biological Availability*;Clinical Trials as Topic;Food-Drug Interactions*;Forecasting;Humans;Models, Biological;Pharmacokinetics*
10507245;Acetylcholinesterase/blood*;Butyrylcholinesterase/blood*;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacokinetics;Cholinesterase Inhibitors/pharmacology*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions/physiology*;Humans;Time Factors;Trichlorfon/administration & dosage;Trichlorfon/adverse effects;Trichlorfon/pharmacokinetics;Trichlorfon/pharmacology*
10496300;Animals;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics;Antimalarials/pharmacology*;Artemisinins*;Clinical Trials as Topic;Drug Combinations;Drug Resistance, Microbial;Drug Resistance, Multiple;Ethanolamines/administration & dosage;Ethanolamines/adverse effects;Ethanolamines/pharmacokinetics*;Ethanolamines/pharmacology*;Fluorenes/administration & dosage;Fluorenes/adverse effects;Fluorenes/pharmacokinetics*;Fluorenes/pharmacology*;Food-Drug Interactions;Humans;Malaria/metabolism*;Plasmodium falciparum/physiology*;Sesquiterpenes/pharmacokinetics*
10485080;Adult;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cohort Studies;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/metabolism;Triazoles/pharmacokinetics*
10471981;Adult;Biological Availability;Cross-Over Studies;Fasting;Female;Food-Drug Interactions/physiology*;Humans;Indoles/adverse effects;Indoles/blood*;Male;Models, Statistical;Time Factors
10471070;Adult;Chlorzoxazone/pharmacokinetics*;Citrus;Cohort Studies;Cytochrome P-450 CYP2E1/genetics*;Female;Food-Drug Interactions;Humans;Life Style;Male;Microsomes, Liver/enzymology;Middle Aged;Neuromuscular Agents/pharmacokinetics*;Obesity/metabolism;Phenotype;Solvents
10460103;Adult;Analysis of Variance;Antacids/pharmacokinetics*;Antitubercular Agents/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Interactions;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Regression Analysis;Statistics, Nonparametric
10442206;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions;Half-Life;Humans;Male;Tramadol/administration & dosage*;Tramadol/pharmacokinetics*
10440622;Adolescent;Adult;Animals;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Milk
10431417;Cheese*;Female;Food-Drug Interactions*;Headache/chemically induced*;Humans;Hypertension/chemically induced*;Middle Aged;Monoamine Oxidase Inhibitors/adverse effects*;Tranylcypromine/adverse effects
10431317;Biological Availability;Diuretics/administration & dosage;Diuretics/metabolism*;Diuretics/pharmacokinetics*;Food-Drug Interactions;Heart Failure/drug therapy*;Heart Failure/metabolism*;Humans;Intestinal Absorption;Metabolic Clearance Rate;Solubility
10423213;Anticoagulants/adverse effects*;Beverages*;Citrus*;Food-Drug Interactions;Humans;Male;Middle Aged;Warfarin/adverse effects*
10412889;Albendazole/metabolism*;Animal Feed;Animals;Anthelmintics/metabolism*;Benzimidazoles/analysis;Biotransformation;Chromatography, High Pressure Liquid;Diet/veterinary*;Food-Drug Interactions;Guanidines/metabolism*;In Vitro Techniques;Prodrugs/metabolism;Reproducibility of Results;Rumen/metabolism*;Rumen/microbiology;Sheep/metabolism*
10399135;Animals;Blood Glucose/drug effects*;Body Weight/drug effects;Constriction;Dietary Fats, Unsaturated/pharmacology*;Dose-Response Relationship, Drug;Drinking/drug effects;Eating/drug effects;Fish Oils/chemistry*;Food-Drug Interactions;Hemodynamics/drug effects;Insulin/pharmacology*;Male;Random Allocation;Rats;Rats, Wistar
10391425;Diet, Protein-Restricted/adverse effects;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Epilepsy/diet therapy*;Food-Drug Interactions;Humans;Ketosis*/etiology;Pharmaceutical Services*/standards;Starvation/complications;Starvation/physiopathology*
10367106;Administration, Oral;Adrenergic alpha-1 Receptor Agonists*;Adrenergic alpha-Agonists/administration & dosage;Adrenergic alpha-Agonists/pharmacokinetics*;Adrenergic alpha-Agonists/urine;Anilides/administration & dosage;Anilides/pharmacokinetics*;Anilides/urine;Animals;Bile/metabolism;Blood Proteins/metabolism;Erythrocytes/metabolism;Feces/chemistry;Female;Food-Drug Interactions;Injections, Intravenous;Intestinal Absorption;Lung/metabolism;Male;Protein Binding;Rats;Rats, Sprague-Dawley;Sex Characteristics
10354963;Absorption;Adolescent;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Headache/chemically induced;Humans;Lamivudine/adverse effects;Lamivudine/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Tablets;Therapeutic Equivalency;Zidovudine/adverse effects;Zidovudine/pharmacokinetics*
10351030;Avitaminosis/chemically induced;Digestive System/drug effects;Drug-Related Side Effects and Adverse Reactions*;Education, Pharmacy, Continuing;Electrolytes/blood;Enteral Nutrition;Food-Drug Interactions*;Humans;Nutritional Support*;Parenteral Nutrition;Pharmaceutical Vehicles;Pharmacokinetics;United States
10349562;Chemistry, Pharmaceutical;Eating*;Excipients/chemistry;Felodipine/chemistry;Food-Drug Interactions*;Hydrogen-Ion Concentration;In Vitro Techniques;Nifedipine/chemistry;Solubility;Surface-Active Agents/chemistry;Tablets/metabolism*;Water/chemistry*
10334118;Antitubercular Agents/pharmacokinetics*;Biological Availability;Drug Interactions;Food-Drug Interactions;Humans;Isoniazid/pharmacokinetics*
10326940;Adult;Alcohol Drinking/blood*;Cholesterol/blood;Dietary Fats/administration & dosage*;Drug Synergism;Fasting/blood*;Fatty Acids/blood;Female;Food-Drug Interactions;Humans;Hypertriglyceridemia/blood*;Male;Middle Aged;Triglycerides/blood*
10225572;Administration, Oral;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Ciprofloxacin/administration & dosage;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Cross-Over Studies;Drug Administration Schedule;Fasting/blood;Fasting/metabolism;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Suspensions;Tablets;Therapeutic Equivalency
10223170;Administration, Oral;Animals;Chemistry, Pharmaceutical;Delayed-Action Preparations;Digestive System/metabolism;Food-Drug Interactions*;Humans;Intestinal Absorption/physiology*;Pharmacokinetics*
10220126;Adult;Aged;Beverages;Citrus*;Female;Food-Drug Interactions*;Haloperidol/blood;Haloperidol/pharmacology*;Haloperidol/therapeutic use;Humans;Middle Aged;Psychiatric Status Rating Scales;Schizophrenia/blood;Schizophrenia/drug therapy*;Schizophrenic Psychology
10206085;Adolescent;Adult;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions/physiology*;Humans;Hypoglycemic Agents/blood*;Male;Thiazoles/adverse effects;Thiazoles/blood*;Thiazolidinediones*
10192596;Acute Disease;Bread/analysis;Cheese/analysis;Chromatography, High Pressure Liquid;Diet/adverse effects*;Food Analysis/statistics & numerical data;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/adverse effects*;Soybeans/chemistry*;Tyramine/adverse effects*;Tyramine/analysis
10102975;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/pharmacology*;Cross-Over Studies;Double-Blind Method;Famotidine/administration & dosage;Famotidine/pharmacology*;Female;Food-Drug Interactions*;Gastric Acid/secretion*;Humans;Hydrogen-Ion Concentration;Male;Ranitidine/administration & dosage;Ranitidine/pharmacology*
10096315;Administration, Oral;Adult;Age Factors;Aged;Alcohol Drinking/blood*;Area Under Curve;Central Nervous System Depressants/administration & dosage;Central Nervous System Depressants/blood*;Cohort Studies;Cross-Sectional Studies;Ethanol/administration & dosage;Ethanol/blood*;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Male;Middle Aged;Reference Values;Sex Factors;Substance Abuse Detection/standards*;Time Factors
10096255;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Beverages;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacology*;Female;Food-Drug Interactions;Furocoumarins/pharmacology*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Intestinal Mucosa/cytology;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism*;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Mixed Function Oxygenases/metabolism;Reference Values
10090652;Animals;Behavior, Animal/drug effects;Drug Administration Schedule;Drug Interactions;Ethanol/administration & dosage;Ethanol/pharmacology*;Excitatory Amino Acid Antagonists/administration & dosage;Excitatory Amino Acid Antagonists/pharmacology;Food-Drug Interactions;Macaca mulatta;Male;Naltrexone/pharmacology*;Narcotic Antagonists/pharmacology*;Phencyclidine/administration & dosage;Phencyclidine/pharmacology*;Reinforcement (Psychology)*;Saccharin/administration & dosage;Saccharin/pharmacology*;Self Administration
10087023;Animals;Biological Transport, Active;Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology;Cimetidine/metabolism*;Drug Interactions;Food-Drug Interactions;Histamine H2 Antagonists/metabolism*;Hydrogen-Ion Concentration;In Vitro Techniques;Intestinal Absorption*;Intestine, Small/metabolism*;Intestine, Small/ultrastructure;Male;Membrane Potentials;Microvilli/metabolism;Patch-Clamp Techniques;Rats;Rats, Sprague-Dawley;Sodium/metabolism
10049268;Adult;Antacids/pharmacology*;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Double-Blind Method;Drug Interactions;Ethambutol/pharmacokinetics*;Fasting/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Models, Biological
10048159;Alcohol Drinking/adverse effects*;Animals;Cytochrome P-450 CYP2E1/metabolism;Dietary Carbohydrates/administration & dosage*;Dietary Carbohydrates/metabolism;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions;Hepatitis, Alcoholic/etiology;Hepatitis, Alcoholic/metabolism*;Hepatitis, Alcoholic/pathology;Male;Necrosis;Rats;Rats, Sprague-Dawley
9972685;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/pharmacology;Animals;Columbidae;Dose-Response Relationship, Drug;Drug Tolerance;Food-Drug Interactions*;Morphine/administration & dosage*;Morphine/pharmacology
9972684;Analgesia;Analgesics, Opioid/pharmacology*;Animals;Body Weight;Dietary Proteins/pharmacology*;Eating;Food-Drug Interactions;Male;Minerals/pharmacology*;Morphine/pharmacology*;Pain Measurement;Rats;Rats, Long-Evans;Sucrose/pharmacology;Vitamins/pharmacology*
9925057;Adult;Antacids/administration & dosage*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/pharmacokinetics*;Cross-Over Studies;Drug Interactions;Drug Therapy, Combination;Fasting/physiology*;Female;Food-Drug Interactions/physiology*;Humans;Male;Metabolic Clearance Rate/physiology;Rifampin/administration & dosage;Rifampin/pharmacokinetics*
9923580;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Citrus*;Cross-Over Studies;Dihydropyridines/blood;Dihydropyridines/pharmacokinetics*;Dihydropyridines/pharmacology;Food-Drug Interactions/physiology*;Half-Life;Heart Rate/drug effects;Humans;Male
9918208;Administration, Oral;Adult;Aged;Antimetabolites, Antineoplastic/administration & dosage*;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics;Biological Availability;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics
9884817;Antifungal Agents/pharmacokinetics;Antifungal Agents/pharmacology;Antifungal Agents/therapeutic use*;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Itraconazole/pharmacokinetics;Itraconazole/pharmacology;Itraconazole/therapeutic use*;Organ Specificity
9884814;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/therapeutic use;Cardiovascular Diseases/metabolism;Drug Interactions;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Mibefradil;Tetrahydronaphthalenes/pharmacokinetics*;Tetrahydronaphthalenes/therapeutic use
9882081;Adolescent;Adult;Antacids/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Humans;Ketoprofen/analogs & derivatives*;Ketoprofen/pharmacology;Ketoprofen/toxicity;Male;Middle Aged;Tablets;Tromethamine/analogs & derivatives*;Tromethamine/pharmacology;Tromethamine/toxicity
9882026;Animals;Avitaminosis/chemically induced;Biological Availability;Digestive System/drug effects*;Dose-Response Relationship, Drug;Fat Substitutes/adverse effects*;Fat Substitutes/pharmacokinetics;Fatty Acids/adverse effects*;Fatty Acids/pharmacokinetics;Food-Drug Interactions;Humans;Sucrose/adverse effects;Sucrose/analogs & derivatives*;Sucrose/pharmacokinetics
9879808;Air Pollutants, Occupational/metabolism*;Animals;Arsenicals/metabolism*;Chemistry Techniques, Analytical/methods*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Rats
9879571;Biological Transport/drug effects;Electrophoresis, Capillary;Food-Drug Interactions;Micelles;Permeability;Polysaccharides/pharmacology*;Propranolol/metabolism*;Starch/metabolism*
9877005;Amphetamine/pharmacology;Animals;Caffeine/pharmacology*;Central Nervous System Stimulants/pharmacology*;Cocaine/pharmacology;Drinking;Food-Drug Interactions;Male;Nicotine/pharmacology;Rats;Rats, Sprague-Dawley;Reinforcement Schedule*;Substance-Related Disorders
9875172;Beverages/adverse effects*;Citrus/adverse effects*;Complementary Therapies;Female;Food-Drug Interactions*;Humans;Middle Aged;Nifedipine/adverse effects*;Phytotherapy;United States;Vasodilator Agents/adverse effects*
9871430;Adult;Beverages;Buspirone/blood*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mixed Function Oxygenases/drug effects;Reference Values;Serotonin Receptor Agonists/blood*
9855317;Adult;Antacids/pharmacology*;Antitubercular Agents/pharmacokinetics*;Antitubercular Agents/pharmacology;Area Under Curve;Cross-Over Studies;Data Interpretation, Statistical;Fasting;Female;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Middle Aged;Pyrazinamide/pharmacokinetics*;Pyrazinamide/pharmacology
9854915;Anesthetics/metabolism*;Cholinesterase Inhibitors/metabolism*;Food-Drug Interactions*;Humans;Solanaceous Alkaloids/metabolism*
9841049;Anesthetics*;Food-Drug Interactions*;Humans;Solanum tuberosum*
9839088;Aged;Animals;Anthraquinones/administration & dosage;Anthraquinones/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Osteoarthritis/drug therapy;Time Factors
9839087;Age Factors;Alcohol Deterrents/pharmacokinetics*;Alcohol Deterrents/pharmacology;Animals;Desipramine/pharmacokinetics;Diazepam/pharmacokinetics;Disulfiram/pharmacokinetics;Dose-Response Relationship, Drug;Drug Interactions;Ethanol/pharmacokinetics;Food-Drug Interactions;Humans;Imipramine/pharmacokinetics;Psychotropic Drugs/pharmacokinetics;Sex Characteristics;Taurine/analogs & derivatives*;Taurine/pharmacokinetics;Taurine/pharmacology
9834039;Adult;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Hypolipidemic Agents/blood*;Male;Reference Values;Simvastatin/analogs & derivatives*;Simvastatin/blood*
9833595;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Oxazoles/adverse effects;Oxazoles/metabolism;Oxazoles/pharmacokinetics*;Oxazolidinones*;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/metabolism;Serotonin Receptor Agonists/pharmacokinetics*;Tryptamines
9832982;Animals;Dextroamphetamine/administration & dosage;Dextroamphetamine/pharmacology*;Dopamine Agents/administration & dosage;Dopamine Agents/pharmacology*;Drinking;Eating;Female;Food-Drug Interactions;Macaca mulatta;Male;Reinforcement (Psychology)*;Self Administration
9830331;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacology*;Beverages*;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacology;Citrus*;Cyclosporins/blood;Cyclosporins/metabolism;Cyclosporins/pharmacology;Felodipine/blood;Felodipine/metabolism;Felodipine/pharmacology*;Food-Drug Interactions*;Humans;Intestine, Small/metabolism
9829163;Aged;Alzheimer Disease/drug therapy;Depression/drug therapy;Food-Drug Interactions;Humans;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/classification;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Parkinson Disease/drug therapy;Tyramine/adverse effects
9821810;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Antioxidants/pharmacology;Beverages*;Biological Transport/drug effects;Caco-2 Cells/drug effects*;Caco-2 Cells/enzymology;Caco-2 Cells/metabolism*;Cell Survival/drug effects;Citrus*;Cyclosporine/pharmacology;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Inhibitors/pharmacology;Estrogen Antagonists/pharmacology;Flavanones*;Flavonoids/pharmacology;Food-Drug Interactions;Humans;Intestinal Absorption/drug effects;Mixed Function Oxygenases/metabolism;Plant Extracts/pharmacology*;Tritium;Vinblastine/pharmacokinetics*
9818297;Adult;Amitriptyline/metabolism*;Eating;Female;Food-Drug Interactions*;Humans;Middle Aged;Nortriptyline/metabolism*
9808916;Antipsychotic Agents/adverse effects*;Child;Feeding and Eating Disorders/chemically induced*;Feeding and Eating Disorders/diet therapy;Food-Drug Interactions;Humans;Male;Risperidone/adverse effects*;Weight Gain/drug effects
9807638;Anorexia Nervosa/drug therapy*;Anorexia Nervosa/genetics;Anorexia Nervosa/physiopathology;Appetite Regulation/physiology;Bulimia/drug therapy*;Bulimia/genetics;Bulimia/physiopathology;Disease Progression;Food-Drug Interactions;Genetic Predisposition to Disease;Humans;Neural Pathways/physiology;Nutritional Physiological Phenomena/physiology;Obsessive Behavior/physiopathology;Serotonin/physiology*;Serotonin Uptake Inhibitors/pharmacology;Serotonin Uptake Inhibitors/therapeutic use*
9805816;Buspirone/pharmacokinetics*;Cross-Over Studies;Dietary Fats;Food-Drug Interactions*;Humans;Metabolic Clearance Rate;Nifedipine/pharmacokinetics*;Postprandial Period;Theophylline/pharmacokinetics*
9796864;Antidepressive Agents/adverse effects*;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/pharmacology;Beverages/adverse effects*;Citrus/adverse effects*;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Induction/drug effects;Food-Drug Interactions*;Humans;Infant;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Mixed Function Oxygenases/metabolism;Polymorphism, Genetic;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology
9793622;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Dietary Fats;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naproxen/adverse effects*;Naproxen/pharmacokinetics*;Reproducibility of Results;Spectrometry, Fluorescence
9789724;Aged;Aging/metabolism*;Food-Drug Interactions*;Humans;Nutritional Status;Pharmacokinetics*
9786475;Adult;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/adverse effects;Anti-Infective Agents/metabolism;Anti-Infective Agents/pharmacokinetics*;Delayed-Action Preparations;Double-Blind Method;Fluoroquinolones*;Food-Drug Interactions;Humans;Male;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/metabolism;Piperazines/pharmacokinetics*;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/metabolism;Quinolones/pharmacokinetics*;Saliva/chemistry
9784933;Age Factors;Antihypertensive Agents/pharmacokinetics*;Calcium Channel Blockers/pharmacokinetics*;Delayed-Action Preparations;Drug Interactions;Ethnic Groups;Food-Drug Interactions;Humans;Hypertension/metabolism*;Kidney Diseases/metabolism;Liver Diseases/metabolism;Nisoldipine/blood;Nisoldipine/pharmacokinetics*;Stereoisomerism
9784932;Administration, Oral;Administration, Rectal;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Chemistry, Pharmaceutical;Child;Delayed-Action Preparations;Food-Drug Interactions;Humans;Morphine/administration & dosage;Morphine/pharmacokinetics*;Morphine/therapeutic use;Pain/drug therapy*
9775886;Avitaminosis/chemically induced*;Avitaminosis/prevention & control;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans;Nutrition Assessment*;Nutritional Sciences/education;Patient Education as Topic
9764220;Amines/chemistry*;Chromatography, Gas;Food Preservatives/chemistry*;Food-Drug Interactions*;Gas Chromatography-Mass Spectrometry;Magnetic Resonance Spectroscopy;Sorbic Acid/chemistry*
9757923;Adult;Aged;Analysis of Variance;Critical Care/methods*;Enteral Nutrition*;Food-Drug Interactions;Humans;Hypnotics and Sedatives/pharmacokinetics*;Liver/blood supply*;Longitudinal Studies;Middle Aged;Parenteral Nutrition*;Propofol/pharmacokinetics*;Splanchnic Circulation/drug effects;Splanchnic Circulation/physiology;Time Factors
9757152;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Beverages;Carbamazepine/pharmacokinetics*;Citrus/metabolism*;Cross-Over Studies;Drug Administration Schedule;Epilepsy/drug therapy;Epilepsy/metabolism*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Time Factors;Water/metabolism
9757148;Administration, Oral;Adult;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Antioxidants/pharmacology*;Area Under Curve;Beverages;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/pharmacology*;Felodipine/blood;Felodipine/pharmacokinetics*;Flavanones*;Flavonoids/pharmacology*;Food-Drug Interactions;Furocoumarins/pharmacology*;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Reference Values
9737819;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/pharmacology*;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacology*;Female;Food-Drug Interactions*;Gastric Emptying;Humans;Hydrogen-Ion Concentration;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Postprandial Period;Ranitidine/pharmacology;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/pharmacokinetics*;Tryptamines;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/pharmacokinetics*
9737815;Acrylates/administration & dosage;Acrylates/pharmacokinetics*;Administration, Oral;Adult;Analysis of Variance;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Food-Drug Interactions*;Half-Life;Humans;Imidazoles/administration & dosage;Imidazoles/pharmacokinetics*;Injections, Intravenous;Male;Thiophenes*
9725481;Adult;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacokinetics;Dihydropyridines/adverse effects;Dihydropyridines/metabolism;Dihydropyridines/pharmacokinetics*;Double-Blind Method;Food-Drug Interactions*;Humans;Male
9723817;Administration, Oral;Beverages*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Felodipine/pharmacokinetics;Food-Drug Interactions*;Humans;Intestine, Small/metabolism;Mixed Function Oxygenases/metabolism;Pharmacokinetics*
9706183;Aged;Analysis of Variance;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Beverages*;Citrus*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prothrombin Time*;Warfarin/blood;Warfarin/pharmacokinetics*
9696960;Administration, Oral;Aged;Aged, 80 and over;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Verapamil/blood;Verapamil/pharmacokinetics*
9682663;Animals;Culture Techniques;Enzyme Inhibitors/pharmacology;Fluoxetine/pharmacology*;Food-Drug Interactions*;Intestinal Absorption/drug effects*;Intestinal Mucosa/metabolism;Jejunum/metabolism;Leucine/pharmacokinetics*;Male;Microvilli/metabolism;Rats;Rats, Wistar;Serotonin Uptake Inhibitors/pharmacology*;Sodium-Potassium-Exchanging ATPase/metabolism;Time Factors
9676346;Adult;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/pharmacokinetics*
9676344;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/pharmacokinetics*;Anti-Asthmatic Agents/standards*;Bile Acids and Salts/metabolism;Delayed-Action Preparations;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Quality Control;Reproducibility of Results;Surface-Active Agents/chemistry;Theophylline/administration & dosage;Theophylline/pharmacokinetics*;Theophylline/standards*;Therapeutic Equivalency
9663817;Adolescent;Adult;Anthelmintics/administration & dosage;Anthelmintics/adverse effects;Anthelmintics/pharmacokinetics*;Anthelmintics/therapeutic use;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Biological Availability;Child;Cross-Over Studies;Fascioliasis/drug therapy;Fascioliasis/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged
9663198;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Clinical Trials as Topic;Diet;Female;Food-Drug Interactions;Heart Valve Prosthesis/adverse effects*;Humans;Practice Guidelines as Topic;Pregnancy;Pregnancy Complications, Cardiovascular/prevention & control;Thromboembolism/etiology;Thromboembolism/prevention & control*;Vitamin K/administration & dosage;Warfarin/pharmacokinetics;Warfarin/therapeutic use
10185290;Adverse Drug Reaction Reporting Systems*;Centers for Medicare and Medicaid Services (U.S.);Dietary Services/organization & administration;Dietary Services/standards*;Dietetics;Food Service, Hospital/organization & administration;Food Service, Hospital/standards*;Food-Drug Interactions*;Humans;Joint Commission on Accreditation of Healthcare Organizations;United States
10185288;Adverse Drug Reaction Reporting Systems*;Counseling;Dietary Services/organization & administration;Dietary Services/standards*;Food Service, Hospital/organization & administration;Food Service, Hospital/standards*;Food-Drug Interactions*;Guideline Adherence;Humans;Joint Commission on Accreditation of Healthcare Organizations;Patient Education as Topic/standards;Total Quality Management;United States
9650536;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Calcium Channel Blockers/therapeutic use*;Diabetic Nephropathies/drug therapy;Diabetic Nephropathies/metabolism;Diuretics/therapeutic use*;Drug Therapy, Combination;Food-Drug Interactions;Heart Diseases/drug therapy*;Heart Diseases/metabolism;Humans;Hypertension/drug therapy*;Hypertension/metabolism;Myocardial Infarction/drug therapy;Myocardial Infarction/metabolism
9638385;Drug Administration Schedule;Drug Labeling;Education, Pharmacy;Food-Drug Interactions*;Humans;Inpatients*;Patient Education as Topic
9629990;Administration, Oral;Adult;Area Under Curve;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics*
9620116;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Biological Availability;Enteral Nutrition*;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Male;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*
9620100;Acetaminophen/adverse effects;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Acetaminophen/therapeutic use;Adolescent;Adult;Aged;Aged, 80 and over;Analgesics/adverse effects;Analgesics/pharmacokinetics;Analgesics/pharmacology*;Analgesics/therapeutic use;Benzophenones/administration & dosage;Benzophenones/pharmacokinetics;Benzophenones/pharmacology*;Benzophenones/therapeutic use;Biological Availability;Bromobenzenes/administration & dosage;Bromobenzenes/pharmacokinetics;Bromobenzenes/pharmacology*;Bromobenzenes/therapeutic use;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naproxen/adverse effects;Naproxen/pharmacokinetics;Naproxen/pharmacology*;Naproxen/therapeutic use;Orthopedic Procedures*;Pain Measurement;Pain, Postoperative/drug therapy*;Time Factors
9612666;Adult;Aryl Hydrocarbon Hydroxylases*;Beverages*;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Female;Food-Drug Interactions*;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine*;Liver/enzymology;Male;Oxidoreductases, N-Demethylating/metabolism*
9611659;Adult;Antitubercular Agents/adverse effects*;Biogenic Amines/adverse effects*;Cheese/adverse effects*;Female;Food Hypersensitivity/diagnosis;Food Hypersensitivity/etiology;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*
9604126;Administration, Oral;Adult;Analysis of Variance;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Triazoles/adverse effects;Triazoles/pharmacokinetics*
9602956;Administration, Oral;Adult;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Biological Availability;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Humans;Male;Tetrazoles/blood;Tetrazoles/pharmacokinetics*
9590459;Adult;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Blood Specimen Collection/methods*;Cross-Over Studies;Food-Drug Interactions;Humans;Nipecotic Acids/blood;Nipecotic Acids/pharmacokinetics*;Reproducibility of Results;Therapeutic Equivalency
9585793;Acids/blood;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Lovastatin/blood*;Male;Mixed Function Oxygenases/metabolism;Reference Values
9579961;Acetates/analysis;Acetates/blood;Acetates/pharmacokinetics*;Adult;Amines*;Anticonvulsants/pharmacokinetics*;Cyclohexanecarboxylic Acids*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacokinetics*;Epilepsy/blood;Epilepsy/drug therapy*;Epilepsy/metabolism*;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Saliva/chemistry;gamma-Aminobutyric Acid*
9579238;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Deamino Arginine Vasopressin/blood;Deamino Arginine Vasopressin/pharmacokinetics*;Eating*;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Renal Agents/blood;Renal Agents/pharmacokinetics*;Single-Blind Method;Sodium/blood;Time Factors
9563888;Administration, Oral;Aged;Aged, 80 and over;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Capecitabine;Colorectal Neoplasms/metabolism*;Cross-Over Studies;Deoxycytidine/administration & dosage;Deoxycytidine/analogs & derivatives*;Deoxycytidine/blood;Deoxycytidine/pharmacokinetics;Double-Blind Method;Female;Fluorouracil/analogs & derivatives;Food-Drug Interactions*;Humans;Male;Middle Aged
9578193;Aged;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Antiparkinson Agents/therapeutic use;Area Under Curve;Female;Food-Drug Interactions*;Half-Life;Humans;Indoles/adverse effects;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Parkinson Disease/drug therapy;Parkinson Disease/metabolism*
9578182;Adult;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/metabolism;Saquinavir/pharmacokinetics*
9563073;Adult;Animals;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage*;Dietary Fats/blood;Disopyramide/blood;Disopyramide/pharmacokinetics*;Dogs;Female;Food-Drug Interactions*;Humans;Intestinal Absorption;Liver/metabolism;Male;Piperidines/blood;Piperidines/pharmacokinetics*;Species Specificity;Structure-Activity Relationship
9563071;Adult;Area Under Curve;Biological Availability;Capsules;Colon/diagnostic imaging*;Cross-Over Studies;Eating;Female;Food-Drug Interactions*;Gastric Emptying;Gastrointestinal Transit;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Humans;Intestinal Absorption;Intestine, Small/diagnostic imaging*;Male;Radionuclide Imaging;Saquinavir/blood;Saquinavir/pharmacokinetics*;Technetium
9562227;Administration, Oral;Adult;Analysis of Variance;Antioxidants/pharmacology;Area Under Curve;Beverages*;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Gas;Citrus*;Confidence Intervals;Cross-Over Studies;Flavanones*;Flavonoids/blood;Flavonoids/pharmacology;Food-Drug Interactions*;Hemodynamics/drug effects;Humans;Male;Nimodipine/administration & dosage;Nimodipine/blood;Nimodipine/pharmacokinetics*;Reference Values;Water
9562133;Acetates/blood;Acetates/pharmacokinetics*;Adult;Amines*;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cyclohexanecarboxylic Acids*;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Female;Food-Drug Interactions*;Humans;Male;gamma-Aminobutyric Acid*
9559810;Adult;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Beverages*;Citrus/chemistry*;Clarithromycin/pharmacokinetics*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Humans;Male;Mixed Function Oxygenases/metabolism
9555149;Anti-Allergic Agents/adverse effects*;Citrus/adverse effects*;Food-Drug Interactions*;Terfenadine/adverse effects*
9555148;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans;Terfenadine/adverse effects*;Terfenadine/pharmacology
9554320;Animals;Antidepressive Agents/metabolism;Antidepressive Agents/pharmacokinetics*;Antidepressive Agents/pharmacology;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Enzyme Induction/drug effects;Food-Drug Interactions;Genetic Variation;Humans;Polymorphism, Genetic;Serotonin/physiology;Serotonin/poisoning;Serotonin Uptake Inhibitors/metabolism;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology;Stereoisomerism;Syndrome
9550749;Citrus/adverse effects*;Drug Synergism;Food-Drug Interactions*;Humans;Terfenadine/pharmacokinetics*;Terfenadine/therapeutic use
9545149;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/antagonists & inhibitors;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Cyclodextrins/blood;Cyclodextrins/urine;Dose-Response Relationship, Drug;Drug Evaluation;Eating;Fasting;Food/adverse effects*;Food-Drug Interactions/physiology*;Humans;Itraconazole/administration & dosage;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Middle Aged;Pharmaceutical Solutions;beta-Cyclodextrins*
9533066;Acetazolamide/therapeutic use;Anticonvulsants/therapeutic use;Avitaminosis/chemically induced;Child;Child, Preschool;Dehydration/chemically induced;Food, Formulated*/adverse effects;Food-Drug Interactions;Forecasting;Humans;Infant;Phenobarbital/therapeutic use;Seizures/diet therapy*;Seizures/drug therapy
9527781;Adult;Analysis of Variance;Dietary Fats/adverse effects*;Double-Blind Method;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/administration & dosage*;Indinavir/blood;Indinavir/pharmacokinetics*;Male;Metabolic Clearance Rate
9523309;Acetaminophen/pharmacokinetics*;Adult;Area Under Curve;Caffeine/pharmacokinetics*;Female;Food-Drug Interactions*;Gastric Emptying*;Humans;Male;Viscosity
9523307;Animals;Anti-Arrhythmia Agents/administration & dosage;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Dogs;Female;Food-Drug Interactions*;Humans;Infusions, Intravenous;Intestinal Absorption*;Male;Piperidines/administration & dosage;Piperidines/blood;Piperidines/pharmacokinetics*;Viscosity
9522033;Amylases/secretion;Animals;Bicarbonates/metabolism;Dogs;Female;Food-Drug Interactions*;Hormone Antagonists/blood;Hormone Antagonists/pharmacology*;Male;Pancreas/drug effects;Pancreas/enzymology;Pancreas/secretion*;Pancreatic Juice/drug effects;Pancreatic Juice/metabolism;Proglumide/analogs & derivatives*;Proglumide/blood;Proglumide/pharmacology;Receptors, Cholecystokinin/antagonists & inhibitors*;Trypsin/secretion
9510981;Adult;Area Under Curve;Biological Availability;Chromatography, Liquid;Cross-Over Studies;Fasting/metabolism;Food-Drug Interactions*;Half-Life;Humans;Indoles/pharmacokinetics*;Mass Spectrometry;Quinolizines/pharmacokinetics*;Serotonin Antagonists/pharmacokinetics*;Tablets
9503566;Blood Pressure/drug effects*;Diet*;Food-Drug Interactions*;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Substrate Specificity;Tyramine/administration & dosage*;Tyramine/metabolism
9505992;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Area Under Curve;Bilirubin/metabolism*;Cross-Over Studies;Cyclosporins/administration & dosage;Cyclosporins/pharmacokinetics*;Dietary Fats/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics*
9505987;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclohexanols/blood;Cyclohexanols/pharmacokinetics*;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Serotonin Uptake Inhibitors/blood;Serotonin Uptake Inhibitors/pharmacokinetics*;Venlafaxine Hydrochloride
9494251;Adolescent;Adult;Amino Acids/administration & dosage;Child;Child, Preschool;Diet;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Doping in Sports;Energy Intake;Energy Metabolism;Female;Food-Drug Interactions;Humans;Infant;Male;Middle Aged;Minerals/administration & dosage;Nutritional Physiological Phenomena*;Physical Exertion;Sports*/physiology;Vitamins/administration & dosage;Work/physiology
9475824;Common Cold/drug therapy*;Common Cold/prevention & control;Food-Drug Interactions;Gluconates/administration & dosage;Gluconates/adverse effects;Gluconates/therapeutic use;Humans;Placebo Effect;Randomized Controlled Trials as Topic;Tablets;Zinc/administration & dosage;Zinc/adverse effects;Zinc/therapeutic use*;Zinc Acetate/adverse effects;Zinc Acetate/therapeutic use
9469677;Adult;Area Under Curve;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Female;Food-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Kidney Failure, Chronic/metabolism;Kidney Failure, Chronic/therapy;Kidney Transplantation/physiology*;Male;Middle Aged
9469675;Adolescent;Adult;Antipsychotic Agents/pharmacokinetics*;Antipsychotic Agents/pharmacology;Area Under Curve;Attention/drug effects*;Cross-Over Studies;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Piperazines/pharmacokinetics*;Piperazines/pharmacology;Thiazoles/pharmacokinetics*;Thiazoles/pharmacology
9465974;Education, Pharmacy/standards*;Food-Drug Interactions*;Georgia;Humans;Joint Commission on Accreditation of Healthcare Organizations;Patient Education as Topic*;Pharmacy Service, Hospital/standards*
9465845;Beverages;Citrus*;Drug Labeling*;Food-Drug Interactions*;Humans;Pharmacy;Practice Guidelines as Topic;Victoria
9455715;Area Under Curve;Biological Availability;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Diet;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Fasting;Food-Drug Interactions*;Gastric Emptying/physiology;Humans;Intestinal Absorption;Lipid Metabolism;Lipids/chemistry;Male;Tablets;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
9455713;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamazepine/administration & dosage;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions*;Humans;Intestinal Absorption;Male
9450162;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Male;Valproic Acid/pharmacokinetics*
9386217;Contraindications;Enteral Nutrition/adverse effects;Enteral Nutrition/instrumentation;Enteral Nutrition/nursing*;Food, Formulated;Food-Drug Interactions;Humans;Parenteral Nutrition;Patient Selection
9423141;Adenine/administration & dosage;Adenine/analogs & derivatives*;Adenine/pharmacokinetics;Adenine/therapeutic use;Administration, Oral;Animals;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacokinetics*;Antiviral Agents/therapeutic use;Biological Availability;Dogs;Fasting;Food-Drug Interactions;Hydrogen-Ion Concentration;Injections, Intravenous;Male;Organophosphonates*;Pentagastrin/pharmacology;Solubility;Tablets
9390116;Beverages;Citrus*;Food-Drug Interactions;Histamine H1 Antagonists/pharmacokinetics*;Humans;Information Services*;Terfenadine/pharmacokinetics*;United States
9357093;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Citrus*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Pectins/pharmacology*;Valproic Acid/pharmacokinetics*
9354216;2-Pyridinylmethylsulfinylbenzimidazoles;Amoxicillin/therapeutic use;Anti-Bacterial Agents/administration & dosage*;Anti-Ulcer Agents/administration & dosage*;Clarithromycin/therapeutic use;Drug Therapy, Combination;Food-Drug Interactions*;Helicobacter Infections/drug therapy*;Helicobacter pylori*;Humans;Lansoprazole;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives*
9353575;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Diet, Fat-Restricted;Dietary Fats/administration & dosage;Food-Drug Interactions;Humans;Intestinal Absorption;Isosorbide Dinitrate/administration & dosage;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/pharmacokinetics;Male;Middle Aged;Vasodilator Agents/administration & dosage;Vasodilator Agents/pharmacokinetics*
9330784;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Diet;Dietary Fats/administration & dosage*;Fasting;Food-Drug Interactions*;Histamine Antagonists/administration & dosage;Histamine Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Mass Spectrometry;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics
9330779;Administration, Oral;Adult;Analysis of Variance;Antidepressive Agents/administration & dosage;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Diet;Fasting;Food-Drug Interactions*;Humans;Male;Piperazines/administration & dosage;Piperazines/pharmacokinetics*;Pyrimidines/administration & dosage;Pyrimidines/pharmacokinetics*
9333047;Adolescent;Adult;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Anti-Ulcer Agents/pharmacology*;Area Under Curve;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Half-Life;Humans;Levofloxacin*;Male;Ofloxacin/adverse effects;Ofloxacin/pharmacokinetics*;Reference Values;Spectrophotometry, Ultraviolet;Sucralfate/pharmacology*
9322548;Absorption;Adolescent;Adult;Aged;Aging/metabolism*;Anemia, Pernicious/metabolism;Food-Drug Interactions;Humans;Malabsorption Syndromes/etiology;Malabsorption Syndromes/metabolism;Middle Aged;Stomach/metabolism*;Vitamin B 12/blood*;Vitamin B 12/metabolism;Vitamin B 12/pharmacokinetics;Vitamin B 12 Deficiency/blood*;Vitamin B 12 Deficiency/etiology;Vitamin B 12 Deficiency/metabolism
9332549;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use;Antifungal Agents/pharmacokinetics*;Antifungal Agents/therapeutic use;Antiviral Agents/pharmacokinetics;Antiviral Agents/therapeutic use;Biological Availability;Food-Drug Interactions*;Ganciclovir/pharmacokinetics;Ganciclovir/therapeutic use;Gastric Acid/metabolism;Humans;Itraconazole/pharmacokinetics*;Itraconazole/therapeutic use;Saquinavir/pharmacokinetics;Saquinavir/therapeutic use
9312310;Administration, Oral;Adult;Analysis of Variance;Androgen Antagonists/administration & dosage;Androgen Antagonists/blood;Androgen Antagonists/pharmacokinetics*;Anilides/administration & dosage;Anilides/blood;Anilides/pharmacokinetics*;Animals;Area Under Curve;Dietary Fats/administration & dosage;Eating;Fasting/blood;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Nitriles;Rats;Stereoisomerism;Tosyl Compounds
9279885;Animals;Anti-Arrhythmia Agents/pharmacokinetics*;Bile/metabolism;Colon/metabolism;Disopyramide/pharmacokinetics*;Fasting;Food-Drug Interactions*;Gastrointestinal Transit/drug effects;Hydrogen-Ion Concentration;Ileum/metabolism;Intestinal Absorption/drug effects;Jejunum/metabolism;Male;Permeability;Piperidines/pharmacokinetics*;Rats;Sodium Chloride/pharmacology
9269874;Acetates/administration & dosage;Acetates/blood*;Amines*;Animals;Anticonvulsants/administration & dosage;Anticonvulsants/blood*;Area Under Curve;Cyclohexanecarboxylic Acids*;Diet;Dogs;Female;Food-Drug Interactions;Intestinal Absorption;Jejunum;Male;Rats;Rats, Sprague-Dawley;gamma-Aminobutyric Acid*
9267685;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology*;Analysis of Variance;Antacids/pharmacology*;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting/blood;Food-Drug Interactions*;Humans;Imidazoles/administration & dosage;Imidazoles/blood;Imidazoles/pharmacokinetics*;Indoles/administration & dosage;Indoles/blood;Indoles/pharmacokinetics*;Magnesium Hydroxide/pharmacology*;Male;Solutions;Tablets
9267682;Absorption;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Aromatase Inhibitors*;Biological Availability;Cross-Over Studies;Eating;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Fasting/blood;Food-Drug Interactions*;Humans;Male;Nitriles/administration & dosage;Nitriles/blood;Nitriles/pharmacokinetics*;Reproducibility of Results;Tablets, Enteric-Coated;Triazoles/administration & dosage;Triazoles/blood;Triazoles/pharmacokinetics*
9263375;Area Under Curve;Chemistry, Pharmaceutical;Clinical Trials as Topic;Cyclosporine/chemistry;Cyclosporine/pharmacokinetics*;Food-Drug Interactions;Guidelines as Topic;Humans;Immunosuppressive Agents/chemistry;Immunosuppressive Agents/pharmacokinetics*;Therapeutic Equivalency*;Time Factors;Transplantation
9262944;Animals;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Digestive System/drug effects*;Digestive System/microbiology;Digestive System Physiological Phenomena;Fat Substitutes/chemistry;Fat Substitutes/metabolism*;Fat Substitutes/toxicity*;Fatty Acids/chemistry;Fatty Acids/metabolism*;Fatty Acids/toxicity*;Food-Drug Interactions;Guidelines as Topic;Humans;Intestinal Absorption;Pharmaceutical Preparations/metabolism;Sucrose/analogs & derivatives*;Sucrose/chemistry;Sucrose/metabolism;Sucrose/toxicity
9260035;Adrenergic Uptake Inhibitors/chemistry;Adrenergic Uptake Inhibitors/pharmacokinetics*;Anti-Arrhythmia Agents/chemistry;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Antirheumatic Agents/chemistry;Antirheumatic Agents/pharmacokinetics*;Area Under Curve;Computer Simulation;Disopyramide/chemistry;Disopyramide/pharmacokinetics;Doxepin/chemistry;Doxepin/pharmacokinetics;Drug Interactions;Flurbiprofen/chemistry;Flurbiprofen/pharmacokinetics;Food-Drug Interactions;Guidelines as Topic;Hydroxychloroquine/chemistry;Hydroxychloroquine/pharmacokinetics;Ibuprofen/chemistry;Ibuprofen/pharmacokinetics;Nadolol/chemistry;Nadolol/pharmacokinetics;Nortriptyline/chemistry;Nortriptyline/pharmacokinetics;Propafenone/chemistry;Propafenone/pharmacokinetics;Stereoisomerism;Therapeutic Equivalency;Verapamil/chemistry;Verapamil/pharmacokinetics
9260033;Administration, Cutaneous;Aging/metabolism;Area Under Curve;Cohort Studies;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology;Male;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacokinetics*;Monoamine Oxidase Inhibitors/pharmacology*;Selegiline/administration & dosage;Selegiline/pharmacokinetics*;Selegiline/pharmacology*;Sex Factors;Structure-Activity Relationship;Tissue Distribution
9241001;Beverages*;Child;Food-Drug Interactions*;Fruit*;Humans;Psychotropic Drugs/pharmacology*
9290996;Adult;Aged;Anti-Ulcer Agents/adverse effects*;Enteral Nutrition/adverse effects*;Equipment Failure;Esophageal Stenosis/diagnosis;Esophageal Stenosis/etiology*;Esophageal Stenosis/therapy;Fatal Outcome;Female;Food-Drug Interactions;Humans;Intubation, Gastrointestinal/adverse effects*;Male;Middle Aged;Sucralfate/adverse effects*;Vomiting/etiology*
9220063;Anaphylaxis/diagnosis;Animals;Antitubercular Agents/adverse effects*;Diagnosis, Differential;Food-Drug Interactions*;Foodborne Diseases/diagnosis*;Foodborne Diseases/etiology;Humans;Isoniazid/adverse effects*;Tuna*
9210983;Adult;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Coffee*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Milk*;Tea*;Tetracycline/administration & dosage;Tetracycline/pharmacokinetics*
9211455;Biological Availability;Diet;Enteral Nutrition/adverse effects;Enteral Nutrition/nursing*;Food-Drug Interactions*;Gastric Emptying/physiology;Humans;Intubation, Gastrointestinal;Sorbitol/adverse effects
9205821;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Blood Cell Count/drug effects;Blood Chemical Analysis;Blood Pressure/drug effects;Body Temperature/drug effects;Chromatography, Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Endopeptidases/metabolism;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Food-Drug Interactions;Heart Rate/drug effects;Humans;Japan;Male;Mass Spectrometry;Pilot Projects;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine
9845494;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Biological Availability;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/blood;HIV Infections/etiology;HIV Infections/prevention & control*;Health Personnel*;Humans;Occupational Exposure/adverse effects*;Patient Compliance
9164129;Food-Drug Interactions;Humans;Nutritional Requirements*;Nutritional Support*;Parkinson Disease/diet therapy*;Parkinson Disease/physiopathology
9160173;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use*;Arteriosclerosis/drug therapy;Arteriosclerosis/etiology;Brain/metabolism;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/therapeutic use*;Fatty Acids, Monounsaturated/pharmacokinetics;Fatty Acids, Monounsaturated/therapeutic use;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hypercholesterolemia/complications;Hypercholesterolemia/drug therapy;Indoles/pharmacokinetics;Indoles/therapeutic use;Liver/metabolism;Lovastatin/analogs & derivatives;Lovastatin/pharmacokinetics;Lovastatin/therapeutic use;Pravastatin/pharmacokinetics;Pravastatin/therapeutic use;Simvastatin
9155792;Adult;Cheese/adverse effects*;Emergencies;Female;Food-Drug Interactions*;Humans;Hypertension/drug therapy;Hypertension/etiology*;Hypertension/nursing;Monoamine Oxidase Inhibitors/adverse effects*
9140560;Allopurinol/administration & dosage;Allopurinol/blood;Allopurinol/pharmacokinetics*;Animals;Chromatography, High Pressure Liquid/methods;Chromatography, High Pressure Liquid/veterinary;Creatinine/urine;Cross-Over Studies;Diet/veterinary*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacology*;Dogs/blood;Dogs/metabolism*;Dose-Response Relationship, Drug;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions;Injections, Intravenous;Minerals/analysis;Oxypurinol/administration & dosage;Oxypurinol/blood;Oxypurinol/pharmacokinetics*;Time Factors
9129871;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology;Calcium Channel Blockers/therapeutic use*;Delayed-Action Preparations;Drug Interactions;Food-Drug Interactions;Humans;Myocardial Ischemia/drug therapy*;Myocardial Ischemia/metabolism;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology;Nisoldipine/therapeutic use*;Randomized Controlled Trials as Topic
9274239;Adolescent;Adult;Age Factors;Aged;Calcium Compounds/therapeutic use*;Calcium, Dietary/administration & dosage*;Calcium, Dietary/adverse effects;Child;Child, Preschool;Female;Food, Fortified*;Food-Drug Interactions;Humans;Infant;Infant, Newborn;Male;Middle Aged;Nutritional Requirements*;Pregnancy;Sex Factors
9169308;Adrenergic Uptake Inhibitors/pharmacokinetics*;Age Factors;Animals;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Brain/metabolism;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver/drug effects;Liver/enzymology;Liver Diseases/metabolism;Morpholines/pharmacokinetics*;Morpholines/urine;Stereoisomerism
9129557;Adult;Anti-Allergic Agents/pharmacokinetics*;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus/adverse effects*;Electrocardiography/drug effects;Food-Drug Interactions*;Humans;Male;Oxidation-Reduction;Reference Values;Terfenadine/pharmacokinetics*
9129556;Anti-Allergic Agents/adverse effects;Anti-Asthmatic Agents/adverse effects;Citrus*;Food-Drug Interactions*;Humans;Pharmacology;Societies;Terfenadine/adverse effects;Torsades de Pointes/chemically induced;United States;United States Food and Drug Administration
9113437;Absorption;Adolescent;Adult;Aged;Aged, 80 and over;Aging/metabolism;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/urine;Child;Child, Preschool;Clinical Trials as Topic;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Middle Aged;Naproxen/administration & dosage;Naproxen/blood;Naproxen/pharmacokinetics*;Naproxen/urine;Tissue Distribution
9112140;Clinical Trials, Phase I as Topic/methods*;Clinical Trials, Phase I as Topic/standards;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Hemodynamics/drug effects;Hemodynamics/physiology*;Homeostasis;Humans;Pharmacokinetics*;Pharmacology, Clinical*/methods;Pharmacology, Clinical*/standards;Reproducibility of Results;Risk Assessment;Therapeutic Equivalency;Volunteers
9075501;Anticoagulants/antagonists & inhibitors*;Food, Fortified;Food-Drug Interactions*;Humans;Male;Middle Aged;Panax*;Plant Extracts/pharmacology;Plants, Medicinal*;Warfarin/antagonists & inhibitors*
9144013;Aged;Aged, 80 and over;Animals;Female;Food-Drug Interactions*;Histamine/poisoning*;Humans;Isoniazid/administration & dosage;Isoniazid/adverse effects*;Tuberculosis, Lymph Node/drug therapy*;Tuna*
9105546;Administration, Oral;Animals;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Autoradiography;Biotransformation;Dioxolanes/administration & dosage;Dioxolanes/blood;Dioxolanes/pharmacokinetics*;Dogs;Female;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Injections, Intravenous;Intestinal Absorption;Macaca fascicularis;Male;Piperazines/administration & dosage;Piperazines/blood;Piperazines/pharmacokinetics*;Quinolones/administration & dosage;Quinolones/blood;Quinolones/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Sex Characteristics;Tissue Distribution
9082033;16,16-Dimethylprostaglandin E2/administration & dosage;16,16-Dimethylprostaglandin E2/pharmacology*;Absorption;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacology*;Chromium/pharmacokinetics*;Chromium/urine;Chromium Radioisotopes;Enteral Nutrition;Epoprostenol/administration & dosage;Epoprostenol/pharmacology*;Food-Drug Interactions;Indomethacin/administration & dosage;Indomethacin/pharmacology*;Injections, Intraperitoneal;Male;Misoprostol/administration & dosage;Misoprostol/pharmacology*;Random Allocation;Rats;Rats, Sprague-Dawley;Tissue Distribution
9050793;Bile/metabolism;Biological Availability;Clinical Trials as Topic;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions/physiology*;Gastrointestinal Transit/drug effects;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects*;Intestinal Absorption/physiology;Lymphatic System/metabolism;Permeability;Pharmaceutical Preparations/metabolism*;Postprandial Period;Stomach/drug effects*;Stomach/metabolism
9095977;Drug Therapy/methods*;Enteral Nutrition;Food-Drug Interactions;Humans;Intestinal Absorption
9043563;Adult;Drug Administration Schedule;Drug Labeling*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Nurses;Nutritional Status/drug effects;Patient Education as Topic;Pharmacists;Pharmacy Service, Hospital;Pilot Projects;Surveys and Questionnaires
10423596;Adult;Area Under Curve;Biological Availability;Butyrophenones/administration & dosage;Butyrophenones/adverse effects;Butyrophenones/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Food-Drug Interactions;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Tablets
9552426;Calorimetry, Differential Scanning;Cellulose/chemistry;Chemistry, Pharmaceutical;Chlorpheniramine/administration & dosage;Delayed-Action Preparations*;Dietary Fats;Elasticity;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/administration & dosage;Microscopy, Electron, Scanning;Peanut Oil;Plant Oils;Solubility;Spectrophotometry, Ultraviolet
9162174;Asthma/chemically induced;Asthma/immunology;Asthma/pathology;Benzoates/adverse effects*;Child;Child, Preschool;Drug Compounding;Drug Eruptions/etiology;Drug Eruptions/immunology;Drug Eruptions/pathology;Drug Hypersensitivity/epidemiology;Drug Hypersensitivity/etiology*;Drug Hypersensitivity/immunology;Drug Hypersensitivity/pathology;Eczema/chemically induced;Eczema/immunology;Eczema/pathology;Female;Food Hypersensitivity/epidemiology;Food Hypersensitivity/etiology*;Food Hypersensitivity/immunology;Food Hypersensitivity/pathology;Food Preservatives/adverse effects*;Food-Drug Interactions;Humans;Hypersensitivity, Immediate/genetics;Infant;Male;Radioallergosorbent Test;Skin Tests;Urticaria/chemically induced;Urticaria/immunology;Urticaria/pathology
9147710;Adult;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/blood;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Food-Drug Interactions/physiology*;Half-Life;Humans;Spectrophotometry, Ultraviolet;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
9062858;Analysis of Variance;Chlorhexidine/adverse effects;Chlorhexidine/chemistry;Chlorhexidine/pharmacology*;Coffee/adverse effects*;Food-Drug Interactions*;Humans;Saliva;Spectrophotometry, Ultraviolet;Tea/adverse effects*;Tooth Discoloration/chemically induced*
9062853;Anti-Infective Agents, Local/chemistry;Anti-Infective Agents, Local/pharmacology*;Bacteria, Anaerobic/drug effects*;Food-Drug Interactions*;Gels;Microbial Sensitivity Tests;Tea*/adverse effects;Tea*/chemistry;Tin Fluorides/adverse effects;Tin Fluorides/chemistry;Tin Fluorides/pharmacology*;Tin Polyphosphates/chemistry;Tin Polyphosphates/pharmacology;Tooth Discoloration/chemically induced*;Toothpastes
9022564;Acute Kidney Injury/chemically induced;Aminoglycosides;Amphotericin B/adverse effects;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Animals;Anti-Bacterial Agents/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Antihypertensive Agents/pharmacology;Antihypertensive Agents/therapeutic use;Cisplatin/adverse effects;Contrast Media/adverse effects;Diet, Sodium-Restricted/adverse effects*;Food-Drug Interactions*;Humans;Hypertension/therapy*;Immunosuppressive Agents/adverse effects;Renal Circulation/drug effects
9480647;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects;Bacteriophages/drug effects;Dietary Fiber/pharmacology;Drug Antagonism;Food-Drug Interactions;Pectins/pharmacology*;Penicillinase/metabolism*;Penicillins/pharmacology*;Plant Proteins/pharmacology;Soybean Proteins/pharmacology
9433652;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Diet;Drug Interactions;Famotidine/pharmacology*;Fasting;Fluoroquinolones*;Food-Drug Interactions*;Gastric Acid*;Histamine H2 Antagonists/pharmacology*;Humans;Male;Piperazines/administration & dosage;Piperazines/blood;Piperazines/pharmacokinetics*;Quinolones/administration & dosage;Quinolones/blood;Quinolones/pharmacokinetics*
9342171;Animals;Beverages;Binding Sites;Cimetidine/metabolism;Citrus;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions*;Ethinyl Estradiol/metabolism;Food-Drug Interactions;Humans;Mixed Function Oxygenases/metabolism;Pharmaceutical Preparations/metabolism*;Terfenadine/metabolism
9248388;Food-Drug Interactions*;Humans;Risk Factors
9112062;Adult;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Delayed-Action Preparations;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Hypertension/drug therapy;Hypertension/physiopathology;Male;Middle Aged;Models, Biological;Nisoldipine/administration & dosage;Nisoldipine/pharmacokinetics*;Nisoldipine/pharmacology*
9068936;1-Naphthylamine/administration & dosage;1-Naphthylamine/analogs & derivatives*;1-Naphthylamine/pharmacokinetics;Adolescent;Adult;Area Under Curve;Circadian Rhythm;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Middle Aged;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacokinetics*;Sertraline
9049582;Administration, Oral;Adult;Cholesterol/blood*;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics*;Single-Blind Method;Sterol O-Acyltransferase/antagonists & inhibitors*;Sterol O-Acyltransferase/blood*
8996854;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/chemistry;Diclofenac/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
8988067;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Acetaminophen/urine;Administration, Oral;Adult;Anticarcinogenic Agents/metabolism;Chromatography, High Pressure Liquid;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Isothiocyanates/metabolism;Lung Neoplasms/metabolism;Lung Neoplasms/prevention & control;Male;Middle Aged;Oxidation-Reduction;Reference Values;Vegetables*
8971430;Adult;Area Under Curve;Biological Availability;Bumetanide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Diuretics/pharmacokinetics*;Food-Drug Interactions*;Furosemide/pharmacokinetics*;Humans;Intestinal Absorption;Male
9074912;Aged;Antiparkinson Agents/therapeutic use*;Blood Pressure/drug effects;Brain Chemistry/drug effects*;Bromocriptine/therapeutic use*;Double-Blind Method;Female;Food-Drug Interactions;Heart Rate/drug effects;Hemodynamics/drug effects*;Humans;Levodopa/therapeutic use*;Lisuride/therapeutic use*;Male;Middle Aged;Parkinson Disease/drug therapy*;Parkinson Disease/physiopathology;Tilt-Table Test
8947993;Adult;Analgesics/administration & dosage*;Analgesics/pharmacokinetics*;Animals;Benzophenones/administration & dosage*;Benzophenones/pharmacokinetics*;Biological Availability;Bromobenzenes/administration & dosage*;Bromobenzenes/pharmacokinetics*;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Mice;Models, Biological;Pain/drug therapy*;Randomized Controlled Trials as Topic;Retrospective Studies
8947977;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects*;Caffeine/pharmacokinetics*;Caffeine/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male
8947972;Anticoagulants/blood;Anticoagulants/therapeutic use*;Drug Antagonism;Drug Resistance;Food-Drug Interactions;Humans;Thrombosis/drug therapy;Treatment Refusal;Vitamin K/pharmacology;Warfarin/blood;Warfarin/therapeutic use*
8906150;Dietetics/standards*;Food Service, Hospital/standards*;Food-Drug Interactions;Guidelines as Topic;Humans;Joint Commission on Accreditation of Healthcare Organizations*;Nutrition Assessment;Patient Education as Topic/standards;United States
8906141;Animals;Food-Drug Interactions;Humans;Immune System/physiology*;Nutrition Disorders/immunology*;Nutritional Physiological Phenomena*
8932097;Computer-Assisted Instruction/methods*;Drug Therapy/methods*;Food-Drug Interactions*;Humans;Patient Care Team;Patient Education as Topic/methods*
8930779;Adult;Analysis of Variance;Biological Availability;Chromatography;Cross-Over Studies;Delayed-Action Preparations;Drug Combinations;Ephedrine/administration & dosage;Ephedrine/adverse effects;Ephedrine/blood;Ephedrine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Loratadine/administration & dosage;Loratadine/adverse effects;Loratadine/blood;Loratadine/pharmacokinetics*;Male;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/adverse effects;Vasoconstrictor Agents/blood;Vasoconstrictor Agents/pharmacokinetics*
8930778;Adult;Biological Availability;Clemastine/administration & dosage;Clemastine/blood;Clemastine/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Combinations;Drug Therapy, Combination;Food-Drug Interactions;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Least-Squares Analysis;Male;Metabolic Clearance Rate;Middle Aged;Phenylpropanolamine/administration & dosage;Phenylpropanolamine/blood;Phenylpropanolamine/pharmacokinetics*;Radioimmunoassay;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/blood;Vasoconstrictor Agents/pharmacokinetics*
8930774;Adolescent;Adult;Analysis of Variance;Anticonvulsants/administration & dosage;Anticonvulsants/analysis;Anticonvulsants/pharmacokinetics*;Biological Availability;Chromatography, Gas;Double-Blind Method;Food-Drug Interactions*;Fructose/administration & dosage;Fructose/analogs & derivatives*;Fructose/analysis;Fructose/pharmacokinetics;Humans;Linear Models;Male;Metabolic Clearance Rate
8859044;Adult;Beverages*;Citrus*;Cyclosporine/administration & dosage*;Food-Drug Interactions;Humans;Male;Middle Aged;Psoriasis/drug therapy*
8889900;Adult;Area Under Curve;Drug Interactions;Female;Food*;Food Analysis;Food-Drug Interactions;Humans;Isotretinoin/pharmacokinetics;Keratolytic Agents/pharmacokinetics*;Metabolic Clearance Rate;Retinoids/blood;Retinoids/pharmacokinetics*;Tretinoin/pharmacokinetics;Vitamin A/administration & dosage*;Vitamin A/analysis
8888098;Deamino Arginine Vasopressin/adverse effects*;Food-Drug Interactions;Humans;Renal Agents/adverse effects*;Water Intoxication/etiology*
9070019;Anticonvulsants/administration & dosage*;Anticonvulsants/pharmacokinetics;Enteral Nutrition*;Food-Drug Interactions;Humans;Phenytoin/administration & dosage*;Phenytoin/pharmacokinetics;Research Design;Time Factors
8881693;Dermatitis, Phototoxic/pathology*;Female;Food-Drug Interactions;Humans;Middle Aged;PUVA Therapy/adverse effects*;Vegetables/adverse effects*
8866042;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diet, Vegetarian;Flurbiprofen/administration & dosage;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Humans;Ibuprofen/administration & dosage;Ibuprofen/pharmacokinetics*;Male
8866038;Administration, Oral;Adult;Area Under Curve;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Excipients;Fasting/metabolism;Food-Drug Interactions;Humans;Male;Middle Aged;Nicardipine/administration & dosage;Nicardipine/pharmacokinetics*;Tablets;Therapeutic Equivalency
11363607;Anti-Infective Agents/administration & dosage*;Antiviral Agents/administration & dosage*;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage*;Humans
8980916;Biological Availability;Diet;Food*;Food-Drug Interactions;Humans;Intestinal Absorption/physiology*;Micronutrients;Nutrition Disorders;Pharmaceutical Preparations/metabolism*
8927634;Animals;Drug Interactions*;Food-Drug Interactions*;Humans;Pharmacokinetics*
8844449;Absorption;Adult;Analysis of Variance;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacokinetics*;Enzyme Inhibitors/pharmacology*;Food-Drug Interactions;Humans;Lactones/pharmacology*;Male;Middle Aged;Phenytoin/blood;Phenytoin/pharmacokinetics*
8842054;Administration, Oral;Adrenergic beta-Antagonists/pharmacokinetics*;Adult;Cross-Over Studies;Dose-Response Relationship, Drug;Eating;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged;Nadolol/pharmacokinetics*;Therapeutic Equivalency
8812227;Acetonitriles/pharmacokinetics*;Animals;Cyanides/blood*;Dietary Proteins/administration & dosage*;Food-Drug Interactions*;Inactivation, Metabolic;Male;Rats;Rats, Sprague-Dawley
8665000;Adrenergic alpha-Antagonists/therapeutic use*;Beverages*;Blood Pressure/drug effects*;Calcium Channel Blockers/therapeutic use*;Citrus*;Food-Drug Interactions;Humans;Hypertension, Renovascular/drug therapy*;Male;Middle Aged;Nifedipine/therapeutic use*;Prazosin/analogs & derivatives*;Prazosin/therapeutic use
8818844;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Azithromycin/administration & dosage;Azithromycin/pharmacokinetics*;Biological Availability;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Powders;Suspensions;Tablets
8799515;Administration, Oral;Aged;Aluminum Hydroxide/pharmacology*;Antacids/pharmacology*;Area Under Curve;Arthritis, Rheumatoid/blood;Arthritis, Rheumatoid/drug therapy;Arthritis, Rheumatoid/metabolism*;Cross-Over Studies;Drug Combinations;Fasting;Female;Food*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Magnesium Hydroxide/pharmacology*;Male;Middle Aged;Mycophenolic Acid/administration & dosage;Mycophenolic Acid/analogs & derivatives*;Mycophenolic Acid/blood;Mycophenolic Acid/pharmacokinetics
8735684;Adolescent;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Middle Aged;Morphine/blood;Morphine/pharmacokinetics*;Narcotics/blood;Narcotics/pharmacokinetics*;Tablets
8726601;Adult;Analysis of Variance;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Antifungal Agents/urine;Cross-Over Studies;Dextrins/administration & dosage*;Dosage Forms;Drug Delivery Systems;Female;Food-Drug Interactions*;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacokinetics*;Itraconazole/urine;Male;Middle Aged
8711315;Anticoagulants/therapeutic use*;Food-Drug Interactions*;Humans;Nutritional Sciences/education*;Patient Discharge*;Vitamin K/pharmacology*;Warfarin/therapeutic use*
8616441;Acne Vulgaris/drug therapy*;Adult;Anti-Bacterial Agents/therapeutic use*;Biological Availability;Food-Drug Interactions*;Humans;Minocycline/therapeutic use*
8901078;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Male;Middle Aged;Nausea/chemically induced;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*
8728348;Adolescent;Adult;Aged;Beverages*;Biological Availability;Citrus*;Cohort Studies;Electroencephalography/drug effects;Female;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Phenotype;Prospective Studies;Terfenadine/blood;Terfenadine/pharmacokinetics*
8713690;Animals;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use
8851570;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Atovaquone;Biological Availability;Food-Drug Interactions;HIV Seropositivity/metabolism*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Suspensions
8786524;Animals;Food-Drug Interactions*;Humans;Nutritional Physiological Phenomena*;Pharmaceutical Preparations*
8693949;Alcoholic Beverages;Beverages;Diet*;Food-Drug Interactions*;Humans;Hypertension/chemically induced*;Mental Disorders/drug therapy;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/metabolism
8617704;Acute Disease;Animals;Beer;Cheese/adverse effects;Depressive Disorder/drug therapy;Diet/adverse effects*;Fishes;Food-Drug Interactions*;Fruit;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Meat;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Poultry;Tyramine/adverse effects;Vegetables
8700059;Algorithms*;Decision Trees*;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Nursing Assessment;Phenytoin/adverse effects*
8920203;Biological Availability;Drug Interactions;Food-Drug Interactions*;Intestinal Absorption/drug effects*
8858282;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Postprandial Period;Stereoisomerism;Thioctic Acid/blood;Thioctic Acid/pharmacokinetics*
8858279;Adult;Beverages*;Citrus*;Cross-Over Studies;Double-Blind Method;Erythromycin/pharmacology;Female;Food-Drug Interactions;Humans;Hypnotics and Sedatives/pharmacology*;Male;Midazolam/blood;Midazolam/pharmacology*;Psychomotor Performance/drug effects*;Triazolam/pharmacology*
8857073;Adult;Analysis of Variance;Anti-Allergic Agents/adverse effects;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Double-Blind Method;Drug Design;Drug Hypersensitivity/drug therapy;Drug Packaging;Food-Drug Interactions;Histamine/pharmacology;Humans;Male;Middle Aged
8857072;Adrenergic Agents/pharmacology*;Adult;Analysis of Variance;Benzamides/adverse effects;Benzamides/therapeutic use*;Blood Pressure/drug effects;Double-Blind Method;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypertension/chemically induced;Injections, Intravenous;Male;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Selegiline/adverse effects;Selegiline/therapeutic use*;Tyramine/pharmacology*
8803526;Administration, Oral;Adult;Analysis of Variance;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Propafenone/analogs & derivatives*;Propafenone/blood;Propafenone/pharmacokinetics
8803525;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;Adult;Bridged Bicyclo Compounds/pharmacokinetics*;Bridged Bicyclo Compounds/pharmacology;Fatty Acids, Monounsaturated/pharmacokinetics*;Fatty Acids, Monounsaturated/pharmacology;Food-Drug Interactions*;Humans;Male;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/pharmacokinetics*;Platelet Aggregation Inhibitors/pharmacology;Prostaglandin Antagonists/pharmacokinetics*;Prostaglandin Endoperoxides, Synthetic/antagonists & inhibitors;Thromboxane A2/analogs & derivatives;Thromboxane A2/antagonists & inhibitors;Vasoconstrictor Agents/antagonists & inhibitors
8737764;Anticoagulants/pharmacokinetics*;Antioxidants/analysis;Beverages*;Chromatography, High Pressure Liquid;Citrus*;Coumarins/pharmacokinetics*;Coumarins/urine;Flavanones*;Flavonoids/analysis;Fluorescence;Food-Drug Interactions*;Humans;Male;Umbelliferones/urine
8737763;Adult;Area Under Curve;Biological Availability;Cholinergic Antagonists/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Female;Food*;Food-Drug Interactions*;Half-Life;Humans;Male;Mandelic Acids/pharmacokinetics*
8729584;Adult;Age Factors;Aged;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use;Drug Interactions;Fatty Acids, Monounsaturated/pharmacokinetics*;Fatty Acids, Monounsaturated/therapeutic use;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Sex Factors;Time Factors
8707145;Caffeine/adverse effects*;Food-Drug Interactions*;Humans;Nicotine/adverse effects*;Nursing Assessment
8685023;Child Nutritional Physiological Phenomena*;Child, Preschool;Diet*;Digestion;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Infant;Infant Food*;Infant, Newborn;Intestinal Absorption;Male;Pharmacokinetics
8603792;Animals;Anisoles/pharmacology;Antimutagenic Agents/pharmacology*;Antioxidants/pharmacology;Bone Marrow/drug effects;Caffeic Acids/pharmacology;Carotenoids/pharmacology;Chlorogenic Acid/pharmacology;Coffee*/metabolism;Coumaric Acids/pharmacology;Curcumin/pharmacology;DNA Damage*/drug effects;Diet*;Ellagic Acid/pharmacology;Eugenol/pharmacology;Flavoring Agents/pharmacology;Food-Drug Interactions*;Male;Mice;Micronucleus Tests;Mutagens/toxicity;Vitamin E/pharmacology;beta Carotene
8603789;Animals;Coffee*/metabolism;Cyclophosphamide/toxicity;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Drosophila melanogaster;Female;Food-Drug Interactions;Male;Mitomycin/toxicity;Mitosis*/drug effects;Mutagens/toxicity*;Mutation*/drug effects;Recombination, Genetic*/drug effects;Urethane/toxicity
8592993;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Biotransformation;Blood Proteins/metabolism;Creatinine/blood;Creatinine/urine;Feces/chemistry;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Humans;Male;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Probenecid/pharmacology;Quinolones/administration & dosage;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Renal Agents/pharmacology;Saliva/metabolism
8564609;Angiotensin-Converting Enzyme Inhibitors/chemistry*;Beverages*;Drug Stability;Drug Storage;Food-Drug Interactions;Fruit/chemistry*;Polyethylene Terephthalates;Ramipril/chemistry*;Solutions;Time Factors;Water/chemistry*
10151952;CD-ROM;Clinical Pharmacy Information Systems/standards*;Computer Graphics;Costs and Cost Analysis;Drug Interactions*;Evaluation Studies as Topic;Food-Drug Interactions;Humans;Microcomputers*;Software/economics;Software/standards*;United States;User-Computer Interface
8587159;Administration, Oral;Animals;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/pharmacology;Biological Availability;Dogs/metabolism*;Dogs/microbiology;Eating/physiology*;Erythromycin/administration & dosage;Erythromycin/blood;Erythromycin/pharmacokinetics;Erythromycin/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions;Gram-Positive Bacteria/drug effects;Intestinal Absorption;Male;Microbial Sensitivity Tests/veterinary;Roxithromycin/administration & dosage;Roxithromycin/blood;Roxithromycin/pharmacokinetics*;Roxithromycin/pharmacology
8587148;Albendazole/administration & dosage;Albendazole/analysis*;Animals;Anthelmintics/administration & dosage;Anthelmintics/analysis*;Diet;Drug Residues/analysis;Drug Residues/standards*;Eating;Food-Drug Interactions;Guidelines as Topic;Humans;International Cooperation;Ivermectin/administration & dosage;Ivermectin/analysis*;Meat Products/analysis;Meat Products/standards*;Therapeutic Equivalency;World Health Organization
8584285;Age Factors;Aged;Anticholesteremic Agents/pharmacokinetics;Drug Interactions;Food-Drug Interactions*;Humans;Hypoglycemic Agents/pharmacokinetics;Intestinal Absorption;Nutritional Status*;Pharmacokinetics
8568017;Administration, Oral;Adult;Atorvastatin Calcium;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Enzyme Inhibitors/pharmacokinetics*;Fasting/blood;Female;Food-Drug Interactions*;Heptanoic Acids/blood;Heptanoic Acids/pharmacokinetics*;Humans;Hydroxymethylglutaryl CoA Reductases/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Male;Middle Aged;Pyrroles/blood;Pyrroles/pharmacokinetics*
8549555;Dietary Fiber/analysis;Dietary Fiber/metabolism*;Food Handling/methods*;Food-Drug Interactions*;Humans;Nutritive Value
8549508;Dietary Fiber/metabolism*;Food-Drug Interactions*;Humans;Intestinal Absorption;Kidney/metabolism;Liver/metabolism;Metabolic Clearance Rate;Tissue Distribution
7573208;Adolescent;Adult;Aged;Aged, 80 and over;Child;Child, Preschool;Drug Hypersensitivity/etiology;Drug Therapy*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions;Humans;Infant;Infant, Newborn;Male;Middle Aged;Patient Education as Topic;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism;Risk
7572551;Asthma/blood;Asthma/drug therapy;Bronchodilator Agents/administration & dosage*;Bronchodilator Agents/pharmacokinetics;Delayed-Action Preparations;Dietary Fats/administration & dosage*;Fasting;Food-Drug Interactions;Humans;Theophylline/administration & dosage*;Theophylline/pharmacokinetics
8577211;Adult;Aged;Analysis of Variance;Biological Availability;Diabetes Mellitus/drug therapy;Diabetes Mellitus/metabolism*;Diet;Eating*;Fasting;Female;Food-Drug Interactions*;Humans;Hypoglycemic Agents/metabolism;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/pharmacokinetics*;Metformin/therapeutic use;Middle Aged;Therapeutic Equivalency
7496046;Alanine/pharmacokinetics;Alkaline Phosphatase/metabolism;Biological Transport/drug effects;Calcium/pharmacokinetics;Choline/pharmacokinetics;Female;Food-Drug Interactions;Humans;Liposomes/metabolism;Microvilli/metabolism;Nutritive Value;Pharmacology/methods*;Placenta/metabolism*;Placenta/ultrastructure*;Pregnancy;Reproducibility of Results;Tritium
7630329;Beverages*;Caffeine/pharmacokinetics;Citrus*;Cyclosporine/pharmacokinetics;Estrogens/pharmacokinetics;Felodipine/pharmacokinetics;Food-Drug Interactions*;Humans;Midazolam/pharmacokinetics;Nifedipine/pharmacokinetics;Terfenadine/pharmacokinetics
8562295;Adult;Analysis of Variance;Beverages;Calcium Channel Blockers/pharmacokinetics*;Citrus*/chemistry;Cross-Over Studies;Delayed-Action Preparations;European Continental Ancestry Group;Felodipine/administration & dosage;Felodipine/analogs & derivatives*;Felodipine/metabolism;Felodipine/pharmacokinetics*;Food-Drug Interactions;Humans;Linear Models;Male;Reproducibility of Results
7648762;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Female;Food-Drug Interactions;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Reference Values;Sleep Stages/drug effects;Triazolam/administration & dosage;Triazolam/blood;Triazolam/pharmacokinetics*;Triazolam/pharmacology
7493544;Adrenergic beta-Antagonists/pharmacokinetics*;Amino Acids/pharmacology*;Animals;Biological Availability;Biotransformation;Dietary Proteins/pharmacology;Dose-Response Relationship, Drug;Food-Drug Interactions*;In Vitro Techniques;Liver/drug effects;Liver/metabolism*;Male;Propranolol/pharmacokinetics*;Rats;Rats, Sprague-Dawley
7473485;Administration, Oral;Adolescent;Antirheumatic Agents/administration & dosage;Antirheumatic Agents/blood;Antirheumatic Agents/pharmacokinetics*;Arthritis, Juvenile/drug therapy*;Biological Availability;Child;Child, Preschool;Fasting*;Female;Food*;Food-Drug Interactions;Humans;Male;Methotrexate/administration & dosage;Methotrexate/blood;Methotrexate/pharmacokinetics*
8751044;Adult;Beverages;Citrus*;Estradiol/metabolism*;Estriol/antagonists & inhibitors;Estriol/metabolism;Estrogen Antagonists/pharmacology*;Estrone/antagonists & inhibitors;Estrone/metabolism;Flavanones*;Flavonoids/pharmacology*;Food-Drug Interactions;Humans;In Vitro Techniques;Kaempferols*;Male;Microsomes, Liver/metabolism*;Middle Aged;Quercetin/analogs & derivatives*;Quercetin/pharmacology*
8751037;Animals;Bronchodilator Agents/blood;Bronchodilator Agents/pharmacokinetics*;Bronchodilator Agents/urine;Capsicum*;Food-Drug Interactions;Male;Plants, Medicinal*;Rabbits;Theophylline/blood;Theophylline/pharmacokinetics*;Theophylline/urine
8580149;Administration, Oral;Animals;Biological Availability;Biotransformation;Blood Proteins/metabolism;Chromatography, High Pressure Liquid;Doping in Sports;Fasting/metabolism;Female;Fenoprofen/pharmacokinetics*;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Horses/metabolism*;Hydrogen-Ion Concentration;Hydrolysis;Indicators and Reagents;Protein Binding;Temperature;Time Factors
8520091;Anticonvulsants/pharmacokinetics;Anticonvulsants/pharmacology*;Anticonvulsants/therapeutic use;Clinical Trials as Topic;Epilepsy/drug therapy;Folic Acid/pharmacology*;Folic Acid Deficiency/drug therapy;Food, Fortified;Food-Drug Interactions*;Humans;Phenytoin/pharmacokinetics;Phenytoin/pharmacology*;Phenytoin/therapeutic use
7628179;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Midazolam/metabolism;Midazolam/pharmacokinetics*;Midazolam/pharmacology*
7592095;Animals;Cattle;Cattle Diseases/physiopathology*;Cholesterol/blood;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Drug Implants;Estrus/physiology;Female;Food-Drug Interactions;Growth Hormone/blood;Insulin/blood;Luteal Phase/drug effects;Luteal Phase/physiology*;Nutrition Disorders/physiopathology;Nutrition Disorders/veterinary*;Ovulation/physiology*;Ovulation Induction/veterinary;Postpartum Period/physiology;Pregnenediones/administration & dosage;Pregnenediones/pharmacology;Progesterone Congeners/administration & dosage;Progesterone Congeners/pharmacology;Random Allocation
7581255;Animals;Biological Availability;Chemical Phenomena;Chemistry, Physical;Cholinergic Antagonists/pharmacology;Delayed-Action Preparations;Dogs;Drug Interactions;Food-Drug Interactions;Hardness Tests;Histamine H1 Antagonists/administration & dosage*;Histamine H1 Antagonists/pharmacokinetics*;In Vitro Techniques;Male;Niacinamide/administration & dosage;Niacinamide/analogs & derivatives*;Niacinamide/pharmacokinetics;Solubility;Tablets;Waxes
7560252;Adolescent;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Drug Tolerance;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Isoxazoles/administration & dosage;Isoxazoles/adverse effects;Isoxazoles/pharmacokinetics*;Male;Metabolic Clearance Rate;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Time Factors
7651978;Biological Availability;Food-Drug Interactions*;Pectins/chemistry;Pectins/pharmacology*;Permeability;Propranolol/pharmacokinetics*;Structure-Activity Relationship;Viscosity
7582380;Absorption;Administration, Oral;Adult;Analysis of Variance;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Beverages*;Biotransformation;Chemical Fractionation;Chromatography, High Pressure Liquid;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP1A2;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Flavanones*;Flavonoids/pharmacokinetics;Flavonoids/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Male;Oxidoreductases/metabolism;Reference Values;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
7550125;Clarithromycin/chemistry;Clarithromycin/pharmacokinetics;Food-Drug Interactions;Gastrointestinal Transit/physiology*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Models, Biological;Pharmacokinetics*;Solubility
7722194;Administration, Oral;Alcoholic Beverages/adverse effects;Allium;Anticoagulants/administration & dosage;Anticoagulants/pharmacology*;Beverages;Caffeine/pharmacology;Coumarins/administration & dosage;Coumarins/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Peptide Hydrolases/administration & dosage;Peptide Hydrolases/pharmacology;Silicones/administration & dosage;Silicones/pharmacology;Vitamin K/administration & dosage;Vitamin K/pharmacology;Vitamins/administration & dosage;Vitamins/pharmacology
7722187;Adult;Aged;Bumetanide/adverse effects;Bumetanide/therapeutic use*;Cross-Sectional Studies;Diet Records;Female;Food-Drug Interactions;Furosemide/adverse effects;Furosemide/therapeutic use*;Heart Failure/complications;Heart Failure/drug therapy*;Heart Failure/physiopathology;Humans;Male;Middle Aged;Prevalence;Risk Factors;Thiamine/administration & dosage;Thiamine Deficiency/chemically induced;Thiamine Deficiency/epidemiology*;Thiamine Deficiency/etiology;Ventricular Function, Left
7669261;Absorption;Anti-Infective Agents/pharmacokinetics*;Chelating Agents/pharmacology;Drug Interactions;Fluoroquinolones;Food-Drug Interactions;Humans
7661453;Allopurinol/pharmacology*;Ammonia/urine*;Animals;Diet, Protein-Restricted/veterinary;Dietary Proteins/pharmacology*;Dogs/urine*;Female;Food-Drug Interactions;Uric Acid/blood;Uric Acid/urine*;Urinary Calculi/therapy;Urinary Calculi/veterinary;Xanthines/blood;Xanthines/urine*
7659846;Amikacin/metabolism;Ampicillin/metabolism;Animals;Anti-Bacterial Agents/metabolism*;Cecum/metabolism*;Food-Drug Interactions*;Gastrointestinal Contents;Horses/metabolism*;Hydrogen-Ion Concentration;In Vitro Techniques;Oxytetracycline/metabolism;Penicillin G/metabolism;Time Factors
7659841;Animals;Biological Availability;Digoxin/blood;Digoxin/pharmacokinetics*;Dogs/metabolism*;Dose-Response Relationship, Drug;Eating;Female;Food-Drug Interactions;Male;Tablets
7657851;Adult;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics;Cross-Over Studies;Diet, Atherogenic;Food*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Prodrugs/pharmacokinetics*;Time Factors
7621642;Adult;Extremities/blood supply*;Fasting/metabolism;Female;Food-Drug Interactions*;Forearm/blood supply;Humans;Leg/blood supply;Male;Plethysmography*;Regional Blood Flow/physiology
7585849;Adult;Anti-Ulcer Agents/pharmacology*;Chronic Disease;Dietary Fats/pharmacology;Feces/chemistry;Food-Drug Interactions;Gastric Acid/metabolism*;Humans;Hydrogen-Ion Concentration;Intestine, Small/drug effects;Intestine, Small/metabolism*;Lipid Metabolism;Middle Aged;Omeprazole/pharmacology*;Pancreatitis/blood;Pancreatitis/complications;Pancreatitis/metabolism*;Proton Pump Inhibitors
7634121;Biological Availability;Carbohydrates/pharmacology*;Ciprofloxacin/pharmacokinetics*;Dietary Sucrose*;Food, Formulated*;Food-Drug Interactions*;Humans;Intestinal Absorption;Ofloxacin/pharmacokinetics*
8681219;Adolescent;Adult;Age Factors;Child;Child, Preschool;Drug Therapy/classification;Drug Therapy/methods;Drug Therapy/nursing*;Food-Drug Interactions;Humans;Infant;Infant, Newborn
7790687;Education, Medical;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Internship and Residency*;Patient Education as Topic;Physician's Role;Physicians, Family/education*
7790684;Education, Medical*;Food-Drug Interactions*;Humans;Nutritional Physiological Phenomena
7709893;Absorption;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage;Pharmacokinetics
7776769;Depression/drug therapy;Drug Interactions;Food-Drug Interactions;Humans;Mental Disorders/drug therapy;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*
7884114;Aged;Calcium, Dietary/pharmacokinetics*;Cross-Over Studies;Female;Food, Fortified*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Middle Aged;Postmenopause;Psyllium/pharmacology*
7860949;Adult;Cross-Over Studies;Drug Interactions;Female;Folic Acid/administration & dosage;Folic Acid/blood;Folic Acid/pharmacology*;Food-Drug Interactions;Humans;Phenytoin/blood;Phenytoin/pharmacokinetics*
7860942;Aged;Aged, 80 and over;Algorithms;Biological Availability;Data Collection/methods;Eating;Female;Follow-Up Studies;Food Services/standards*;Food-Drug Interactions*;Humans;Hyperkalemia/epidemiology;Hyperkalemia/etiology;Hypokalemia/epidemiology;Hypokalemia/etiology;Incidence;Intermediate Care Facilities*;Male;Medical Records;New York;Nutritional Status;Retrospective Studies;Skilled Nursing Facilities*;Time Factors
7697949;Adult;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Kidney Transplantation*;Male;Prednisolone/pharmacokinetics;Prednisone/pharmacokinetics*
7627861;Acetaminophen/blood;Adult;Blood Glucose/metabolism;Duodenum/physiology;Eating/physiology*;Food-Drug Interactions;Gastric Emptying/physiology*;Gastrins/blood;Gastrointestinal Motility/physiology*;Humans;Male;Manometry;Myoelectric Complex, Migrating/physiology*;Pyloric Antrum/physiology
7608314;Adolescent;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Diet, Atherogenic;Drug Administration Schedule;Ephedrine/administration & dosage*;Ephedrine/blood;Ephedrine/pharmacokinetics;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Therapeutic Equivalency
7769577;Food-Drug Interactions*;Humans;Inservice Training;Patient Education as Topic*;Psychiatric Nursing/education;Psychotropic Drugs/administration & dosage;Psychotropic Drugs/adverse effects*
7751427;Adult;Chemistry, Pharmaceutical;Delayed-Action Preparations;Drug Administration Schedule;Drugs, Generic/administration & dosage;Drugs, Generic/pharmacokinetics*;Fasting/metabolism;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Tablets;Therapeutic Equivalency;Verapamil/administration & dosage;Verapamil/analogs & derivatives;Verapamil/pharmacokinetics*
7751425;Administration, Oral;Adult;Biological Availability;Delayed-Action Preparations;Food-Drug Interactions*;Gastric Emptying;Humans;Isosorbide Dinitrate/administration & dosage;Isosorbide Dinitrate/analogs & derivatives*;Isosorbide Dinitrate/pharmacokinetics;Male;Monitoring, Physiologic
7742206;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Food-Drug Interactions*;Humans
7742162;Adult;Animals;Cross-Over Studies;Enoxacin/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/physiology;Male;Milk/physiology*
7738788;Administration, Oral;Aminoquinolines/administration & dosage;Aminoquinolines/pharmacokinetics*;Animals;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/pharmacokinetics*;Biological Availability;Dogs;Food-Drug Interactions*;Half-Life;Sesame Oil/pharmacology*;Sterol O-Acyltransferase/antagonists & inhibitors*
7723291;Administration, Oral;Ampicillin/administration & dosage;Ampicillin/blood;Ampicillin/pharmacokinetics*;Animal Feed;Animals;Biological Availability;Dogs;Eating*;Fasting;Female;Food-Drug Interactions*;Male;Time Factors
8845456;Absorption;Anti-Bacterial Agents/pharmacokinetics;Anticoagulants/pharmacokinetics;Antidepressive Agents/pharmacokinetics;Antiparkinson Agents/pharmacokinetics;Antiviral Agents/pharmacokinetics;Biological Availability;Delayed-Action Preparations/pharmacokinetics;Diphosphonates/pharmacokinetics;Food-Drug Interactions*;Humans
8845455;Antidepressive Agents/administration & dosage;Antidepressive Agents/pharmacology;Antidepressive Agents/therapeutic use*;Antidepressive Agents, Tricyclic/administration & dosage;Antidepressive Agents, Tricyclic/pharmacology;Antidepressive Agents, Tricyclic/therapeutic use;Depression/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacology;Serotonin Uptake Inhibitors/therapeutic use
8620672;Absorption;Adult;Analysis of Variance;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Eating/physiology*;Fasting/physiology;Food-Drug Interactions*;Humans;Hydroxyurea/administration & dosage;Hydroxyurea/analogs & derivatives*;Hydroxyurea/blood;Hydroxyurea/pharmacokinetics;Lipoxygenase Inhibitors/administration & dosage;Lipoxygenase Inhibitors/blood;Lipoxygenase Inhibitors/pharmacokinetics*;Male;Reproducibility of Results
8549357;Animals;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Female;Fleroxacin/blood;Fleroxacin/pharmacokinetics*;Food-Drug Interactions;Humans;Male;Milk*
8549353;Adult;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Cross-Over Studies;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Humans;Male;Oxazines/blood;Oxazines/pharmacokinetics*;Saliva/metabolism
7777652;Adolescent;Adrenocorticotropic Hormone/blood*;Adult;Corticotropin-Releasing Hormone/blood*;Delta Sleep-Inducing Peptide/administration & dosage;Delta Sleep-Inducing Peptide/pharmacology*;Electroencephalography/drug effects;Food-Drug Interactions;Humans;Hydrocortisone/blood*;Infusions, Intravenous;Male
7547087;Adult;Aluminum Hydroxide/pharmacology*;Analysis of Variance;Antacids/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Cross-Over Studies;Drug Combinations;Drug Interactions;Fasting;Food-Drug Interactions;Humans;Indoles/blood;Indoles/pharmacokinetics*;Magnesium Hydroxide/pharmacology*;Male
19489169;Adult;Age Factors;Aged;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use;Drug Interactions;Fatty Acids, Monounsaturated/pharmacokinetics*;Fatty Acids, Monounsaturated/therapeutic use;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Sex Factors;Time Factors
7857345;Adult;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Immunologic Factors/blood;Immunologic Factors/pharmacokinetics*;Male;Pyrrolidonecarboxylic Acid/adverse effects;Pyrrolidonecarboxylic Acid/analogs & derivatives*;Pyrrolidonecarboxylic Acid/blood;Pyrrolidonecarboxylic Acid/pharmacokinetics;Spectrophotometry, Ultraviolet;Therapeutic Equivalency;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazolidines
7813990;Animals;Beverages*;Citrus*;Food-Drug Interactions*;Liver/drug effects;Liver/metabolism;Male;Oxotremorine/metabolism;Pentobarbital/metabolism*;Pentobarbital/pharmacology;Rats;Rats, Sprague-Dawley;Theophylline/blood;Theophylline/pharmacokinetics*;Tremorine/metabolism*
7727796;Alkalies/metabolism*;Animals;Arginine/analogs & derivatives;Arginine/pharmacology;Bicarbonates/metabolism;Capsaicin/pharmacology;Dogs;Duodenum/drug effects;Duodenum/metabolism*;Food-Drug Interactions;Gastric Mucosa/drug effects;Gastric Mucosa/metabolism;Meat;Nitric Oxide/antagonists & inhibitors;Nitric Oxide/physiology*;Nitroarginine;Nitroglycerin/pharmacology;Prostaglandin Antagonists/pharmacology;Prostaglandins/pharmacology;Stomach/drug effects;Stomach/metabolism*
7944078;Animals;Clinical Trials as Topic;Drug Interactions*;Food-Drug Interactions*;Humans;Warfarin/pharmacology*
7821234;Administration, Inhalation;Animals;Behavior, Animal;Conditioning, Operant;Food-Drug Interactions*;Male;Mice;Milk*;Trichloroethanes/administration & dosage;Trichloroethanes/pharmacokinetics*
7814718;Animals;Cattle/metabolism*;Cobalt/administration & dosage;Cobalt/pharmacology*;Dietary Fiber*;Digestion/drug effects*;Food-Drug Interactions;In Vitro Techniques;Linear Models;Male
7698084;Aflatoxin B1/metabolism*;Animals;Aryl Hydrocarbon Hydroxylases*;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2A6;Cytochrome P-450 CYP2E1;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Ethanol/metabolism*;Food-Drug Interactions;Humans;Mice;Microsomes, Liver/enzymology;Microsomes, Liver/metabolism;Mixed Function Oxygenases/metabolism*;Oxidoreductases/metabolism*;Oxidoreductases, N-Demethylating/metabolism*;Plants, Toxic*;Rats;Tobacco/metabolism*;Urethane/metabolism
7858704;Altretamine/blood*;Chromatography, High Pressure Liquid;Female;Food-Drug Interactions*;Humans;Indicators and Reagents;Intestinal Absorption;Ovarian Neoplasms/metabolism
7836549;Aged;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Intestinal Absorption;Middle Aged;Tacrine/adverse effects;Tacrine/blood;Tacrine/pharmacokinetics*
7836548;Adolescent;Adult;Biological Availability;Cholestyramine Resin/pharmacology;Chromatography, High Pressure Liquid;Diet, Fat-Restricted;Drug Interactions;Enterohepatic Circulation/drug effects;Enterohepatic Circulation/physiology*;Fasting/metabolism*;Food-Drug Interactions*;Gilbert Disease/metabolism*;Glucuronates/metabolism;Humans;Infusions, Intravenous;Lorazepam/administration & dosage;Lorazepam/pharmacokinetics*;Male;Neomycin/pharmacology
7972311;Adult;Beverages*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Diltiazem/analogs & derivatives;Diltiazem/blood;Diltiazem/pharmacokinetics*;Diltiazem/pharmacology;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Spectrophotometry, Ultraviolet
7899804;Adolescent;Adult;Animals;Antimalarials/pharmacokinetics*;Antimalarials/pharmacology;Antimalarials/toxicity*;Artemisinins*;Bridged Bicyclo Compounds/pharmacokinetics*;Bridged Bicyclo Compounds/pharmacology;Bridged Bicyclo Compounds/toxicity*;Bridged Bicyclo Compounds, Heterocyclic*;Food-Drug Interactions;Humans;Male;Middle Aged;Plasmodium falciparum/drug effects;Styrenes/pharmacokinetics*;Styrenes/pharmacology;Styrenes/toxicity*
7899788;Adolescent;Adult;Albendazole/adverse effects;Albendazole/pharmacokinetics*;Albendazole/therapeutic use*;Animals;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions;Humans;Ivermectin/adverse effects;Ivermectin/therapeutic use*;Male;Microfilariae/drug effects;Middle Aged;Onchocerca/drug effects;Onchocerca/embryology;Onchocerca/growth & development;Onchocerciasis/drug therapy*;Onchocerciasis/parasitology
7859239;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Fasting;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/adverse effects;Theophylline/pharmacokinetics*;Therapeutic Equivalency
7937514;Animals;Calorimetry*;Chemistry, Pharmaceutical/instrumentation*;Drug Stability;Excipients;Food-Drug Interactions;Humans
7988627;Adult;Drug Interactions;Fasting/metabolism;Food-Drug Interactions*;Humans;Male;Ofloxacin/pharmacokinetics*;Sucralfate/pharmacology*
7984681;Adult;Blood Pressure/drug effects;Diet;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Mexico;Nifedipine/pharmacokinetics*;Nifedipine/pharmacology;Zea mays*
7875640;Adult;Analysis of Variance;Anti-Arrhythmia Agents/pharmacokinetics*;Body Weight/physiology*;Fasting/metabolism;Female;Food-Drug Interactions*;Humans;Male;Propylamines/pharmacokinetics*;Pyridines/pharmacokinetics*;Sex Factors
7830228;Aged;Barbados;Female;Food-Drug Interactions*;Geriatric Assessment*;Humans;Male;Medical Audit*;Middle Aged;Prevalence;Risk Factors;Sampling Studies;Sensitivity and Specificity
71616;Aged;Animals;Depression/drug therapy;Drug Combinations;Drug Synergism;Eggs/adverse effects*;Female;Fishes*;Humans;Hypertension/chemically induced*;Tranylcypromine/pharmacology*;Tranylcypromine/therapeutic use;Trifluoperazine/pharmacology*;Trifluoperazine/therapeutic use;Tyramine/adverse effects*
83942;Adult;Biological Availability;Dicumarol/blood;Dicumarol/metabolism*;Female;Food*;Half-Life;Humans;Male;Time Factors
85186;Adult;Chlorpropamide/metabolism*;Chlorpropamide/therapeutic use;Diabetes Mellitus/drug therapy;Diabetes Mellitus/therapy*;Drug Synergism;England;Female;Garlic;Humans;Hypoglycemic Agents*;Pakistan/ethnology;Phytotherapy;Plants, Medicinal;Vegetables*
85872;Absorption;Acetaminophen/metabolism*;Adult;Blood Glucose/analysis;Blood Glucose/antagonists & inhibitors;Cellulose/metabolism*;Depression, Chemical;Dietary Fiber/metabolism*;Female;Gastrectomy;Gastric Emptying*/drug effects;Gels;Glucose/metabolism*;Glucose Tolerance Test;Humans;Male;Metoclopramide/pharmacology;Pectins/pharmacology;Propantheline/pharmacology
214657;Acute Disease;Adult;Blood Platelets/drug effects;Blood Platelets/metabolism*;Caffeine/pharmacology;Chronic Disease;Cyclic AMP/blood*;Humans;In Vitro Techniques;Prostaglandins E/pharmacology*;Schizophrenia/blood*;Time Factors
314074;Adult;Drug Interactions;Ergotamines/adverse effects*;Ergotamines/therapeutic use;Ergotism/drug therapy;Ergotism/etiology*;Female;Humans;Middle Aged;Migraine Disorders/drug therapy;Nitroprusside/therapeutic use;Troleandomycin/adverse effects*
323461;Adult;Amoxicillin/blood;Amoxicillin/metabolism*;Amoxicillin/urine;Ampicillin/analogs & derivatives*;Ampicillin/blood;Ampicillin/metabolism*;Ampicillin/urine;Biological Availability;Clinical Trials as Topic;Drinking;Fasting*;Female;Food;Half-Life;Humans;Kinetics;Male;Models, Biological;Time Factors
363052;Administration, Oral;Adult;Amoxicillin/blood;Amoxicillin/metabolism*;Amoxicillin/urine;Ampicillin/analogs & derivatives*;Ampicillin/blood;Ampicillin/metabolism*;Ampicillin/urine;Clinical Trials as Topic;Double-Blind Method;Food*;Humans;Intestinal Absorption;Kinetics;Male
406701;Adolescent;Adult;Amine Oxidase (Copper-Containing)/antagonists & inhibitors;Animals;Drug Interactions;Female;Fishes*;Food Hypersensitivity/etiology*;Histamine/poisoning*;Humans;Isoniazid/adverse effects*;Isoniazid/therapeutic use;Male;Tuberculosis/drug therapy
427007;Adult;Biological Availability;Delayed-Action Preparations;Fasting*;Female;Humans;Kinetics;Oxprenolol/administration & dosage;Oxprenolol/metabolism*;Time Factors
438273;Arthroplasty;Ergotamine/administration & dosage;Ergotamine/adverse effects*;Ergotamine/therapeutic use;Female;Gangrene/chemically induced*;Hallux*/blood supply;Hallux Valgus/surgery;Humans;Methysergide/administration & dosage;Methysergide/adverse effects*;Methysergide/therapeutic use;Middle Aged;Migraine Disorders/drug therapy
445958;Aged;Cellulose*;Dietary Fiber*;Digoxin/blood;Digoxin/metabolism*;Female;Humans;Intestinal Absorption*;Male;Patient Compliance;Time Factors
463881;Adult;Beverages*;Caffeine/adverse effects*;Carbonated Beverages*;Drug Interactions;Female;Headache/chemically induced*;Humans;Hypertension/chemically induced;Phenelzine/adverse effects*
496127;Adult;Cheese*;Drug Interactions;Humans;Hyperemia/chemically induced;Hypertension/chemically induced*;Isoniazid/adverse effects*;Male
501875;Adult;Beverages/poisoning*;Female;Humans;Hypotension/etiology;Plant Poisoning/complications*;Wisconsin
512843;Adolescent;Adult;Anti-Inflammatory Agents/adverse effects;Anti-Inflammatory Agents/blood;Anti-Inflammatory Agents/metabolism*;Biological Availability;Fasting;Food;Half-Life;Humans;Intestinal Absorption;Kinetics;Male;Pyridines/adverse effects;Pyridines/blood;Pyridines/metabolism*;Thiazines/adverse effects;Thiazines/blood;Thiazines/metabolism*
520399;Adult;Atenolol/blood;Atenolol/metabolism*;Biological Availability;Female;Food*;Humans;Kinetics;Male;Propanolamines/metabolism*;Time Factors
558210;Aldehyde Oxidoreductases/antagonists & inhibitors*;Coprinus;Cyclopropanes/chemical synthesis;Cyclopropanes/isolation & purification*;Glutamine/analogs & derivatives*;Glutamine/chemical synthesis;Glutamine/isolation & purification;Methods
564228;Agaricales/pathogenicity*;Alcoholic Beverages/adverse effects*;Coprinus/pathogenicity*;Drug Interactions;Humans;Mushroom Poisoning/etiology
569766;Agaricales/pathogenicity*;Alcoholic Beverages*;Humans;Mushroom Poisoning/etiology*
571023;Adult;Aged;Animals;Female;Fishes*;Foodborne Diseases/etiology*;Histamine/poisoning*;Humans;Isoniazid/therapeutic use;Male;Middle Aged;Tuberculosis*/drug therapy
581516;Administration, Oral;Ampicillin/administration & dosage;Ampicillin/metabolism;Animals;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/metabolism;Biological Availability;Cephalexin/administration & dosage;Cephalexin/metabolism;Child, Preschool;Eating*;Erythromycin/administration & dosage;Erythromycin/metabolism;Humans;Infant;Milk*;Penicillins/administration & dosage;Penicillins/metabolism;Saliva/metabolism;Tears/metabolism
589392;Adult;Alcohol Drinking;Arrhythmias, Cardiac/etiology*;Coprinus;Humans;Male;Mushroom Poisoning/complications*
637437;Adult;Cheese/adverse effects*;Cheese/analysis;Female;Humans;Hypertension/chemically induced*;Isoniazid/adverse effects*;Monoamine Oxidase Inhibitors/adverse effects;Tyramine/adverse effects;Tyramine/analysis
647881;Adsorption;Adult;Aminosalicylic Acid/pharmacology;Anticholesteremic Agents/pharmacology*;Biological Availability;Cholestyramine Resin/pharmacology;Dietary Fiber;Digoxin/metabolism*;Drug Interactions;Humans;Time Factors
665675;Biological Availability;Cellulose/pharmacology*;Dietary Fiber/pharmacology*;Digoxin/metabolism*;Humans
758247;Acetaminophen/blood;Adult;Antipyrine/blood;Antipyrine/metabolism;Biological Availability;Diet;Female;Humans;Male;Pharmaceutical Preparations/metabolism*;Phenacetin/blood;Phenacetin/metabolism;Vegetables*
780287;Adult;Clinical Trials as Topic;Clopamide/pharmacology*;Eating*;Fasting;Female;Humans;Intestinal Absorption/drug effects;Kinetics;Male;Models, Biological;Pindolol/metabolism*
838114;Adult;Ampicillin/analogs & derivatives*;Ampicillin/metabolism*;Eating*;Food;Humans;Intestinal Absorption*;Metabolic Clearance Rate;Pivampicillin/metabolism*
872490;Adult;Biological Availability;Food*;Humans;Hydralazine/administration & dosage;Hydralazine/blood*;Kinetics;Male;Tablets;Time Factors
872491;Administration, Oral;Adult;Biological Availability;Female;Food*;Humans;Kinetics;Male;Metoprolol/administration & dosage;Metoprolol/blood*;Propanolamines/blood*;Propranolol/administration & dosage;Propranolol/blood*;Time Factors
970990;Administration, Oral;Adult;Antacids/pharmacology*;Arthritis, Rheumatoid/drug therapy;Biological Availability;Fasting;Female;Food*;Humans;Indomethacin/administration & dosage;Indomethacin/blood*;Male;Middle Aged;Time Factors
991535;Adult;Antipyrine/blood*;Diet;Dietary Carbohydrates*;Dietary Proteins*;Half-Life;Humans;Male;Metabolic Clearance Rate;Theophylline/blood*
1036443;Agaricales*/analysis;Animals;Coprinus*/analysis;Disulfiram/analysis;Disulfiram/pharmacology*;Drug Synergism;Ethanol/pharmacology;Female;Methods;Mice;Plant Extracts/analysis;Plant Extracts/pharmacology*;Postural Balance/drug effects;Reflex/drug effects
1167931;Basidiomycota*;Folklore;Humans;Mushroom Poisoning;Nigeria;Plants, Edible;Terminology as Topic
1195132;Analgesia;Animals;Anti-Bacterial Agents/pharmacology*;Brain/metabolism;Calcium/pharmacology;Calcium Radioisotopes;Cations, Divalent*;Chelating Agents/pharmacology*;Drug Interactions;Drug Tolerance;Hydroxydopamines/pharmacology;Lasalocid/pharmacology*;Male;Mice;Mice, Inbred ICR;Morphine/antagonists & inhibitors;Morphine/metabolism;Morphine/pharmacology*;Naloxone/metabolism;Pargyline/pharmacology;Reaction Time/drug effects
1215448;Adult;Automobile Driving;Caffeine/pharmacology*;Ethanol/antagonists & inhibitors*;Ethanol/blood;Ethanol/pharmacology;Female;Humans;Lactates/blood;Male;Mental Processes/drug effects;Motor Skills/drug effects*;Postural Balance/drug effects;Reaction Time/drug effects*
1241098;Acetaldehyde/blood;Agaricales/analysis*;Aldehyde Oxidoreductases/antagonists & inhibitors;Animals;Biological Assay;Chemical Phenomena;Chemistry;Coprinus/analysis*;Disulfiram/isolation & purification*;Disulfiram/pharmacology;Ethanol/blood;Ethanol/pharmacology;Glutamine/analogs & derivatives*;Glutamine/isolation & purification;Glutamine/pharmacology;Liver/enzymology;Male;Mice
1297641;Absorption;Adult;Biological Availability;Chromatography, High Pressure Liquid;Delayed-Action Preparations;Eating*;Fasting;Female;Half-Life;Humans;Male;Middle Aged;Naproxen/administration & dosage;Naproxen/blood;Naproxen/pharmacokinetics*
1335461;Adult;Antidepressive Agents, Tricyclic/blood*;Antidepressive Agents, Tricyclic/therapeutic use;Chromatography, Gas;Depressive Disorder/drug therapy*;Dietary Fiber/administration & dosage;Dietary Fiber/adverse effects*;Female;Humans;Male;Middle Aged
1351673;Anti-Anxiety Agents/antagonists & inhibitors*;Azabicyclo Compounds;Caffeine/pharmacology*;Double-Blind Method;Humans;Piperazines/antagonists & inhibitors*;Psychomotor Performance/drug effects*;Reference Values;Triazolam/antagonists & inhibitors*
1404208;Aluminum Hydroxide/adverse effects*;Anti-Ulcer Agents/adverse effects*;Bismuth/adverse effects*;Drug Combinations;Glycyrrhiza;Humans;Hypercalcemia/chemically induced*;Magnesium Hydroxide;Male;Middle Aged;Plant Extracts/adverse effects*;Sodium Bicarbonate
1424410;Administration, Oral;Analysis of Variance;Blood Pressure/drug effects*;Drug Synergism;Humans;Male;Monoamine Oxidase Inhibitors/blood;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/pharmacology*;Oxazoles/blood;Oxazoles/pharmacokinetics;Oxazoles/pharmacology*;Oxazolidinones*;Reference Values;Single-Blind Method;Tyramine/blood;Tyramine/pharmacokinetics;Tyramine/pharmacology*
1468429;Acetylcysteine/administration & dosage*;Administration, Oral;Adult;Cephalosporins/administration & dosage;Cephalosporins/blood;Cephalosporins/pharmacokinetics*;Cephalosporins/urine;Drug Combinations;Drug Interactions;Eating;Fasting;Humans;Male
1476449;Electrophoresis, Polyacrylamide Gel;Enterotoxins/isolation & purification*;Evaluation Studies as Topic;Food Contamination;Food Microbiology*;Humans;Immunoblotting/methods*;Immunoblotting/statistics & numerical data;Sensitivity and Specificity;Staphylococcal Food Poisoning/prevention & control;Staphylococcus aureus/isolation & purification*
1483487;Administration, Oral;Adult;Antidepressive Agents/pharmacology*;Benzamides/pharmacology*;Blood Pressure/drug effects*;Blood Pressure/physiology;Dietary Fats/pharmacology*;Dietary Proteins/pharmacology*;Drug Synergism;Eating/physiology;Exercise Test;Female;Humans;Male;Moclobemide;Monoamine Oxidase Inhibitors/pharmacology*;Systole/drug effects;Systole/physiology;Tyramine/pharmacology*
1577050;Adult;Analysis of Variance;Beverages*;Blood Pressure/drug effects;Citrus*;Felodipine/pharmacokinetics*;Heart Rate/drug effects;Humans;Male;Middle Aged
1605619;Adult;Animals;Biological Availability;Chromatography, High Pressure Liquid;Dairy Products*;Female;Humans;Intestinal Absorption*;Male;Milk;Norfloxacin/pharmacokinetics*;Yogurt
1612815;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Adolescent;Adult;Animals;Biological Availability;Eggs;Ethnic Groups;Fasting/blood;Female;Food*/classification;Humans;Intestinal Absorption*;Meat;South Africa;Swine;Tablets;Zea mays
1621740;Adult;Age Factors;Biological Availability;Cephalosporins/administration & dosage;Cephalosporins/metabolism;Cephalosporins/pharmacokinetics*;Child;Clinical Trials as Topic;Food;Humans;Kidney Diseases/drug therapy;Kidney Diseases/metabolism;Metabolic Clearance Rate;Probenecid/pharmacology
1656742;Adolescent;Adult;Age Factors;Aged;Aged, 80 and over;Azithromycin;Bacterial Infections/drug therapy*;Carbamazepine/pharmacology;Child;Child, Preschool;Cimetidine/pharmacology;Contraindications;Drug Evaluation;Drug Interactions;Eating;Erythromycin/adverse effects;Erythromycin/analogs & derivatives*;Erythromycin/pharmacokinetics;Female;Humans;Male;Methylprednisolone/pharmacology;Middle Aged;Respiratory Tract Infections/drug therapy;Skin Diseases, Infectious/drug therapy;Theophylline/pharmacology;Urethritis/drug therapy;Uterine Cervicitis/drug therapy
1662623;Administration, Oral;Azithromycin;Biological Availability;Drug Interactions;Drug Stability;Erythromycin/administration & dosage;Erythromycin/analogs & derivatives*;Erythromycin/blood;Erythromycin/pharmacokinetics;Half-Life;Humans;Time Factors;Tissue Distribution
1672944;Beverages*;Biological Availability;Citrus/metabolism*;Drug Interactions;Felodipine/metabolism*;Humans;Nifedipine/metabolism*
1672990;Adolescent;Adult;Cerebral Infarction/drug therapy;Female;Humans;Pregnancy;Pregnancy Complications, Hematologic/drug therapy;Pulmonary Embolism/drug therapy;Vegetables*/analysis;Vitamin K/analysis;Warfarin/antagonists & inhibitors*;Warfarin/therapeutic use
1679514;Cholesterol, LDL/blood;Dietary Fiber/adverse effects*;Drug Interactions;Female;Humans;Hypercholesterolemia/drug therapy;Lovastatin/adverse effects*;Middle Aged;Pectins/adverse effects*
1681621;Antipsychotic Agents/chemistry*;Beverages/analysis*;Caffeine/chemistry*;Chemistry, Pharmaceutical;Phenothiazines
1683458;Administration, Oral;Aluminum Hydroxide/urine*;Ascorbic Acid/pharmacology*;Drug Combinations;Humans;Intestinal Absorption/drug effects*
1706804;Administration, Oral;Adult;Biological Availability;Delayed-Action Preparations;Double-Blind Method;Eating/physiology*;Female;Humans;Hydralazine/administration & dosage;Hydralazine/blood*;Hydralazine/pharmacokinetics*;Hypertension/drug therapy*;Hypertension/physiopathology;Male;Middle Aged
1748529;Adult;Aluminum/blood;Aluminum/pharmacokinetics*;Aluminum Hydroxide/administration & dosage;Citrates/pharmacology*;Citric Acid;Female;Humans;Intestinal Absorption/drug effects;Kidney Failure, Chronic/metabolism*;Male;Middle Aged
1752235;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal;Chromatography, High Pressure Liquid;Drug Interactions;Glycyrrhetinic Acid/analogs & derivatives*;Glycyrrhetinic Acid/pharmacology;Glycyrrhizic Acid;Humans;Injections, Intravenous;Male;Metabolic Clearance Rate/drug effects;Prednisolone/analogs & derivatives*;Prednisolone/pharmacokinetics
1766062;Adult;Cimetidine/pharmacology*;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/pharmacology*;Dietary Proteins/administration & dosage;Dietary Proteins/pharmacology*;Humans;Liver/metabolism*;Male;Theophylline/pharmacokinetics*
1772462;Administration, Oral;Biological Availability;Delayed-Action Preparations;Food;Humans;Theophylline/administration & dosage;Theophylline/pharmacokinetics*
1774159;Adolescent;Adult;Aged;Cluster Headache/drug therapy;Coronary Disease/chemically induced*;Drug Therapy, Combination;Ergot Alkaloids/adverse effects*;Ergot Alkaloids/therapeutic use;Female;Humans;Male;Methysergide/therapeutic use
1780961;Administration, Oral;Adult;Biological Availability;Drug Interactions;Enteral Nutrition*;Fasting;Female;Food, Formulated*;Humans;Hydralazine/administration & dosage;Hydralazine/pharmacokinetics*;Intubation, Gastrointestinal;Male
1781863;Administration, Sublingual;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Nifedipine/administration & dosage*;Nifedipine/pharmacokinetics
1797525;Animals;Appetitive Behavior/drug effects;Association Learning/drug effects;Cocaine/analogs & derivatives*;Cocaine/pharmacology*;Discrimination Learning/drug effects*;Dose-Response Relationship, Drug;Male;Rats;Receptors, Dopamine/drug effects;Structure-Activity Relationship
1912131;Adult;Bipolar Disorder/chemically induced*;Coffee/adverse effects*;Drug Interactions;Female;Humans;Phenylpropanolamine/adverse effects*
1914371;Adult;Analysis of Variance;Blood Pressure/drug effects;Caffeine/pharmacokinetics;Caffeine/pharmacology*;Catecholamines/blood;Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions/physiology;Female;Heart Rate/drug effects;Humans;Male;Natriuresis/drug effects;Phenylpropanolamine/pharmacokinetics;Phenylpropanolamine/pharmacology*;Random Allocation;Reference Values;Renin-Angiotensin System/drug effects;Research Design;Time Factors
1914375;Adult;Beverages*;Cimetidine/pharmacology*;Citrus*;Confidence Intervals;Double-Blind Method;Drug Interactions;Headache/chemically induced;Heart Rate/drug effects;Humans;Male;Metabolism/drug effects;Nitrendipine/pharmacokinetics*;Nitrendipine/pharmacology;Random Allocation;Reference Values;Stereoisomerism
1934862;Administration, Oral;Adult;Animals;Biological Availability;Chromatography, High Pressure Liquid;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Ciprofloxacin/urine;Female;Humans;Intestinal Absorption;Male;Milk*;Random Allocation;Yogurt*
1934866;Adult;Blood Pressure/drug effects*;Caffeine/pharmacology*;Dipyridamole/antagonists & inhibitors*;Dipyridamole/pharmacology;Dose-Response Relationship, Drug;Double-Blind Method;Female;Heart Rate/drug effects*;Humans;Infusions, Intravenous;Male;Random Allocation
1956499;Aluminum/toxicity*;Aluminum Hydroxide/administration & dosage;Aluminum Hydroxide/metabolism;Aluminum Hydroxide/therapeutic use*;Calcium/administration & dosage;Calcium/therapeutic use*;Citrates/administration & dosage;Citric Acid;Drug Interactions;Humans;Intestinal Absorption*;Kidney Failure, Chronic/therapy*;Tablets
1981783;Adult;Bisacodyl/adverse effects;Bisacodyl/pharmacology*;Digoxin/adverse effects;Digoxin/blood*;Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate
1988422;Drug Interactions;Hong Kong;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/pharmacology;Sodium Glutamate/adverse effects*;Sodium Glutamate/pharmacology;Soybeans;Tyramine/adverse effects;Tyramine/pharmacology
2042654;Adult;Aluminum/blood;Aluminum/pharmacokinetics*;Aluminum/urine;Aluminum Hydroxide/pharmacokinetics*;Antacids/pharmacokinetics*;Citrates/pharmacokinetics*;Citric Acid;Contraindications;Drug Synergism;Humans;Intestinal Absorption/drug effects;Male;Middle Aged;Reference Values;Time Factors
2045759;Adult;Aged;Analysis of Variance;Blood Coagulation/drug effects*;Clinical Protocols;Diet*;Drug Resistance;Female;Humans;Male;Middle Aged;Vegetables;Vitamin K/pharmacology*;Vitamin K 1/pharmacology;Warfarin/pharmacology*
2049250;Acetaminophen/pharmacokinetics;Adult;Dietary Proteins/administration & dosage*;Gastric Emptying;Humans;Intestinal Absorption;Levodopa/pharmacokinetics*;Male;Parkinson Disease/drug therapy
2051716;Acids/administration & dosage;Aluminum/pharmacokinetics*;Aluminum/toxicity;Aluminum Hydroxide/administration & dosage;Animals;Chelating Agents/administration & dosage;Citrates/administration & dosage;Citric Acid;Diet*;Female;Intestinal Absorption/drug effects;Rats;Rats, Inbred Strains;Tissue Distribution
2058471;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Food*;Humans;Kinetics;Male;Thiazines/blood;Thiazines/pharmacokinetics*;Thiazoles/blood;Thiazoles/pharmacokinetics*
2065699;Acetaldehyde/blood*;Acetaldehyde/urine*;Adult;Alcohol Drinking/adverse effects;Alcohol Drinking/metabolism*;Drug Combinations;Ethanol/blood*;Ethanol/urine*;Humans;Male;Middle Aged;Plant Extracts/pharmacology*
2065700;Acetaldehyde/blood;Adult;Drug Combinations;Ethanol/blood;Ethanol/metabolism*;Humans;Intestinal Absorption/drug effects;Male;Plant Extracts/pharmacology*
2066050;Administration, Oral;Adult;Dihydroergotamine/administration & dosage;Dihydroergotamine/blood;Dihydroergotamine/pharmacokinetics*;Drug Tolerance;Female;Humans;Male;Miocamycin/pharmacology*;Time Factors
2069371;4-Quinolones;Adult;Anti-Infective Agents/pharmacokinetics;Anti-Infective Agents/pharmacology*;Caffeine/pharmacokinetics*;Double-Blind Method;Drug Interactions;Fluoroquinolones*;Half-Life;Humans;Male;Quinolones*;Theophylline/pharmacokinetics
2071262;4-Quinolones;Adult;Anti-Infective Agents/pharmacology*;Caffeine/blood;Caffeine/pharmacokinetics*;Fluoroquinolones*;Humans;Male;Quinolones*;Theophylline/blood;Theophylline/pharmacokinetics*
2091623;Adult;Blood Pressure/drug effects*;Dose-Response Relationship, Drug;Drug Interactions;Glutamates/pharmacology*;Heart Rate/drug effects*;Humans;Hypertension/chemically induced;Male;Placebos;Sodium Glutamate/pharmacology*;Tranylcypromine/adverse effects;Tranylcypromine/pharmacology*
2099431;Adult;Aortic Valve;Blood Coagulation/drug effects*;Diet*;Drug Interactions;Female;Heart Valve Prosthesis;Humans;Male;Middle Aged;Skin Diseases/etiology;Thrombosis/etiology;Vitamin K/administration & dosage*;Vitamin K/pharmacology;Vitamin K Deficiency/complications;Warfarin/therapeutic use*
2106407;Aged;Drug Interactions;Drug Resistance;Enteral Nutrition*;Female;Food, Formulated/adverse effects*;Humans;Warfarin/administration & dosage;Warfarin/therapeutic use*
2107985;Adult;Aged;Aminophylline/therapeutic use;Bronchial Spasm/chemically induced;Bronchial Spasm/drug therapy;Chest Pain/chemically induced;Chest Pain/drug therapy;Dipyridamole/adverse effects*;Female;Headache/chemically induced;Heart/diagnostic imaging*;Hemodynamics/drug effects;Humans;Injections, Intravenous;Male;Middle Aged;Myocardial Infarction/chemically induced;Nausea/chemically induced;Nitroglycerin/therapeutic use;Perfusion;Radionuclide Imaging;Thallium*
2112643;Adult;Amino Acids/administration & dosage*;Amino Acids/pharmacology;Ampicillin/blood;Ampicillin/pharmacokinetics*;Ampicillin/urine;Food, Formulated*;Glomerular Filtration Rate/drug effects;Humans;Male;Metabolic Clearance Rate/drug effects;Parenteral Nutrition*
2114955;Absorption;Aged;Biological Availability;Body Weight;Ciprofloxacin/administration & dosage;Ciprofloxacin/pharmacokinetics*;Enteral Nutrition*;Humans;Intubation, Gastrointestinal*;Male;Middle Aged
2122025;Animals;Biological Availability;Enteral Nutrition/adverse effects*;Enteral Nutrition/instrumentation;Glass*;Humans;Hydrogen-Ion Concentration;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/pharmacokinetics*;Polyurethanes*;Rats
2122422;Administration, Oral;Adult;Aminophylline/administration & dosage;Aminophylline/blood;Aminophylline/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Enteral Nutrition*;Humans;Infusions, Intravenous;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*;Time Factors
2171446;Administration, Oral;Adult;Aluminum/adverse effects;Aluminum/pharmacokinetics*;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Bicarbonates/pharmacology*;Citrates/pharmacology*;Citric Acid;Drug Synergism;Female;Humans;Intestinal Absorption/drug effects*;Male;Sodium/pharmacology*;Sodium Bicarbonate
2177401;Caffeine/pharmacokinetics*;Ciprofloxacin/pharmacology;Drug Interactions;Enoxacin/pharmacology;Humans;Male;Models, Biological;Norfloxacin/pharmacology;Ofloxacin/pharmacology;Pipemidic Acid/pharmacology;Quinolones/pharmacology*
2200264;Drug Combinations;Drug Interactions;Humans;Phenylpropanolamine/administration & dosage;Phenylpropanolamine/adverse effects*;Stereoisomerism
2253583;Adult;Chromatography, High Pressure Liquid;Dialysis;Drug Interactions;Glycyrrhetinic Acid/analogs & derivatives*;Glycyrrhetinic Acid/pharmacology;Glycyrrhizic Acid;Humans;Male;Metabolic Clearance Rate/physiology;Prednisolone/administration & dosage;Prednisolone/analogs & derivatives*;Prednisolone/blood;Prednisolone/pharmacokinetics
2271748;Adult;Beverages*;Biological Availability;Calcium/blood;Citrus*;Coffee*;Female;Humans;Male;Tetracycline/pharmacokinetics*;Tetracycline/urine
2285293;4-Quinolones;Absorption;Adult;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Anti-Infective Agents/pharmacology*;Anti-Infective Agents/urine;Chromatography, High Pressure Liquid;Female;Fluoroquinolones*;Food*;Humans;Male;Quinolones*;Time Factors
2311339;Administration, Oral;Adult;Angiotensin-Converting Enzyme Inhibitors/blood*;Biological Availability;Fasting/metabolism;Food*;Humans;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Perindopril;Random Allocation
2338118;Aged;Animals;Biological Availability;Chromatography, Gas;Estramustine/pharmacokinetics*;Estramustine/therapeutic use;Estrone/pharmacokinetics;Food*;Humans;Male;Middle Aged;Milk*;Nitrogen Mustard Compounds/pharmacokinetics*;Prostatic Neoplasms/drug therapy;Radioimmunoassay;Random Allocation;Solubility
2352608;Aged;Aged, 80 and over;Blood Platelet Disorders/complications*;Diet;Garlic/adverse effects*;Hematoma, Epidural, Cranial/etiology*;Hematoma, Epidural, Cranial/surgery;Humans;Male;Plants, Medicinal*
2353062;Animals;Panax/analysis*;Plants, Medicinal*;Platelet Aggregation Inhibitors/analysis*;Rabbits
2357862;Adult;Affect/drug effects;Blood Pressure/drug effects;Caffeine/blood*;Caffeine/pharmacology;Drug Interactions;Drug Synergism;Epinephrine/blood;Female;Humans;Male;Norepinephrine/blood;Phenylpropanolamine/pharmacokinetics*;Phenylpropanolamine/pharmacology;Sympathetic Nervous System/drug effects
2360879;Adult;Animals;Female;Humans;Male;Middle Aged;Rabbits;Soybeans*;Vitamin K/blood*;Warfarin/antagonists & inhibitors*
2396245;Animals;Carbadox/toxicity;Drug Residues/poisoning*;Drug Therapy/veterinary*;Drug-Related Side Effects and Adverse Reactions;Food Additives/poisoning*;Furazolidone/toxicity;Humans;Rhinitis, Atrophic/prevention & control;Rhinitis, Atrophic/veterinary;Sulfamethazine/administration & dosage;Sulfamethazine/adverse effects;Swine;Swine Diseases/prevention & control
2450251;Absorption;Administration, Oral;Adult;Benzamides/administration & dosage*;Blood Pressure/drug effects*;Drug Synergism;Humans;Injections, Intravenous;Male;Moclobemide;Monoamine Oxidase Inhibitors/administration & dosage;Norepinephrine/blood;Tyramine/administration & dosage;Tyramine/blood;Tyramine/pharmacokinetics*
2492043;Aged;Aged, 80 and over;Drug Interactions;Enteral Nutrition*;Female;Humans;Intubation, Gastrointestinal;Phenytoin/blood*;Solutions/adverse effects*
2496251;Adult;Drug Administration Routes;Drug Resistance;Enteral Nutrition/adverse effects*;Humans;Male;Prothrombin Time;Pulmonary Embolism/drug therapy;Vitamin K/administration & dosage;Warfarin/administration & dosage;Warfarin/pharmacology*;Wounds, Gunshot/therapy
2501937;Adult;Enteral Nutrition*;Humans;Intestinal Absorption;Male;Phenytoin/blood;Phenytoin/pharmacokinetics*
2506806;Adult;Biological Availability;Ciprofloxacin/administration & dosage;Ciprofloxacin/pharmacokinetics*;Enteral Nutrition*;Humans;Intubation, Gastrointestinal;Male
2510372;Adult;Delayed-Action Preparations;Enteral Nutrition*;Food, Formulated/adverse effects*;Humans;Infant Food/adverse effects*;Male;Random Allocation;Theophylline/administration & dosage;Theophylline/pharmacokinetics*
2527534;Adolescent;Adult;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Biological Availability;Cilazapril;Food*;Humans;Pyridazines/blood;Pyridazines/pharmacokinetics*;Pyridazines/pharmacology;Pyridazines/urine
2565585;Antipsychotic Agents/adverse effects*;Bipolar Disorder/drug therapy*;Double-Blind Method;Dyskinesia, Drug-Induced/blood;Dyskinesia, Drug-Induced/therapy*;Fatty Acids, Essential/administration & dosage*;Fatty Acids, Essential/deficiency;Female;Humans;Linoleic Acids;Male;Middle Aged;Personality Disorders/drug therapy*;Plant Oils;Schizophrenia/drug therapy*;gamma-Linolenic Acid
2580171;Adult;Aged;Bendroflumethiazide/therapeutic use;Blood Pressure/drug effects*;Captopril/blood;Captopril/pharmacology*;Captopril/therapeutic use;Captopril/urine;Eating;Female;Food*;Half-Life;Heart Rate/drug effects;Humans;Hypertension/drug therapy;Kinetics;Male;Middle Aged;Proline/analogs & derivatives*;Protein Binding
2580172;Adult;Aldosterone/blood;Captopril/therapeutic use*;Fasting;Female;Food*;Hemodynamics/drug effects;Humans;Hypertension/drug therapy*;Male;Middle Aged;Peptidyl-Dipeptidase A/blood;Proline/analogs & derivatives*;Renin/blood;Time Factors
2589383;Adult;Bacteria/drug effects;Ciprofloxacin/administration & dosage*;Ciprofloxacin/pharmacokinetics;Clindamycin/administration & dosage*;Clindamycin/pharmacokinetics;Drug Synergism;Drug Therapy, Combination;Female;Humans;Infusions, Intravenous;Male;Metronidazole/administration & dosage*;Metronidazole/pharmacokinetics
2612087;Adult;Biological Availability;Blood Pressure/drug effects;Drug Synergism;Ethanol/blood;Ethanol/pharmacology*;Felodipine/adverse effects*;Felodipine/pharmacokinetics;Felodipine/therapeutic use;Heart Rate/drug effects;Hemodynamics/drug effects*;Humans;Hypertension/drug therapy;Hypertension/physiopathology;Male;Middle Aged;Urodynamics/drug effects
2613389;Acetaminophen/administration & dosage;Acetaminophen/pharmacokinetics*;Adult;Biological Availability;Blood Glucose/metabolism*;Diet;Food, Formulated*;Gallbladder/anatomy & histology;Gallbladder/drug effects*;Humans;Male;Random Allocation
2663579;Adult;Female;Food, Fortified/adverse effects*;Humans;Pulmonary Embolism/drug therapy;Vitamin K/adverse effects*;Warfarin/administration & dosage;Warfarin/pharmacology*;Warfarin/therapeutic use
2666453;Diet;Humans;Hypertension/chemically induced*;Hypertension/physiopathology;Monoamine Oxidase Inhibitors/adverse effects*;Tyramine/adverse effects*
2673623;Administration, Oral;Adult;Benzamides/adverse effects;Benzamides/therapeutic use*;Blood Pressure/drug effects*;Clinical Trials as Topic;Dose-Response Relationship, Drug;Double-Blind Method;Drug Synergism;Humans;Male;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Placebos;Pressoreceptors/drug effects;Random Allocation;Reference Values;Tranylcypromine/adverse effects;Tranylcypromine/therapeutic use*;Tyramine/administration & dosage;Tyramine/pharmacology*
2686430;Antacids/pharmacology;Caffeine/metabolism;Ciprofloxacin/pharmacokinetics;Ciprofloxacin/pharmacology*;Cyclosporins/pharmacokinetics;Drug Interactions;Humans;Intestinal Absorption;Rifampin/pharmacology;Theophylline/metabolism
2714732;Adult;Benzamides/adverse effects*;Benzamides/therapeutic use;Blood Pressure/drug effects;Depressive Disorder/complications*;Depressive Disorder/drug therapy;Drug Interactions;Female;Heart Rate/drug effects;Humans;Male;Middle Aged;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects*
2729942;Adult;Caffeine/pharmacokinetics*;Ciprofloxacin/pharmacokinetics;Ciprofloxacin/pharmacology*;Drug Interactions;Half-Life;Humans;Male;Theophylline/pharmacokinetics
2735334;Adolescent;Adult;Food*;Humans;Ketoprofen/administration & dosage;Ketoprofen/pharmacokinetics*;Male;Naproxen/administration & dosage;Naproxen/pharmacokinetics*;Phenylpropionates/pharmacokinetics*;Sucralfate/pharmacology*
2764304;Adult;Aminophylline/therapeutic use*;Anesthesia, Epidural;Anesthesia, General;Consciousness/drug effects;Humans;Male;Midazolam/antagonists & inhibitors*;Middle Aged
2767766;Absorption;Adult;Animals;Biological Availability;Doxycycline/blood;Doxycycline/pharmacokinetics*;Fasting;Female;Humans;Male;Milk*;Water
2794993;Adult;Benzamides/pharmacology*;Blood Pressure/drug effects*;Drug Synergism;Female;Humans;Male;Moclobemide;Monoamine Oxidase Inhibitors/pharmacology*;Piperidines/pharmacology*;Time Factors;Tyramine/pharmacology*
2795213;Caffeine/blood;Caffeine/therapeutic use*;Coronary Disease/chemically induced;Coronary Disease/diagnostic imaging;Coronary Disease/drug therapy*;Dipyridamole/adverse effects*;Electrocardiography;Heart/diagnostic imaging;Heart/physiopathology;Humans;Male;Middle Aged;Radionuclide Imaging;Thallium Radioisotopes
2821081;Adult;Biological Availability;Capsules;Dietary Fiber/pharmacology*;Digoxin/administration & dosage;Digoxin/pharmacokinetics*;Female;Humans;Male
2875358;Aged;Dihydroergotamine/adverse effects*;Embolism/prevention & control*;Ergotism/etiology*;Heparin/adverse effects*;Humans;Thrombosis/prevention & control*
2876719;Aged;Alfentanil;Analgesics, Opioid/administration & dosage*;Critical Care;Female;Fentanyl/administration & dosage;Fentanyl/analogs & derivatives*;Fentanyl/blood;Humans;Hydrocortisone/blood;Hypnotics and Sedatives*;Kinetics;Male;Meperidine/administration & dosage*;Middle Aged;Respiration, Artificial*
2880045;Adult;Aged;Dihydroergotamine/adverse effects*;Drug Combinations/adverse effects;Ergotism/etiology*;Heparin/adverse effects*;Heparin, Low-Molecular-Weight*;Humans;Thromboembolism/prevention & control*
2901653;Acenocoumarol/administration & dosage;Blood Coagulation Disorders/etiology*;Diet, Reducing/adverse effects*;Female;Humans;Middle Aged;Vitamin K/administration & dosage
2913801;Acute Kidney Injury/complications;Acute Kidney Injury/therapy;Aged;Aluminum/blood;Aluminum/poisoning*;Aluminum Hydroxide/adverse effects*;Citrates/adverse effects*;Citric Acid;Coma/chemically induced;Diabetes Complications;Drug Interactions;Female;Humans;Hypertension/complications;Intestinal Absorption;Middle Aged;Renal Dialysis
2914409;Adult;Age Factors;Aged;Aluminum/blood*;Aluminum Hydroxide/adverse effects*;Antacids/adverse effects*;Brain Diseases/chemically induced*;Citrates/adverse effects*;Citric Acid;Drug Interactions;Female;Humans;Kidney Failure, Chronic/therapy*;Male;Middle Aged
2929629;Adult;Blood Pressure/drug effects;Caffeine/administration & dosage;Caffeine/adverse effects*;Double-Blind Method;Drug Interactions;Electrocardiography;Female;Follow-Up Studies;Heart Rate;Humans;Hypertension/chemically induced*;Male;Phenylpropanolamine/administration & dosage;Phenylpropanolamine/adverse effects*;Placebos;Random Allocation
2938522;Aminophylline/pharmacology*;Anesthesia Recovery Period*;Benzodiazepines/antagonists & inhibitors*;Humans;Midazolam;Postoperative Period*
2985676;Antacids/metabolism;Anti-Arrhythmia Agents/metabolism;Anti-Bacterial Agents/metabolism;Anti-Inflammatory Agents/metabolism;Biological Availability;Calcium Channel Blockers/metabolism;Cholestyramine Resin/metabolism;Dietary Fiber/metabolism;Digoxin/metabolism*;Diuretics/metabolism;Drug Interactions;Humans;Kaolin/metabolism;Kinetics;Rifampin/metabolism
3014110;Adult;Angiotensin-Converting Enzyme Inhibitors*;Biological Availability;Enalapril/analogs & derivatives*;Enalapril/blood;Enalapril/metabolism;Enalapril/urine;Food;Humans;Intestinal Absorption;Lisinopril;Time Factors
3038451;Absorption;Adult;Amoxicillin/metabolism*;Biological Availability;Dietary Fiber/administration & dosage;Dietary Fiber/pharmacology*;Humans;Kinetics;Male
3038494;Aged*;Aged, 80 and over;Biological Availability;Cathartics/therapeutic use*;Constipation/diet therapy;Constipation/drug therapy;Dietary Fiber/therapeutic use*;Digoxin/blood*;Drug Interactions;Humans;Inpatients;Middle Aged;Psyllium/therapeutic use*
3040815;Adolescent;Adult;Dermatomycoses/drug therapy*;Dermatomycoses/metabolism;Eating*;Female;Humans;Itraconazole;Ketoconazole/analogs & derivatives*;Ketoconazole/metabolism;Ketoconazole/therapeutic use;Kinetics;Male;Middle Aged;Random Allocation
3053579;4-Quinolones;Anti-Infective Agents/pharmacokinetics;Anti-Infective Agents/pharmacology*;Drug Interactions;Humans
3085485;Enteral Nutrition;Food, Formulated/analysis*;Humans;Infant;Phenytoin/administration & dosage;Phenytoin/analysis*;Ultrafiltration
3100311;Administration, Oral;Adult;Aluminum/administration & dosage*;Aluminum/metabolism;Antacids/administration & dosage*;Antacids/metabolism;Citrates/administration & dosage;Citric Acid;Drug Combinations;Female;Humans;Intestinal Absorption*;Male;Water/administration & dosage
3110450;Adult;Dietary Fats/administration & dosage*;Drug Resistance;Fat Emulsions, Intravenous/adverse effects*;Humans;Male;Parenteral Nutrition/adverse effects*;Prothrombin Time;Short Bowel Syndrome/therapy;Warfarin/therapeutic use*
3116961;Cerebral Hemorrhage/drug therapy;Enteral Nutrition/adverse effects*;Female;Humans;Intestinal Absorption;Middle Aged;Phenytoin/administration & dosage*;Phenytoin/pharmacokinetics;Suspensions
3121288;Administration, Oral;Adult;Biological Availability;Drug Interactions;Enteral Nutrition/methods*;Female;Humans;Male;Phenytoin/analysis;Phenytoin/pharmacokinetics*;Random Allocation;Suspensions;Time Factors
3127188;Adult;Capsules;Enteral Nutrition*;Female;Humans;Intestinal Absorption;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*
3189445;Adult;Cosmetics/adverse effects*;Female;Hemorrhage/chemically induced*;Humans;Menopause;Panax*;Plants, Medicinal*;Vaginal Diseases/chemically induced*
3220610;Adult;Delayed-Action Preparations;Female;Food*;Humans;Male;Theophylline/administration & dosage;Theophylline/blood*;Theophylline/pharmacokinetics
3228106;Chromatography, High Pressure Liquid;Drug Stability;Food, Formulated;Phenytoin/analysis*;Solvents;Time Factors;Ultrafiltration
3243931;Adult;Delayed-Action Preparations;Eating;Half-Life;Humans;Intestinal Absorption;Male;Naproxen/administration & dosage;Naproxen/pharmacokinetics*
3259827;Administration, Oral;Blood Pressure/drug effects;Coronary Angiography;Coronary Disease/diagnostic imaging;Coronary Disease/physiopathology;Dipyridamole*;Heart/diagnostic imaging*;Heart Rate/drug effects;Hemodynamics/drug effects*;Humans;Male;Middle Aged;Thallium Radioisotopes*;Theophylline/administration & dosage*;Theophylline/therapeutic use;Tomography, Emission-Computed*
3278460;Absorption;Adult;Animals;Cholestyramine Resin/therapeutic use*;Cyclosporins/administration & dosage;Cyclosporins/pharmacokinetics*;Drug Interactions;Fasting;Food*;Fruit;Heart Transplantation*;Humans;Male;Middle Aged;Milk
3283290;Animals;Benzamides/adverse effects*;Beverages/adverse effects;Drug Synergism;Food/adverse effects*;Humans;Hypertension/chemically induced;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects*;Phenethylamines/adverse effects;Tyramine/adverse effects*
3338980;Adult;Bipolar Disorder/drug therapy;Caffeine/adverse effects*;Caffeine/pharmacology;Coffee*;Female;Humans;Lithium/administration & dosage;Lithium/adverse effects*;Lithium/metabolism;Middle Aged;Substance Withdrawal Syndrome/metabolism*;Tremor/chemically induced*
3356120;Administration, Oral;Adult;Biological Availability;Chromatography, High Pressure Liquid;Female;Food*;Gastric Acid/secretion*;Humans;Intestinal Absorption;Ketoconazole/administration & dosage;Ketoconazole/pharmacokinetics*;Male;Tablets
3366169;Administration, Oral;Adult;Dosage Forms;Female;Food;Humans;Ketoprofen/administration & dosage;Ketoprofen/pharmacokinetics*;Male;Middle Aged;Phenylpropionates/pharmacokinetics*
3372933;Food, Formulated/adverse effects*;Humans;Male;Middle Aged;Neurocognitive Disorders/complications;Neurocognitive Disorders/drug therapy;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*;Pneumonia, Aspiration/complications;Seizures/drug therapy;Seizures/etiology
3389610;Aged;Dihydroergotamine/adverse effects*;Drug Interactions;Ergotism/etiology*;Erythromycin/adverse effects*;Humans;Male
3392235;Administration, Oral;Adult;Anti-Anxiety Agents*;Benzodiazepines*;Benzodiazepinones/administration & dosage;Benzodiazepinones/blood;Benzodiazepinones/pharmacokinetics*;Eating*;Flunitrazepam/administration & dosage;Flunitrazepam/blood;Flunitrazepam/pharmacokinetics*;Half-Life;Humans;Male;Time Factors
3414579;Adult;Anemia, Hypochromic/etiology*;Animals;Birth Weight;Body Weight;Coffee/adverse effects*;Erythrocyte Count;Female;Gestational Age;Hematocrit;Hemoglobins/metabolism;Humans;Infant, Newborn;Iron/metabolism;Maternal-Fetal Exchange*;Milk, Human/metabolism;Pregnancy;Regression Analysis
3460737;Adult;Anti-Infective Agents/blood;Anti-Infective Agents/metabolism*;Anti-Infective Agents/urine;Eating*;Fasting;Humans;Kinetics;Male;Ofloxacin;Oxazines/blood;Oxazines/metabolism*;Oxazines/urine;Random Allocation
3475034;Administration, Oral;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Enoxacin;Food*;Humans;Intestinal Absorption/drug effects;Kinetics;Naphthyridines/administration & dosage;Naphthyridines/metabolism*
3480885;Adult;Anti-Infective Agents/pharmacology;Caffeine/blood;Caffeine/pharmacokinetics*;Chromatography, High Pressure Liquid;Ciprofloxacin/pharmacology;Drug Interactions;Enoxacin;Half-Life;Humans;Male;Naphthyridines/pharmacology;Ofloxacin;Oxazines/pharmacology;Quinolines/pharmacology*
3481318;Adult;Anti-Infective Agents/pharmacology*;Caffeine/pharmacokinetics*;Ciprofloxacin/pharmacology;Drug Interactions;Enoxacin;Humans;Male;Middle Aged;Naphthyridines/pharmacology;Ofloxacin;Oxazines/pharmacology;Quinolines/pharmacology*
3499163;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Female;Food*;Humans;Intestinal Absorption/drug effects;Magnesium Hydroxide/pharmacology;Male;Middle Aged;Piroxicam/analogs & derivatives*;Piroxicam/pharmacokinetics
3517081;Adolescent;Adult;Caffeine/administration & dosage;Caffeine/blood;Caffeine/metabolism;Caffeine/pharmacology*;Clinical Trials as Topic;Cognition/drug effects;Diazepam/administration & dosage;Diazepam/blood;Diazepam/metabolism;Diazepam/pharmacology*;Double-Blind Method;Drug Interactions;Drug Tolerance;Emotions/drug effects;Female;Humans;Kinetics;Learning/drug effects;Male;Memory/drug effects;Psychological Tests;Random Allocation
3525654;Diet*;Food Analysis;Humans;Monoamine Oxidase Inhibitors/metabolism*;Patient Education as Topic;Tyramine/analysis;Tyramine/metabolism*
3541503;Adult;Aged;Clinical Trials as Topic;Drug Interactions;Female;Humans;Male;Middle Aged;Vegetables*;Vitamin K/administration & dosage;Vitamin K/metabolism*;Warfarin/administration & dosage;Warfarin/metabolism*;Wine*
3565796;Adult;Aminophylline/therapeutic use*;Anesthesia, Intravenous;Anesthesia, Spinal;Female;Flunitrazepam*;Humans;Male;Psychomotor Performance;Time Factors
3665325;Adult;Delayed-Action Preparations;Food;Humans;Male;Theophylline/administration & dosage;Theophylline/pharmacokinetics*
3682151;Adult;Female;Humans;Hypertension/etiology*;Monoamine Oxidase Inhibitors/adverse effects*;Soybeans/adverse effects*
3693341;Adult;Depressive Disorder/drug therapy;Dietary Proteins/adverse effects*;Drug Interactions;Female;Food, Fortified/adverse effects;Humans;Hypertension/chemically induced*;Phenelzine/adverse effects*;Yeast, Dried/adverse effects*
3693584;Adult;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Chromatography, Gas;Food*;Humans;Isoquinolines/pharmacokinetics*;Male;Middle Aged;Tetrahydroisoquinolines*
3720177;Absorption;Adult;Biological Availability;Delayed-Action Preparations;Female;Food*;Humans;Kinetics;Middle Aged;Propranolol/blood;Propranolol/metabolism*
3734141;Adult;Breath Tests;Buspirone;Diazepam/metabolism;Diazepam/pharmacology*;Drug Interactions;Ethanol/metabolism;Ethanol/pharmacology*;Evoked Potentials/drug effects*;Humans;Kinetics;Male;Psychomotor Performance/drug effects*;Pyrimidines/metabolism;Pyrimidines/pharmacology*;Random Allocation;Reaction Time/drug effects
3778707;Aged;Aluminum/blood;Aluminum/poisoning*;Diabetic Nephropathies/therapy;Encephalitis/chemically induced*;Female;Humans;Kidney Failure, Chronic/etiology;Kidney Failure, Chronic/therapy*;Male;Middle Aged;Nephrotic Syndrome/complications;Nephrotic Syndrome/therapy*;Renal Dialysis/adverse effects*;Uremia/therapy*
3790404;Absorption;Adolescent;Adult;Biological Availability;Child;Delayed-Action Preparations;Fasting;Female;Food*;Humans;Kinetics;Male;Theophylline/administration & dosage;Theophylline/adverse effects;Theophylline/metabolism*
3807390;Adult;Blood Glucose/metabolism;Diabetes Mellitus, Type 2/drug therapy*;Glucose Tolerance Test;Humans;Hypoglycemic Agents/therapeutic use*;Plants, Medicinal/analysis*;Sri Lanka
3824426;Food, Formulated;Humans;Intestinal Absorption;Intubation, Gastrointestinal;Male;Middle Aged;Theophylline/metabolism*
3838321;Animals;Delayed-Action Preparations;Ferrous Compounds/pharmacology*;Food*;Humans;Intestinal Absorption*;Iron/pharmacology*;Milk*;Minocycline/administration & dosage;Minocycline/blood*;Tetracycline/administration & dosage;Tetracycline/blood*;Tetracyclines/blood*;Time Factors
3838971;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology;Amoxicillin/administration & dosage;Amoxicillin/metabolism*;Amoxicillin-Potassium Clavulanate Combination;Animals;Cimetidine/metabolism;Clavulanic Acid;Clavulanic Acids/administration & dosage;Clavulanic Acids/blood;Clavulanic Acids/metabolism*;Drug Combinations;Drug Interactions;Humans;Metabolic Clearance Rate/drug effects;Milk/metabolism
3877043;Animals;Anti-Bacterial Agents/adverse effects*;Anti-Bacterial Agents/pharmacology;Chemical and Drug Induced Liver Injury/etiology*;Cytochrome P-450 Enzyme System/biosynthesis;Drug Interactions;Enzyme Induction;Erythromycin/adverse effects;Erythromycin/analogs & derivatives;Humans;Liver/drug effects;Liver/pathology;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Rats;Structure-Activity Relationship;Troleandomycin/adverse effects
3910768;Adult;Aged;Blood Pressure/drug effects;Captopril/blood;Captopril/pharmacology*;Captopril/therapeutic use;Eating*;Female;Hemodynamics/drug effects*;Humans;Hypertension/drug therapy*;Hypertension/physiopathology;Male;Middle Aged
3948402;Adult;Aluminum/blood;Aluminum/metabolism*;Antacids/metabolism*;Citrates/pharmacology*;Citric Acid;Diet*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects*;Male
3988971;Akathisia, Drug-Induced*;Aspartame/adverse effects*;Dipeptides/adverse effects*;Drug Interactions;Female;Humans;Male;Middle Aged;Panax*;Phenelzine/adverse effects*;Plants, Medicinal*;Sleep Initiation and Maintenance Disorders/chemically induced*;Tremor/chemically induced*
3998202;Adult;Drug Interactions;Female;Humans;Male;Mental Disorders/drug therapy*;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use
3998343;Aged;Drug Interactions;Female;Food, Formulated/adverse effects*;Food, Formulated/analysis;Humans;Male;Middle Aged;Prothrombin Time;Vitamin K/pharmacology*;Warfarin/antagonists & inhibitors*;Warfarin/therapeutic use
4000229;Adult;Drug Synergism;Ethanolamines/administration & dosage*;Female;Foodborne Diseases/drug therapy;Humans;Hypertension/chemically induced;Hypertension/drug therapy*;Injections, Intravenous;Labetalol/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects*;Tranylcypromine/adverse effects;Tyramine/adverse effects*
4003328;Anemia/blood;Anemia/epidemiology*;Anemia/etiology;Breast Feeding;Erythrocytes, Abnormal*;Female;Hemoglobins/analysis;Humans;Infant;Infant Nutritional Physiological Phenomena*;Israel;Male;Social Class;Tea/adverse effects*
4005122;Administration, Oral;Adult;Delayed-Action Preparations;Female;Food*;Humans;Kinetics;Male;Oxprenolol/administration & dosage;Oxprenolol/blood*
4006379;Absorption;Administration, Oral;Adult;Biological Availability;Delayed-Action Preparations;Dietary Fats*;Fasting;Humans;Hydrogen-Ion Concentration;Kinetics;Male;Random Allocation;Theophylline/blood;Theophylline/metabolism*
4014747;Adult;Aged;Aminophylline/pharmacology*;Female;Humans;Infusions, Parenteral;Injections, Intravenous;Lorazepam/antagonists & inhibitors*;Male;Middle Aged;Wakefulness/drug effects
4029248;Adult;Caffeine/metabolism*;Contraceptives, Oral/adverse effects*;Contraceptives, Oral, Hormonal/adverse effects*;Cytochrome P-450 Enzyme System/analysis;Drug Interactions;Estrogens/adverse effects*;Female;Humans;Liver/metabolism;Metabolic Clearance Rate/drug effects
4042520;Absorption;Administration, Oral;Adolescent;Adult;Alcohol Drinking;Analysis of Variance;Chromatography, Gas;Contraceptives, Oral, Hormonal/pharmacology*;Drug Interactions;Ethanol/blood*;Ethanol/metabolism;Female;Humans;Reaction Time;Smoking
4064930;Adult;Dietary Carbohydrates/adverse effects;Dietary Fats/adverse effects;Dietary Proteins/adverse effects;Female;Food*;Humans;Intestinal Absorption*;Kinetics;Male;Middle Aged;Theophylline/metabolism*
4099618;Cheese*/analysis;Fluorometry;Humans;Hydrogen-Ion Concentration;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/antagonists & inhibitors;Mouth Mucosa/metabolism;Tyramine/analysis;Tyramine/metabolism*
4909796;Adult;Antidepressive Agents/administration & dosage*;Behavior Therapy;Child;Chlordiazepoxide/administration & dosage*;Clinical Trials as Topic;Depression/drug therapy;Drug Synergism;Female;Humans;Male;Monoamine Oxidase Inhibitors/administration & dosage*;Phobic Disorders/drug therapy*
4964450;Demeclocycline/metabolism;Demeclocycline/pharmacology*;Humans;Oxytetracycline/metabolism;Oxytetracycline/pharmacology*;Protein Binding
4967225;Adult;Humans;Male;Methods;Middle Aged;Prothrombin Time*;Vitamin K/pharmacology*;Warfarin/pharmacology*
5104893;Adult;Drug Synergism;Feeding Behavior*;Humans;Hypoprothrombinemias/chemically induced;Male;Plant Extracts/pharmacology;Prothrombin Time;Pulmonary Embolism/drug therapy;Soybeans/analysis;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacology*
5132558;Animals;Body Temperature/drug effects;Brain/drug effects;Caffeine/toxicity*;Drug Interactions;Female;Lethal Dose 50;Monoamine Oxidase Inhibitors/pharmacology*;Rats;Rats, Inbred Strains;Theobromine/toxicity*;Theophylline/toxicity*
5304704;Adult;Ergotamine/metabolism;Ergotamine/therapeutic use;Ergotism/etiology*;Humans;Liver/metabolism;Male;Migraine Disorders/drug therapy;Tartrates;Troleandomycin/adverse effects*
5676383;Acetazolamide/pharmacology;Adult;Aminophylline/pharmacology;Ammonium Chloride/pharmacology;Bendroflumethiazide/pharmacology;Bicarbonates/pharmacology;Creatinine/blood;Creatinine/urine;Diuresis;Ethacrynic Acid/pharmacology;Female;Furosemide/pharmacology;Humans;Kidney/physiology*;Lithium/blood;Lithium/urine*;Middle Aged;Potassium/blood;Potassium/urine;Sodium/blood;Sodium/urine;Spironolactone/pharmacology;Urea/pharmacology
5897315;Absorption;Diet;Humans;Neomycin/pharmacology*;Prothrombin Time;Vitamin K/metabolism*;Vitamin K 1/pharmacology*;Warfarin/metabolism*;Warfarin/therapeutic use*
5948152;Animals;Humans;Hypertension/etiology*;Poultry*;Tranquilizing Agents/pharmacology;Tranylcypromine/adverse effects*;Tyramine/adverse effects*
6034391;Adolescent;Adult;Cerebral Hemorrhage/chemically induced;Cheese*;Female;Humans;Hypertension/chemically induced;Male;Middle Aged;Monoamine Oxidase Inhibitors/adverse effects*;Pargyline/adverse effects*;Phenelzine/adverse effects*;Subarachnoid Hemorrhage/chemically induced;Tranylcypromine/adverse effects*;Tyramine/pharmacology*;Yeast, Dried/adverse effects*
6091711;Adult;Ampicillin/analogs & derivatives*;Ampicillin/metabolism;Bicarbonates/pharmacology;Biological Availability;Cefuroxime/analogs & derivatives*;Cefuroxime/metabolism;Cephalosporins*;Female;Food*;Gastric Acid/physiology*;Gastric Acidity Determination;Humans;Male;Ranitidine/pharmacology;Sodium Bicarbonate
6097665;Adult;Antihypertensive Agents/metabolism*;Antihypertensive Agents/urine;Biological Availability;Dipeptides/metabolism*;Dipeptides/urine;Enalapril;Food*;Humans;Male
6112560;Antipsychotic Agents/blood*;Antipsychotic Agents/pharmacology;Caffeine/pharmacology*;Coffee*;Drug Antagonism;Female;Humans;Tea*
6113376;Adult;Amphotericin B/adverse effects*;Diet, Sodium-Restricted/adverse effects;Female;Humans;Kidney/drug effects*;Kidney Diseases/chemically induced*;Male;Middle Aged;Sodium/blood*
6116064;Administration, Oral;Adult;Coffee*;Female;Fluphenazine/blood;Fluphenazine/pharmacology*;Humans;Male;Tea*
6124334;Adult;Analysis of Variance;Anti-Anxiety Agents/pharmacology*;Buspirone;Double-Blind Method;Drug Interactions;Ethanol/pharmacology*;Humans;Lorazepam/pharmacology*;Male;Mental Processes/drug effects*;Motor Skills/drug effects*;Pyrimidines/pharmacology*
6129542;Aminophylline/pharmacology*;Clinical Trials as Topic;Diazepam/antagonists & inhibitors*;Double-Blind Method;Drug Antagonism;Female;Humans;Male;Random Allocation
6130074;Adult;Anti-Anxiety Agents/pharmacology*;Buspirone;Double-Blind Method;Drug Interactions;Ethanol/pharmacology*;Humans;Lorazepam/pharmacology;Male;Motor Skills/drug effects;Psychomotor Performance/drug effects*;Pyrimidines/pharmacology*
6133016;Acetaminophen/adverse effects;Adult;Back Pain/drug therapy;Beverages/adverse effects*;Dextropropoxyphene/adverse effects;Drug Synergism;Female;Headache/drug therapy;Hemorrhagic Disorders/etiology*;Humans;Magnoliopsida*;Metrorrhagia/etiology;Metrorrhagia/therapy
6142202;Adenosine/antagonists & inhibitors*;Aminophylline/pharmacology*;Diazepam/antagonists & inhibitors*;Humans;Receptors, Cell Surface/drug effects*;Receptors, GABA-A
6149298;Antidepressive Agents, Tricyclic*;Antipsychotic Agents*;Chemical Phenomena;Chemistry;Coffee*;Drug Interactions;Gallic Acid;Hydrogen-Ion Concentration;Hydrolyzable Tannins;Tannins*;Tea*
6236021;Acne Vulgaris/drug therapy*;Adult;Drug Synergism;Ergotamine;Ergotamines/adverse effects*;Ergotamines/therapeutic use;Erythromycin/adverse effects;Erythromycin/analogs & derivatives*;Erythromycin/therapeutic use;Female;Humans;Intermittent Claudication/chemically induced*;Ischemia/chemically induced;Kidney/blood supply;Leg/blood supply;Migraine Disorders/drug therapy*
6242951;Adult;Analysis of Variance;Eating*;Fasting;Homeostasis;Humans;Iron/pharmacology*;Male;Osmolar Concentration;Piroxicam/blood;Piroxicam/pharmacokinetics*
6282000;Administration, Oral;Adult;Biological Availability;Dietary Fiber*;Digoxin/administration & dosage;Digoxin/blood*;Humans;Intestinal Absorption/drug effects;Male
6285814;Adult;Antifungal Agents/blood;Antifungal Agents/metabolism*;Chromatography, High Pressure Liquid/methods;Female;Food*;Humans;Imidazoles/blood;Imidazoles/metabolism*;Intestinal Absorption*;Ketoconazole;Kinetics;Male;Miconazole/metabolism;Piperazines/blood;Piperazines/metabolism*;Tablets
6322675;Adult;Eating;Fasting*;Female;Half-Life;Humans;Ketoconazole/blood;Ketoconazole/metabolism*;Kinetics;Male
6327318;Adult;Dietary Fiber/pharmacology*;Digoxin/metabolism*;Double-Blind Method;Female;Galactans/pharmacology*;Humans;Hydrogen-Ion Concentration;Intestinal Absorption/drug effects;Kinetics;Male;Mannans/pharmacology*;Penicillin V/metabolism;Penicillins/metabolism*;Plant Gums
6374311;Adult;Caffeine/administration & dosage;Caffeine/pharmacology*;Clinical Trials as Topic;Cognition/drug effects;Diazepam/administration & dosage;Diazepam/antagonists & inhibitors*;Diazepam/pharmacology;Dose-Response Relationship, Drug;Double-Blind Method;Drug Antagonism;Female;Flicker Fusion/drug effects;Humans;Male;Psychomotor Performance/drug effects*;Theophylline/administration & dosage;Theophylline/pharmacology*
6389377;Adult;Antacids/pharmacology*;Biological Availability;Blood Pressure/drug effects;Captopril/blood;Captopril/metabolism*;Captopril/urine;Double-Blind Method;Drug Interactions;Female;Food*;Heart Rate/drug effects;Humans;Kinetics;Male;Proline/analogs & derivatives*;Random Allocation
6394124;Animals;Cheese/analysis;Dairy Products/analysis;Depressive Disorder/drug therapy*;Diet*;Ethanol/adverse effects;Fishes;Food Analysis;Food Preservation;Humans;Liver/analysis;Meat/analysis;Meat Products/analysis;Monoamine Oxidase Inhibitors/therapeutic use*;Tyramine/adverse effects*;Tyramine/analysis;Wine/analysis;Yeast, Dried/analysis
6419147;Absorption;Adult;Humans;Male;Parenteral Nutrition/adverse effects*;Phenytoin/metabolism*
6421377;Enteral Nutrition*;Humans;Male;Middle Aged;Vitamin K/pharmacology*;Warfarin/antagonists & inhibitors*
6437219;Drug Interactions;Enteral Nutrition/adverse effects*;Humans;Vitamin K 1/adverse effects*;Warfarin/antagonists & inhibitors*
6438282;Adult;Aged;Enteral Nutrition*;Humans;Intestinal Absorption;Middle Aged;Phenytoin/blood*;Phenytoin/metabolism;Phenytoin/therapeutic use;Time Factors
6486489;Aminophylline/metabolism;Aminophylline/pharmacology*;Arousal/drug effects*;Diazepam/antagonists & inhibitors*;Double-Blind Method;Flicker Fusion/drug effects;Humans;Male;Random Allocation;Reaction Time/drug effects;Theophylline/blood
6486994;Adult;Diet Fads/adverse effects*;Drug Resistance;Female;Heart Valve Prosthesis/adverse effects;Humans;Myocardial Infarction/etiology*;Vitamin K/adverse effects;Warfarin/therapeutic use*
6522416;Adult;Diazepam/pharmacology;Female;Flurazepam/pharmacology*;Humans;Lorazepam/pharmacology;Male;Reinforcement (Psychology)*
6612697;Adult;Biological Availability;Biotransformation;Dihydroergotamine/administration & dosage*;Dihydroergotamine/blood;Drug Combinations;Drug Interactions;Heparin/administration & dosage*;Heparin/blood;Humans;Injections, Subcutaneous;Kinetics;Male;Middle Aged
6614033;Aged;Amphotericin B/adverse effects*;Creatinine/blood;Diet;Female;Humans;Kidney Diseases/chemically induced*;Kidney Diseases/drug therapy;Male;Middle Aged;Sodium/deficiency*;Sodium Chloride/therapeutic use*;Urea/blood
6626418;Adolescent;Adult;Aged;Delayed-Action Preparations;Diet*;Dietary Carbohydrates/pharmacology;Dietary Proteins/pharmacology;Female;Humans;Male;Middle Aged;Theophylline/administration & dosage;Theophylline/blood*
6662173;Administration, Oral;Adult;Anxiety/chemically induced;Diazepam/antagonists & inhibitors*;Diazepam/metabolism;Humans;Infusions, Parenteral;Kinetics;Male;Middle Aged;Psychomotor Performance/drug effects*;Theophylline/pharmacology*
6678751;Adult;Dietary Carbohydrates/pharmacology*;Dietary Fats/pharmacology;Dietary Proteins/pharmacology*;Female;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Kinetics;Middle Aged;Phenytoin/metabolism*
6688049;Adult;Animals;Doxycycline/blood;Doxycycline/metabolism*;Female;Half-Life;Humans;Kinetics;Male;Milk*
6688407;Acetaminophen/pharmacology;Administration, Oral;Adult;Analgesics/pharmacology*;Animals;Antacids/pharmacology*;Anti-Inflammatory Agents/metabolism*;Aspirin/pharmacology;Biological Availability;Butanones/metabolism*;Drug Interactions;Female;Food;Humans;Intestinal Absorption/drug effects;Male;Milk;Sex Factors
6692645;Acetaminophen/analogs & derivatives;Acetaminophen/blood;Acetaminophen/metabolism*;Acetaminophen/urine;Adult;Chromatography, High Pressure Liquid;Humans;Kinetics;Male;Oxazepam/analogs & derivatives;Oxazepam/blood;Oxazepam/metabolism*;Oxazepam/urine;Vegetables*
6723218;Adult;Diet*;Female;Humans;Intestinal Absorption;Phenytoin/metabolism*
6734044;Administration, Oral;Adult;Aged;Blood Pressure/drug effects;Chromatography, High Pressure Liquid;Female;Food*;Heart Rate/drug effects;Humans;Hydralazine/blood*;Hydralazine/therapeutic use;Hypertension/drug therapy;Indocyanine Green/metabolism;Liver/blood supply;Liver/drug effects;Male;Middle Aged;Phenotype
6734698;Adolescent;Adult;Caffeine/blood*;Contraceptives, Oral/adverse effects*;Contraceptives, Oral, Hormonal/adverse effects*;Female;Half-Life;Humans;Kinetics
6741669;Adolescent;Adult;Alcohol Drinking*;Alcoholic Intoxication/blood;Contraceptives, Oral, Hormonal/administration & dosage;Discrimination (Psychology)*/drug effects;Drug Tolerance;Ethanol/blood*;Female;Humans;Menstruation*/drug effects;Set (Psychology)
6786635;Animals;Blood Glucose/metabolism*;Diabetes Mellitus/blood*;Diabetes Mellitus/diet therapy;Female;Fruit*;Glucose Tolerance Test;Humans;Insulin/blood;Male;Rats
6794970;Absorption;Administration, Oral;Aged;Biological Availability;Blood Pressure/drug effects;Dihydroergotamine/administration & dosage;Dihydroergotamine/metabolism*;Female;Humans;Hypotension, Orthostatic/drug therapy;Hypotension, Orthostatic/metabolism*;Injections, Intravenous;Male;Middle Aged;Nitroglycerin/pharmacology;Splanchnic Circulation
6803191;Adult;Female;Humans;Intubation, Gastrointestinal/adverse effects*;Male;Parenteral Nutrition/adverse effects*;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/metabolism*;Seizures/drug therapy
6806502;Adult;Blood Glucose/analysis;Diabetes Mellitus/diet therapy*;Female;Fruit*;Humans;Male;Middle Aged
6807440;Adult;Arterial Occlusive Diseases/chemically induced*;Ergotamine/administration & dosage;Ergotamine/adverse effects*;Humans;Injections, Intravenous;Injections, Subcutaneous;Male;Methysergide/adverse effects*;Migraine Disorders/drug therapy*
6821036;Enteral Nutrition;Humans;Male;Middle Aged;Warfarin/therapeutic use*
6834589;Aged;Female;Humans;Panax*;Plants, Medicinal*;Uterine Hemorrhage/chemically induced*
6843604;Female;Humans;Prothrombin Time;Vegetables*/analysis;Vitamin K/analysis;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
6882312;Adult;Caffeine/adverse effects*;Drug Interactions;Drug Synergism;Ethanol/adverse effects*;Female;Humans;Male;Memory/drug effects;Reaction Time/drug effects*
6883912;Acetaminophen/metabolism*;Adult;Animals;Cattle;Cooking;Diet*;Female;Half-Life;Humans;Male;Meat*
6926836;Acetylation;Adult;Biological Availability;Delayed-Action Preparations;Female;Food*;Humans;Hydralazine/administration & dosage;Hydralazine/blood;Hydralazine/metabolism*;Male;Tablets
6956293;Absorption;Biological Availability;Female;Food*;Humans;Male;Phenytoin/metabolism*
7040498;Adolescent;Adult;Biological Availability;Biotransformation;Captopril/administration & dosage;Captopril/metabolism*;Feces/analysis;Food*;Humans;Male;Proline/analogs & derivatives*;Time Factors
7053307;Adult;Caffeine/blood;Caffeine/pharmacology*;Coffee;Double-Blind Method;Drug Interactions;Emotions/drug effects*;Ethanol/blood;Ethanol/pharmacology*;Humans;Kinetics;Male;Motor Skills/drug effects*
7076627;Diet*;Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Tyramine/adverse effects
7098543;Adult;Caffeine/pharmacology*;Diazepam/antagonists & inhibitors*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Flicker Fusion/drug effects;Humans;Male;Mental Processes/drug effects*;Muscle Contraction/drug effects*;Muscle Relaxation/drug effects*;Placebos;Temperament/drug effects
7104169;Administration, Oral;Adult;Biological Availability;Blood Pressure/drug effects;Ethanolamines/metabolism*;Female;Food*;Half-Life;Humans;Injections, Intravenous;Kinetics;Labetalol/administration & dosage;Labetalol/metabolism*;Labetalol/pharmacology;Male;Pulse/drug effects
7105982;Adult;Cardiovascular Diseases/etiology;Cheese*;Drug Interactions;Humans;Isoniazid/adverse effects*;Wine*
7118763;Adolescent;Adult;Amoxicillin/adverse effects;Amoxicillin/metabolism*;Amoxicillin-Potassium Clavulanate Combination;Biological Availability;Drug Combinations/adverse effects;Drug Combinations/metabolism;Female;Food*;Humans;Kinetics;Male;Time Factors
7174567;Acetylation;Adult;Biological Availability;Diet*;Fasting;Female;Humans;Intestinal Absorption;Isoniazid/metabolism*;Male
7188722;Adult;Animals;Drug Interactions;Female;Fishes*;Foodborne Diseases/etiology*;Histamine/poisoning*;Humans;Isoniazid/adverse effects*;Isoniazid/therapeutic use;Male;Middle Aged;Tuberculosis, Lymph Node/drug therapy*;Tuberculosis, Pulmonary/drug therapy*;Tuna*
7197483;Aged;Aminophylline/pharmacology*;Diazepam/antagonists & inhibitors*;Humans;Male
7197984;Animals;Catalepsy/chemically induced;Chemical Precipitation;Chlorpromazine/metabolism*;Coffee/adverse effects*;Drug Interactions;Humans;Intestinal Absorption/drug effects;Male;Rats;Rats, Inbred Strains;Tea/adverse effects*
7212893;Adult;Diet;Diet, Reducing*;Drug Resistance;Female;Humans;Prothrombin Time;Vitamin K/administration & dosage;Warfarin/blood;Warfarin/therapeutic use*
7237895;Adolescent;Adult;Biological Availability;Female;Food*;Humans;Kinetics;Liver/metabolism*;Male;Propranolol/metabolism*
7270565;Aged;Drug Interactions;Drug Resistance;Female;Food, Formulated;Humans;Vitamin K/adverse effects*;Warfarin/pharmacology*
7274023;Drug Interactions;Drug Resistance;Humans;Male;Vitamins/adverse effects*;Warfarin/pharmacology*
7308273;Adult;Biological Availability;Blood Pressure/drug effects;Female;Food*;Heart Rate/drug effects;Humans;Hydralazine/metabolism*;Hydralazine/pharmacology;Intestinal Absorption;Male;Saliva/analysis
7312071;Coumarins/antagonists & inhibitors*;Drug Resistance;Food, Formulated*;Humans;Netherlands;Vitamin K 1/pharmacology*
7343191;Adult;Animals;Body Weight;Contraceptives, Oral/pharmacology*;Contraceptives, Oral, Hormonal/pharmacology*;Ethanol/blood;Ethanol/metabolism*;European Continental Ancestry Group;Female;Humans;Menstruation*;Papio
7359014;Absorption;Adolescent;Adult;Aged;Binding Sites;Caffeine/blood;Caffeine/metabolism*;Contraceptives, Oral/pharmacology*;Female;Half-Life;Humans;Kinetics;Male;Menstruation;Middle Aged;Sex Factors;Time Factors
7371698;Adult;Biotransformation;Caffeine/metabolism*;Drug Interactions;Ethanolamines/pharmacology*;Half-Life;Humans;Kinetics;Male;Models, Biological;Muscle Relaxants, Central/pharmacology*;Time Factors;Xanthines/urine
7383081;Aged;Drug Resistance;Female;Food, Fortified/adverse effects;Food, Fortified/analysis*;Humans;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Vitamin K/analysis;Warfarin/antagonists & inhibitors*;Warfarin/pharmacology
7406391;Female;Food, Formulated*;Humans;Middle Aged;Vitamin K/administration & dosage*;Warfarin/antagonists & inhibitors*
7454487;Adolescent;Biodegradation, Environmental;Child;Dietary Carbohydrates/pharmacology*;Dietary Proteins/pharmacology*;Female;Half-Life;Humans;Individuality;Kinetics;Male;Microsomes, Liver/metabolism;Theophylline/metabolism*
7486898;Achlorhydria/chemically induced;Achlorhydria/metabolism;Adult;Carbonated Beverages*;Female;Gastric Acid;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Ketoconazole/pharmacokinetics*;Male;Omeprazole;Prospective Studies
7551902;Aged;Blood Loss, Surgical*;Garlic/adverse effects*;Humans;Male;Plants, Medicinal*;Postoperative Hemorrhage/etiology;Prostatectomy*
7582380;Absorption;Administration, Oral;Adult;Analysis of Variance;Antioxidants/pharmacokinetics;Antioxidants/pharmacology;Beverages*;Biotransformation;Chemical Fractionation;Chromatography, High Pressure Liquid;Citrus/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP1A2;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Flavanones*;Flavonoids/pharmacokinetics;Flavonoids/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Male;Oxidoreductases/metabolism;Reference Values;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
7589032;Administration, Oral;Adult;Caffeine/pharmacokinetics*;Contraceptives, Oral/pharmacology*;Estradiol/analogs & derivatives*;Estradiol/pharmacology*;Female;Humans;Kinetics;Levonorgestrel/pharmacology*;Norpregnenes/pharmacology*;Time Factors;Volunteers
7619679;Beverages*;Citrus*;Cross-Over Studies;Cyclosporine/blood*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Female;Humans;Kidney Transplantation*;Male;Middle Aged;Mixed Function Oxygenases/antagonists & inhibitors
7628179;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Midazolam/metabolism;Midazolam/pharmacokinetics*;Midazolam/pharmacology*
7640830;Adult;Drug Interactions;Emergency Service, Hospital;Ephedrine/adverse effects;Female;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/poisoning;Phenelzine/adverse effects;Pneumonia/complications;Poisoning/therapy;Respiratory Distress Syndrome, Adult/complications;Risk Factors;Time Factors
7648762;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Female;Food-Drug Interactions;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Reference Values;Sleep Stages/drug effects;Triazolam/administration & dosage;Triazolam/blood;Triazolam/pharmacokinetics*;Triazolam/pharmacology
7677856;Absorption;Adult;Beverages*;Citrus*;Cyclosporine/blood*;Cyclosporine/pharmacokinetics;Cytochrome P-450 Enzyme System/metabolism;Humans;Kidney Transplantation
7697949;Adult;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Kidney Transplantation*;Male;Prednisolone/pharmacokinetics;Prednisone/pharmacokinetics*
7715468;Beverages*;Biological Availability;Biotransformation/drug effects;Citrus*;Cross-Over Studies;Drug Interactions;Estradiol/administration & dosage;Estradiol/pharmacokinetics*;Estrogen Replacement Therapy*;Estrone/blood;Female;Flavonoids/pharmacology;Humans;Metabolic Clearance Rate/drug effects;Middle Aged
7742162;Adult;Animals;Cross-Over Studies;Enoxacin/pharmacokinetics*;Female;Food-Drug Interactions/physiology*;Humans;Intestinal Absorption/physiology;Male;Milk/physiology*
7748990;Adult;Aged;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Caffeine/adverse effects*;Dose-Response Relationship, Drug;Female;Humans;Lithium/pharmacokinetics*;Lithium/therapeutic use;Male;Middle Aged;Personality Inventory;Substance Withdrawal Syndrome/blood*
7768070;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics*;Humans;Infusions, Intravenous;Male;Metabolic Clearance Rate;Radioimmunoassay
7811026;Administration, Oral;Adult;Biological Availability;Carbohydrates/administration & dosage;Carbohydrates/pharmacology*;Ciprofloxacin/administration & dosage;Ciprofloxacin/pharmacokinetics*;Cross-Over Studies;Dietary Sucrose*;Enteral Nutrition*;Female;Food, Formulated;Humans;Intestinal Absorption;Male;Ofloxacin/administration & dosage;Ofloxacin/pharmacokinetics*
7856583;Adult;Ciprofloxacin/administration & dosage;Ciprofloxacin/pharmacokinetics*;Cross-Over Studies;Food, Fortified*;Humans;Intestinal Absorption;Prospective Studies
7859239;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Fasting;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/adverse effects;Theophylline/pharmacokinetics*;Therapeutic Equivalency
7875189;Administration, Oral;Adolescent;Adult;Biological Availability;Delayed-Action Preparations;Diet*;Eating;Humans;Ketoprofen/pharmacokinetics*;Male;Urine
7881701;Adult;Aged;Alprazolam/blood*;Coronary Artery Disease/blood;Drug Interactions;Drug Therapy, Combination;Female;Heart Failure/blood;Humans;Lung Diseases/blood;Male;Middle Aged;Theophylline/pharmacology*;Time Factors
7955811;Absorption/drug effects;Adult;Animals;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Calcium Carbonate/pharmacology*;Cross-Over Studies;Female;Ferrous Compounds/pharmacology*;Fluoroquinolones*;Humans;Male;Milk*;Quinolones/blood;Quinolones/pharmacokinetics*;Sucralfate/pharmacology*
7962690;Adult;Caffeine/administration & dosage;Caffeine/adverse effects*;Clozapine/administration & dosage;Clozapine/adverse effects*;Coffee/adverse effects*;Dose-Response Relationship, Drug;Drug Therapy, Combination;Humans;Male;Psychoses, Substance-Induced/etiology;Schizophrenia/drug therapy*;Schizophrenic Psychology*
7967987;Activities of Daily Living;Autonomic Nervous System Diseases/complications;Autonomic Nervous System Diseases/diagnosis;Autonomic Nervous System Diseases/drug therapy*;Benzamides/pharmacology;Benzamides/therapeutic use*;Blood Pressure/drug effects;Blood Pressure Monitoring, Ambulatory;Drug Therapy, Combination;Female;Heart Rate/drug effects;Humans;Hypotension, Orthostatic/diagnosis;Hypotension, Orthostatic/etiology*;Hypotension, Orthostatic/physiopathology;Middle Aged;Moclobemide;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Treatment Outcome;Tyramine/pharmacology;Tyramine/therapeutic use*;Yeast, Dried/pharmacology;Yeast, Dried/therapeutic use*
7972311;Adult;Beverages*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Diltiazem/analogs & derivatives;Diltiazem/blood;Diltiazem/pharmacokinetics*;Diltiazem/pharmacology;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Spectrophotometry, Ultraviolet
7979646;Adult;Albendazole/blood;Albendazole/pharmacokinetics*;Cross-Over Studies;Drug Synergism;Fasting/blood;Food;Humans;Male;Praziquantel/blood;Praziquantel/pharmacokinetics*;Sudan;Time Factors
7990219;Acetaminophen/adverse effects*;Acetaminophen/metabolism;Acetaminophen/poisoning;Adolescent;Adult;Aged;Alcohol Drinking/adverse effects;Alcoholism/complications*;Chemical and Drug Induced Liver Injury*;Drug Overdose/complications;Drug Synergism;Ethanol/adverse effects*;Ethanol/metabolism;Fasting/adverse effects*;Fasting/metabolism;Female;Humans;Liver/drug effects;Liver/metabolism;Male;Middle Aged;Retrospective Studies
8004359;Administration, Oral;Adult;Biological Availability;Chromatography, High Pressure Liquid;Drug Interactions;Drugs, Chinese Herbal/pharmacology*;Half-Life;Humans;Intestinal Absorption/drug effects;Male;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Ofloxacin/urine
8039534;Administration, Oral;Adult;Analysis of Variance;Eating/physiology*;Female;Fluconazole/administration & dosage;Fluconazole/pharmacokinetics*;Gastric Acidity Determination;Humans;Intestinal Absorption/physiology;Itraconazole/administration & dosage;Itraconazole/pharmacokinetics*;Male;Reference Values;Time Factors
8049637;Acetaminophen/analogs & derivatives;Acetaminophen/pharmacokinetics*;Adult;Allyl Compounds*;Carcinogens/pharmacokinetics;Garlic*;Half-Life;Humans;Inactivation, Metabolic;Male;Metabolic Clearance Rate/drug effects;Neoplasms/prevention & control;Plant Extracts/pharmacology*;Plants, Medicinal*;Sulfides/pharmacology
8061850;Adult;Age Factors;Aged;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Interactions;Enalapril/analogs & derivatives*;Enalapril/pharmacokinetics;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Reference Values
8064267;Adult;Alcohol Drinking/metabolism*;Eating/physiology*;Ethanol/blood*;Ethanol/pharmacokinetics;Fasting/blood;Humans;Intestinal Absorption;Male;Reference Values
8073064;Adult;Beverages*;Biological Availability;Citrus*;Delayed-Action Preparations;Half-Life;Humans;Male;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics*
8148213;Adult;Atovaquone;Chromatography, High Pressure Liquid;Dietary Fats/administration & dosage*;Fasting;Food*;Humans;Infusions, Intravenous;Intestinal Absorption*/drug effects;Male;Middle Aged;Naphthoquinones/administration & dosage;Naphthoquinones/blood;Naphthoquinones/pharmacokinetics*;Sincalide/administration & dosage;Sincalide/pharmacology;Suspensions;Tablets
8200332;Absorption;Adult;Aluminum/urine*;Aluminum Hydroxide/pharmacokinetics*;Animals;Antacids/pharmacology*;Ascorbic Acid/pharmacokinetics;Beverages*;Calcium/pharmacokinetics;Chromatography, High Pressure Liquid;Citrates/pharmacokinetics;Citric Acid;Citrus*;Drug Combinations;Drug Interactions;Female;Humans;Magnesium Hydroxide/pharmacokinetics*;Male;Milk*
8218972;Adult;Biological Availability;Diet;Food;Humans;Mexico;Tetracycline/pharmacokinetics*
8275614;Adolescent;Adult;Antioxidants/pharmacology;Beverages*;Blood Pressure/drug effects;Citrus*;Drug Interactions;Flavanones*;Flavonoids/pharmacology*;Heart Rate/drug effects;Humans;Male;Nisoldipine/blood;Nisoldipine/pharmacokinetics*;Nisoldipine/pharmacology
8364261;Adult;Aged;Aged, 80 and over;Female;Humans;Infusions, Intravenous;Male;Middle Aged;Nutrition Disorders/metabolism*;Nutritional Status;Parenteral Nutrition*;Theophylline/administration & dosage;Theophylline/pharmacokinetics*
8365689;Acenocoumarol/pharmacology;Acenocoumarol/therapeutic use*;Adult;Aged;Blood Coagulation/drug effects;Blood Coagulation Disorders/drug therapy*;Combined Modality Therapy;Diet*;Drug Interactions;Female;Humans;Male;Middle Aged;Prothrombin Time;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Vitamin K/pharmacology
8388198;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Biological Availability;Capsules;Chromatography, High Pressure Liquid;Food*;Humans;Hydroxylation;Itraconazole;Ketoconazole/administration & dosage;Ketoconazole/adverse effects;Ketoconazole/analogs & derivatives*;Ketoconazole/pharmacokinetics;Male
8390020;Adult;Beverages*;Citrus*;Cyclosporine/blood*;Female;Humans;Kidney Transplantation;Male;Middle Aged;Osmolar Concentration;Postoperative Care
8391300;Adult;Angiography;Drug Interactions;Ergotamine/poisoning*;Erythromycin/adverse effects*;Female;Humans;Ischemia/chemically induced*;Ischemia/diagnosis;Ischemia/diagnostic imaging;Ischemia/drug therapy;Leg/blood supply*;Leg/innervation;Neural Conduction;Peripheral Nervous System Diseases/chemically induced*;Peripheral Nervous System Diseases/diagnosis
8395986;Beverages;Cross Reactions;Digoxin/immunology;Digoxin/pharmacokinetics;Digoxin/pharmacology*;Humans;Intestinal Absorption;Magnoliopsida/chemistry*;Male;Middle Aged;Ouabain/metabolism;Plant Extracts/immunology;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors;Sodium-Potassium-Exchanging ATPase/metabolism;Tea/chemistry*
8453178;Aged;Enteral Nutrition;Food, Formulated*;Humans;Intestinal Absorption/drug effects*;Male;Phenytoin/blood*;Phenytoin/therapeutic use;Seizures/drug therapy
8513655;Adult;Beverages*;Biological Availability;Citrus*;Drug Interactions;Felodipine/analogs & derivatives;Felodipine/blood;Felodipine/pharmacokinetics*;Flavanones*;Flavonoids/analysis;Flavonoids/pharmacology*;Humans;Male
8521677;Adult;Age Factors;Aged;Disease;Drug Interactions;Female;Humans;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/pharmacology*;Hypnotics and Sedatives/therapeutic use;Male;Pyridines/pharmacokinetics*;Pyridines/pharmacology*;Pyridines/therapeutic use;Sex Characteristics
8527268;Administration, Oral;Adult;Asian Continental Ancestry Group;Beverages;Biological Availability;Citrus;European Continental Ancestry Group;Female;Half-Life;Humans;Injections, Intravenous;Liver/enzymology;Male;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics*;Pyridines/metabolism
8540731;Adult;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Anti-Infective Agents/urine;Biological Availability;Cross-Over Studies;Drugs, Chinese Herbal/pharmacology*;Humans;Levofloxacin*;Male;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Ofloxacin/urine;Protein Binding
8549357;Animals;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Female;Fleroxacin/blood;Fleroxacin/pharmacokinetics*;Food-Drug Interactions;Humans;Male;Milk*
8549360;Adult;Anti-Infective Agents/pharmacology*;Caffeine/administration & dosage;Caffeine/pharmacokinetics*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacokinetics*;Ciprofloxacin/pharmacology*;Cross-Over Studies;Female;Fleroxacin/pharmacology*;Humans;Male;Single-Blind Method
8554942;Adult;Caffeine/pharmacology*;Double-Blind Method;Drug Interactions;Ethanol/pharmacology*;Evoked Potentials, Visual/drug effects;Humans;Male;Placebos;Psychomotor Performance/drug effects
8562295;Adult;Analysis of Variance;Beverages;Calcium Channel Blockers/pharmacokinetics*;Citrus*/chemistry;Cross-Over Studies;Delayed-Action Preparations;European Continental Ancestry Group;Felodipine/administration & dosage;Felodipine/analogs & derivatives*;Felodipine/metabolism;Felodipine/pharmacokinetics*;Food-Drug Interactions;Humans;Linear Models;Male;Reproducibility of Results
8601555;Adult;Caffeine/metabolism*;Caffeine/pharmacology;Clozapine/analogs & derivatives;Clozapine/blood*;Clozapine/pharmacokinetics;Clozapine/therapeutic use;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2D6;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Female;Humans;Mixed Function Oxygenases/metabolism;Oxidoreductases/antagonists & inhibitors;Oxidoreductases/metabolism;Psychotic Disorders/blood;Psychotic Disorders/drug therapy*
8602393;Adult;Drug Interactions;Enteral Nutrition*;Epilepsy, Tonic-Clonic/drug therapy;Epilepsy, Tonic-Clonic/metabolism;Female;Humans;Intestinal Absorption;Intubation, Gastrointestinal;Jejunostomy*/methods;Phenytoin/administration & dosage;Phenytoin/blood;Phenytoin/pharmacokinetics*;Suspensions
8607732;Clarithromycin/adverse effects*;Drug Synergism;Ergotamine/adverse effects*;Ergotism/etiology*;Female;Humans;Ischemia/chemically induced*;Middle Aged;Migraine Disorders/drug therapy;Sinusitis/drug therapy;Tongue/blood supply*
8612381;Adult;Beverages*;Biological Availability;Citrus*;Electrocardiography/drug effects*;Female;Heart Conduction System/drug effects*;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Prospective Studies;Terfenadine/pharmacokinetics*;Time Factors
8617704;Acute Disease;Animals;Beer;Cheese/adverse effects;Depressive Disorder/drug therapy;Diet/adverse effects*;Fishes;Food-Drug Interactions*;Fruit;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Meat;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Poultry;Tyramine/adverse effects;Vegetables
8631189;Administration, Oral;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Cytochrome P-450 Enzyme System;Estradiol/blood;Estradiol Congeners/administration & dosage;Estradiol Congeners/blood;Estradiol Congeners/pharmacokinetics*;Ethinyl Estradiol/administration & dosage;Ethinyl Estradiol/blood;Ethinyl Estradiol/pharmacokinetics*;Female;Humans;Menstrual Cycle/physiology;Radioimmunoassay;Tea;Time Factors
8642453;Animals;Biological Availability;Bone and Bones/physiology*;Food Analysis;Humans;Liver/metabolism;Vitamin K/chemistry;Vitamin K/metabolism*;Vitamin K 1/analysis
8649594;Adult;Beverages/adverse effects*;Bleeding Time;Female;Hematoma, Subdural/chemically induced*;Hematoma, Subdural/pathology;Humans;Magnetic Resonance Imaging;Plants, Medicinal*;Platelet Aggregation Inhibitors/adverse effects*;Rupture, Spontaneous
8689808;Adolescent;Adult;Anti-Bacterial Agents/pharmacology*;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Cross-Over Studies;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Erythromycin/pharmacology*;Felodipine/pharmacokinetics*;Humans;Male
8693526;Adult;Aged;Beverages;Biological Availability;Citrus*;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Humans;Kidney Transplantation;Male;Middle Aged;Mixed Function Oxygenases/metabolism
8728348;Adolescent;Adult;Aged;Beverages*;Biological Availability;Citrus*;Cohort Studies;Electroencephalography/drug effects;Female;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Phenotype;Prospective Studies;Terfenadine/blood;Terfenadine/pharmacokinetics*
8735685;Adult;Aged;Caffeine/blood;Caffeine/metabolism*;Caffeine/urine;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/metabolism*;Central Nervous System Stimulants/urine;Female;Humans;Male;Methoxsalen/analogs & derivatives*;Methoxsalen/blood;Methoxsalen/pharmacology;Methoxsalen/urine;Middle Aged;Psoriasis/drug therapy*
8739026;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/pharmacology*;Beverages*;Citrus*;Cross-Over Studies;Humans;Male;Quinidine/pharmacokinetics*;Quinidine/pharmacology*
8751023;Adult;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Cross-Over Studies;Felodipine/adverse effects;Felodipine/analogs & derivatives;Felodipine/blood;Felodipine/metabolism;Felodipine/pharmacokinetics*;Heart Rate/drug effects;Humans;Male;Time Factors
8787869;Adult;Aged;Aged, 80 and over;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Ciprofloxacin/administration & dosage;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Cross-Over Studies;Enteral Nutrition/adverse effects*;Female;Gastrostomy/adverse effects*;Gastrostomy/instrumentation;Humans;Intestinal Absorption*;Intubation, Gastrointestinal/adverse effects*;Jejunostomy/adverse effects*;Jejunostomy/instrumentation;Male;Middle Aged
8813897;Adult;Biological Availability;Butter;Female;Food*;Hemostatics/administration & dosage;Hemostatics/pharmacokinetics;Humans;Intestinal Absorption/physiology*;Male;Middle Aged;Spinacia oleracea;Vitamin K/administration & dosage;Vitamin K/analogs & derivatives;Vitamin K/metabolism*;Vitamin K/pharmacokinetics;Vitamin K 1/administration & dosage;Vitamin K 1/pharmacokinetics;Vitamin K 2/analogs & derivatives
8830073;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects*;Caffeine/administration & dosage;Caffeine/adverse effects*;Clozapine/administration & dosage;Clozapine/adverse effects*;Cytochrome P-450 CYP1A2;Cytochrome P-450 Enzyme Inhibitors;Dose-Response Relationship, Drug;Drug Synergism;Humans;Male;Oxidoreductases/antagonists & inhibitors;Psychoses, Substance-Induced/etiology*;Risk Factors
8851570;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Atovaquone;Biological Availability;Food-Drug Interactions;HIV Seropositivity/metabolism*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Suspensions
8866042;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diet, Vegetarian;Flurbiprofen/administration & dosage;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Humans;Ibuprofen/administration & dosage;Ibuprofen/pharmacokinetics*;Male
8869767;Adult;Autonomic Nervous System Diseases/chemically induced*;Dihydroergotamine/administration & dosage;Dihydroergotamine/adverse effects;Dihydroergotamine/therapeutic use;Drug Synergism;Female;Gastrointestinal Diseases/chemically induced;Humans;Injections, Intravenous;Injections, Subcutaneous;Lithium/adverse effects;Mental Disorders/chemically induced*;Migraine Disorders/drug therapy;Migraine Disorders/prevention & control*;Movement Disorders/etiology*;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/adverse effects*;Serotonin Receptor Agonists/therapeutic use;Sumatriptan/administration & dosage;Sumatriptan/adverse effects;Sumatriptan/therapeutic use;Syndrome
8881693;Dermatitis, Phototoxic/pathology*;Female;Food-Drug Interactions;Humans;Middle Aged;PUVA Therapy/adverse effects*;Vegetables/adverse effects*
8911887;Administration, Oral;Adult;Amlodipine/administration & dosage;Amlodipine/pharmacokinetics*;Amlodipine/pharmacology;Beverages*;Blood Pressure/drug effects;Citrus*;Cross-Over Studies;Drinking;Heart Rate/drug effects;Humans;Male
8925804;Acetates/pharmacokinetics*;Adult;Amines*;Anticonvulsants/pharmacokinetics*;Cyclohexanecarboxylic Acids*;Dietary Proteins*;Eating;Female;Humans;Male;gamma-Aminobutyric Acid*
8926537;Adult;Capsicum*;Carbohydrate Metabolism;Diet*;Energy Metabolism*/drug effects;Humans;Lipid Peroxidation/drug effects;Male;Oxygen Consumption/drug effects;Plants, Medicinal*;Propranolol/pharmacology;Running
8929750;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Diclofenac/pharmacokinetics*;Drug Interactions;Eating*;Enzyme Inhibitors/pharmacology*;Gastric Acid/secretion*;Half-Life;Humans;Hydrogen-Ion Concentration;Male;Middle Aged;Omeprazole/pharmacology*;Reference Values;Stomach/drug effects*;Stomach/metabolism;Suspensions
8947977;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects*;Caffeine/pharmacokinetics*;Caffeine/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male
8961058;APACHE;Adult;Aged;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Ciprofloxacin/administration & dosage;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Critical Illness*;Enteral Nutrition*;Female;Humans;Intestinal Absorption*;Male;Middle Aged;Pneumonia/drug therapy;Pneumonia/metabolism
8971132;Animals;Aryl Hydrocarbon Hydroxylases*;Beverages/analysis*;Chromatography, High Pressure Liquid;Chromatography, Thin Layer;Citrus/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Furocoumarins/isolation & purification*;Furocoumarins/pharmacology;In Vitro Techniques;Magnetic Resonance Spectroscopy;Male;Mass Spectrometry;Methylene Chloride/chemistry;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Rats;Rats, Sprague-Dawley
8988067;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Acetaminophen/urine;Administration, Oral;Adult;Anticarcinogenic Agents/metabolism;Chromatography, High Pressure Liquid;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Isothiocyanates/metabolism;Lung Neoplasms/metabolism;Lung Neoplasms/prevention & control;Male;Middle Aged;Oxidation-Reduction;Reference Values;Vegetables*
9002010;Adult;Autoimmune Diseases/metabolism*;Beverages*;Citrus/metabolism*;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics;Cyclosporine/pharmacology*;Dose-Response Relationship, Drug;Drug Interactions;Female;Humans;Male;Middle Aged
9075501;Anticoagulants/antagonists & inhibitors*;Food, Fortified;Food-Drug Interactions*;Humans;Male;Middle Aged;Panax*;Plant Extracts/pharmacology;Plants, Medicinal*;Warfarin/antagonists & inhibitors*
9091822;Aged;Aspirin/therapeutic use;Humans;Hyphema/chemically induced*;Male;Plant Extracts/adverse effects*;Platelet Aggregation Inhibitors/therapeutic use;Trees
9114910;Absorption;Acetaminophen/blood;Acetaminophen/pharmacokinetics*;Administration, Oral;Adult;Analgesics, Non-Narcotic/pharmacokinetics*;Diet, Vegetarian*;Humans;Male;Middle Aged
9129557;Adult;Anti-Allergic Agents/pharmacokinetics*;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus/adverse effects*;Electrocardiography/drug effects;Food-Drug Interactions*;Humans;Male;Oxidation-Reduction;Reference Values;Terfenadine/pharmacokinetics*
9147710;Adult;Anti-Asthmatic Agents/administration & dosage;Anti-Asthmatic Agents/blood;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Food-Drug Interactions/physiology*;Half-Life;Humans;Spectrophotometry, Ultraviolet;Theophylline/administration & dosage;Theophylline/blood;Theophylline/pharmacokinetics*
9153347;Administration, Oral;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Cross-Over Studies;Eating;Fasting*;Female;Humans;Ibuprofen/administration & dosage;Ibuprofen/pharmacokinetics*;Male;Postprandial Period*;Stereoisomerism
9159606;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Blood Coagulation Tests;Drug Combinations;Drug Synergism;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Female;Humans;Middle Aged;Phenanthrolines/adverse effects*;Phenanthrolines/therapeutic use;Plant Extracts*;Warfarin/adverse effects*;Warfarin/therapeutic use
9174684;Administration, Oral;Adult;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Cross-Over Studies;Drug Interactions;Felodipine/adverse effects;Felodipine/analogs & derivatives;Felodipine/blood;Felodipine/pharmacokinetics*;Heart Rate/drug effects;Hemodynamics/drug effects*;Humans;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/drug effects;Intestines/metabolism;Liver/drug effects;Liver/metabolism;Male;Tissue Distribution/drug effects;Water
9217843;Adult;Female;Humans;Magnoliopsida*;Methoxsalen/adverse effects*;PUVA Therapy*;Photosensitivity Disorders/etiology*;Photosensitizing Agents/adverse effects*;Vegetables*
9218932;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Beverages*;Cross-Over Studies;Humans;Hydrogen-Ion Concentration;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Time Factors
9220063;Anaphylaxis/diagnosis;Animals;Antitubercular Agents/adverse effects*;Diagnosis, Differential;Food-Drug Interactions*;Foodborne Diseases/diagnosis*;Foodborne Diseases/etiology;Humans;Isoniazid/adverse effects*;Tuna*
9234037;Adult;Affect/drug effects;Alprazolam/pharmacology*;Anti-Anxiety Agents/pharmacology*;Behavior/drug effects*;Breath Tests;Buspirone/pharmacology*;Central Nervous System Depressants/pharmacology*;Dose-Response Relationship, Drug;Drug Interactions;Ethanol/pharmacology*;Female;Humans;Male;Middle Aged;Psychiatric Status Rating Scales;Psychomotor Performance/drug effects;Self-Assessment;Surveys and Questionnaires;Time Factors
9248771;Adult;Area Under Curve;Beverages*;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Electrocardiography/drug effects*;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics;Histamine H1 Antagonists/pharmacology*;Humans;Male;Middle Aged;Terfenadine/antagonists & inhibitors;Terfenadine/blood;Terfenadine/pharmacokinetics;Terfenadine/pharmacology*
9315022;Antineoplastic Agents*;Breast Neoplasms/drug therapy*;Complementary Therapies*;Drug Interactions;Female;Humans;Phytotherapy*;Plant Extracts/adverse effects*
9357093;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Citrus*;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Pectins/pharmacology*;Valproic Acid/pharmacokinetics*
9385040;Acetaminophen/administration & dosage;Acetaminophen/blood;Acetaminophen/metabolism;Acetaminophen/pharmacokinetics*;Administration, Oral;Adult;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/metabolism;Analgesics, Non-Narcotic/pharmacokinetics*;Animals;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacokinetics;Antiviral Agents/pharmacology*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Interactions;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacokinetics;Drugs, Chinese Herbal/pharmacology*;Female;Half-Life;Humans;Male;Middle Aged;Rats;Rats, Wistar;Time Factors
9399621;Adult;Anesthetics, Intravenous*;Anticoagulants/therapeutic use*;Crohn Disease/complications;Drug Interactions;Drug Resistance;Fat Emulsions, Intravenous/adverse effects*;Female;Humans;Parenteral Nutrition, Total;Propofol*;Tomography, X-Ray Computed;Warfarin/therapeutic use*
9414309;Administration, Oral;Adult;Aged;Autoimmune Diseases/blood;Autoimmune Diseases/drug therapy*;Beverages*;Biological Availability;Citrus*/chemistry;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Drug Synergism;Evaluation Studies as Topic;Female;Flavonoids/pharmacology*;Hematologic Diseases/blood;Hematologic Diseases/drug therapy*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Treatment Outcome
9431825;Administration, Oral;Adult;Area Under Curve;Central Nervous System Depressants/administration & dosage;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Chromatography, Gas;Cross-Over Studies;Dietary Carbohydrates/pharmacology*;Dietary Fats/pharmacology*;Dietary Proteins/pharmacology*;Ethanol/administration & dosage;Ethanol/blood;Ethanol/pharmacokinetics*;Humans;Infusions, Intravenous;Male
9469677;Adult;Area Under Curve;Beverages*;Citrus*;Cyclosporine/pharmacokinetics*;Cyclosporine/therapeutic use;Female;Food-Drug Interactions*;Humans;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/therapeutic use;Kidney Failure, Chronic/metabolism;Kidney Failure, Chronic/therapy;Kidney Transplantation/physiology*;Male;Middle Aged
9518947;Antidepressive Agents/adverse effects*;Central Nervous System/drug effects*;Drug Synergism;Female;Humans;Middle Aged;Paroxetine/adverse effects*;Plant Extracts/adverse effects*;Serotonin Uptake Inhibitors/adverse effects*
9545149;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/antagonists & inhibitors;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Cyclodextrins/blood;Cyclodextrins/urine;Dose-Response Relationship, Drug;Drug Evaluation;Eating;Fasting;Food/adverse effects*;Food-Drug Interactions/physiology*;Humans;Itraconazole/administration & dosage;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Middle Aged;Pharmaceutical Solutions;beta-Cyclodextrins*
9555149;Anti-Allergic Agents/adverse effects*;Citrus/adverse effects*;Food-Drug Interactions*;Terfenadine/adverse effects*
9562133;Acetates/blood;Acetates/pharmacokinetics*;Adult;Amines*;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Cyclohexanecarboxylic Acids*;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Female;Food-Drug Interactions*;Humans;Male;gamma-Aminobutyric Acid*
9562227;Administration, Oral;Adult;Analysis of Variance;Antioxidants/pharmacology;Area Under Curve;Beverages*;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Gas;Citrus*;Confidence Intervals;Cross-Over Studies;Flavanones*;Flavonoids/blood;Flavonoids/pharmacology;Food-Drug Interactions*;Hemodynamics/drug effects;Humans;Male;Nimodipine/administration & dosage;Nimodipine/blood;Nimodipine/pharmacokinetics*;Reference Values;Water
9566982;Adolescent;Adult;Aged;Aged, 80 and over;Child;Diet/standards*;Female;Humans;Male;Middle Aged;Nutrition Policy;Vitamin K/administration & dosage*;Vitamin K/chemistry;Vitamin K/metabolism;Vitamin K Deficiency*/blood;Vitamin K Deficiency*/metabolism;Vitamin K Deficiency*/physiopathology
9578182;Adult;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics*;Half-Life;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/metabolism;Saquinavir/pharmacokinetics*
9585793;Acids/blood;Adult;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Lovastatin/blood*;Male;Mixed Function Oxygenases/metabolism;Reference Values
9591935;Adult;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Citrus*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Synergism;Felodipine/adverse effects;Felodipine/analogs & derivatives;Felodipine/pharmacokinetics*;Felodipine/pharmacology;Heart Rate/drug effects;Humans;Male
9604823;Adolescent;Adult;Aged;Anticonvulsants/administration & dosage*;Anticonvulsants/blood*;Brain Injuries/drug therapy;Clinical Nursing Research;Constriction;Drug Monitoring;Enteral Nutrition/methods*;Female;Gastrostomy*;Humans;Male;Middle Aged;Phenytoin/administration & dosage*;Phenytoin/blood*;Retrospective Studies;Serum Albumin/analysis;Time Factors
9609412;Adult;Aged;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Ciprofloxacin/administration & dosage*;Ciprofloxacin/pharmacokinetics*;Creatinine/blood;Critical Care;Critical Illness;Cross-Over Studies;Drug Monitoring;Enteral Nutrition*;Gram-Negative Bacterial Infections/drug therapy*;Gram-Negative Bacterial Infections/metabolism;Humans;Infusions, Intravenous*;Middle Aged;Peritonitis/drug therapy*;Peritonitis/metabolism
9620100;Acetaminophen/adverse effects;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Acetaminophen/therapeutic use;Adolescent;Adult;Aged;Aged, 80 and over;Analgesics/adverse effects;Analgesics/pharmacokinetics;Analgesics/pharmacology*;Analgesics/therapeutic use;Benzophenones/administration & dosage;Benzophenones/pharmacokinetics;Benzophenones/pharmacology*;Benzophenones/therapeutic use;Biological Availability;Bromobenzenes/administration & dosage;Bromobenzenes/pharmacokinetics;Bromobenzenes/pharmacology*;Bromobenzenes/therapeutic use;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naproxen/adverse effects;Naproxen/pharmacokinetics;Naproxen/pharmacology*;Naproxen/therapeutic use;Orthopedic Procedures*;Pain Measurement;Pain, Postoperative/drug therapy*;Time Factors
9620116;Adult;Anticonvulsants/administration & dosage;Anticonvulsants/pharmacokinetics*;Biological Availability;Enteral Nutrition*;Female;Food-Drug Interactions;Humans;Injections, Intravenous;Male;Phenytoin/administration & dosage;Phenytoin/pharmacokinetics*
9625273;Adult;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Cytochrome P-450 Enzyme System/physiology;Diazepam/pharmacokinetics*;Female;Humans;Male
9633781;Aged;Cerebral Hemorrhage/etiology*;Female;Humans;Plants, Medicinal/adverse effects*
9660036;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Beverages*;Citrus*;Half-Life;Humans;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male
9696960;Administration, Oral;Aged;Aged, 80 and over;Beverages*;Calcium Channel Blockers/pharmacokinetics*;Citrus*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Verapamil/blood;Verapamil/pharmacokinetics*
9706183;Aged;Analysis of Variance;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Beverages*;Citrus*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prothrombin Time*;Warfarin/blood;Warfarin/pharmacokinetics*
9738088;Adult;Dietary Supplements/adverse effects*;Dietary Supplements/analysis*;Digitalis;Digoxin/blood;Drug Contamination*;Female;Heart Block/chemically induced;Humans;Lanatosides/adverse effects;Lanatosides/analysis*;Middle Aged;Plantago/adverse effects;Plantago/chemistry*;Plants, Medicinal*;Plants, Toxic;Vomiting/chemically induced
9757152;Adult;Anticonvulsants/pharmacokinetics*;Area Under Curve;Beverages;Carbamazepine/pharmacokinetics*;Citrus/metabolism*;Cross-Over Studies;Drug Administration Schedule;Epilepsy/drug therapy;Epilepsy/metabolism*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Time Factors;Water/metabolism
9768962;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Drug Combinations;Drug Interactions;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/therapeutic use;Heart Valve Prosthesis Implantation;Humans;Male;Middle Aged;Mitral Valve Insufficiency/surgery;Phenanthrolines/adverse effects*;Phenanthrolines/therapeutic use;Plant Extracts*;Warfarin/adverse effects;Warfarin/therapeutic use*
9793589;Administration, Oral;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Atovaquone;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Supplements*;Enteral Nutrition*;Fasting;Female;Humans;Male;Middle Aged;Naphthoquinones/blood;Naphthoquinones/pharmacokinetics*;Postprandial Period;Suspensions
9793622;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Dietary Fats;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naproxen/adverse effects*;Naproxen/pharmacokinetics*;Reproducibility of Results;Spectrometry, Fluorescence
9800751;Adult;Ginkgo biloba*;Humans;Male;Plant Extracts/adverse effects*;Plants, Medicinal*;Subarachnoid Hemorrhage/chemically induced*
9807978;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Emulsions;Female;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Infusions, Intravenous;Male;Metabolic Clearance Rate;Water
9818297;Adult;Amitriptyline/metabolism*;Eating;Female;Food-Drug Interactions*;Humans;Middle Aged;Nortriptyline/metabolism*
9834039;Adult;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Hypolipidemic Agents/blood*;Male;Reference Values;Simvastatin/analogs & derivatives*;Simvastatin/blood*
9840238;Adult;Aged;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Ciprofloxacin/administration & dosage*;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Critical Illness;Cross-Over Studies;Drug Monitoring;Enteral Nutrition/methods*;Female;Humans;Infusions, Intravenous;Intubation, Gastrointestinal*;Male;Middle Aged;Prospective Studies;Time Factors
9871430;Adult;Beverages;Buspirone/blood*;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mixed Function Oxygenases/drug effects;Reference Values;Serotonin Receptor Agonists/blood*
9882081;Adolescent;Adult;Antacids/pharmacology*;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Humans;Ketoprofen/analogs & derivatives*;Ketoprofen/pharmacology;Ketoprofen/toxicity;Male;Middle Aged;Tablets;Tromethamine/analogs & derivatives*;Tromethamine/pharmacology;Tromethamine/toxicity
9924842;Adult;Brazil;Drug Interactions;Fluoxetine/adverse effects;Herb-Drug Interactions;Humans;Male;Plants, Medicinal/adverse effects*;Plants, Medicinal/chemistry;Serotonin Syndrome/chemically induced*;Serotonin Syndrome/psychology;Serotonin Uptake Inhibitors/adverse effects*
10030529;Drug Interactions;Humans;Patient Education as Topic;Pharmacists;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use*;Plants, Medicinal*
10073324;Adult;Antidepressive Agents, Second-Generation/pharmacology*;Area Under Curve;Caffeine/metabolism;Caffeine/pharmacokinetics*;Caffeine/urine;Central Nervous System Stimulants/metabolism;Central Nervous System Stimulants/pharmacokinetics*;Cyclohexanols/blood;Cyclohexanols/pharmacology*;Cytochrome P-450 CYP1A2/physiology*;Desvenlafaxine Succinate;Drug Interactions;Female;Humans;Male;Patient Dropouts;Time Factors;Venlafaxine Hydrochloride
10082701;Adult;Analgesics, Non-Narcotic/adverse effects*;Anti-HIV Agents/adverse effects*;Drug Interactions;Ergotamine/adverse effects*;Female;Humans;Ritonavir/adverse effects*
10086430;Adult;Anti-HIV Agents/pharmacology*;Drug Interactions;Ergotamine/pharmacology*;Ergotism/etiology*;HIV Protease Inhibitors/pharmacology*;Humans;Indinavir/pharmacology*;Male;Vasoconstrictor Agents/pharmacology*
10096255;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Beverages;Citrus*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacology*;Female;Food-Drug Interactions;Furocoumarins/pharmacology*;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Intestinal Mucosa/cytology;Intestinal Mucosa/drug effects;Intestinal Mucosa/metabolism*;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Mixed Function Oxygenases/metabolism;Reference Values
10096258;Adult;Anti-Infective Agents/pharmacology*;Area Under Curve;Caffeine/pharmacokinetics*;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Drug Interactions;Enoxacin/pharmacology*;Female;Humans;Male;Methylation/drug effects;Microsomes, Liver/drug effects*;Microsomes, Liver/enzymology;Pefloxacin/pharmacology*;Reference Values
10102468;Adult;Aged;Anticoagulants/pharmacology*;Diet/adverse effects;Drug Interactions;Drug Tolerance;Female;Hemostatics/administration & dosage*;Humans;Male;Middle Aged;Vitamin K/administration & dosage*;Warfarin/pharmacology*
10192596;Acute Disease;Bread/analysis;Cheese/analysis;Chromatography, High Pressure Liquid;Diet/adverse effects*;Food Analysis/statistics & numerical data;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/adverse effects*;Soybeans/chemistry*;Tyramine/adverse effects*;Tyramine/analysis
10217316;Animals;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Chromatography, High Pressure Liquid;Drug Interactions;Male;Panax*;Plant Roots/anatomy & histology;Plant Roots/chemistry;Plants, Medicinal*;Prothrombin Time;Rats;Rats, Sprague-Dawley;Vitamin K/analysis;Warfarin/blood;Warfarin/pharmacokinetics*;Warfarin/pharmacology
10220126;Adult;Aged;Beverages;Citrus*;Female;Food-Drug Interactions*;Haloperidol/blood;Haloperidol/pharmacology*;Haloperidol/therapeutic use;Humans;Middle Aged;Psychiatric Status Rating Scales;Schizophrenia/blood;Schizophrenia/drug therapy*;Schizophrenic Psychology
10243361;Hospital Bed Capacity, 500 and over;Hospital Volunteers*;Humans;Nebraska;Patients;Social Environment*
10332534;Adult;Anticoagulants/pharmacology*;Humans;Male;Tea/chemistry*;Thromboembolism/prevention & control;Warfarin/antagonists & inhibitors*
10350016;Adult;Aged;Cross-Over Studies;Eating*;Gastric Acidity Determination;HIV Infections/drug therapy*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics;Humans;Hydrogen-Ion Concentration;Indinavir/administration & dosage*;Indinavir/blood;Indinavir/pharmacokinetics;Intestinal Absorption;Male;Middle Aged;Viscosity
10365642;Adult;Antifungal Agents/pharmacokinetics*;Biological Availability;Capsules;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Itraconazole/pharmacokinetics*;Male;Mixed Function Oxygenases/metabolism;Reference Values
10375176;Analysis of Variance;Animals;Anticonvulsants/pharmacokinetics*;Antiviral Agents/administration & dosage;Antiviral Agents/pharmacology;Carbamazepine/pharmacokinetics*;Drug Interactions;Drugs, Chinese Herbal/administration & dosage;Drugs, Chinese Herbal/pharmacology*;Herb-Drug Interactions;Male;Medicine, Chinese Traditional;Phytotherapy;Protein Binding/drug effects;Rats;Rats, Wistar
10423213;Anticoagulants/adverse effects*;Beverages*;Citrus*;Food-Drug Interactions;Humans;Male;Middle Aged;Warfarin/adverse effects*
10440622;Adolescent;Adult;Animals;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Milk
10456490;Antimalarials/blood;Antimalarials/pharmacokinetics*;Antimalarials/urine;Beverages;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Drug Interactions;Humans;Male;Quinidine/analogs & derivatives;Quinidine/analysis;Quinidine/blood;Quinidine/urine;Quinine/blood;Quinine/pharmacokinetics*;Quinine/urine
10456492;Adult;Antimalarials/pharmacokinetics*;Artemisinins*;Biological Availability;Chromatography, High Pressure Liquid;Citrus/chemistry*;Drug Interactions;Electrocardiography/drug effects;Heart/drug effects;Humans;Male;Saliva/chemistry*;Sesquiterpenes/blood;Sesquiterpenes/metabolism;Sesquiterpenes/pharmacokinetics*
10460065;Adult;Anticholesteremic Agents/blood*;Atorvastatin Calcium;Beverages*;Citrus/metabolism*;Cross-Over Studies;Female;Gas Chromatography-Mass Spectrometry;Half-Life;Heptanoic Acids/blood*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Male;Pravastatin/blood*;Pyrroles/blood*;Reference Values;Volunteers
10460103;Adult;Analysis of Variance;Antacids/pharmacokinetics*;Antitubercular Agents/pharmacokinetics*;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Drug Interactions;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Isoniazid/pharmacokinetics*;Male;Regression Analysis;Statistics, Nonparametric
10471985;Aged;Caffeine/administration & dosage;Caffeine/blood;Caffeine/metabolism*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/metabolism;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP1A2/physiology*;Cytochrome P-450 CYP1A2 Inhibitors;Drug Interactions;Estradiol/administration & dosage;Estradiol/pharmacology*;Estrogen Replacement Therapy/adverse effects*;Female;Humans;Menopause/metabolism*;Middle Aged;Theophylline/blood*
10510161;Adult;Cardiotonic Agents/blood;Cardiotonic Agents/pharmacokinetics*;Cathartics/pharmacology*;Cross-Over Studies;Digoxin/blood;Digoxin/pharmacokinetics*;Double-Blind Method;Drug Interactions;Female;Humans;Male;Polyethylene Glycols/pharmacology*
10533874;Anesthetics*;Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal/adverse effects*;Risk Factors;Surgical Procedures, Operative*
10546917;Adult;Analysis of Variance;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/pharmacokinetics*;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Area Under Curve;Cardiotonic Agents/blood;Cardiotonic Agents/pharmacokinetics*;Digoxin/blood;Digoxin/pharmacokinetics*;Drug Administration Schedule;Female;Humans;Hypericum/adverse effects*;Hypericum/therapeutic use;Male;Phytotherapy;Plants, Medicinal*;Reference Values;Single-Blind Method;Time Factors
10546919;Adult;Analysis of Variance;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/blood*;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood*;Lovastatin/administration & dosage;Lovastatin/blood*;Male;Reference Values
10546925;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/blood;Antimalarials/pharmacokinetics*;Antiprotozoal Agents/administration & dosage;Antiprotozoal Agents/blood;Antiprotozoal Agents/pharmacokinetics*;Artemisinins*;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Male;Reference Values;Sesquiterpenes/administration & dosage;Sesquiterpenes/blood;Sesquiterpenes/pharmacokinetics*;Time Factors
10556183;Adolescent;Age Factors;Anticoagulants/administration & dosage*;Child;Child, Preschool;Cohort Studies;Drug Monitoring;Female;Heparin/administration & dosage;Humans;Infant;International Normalized Ratio;Male;Multivariate Analysis;Prospective Studies;Thromboembolism/drug therapy*;Treatment Outcome;Warfarin/administration & dosage*
10568341;Anticoagulants/pharmacology*;Diet*;Drug Interactions;Food Analysis;Humans;Vitamin K/administration & dosage*;Vitamin K/analysis;Vitamin K/therapeutic use;Warfarin/pharmacology*
10578942;Anxiety/drug therapy*;Humans;Kava/therapeutic use*;Phytotherapy*;Plants, Medicinal/therapeutic use*;Treatment Outcome;Valerian/therapeutic use*
10583025;ATP-Binding Cassette, Sub-Family B, Member 1/physiology*;Beverages;Caco-2 Cells;Citrus/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects*;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Gas Chromatography-Mass Spectrometry;HIV Protease Inhibitors/metabolism*;HIV Protease Inhibitors/pharmacokinetics;Humans;In Vitro Techniques;Ketoconazole/pharmacology;Liver/metabolism*;Mixed Function Oxygenases/drug effects*;Mixed Function Oxygenases/physiology;Plant Extracts/pharmacology*;Saquinavir/metabolism*;Saquinavir/pharmacokinetics;Time Factors;Verapamil/pharmacology
10594487;Adult;Aryl Hydrocarbon Hydroxylases*;Beverages*;Citrus/metabolism*;Cytochrome P-450 CYP1A2;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2E1/metabolism;Cytochrome P-450 CYP2E1 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism*;Diclofenac/pharmacology*;Disulfiram/pharmacology*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Erythromycin/pharmacology*;Humans;Itraconazole/pharmacology*;Male;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/metabolism*;Oxidation-Reduction;Quinidine/metabolism;Quinidine/pharmacokinetics*;Steroid 16-alpha-Hydroxylase*;Steroid Hydroxylases/metabolism
10606838;Adult;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Area Under Curve;Biotransformation;Caffeine/blood;Caffeine/pharmacology*;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/pharmacology*;Chromatography, High Pressure Liquid;Clozapine/adverse effects;Clozapine/blood;Clozapine/pharmacokinetics*;Cross-Over Studies;Humans;Male;Theophylline/blood
10610011;AIDS-Related Opportunistic Infections/metabolism;AIDS-Related Opportunistic Infections/prevention & control;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects*;Antifungal Agents/pharmacokinetics*;Atovaquone;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects*;Naphthoquinones/pharmacokinetics*;Pneumonia, Pneumocystis/prevention & control;Trimethoprim, Sulfamethoxazole Drug Combination/pharmacokinetics
10615351;Adult;Ergotism/complications;Ergotism/etiology*;HIV Infections/drug therapy;HIV Protease Inhibitors/adverse effects*;HIV Protease Inhibitors/therapeutic use;Humans;Male;Neuritis/etiology*;Ritonavir/adverse effects*;Ritonavir/therapeutic use
10636361;Adult;Adverse Drug Reaction Reporting Systems;Aged;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Clinical Trials as Topic;Depressive Disorder/drug therapy*;Drug Interactions;Female;Humans;Hypericum/adverse effects*;Male;Middle Aged;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Plants, Medicinal*;Treatment Outcome
10638471;Anti-Infective Agents/analysis*;Calcium Chloride;Chromatography, High Pressure Liquid;Ciprofloxacin/analysis;Dietary Sucrose/analysis;Enteral Nutrition*;Food, Formulated/analysis*;Levofloxacin;Magnesium Chloride;Ofloxacin/analysis;Temperature;Time Factors;Water
10681341;Adult;Animals;Antimalarials/pharmacokinetics*;Antimalarials/therapeutic use*;Area Under Curve;Artemisinins*;Biological Availability;Child;Double-Blind Method;Drug Therapy, Combination;Electrocardiography;Ethanolamines/pharmacokinetics*;Ethanolamines/therapeutic use*;Fluorenes/pharmacokinetics*;Fluorenes/therapeutic use*;Food-Drug Interactions;Humans;Malaria, Falciparum/drug therapy*;Plasmodium falciparum/isolation & purification;Prospective Studies;Sesquiterpenes/therapeutic use;Treatment Outcome
10683008;Azathioprine/blood;Cyclosporine/blood*;Drug Interactions;Graft Rejection/chemically induced*;Heart Transplantation*;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/blood*;Male;Middle Aged;Plants, Medicinal*
10702883;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism;Humans;Male;Middle Aged;Suspensions;Tablets;Tetrazoles/administration & dosage;Tetrazoles/blood;Tetrazoles/metabolism;Tetrazoles/pharmacokinetics*;Vasodilator Agents/administration & dosage;Vasodilator Agents/blood;Vasodilator Agents/metabolism;Vasodilator Agents/pharmacokinetics*
10706847;Abscess/therapy;Adult;Anti-Bacterial Agents/adverse effects*;Anti-Bacterial Agents/therapeutic use;Caffeine/administration & dosage;Caffeine/adverse effects*;Drug Combinations;Ergotamine/administration & dosage;Ergotamine/adverse effects*;Ergotism/etiology*;Erythromycin/adverse effects*;Erythromycin/therapeutic use;Humans;Ischemia/etiology*;Male;Migraine Disorders/drug therapy
10740993;Aged;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Beverages*;Citrus*;Female;Fluoxetine/adverse effects*;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions*;Humans
10741622;Adult;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Nisoldipine/adverse effects;Nisoldipine/blood;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology*;Reference Values;Time Factors;Vasodilator Agents/pharmacology
10759694;Adult;Amiodarone/analogs & derivatives;Amiodarone/blood;Amiodarone/pharmacokinetics*;Anti-Arrhythmia Agents/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases*;Beverages*;Biotransformation;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Electrocardiography/drug effects;Food-Drug Interactions*;Half-Life;Humans;Male;Oxidoreductases, N-Demethylating/metabolism
10852634;Cyclosporine/blood*;Cyclosporine/therapeutic use;Dose-Response Relationship, Drug;Drug Interactions;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/blood*;Immunosuppressive Agents/therapeutic use;Kidney Transplantation/immunology;Kidney Transplantation/physiology*;Plants, Medicinal*
10872652;Anticholesteremic Agents/pharmacology*;Area Under Curve;Beverages;Citrus/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology*;Liver/enzymology;Lovastatin/pharmacology*;Mixed Function Oxygenases/antagonists & inhibitors*
10878206;Acute Disease;Adult;Antacids/adverse effects*;Female;Humans;Hypercalcemia/chemically induced*;Hypercalcemia/complications;Nonprescription Drugs/adverse effects*;Pancreatitis/etiology*;Syndrome
10893655;Acetaminophen/pharmacokinetics*;Adult;Analgesics, Non-Narcotic/pharmacokinetics*;Analysis of Variance;Aspirin/pharmacokinetics*;Biological Availability;Consumer Product Safety;Cross-Over Studies;Fasting;Feeding Behavior*;Humans;Male;Statistics, Nonparametric
10930711;Alcoholism/drug therapy*;Animals;Antidepressive Agents/therapeutic use*;Disease Models, Animal;Humans;Hypericum;Panax;Phytotherapy*;Plant Extracts/therapeutic use*;Plant Roots;Plants, Medicinal*;Pueraria;Rats;Salvia;Tabernaemontana
10945313;Aged;Aged, 80 and over;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacology*;Area Under Curve;Beverages;Blood Pressure/drug effects*;Citrus*;Diastole/drug effects;Felodipine/administration & dosage;Felodipine/analogs & derivatives*;Felodipine/blood;Felodipine/pharmacology*;Female;Food-Drug Interactions;Half-Life;Heart Rate/drug effects;Humans;Male;Posture;Reference Values;Systole/drug effects;Time Factors
10968409;Adult;Alcohol Drinking/adverse effects*;Alcohol Drinking/metabolism;Alcohol Drinking/urine;Diarrhea/chemically induced;Diet;Drug Synergism;Ethanol/adverse effects*;Fatigue/chemically induced;Female;Headache/chemically induced;Humans;Hydroxyindoleacetic Acid/urine;Hydroxytryptophol/urine*;Male;Serotonin/administration & dosage;Serotonin/adverse effects*;Serotonin/metabolism;Zingiberales
11002387;Adult;Anticonvulsants/poisoning*;Carbamazepine/poisoning;Drug Combinations;Drug Contamination;Drugs, Chinese Herbal/poisoning*;Female;Humans;Phenytoin/poisoning*;Valproic Acid/poisoning
11009051;Adult;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Beverages*;Biological Availability;Citrus*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Half-Life;Humans;Logistic Models;Male;Psychomotor Performance/drug effects;Triazolam/blood;Triazolam/pharmacokinetics*
11049012;Adult;Anti-Inflammatory Agents/blood*;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Hydrocortisone/blood;Male;Methylprednisolone/blood*
11061578;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Drug Administration Schedule;Female;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/blood;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Hypolipidemic Agents/pharmacokinetics;Male;Mixed Function Oxygenases/metabolism*;Reference Values;Simvastatin/administration & dosage;Simvastatin/blood;Simvastatin/pharmacokinetics*;Time Factors
11069440;Administration, Oral;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Amlodipine/pharmacology*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Middle Aged;Placebos;Pulse;Stereoisomerism
11073292;Cyclosporine/pharmacokinetics*;Cyclosporine/pharmacology*;Drug Interactions/physiology*;Female;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/pharmacokinetics*;Immunosuppressive Agents/pharmacology*;Middle Aged;Plants, Medicinal*
11079273;Administration, Oral;Adolescent;Child;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics*;Drug Interactions;Emulsions;Female;Fruit*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Male
11103749;Administration, Oral;Adult;Antioxidants/pharmacology;Area Under Curve;Beverages;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Delayed-Action Preparations;Drug Interactions;Felodipine/analogs & derivatives;Felodipine/pharmacokinetics*;Female;Flavanones*;Flavonoids/pharmacology;Furocoumarins/pharmacology;Half-Life;Humans;Male;Mixed Function Oxygenases/antagonists & inhibitors;Radiation-Sensitizing Agents/pharmacology
11108077;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Drug Synergism;Ergotamine/administration & dosage;Ergotamine/adverse effects;Ergotism/complications*;Erythromycin/administration & dosage;Erythromycin/adverse effects*;Hand/blood supply*;Humans;Ischemia/chemically induced*;Male;Middle Aged;Migraine Disorders/drug therapy;Respiratory Tract Infections/drug therapy
11117974;Adolescent;Adult;Adverse Drug Reaction Reporting Systems;Arrhythmias, Cardiac/chemically induced;Cardiovascular Diseases/chemically induced*;Dietary Supplements/adverse effects*;Drugs, Chinese Herbal/adverse effects*;Ephedra sinica*;Ephedrine/adverse effects*;Fatal Outcome;Female;Humans;Hypertension/chemically induced;Intracranial Hemorrhages/chemically induced;Male;Middle Aged;Plant Preparations;Seizures/chemically induced;United States;United States Food and Drug Administration
11144706;Anticoagulants/pharmacology;Dietary Supplements;Drug Interactions;Drugs, Chinese Herbal/pharmacology*;Garlic/chemistry;Ginger/chemistry;Ginkgo biloba/chemistry;Herb-Drug Interactions;Humans;Panax/chemistry;Plant Extracts/pharmacology;Plants, Medicinal;Warfarin/pharmacology*
11161079;Bleeding Time;Cerebral Hemorrhage/chemically induced*;Ginkgo biloba/adverse effects*;Humans;Male;Middle Aged;Plants, Medicinal*
11161541;Adult;Area Under Curve;Bone Marrow Transplantation*;Cross-Over Studies;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Fat Emulsions, Intravenous/administration & dosage*;Fat Emulsions, Intravenous/pharmacology;Female;Humans;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Parenteral Nutrition*;Prospective Studies
11180019;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis*;Adult;Animals;Biological Availability;Cardiotonic Agents/pharmacokinetics;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/biosynthesis*;Digoxin/pharmacokinetics;Drug Interactions;Duodenum/drug effects;Duodenum/enzymology;Duodenum/metabolism;Enzyme Induction/drug effects;Humans;Hypericum/adverse effects*;Intestine, Small/drug effects*;Intestine, Small/enzymology;Intestine, Small/metabolism;Liver/drug effects*;Liver/enzymology;Male;Mixed Function Oxygenases/biosynthesis*;Plant Extracts/adverse effects;Plant Extracts/pharmacology;Plants, Medicinal*;Rats;Rats, Sprague-Dawley
11180020;Adult;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Carbamazepine/analogs & derivatives*;Carbamazepine/blood;Carbamazepine/pharmacokinetics*;Drug Interactions;Humans;Hypericum/adverse effects*;Male;Plants, Medicinal*
11180034;Administration, Oral;Adult;Antihypertensive Agents/pharmacokinetics*;Beverages*/analysis;Biological Availability;Caco-2 Cells/drug effects;Caco-2 Cells/enzymology;Citrus*/chemistry;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics;Cytochrome P-450 Enzyme System/metabolism;DNA, Complementary/genetics;Enzyme Activation/drug effects;Enzyme Inhibitors/analysis;Enzyme Inhibitors/pharmacology;Felodipine/pharmacokinetics*;Female;Food-Drug Interactions*;Furocoumarins/analysis;Furocoumarins/pharmacology*;Humans;Male;Methoxsalen/analogs & derivatives*;Methoxsalen/analysis;Methoxsalen/pharmacology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/genetics;Mixed Function Oxygenases/metabolism
11185412;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/metabolism;Dietary Fats/pharmacology*;Female;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Middle Aged;Naphthyridines/administration & dosage;Naphthyridines/pharmacokinetics*
11194535;Adult;Aged;Aged, 80 and over;Anticoagulants/therapeutic use;Diet;Diet Records;Humans;Middle Aged;Nutrition Assessment*;Reproducibility of Results;Vitamin K/administration & dosage*;Vitamin K/blood*;Warfarin/therapeutic use
11203429;Adult;Anesthesia, General/adverse effects*;Antidepressive Agents/adverse effects*;Female;Hemodynamics/drug effects*;Humans;Hypericum/adverse effects*;Monoamine Oxidase Inhibitors/adverse effects*;Plants, Medicinal*;Shock/chemically induced*
11206893;Adult;Anticoagulants/therapeutic use;Cholecystectomy, Laparoscopic*;Drug Interactions;Ginkgo biloba/adverse effects*;Ginkgo biloba/therapeutic use;Humans;Male;Phytotherapy*;Plants, Medicinal*;Platelet Aggregation Inhibitors/therapeutic use;Postoperative Hemorrhage/etiology*
11214770;Adult;Area Under Curve;Beverages*;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacology*;Citrus/chemistry*;Cross-Over Studies;Humans;Intestines/metabolism*;Liver/metabolism;Male;Nicardipine/blood;Nicardipine/chemistry;Nicardipine/pharmacokinetics*;Stereoisomerism
11214778;Adult;Area Under Curve;Beverages*;Biotransformation;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Double-Blind Method;Female;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Stereoisomerism;Verapamil/pharmacokinetics*;Verapamil/pharmacology
11231102;ATP-Binding Cassette, Sub-Family B, Member 1/pharmacokinetics*;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*;Biological Availability;Caco-2 Cells/metabolism;Citrus*;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Intestinal Absorption/physiology*;Male;Propanolamines/pharmacokinetics*;Rats;Rats, Sprague-Dawley;Stereoisomerism
11257244;Adult;Contraceptives, Oral/administration & dosage;Contraceptives, Oral/pharmacokinetics;Cross-Over Studies;Ethanol/blood;Ethanol/pharmacology*;Ethinyl Estradiol/administration & dosage;Ethinyl Estradiol/blood*;Ethinyl Estradiol/pharmacokinetics;Female;Humans;Norpregnenes/administration & dosage;Placebos;Premenopause*
11269572;Adolescent;Adult;African Continental Ancestry Group*;Area Under Curve;Beverages*;Biological Availability;Citrus/metabolism*;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Emulsions;European Continental Ancestry Group*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*
11276296;Antidepressive Agents/adverse effects;Antidepressive Agents/therapeutic use*;Depressive Disorder, Major/drug therapy*;Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/therapeutic use*;MEDLINE;Phytotherapy*;Plant Extracts/adverse effects;Plant Extracts/therapeutic use;Plants, Medicinal*;Safety;Treatment Outcome
11310527;Aged;Anticoagulants/therapeutic use*;Atrial Fibrillation/drug therapy*;Bleeding Time;Drug Interactions;Female;Humans;Hypoglycemic Agents/pharmacology*;International Normalized Ratio*;Plant Extracts/pharmacology*;Trigonella;Warfarin/therapeutic use*
11322025;Anticonvulsants/pharmacokinetics*;Carbamazepine/pharmacokinetics*;Citrus*;Food-Drug Interactions*;Humans;Male;Middle Aged
11327742;Acetaminophen/administration & dosage;Acetaminophen/adverse effects;Acetaminophen/pharmacokinetics*;Administration, Oral;Adult;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/pharmacokinetics*;Diet, Reducing*;Female;Humans;Liver/drug effects;Liver/metabolism*;Male;Middle Aged;Obesity/metabolism*;Prospective Studies;Time Factors;Weight Loss
11347624;Adult;Drug Interactions;Ergotamine/adverse effects*;Ergotism/etiology*;Female;HIV Infections/drug therapy*;HIV Protease Inhibitors/therapeutic use*;HIV-1*;Humans;Nelfinavir/therapeutic use*;Vasoconstrictor Agents/adverse effects*
11352440;Administration, Oral;Adult;Analysis of Variance;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Anti-Infective Agents/urine;Area Under Curve;Aza Compounds*;Biological Availability;Cross-Over Studies;Dairy Products*;Fluoroquinolones*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Quinolines*
11356998;Adult;Antifibrinolytic Agents/analysis;Antifibrinolytic Agents/blood;Antifibrinolytic Agents/pharmacokinetics;Databases, Factual;Food Analysis*;Humans;Male;Nutrition Assessment;Nutritive Value;Spinacia oleracea/chemistry;Vegetables/chemistry;Vitamin K/analysis;Vitamin K/blood;Vitamin K/pharmacokinetics*;Vitamin K 1/analysis;Vitamin K 1/blood;Vitamin K 1/pharmacokinetics*
11361052;Acetamides/pharmacokinetics;Acetamides/pharmacology*;Administration, Oral;Adult;Analysis of Variance;Anti-Infective Agents/pharmacokinetics;Anti-Infective Agents/pharmacology*;Area Under Curve;Blood Pressure/drug effects*;Catecholamines/urine;Dose-Response Relationship, Drug;Heart Rate/drug effects;Humans;Linezolid;Male;Metabolic Clearance Rate/drug effects;Moclobemide/blood;Moclobemide/pharmacology;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/pharmacology*;Oxazolidinones/pharmacokinetics;Oxazolidinones/pharmacology*;Tyramine/pharmacokinetics;Tyramine/pharmacology*
11365266;HIV Infections/therapy*;Humans;Phytotherapy*;United States
11376916;Adult;Alcoholic Intoxication/diagnosis;Alcoholic Intoxication/drug therapy*;Alcoholic Intoxication/psychology;Attention/drug effects;Automobile Driving/psychology*;Caffeine/administration & dosage*;Dose-Response Relationship, Drug;Double-Blind Method;Ethanol/antagonists & inhibitors*;Female;Humans;Male;Middle Aged;Postural Balance/drug effects;Psychomotor Performance/drug effects;Reaction Time/drug effects
11410431;Adult;Anemia, Iron-Deficiency/drug therapy*;Drug Antagonism;Female;Humans;Iron/administration & dosage;Tea/adverse effects*
11426073;Adult;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/therapeutic use;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Depression/complications;Depression/drug therapy*;Drug Interactions;Female;Fluoxetine/adverse effects;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions;HIV Infections/complications;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/therapeutic use
11454132;Aged;Anticoagulants/adverse effects*;Blood Coagulation Disorders/blood;Blood Coagulation Disorders/chemically induced*;Blood Coagulation Disorders/drug therapy;Cucurbitaceae*;Drug Combinations;Drug Interactions;Humans;International Normalized Ratio;Male;Middle Aged;Plant Extracts/adverse effects*;Sweden;Vitamin E/adverse effects*;Vitamin K/therapeutic use;Warfarin/adverse effects*
11474706;Anxiety/therapy;Cyclosporine/blood*;Depression/therapy;Drug Interactions;Heart Transplantation*;Humans;Hypericum/adverse effects*;Pain Management;Plants, Medicinal*;Self Medication/adverse effects;Sleep Deprivation/therapy
11477318;Adult;Anti-Arrhythmia Agents/pharmacokinetics*;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Female;Half-Life;Humans;Imidazoles/pharmacokinetics*;Losartan/pharmacokinetics*;Male;Tetrazoles/pharmacokinetics*
11481175;Adult;Diuretics/adverse effects*;Diuretics/pharmacokinetics;Diuretics/therapeutic use;Drug Interactions;Female;Humans;Lithium/adverse effects*;Lithium/pharmacokinetics;Lithium/therapeutic use;Magnoliopsida/adverse effects*;Magnoliopsida/therapeutic use;Phytotherapy
11501187;2-Pyridinylmethylsulfinylbenzimidazoles;Antibodies, Monoclonal/pharmacology;Aryl Hydrocarbon Hydroxylases*;Asian Continental Ancestry Group;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/immunology;Cytochrome P-450 Enzyme System/metabolism*;Humans;Microsomes, Liver/metabolism*;Mixed Function Oxygenases/immunology;Mixed Function Oxygenases/metabolism*;Omeprazole/analogs & derivatives;Omeprazole/metabolism*
11524501;Adult;Drug Therapy, Combination;Ergotamine/adverse effects*;Ergotism/diagnosis;Female;HIV Protease Inhibitors/adverse effects*;Humans;Ritonavir/adverse effects*;Vasoconstrictor Agents/adverse effects*;Vasospasm, Intracranial/chemically induced*;Vasospasm, Intracranial/diagnosis
11554427;Animals;Anticonvulsants/pharmacokinetics*;Anticonvulsants/pharmacology*;Biotransformation;Blood Proteins/metabolism;Carbamazepine/pharmacokinetics*;Carbamazepine/pharmacology*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drugs, Chinese Herbal/pharmacokinetics*;Drugs, Chinese Herbal/pharmacology*;Female;Herb-Drug Interactions;In Vitro Techniques;Liver/drug effects;Liver/enzymology;Male;Medicine, Kampo;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Protein Binding;Rats;Rats, Wistar
11558205;Drug Interactions*;Humans;Phytotherapy*
11570073;Anti-HIV Agents/blood*;Drug Interactions;HIV Infections/blood*;Humans;Hypericum/therapeutic use*;Nevirapine/blood*;Phytotherapy*;Plants, Medicinal*;Reverse Transcriptase Inhibitors/blood*
11673746;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Area Under Curve;Beverages*;Citrus*;Cross-Over Studies;Digoxin/pharmacokinetics*;Food-Drug Interactions*;Genotype;Humans;Polymorphism, Genetic
11675844;Anticoagulants/metabolism;Anticoagulants/therapeutic use*;Aryl Hydrocarbon Hydroxylases*;Atrial Fibrillation/drug therapy*;Beverages*;Cytochrome P-450 CYP2C9;Cytochrome P-450 Enzyme System/drug effects;Drug Interactions;Female;Humans;International Normalized Ratio;Middle Aged;Steroid 16-alpha-Hydroxylase*;Steroid Hydroxylases/drug effects;Warfarin/metabolism;Warfarin/therapeutic use*
11693229;Adult;Alcohol Drinking/adverse effects*;Caffeine/administration & dosage;Caffeine/adverse effects*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects*;Drug Interactions;Ephedrine/administration & dosage;Ephedrine/adverse effects*;Ethanol/adverse effects*;Humans;Male;Obesity/drug therapy;Phytotherapy/adverse effects*;Psychoses, Substance-Induced/etiology*;Substance Abuse Detection;Violence/legislation & jurisprudence
11718495;Administration, Oral;Adult;Aminosalicylic Acid/pharmacology;Antacids/pharmacology*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Clofazimine/pharmacology;Cross-Over Studies;Cycloserine/administration & dosage;Cycloserine/adverse effects;Cycloserine/pharmacokinetics*;Dietary Fats/pharmacology*;Drug Interactions;Electrophoresis, Capillary;Ethionamide/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male
11728055;Adult;Analgesics, Non-Narcotic/adverse effects*;Drug Interactions;Drug Therapy, Combination;Ergotamine/adverse effects*;Ergotism/etiology*;HIV Infections/drug therapy;HIV Protease Inhibitors/adverse effects*;Humans;Male;Ritonavir/adverse effects*
11728770;Adult;Caffeine/adverse effects*;Clarithromycin/adverse effects*;Drug Combinations;Drug Interactions;Ergotamine/adverse effects*;Ergotism/etiology*;Female;Humans;Ischemia/chemically induced*;Leg/blood supply*;Migraine Disorders/drug therapy
11740713;Administration, Oral;Adult;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements*/adverse effects;Drug Administration Schedule;Drug Combinations;Enterocytes/drug effects;Enterocytes/enzymology;Female;Garlic*/adverse effects;HIV Infections/drug therapy;HIV Infections/enzymology;HIV-1/drug effects;HIV-1/enzymology;Humans;Intestine, Small/drug effects;Intestine, Small/enzymology;Longitudinal Studies;Male;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/blood;Plant Extracts/pharmacology;Saquinavir/adverse effects;Saquinavir/blood;Saquinavir/pharmacokinetics*
11745911;Acetamides/administration & dosage;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacokinetics;Fasting/physiology;Female;Food-Drug Interactions/physiology*;Humans;Injections, Intravenous;Linezolid;Male;Middle Aged;Oxazolidinones/administration & dosage;Oxazolidinones/blood;Oxazolidinones/pharmacokinetics*
11753267;Adult;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biotransformation;Chromatography, Liquid;Cross-Over Studies;Double-Blind Method;Drug Interactions;Female;Humans;Hypericum/adverse effects*;Male;Mass Spectrometry;Phytotherapy/adverse effects*;Pravastatin/pharmacokinetics*;Simvastatin/pharmacokinetics*
11762562;Adult;Breath Tests;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacokinetics*;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Dietary Proteins/pharmacology;Energy Intake;Ethanol/blood;Ethanol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Male
11763808;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Diet;Female;Food-Drug Interactions*;Hemostatics/administration & dosage;Hemostatics/adverse effects*;Hemostatics/therapeutic use;Humans;International Normalized Ratio;Seaweed/chemistry*;Vitamin K/administration & dosage;Vitamin K/adverse effects*;Vitamin K/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects*;Warfarin/therapeutic use
11791889;Adult;Antifungal Agents/pharmacology;Antipsychotic Agents/blood*;Antipsychotic Agents/therapeutic use;Beverages*;Citrus*;Clozapine/blood*;Clozapine/therapeutic use;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/physiology;Drug Interactions;Enzyme Inhibitors/pharmacology;Food-Drug Interactions;Humans;Ketoconazole/pharmacology;Male;Mixed Function Oxygenases/antagonists & inhibitors*;Mixed Function Oxygenases/physiology;Schizophrenia/blood*;Schizophrenia/drug therapy
11797495;Aged;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Dietary Supplements/adverse effects*;Drug Interactions;Hematoma, Subdural/etiology*;Humans;Lactones/adverse effects*;Male;Sulfones
11823753;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carrier Proteins/metabolism;Citrus;Double-Blind Method;Female;Flavonoids/metabolism;Food-Drug Interactions/physiology*;Fruit*;HeLa Cells;Histamine H1 Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Malus;Membrane Transport Proteins*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Dependent;Symporters;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
11823754;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Calibration;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions/physiology*;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Purines;Quality Control;Sildenafil Citrate;Sulfones
11871046;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adult;Cyclosporine/pharmacokinetics*;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements;Drug Interactions;Female;Graft Rejection/immunology*;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Pancreas Transplantation*;Plant Preparations/adverse effects*
11906584;Diarrhea/therapy*;Enteral Nutrition/adverse effects*;Humans;Probiotics/therapeutic use*
11936572;Adult;Analysis of Variance;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics;Area Under Curve;Beverages*;Calcium/pharmacokinetics*;Ciprofloxacin/blood*;Ciprofloxacin/pharmacokinetics;Citrus/metabolism*;Cross-Over Studies;Female;Food, Fortified*/adverse effects;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Statistics, Nonparametric;Therapeutic Equivalency
11953006;Adult;Anti-Anxiety Agents/adverse effects;Anti-Anxiety Agents/pharmacology*;Bipolar Disorder/chemically induced*;Brain Injuries/complications;Brain Injuries/psychology*;Buspirone/adverse effects;Buspirone/pharmacology*;Depression/drug therapy*;Depression/etiology;Drug Interactions;Drug Therapy, Combination;Female;Fluoxetine/adverse effects;Fluoxetine/pharmacology*;Ginkgo biloba/adverse effects*;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Plant Preparations/therapeutic use;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacology*
11956673;Adult;Beverages*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/urine;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavanones*;Flavonoids/blood;Flavonoids/pharmacokinetics;Flavonoids/urine;Food-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Mixed Function Oxygenases/metabolism;Smoking/blood*;Stereoisomerism;Verapamil/adverse effects;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/urine
11959616;Adult;Anthelmintics/administration & dosage*;Anthelmintics/pharmacokinetics;Beverages*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Male;Praziquantel/administration & dosage*;Praziquantel/pharmacokinetics
11966676;Amlodipine/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Citrus*;Food-Drug Interactions*;Humans
12014354;Aged;Aged, 80 and over;Anacardiaceae*/adverse effects;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Disorders/chemically induced;Food-Drug Interactions*;Fruit/adverse effects;Humans;International Normalized Ratio/adverse effects;Male;Middle Aged;Warfarin/adverse effects;Warfarin/therapeutic use*
12040751;Adult;Calcium Channel Blockers/pharmacokinetics*;Citrus*/chemistry;Flavanones*;Flavonoids/analysis;Food-Drug Interactions*;Humans;Male;Nifedipine/pharmacokinetics*;Nisoldipine/pharmacokinetics*
12087344;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adult;Anti-Allergic Agents/pharmacokinetics;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Histamine H1 Antagonists/pharmacokinetics;Humans;Hypericum/adverse effects*;Male;Reference Values;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics*
12187697;Agaricales/chemistry;Alcoholic Beverages/adverse effects*;Humans;Male;Middle Aged;Muscarine/isolation & purification;Muscarine/poisoning;Mushroom Poisoning/etiology*;Mushroom Poisoning/therapy;Severity of Illness Index;Treatment Outcome
12362932;Adult;Beverages;Chromatography, High Pressure Liquid;Citrus*;Citrus paradisi;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions*;HIV Protease Inhibitors/blood*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/blood*;Indinavir/pharmacokinetics*;Male
12391711;Aged;Complementary Therapies/utilization*;Dietary Supplements/utilization*;Female;Humans;Male;Middle Aged;Nonprescription Drugs;Osteoarthritis/drug therapy;Osteoarthritis/therapy*;Phytotherapy;Plant Preparations/therapeutic use*;Quality of Life
12393786;Adult;Drug Interactions;Female;Humans;Male;Middle Aged;Phytotherapy/adverse effects;Phytotherapy/utilization*;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Preoperative Care/methods*;Self Care/methods
12394419;Adult;Affect/drug effects;Alcohol Drinking/genetics;Alcohol Drinking/psychology*;Alprazolam/pharmacology*;Anti-Anxiety Agents/pharmacology*;Buspirone/pharmacology*;Dose-Response Relationship, Drug;Female;Humans;Psychomotor Performance/drug effects;Surveys and Questionnaires
12404692;Adult;Alcohol Drinking/adverse effects;Analysis of Variance;Caffeine/pharmacology*;Chi-Square Distribution;Drug Interactions/physiology;Ethanol/pharmacology*;Female;Humans;Male;Psychomotor Performance/drug effects*;Psychomotor Performance/physiology;Reaction Time/drug effects;Reaction Time/physiology
12451428;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood*;Calcium Channel Blockers/pharmacology;Citrus paradisi*;Cross-Over Studies;Diltiazem/administration & dosage;Diltiazem/blood*;Diltiazem/pharmacology;Food-Drug Interactions*;Heart Rate/drug effects;Humans;Male;Time Factors
12452752;Aged;Anticoagulants/administration & dosage;Anticoagulants/pharmacology;Food-Drug Interactions*;Humans;International Normalized Ratio*;Male;Soybean Proteins/administration & dosage*;Soybean Proteins/pharmacology*;Soybeans*;Warfarin/administration & dosage*;Warfarin/pharmacology*
12463728;Adult;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Benzodiazepines*;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Fasting;Food-Drug Interactions*;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Time Factors
12472986;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Antimalarials/urine;Biological Availability;Chromatography, High Pressure Liquid;Cloxacillin/administration & dosage;Cloxacillin/adverse effects;Cloxacillin/pharmacokinetics*;Cloxacillin/urine;Cross-Over Studies;Drug Interactions;Female;Humans;Male;Proguanil/administration & dosage;Proguanil/adverse effects;Proguanil/pharmacology*;Reference Values
12482227;Acquired Immunodeficiency Syndrome/complications;Acquired Immunodeficiency Syndrome/drug therapy*;Caffeine/adverse effects*;Caffeine/therapeutic use;Drug Combinations;Drug Interactions;Ergotamine/adverse effects*;Ergotamine/therapeutic use;Ergotism/etiology*;Fatal Outcome;HIV Protease Inhibitors/adverse effects*;HIV Protease Inhibitors/therapeutic use;Headache/complications;Headache/drug therapy*;Humans;Hypoxia-Ischemia, Brain/chemically induced;Male;Middle Aged
12495014;Bacteriological Techniques;Beverages/analysis;Beverages/microbiology*;Escherichia coli/enzymology;Escherichia coli/isolation & purification*;False Negative Reactions;Fluorescent Dyes;Food Microbiology*;Hydrogen-Ion Concentration;Hymecromone/analogs & derivatives*;Sample Size
12503845;Adult;Agoraphobia/drug therapy;Agoraphobia/psychology;Buspirone/adverse effects*;Drug Interactions;Female;Humans;Hypericum/adverse effects*;Psychiatric Status Rating Scales;Serotonin Receptor Agonists/adverse effects*;Serotonin Syndrome/etiology*;Serotonin Syndrome/psychology
12520633;Adolescent;Adult;Anti-Infective Agents/pharmacokinetics*;Beverages*;Calcium*;Citrus sinensis*;Female;Fluoroquinolones*;Food, Fortified*;Food-Drug Interactions*;Humans;Male;Therapeutic Equivalency
12545142;Adult;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Aryl Hydrocarbon Hydroxylases/metabolism;Cross-Over Studies;Cyclosporine/pharmacokinetics;Cytochrome P-450 CYP3A;Drug Administration Schedule;Enzyme Induction/drug effects;Female;Gene Expression Regulation/drug effects;Genes, MDR/drug effects*;Humans;Hypericum*;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology;Liver/drug effects;Liver/enzymology;Male;Midazolam/pharmacokinetics;Middle Aged;Oxidoreductases, N-Demethylating/biosynthesis*;Oxidoreductases, N-Demethylating/metabolism;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Reference Values;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics
12554137;Adult;Analgesics, Opioid/analysis;Analgesics, Opioid/urine*;Beverages/analysis;Gas Chromatography-Mass Spectrometry;Humans;Indicators and Reagents;Male;Morphine/analysis;Morphine/urine*;Papaver/chemistry*;Reference Standards;Reproducibility of Results;Substance Abuse Detection*
12580002;Animals;Chemistry, Clinical/methods*;Digoxin/blood;Digoxin/chemistry*;Digoxin/pharmacokinetics;Drug Interactions;Drug Monitoring;Eleutherococcus/chemistry*;Eleutherococcus/immunology;Eleutherococcus/metabolism;False Negative Reactions;False Positive Reactions;Humans;Immunoassay/methods*;Mice;Panax/chemistry*;Panax/immunology;Panax/metabolism;Plant Preparations/pharmacology;Reproducibility of Results
12580992;Administration, Oral;Analysis of Variance;Chromatography, High Pressure Liquid;Cross-Over Studies;Female;Garlic*;HIV Protease Inhibitors/pharmacokinetics*;Humans;Male;Plant Extracts/pharmacology;Plant Preparations/pharmacology*;Ritonavir/pharmacokinetics*
12580993;Adult;Aged;Aged, 80 and over;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Drug Interactions;Female;Humans;Hypericum*;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation*;Male;Middle Aged;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*
12589390;Adult;Analysis of Variance;Caffeine/pharmacology*;Dose-Response Relationship, Drug;Ethanol/pharmacology*;Female;Humans;Male;Memory/drug effects*;Memory/physiology;Psychomotor Performance/drug effects*;Psychomotor Performance/physiology;Sleep/drug effects*;Sleep/physiology
12618710;Adult;Angiography;Drug Interactions;Ergotamine/adverse effects*;Ergotism/etiology*;HIV Infections/complications;HIV Infections/drug therapy;HIV Protease Inhibitors/adverse effects*;Humans;Leg/blood supply;Male;Migraine Disorders/drug therapy;Vasoconstrictor Agents/adverse effects*
12621384;Administration, Oral;Adrenergic beta-Antagonists/administration & dosage;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Blood Pressure/drug effects;Celiprolol/administration & dosage;Celiprolol/blood;Celiprolol/pharmacokinetics*;Celiprolol/urine;Chromatography, High Pressure Liquid;Citrus paradisi*;Cross-Over Studies;Drug Interactions;Female;Heart Rate/drug effects;Humans;Itraconazole/administration & dosage;Itraconazole/blood;Itraconazole/pharmacology*;Male;Reference Values
12636154;Beverages*;Biological Transport/physiology;Caco-2 Cells/metabolism*;Citrus/metabolism*;Citrus aurantiifolia/metabolism;Citrus paradisi/metabolism;Digoxin/pharmacokinetics*;Humans
12649774;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/blood;Depressive Disorder/blood;Depressive Disorder/drug therapy*;Drug Interactions;Drug Therapy, Combination;Humans;Hypericum*;Male;Methadone/administration & dosage*;Methadone/blood;Plant Preparations/administration & dosage*;Substance-Related Disorders/blood;Substance-Related Disorders/drug therapy;Substance-Related Disorders/rehabilitation*
12672771;Anti-Obesity Agents/pharmacology;Anti-Obesity Agents/therapeutic use;Caffeine/pharmacology;Caffeine/therapeutic use;Controlled Clinical Trials as Topic;Dietary Supplements*/adverse effects;Ephedra*/adverse effects;Ephedrine*/adverse effects;Ephedrine*/pharmacology;Ephedrine*/therapeutic use;Humans;Physical Endurance/drug effects*;Plant Preparations*/adverse effects;Plant Preparations*/pharmacology;Plant Preparations*/therapeutic use;Randomized Controlled Trials as Topic;Risk;Sports;Weight Loss/drug effects*
12677367;Beverages/adverse effects*;Cyclosporine/adverse effects*;Drug Interactions;Humans;Hypericum/adverse effects*;Immunosuppressive Agents/adverse effects*;Kidney Transplantation;Middle Aged
12680887;Administration, Oral;Adult;Anti-Anxiety Agents/administration & dosage;Anti-Anxiety Agents/pharmacokinetics*;Anti-Anxiety Agents/pharmacology;Benzodiazepines*;Cross-Over Studies;Eating/physiology*;Fasting/physiology;Fatigue/chemically induced;Food-Drug Interactions/physiology*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/pharmacology;Male;Psychomotor Performance/drug effects;Thinking/drug effects;Time Factors
12695337;Adult;Alprazolam/blood;Alprazolam/pharmacokinetics;Area Under Curve;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/pharmacokinetics;Dextromethorphan/urine;Drug Interactions;Eleutherococcus/chemistry*;Female;Half-Life;Humans;Male;Plant Extracts/pharmacology;Time Factors
12757117;Adult;Female;Humans;Male;Nutritional Requirements;Parenteral Nutrition, Total;United States;United States Food and Drug Administration*;Vitamin K*/administration & dosage;Vitamin K*/physiology;Vitamin K*/therapeutic use;Vitamins*
12773074;Blood Coagulation/drug effects*;Blood Coagulation/physiology;Drug Interactions/physiology;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/pharmacokinetics;Humans;International Normalized Ratio/statistics & numerical data;Male;Middle Aged;Phytotherapy/methods;Plant Preparations/adverse effects;Plant Preparations/pharmacokinetics;Warfarin/adverse effects*;Warfarin/pharmacokinetics
12782911;Adult;Aged;Drugs, Chinese Herbal/therapeutic use*;Dyspepsia/chemically induced;Dyspepsia/drug therapy*;Female;Humans;Male;Medicine, Kampo;Middle Aged;Nausea/chemically induced;Nausea/drug therapy*;Phytotherapy*;Serotonin Uptake Inhibitors/adverse effects*;Treatment Outcome
12811362;Adult;Area Under Curve;Beverages*;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Citrus*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Furocoumarins/pharmacology*;Half-Life;Humans;Male;Middle Aged;NADP/metabolism;Radiation-Sensitizing Agents/pharmacology*;Wine*
12818420;Aged;Cerebral Hemorrhage/chemically induced*;Drug Interactions;Fatal Outcome;Ginkgo biloba/adverse effects*;Humans;Ibuprofen/administration & dosage;Ibuprofen/adverse effects*;Male;Plant Extracts/adverse effects*;Risk Assessment
12825970;Blood Coagulation/drug effects*;Cardiovascular Diseases/drug therapy;Contraindications;Drug Interactions;Drugs, Chinese Herbal*/therapeutic use;Female;Humans;International Normalized Ratio;Male;Middle Aged;Patient Education as Topic;Surveys and Questionnaires*;Warfarin/therapeutic use*
12845387;Adult;Area Under Curve;Cardiotonic Agents/pharmacokinetics*;Cross-Over Studies;Digoxin/pharmacokinetics*;Drug Interactions;Female;Ginkgo biloba*;Half-Life;Humans;Male;Metabolic Clearance Rate;Plant Preparations/pharmacology*
12891227;Adult;Alprazolam/pharmacokinetics;Area Under Curve;Biotransformation;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/pharmacokinetics;Dietary Supplements*;Female;Garlic*;Half-Life;Humans;Isoenzymes/metabolism;Male;Sulfinic Acids/metabolism
12906366;Caffeine/administration & dosage;Caffeine/pharmacokinetics;Caffeine/pharmacology*;Capsules;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/pharmacokinetics;Central Nervous System Stimulants/pharmacology*;Cytochrome P-450 CYP1A2/metabolism*;Female;Humans;Male;Melatonin/blood*;Reference Values
12908854;Administration, Oral;Adult;Area Under Curve;Body Weight/drug effects*;Body Weight/physiology;Caffeine/metabolism*;Ciprofloxacin/blood;Ciprofloxacin/pharmacokinetics*;Ciprofloxacin/urine;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Drug Interactions*;Female;Fleroxacin/blood;Fleroxacin/pharmacokinetics*;Fleroxacin/urine;Humans;Male;Sex Factors
12915954;Administration, Oral;Adolescent;Adult;Area Under Curve;Caffeine/blood;Caffeine/pharmacokinetics*;Caffeine/pharmacology*;Coffee;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Double-Blind Method;Drug Interactions;Female;Half-Life;Heart Rate/drug effects;Humans;Menthol/administration & dosage;Menthol/pharmacology*;Middle Aged;Time Factors
12921244;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Adult;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Digoxin/pharmacokinetics*;Female;Food-Drug Interactions*;Genes, MDR;Genotype;Humans;Intestines/metabolism*;Male
12940502;Adult;Behavior Control/psychology*;Caffeine/antagonists & inhibitors;Caffeine/pharmacology*;Central Nervous System Depressants/antagonists & inhibitors*;Central Nervous System Depressants/blood;Central Nervous System Depressants/pharmacology*;Central Nervous System Stimulants/antagonists & inhibitors;Central Nervous System Stimulants/pharmacology*;Cues;Dose-Response Relationship, Drug;Ethanol/antagonists & inhibitors*;Ethanol/blood;Ethanol/pharmacology*;Female;Humans;Male;Mental Processes/drug effects;Reaction Time/drug effects;Surveys and Questionnaires
12942422;Adult;Brain Death/diagnosis*;Drug Interactions;Ergotamine/poisoning*;Ergotamine/therapeutic use*;Female;HIV Infections/drug therapy;Humans;Ritonavir/therapeutic use*
12959294;Adult;Citrus*;Cyclosporine/blood*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Dose-Response Relationship, Drug;Enzyme Inhibitors/blood*;Female;Humans;Immunosuppressive Agents/blood*;Male;Middle Aged;Plant Extracts/administration & dosage
12971031;Adult;Animals;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics*;Beverages;Calcium, Dietary/administration & dosage*;Citrus;Cross-Over Studies;Edible Grain;Fasting;Female;Food, Fortified*;Food-Drug Interactions*;Humans;Levofloxacin*;Male;Middle Aged;Milk;Ofloxacin/administration & dosage;Ofloxacin/blood;Ofloxacin/pharmacokinetics*;Therapeutic Equivalency
13309332;Anti-Bacterial Agents*;Cations*;Ions*;Metals*;Tetracycline*;Tetracyclines*
13358299;Alcoholic Intoxication*;Ethanol*;Humans;Hydroxylamines/pharmacology*;Oximes*
13359661;Amphetamine/analogs & derivatives;Amphetamines*;Caffeine/pharmacology*;Dextroamphetamine*;Ethanol/pharmacology*;Humans;Male
13811223;Antipsychotic Agents*;Humans;Tranquilizing Agents/toxicity*
13855374;Agaricales/chemistry*;Coprinus*;Disulfiram/chemistry*;Vegetables*
14088308;Hypertension*;Monoamine Oxidase Inhibitors*
14100187;Cerebral Hemorrhage*;Cheese*;Headache*;Hypertension*;Syndrome*;Toxicology*;Tranylcypromine*;Trifluoperazine*
14132623;Dihydroxyphenylalanine*;Fabaceae*;Headache*;Hypertension*;Monoamine Oxidase Inhibitors*;Oxidoreductases*;Pargyline*;Toxicology*;Vegetables*
14172385;Cheese*;Medical Records*;Monoamine Oxidase Inhibitors*;Oxidoreductases*;Toxicology*
14214493;Drug Industry*;Legislation, Medical*;Pharmaceutical Preparations*;Physicians*;United States;United States Food and Drug Administration*
14254960;Antidepressive Agents*;Central Nervous System Stimulants*;Drug Therapy*;Imipramine*;Iproniazid*;Pharmacology*;Toxicology*
14280527;Animals;Anxiety*;Anxiety Disorders*;Drug Therapy*;Fishes*;Hypersensitivity, Immediate*;Seafood*;Toxicology*;Tranylcypromine*;Trifluoperazine*;Tyramine*
14498173;Chlortetracycline/analogs & derivatives;Demeclocycline*;Gastrointestinal Tract/pharmacology*
14567065;Anesthesia;Angiotensin I/antagonists & inhibitors;Angiotensin I/pharmacology;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Animals;Aorta, Thoracic/drug effects;Aorta, Thoracic/metabolism;Berberine/pharmacology*;Blood Pressure/drug effects;Blood Vessels/drug effects;Blood Vessels/metabolism;Blood Vessels/physiology*;Colorimetry;Cyclic AMP/metabolism;Cyclic AMP/physiology*;Dose-Response Relationship, Drug;Endothelium, Vascular/physiology;In Vitro Techniques;Isometric Contraction/drug effects;Male;Muscle Relaxation/drug effects;Muscle, Smooth, Vascular/drug effects;Nitric Oxide/metabolism;Nitric Oxide/physiology*;Rats;Rats, Sprague-Dawley;Vasoconstrictor Agents/pharmacology
14595580;Administration, Oral;Animals;Area Under Curve;Dose-Response Relationship, Drug;Drug Interactions;Drugs, Chinese Herbal*;Infusions, Intravenous;Male;Medicine, Chinese Traditional;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/blood;Plant Extracts/pharmacokinetics;Plant Extracts/pharmacology*;Plant Extracts/therapeutic use;Plant Roots;Platelet Aggregation/drug effects*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacology*;Rats;Rats, Wistar;Thrombocytopenia/drug therapy;Ticlopidine/blood;Ticlopidine/pharmacology*
14612100;Adolescent;Adult;Beverages*;Child;Citrus paradisi*;Cross-Over Studies;Cyclosporine/blood*;Cyclosporine/therapeutic use;Female;Humans;Immunosuppressive Agents/blood;Immunosuppressive Agents/therapeutic use;Iran;Kidney Transplantation/immunology;Kidney Transplantation/physiology*;Male;Middle Aged;Placebos
14616409;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Voriconazole
14616429;Administration, Oral;Adolescent;Adult;Caffeine/pharmacology*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism*;Drug Combinations;Female;Heterozygote;Homozygote;Humans;Male;Melatonin/administration & dosage;Melatonin/pharmacokinetics*
14629295;Cimicifuga/adverse effects;Creatinine/blood;Female;Graft Rejection/etiology;Graft Rejection/physiopathology*;Herbal Medicine*;Humans;Kidney/pathology;Kidney Transplantation;Medicago sativa/adverse effects;Middle Aged;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*
14653226;Adult;Benzodiazepines/administration & dosage;Benzodiazepines/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Tolerance;Fasting;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Random Allocation;Therapeutic Equivalency;Time Factors
14663456;Adult;Alprazolam/pharmacokinetics*;Androgen Antagonists/administration & dosage;Androgen Antagonists/pharmacology*;Anti-Anxiety Agents/pharmacokinetics*;Antitussive Agents/metabolism*;Area Under Curve;Cytochrome P-450 CYP2D6/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Dextromethorphan/metabolism*;Dose-Response Relationship, Drug;Drug Interactions;Female;Half-Life;Humans;Male;Metabolic Clearance Rate;Plant Extracts/pharmacology*;Serenoa
14684645;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Fatal Outcome;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced;Heart Diseases/chemically induced;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Male;Pericardium;Vaccinium macrocarpon*;Warfarin/adverse effects*
14713367;Adult;Aryl Hydrocarbon Hydroxylases/metabolism*;Caffeine/metabolism;Caffeine/pharmacology;Cytochrome P-450 CYP1A2/metabolism*;Cytochrome P-450 CYP3A;Drugs, Chinese Herbal/pharmacology*;Enzyme Activation/drug effects;Female;Humans;Male;Oxidoreductases, N-Demethylating/metabolism*;Xanthine Oxidase/metabolism*
14717783;Adult;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects*;Blood Coagulation Disorders/blood;Blood Coagulation Disorders/drug therapy*;Body Composition;Dietary Supplements*;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Humans;Male;Middle Aged;Regression Analysis;Treatment Outcome;Vitamin K/administration & dosage*;Vitamin K/blood;Warfarin/therapeutic use*
14725610;Adult;Antipsychotic Agents/blood*;Antipsychotic Agents/metabolism;C-Reactive Protein/metabolism;Caffeine/administration & dosage;Caffeine/pharmacology*;Clozapine/blood*;Clozapine/metabolism;Coffee*;Cross-Over Studies;Cytochrome P-450 CYP1A2 Inhibitors;Female;Hospitalization;Humans;Male;Middle Aged
14742762;Aged;Anticoagulants/therapeutic use*;Drug Interactions;Epistaxis/etiology*;Female;Ginger/adverse effects*;Humans;International Normalized Ratio;Phenprocoumon/therapeutic use*
14749695;Administration, Oral;Adult;Area Under Curve;Caffeine/administration & dosage;Caffeine/pharmacokinetics;Cytochrome P-450 Enzyme System/drug effects*;Dextromethorphan/administration & dosage;Dextromethorphan/pharmacokinetics;Echinacea*;Female;Herb-Drug Interactions;Humans;Infusions, Intravenous;Male;Midazolam/administration & dosage;Midazolam/pharmacokinetics;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/pharmacology*;Plant Roots;Reference Values;Tolbutamide/administration & dosage;Tolbutamide/pharmacokinetics
14765835;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Beverages*;Food-Drug Interactions*;Humans;Male;Reference Values;Vaccinium macrocarpon*;Warfarin/blood;Warfarin/pharmacology*
14981197;Adult;Anticholesteremic Agents/adverse effects*;Anticholesteremic Agents/pharmacokinetics;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacology;Female;Furocoumarins/adverse effects;Furocoumarins/pharmacology;Humans;Hyperlipoproteinemia Type II/drug therapy;Inactivation, Metabolic;Rhabdomyolysis/chemically induced*;Simvastatin/adverse effects*;Simvastatin/pharmacokinetics
15001969;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Biological Availability;Celiprolol/antagonists & inhibitors*;Celiprolol/blood;Celiprolol/pharmacokinetics*;Celiprolol/urine;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Receptors, Adrenergic, beta/metabolism;Statistics, Nonparametric
15001970;Adolescent;Adult;Analysis of Variance;Area Under Curve;Aryl Hydrocarbon Hydroxylases/blood;Aryl Hydrocarbon Hydroxylases/metabolism*;Catalysis/drug effects;Cross-Over Studies;Cytochrome P-450 CYP2C19;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/blood;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions/physiology;Humans;Hydroxylation/drug effects;Hypericum/physiology*;Male;Mixed Function Oxygenases/blood;Mixed Function Oxygenases/metabolism*;Omeprazole/blood;Omeprazole/metabolism*;Plant Extracts/pharmacology;Sulfoxides/blood;Sulfoxides/metabolism
15025743;Adult;Anticholesteremic Agents/pharmacokinetics*;Atorvastatin Calcium;Beverages;Citrus*;Cross-Over Studies;Drug Combinations;Drug Therapy, Combination;Heptanoic Acids/pharmacokinetics*;Humans;Male;Pravastatin/pharmacokinetics*;Pyrroles/pharmacokinetics*
15025748;Adult;Arylamine N-Acetyltransferase/metabolism*;Caffeine/metabolism;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism*;Female;Humans;Hydrocortisone/urine;Hypericum*;Male;Middle Aged;Xanthine Oxidase/metabolism*
15060505;Adolescent;Adult;Area Under Curve;Biological Availability;Blood Pressure/drug effects;Caffeine/administration & dosage*;Caffeine/pharmacokinetics*;Cardiovascular System/drug effects*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects*;Central Nervous System Stimulants/pharmacokinetics;Confidence Intervals;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Drug Interactions;Ephedrine/administration & dosage*;Ephedrine/pharmacokinetics*;Female;Heart Rate/drug effects;Hemodynamics/drug effects;Humans;Male;Middle Aged;Risk Assessment;Sensitivity and Specificity
15060508;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions*;Half-Life;Humans;Hypericum*;Intestinal Absorption/drug effects*;Jejunum/drug effects;Jejunum/physiology;Male;Perfusion;Phytotherapy*;Plant Preparations/administration & dosage*;Sensitivity and Specificity;Verapamil/administration & dosage;Verapamil/pharmacokinetics*
15089812;Analysis of Variance;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Cross-Over Studies;Herb-Drug Interactions;Humans;Hypericum*;International Normalized Ratio;Male;Panax*;Plant Extracts/pharmacology*;Platelet Aggregation/drug effects;Prothrombin Time;Warfarin/analogs & derivatives*;Warfarin/blood;Warfarin/pharmacokinetics*;Warfarin/pharmacology;Warfarin/urine
15098799;2-Hydroxypropyl-beta-cyclodextrin;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Beverages*;Biological Availability;Citrus paradisi*;Cross-Over Studies;Cyclodextrins;Female;Food-Drug Interactions*;Humans;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Pharmaceutical Solutions;beta-Cyclodextrins*
15121490;Administration, Oral;Anticoagulants/pharmacology*;Blood Coagulation/drug effects*;Case-Control Studies;Cross-Over Studies;Diet*;Drug Monitoring;Female;Food-Drug Interactions*;Humans;Logistic Models;Male;Middle Aged;Multivariate Analysis;Observation;Phenprocoumon/pharmacology;Prospective Studies;Vitamin K/pharmacology*;Warfarin/pharmacology
15151167;Acetaminophen/pharmacokinetics*;Adult;Beverages*;Food-Drug Interactions/physiology;Hibiscus*;Humans;Male;Plant Extracts/isolation & purification;Plant Extracts/pharmacokinetics;Water/metabolism
15169710;Adult;Anaphylaxis/chemically induced;Cyclohexanols/adverse effects*;Cyclohexanols/therapeutic use;Depressive Disorder/drug therapy;Drug Interactions;Drug Therapy, Combination;Drugs, Chinese Herbal/adverse effects*;Drugs, Chinese Herbal/therapeutic use;Female;Humans;Phytotherapy/adverse effects*;Serotonin Syndrome/chemically induced*;Venlafaxine Hydrochloride;Ziziphus/adverse effects*
15176651;Adult;Aged;Anti-Arrhythmia Agents/blood*;Antidiarrheals/blood*;Apocynaceae/chemistry*;Digitoxin/blood;Digoxin/blood;False Positive Reactions;Female;Glycosides/blood*;Half-Life;Herb-Drug Interactions;Humans;Male;Pilot Projects;Plant Extracts/blood;Plant Roots/chemistry
15179409;Adolescent;Adult;Area Under Curve;Chemistry, Pharmaceutical;Confidence Intervals;Digoxin/pharmacokinetics*;Double-Blind Method;Drug Interactions;Female;Humans;Hypericum/metabolism*;Male;Plant Extracts/administration & dosage;Plant Extracts/pharmacokinetics;Powders;Tablets, Enteric-Coated;Tea/metabolism
15186565;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Attitude to Health;Blood Coagulation Disorders/chemically induced*;Drug Interactions;Female;Humans;Male;Phytotherapy/adverse effects*;Plant Preparations/administration & dosage;Plant Preparations/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
15206993;Adult;Anticholesteremic Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Simvastatin/analogs & derivatives*;Simvastatin/metabolism;Simvastatin/pharmacokinetics*
15223879;Adult;Antitubercular Agents/adverse effects*;Cheese/adverse effects*;Drug Hypersensitivity/etiology*;Drug Therapy, Combination;Female;Humans;Mastitis/drug therapy*;Milk Hypersensitivity/etiology*;Mycobacterium tuberculosis;Tuberculosis, Multidrug-Resistant/drug therapy*
15229464;Adult;Area Under Curve;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/physiology;Female;Humans;Male;Metabolic Clearance Rate;Methadone/pharmacokinetics*;Middle Aged;Stereoisomerism
15231565;Adult;Anticoagulants/administration & dosage;Anticoagulants/therapeutic use*;Biological Availability;Brassica;Dietary Supplements;Dose-Response Relationship, Drug;Drug Antagonism;Drug Stability;Female;Humans;International Normalized Ratio;Male;Osteocalcin/blood;Prothrombin/analysis;Spinacia oleracea;Vitamin K/administration & dosage;Vitamin K/pharmacology*
15238367;Adult;Anticoagulants/pharmacokinetics;Anticoagulants/pharmacology*;Area Under Curve;Drug Interactions;Female;Humans;International Normalized Ratio;Male;Panax/adverse effects*;Phytotherapy/adverse effects*;Plant Preparations/adverse effects*;Warfarin/pharmacokinetics;Warfarin/pharmacology*
15292490;Adult;Aloe/adverse effects*;Anesthetics, Inhalation/adverse effects*;Drug Interactions;Female;Humans;Methyl Ethers/adverse effects*;Plant Preparations/adverse effects;Postoperative Hemorrhage/chemically induced*
15307118;Adult;Dietary Supplements;Drug Interactions;Drug Resistance/drug effects*;Female;Humans;International Normalized Ratio;Morinda/adverse effects*;Plant Preparations/adverse effects;Vitamin K/adverse effects;Warfarin*/therapeutic use
15329598;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/pharmacology*;Antibiotics, Antitubercular/pharmacology;Antiemetics/pharmacology;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages;Chromatography, High Pressure Liquid;Citrus;Cross-Over Studies;Cytochrome P-450 CYP3A;Drug Interactions;Female;Fentanyl/administration & dosage;Fentanyl/analogs & derivatives*;Fentanyl/blood;Fentanyl/pharmacokinetics*;Fentanyl/pharmacology*;Food-Drug Interactions;Half-Life;Humans;Intestines/enzymology*;Liver/enzymology*;Male;Oxidoreductases, N-Demethylating/metabolism*;Pupil/drug effects;Rifampin/pharmacology;Spectrometry, Mass, Electrospray Ionization;Troleandomycin/pharmacology
15344253;Dementia/prevention & control*;Ginkgo biloba*;Phytotherapy*
15372129;Adult;Antidepressive Agents/blood;Antidepressive Agents/pharmacokinetics*;Area Under Curve;Carbamazepine/pharmacology*;Chromatography, High Pressure Liquid;Cimetidine/pharmacology*;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Double-Blind Method;Drug Interactions;Enzyme Inhibitors/pharmacology*;Humans;Hypericum;Perylene/analogs & derivatives*;Perylene/blood;Perylene/pharmacokinetics*;Time Factors
15449760;Acetaminophen/adverse effects;Aged;Analgesics, Non-Narcotic/adverse effects;Anticoagulants/adverse effects*;Drug Interactions;Female;Ginger/adverse effects;Gingival Hemorrhage/etiology*;Hematuria/etiology*;Humans;International Normalized Ratio;Phytotherapy/adverse effects;Warfarin/adverse effects*
15470332;Adult;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects;Antidepressive Agents/chemistry;Antidepressive Agents/pharmacology*;Area Under Curve;Bridged Bicyclo Compounds;Cross-Over Studies;Cyclosporine/pharmacokinetics*;Drug Interactions;Female;Humans;Hypericum*;Immunosuppressive Agents/pharmacokinetics*;Kidney Transplantation;Male;Middle Aged;Phloroglucinol/analogs & derivatives;Phytotherapy*;Plant Extracts/administration & dosage;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Terpenes/analysis*
15506876;Adolescent;Adult;Affect/drug effects*;Affect/physiology;Alcohol Drinking/blood*;Analysis of Variance;Blood Glucose/drug effects*;Blood Glucose/metabolism;Cognition/drug effects*;Cognition/physiology;Dietary Sucrose/blood;Dietary Sucrose/pharmacology*;Female;Food/statistics & numerical data;Humans;Time Factors
15521566;Administration, Oral;Aged;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Fruit;Humans;Hypoglycemia/blood;Hypoglycemic Agents/isolation & purification;Hypoglycemic Agents/therapeutic use*;Middle Aged;Momordica charantia*;Phytotherapy/methods*;Plant Extracts/administration & dosage;Plant Extracts/isolation & purification
15521893;Acetamides/administration & dosage*;Acetamides/pharmacology;Administration, Oral;Adult;Blood Pressure/drug effects*;Body Mass Index;Cross-Over Studies;Humans;Infusions, Intravenous;Linezolid;Male;Middle Aged;Moclobemide/administration & dosage;Moclobemide/pharmacology*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/pharmacology*;Oxazolidinones/administration & dosage*;Oxazolidinones/pharmacology;Tyramine/administration & dosage;Tyramine/pharmacology*
15536458;Adrenergic Agents/pharmacokinetics;Adult;Caffeine/pharmacokinetics;Central Nervous System Stimulants/pharmacokinetics;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cytochrome P-450 Enzyme System/metabolism*;Debrisoquin/pharmacokinetics;Dietary Supplements;Drug Interactions;Echinacea/chemistry*;Female;GABA Modulators/pharmacokinetics;Humans;Isoenzymes/metabolism;Kinetics;Male;Midazolam/pharmacokinetics;Milk Thistle/chemistry*;Phenotype;Plant Extracts/administration & dosage;Plant Extracts/chemistry*;Serenoa;Solubility
15581264;Administration, Oral;Adult;Area Under Curve;Cross-Over Studies;Cyclosporine/administration & dosage;Cyclosporine/pharmacokinetics*;Drug Interactions;Flavonoids/administration & dosage;Flavonoids/pharmacology*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics*;Infusions, Intravenous;Male;Quercetin/administration & dosage;Quercetin/pharmacology*
15592321;Anticoagulants/adverse effects;Anticoagulants/analysis*;Blood Coagulation/drug effects;Coumarins/adverse effects;Coumarins/analysis*;Dietary Supplements/adverse effects;Dietary Supplements/analysis*;Humans;Mass Spectrometry;Medicago/chemistry;Plants/chemistry
15592332;Adult;Area Under Curve;Biological Availability;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Calcium Channel Blockers/pharmacology*;Capsules;Chromatography, High Pressure Liquid;Citrus/chemistry*;Cross-Over Studies;Delayed-Action Preparations;Felodipine/pharmacokinetics;Felodipine/pharmacology*;Female;Food-Drug Interactions*;Furocoumarins/administration & dosage;Furocoumarins/pharmacology*;Humans;Male;Spectrophotometry, Ultraviolet
15608563;Adult;Aryl Hydrocarbon Hydroxylases/blood;Aryl Hydrocarbon Hydroxylases/metabolism*;Asian Continental Ancestry Group;Cytochrome P-450 CYP2C19;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/pharmacology*;Ginkgo biloba*;Herb-Drug Interactions*;Humans;Male;Mixed Function Oxygenases/blood;Mixed Function Oxygenases/metabolism*;Omeprazole/analogs & derivatives*;Omeprazole/blood;Omeprazole/pharmacokinetics;Omeprazole/pharmacology*;Omeprazole/urine;Pharmacogenetics*;Plant Extracts/pharmacology;Time Factors
15635366;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Blood Pressure/drug effects*;Cheese;Depression/drug therapy;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Nutrition Policy*;Tyramine/administration & dosage*;United States
15655860;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Herb-Drug Interactions*;Humans;Panax/adverse effects*;Warfarin/administration & dosage;Warfarin/adverse effects*
15673597;Animals;Anticonvulsants/pharmacokinetics*;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism*;Beverages*;Carbamazepine/pharmacokinetics*;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP3A;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Oxidoreductases, N-Demethylating/metabolism*;Punicaceae*;Rats;Rats, Wistar;Spectrophotometry, Ultraviolet
15735611;Administration, Oral;Adult;Area Under Curve;Biological Availability;Citrus paradisi/physiology*;Cross-Over Studies;Drinking;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Organic Anion Transporters/chemistry;Organic Anion Transporters/metabolism*;Peptides/chemistry;Peptides/metabolism*;Terfenadine/administration & dosage;Terfenadine/analogs & derivatives*;Terfenadine/blood;Terfenadine/pharmacokinetics*;Water/metabolism;Water/pharmacology
15735617;Area Under Curve;Canada;Celecoxib;Child;Clinical Trials, Phase I as Topic;Dietary Fats/administration & dosage;Dietary Fats/pharmacokinetics;Drug Administration Schedule;Food*;Humans;Pilot Projects;Pyrazoles/administration & dosage;Pyrazoles/metabolism;Pyrazoles/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/metabolism;Sulfonamides/pharmacokinetics*;Time Factors
15801937;Administration, Oral;Adult;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology;Area Under Curve;Cross-Over Studies;Ginger/metabolism*;Ginkgo biloba/metabolism*;Herb-Drug Interactions*;Humans;International Normalized Ratio;Male;Platelet Aggregation/drug effects;Protein Binding/drug effects;Warfarin/pharmacokinetics*;Warfarin/pharmacology
15856409;Adult;Alprazolam/blood;Alprazolam/pharmacokinetics;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics;Area Under Curve;Caffeine/blood;Caffeine/pharmacokinetics;Cardiotonic Agents/blood;Cardiotonic Agents/pharmacokinetics;Central Nervous System Stimulants/blood;Central Nervous System Stimulants/pharmacokinetics;Digoxin/blood;Digoxin/pharmacokinetics;Double-Blind Method;Drug Interactions;Female;Humans;Hypericum*;Hypoglycemic Agents/blood;Hypoglycemic Agents/pharmacokinetics;Male;Middle Aged;Phytotherapy*;Plant Extracts/pharmacology*;Tolbutamide/blood;Tolbutamide/pharmacokinetics;Treatment Outcome
15886802;Adult;Aged;Aged, 80 and over;Anticoagulants/pharmacology*;Atrial Fibrillation/drug therapy*;Blood Coagulation;Diet*;Drug Interactions;Female;Humans;International Normalized Ratio;Male;Middle Aged;Nutritional Status;Time Factors;Treatment Outcome;Venous Thrombosis/drug therapy*;Vitamin K/pharmacology*;Warfarin/pharmacology
15900287;Adult;Aryl Hydrocarbon Hydroxylases/drug effects*;Aryl Hydrocarbon Hydroxylases/genetics*;Caffeine/pharmacology;Capsules;Cimicifuga/chemistry;Cimicifuga/metabolism*;Dietary Supplements;Drug Administration Schedule;Female;Herb-Drug Interactions/physiology;Humans;Hydrastis/chemistry;Hydrastis/metabolism*;Kava/chemistry;Kava/metabolism*;Male;Midazolam/pharmacology;Patient Selection;Phenotype*;Time Factors;Valerian/chemistry*;Valerian/metabolism
15900292;Carcinogens, Environmental/adverse effects*;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Female;Forecasting;Humans;Kava/chemistry*;Male;Medicine, East Asian Traditional*;New Caledonia/ethnology;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics*;Self Administration;Time Factors;Up-Regulation;Water
15901751;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Area Under Curve;Aryl Hydrocarbon Hydroxylases/genetics*;Aryl Hydrocarbon Hydroxylases/metabolism;Aryl Hydrocarbon Hydroxylases/pharmacology;Beverages*;Chromatography, High Pressure Liquid/methods;Citrus paradisi*;Cross-Over Studies;Cytochrome P-450 CYP2C19;Female;Genotype;Half-Life;Humans;Lansoprazole;Male;Mixed Function Oxygenases/genetics*;Mixed Function Oxygenases/metabolism;Mixed Function Oxygenases/pharmacology;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives*;Omeprazole/blood;Omeprazole/metabolism;Omeprazole/pharmacokinetics;Plant Extracts/administration & dosage;Plant Extracts/chemistry;Plant Extracts/pharmacokinetics*;Water/administration & dosage;Water/chemistry
15903127;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Beverages*;Blotting, Western;Citrus paradisi*;Duodenum/metabolism;Food-Drug Interactions*;Genes, MDR/genetics;Humans;Male;Propanolamines/blood;Propanolamines/pharmacokinetics*;Propanolamines/urine;RNA, Messenger/analysis
15983823;Adrenergic beta-Antagonists/blood;Adrenergic beta-Antagonists/pharmacokinetics*;Adrenergic beta-Antagonists/urine;Adult;Area Under Curve;Atenolol/blood;Atenolol/pharmacokinetics*;Atenolol/urine;Beverages*;Biological Availability;Blood Pressure/drug effects;Citrus sinensis*;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Heart Rate/drug effects;Humans;Male;Metabolic Clearance Rate
16062162;Adrenal Cortex Hormones/therapeutic use;Analgesics, Opioid/therapeutic use;Dietary Supplements/adverse effects*;Herb-Drug Interactions*;Herbal Medicine*;Humans;Neoplasms/drug therapy*;Neoplasms/surgery;Practice Guidelines as Topic*;Preoperative Care
16100300;Adult;Anti-Inflammatory Agents, Non-Steroidal/chemistry;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Biological Availability;Chemistry, Pharmaceutical;Female;Food-Drug Interactions*;Humans;Ibuprofen/analogs & derivatives*;Ibuprofen/chemistry;Ibuprofen/pharmacokinetics*;Intestinal Absorption;Lysine/analogs & derivatives*;Lysine/pharmacokinetics;Male;Middle Aged;Pharmaceutic Aids;Povidone;Solubility;Tablets;Therapeutic Equivalency
16116693;Alkalosis/chemically induced*;Antacids/adverse effects*;Bicarbonates/blood;Calcium Carbonate/adverse effects*;Drug Labeling;Female;Histamine H2 Antagonists/therapeutic use;Humans;Hypercalcemia/chemically induced*;Pregnancy/blood;Pregnancy Complications/chemically induced*;Proton Pump Inhibitors;Reference Values
16120075;Adult;Beverages;Biological Availability;Citrus*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Thyroxine/blood;Thyroxine/pharmacokinetics*
16122283;Absorption;Administration, Oral;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Aza Compounds/administration & dosage;Aza Compounds/blood;Aza Compounds/pharmacokinetics*;Biological Availability;Enteral Nutrition*;Female;Fluoroquinolones;Humans;Intubation, Gastrointestinal;Male;Quinolines/administration & dosage;Quinolines/blood;Quinolines/pharmacokinetics*;Suspensions;Tablets
16133554;Adult;Antidiarrheals/pharmacology;Berberine/pharmacology*;Cyclosporine/blood;Cyclosporine/pharmacokinetics*;Drug Interactions;Female;Humans;Kidney Transplantation*;Male;Medicine, Chinese Traditional;Middle Aged
16203421
16221754;Administration, Oral;Adult;Area Under Curve;Cimicifuga*;Clarithromycin/administration & dosage;Clarithromycin/pharmacokinetics;Dietary Supplements;Digoxin/antagonists & inhibitors;Digoxin/blood;Digoxin/pharmacokinetics*;Drug Administration Schedule;Female;Genes, MDR/genetics;Half-Life;Haplotypes/genetics;Herb-Drug Interactions;Humans;Male;Milk Thistle*;Plant Preparations/administration & dosage;Plant Preparations/pharmacology*;Rifampin/administration & dosage;Rifampin/pharmacokinetics;Rifampin/urine
16236039;Adult;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cross-Over Studies;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Enzyme Inhibitors/pharmacokinetics*;Food-Drug Interactions/physiology;Heptanoic Acids/pharmacokinetics*;Humans;Male;Pyrroles/pharmacokinetics*;Quinolines/pharmacokinetics*
16261361;Adult;Antimalarials/pharmacology*;Antinematodal Agents/pharmacology*;Area Under Curve;Artemisinins/pharmacology*;Caffeine/pharmacokinetics;Chromatography, High Pressure Liquid;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Female;Humans;Male;Mass Spectrometry;Middle Aged;Theophylline/metabolism;Thiabendazole/metabolism;Thiabendazole/pharmacology*
16305592;Acebutolol/analogs & derivatives;Acebutolol/blood*;Acebutolol/urine;Adrenergic beta-Antagonists/blood*;Adrenergic beta-Antagonists/urine;Adult;Anti-Arrhythmia Agents/blood;Anti-Arrhythmia Agents/urine;Antihypertensive Agents/therapeutic use;Beverages*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Hemodynamics/drug effects;Humans;Male
16388930;Acetamides/administration & dosage;Acetamides/blood*;Acetamides/pharmacokinetics*;Adipose Tissue/metabolism;Administration, Oral;Aged;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/blood*;Anti-Bacterial Agents/pharmacokinetics*;Extracellular Fluid/metabolism;Female;Food;Humans;Intestinal Absorption;Linezolid;Male;Microdialysis;Middle Aged;Muscle, Skeletal/metabolism;Oxazolidinones/administration & dosage;Oxazolidinones/blood*;Oxazolidinones/pharmacokinetics*;Pilot Projects;Tissue Distribution
16412477;Adult;Animals;Beverages;Biological Availability;Blotting, Western;Carrier Proteins/metabolism;Citrus sinensis/chemistry*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Female;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Intestines/drug effects;Intestines/metabolism;Male;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Organic Anion Transporters, Sodium-Independent/biosynthesis;Organic Anion Transporters, Sodium-Independent/genetics;Pravastatin/pharmacokinetics*;RNA, Messenger/biosynthesis;RNA, Messenger/genetics;Rats;Rats, Sprague-Dawley;Reverse Transcriptase Polymerase Chain Reaction;Simvastatin/pharmacokinetics
16413247;Adult;Algorithms;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Antifungal Agents/blood;Antifungal Agents/pharmacology*;Area Under Curve;Beverages;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Interactions;Female;Fluconazole/blood;Fluconazole/pharmacology*;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Tea*;Vaccinium macrocarpon*;Vitis*
16416305;Adult;Analysis of Variance;Area Under Curve;Aryl Hydrocarbon Hydroxylases/metabolism;Benzodiazepines/blood;Benzodiazepines/metabolism;Benzodiazepines/pharmacokinetics*;Beverages*;Chromatography, High Pressure Liquid;Citrus paradisi/chemistry*;Cross-Over Studies;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Dose-Response Relationship, Drug;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/metabolism;Hypnotics and Sedatives/pharmacokinetics*;Male;Metabolic Clearance Rate;Time Factors;Triazolam/blood;Triazolam/metabolism;Triazolam/pharmacokinetics*
16428919;Adult;Aryl Hydrocarbon Hydroxylases/metabolism*;Cytochrome P-450 CYP2C9;Diclofenac/pharmacokinetics*;Drug Synergism;Female;Ginkgo biloba*;Herb-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes, Liver/metabolism;Plant Extracts/pharmacokinetics;Tolbutamide/pharmacokinetics*
16484565;Adult;Aged;Anticoagulants/therapeutic use*;Blood Pressure/drug effects*;Double-Blind Method;Drug Interactions;Female;Garlic*;Humans;Hypercholesterolemia/drug therapy;Male;Middle Aged;Pilot Projects;Placebos;Plant Extracts/therapeutic use*;Safety;Thrombosis/drug therapy;Warfarin/therapeutic use*
16541194;Adult;Berberine/pharmacology*;Biological Availability;Cyclosporine/pharmacokinetics*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Inhibitors/pharmacology*;Gastric Emptying/drug effects;Humans;Intestine, Small/enzymology;Liver/enzymology;Male
16636327;Aged;Anticoagulants/adverse effects*;Beverages;Female;Herb-Drug Interactions*;Humans;Matricaria/adverse effects*;Ointments;Warfarin/adverse effects*
16704760;Cardiac Glycosides/therapeutic use*;Cardiotonic Agents/therapeutic use*;Chromatography, Thin Layer;Digoxin/therapeutic use*;Drug Interactions;Drug Monitoring*;Fluorescence Polarization Immunoassay;Humans;Immunoassay;Plantago/metabolism*
16772772;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Drug Synergism;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Hypoprothrombinemias/chemically induced*;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
16923466;Beverages*;Creatine Kinase/blood;Fluorobenzenes/therapeutic use;Follow-Up Studies;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hyperlipoproteinemia Type II/diet therapy;Hyperlipoproteinemia Type II/drug therapy;Male;Middle Aged;Punicaceae/adverse effects*;Pyrimidines/therapeutic use;Rhabdomyolysis/enzymology;Rhabdomyolysis/etiology*;Rosuvastatin Calcium;Sulfonamides/therapeutic use
16941417;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Blood Coagulation/drug effects;Blood Coagulation/physiology*;Female;Humans;International Normalized Ratio;Male;Middle Aged;Prospective Studies;Prothrombin Time;Statistics, Nonparametric;Vitamin K/administration & dosage*;Warfarin/blood;Warfarin/pharmacology*
17016323
17018502;Antacids/adverse effects;Calcium/adverse effects;Calcium/blood;Creatinine/blood;Diagnosis, Differential;Female;Gastroesophageal Reflux/drug therapy;Gestational Age;Humans;Hypercalcemia/chemically induced;Hypercalcemia/complications;Hypercalcemia/diagnosis*;Pregnancy;Pregnancy Complications/diagnosis*;Renal Insufficiency*
17062300;Acetaminophen/administration & dosage;Acetaminophen/therapeutic use*;Acute Disease;Administration, Oral;Adult;Analgesia/methods*;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/therapeutic use*;Double-Blind Method;Drug Combinations;Female;Follow-Up Studies;Humans;Male;Pain/drug therapy*;Pain/etiology;Pain/physiopathology;Pain Measurement;Pharyngitis/complications;Pharyngitis/drug therapy*;Pharyngitis/physiopathology;Sodium Bicarbonate/administration & dosage;Sodium Bicarbonate/therapeutic use*;Treatment Outcome
17079360;Adult;Cardiotonic Agents/pharmacokinetics*;Clarithromycin/pharmacology;Cytochrome P-450 CYP2D6 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Digoxin/pharmacokinetics*;Drug Interactions;Female;Herb-Drug Interactions*;Humans;Hydrastis*;Kava*;Male;Rifampin/pharmacology
17089110;Administration, Oral;Adolescent;Adult;Biometry;Caffeine/administration & dosage;Caffeine/metabolism*;Cohort Studies;Cytochrome P-450 CYP1A2/genetics;Cytochrome P-450 CYP1A2/metabolism*;Environmental Pollutants/chemistry;Environmental Pollutants/metabolism;Environmental Pollutants/poisoning;Female;Genotype;Humans;Male;Methylation;Middle Aged;Polychlorinated Biphenyls/chemistry;Polychlorinated Biphenyls/metabolism;Polychlorinated Biphenyls/poisoning*;Sex Factors;Smoking/metabolism;Uracil/analogs & derivatives;Uracil/metabolism;Uric Acid/analogs & derivatives;Uric Acid/metabolism;Xanthines/metabolism
17546822;Acute Kidney Injury/etiology*;Female;Humans;Hypercalcemia/complications;Hypercalcemia/etiology*;Middle Aged;Nephritis, Interstitial/etiology*;Sarcoidosis, Pulmonary/complications*
17641611;Antioxidants/therapeutic use*;Arteriosclerosis Obliterans/drug therapy*;Arteriosclerosis Obliterans/physiopathology*;Atherosclerosis;Chronic Disease;Humans;Lower Extremity/blood supply*;Plant Extracts/therapeutic use;Vasodilator Agents/therapeutic use
18226589;Automation*;Blood Proteins/analysis*;Calibration;Chemical Precipitation;Chromatography, Liquid/methods*;Reference Standards;Tandem Mass Spectrometry/methods*
20238900;Blood*;Blood Coagulation*;Humans;Prothrombin*;Quinine*;Sulfates*
20301621
21010059;Antifibrinolytic Agents*;Blood*;Heparin Antagonists*;Humans;Naphthoquinones*;Prothrombin*;Quinine/pharmacology*;Retinoids*;Vitamin K*;Vitamins*
21090491;Animals;Ethanol/blood*;Female;Male;Milk*
22282124
25032445
8347123;Acetaldehyde/blood;Aldehyde Dehydrogenase/antagonists & inhibitors*;Animals;Biotransformation;Cytochrome P-450 Enzyme System/metabolism*;Hydroxylamine;Hydroxylamines/pharmacology;Microsomes, Liver/enzymology*;NADP;Nitriles/metabolism;Oximes/metabolism*;Oximes/pharmacology;Oxygen;Rats
12098842;Acetaminophen/chemistry*;Acetaminophen/pharmacokinetics;Analgesics, Non-Narcotic/chemistry*;Analgesics, Non-Narcotic/pharmacokinetics;Chemistry, Pharmaceutical;Excipients/chemistry*;Humans;Models, Biological;Sodium Bicarbonate/chemistry*;Solubility;Tablets
14255341;Agaricales*;Alcoholic Beverages*;Alcohols*;Beer*;Disulfiram*;Foodborne Diseases*;Postoperative Complications*;Toxicology*;Vegetables*
3677487;Adult;Ethanol/blood*;Humans;Male;Metabolic Clearance Rate/drug effects;Panax*;Plants, Medicinal*
54620;Amino Acids/blood*;Blood-Brain Barrier/drug effects;Histidine/blood;Humans;Levodopa/pharmacology;Levodopa/therapeutic use*;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Phenylalanine/blood;Tryptophan/blood
477711;Adult;Biological Availability;Female;Food*;Half-Life;Humans;Intestinal Absorption;Kinetics;Male;Phenytoin/blood;Phenytoin/metabolism*;Time Factors
819224;Adult;Dextropropoxyphene/administration & dosage;Dextropropoxyphene/blood;Dextropropoxyphene/pharmacology*;Dietary Carbohydrates/adverse effects;Dietary Fats/adverse effects;Dietary Proteins/adverse effects;Drinking*;Eating*;Fasting;Humans;Intestinal Absorption;Male;Time Factors
872489;Administration, Oral;Adult;Biological Availability;Canrenone/blood*;Food*;Humans;Kinetics;Male;Pregnadienes/blood*;Spironolactone/administration & dosage;Spironolactone/metabolism*;Time Factors
1151647;Adult;Biological Availability;Emulsions;Griseofulvin/administration & dosage*;Humans;Male;Oils;Suspensions;Tablets;Time Factors;Water;Zea mays
1389940;Dietary Proteins/administration & dosage*;HIV Infections/metabolism*;Half-Life;Humans;Kidney/physiopathology;Male;Zidovudine/pharmacokinetics*
1482370;Animals;Aorta;Cattle;Cell Adhesion/drug effects;Cell Adhesion/physiology*;Cell Line;Cells, Cultured;Endothelium, Vascular/physiology*;Fatty Acids, Nonesterified/pharmacology*;Female;Humans;Kinetics;Lipolysis*;Lipoprotein Lipase/metabolism*;Lipoproteins/blood;Lipoproteins/isolation & purification;Lipoproteins/pharmacology*;Lipoproteins, HDL/blood;Lipoproteins, HDL/isolation & purification;Lipoproteins, HDL/pharmacology;Lipoproteins, LDL/blood;Lipoproteins, LDL/isolation & purification;Lipoproteins, LDL/pharmacology;Lipoproteins, VLDL/blood;Lipoproteins, VLDL/isolation & purification;Lipoproteins, VLDL/pharmacology;Milk/enzymology;Monocytes/physiology*;Oleic Acid;Oleic Acids/pharmacology*;Swine
1487562;Adult;Cephalosporins/pharmacokinetics*;Drug Interactions;Fasting/metabolism;Food*;Gastrointestinal Motility/drug effects*;Half-Life;Humans;Isomerism;Kidney Tubules/drug effects*;Kidney Tubules/secretion;Male;Metabolic Clearance Rate;Metoclopramide/pharmacology*;Middle Aged;Probenecid/pharmacology*;Propantheline/pharmacology*
1622413;Administration, Oral;Adult;Biological Availability;Eating/physiology*;Fasting/physiology;Humans;Intestinal Absorption;Male;Methotrexate/administration & dosage;Methotrexate/adverse effects;Methotrexate/blood*;Middle Aged;Reference Values
1742694;Diabetes Mellitus, Type 2/complications;Diabetes Mellitus, Type 2/therapy*;Diet, Diabetic*;Humans;Hyperlipidemias/complications;Hyperlipidemias/therapy;Hypoglycemic Agents/therapeutic use*;Insulin/administration & dosage
1814735;Administration, Oral;Adult;Biological Availability;Bromocriptine/administration & dosage;Bromocriptine/adverse effects;Bromocriptine/blood;Bromocriptine/pharmacokinetics*;Food*;Humans;Male;Metoclopramide/pharmacology*;Radioimmunoassay
1820900;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/pharmacokinetics*;Biological Availability;Drug Combinations;Female;Food*;Half-Life;Humans;Lansoprazole;Magnesium Hydroxide/pharmacology;Male;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives*;Omeprazole/pharmacokinetics;Tablets, Enteric-Coated
1914362;Acquired Immunodeficiency Syndrome/drug therapy;Acquired Immunodeficiency Syndrome/metabolism*;Administration, Oral;Biological Availability;Delayed-Action Preparations;Didanosine/administration & dosage;Didanosine/blood;Didanosine/pharmacokinetics*;Ganciclovir/pharmacology*;Humans;Injections, Intravenous;Powders;Ranitidine/pharmacology*;Solutions;Tablets
1934863;Administration, Oral;Adult;Biological Availability;Chromatography, High Pressure Liquid;Didanosine/blood;Didanosine/pharmacokinetics*;Didanosine/urine;Food*;HIV Seropositivity/metabolism;Half-Life;Humans;Male
2060570;Acquired Immunodeficiency Syndrome/blood;Acquired Immunodeficiency Syndrome/metabolism*;Adult;Biological Availability;Eating;Fasting/metabolism;Female;Humans;Male;Middle Aged;Time Factors;Zidovudine/blood;Zidovudine/pharmacokinetics*
2221865;Absorption;Administration, Oral;Adult;Biological Availability;Body Fluids/physiology;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics;Food*;Humans;Infusions, Intravenous;Intestinal Absorption;Male;Random Allocation;Reference Values
2286418;Adult;Biological Availability;Female;Griseofulvin/administration & dosage;Griseofulvin/blood;Griseofulvin/pharmacokinetics*;Humans;Male;Spectrometry, Fluorescence;Tablets
2328299;Administration, Oral;Adolescent;Adult;Biological Availability;Delayed-Action Preparations;Diltiazem/administration & dosage;Diltiazem/analogs & derivatives;Diltiazem/blood;Diltiazem/metabolism;Diltiazem/pharmacokinetics*;Drug Administration Schedule;Food;Humans;Male;Middle Aged
2350441;Acquired Immunodeficiency Syndrome/drug therapy*;Acquired Immunodeficiency Syndrome/metabolism;Administration, Oral;Dietary Fats/administration & dosage;Food;Humans;Intestinal Absorption;Male;Zidovudine/administration & dosage*;Zidovudine/pharmacokinetics
2401752;Administration, Oral;Adult;Antacids/pharmacology*;Biological Availability;Drug Administration Schedule;Fasting/blood;Food*;Humans;Intestinal Absorption/drug effects*;Male;Random Allocation;Ticlopidine/administration & dosage;Ticlopidine/adverse effects;Ticlopidine/blood;Ticlopidine/pharmacokinetics*
2528959;Adult;Amlodipine;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Capsules;Food*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/analogs & derivatives*;Nifedipine/blood;Nifedipine/pharmacokinetics;Solutions
2530802;Administration, Oral;Adult;Aluminum Hydroxide/administration & dosage*;Animals;Antidepressive Agents/pharmacokinetics*;Clinical Trials as Topic;Dietary Fats/administration & dosage;Feeding Behavior*;Humans;Intestinal Absorption/drug effects*;Male;Milk;Paroxetine;Piperidines/pharmacokinetics*;Serotonin Antagonists/pharmacokinetics*
2557183;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology;Bicarbonates/pharmacology;Ceftizoxime/administration & dosage;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Esters;Fasting;Food*;Gastric Acid/secretion;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Male;Molecular Structure;Pentagastrin/pharmacology;Prodrugs/administration & dosage;Prodrugs/pharmacokinetics*;Randomized Controlled Trials as Topic;Ranitidine/pharmacology;Regression Analysis;Sodium/pharmacology;Sodium Bicarbonate;Stomach/drug effects;Stomach/metabolism*
2648188;Aged;Amino Acids/blood;Carbidopa/therapeutic use;Clinical Trials as Topic;Dietary Proteins*;Drug Combinations;Humans;Levodopa/therapeutic use*;Middle Aged;Parkinson Disease/diet therapy;Parkinson Disease/drug therapy*;Parkinson Disease/physiopathology
2688391;Animals;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/classification;Anti-Arrhythmia Agents/pharmacokinetics;Anti-Arrhythmia Agents/therapeutic use*;Arrhythmias, Cardiac/drug therapy;Arrhythmias, Cardiac/metabolism;Arrhythmias, Cardiac/physiopathology;Chemistry, Pharmaceutical/trends*;Electrophysiology;Half-Life;Humans;Kinetics
2702064;Administration, Oral;Adolescent;Biological Availability;Child;Child, Preschool;Drug Administration Schedule;Fasting;Female;Food;Hodgkin Disease/blood;Hodgkin Disease/drug therapy;Humans;Intestinal Absorption;Male;Mercaptopurine/administration & dosage;Mercaptopurine/blood;Mercaptopurine/pharmacokinetics*;Mercaptopurine/therapeutic use;Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
2775616;Adult;Antimalarials/administration & dosage;Antimalarials/pharmacokinetics*;Fasting;Food*;Half-Life;Humans;Male;Phenanthrenes/administration & dosage;Phenanthrenes/pharmacokinetics*
2791448;Administration, Oral;Adult;Aged;Dietary Fats/pharmacology*;Fasting;Female;Humans;Intestinal Absorption/drug effects*;Male;Middle Aged;Morphine/administration & dosage;Morphine/blood;Morphine/pharmacokinetics*;Morphine/therapeutic use;Pain/drug therapy*
2860234;Adult;Biological Availability;Dietary Fats/pharmacology*;Griseofulvin/analogs & derivatives;Griseofulvin/metabolism*;Griseofulvin/urine;Humans;Male
2977392;Acitretin;Administration, Oral;Adult;Biological Availability;Diet;Food;Humans;Male;Tretinoin/administration & dosage;Tretinoin/analogs & derivatives*;Tretinoin/blood;Tretinoin/pharmacokinetics
2994705;Administration, Oral;Antineoplastic Combined Chemotherapy Protocols/pharmacology*;Biological Availability;Carcinoma, Small Cell/metabolism*;Drug Interactions;Etoposide/administration & dosage;Etoposide/metabolism*;Food*;Humans;Kinetics;Lung Neoplasms/metabolism*;Podophyllotoxin/analogs & derivatives*
3094570;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology*;Biological Availability;Chromatography, Gas;Eating*;Flecainide/administration & dosage;Flecainide/metabolism*;Half-Life;Humans;Injections, Intravenous;Kinetics;Male;Time Factors
3153245;Administration, Oral;Adolescent;Biological Availability;Child;Child, Preschool;Eating;Fasting;Female;Food*;Humans;Infant;Intestinal Absorption;Male;Mercaptopurine/administration & dosage;Mercaptopurine/blood;Mercaptopurine/pharmacokinetics*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy*;Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism
3203716;Administration, Oral;Adolescent;Adult;Cefixime;Cefotaxime/analogs & derivatives*;Cefotaxime/blood;Cefotaxime/pharmacokinetics;Cefotaxime/urine;Fasting*;Food*;Humans;Male
3377466;Administration, Oral;Adult;Biological Availability;Ceftizoxime*/analogs & derivatives*;Cephalosporins/administration & dosage;Cephalosporins/pharmacokinetics*;Chromatography, High Pressure Liquid;Fasting;Humans;Infusions, Intravenous;Male;Protein Binding;Random Allocation
3427209;Adult;Biological Availability;Cefuroxime/administration & dosage;Cefuroxime/analogs & derivatives*;Cefuroxime/blood;Cefuroxime/pharmacokinetics;Cefuroxime/urine;Cephalosporins*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Food*;Humans;Male;Prodrugs/pharmacokinetics;Random Allocation
3503594;Biological Availability;Delayed-Action Preparations;Humans;Intestinal Absorption;Nifedipine/administration & dosage;Nifedipine/blood;Nifedipine/pharmacokinetics*;Osmosis;Tablets
3595068;Administration, Oral;Adolescent;Adult;Dietary Carbohydrates/pharmacology*;Dietary Fats/pharmacology*;Humans;Intestinal Absorption;Kinetics;Male;Nifedipine/metabolism*
3609121;Absorption;Adult;Biological Availability;Female;Food*;Galactans/pharmacology*;Humans;Male;Mannans/pharmacology*;Middle Aged;Plant Gums;Trimethoprim/metabolism*
3632369;Amino Acids/blood*;Carbidopa/therapeutic use;Dietary Proteins/pharmacology*;Female;Humans;Levodopa/blood;Levodopa/therapeutic use*;Male;Middle Aged;Parkinson Disease/blood;Parkinson Disease/drug therapy*
3709617;Adult;Biological Availability;Diuresis/drug effects;Food*;Furosemide/metabolism;Furosemide/pharmacology*;Humans;Kinetics;Male
3757164;Administration, Oral;Adult;Aged;Biological Availability;Child;Food*;Humans;Mercaptopurine/administration & dosage;Mercaptopurine/metabolism*;Middle Aged;Pilot Projects
3763312;Adolescent;Adult;Child;Drug Interactions;Epilepsy/blood;Female;Food, Formulated/adverse effects*;Humans;Male;Middle Aged;Phenytoin/blood*
3769384;Adolescent;Adult;Biological Availability;Canrenone/metabolism;Fasting;Female;Food*;Humans;Kinetics;Male;Middle Aged;Spironolactone/metabolism*
3823614;Administration, Oral;Adolescent;Child;Child, Preschool;Female;Food*;Humans;Kinetics;Male;Methotrexate/blood;Methotrexate/metabolism*;Sex Factors
3841130;Adult;Animals;Dietary Carbohydrates/pharmacology*;Dietary Fats/pharmacology*;Drug Administration Schedule;Etretinate/administration & dosage;Etretinate/adverse effects;Etretinate/metabolism*;Fasting;Humans;Intestinal Absorption;Kinetics;Male;Middle Aged;Milk*;Random Allocation
3895624;Absorption;Administration, Oral;Adolescent;Adult;Biological Availability;Cyclosporins/administration & dosage*;Cyclosporins/metabolism;Drug Administration Schedule;Female;Food*;Humans;Kidney Transplantation;Kinetics;Male;Middle Aged
3948305;Absorption;Administration, Oral;Aged;Biological Availability;Chromatography, High Pressure Liquid;Fasting;Female;Food*;Humans;Injections, Intravenous;Kinetics;Male;Melphalan/administration & dosage;Melphalan/blood;Melphalan/metabolism*;Melphalan/therapeutic use;Middle Aged;Neoplasms/drug therapy
4386950;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacology*;Anti-Bacterial Agents/urine;Clinical Trials as Topic;Diarrhea/etiology;Erythromycin/pharmacology;Haemophilus influenzae/drug effects;Humans;Injections, Intramuscular;Intestinal Absorption;Lincomycin/administration & dosage;Lincomycin/adverse effects;Lincomycin/blood;Lincomycin/pharmacology*;Lincomycin/urine;Male;Mycoplasma/drug effects;Nausea/etiology;Neisseria gonorrhoeae/drug effects;Neisseria meningitidis/drug effects;Staphylococcus/drug effects;Streptococcus/drug effects;Streptococcus pneumoniae/drug effects;Tetracycline/pharmacology
4436447;Administration, Oral;Biopharmaceutics;Cephalosporins/administration & dosage;Cephalosporins/adverse effects;Cephalosporins/blood;Cephalosporins/metabolism*;Cephalosporins/pharmacology;Cephalosporins/urine;Cyclohexanes/administration & dosage;Cyclohexanes/adverse effects;Cyclohexanes/analogs & derivatives;Cyclohexanes/blood;Food*;Humans;Injections, Intramuscular;Male;Probenecid/pharmacology*;Sarcina/drug effects;Time Factors
4572702;Amino Acids/administration & dosage;Calcium, Dietary/administration & dosage;Clinical Trials as Topic;Diet*;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Dihydroxyphenylalanine/metabolism;Dihydroxyphenylalanine/therapeutic use*;Humans;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Vitamins/administration & dosage
4812154;Adolescent;Adult;Biopharmaceutics;Diuretics/pharmacology;Fasting;Furosemide/metabolism*;Humans;Injections, Intravenous;Intestinal Absorption;Kinetics;Middle Aged;Solutions;Sulfur Radioisotopes;Tablets;Time Factors
4932544;Age Factors;Alkaline Phosphatase/blood;Amantadine/administration & dosage;Amantadine/adverse effects;Amantadine/metabolism;Amantadine/therapeutic use*;Blood Glucose/analysis;Blood Urea Nitrogen;Clinical Trials as Topic;Dihydroxyphenylalanine/therapeutic use;Dopamine/metabolism;European Continental Ancestry Group;Female;Humans;L-Lactate Dehydrogenase/blood;Lactose/administration & dosage;Male;Parasympatholytics/therapeutic use;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Parkinson Disease/enzymology;Placebos;Sex Factors;Time Factors;Uric Acid/urine
4951792;Absorption;Administration, Oral;Adult;Humans;Injections, Intramuscular;Injections, Intravenous;Lincomycin/pharmacokinetics*;Lincomycin/pharmacology;Lincomycin/urine;Male;Microbial Sensitivity Tests
5664330;Adult;Biological Assay;Blood Bactericidal Activity;Capsules;Fats;Humans;Lincomycin/administration & dosage;Lincomycin/blood;Lincomycin/metabolism*;Lincomycin/urine;Male;Tablets
5776857;Absorption;Dosage Forms;Kinetics;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/metabolism;Pharmacology*;Receptors, Drug/drug effects
6107590;Administration, Oral/methods;Adolescent;Age Factors;Child;Child, Preschool;Eating;Fasting;Food*;Humans;Intestinal Absorption;Leukemia, Lymphoid/blood;Leukemia, Lymphoid/drug therapy*;Leukemia, Lymphoid/metabolism;Methotrexate/administration & dosage;Methotrexate/blood;Methotrexate/metabolism*;Milk Proteins/administration & dosage
6233379;Acitretin;Animals;Darier Disease/blood;Darier Disease/drug therapy*;Etretinate/blood*;Etretinate/therapeutic use;Humans;Milk/adverse effects*;Psoriasis/blood;Psoriasis/drug therapy*;Tretinoin/analogs & derivatives;Tretinoin/blood;Water/administration & dosage
6374280;Administration, Oral;Adult;Blood Pressure/drug effects;Clinical Trials as Topic;Eating;Fasting;Female;Heart Rate/drug effects;Hemodynamics/drug effects*;Humans;Kinetics;Male;Myocardial Contraction/drug effects;Nifedipine/administration & dosage*;Nifedipine/blood
6582073;Adult;Analysis of Variance;Biological Availability;Eating*;Fasting;Humans;Isotretinoin;Male;Tretinoin/blood;Tretinoin/metabolism*
6643696;Adult;Biological Availability;Diet;Food*;Humans;Kinetics;Male;Rifampin/administration & dosage;Rifampin/metabolism*;Triticum
6678756;Adult;Blood Pressure/drug effects;Canrenone/metabolism;Creatinine/blood;Female;Food*;Heart Rate/drug effects;Humans;Hypertension/physiopathology;Male;Middle Aged;Potassium/blood;Sodium/blood;Spironolactone/blood;Spironolactone/pharmacology*
6723758;Administration, Oral;Adult;Biological Availability;Female;Food;Furosemide/administration & dosage;Furosemide/metabolism*;Humans;Injections, Intravenous;Intestinal Absorption;Kinetics;Male;Models, Biological
6831825;Absorption;Adult;Antacids/pharmacology*;Chromatography, High Pressure Liquid;Copper/urine;Drug Interactions;Ferrous Compounds/pharmacology*;Food*;Humans;Iron/pharmacology*;Male;Penicillamine/metabolism*;Random Allocation;Spectrophotometry, Atomic
6842493;Adult;Biological Availability;Eating*;Fasting;Food;Humans;Male;Penicillamine/metabolism*
7097474;Adult;Biological Availability;Food*;Griseofulvin/administration & dosage;Griseofulvin/metabolism*;Humans;Kinetics;Male;Middle Aged;Particle Size;Polyethylene Glycols;Solubility;Tablets
7273605;Adult;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Eating/drug effects;Fasting;Female;Half-Life;Humans;Kinetics;Male;Metabolic Clearance Rate/drug effects;Penicillamine/administration & dosage;Penicillamine/blood;Penicillamine/metabolism*;Penicillamine/urine
7312923;Adult;Dietary Fats/pharmacology*;Griseofulvin/administration & dosage;Griseofulvin/metabolism*;Griseofulvin/urine;Humans;Intestinal Absorption;Middle Aged;Tablets;Time Factors
7628834;Administration, Oral;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Diltiazem/administration & dosage*;Diltiazem/pharmacokinetics*;Drug Administration Schedule;Eating*;Humans;Male;Time Factors
7657851;Adult;Ceftizoxime/analogs & derivatives*;Ceftizoxime/pharmacokinetics;Cross-Over Studies;Diet, Atherogenic;Food*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Prodrugs/pharmacokinetics*;Time Factors
7695323;Administration, Oral;Adult;Ceftizoxime/analogs & derivatives*;Ceftizoxime/blood;Ceftizoxime/pharmacokinetics;Chromatography, High Pressure Liquid;Cross-Over Studies;Fasting;Food;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Prodrugs/pharmacokinetics*
7787134;Adult;Cross-Over Studies;Delayed-Action Preparations;Female;Food;Furosemide/administration & dosage;Furosemide/pharmacokinetics*;Humans;Male
7965657;Absorption;Administration, Oral;Adult;Antacids/pharmacology*;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Drug Interactions;Fasting;Food;Humans;Male;Ondansetron/administration & dosage*;Ondansetron/pharmacokinetics*;Ondansetron/pharmacology;Solutions;Tablets
8257138;Acquired Immunodeficiency Syndrome/blood;Acquired Immunodeficiency Syndrome/drug therapy;Acquired Immunodeficiency Syndrome/metabolism*;Administration, Oral;Adult;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Eating/physiology*;Fasting/blood;Fasting/metabolism;Fasting/urine;Female;Humans;Male;Middle Aged;Zidovudine/blood;Zidovudine/pharmacokinetics*;Zidovudine/therapeutic use
8366182;Administration, Oral;Adult;Biological Availability;Chromatography, High Pressure Liquid;Didanosine/administration & dosage;Didanosine/blood;Didanosine/pharmacokinetics*;Eating;Fasting/blood;Food*;HIV Seropositivity/metabolism*;Humans;Male;Mastication;Tablets;Time Factors
8700059;Algorithms*;Decision Trees*;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Nursing Assessment;Phenytoin/adverse effects*
8750736;Animals;Arginine/analogs & derivatives*;Arginine/pharmacology;Cells, Cultured;Enzyme Inhibitors/pharmacology*;Female;Leishmaniasis/drug therapy;Leishmaniasis/enzymology;Lysine/analogs & derivatives*;Lysine/pharmacology;Macrophages/enzymology;Mice;Mice, Inbred C57BL;Nitric Oxide Synthase/antagonists & inhibitors*;omega-N-Methylarginine
8830979;Adult;Analysis of Variance;Blood Chemical Analysis;Blood Pressure/physiology;Cross-Over Studies;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/blood;Dopamine Agonists/pharmacokinetics*;Dopamine Agonists/urine;Eating*;Electrocardiography;Ergolines/administration & dosage;Ergolines/adverse effects;Ergolines/blood;Ergolines/pharmacokinetics*;Ergolines/urine;Fasting;Half-Life;Heart Rate/physiology;Humans;Male;Radioimmunoassay
8901078;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Male;Middle Aged;Nausea/chemically induced;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*
8951200;Food;Humans;Morphine/administration & dosage;Morphine/pharmacokinetics*;Narcotics/pharmacokinetics*;Tablets
8971430;Adult;Area Under Curve;Biological Availability;Bumetanide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Diuretics/pharmacokinetics*;Food-Drug Interactions*;Furosemide/pharmacokinetics*;Humans;Intestinal Absorption;Male
9152568;Adolescent;Adult;Analgesics, Opioid/adverse effects;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Capsules;Delayed-Action Preparations;Fasting;Food*;Half-Life;Humans;Intestinal Absorption;Male;Morphine/adverse effects;Morphine/blood;Morphine/pharmacokinetics*
9459045;Adolescent;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Confidence Intervals;Cross-Over Studies;Eating;Fasting;Female;Follow-Up Studies;Food*;Gastric Emptying;Humans;Male;Middle Aged;Omeprazole/administration & dosage;Omeprazole/blood;Omeprazole/pharmacokinetics*;Pylorus/physiology;Tablets, Enteric-Coated;Therapeutic Equivalency;Time Factors
9602956;Administration, Oral;Adult;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics*;Biological Availability;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Cross-Over Studies;Dietary Fats/administration & dosage*;Food-Drug Interactions*;Humans;Male;Tetrazoles/blood;Tetrazoles/pharmacokinetics*
9725481;Adult;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacokinetics;Dihydropyridines/adverse effects;Dihydropyridines/metabolism;Dihydropyridines/pharmacokinetics*;Double-Blind Method;Food-Drug Interactions*;Humans;Male
9950630;Aged;Dystonia/complications*;Dystonia/physiopathology;Electromyography;Facial Pain/etiology*;Facial Pain/physiopathology;Humans;Male;Mouth/innervation*;Trigeminal Nerve/physiopathology*
10442207;Adult;Analgesics, Opioid/administration & dosage*;Analgesics, Opioid/blood;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Delayed-Action Preparations;Humans;Intestinal Absorption;Male;Tramadol/administration & dosage*;Tramadol/blood;Tramadol/pharmacokinetics*
10991886;Adult;Antiplatyhelmintic Agents/administration & dosage;Antiplatyhelmintic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Diet;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Half-Life;Humans;Middle Aged;Praziquantel/administration & dosage;Praziquantel/pharmacokinetics*;Tablets
11865964;Adult;Analysis of Variance;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacokinetics;Eating/physiology*;Endothelin Receptor Antagonists*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Receptors, Endothelin/physiology;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
12240782;2-Pyridinylmethylsulfinylbenzimidazoles;Adult;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics*;Area Under Curve;Beverages;Biological Availability;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Female;Food*;Half-Life;Humans;Lansoprazole;Male;Middle Aged;Omeprazole/administration & dosage;Omeprazole/analogs & derivatives;Omeprazole/blood;Omeprazole/pharmacokinetics*
12520629;Administration, Oral;Adolescent;Adult;Biological Availability;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Sex Factors;Sodium Oxybate/administration & dosage;Sodium Oxybate/adverse effects;Sodium Oxybate/pharmacokinetics*;Solutions
12820815;Animals;Anti-Ulcer Agents/chemistry*;Beverages*;Capsules;Citrus sinensis;Dairy Products*;Drug Stability;Esomeprazole/chemistry*;Food-Drug Interactions*;Gastric Acid/chemistry;Hydrochloric Acid/chemistry;Malus;Milk;Yogurt
13882411;Diet*;Fats*;Gastrointestinal Absorption*;Griseofulvin/metabolism*;Humans;Intestinal Absorption*;Nutrition Assessment*
14078408;Dermatomycoses*;Griseofulvin*;Humans;Mycoses*
14331943;Adolescent;Anti-Bacterial Agents*;Bacteria*;Child;Drug Resistance*;Drug Resistance, Microbial*;Drug Therapy*;Humans;Infant;Lincomycin*;Pharmacology*;Staphylococcus*;Streptococcus*;Streptococcus pneumoniae*;Toxicology*
14527091;Analysis of Variance;Area Under Curve;Biological Availability;Cefaclor/blood;Cefaclor/pharmacokinetics*;Cross-Over Studies;Diet, Vegetarian*;Dietary Fats/blood;Dietary Fats/pharmacokinetics*;Fasting/blood;Fasting/metabolism*;Food-Drug Interactions/physiology*;Humans;Male;Statistics, Nonparametric
14748822;Administration, Oral;Adolescent;Adult;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Male;Middle Aged;Tablets;Triazoles/blood;Triazoles/pharmacokinetics*
15230341;Adult;Area Under Curve;Biological Availability;Cefaclor/administration & dosage*;Cefaclor/pharmacokinetics*;Cephalosporins/administration & dosage*;Cephalosporins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diet, Fat-Restricted;Diet, Vegetarian;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Linear Models;Male;Oryza;Triticum
15561466;Analysis of Variance;Animals;Dose-Response Relationship, Drug;Drinking/drug effects;Drinking/physiology;Drug Interactions;Eating/drug effects;Male;Morphine/adverse effects*;Morphine Dependence/etiology*;Naloxone/therapeutic use;Narcotic Antagonists/therapeutic use;Narcotics/adverse effects*;Rats;Rats, Wistar;Substance Withdrawal Syndrome/drug therapy*;Substance Withdrawal Syndrome/physiopathology;Sucrose/therapeutic use*;Sweetening Agents/therapeutic use*
16459878;Catheterization*;Enteral Nutrition/instrumentation*;Enteral Nutrition/methods*;Equipment Design;Humans
16490803;Absorption;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/pharmacology;Drug Monitoring;Energy Intake;Fasting;Female;Food;Food-Drug Interactions*;Humans;Male;Nucleosides/administration & dosage;Nucleosides/blood;Nucleosides/pharmacokinetics*;Pyrimidinones/administration & dosage;Pyrimidinones/blood;Pyrimidinones/pharmacokinetics*;Thymidine/analogs & derivatives
16490807;Adsorption;Adult;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Carbon/pharmacology*;Cross-Over Studies;Dietary Fats;Drug Administration Schedule;Drug Interactions;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Agents/pharmacology*;Humans;Imidazoles/blood;Imidazoles/pharmacokinetics*;Losartan/blood;Losartan/pharmacokinetics*;Male;Oxides/pharmacology*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Time Factors
16579391;Adult;Analgesics*;Animals;Humans;Infant;Sucrose/pharmacology*
22454900
